Citrus Sinensis ID: 036483
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 721 | 2.2.26 [Sep-21-2011] | |||||||
| Q8VYA3 | 769 | Wall-associated receptor | yes | no | 0.841 | 0.789 | 0.416 | 1e-136 | |
| Q9M092 | 786 | Wall-associated receptor | no | no | 0.855 | 0.784 | 0.434 | 1e-133 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.895 | 0.860 | 0.418 | 1e-132 | |
| Q7X8C5 | 748 | Wall-associated receptor | no | no | 0.536 | 0.517 | 0.554 | 1e-132 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.854 | 0.843 | 0.424 | 1e-131 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.472 | 0.430 | 0.622 | 1e-128 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.536 | 0.508 | 0.547 | 1e-127 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.583 | 0.534 | 0.553 | 1e-127 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.837 | 0.827 | 0.407 | 1e-125 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.518 | 0.489 | 0.582 | 1e-124 |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 485 bits (1249), Expect = e-136, Method: Compositional matrix adjust.
Identities = 291/699 (41%), Positives = 418/699 (59%), Gaps = 92/699 (13%)
Query: 38 YPFGIGEGCYFDKSFEVFCDNSSGSPKPLLKSINLNML-LNF--VFQK------GLIAVE 88
YPFGIG GCY +K +E+ C N+S P L IN ++ ++F ++++ G I +
Sbjct: 38 YPFGIGTGCYLEKWYEIICVNNS---VPFLSIINREVVSISFSDMYRRFFNVGYGSIRIR 94
Query: 89 APVISLNSSKSMGNAKG--VNLTGTPFSFSQKNNKFTTAGCDSYAKLNQKNDSSNSGKCQ 146
P+ S S S G G +N+TG PF + NN GC++ A L N + C+
Sbjct: 95 NPIASKGCS-SGGQEFGSLLNMTGYPF-YLGDNNMLIAVGCNNTASLT--NVEPSIVGCE 150
Query: 147 SVCTCDPTQYADCCDLLCTVPPNTKVFDT----------------------NSSYKYYQS 184
S TC Q D L + N + D+ + +Y Q
Sbjct: 151 S--TCSTNQDIPINDYLGVLYCNARYGDSEYCKNISIMNDTSCNGIGCCKASLPARYQQI 208
Query: 185 IPQE----------CSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEY 234
I E C V F+ ++E+ +N ++ L L W + T +
Sbjct: 209 IGVEIDDSNTESKGCKVAFITDEEYFLSN-GSDPERLHANGYDTVDLRW--FIHTANHSF 265
Query: 235 NSHTKMCNKDNHCLLQLGTGHF---CLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGY 291
+ D + +L+ + CLCDY STT+G+ C G+
Sbjct: 266 IGSLGCKSIDEYTILRRDNREYGIGCLCDYN--------------STTTGYATCSCASGF 311
Query: 292 YLSSY-------------NSDQEPLCS--RSTQLTFG---KKSRNKYIVIGCTSGGFGML 333
+ Y D P+C+ + L G + + ++ +VIG ++ F L
Sbjct: 312 EGNPYIPGECKDINECVRGIDGNPVCTAGKCVNLLGGYTCEYTNHRPLVIGLSTS-FSTL 370
Query: 334 CLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETAT 393
+ G +W+YKF++R+ + K+KFFKRNGGLLLQQ+L +TEGN+D +++F S+ELE AT
Sbjct: 371 VFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKAT 430
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
++++ RILG+GGQGTVYKGML DGRIVA+KKSKV+DE K++EFINEV ILSQINHRN+V
Sbjct: 431 ENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIV 490
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPI-TWEIRLRIAIEVSDAVSYLHSA 512
KLLGCCLET+VP+LVYEFI NG LF++LHD ++++ + TWE+RLRIA++++ A+SYLHSA
Sbjct: 491 KLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSA 550
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
AS PIYHRDIKSTNI+LD K+RAKVSDFG SR++ +D TH+TT V GT GY+DPEYF+SS
Sbjct: 551 ASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSS 610
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632
+FT+KSDVYSFGVVLAEL+TGE+++ +E ++LA YF AMKE+ L +I+DA +
Sbjct: 611 QFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDG 670
Query: 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
+ AK+ +CLN+ G+KRP+M++V++ L I++
Sbjct: 671 CKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9M092|WAKLM_ARATH Wall-associated receptor kinase-like 17 OS=Arabidopsis thaliana GN=WAKL17 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 475 bits (1223), Expect = e-133, Method: Compositional matrix adjust.
Identities = 298/686 (43%), Positives = 402/686 (58%), Gaps = 69/686 (10%)
Query: 38 YPFGIGEGCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVFQK---GLIAVEAPVISL 94
YPFGIG+GCY +KS+E+ C N+SG P L I+ ++ + + G + V +P+ S
Sbjct: 49 YPFGIGKGCYLEKSYEIECLNTSGKLVPFLSVISKEVVSIHLPGRQSFGSVRVRSPITSA 108
Query: 95 N-SSKSMGNAKGVNLTGTPFSFSQKNNKFTTAGCDSYAKLNQKND----------SSNSG 143
SS +A +NLT +PF S NN GC S L ++N+
Sbjct: 109 GCSSDGKDSAPVMNLTDSPFFVSDINN-LVGVGCSSKVSLEHIKQNMVGCELNCSTTNAS 167
Query: 144 KCQSVCTCDPT------QYADCC------DLLC--------TVP--PNTKVFDTNSSYKY 181
S+ D T +A C D+ C ++P P + S
Sbjct: 168 DSNSIPFFDKTGCSFSYTFAQVCTGNKPEDMGCDGRGCCQASLPREPQQVIGIRIESNDG 227
Query: 182 YQSIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYNSHTKMC 241
+ +C V F+ + E+ + T L + L W + T NS
Sbjct: 228 KSTTSGDCRVAFLTD-EFFSLSKLTKPEQLHAKRYATLSLGW-IMQTRNTSFVNSLACKI 285
Query: 242 NKDNHCLLQLGTGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSD-- 299
KD C+CDYT S I S NC EC GY + Y+SD
Sbjct: 286 RKDTDTAYSNDQSIKCICDYTMS----------IISDIRYANC-ECNLGYKGNPYDSDGC 334
Query: 300 -------QEPLCSRSTQLTFGKKS-------RNKYIVIGCTSGGFGMLCLLTGAWWMYKF 345
+ P + T + + K I+IG +G FG+L L+ G WW+ KF
Sbjct: 335 RDIDECKENPKYCKETDTCVNFEGGYRCVGDKTKAIMIGAGTG-FGVLVLVGGVWWLRKF 393
Query: 346 LKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQG 405
L ++ K+KFFKRNGGLLLQQEL + +G ++K+++FTSKELE AT++++ NR+LG G
Sbjct: 394 LVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVLGHG 453
Query: 406 GQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465
GQGTVYKGML DGR VA+KKSKVIDE K+ EFINEV ILSQINHR+VVKLLGCCLETEVP
Sbjct: 454 GQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVP 513
Query: 466 LLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524
+LVYEFIING LF+++H++ +++ + W +RLRIA++++ A+SYLHSAAS PIYHRDIKS
Sbjct: 514 ILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKS 573
Query: 525 TNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFG 584
TNILLD KYRAKV+DFG SRS+ IDQTH TT + GT GY+DPEY+RSS++TEKSDVYSFG
Sbjct: 574 TNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFG 633
Query: 585 VVLAELLTGER-AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643
V+LAEL+TG++ I V N +E +LA +F AMKE L +I+DA + ++ E ++ VA
Sbjct: 634 VILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVAN 693
Query: 644 LTNRCLNLNGKKRPTMKEVAVVLAGI 669
L +CL+ G+ RP M+EV L I
Sbjct: 694 LAMKCLSSRGRNRPNMREVFTELERI 719
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 473 bits (1218), Expect = e-132, Method: Compositional matrix adjust.
Identities = 295/705 (41%), Positives = 417/705 (59%), Gaps = 59/705 (8%)
Query: 8 VLLEIILL-----LCTIDASEPLMCDQCGDFGSD---DYPFGIGE-GCYFDKSFEVFCDN 58
VLL I+ L L T S P C +PFGIG C+ + +EV C++
Sbjct: 10 VLLSILTLFINGPLITTAQSPPSSSTSCNRICGGIEIPFPFGIGRRDCFLNDWYEVVCNS 69
Query: 59 --SSGSPKPLLKSINLNMLLNFVFQK------GLIAVEAPVISLNSSKSMGNAKGVNLTG 110
S S P L IN L++ + G++ +++PV S S+ +NLTG
Sbjct: 70 TTSGKSLAPFLYKIN-RELVSITLRSSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLTG 128
Query: 111 --TPFSFSQKNNKFTTAGCDSYAKLNQKNDSSNSGKCQSVCTCDPTQYADCCD----LLC 164
+PF F +N+ + GCD+ A + + S C+S C D ++ C
Sbjct: 129 KGSPF-FITDSNRLVSVGCDNRALIT--DIESQITGCESSCDGDKSRLDKICGGYTCCQA 185
Query: 165 TVP---PNTKVFDTNSSYKYYQSIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPA-- 219
+P P D SS + C V F+ + Y +V +Q
Sbjct: 186 KIPADRPQVIGVDLESSGGN-TTQGGNCKVAFLTNE-----TYSPANVTEPEQFYTNGFT 239
Query: 220 VLEWGKYKGTCTEEYNSHTKMCNKDNHCLLQLGTGHF-----CLCDYTR--SVASRHCAG 272
V+E G Y T S +++ N C+ TG + C+C+Y +C
Sbjct: 240 VIELGWYFDT------SDSRLTNPVG-CVNLTETGIYTSAPSCVCEYGNFSGFGYSNCYC 292
Query: 273 DLICSTTSGH------NCSECPQGYYLSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCT 326
+ I + + + EC +G LSS S + + K + G
Sbjct: 293 NQIGYRGNPYLPGGCIDIDECEEGKGLSSCGELTCVNVPGSWRCELNGVGKIKPLFPGLV 352
Query: 327 SGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTS 386
G F +L L+ G W + KF+K++ +I+ K+ FFKRNGGLLL+Q+L + GN+ SK+F+S
Sbjct: 353 LG-FPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSS 411
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQ 446
KELE ATD++N NR+LGQGGQGTVYKGML DGRIVA+K+SKV+DE KV+EFINEV +LSQ
Sbjct: 412 KELEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQ 471
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
INHRN+VKL+GCCLETEVP+LVYE I NG LF+ LH ++++ +TW++RLRI++E++ A+
Sbjct: 472 INHRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGAL 531
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
+YLHSAAS P+YHRD+K+TNILLD KYRAKVSDFG SRS+ +DQTH+TT V GTFGYLDP
Sbjct: 532 AYLHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDP 591
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
EYF++S+FT+KSDVYSFGVVL EL+TGE+ V EE++ L ++F AMK++ + +I+D
Sbjct: 592 EYFQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVD 651
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
+ + + + E ++ VAKL RCL+L GKKRP M+EV+V L I++
Sbjct: 652 SRIKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRS 696
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1212), Expect = e-132, Method: Compositional matrix adjust.
Identities = 219/395 (55%), Positives = 304/395 (76%), Gaps = 8/395 (2%)
Query: 329 GFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKE 388
G +L G + +YKF++++ +++ +KFF+RNGG+LL+Q+LA EGN++ S++F+S E
Sbjct: 349 GSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHE 408
Query: 389 LETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN 448
LE ATD++N NR+LGQGGQGTVYKGML DGRIVA+K+SK +DE +V+EFINEV +L+QIN
Sbjct: 409 LEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQIN 468
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
HRN+VKLLGCCLETEVP+LVYEF+ NG L + LHD+++++ +TWE+RL IAIE++ A+SY
Sbjct: 469 HRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSY 528
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHSAAS PIYHRDIK+TNILLD + RAKVSDFG SRS+ IDQTH+TTQV GTFGY+DPEY
Sbjct: 529 LHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEY 588
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628
F+SS+FTEKSDVYSFGVVL ELLTGE+ EE++ LAA+F+ A+KE+ + +I+D
Sbjct: 589 FQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDR 648
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNI--------IQ 680
+ E + + +++VA L RCLN GKKRP M+EV++ L I++ S I
Sbjct: 649 IKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDD 708
Query: 681 ESVESDIAESYETGESFTESYTDSVTIPVDADPLI 715
+++E + +++E G + S ++ + DA+PL+
Sbjct: 709 QAMELNFNDTWEVGATAPASMFNNASPTSDAEPLV 743
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 469 bits (1207), Expect = e-131, Method: Compositional matrix adjust.
Identities = 292/688 (42%), Positives = 409/688 (59%), Gaps = 72/688 (10%)
Query: 30 CGDFGSDDYPFGIG-EGCYFDKSFEVFCDNSSGSPK---PLLKSINLNMLLNFVFQK--- 82
CG S +PFGIG + CY + +EV C+ ++ PLL IN ++N
Sbjct: 43 CGGI-SIPFPFGIGGKDCYLNGWYEVICNTTTSDSNTTVPLLSMINRE-VVNISLPDSNE 100
Query: 83 --GLIAVEAPVISL----NSSKSMGNAKGV-NLTG--TPFSFSQKNNKFTTAGCDSYAKL 133
GL+ ++ PV SL N+S+ N+ V N+TG +P+ F N+ GC A +
Sbjct: 101 PYGLVQIKGPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPY-FLTDENRLVAVGCGIKALM 159
Query: 134 NQKNDSSNSGKCQSVCTCDPTQYADCCDLLCT------------VPPNTKVFDTNSSYKY 181
+ S C+S C + + +L+CT P V NSS
Sbjct: 160 T--DTESEILGCESSCEHRKSG-EEVTNLICTGYRCCQARLPVGRPQAITVNIENSS--- 213
Query: 182 YQSIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQVP----AVLEWGKYKGTCTEEYNSH 237
+ C V F+ ++ + +N + + EQ VLE G Y T + S
Sbjct: 214 --GGEETCKVAFLTDKRYSPSN-------VTEPEQFHNNGYVVLELGWYFATSNSRFKSL 264
Query: 238 ---TKMCNK-----DNHCLLQL----GTGHF-CLCDYTRSVASRHCAGDLICSTTSG-HN 283
T M K D++C + G + C CDY + G + + G HN
Sbjct: 265 LGCTNMSRKGSGFSDDNCSCEYDYFSGMSYRNCYCDYGYTGNPYLRGGCVDTDSCEGNHN 324
Query: 284 CSECPQGYYLSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMY 343
C E + S +C + ++T K ++ G G G L G +W++
Sbjct: 325 CGEDAHCVNMPGPMS----MCRPNPKIT---KPTKPPVLQGILIGLSG-LVFFVGLFWLF 376
Query: 344 KFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILG 403
K +K++ I +KFFKRNGGLLL+Q+L + +GN++ SK+F+SKEL ATD+++ +R+LG
Sbjct: 377 KLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLG 436
Query: 404 QGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463
QGGQGTVYKGML DG IVA+K+SKV+DE K++EFINE+ +LSQINHRN+VKLLGCCLETE
Sbjct: 437 QGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETE 496
Query: 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523
VP+LVYE+I NG LF+ LHD+++++ +TWE+RLRIAIE++ A++Y+HSAAS PI+HRDIK
Sbjct: 497 VPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIK 556
Query: 524 STNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSF 583
+TNILLD KYRAKVSDFG SRS+ +DQTH+TT V GTFGY+DPEYF SS++T KSDVYSF
Sbjct: 557 TTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSF 616
Query: 584 GVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643
GVVL EL+TGE+ + EE + LA +FL AMKE+ + +I+D + E+ E ++ VAK
Sbjct: 617 GVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAK 676
Query: 644 LTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
L +CLN GK RP MKEV+ L I++
Sbjct: 677 LARKCLNRKGKNRPNMKEVSNELERIRS 704
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 461 bits (1185), Expect = e-128, Method: Compositional matrix adjust.
Identities = 213/342 (62%), Positives = 281/342 (82%), Gaps = 1/342 (0%)
Query: 330 FGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKEL 389
FG L + G + +YKF+K++ ++ K+KFFKRNGGLLLQQ+L ST G ++K+ +F+S+EL
Sbjct: 381 FGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSREL 440
Query: 390 ETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINH 449
E AT+++++NRILGQGGQGTVYKGML DGRIVA+KKSKV+DE K++EFINEV ILSQINH
Sbjct: 441 EKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINH 500
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSY 508
RN+VKLLGCCLET+VP+LVYEFI NG LF++LHD+ +E TW IRLRIAI+++ A+SY
Sbjct: 501 RNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSY 560
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHS+AS PIYHRD+KSTNI+LD KYRAKVSDFG SR++ +D TH+TT V GT GY+DPEY
Sbjct: 561 LHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEY 620
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628
F+SS+FT+KSDVYSFGVVL EL+TGE++I +E+++LA YF+ AMKE+ LF+I+DA
Sbjct: 621 FQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDAR 680
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670
+ + AK+ +CLNL G+KRP+M+EV++ L I+
Sbjct: 681 IRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIR 722
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 456 bits (1174), Expect = e-127, Method: Compositional matrix adjust.
Identities = 219/400 (54%), Positives = 296/400 (74%), Gaps = 13/400 (3%)
Query: 329 GFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKE 388
G +L G + +YKF+K++ + FF+RNGG+LL+Q+LA EGN++ SK+F+S E
Sbjct: 357 GSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNE 416
Query: 389 LETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN 448
LE ATD++NTNR+LGQGGQGTVYKGML DGRIVA+K+SK +DE KV+EFINEV +L+QIN
Sbjct: 417 LEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQIN 476
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
HRN+VKLLGCCLETEVP+LVYEF+ NG L + L D+ +++ +TWE+RL IAIE++ A+SY
Sbjct: 477 HRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSY 536
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHSAAS PIYHRDIK+TNILLD KY+ KVSDFG SRS+ IDQTH+TTQV GTFGY+DPEY
Sbjct: 537 LHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEY 596
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628
F+SS+FT+KSDVYSFGVVL EL+TG+ EE++ AA+F+ A+KE+ +I+D
Sbjct: 597 FQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDER 656
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNI---------- 678
+ E + + ++ VAKL RCLN GKKRP M+EV+V L I++ S I
Sbjct: 657 IKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSEIHNDDDDDDDD 716
Query: 679 ---IQESVESDIAESYETGESFTESYTDSVTIPVDADPLI 715
+++E +I E+++ G + S ++ + D +PL+
Sbjct: 717 DDEDDQAMELNIEETWDVGMTAPASMFNNGSPASDVEPLV 756
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 455 bits (1170), Expect = e-127, Method: Compositional matrix adjust.
Identities = 237/428 (55%), Positives = 306/428 (71%), Gaps = 7/428 (1%)
Query: 285 SECPQGYYLSSYNSDQEPLCSR--STQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWM 342
+EC + Y N + C T G K+R I +G FG+L L+ G WW+
Sbjct: 341 NECLRNSYGQRQNCRESDTCVNLPGTFNCIGNKTRVTMIGVG---SAFGILVLVVGIWWL 397
Query: 343 YKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRIL 402
KFLK++ K+KFFKRNGGLLLQQ+L + +GN++K+++F+S+ELE ATD+++ +RIL
Sbjct: 398 RKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRIL 457
Query: 403 GQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLET 462
GQGGQGTVYKGML DGR VA+KKSKV+DE K++EFINEV ILSQINHR+VVKLLGCCLET
Sbjct: 458 GQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLET 517
Query: 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDI 522
EVP LVYEFI NG LFQ++H++++++ TW +RLRIA++++ A+SYLHSAAS PIYHRDI
Sbjct: 518 EVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDI 577
Query: 523 KSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYS 582
KSTNILLD KYR KVSDFG SRS+ ID TH TT + GT GY+DPEY+ SS++T+KSDVYS
Sbjct: 578 KSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYS 637
Query: 583 FGVVLAELLTGER-AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTV 641
FGVVL EL+TGE+ I V+N +E + LA +F AMKE+ FEI+DA + E ++ V
Sbjct: 638 FGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAV 697
Query: 642 AKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNI-IQESVESDIAESYETGESFTES 700
A L RCLN GKKRP M++V L I A S + I+ +D E T + +S
Sbjct: 698 ANLARRCLNSKGKKRPCMRKVFTDLEKILASQEDSLVNIENDDGADDEEEGMTMINIDDS 757
Query: 701 YTDSVTIP 708
T VT P
Sbjct: 758 QTIYVTAP 765
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 450 bits (1158), Expect = e-125, Method: Compositional matrix adjust.
Identities = 279/684 (40%), Positives = 400/684 (58%), Gaps = 80/684 (11%)
Query: 38 YPFGIG-EGCYFDKSFEVFCDNS-SGSPK--PLLKSIN---LNMLL---NFVFQKGLIAV 87
+PFGIG + CY + +EV C+++ SGS K P L IN +N+ L +F G++ +
Sbjct: 48 FPFGIGGKDCYLNSWYEVVCNSTTSGSCKTVPFLTRINREVVNISLPKSDFFSPYGVVHI 107
Query: 88 EAPVISLNSSKSMGNA-----KGVNLTG--TPFSFSQKNNKFTTA--------------- 125
+ PV SL S ++ +N+TG +P+ + +N
Sbjct: 108 KGPVTSLGCSSNISQGLQKTLPDLNITGRGSPYFLTDENRLVAVGCGTKALMTDIESEIL 167
Query: 126 GCDSYAKLNQKNDSSNSGKCQSVCTCDPTQYADCCDLLCTVPPNTKV---FDTNSSYKYY 182
GC+S K + N+ NS C+ + CC V V ++N+ +
Sbjct: 168 GCESSCKDTKSNEVGNS-------LCNGYK---CCQARLPVERPQAVGVNIESNNDTR-- 215
Query: 183 QSIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYNSHTKMCN 242
+ C F+ ++ +N D AV+E G Y T + + N
Sbjct: 216 ---GEGCKAAFLTSMKYFPSNITKPEWFQADGY---AVVELGWYFDTSDSRFRNPLGCTN 269
Query: 243 KDNHCLLQLGTGHF-----CLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYN 297
L +G + CLC Y SR C SG+ + +G +
Sbjct: 270 ------LTRSSGSYFLTDICLCRY--GYFSRMSYRSCYCG--SGYRGNPYIRGGCIDIDE 319
Query: 298 SDQEPLCSRSTQLTFG----------KKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLK 347
+ C T + K ++ +++ G G G+L + G + +YKF++
Sbjct: 320 CEVPNKCGEDTCVNMAGRYSCVPKITKPAKLAHVLRGVLIGLLGLLFFVIGIFGLYKFIR 379
Query: 348 RKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQ 407
++ I+ KFFKRNGGLLL+Q+L + +G+++ SK+F+S+ELE ATD+++ +R+LGQGGQ
Sbjct: 380 KRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKATDNFSIDRVLGQGGQ 439
Query: 408 GTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467
GTVYK ML DG IVA+K+SKV+DE K++EFINE+ +LSQINHRN+VKLLGCCLETEVP+L
Sbjct: 440 GTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPIL 499
Query: 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527
VYE+I NG LF+ LHD+ +++ +TWE+RLRIA+E++ A+SY+HSAAS PI+HRDIK+TNI
Sbjct: 500 VYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAASFPIFHRDIKTTNI 559
Query: 528 LLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVL 587
LLD KYRAK+SDFG SRS+A DQTH+TT V GTFGY+DPEYF SS++T KSDVYSFGVVL
Sbjct: 560 LLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVL 619
Query: 588 AELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNR 647
EL+TGE+ + EE LA YFL AMKE+ +I+D + E+ Q ++ VAKL R
Sbjct: 620 VELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDESKQ--VMAVAKLARR 677
Query: 648 CLNLNGKKRPTMKEVAVVLAGIKA 671
CLN G KRP M+EV++ L I++
Sbjct: 678 CLNRKGNKRPNMREVSIKLERIRS 701
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 222/381 (58%), Positives = 280/381 (73%), Gaps = 7/381 (1%)
Query: 328 GGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSK 387
GF +L + G WW K L+++ K+KFFKRNGGLLLQQ+L +T+G ++K+KLF+S+
Sbjct: 386 AGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSR 445
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI 447
ELE ATD++N NR++GQGGQGTVYKGML DGR VA+KKS V+DE K+ EFINEV ILSQI
Sbjct: 446 ELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQI 505
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
NHR+VVKLLGCCLETEVP+LVYEFI NG LFQ+LH++ +++ W +R+RIA+++S A S
Sbjct: 506 NHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFS 565
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
YLH+AA PIYHRDIKSTNILLD KYRAKVSDFG SRS++ID TH TT + GT GY+DPE
Sbjct: 566 YLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPE 625
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGER-AIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
Y+ SS FTEKSDVYSFGVVL EL+TGE+ I ++ +E LA YF AM+E+ LFEI+D
Sbjct: 626 YYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIID 685
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQESVESD 686
A + + E ++ VA L RCL GK RP M+EV+ L I C + V+
Sbjct: 686 ARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI--CSAPEDF---QVQIQ 740
Query: 687 IAESYETGESFTESYTDSVTI 707
I E ET + F Y+ S I
Sbjct: 741 IDEEDETTKLF-RGYSGSTEI 760
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 721 | ||||||
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.904 | 0.939 | 0.521 | 0.0 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.958 | 0.950 | 0.505 | 0.0 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.894 | 0.868 | 0.508 | 1e-177 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.841 | 0.700 | 0.529 | 1e-173 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.825 | 0.876 | 0.520 | 1e-172 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.852 | 0.748 | 0.511 | 1e-171 | |
| 224103351 | 685 | predicted protein [Populus trichocarpa] | 0.893 | 0.940 | 0.466 | 1e-160 | |
| 224118592 | 642 | predicted protein [Populus trichocarpa] | 0.796 | 0.894 | 0.486 | 1e-158 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.941 | 0.940 | 0.443 | 1e-156 | |
| 224143699 | 635 | predicted protein [Populus trichocarpa] | 0.829 | 0.941 | 0.486 | 1e-154 |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 652 bits (1681), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 356/683 (52%), Positives = 460/683 (67%), Gaps = 31/683 (4%)
Query: 7 LVLLEIILLLCTIDASEPLMCDQ-CGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSGSPKP 65
L+ L++ L+L A C+ CG+ ++PFGIG+GCY D+SFEV C++SS PKP
Sbjct: 12 LIKLQLFLILWLAQARSVEPCESYCGNV-PIEFPFGIGKGCYMDESFEVTCNSSSEPPKP 70
Query: 66 LLKSINLNMLLNFVFQKGLIAVEAPVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTTA 125
L SIN+ +L V + V PVI N S A V+L+GTPF+FS +N+FT
Sbjct: 71 FLTSINMELLE--VLSPNQVQVNNPVIYSNCSHKTSTASRVSLSGTPFTFSNASNRFTAK 128
Query: 126 GCDSYAKLNQKNDSSNSGKCQSVCTCDPTQYADCCDLLC---TVPPNTKVFDTNSSYKYY 182
GC++YA L Q + G C S+C D + C + C T+PP K F+ N + +
Sbjct: 129 GCNNYAILMQ-DIGDTVGGCLSICR-DEANSSGCYGINCWQTTIPPYMKSFEANMTNPFS 186
Query: 183 QSIPQECSVVFVVEQEWLFNNYQTNSVV--LKDQEQVPAVLEWGKYKGTC--TEEYNSHT 238
+ C F+V+Q W ++ + L ++ VPAVL+W Y+G C +E YN
Sbjct: 187 DNT-NNCKSAFMVDQSWFAFQSSSSRSLDDLNYKDHVPAVLDWANYQGYCDISEYYNI-- 243
Query: 239 KMCNKDN-HCLLQLGTGHFCLCDYTRSVASRHCAGDLICS-----TTSGHNCSECPQGYY 292
C D+ +C +L C+C + + C G+NC CP+G+
Sbjct: 244 -TCTTDSSYCWKELNRSQVCICQCEDPNKCPDQSSNYNCRLFCMYRPGGYNCP-CPRGH- 300
Query: 293 LSSYNSDQEPLCSRSTQLTFGKKSRNKY-IVIGCTSGGFGMLCLLTGAWWMYKFLKRKME 351
Y + C ++ F KSR K +I G G L LL G W +YK +KR+
Sbjct: 301 -GKYENSNR--CYPNS--VFWGKSRTKTKSIIIGCGSGIGFLLLLIGIWSLYKIIKRRRA 355
Query: 352 IMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVY 411
+ LKQ FFKRNGGLLL+Q+L+STE ++++K+FTSKELE ATD Y+TNRILGQGGQGTVY
Sbjct: 356 MKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEKATDDYHTNRILGQGGQGTVY 415
Query: 412 KGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471
KGML DGR+VAIKKSKV+DE K+D+FINEV ILSQINHRNVVKL+GCCLETEVPLLVYEF
Sbjct: 416 KGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRNVVKLIGCCLETEVPLLVYEF 475
Query: 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG 531
I NGTL+QY+H+ NEEFP+TWE+RLRIA EV+ A++YLH+AAS+PIYHRDIKS+NILLD
Sbjct: 476 IPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHAAASMPIYHRDIKSSNILLDE 535
Query: 532 KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591
KYRAKV+DFG S+S++IDQTH+TT+VQGTFGYLDPEYF+SS+FTEKSDVYSFGVVL ELL
Sbjct: 536 KYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELL 595
Query: 592 TGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNL 651
TG++ I E++SLA YFL M+E LFEILDA VLKE +E+I+ +AKL +CLNL
Sbjct: 596 TGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLKEGGREEIIAMAKLAEKCLNL 655
Query: 652 NGKKRPTMKEVAVVLAGIKACDG 674
NGKKRP MK VA+ L GI++ G
Sbjct: 656 NGKKRPKMKTVAIELEGIRSSQG 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 644 bits (1661), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/734 (50%), Positives = 484/734 (65%), Gaps = 43/734 (5%)
Query: 7 LVLLEIIL---LLCTIDASEPLMCDQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSGSP 63
++L+++ L LL T A+ P+ + CGD + +PFGIG+GCY + FE+ C++S P
Sbjct: 12 IILIQLWLNQALLAT--AAGPVCQESCGDI-TFPFPFGIGKGCYMSEMFEIVCNDSFTPP 68
Query: 64 KPLLKSINLNMLLNFVFQKGLIAVEAPVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKFT 123
KP L SIN+ +L + I V +PVIS N S + V+L GT F FS ++N+FT
Sbjct: 69 KPFLTSINMELLHDPSIGSERITVNSPVISSNCSNKSSTSTEVSLLGTSFLFSNESNRFT 128
Query: 124 TAGCDSYAKLNQKNDSSNSGKCQSVCTCDPTQYADCCDLLC---TVPPNTKVFDTNSSYK 180
T GCDSYA L Q ++ G C S+C + + + C L C T+PP + F+ N +
Sbjct: 129 TIGCDSYAMLTQSGNTV--GGCLSICRDNSS--SGCYGLNCCQTTIPPYVQSFEVNITNP 184
Query: 181 YYQSIP--QECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYNSHT 238
+ C F+V Q WL + TN ++ + VPAVL+W +G C N +
Sbjct: 185 FNSDGDGRDRCKSAFMVSQNWLASK-STNLDEVRQMDHVPAVLDWANDQGYCDISKNPNI 243
Query: 239 KMCNKDNHCLLQLGTGHFCLCDYTRSVAS-----RHCAGDLICS-TTSGHNCSECPQGYY 292
++ +C QL FC+C V + L C G+NC CP ++
Sbjct: 244 TCTSR--YCWAQLTENQFCICRQCEDVGKCTNPKNYYYCQLKCMYNRGGYNCP-CPVEHH 300
Query: 293 LSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEI 352
+ +C + F KSR K I+IGC SG +L L+ G W YK +KR+
Sbjct: 301 ------KEYSICYPDS--AFAGKSRIKTILIGCGSGLGLLL-LIIGIWLSYKIIKRRRAT 351
Query: 353 MLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYK 412
LKQKFFKRNGGLLL+Q+L+STE +++++K+FTSKELE ATD+Y+T+RILGQGGQGTVYK
Sbjct: 352 KLKQKFFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRILGQGGQGTVYK 411
Query: 413 GMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472
GML DGR+VAIKKSK++DE K+D+FINEV ILSQINHRNVVKL GCCLETEVPLLVYEFI
Sbjct: 412 GMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETEVPLLVYEFI 471
Query: 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532
NGTLFQY+ + N+EFPITWE+RLRIA EV+ A++YLHSAAS+PIYHRDIKS+NILLD K
Sbjct: 472 PNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIKSSNILLDEK 531
Query: 533 YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
YRAKV+DFG S+S+AI+QTH+TT VQGTFGYLDPEYF+SS+FTEKSDVYSFGVVL ELLT
Sbjct: 532 YRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELLT 591
Query: 593 GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLN 652
G++ I E++SLA YFL M+E+ LFEILDA VLKE +E+I+ +AK+ +CLNLN
Sbjct: 592 GQKPISSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAKMAEKCLNLN 651
Query: 653 GKKRPTMKEVAVVLAGIKACDGTSNIIQESVE------SDIAESYETGESFTESYTDSVT 706
GKKRP MK VA+ L GI++ G S+ IQ+ E D S++ S T S +S T
Sbjct: 652 GKKRPKMKTVAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASSSTGSL-NSTT 710
Query: 707 IPV--DADPLISKN 718
I D PL+ N
Sbjct: 711 IRARFDVKPLLPSN 724
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 630 bits (1624), Expect = e-177, Method: Compositional matrix adjust.
Identities = 352/692 (50%), Positives = 447/692 (64%), Gaps = 47/692 (6%)
Query: 7 LVLLEIILLLCTIDAS-------EPLMCDQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNS 59
++L II+ I++S +P D+CG+ + YPFGIGEGCY D F V C+ +
Sbjct: 6 VLLFRIIIFPWLINSSMAAASVAKPGCSDRCGNV-TIPYPFGIGEGCYMDSGFAVTCNKT 64
Query: 60 SGSPKPLLKSINLNMLLNFVFQKGLIAVEAPVISLNSSKSMGNAKGVNLTGTPFSFSQKN 119
S +P L SINL LL + L+ V PV LNS+ N
Sbjct: 65 SLPYRPYLTSINLE-LLRVSLESTLVRVNNPV--LNSNCQDRPPVSDLSFSGSPFSFSDN 121
Query: 120 NKFTTAGCDSYAKLNQKNDSSNSGKCQSVCTCDPTQYA----DCCDLLCTVPPNTKVFDT 175
N+FT GC++ A + +++ G C S+C T+ + +CC ++PP K
Sbjct: 122 NRFTALGCNNLALIYRQDMVI--GGCLSICNVTVTESSCYGINCCQT--SIPPYLKFI-- 175
Query: 176 NSSYKYYQSIPQE-CSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEY 234
N+S + +P E C V F+V++EW +N N L +QVPAVLEWG GTC +
Sbjct: 176 NASLRSIDPVPDEQCRVAFMVDREWFSSNASDNISALLGAKQVPAVLEWGISNGTCADSP 235
Query: 235 NSH--TKMCNKDNHCLLQLGTGHFCLC-------------DYTRSVASRHCAGDLICSTT 279
+ T +C + C +++G + C C D S+ +IC T
Sbjct: 236 GAENSTDICGSNASCSVKVGINYQCSCNQGYEGNPYLSCQDINECEDSQKNKCSMICVNT 295
Query: 280 SGHNCSECPQGYYLSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGA 339
G CP GY N LT G R + ++ S G G+ LL G
Sbjct: 296 PGSYKCSCPDGYISMGNN----------CYLTDGYTERFRPVIAIVLSAGLGIPFLLIGT 345
Query: 340 WWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTN 399
WW+YK KR+ + L+Q+FFKRNGGLLLQQ+L+S+E +I+K+ +FT+KELE ATDHYN N
Sbjct: 346 WWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFTAKELEKATDHYNEN 405
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
RILGQGGQGTVYKGML DG++VAIKKSK+ DESK ++FINEV ILSQINHRNVVKLLGCC
Sbjct: 406 RILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFINEVVILSQINHRNVVKLLGCC 465
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
LETEVPLLVYEFI NGTL+Q+LHD +EEFPITWE+RLRIAIE A+SYLHSAAS+PIYH
Sbjct: 466 LETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSALSYLHSAASVPIYH 525
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RDIKSTNILLD KYRAKVSDFG S+S+A+DQTH+TT+VQGTFGYLDPEYF+SS+FTEKSD
Sbjct: 526 RDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDPEYFQSSQFTEKSD 585
Query: 580 VYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIV 639
VYSFGVVL ELLTG++ I E++SLA YFL +M+++ LFEILDA VLKE +E+I+
Sbjct: 586 VYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEILDARVLKEGGKEEIL 645
Query: 640 TVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
VAKL RCLNLNGKKRPTM+ V + I+A
Sbjct: 646 AVAKLARRCLNLNGKKRPTMRTVVTEVERIRA 677
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 615 bits (1587), Expect = e-173, Method: Compositional matrix adjust.
Identities = 352/665 (52%), Positives = 427/665 (64%), Gaps = 58/665 (8%)
Query: 22 SEPLMCDQCGDFGSDDYPFGIGE-GCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVF 80
++P ++CGD YPFGIG GCYFD+ FEV C+NS+ PKP LK +NL +L V
Sbjct: 33 AKPGCQERCGDV-DIPYPFGIGSAGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVL--NVS 89
Query: 81 QKGLIAVEAPVI-SLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTTAGCDSYAKLNQKNDS 139
G I V PV+ S N S N G PFSFS +FT GC + + Q D
Sbjct: 90 LDGTIRVNNPVLLSQNCSGKPSNDTQW-WEGGPFSFSNTYTRFTAVGCSALVYIMQ--DD 146
Query: 140 SNSGKCQSVCTCDPTQYA--DCCDLLC---TVPPNTKVFDTN-SSYKYYQSIPQE-CSVV 192
+ G C + C D T C L C VPP F N ++ + QE C
Sbjct: 147 TVIGGCMTFCKKDATAAKKASCYGLECCQTQVPPGLLSFTANLGTFSDGSADEQEQCKFA 206
Query: 193 FVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTC---TEEYNSHTKMCNKDNHCLL 249
F+V+QEW +N V KD E VPAVL+W Y TC T N+ T C ++ C
Sbjct: 207 FMVDQEWFISNVPDPHTV-KDMEYVPAVLDWRIYNATCAASTSNLNTSTSFCGENTLCST 265
Query: 250 QLGTGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSDQEPLCSRSTQ 309
T LICS C +G P + Q
Sbjct: 266 DTQTS------------------SLICS------CFPVYEG----------NPYLPQGCQ 291
Query: 310 LTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQ 369
G +S VI T G G L L+ AWW+Y LKR+ +I K+K F RNGGLLL+Q
Sbjct: 292 ---GTQSIEDCAVI--TIGALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQ 346
Query: 370 ELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI 429
+L+STEGNIDK+KLFTSKELE ATD YN NR++GQGG+GTVYKGML DGRIVA+KK K++
Sbjct: 347 QLSSTEGNIDKTKLFTSKELEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIM 406
Query: 430 DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFP 489
+SK+++FINEV IL QINHRNVVKLLGCCLETEVPLLVYEFI NGTL +++H QNEEFP
Sbjct: 407 SDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFP 466
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549
ITWEIRLRIA EV+ A+SYLHSAAS+PIYHRDIKSTNILLD KYRAKV+DFG S+ +AID
Sbjct: 467 ITWEIRLRIATEVAGALSYLHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAID 526
Query: 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609
QTH+TTQVQGTFGYLDPEYF+SS+FTEKSDVYSFG+VL ELLTG++ I T EE KSLA
Sbjct: 527 QTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLA 586
Query: 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+YF+ +M ED L ++LDA V+KE+ +E+I +A L RC+NLNGKKRPTM EVA+ L I
Sbjct: 587 SYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERI 646
Query: 670 KACDG 674
+ C G
Sbjct: 647 RKCQG 651
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1576), Expect = e-172, Method: Compositional matrix adjust.
Identities = 348/669 (52%), Positives = 421/669 (62%), Gaps = 74/669 (11%)
Query: 22 SEPLMCDQCGDFGSDDYPFGIGE-GCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVF 80
++P + CGD YPFGIG GCYFD+ FEV C+NS+ PKP LK +NL +L V
Sbjct: 26 AKPGCQEWCGDV-DIPYPFGIGSSGCYFDEWFEVTCNNSTDPPKPFLKGVNLEVL--NVS 82
Query: 81 QKGLIAVEAPVI-SLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTTAGCDSYAKLNQKNDS 139
G + V PV+ S N S N G PFSFS +FT GC + A Q D
Sbjct: 83 LHGTVRVNNPVLLSQNCSGKPSNDTQW-WEGGPFSFSNTYTRFTAVGCSAMAYFMQ--DD 139
Query: 140 SNSGKCQSVCTCD---PTQYADCCDLLC---TVPPNTKVFDTN-SSYKYYQSIPQE-CSV 191
+ G C ++C D + A C L C VPP F N ++ + QE C
Sbjct: 140 TVIGGCMTLCKKDVATAAKNASCYGLECCQTQVPPGLLSFTANLDTFPEGSADEQEPCKY 199
Query: 192 VFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTC---TEEYNSHTKMCNKDNHCL 248
F+V+QEW +N V KD E VPAVL+W Y TC T N+ T C
Sbjct: 200 AFMVDQEWFISNVPDPHTV-KDMEYVPAVLDWRIYNATCDASTSNLNTSTSFC------- 251
Query: 249 LQLGTGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSDQEPLCSRST 308
G FC D + TS CS CP Y
Sbjct: 252 ---GENTFCSTD----------------TQTSSLTCS-CPLLY----------------- 274
Query: 309 QLTFGKKSRNKYIVIGC---TSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGL 365
N Y+ GC T G G L L+ AWW+Y LKR+ +I K+K F RNGGL
Sbjct: 275 -------EGNPYLPQGCQVITIGSLGTLLLVLCAWWLYIXLKRRKKIKYKEKCFNRNGGL 327
Query: 366 LLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKK 425
LL+Q+L+S+EGNIDK+KLFTSKELE ATD YN NR++GQG QGT YKGML DGRIVA+KK
Sbjct: 328 LLEQQLSSSEGNIDKTKLFTSKELEKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKK 387
Query: 426 SKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN 485
K++ +SK+++FINEV IL QINHRNVVKLLGCCLETEVPLLVYEFI NGTL +++H QN
Sbjct: 388 LKIMSDSKLEQFINEVVILCQINHRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQN 447
Query: 486 EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545
EEFPITWE+RLRIA EV A+SYLHS ASIPIYHRDIKSTNILLB KYRAKV+DFG S+
Sbjct: 448 EEFPITWEMRLRIATEVXGALSYLHSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKF 507
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605
+AIDQTH+TTQVQGTFGYLDPEYF+SS+FTEKSDVYSFG+VL ELLTG++ I EE
Sbjct: 508 VAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSIASEEG 567
Query: 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665
KSLA+YF+ +M ED L ++LDA V+KE+ +E+I +A L RC+NLNGKKRPTM EVA+
Sbjct: 568 KSLASYFILSMNEDRLSDLLDAQVVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAME 627
Query: 666 LAGIKACDG 674
L I+ C G
Sbjct: 628 LERIRKCQG 636
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 608 bits (1567), Expect = e-171, Method: Compositional matrix adjust.
Identities = 346/677 (51%), Positives = 424/677 (62%), Gaps = 62/677 (9%)
Query: 28 DQCGDFGSDDYPFGIGE-GCYFDKSFEVFCDNSSGS--PKPLLKSINLNMLLNFVFQKGL 84
+ CGD YPFGIG GCYFD+ FEV C+NS PKP LK +NL +LN +
Sbjct: 155 ETCGDV-DIPYPFGIGSAGCYFDEWFEVTCNNSIHPHIPKPFLKILNLE-VLNVSLNRST 212
Query: 85 IAVEAPVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTTAGCDSYAKLNQKNDSSNSGK 144
I V PV+ + + + G PFSFS +FT GC + A + Q NDS G
Sbjct: 213 IRVNNPVLGYMNCSGKPSNDAQSWEGGPFSFSDTYTRFTAVGCSTLAYITQ-NDSVIGG- 270
Query: 145 CQSVCTCDPT--QYADCCDLLC---TVPPNTKVFDTN-SSYKYYQSIPQECSVVFVVEQE 198
C S C T + C L C PP + F T + EC F+V+QE
Sbjct: 271 CMSYCKQGTTAAKNGSCYGLKCCQTQFPPGLQYFTTMLGDFPSNSDDQDECKYAFMVDQE 330
Query: 199 WLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYNSHTKMCNKDNHCLLQLGTGHFCL 258
W + Q V KD PAVL+W Y TC +G +
Sbjct: 331 WFISMEQDPDKV-KDVGHAPAVLDWRIYNATCK------------------SVGWNN--- 368
Query: 259 CDYTRSVASRHCAGDLICST---TSGHNCSECPQGYYLSSY------------------- 296
T + ++ C + ICS T C CP+GY + Y
Sbjct: 369 -TSTSNTSTSFCGANAICSADTQTPSLTC-RCPRGYEGNPYLTEGCEGTNYKLYENGTVC 426
Query: 297 -NSDQEPLCSRSTQLTFGKKSRNKYIVIGCTS--GGFGMLCLLTGAWWMYKFLKRKMEIM 353
N + C +L + R + C G G L L+ AWW+YK LKR+ +I
Sbjct: 427 INRNANFSCYPVDKLIVDPRPRRMVLPGICVGILAGVGTLLLVICAWWLYKVLKRRQKIK 486
Query: 354 LKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKG 413
K+K FKRNGGLLL+Q+L+S+EGN+DK+KLFTSKELE ATD YN NR++GQGGQGTVYKG
Sbjct: 487 YKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDRYNENRVIGQGGQGTVYKG 546
Query: 414 MLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473
ML DGRIVA+KK K++ + KV++FINEV ILSQINHRNVVKLLGCCLET VPLLVYEFI
Sbjct: 547 MLMDGRIVAVKKLKIVGDGKVEQFINEVVILSQINHRNVVKLLGCCLETAVPLLVYEFIP 606
Query: 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533
NGTL +++HDQNEEFPITWE+RLRIAIEV+ A+SYLHSAASIPIYHRDIKSTNILLD KY
Sbjct: 607 NGTLSEHIHDQNEEFPITWEMRLRIAIEVAGALSYLHSAASIPIYHRDIKSTNILLDDKY 666
Query: 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
RAKV+DFG S+S+AIDQTH+TTQVQGTFGYLDPEYF+SS+FTEKSDVYSFG+VL ELLTG
Sbjct: 667 RAKVADFGTSKSVAIDQTHLTTQVQGTFGYLDPEYFQSSQFTEKSDVYSFGIVLIELLTG 726
Query: 594 ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNG 653
++ I T EE KSLA+YF+ +M ED L ++LDA V+KE +E+I +A L RC+NLNG
Sbjct: 727 KKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQVVKEGKKEEINAIAFLARRCINLNG 786
Query: 654 KKRPTMKEVAVVLAGIK 670
KKRPTM EVA+ L +K
Sbjct: 787 KKRPTMMEVAMELEILK 803
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224103351|ref|XP_002334062.1| predicted protein [Populus trichocarpa] gi|222869636|gb|EEF06767.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1474), Expect = e-160, Method: Compositional matrix adjust.
Identities = 332/711 (46%), Positives = 443/711 (62%), Gaps = 67/711 (9%)
Query: 22 SEPLMCDQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSG--SPKPLLKSINLNMLLNFV 79
+ P D CG+ S +PFGIG GCY + F V C+ ++ + L SIN+ +L
Sbjct: 2 ARPNCKDTCGNI-SIPFPFGIGTGCYLNYWFSVHCNKTTADSRSRAFLSSINME-VLEIS 59
Query: 80 FQKGLIAVEAPVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTTAGCDSYAKLNQ---- 135
++ ++ V +P+IS S N +++TG+PF+FS +N F GC++ A L++
Sbjct: 60 LRRSVVRVNSPIISSGCSGRGANIS-IDMTGSPFAFSS-SNIFIAMGCNNRALLSRIEPE 117
Query: 136 -----KNDSSNSGKCQSVCTCDPTQYADCCDLLCTVPPNTKVFDTN---SSYKYYQSIPQ 187
SS GK S C+ + +CC T+P N +VF+ + + +
Sbjct: 118 IVGCTTTGSSTEGKENSYCSGN-----NCCQ--TTIPSNLQVFNASLGTTEHPINDQGRN 170
Query: 188 ECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYN-----SHTKMCN 242
+C V F+VE+EW NN + VV +D + VP +L W Y GT E S + +
Sbjct: 171 QCKVAFIVEEEWFRNNISSPEVV-QDMQYVPVILRWLMYYGTDIPEGVTLWGLSTVTLYS 229
Query: 243 KDNHCLLQLG-TGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSDQE 301
C G GH L D + G CS + C P G+Y +
Sbjct: 230 NSITCWCSPGYDGHPYLPDGCTDIDQCKIPGVNWCSGMT--KCVNVP-GWYKCELDK--- 283
Query: 302 PLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKR 361
++TF S G+L LL G W +YK +K++ I LK+KFFKR
Sbjct: 284 ------AKITF-------------LSAATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKR 324
Query: 362 NGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIV 421
NGGLLLQQ+L+S++G+I K+K+FTSKELE ATD +N NRILGQGGQGTVYKGM ADG IV
Sbjct: 325 NGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIV 384
Query: 422 AIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL 481
A+KKS ++DE K++EFINEV ILSQ+NHRNVVKLLGCCLETEVPLLVYEFI NG LF+Y+
Sbjct: 385 AVKKSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYI 444
Query: 482 HDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541
HDQ EEF +WE+RLRIA EV+ A+SYLHSAASIP+YHRDIKSTNI+LD K+RAKVSDFG
Sbjct: 445 HDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFG 504
Query: 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601
SRS+AIDQTH+TT VQGTFGYLDPEYF+SS+FT KSDVYSFGVVLAELL+G++ I
Sbjct: 505 TSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYER 564
Query: 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
E+ +SLA +F+ M+E+ +F+ILD ++ + +E+++ VA L RCLNLNG+KRPTM+E
Sbjct: 565 PEDRRSLATHFILLMEENKIFDILDERLMGQDREEEVIAVANLARRCLNLNGRKRPTMRE 624
Query: 662 VAVVLAGIKACDGTSNIIQ-----ESVESDIAESYETGESFTESYTDSVTI 707
VA+ L I+ G + Q E++ ++ +E T SVTI
Sbjct: 625 VAIELEQIRVSKGAPHAQQSCKDLENIRDEVPNVWEIA-----GPTTSVTI 670
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224118592|ref|XP_002331400.1| predicted protein [Populus trichocarpa] gi|222873614|gb|EEF10745.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 564 bits (1453), Expect = e-158, Method: Compositional matrix adjust.
Identities = 324/666 (48%), Positives = 412/666 (61%), Gaps = 92/666 (13%)
Query: 30 CGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVFQKGLIAVEA 89
CGD S YPFG+ EGCY D+ F++ C++SSG PK + +L + N IAV
Sbjct: 10 CGDI-SIPYPFGMKEGCYLDERFKILCNSSSGVPKLTVNGTDLE-VNNISVDDSTIAVMF 67
Query: 90 PVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTTAGCDSYAKLNQKNDSSNSGKCQSVC 149
P++ N S GN V+L G+PF FS +N F GC + A +NQ + S G C S+C
Sbjct: 68 PIVFANCSGKDGNTV-VDLEGSPFVFSSEN-YFIARGCGNLALMNQ--NQSAIGGCVSLC 123
Query: 150 TCD-PTQYADCCDLLC---TVPPNTKVFDTNSSYKYYQSIP-----QECSVVFVVEQEWL 200
+ + A C + C +P KVF N + K + EC F++++ W
Sbjct: 124 DKNRDSMMASCSGIDCCQTRIPSFLKVF--NVTMKGLEDGKGSRGENECRYAFLIDERWT 181
Query: 201 --------------FNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEE------YNS-HTK 239
F+ Y ++++ VP VL+WG + YNS +T
Sbjct: 182 NYGGYYYDYYFGGNFDFYYDK----RERDHVPVVLDWGIDRRVFESLVKNGSFYNSSYTS 237
Query: 240 MCNKDNHCLLQLGTGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSD 299
C + N L S C G L+ + SS+
Sbjct: 238 TCFEGNPYL------------------SGICQGKLLIVVSQ------------FSSF--- 264
Query: 300 QEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFF 359
S N + C GGFG L LL G WW+YK KRK LK+K+F
Sbjct: 265 ---------------PSMNNAFLKKCV-GGFGALFLLIGLWWLYKVFKRKRSEKLKKKYF 308
Query: 360 KRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGR 419
KRNGGLLLQ++L+S E N++K K+F SKEL+ ATDHYN NR LGQGGQGTVYKGMLADG+
Sbjct: 309 KRNGGLLLQEQLSSGEVNVEKIKMFPSKELDKATDHYNVNRTLGQGGQGTVYKGMLADGK 368
Query: 420 IVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQ 479
IVA+KKSK IDE + +FINEV +LSQINHRNVVKLLGCCLETE+PLL+YEFI NGTLFQ
Sbjct: 369 IVAVKKSKEIDEGNLRQFINEVVLLSQINHRNVVKLLGCCLETELPLLIYEFIPNGTLFQ 428
Query: 480 YLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSD 539
+LHD NEEFP+TWE+RLRIA EV+ A+ YLHSAAS+PI+HRDIKSTNILLD +YRAKV+D
Sbjct: 429 FLHDPNEEFPLTWEMRLRIAAEVAGALFYLHSAASLPIFHRDIKSTNILLDEEYRAKVAD 488
Query: 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRV 599
FG SRS++IDQTH+TT+VQGTFGYLDPEYF+SS+FT+KSDVYSFGVVL ELLTG++ I
Sbjct: 489 FGTSRSVSIDQTHVTTRVQGTFGYLDPEYFQSSQFTDKSDVYSFGVVLVELLTGQKPISF 548
Query: 600 TNFEED-KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT 658
T EE +SLA YF+ AM+ + LF+ILD V+K+ +ED++ VA L CL LNGK+RPT
Sbjct: 549 TRSEEQGRSLATYFIMAMESNCLFDILDPQVVKQGEREDVLMVASLARSCLRLNGKERPT 608
Query: 659 MKEVAV 664
MK V +
Sbjct: 609 MKGVTM 614
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1437), Expect = e-156, Method: Compositional matrix adjust.
Identities = 327/737 (44%), Positives = 444/737 (60%), Gaps = 58/737 (7%)
Query: 7 LVLLEIILLLCTIDASEPLMCDQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSG-SP-K 64
L L+ I + + + P + CG+ + +PFGIG GCY + F V C+ ++ SP +
Sbjct: 13 LFLVPEIATVSALIMARPNCTETCGNI-TIPFPFGIGTGCYMNDWFSVHCNETTADSPSR 71
Query: 65 PLLKSINLNMLLNFVFQKGLIAVEAPVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKFTT 124
L IN+ + + ++ V +P+IS S N +N+TG+PFSFS +N FT
Sbjct: 72 AFLSRINME-VFKISLESSVVRVNSPIISSGCSGRGANL-AINMTGSPFSFSS-SNIFTA 128
Query: 125 AGCDSYAKLNQKND----------SSNSGKCQSVCTCDPTQYADCCDLLCTVPPNTKVFD 174
GC++ A LN +S GK S C+ + +CC T+P + +V +
Sbjct: 129 MGCNNRALLNGIEPEIVGCTSTCGASTEGKENSYCSGN-----NCCQ--TTIPSSLQVVN 181
Query: 175 TNSSYKYYQSIPQ---ECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCT 231
+ + Q +C V F+V+++W NN + VV +D + VP +L+W C
Sbjct: 182 ASLGTPEHPINDQGRNQCKVAFIVQEKWFRNNISSPEVV-QDMQYVPVILDWNSDAMYCD 240
Query: 232 EEYNSHTKMCNKDNHCLLQLGTGHFCLCDYT---RSVASRHCAGDLICSTTSGHNCSECP 288
N + L T C C++ C C G++CS
Sbjct: 241 PPMNLTSGRSGLRTVTLYSNST--ICSCNWGYDGNPYLPDGCTDIDECKIPRGNSCSGM- 297
Query: 289 QGYYLSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKR 348
++ + G K I S G+L LL G W +YK +K+
Sbjct: 298 ----------------TKCVNVPGGFKCELDKAKITFLSAATGLLLLLVGIWRLYKLVKK 341
Query: 349 KMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQG 408
+ I LK+KFFKRNGGLLLQQ+L+S++G+I K+K+FTSKELE ATD +N NRILGQGGQG
Sbjct: 342 RKNIELKKKFFKRNGGLLLQQQLSSSDGSIQKTKIFTSKELEKATDRFNDNRILGQGGQG 401
Query: 409 TVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468
TVYKGM ADG IVA+KKS ++DE K++EFINEV ILSQ+NHRNVVKLLGCCLETEVPLLV
Sbjct: 402 TVYKGMQADGMIVAVKKSILVDEEKLEEFINEVVILSQVNHRNVVKLLGCCLETEVPLLV 461
Query: 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNIL 528
YEFI NG LF+Y+HDQ EEF +WE+RLRIA EV+ A+SYLHSAASIP+YHRDIKSTNI+
Sbjct: 462 YEFIPNGNLFEYIHDQKEEFEFSWEMRLRIATEVARALSYLHSAASIPVYHRDIKSTNIM 521
Query: 529 LDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLA 588
LD K+RAKVSDFG SRS+AIDQTH+TT VQGTFGYLDPEYF+SS+FT KSDVYSFGVVLA
Sbjct: 522 LDEKFRAKVSDFGTSRSIAIDQTHLTTHVQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLA 581
Query: 589 ELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRC 648
ELL+G++ I EE SLA +F+ ++E+ +F+ILD ++ + +E+++ VA L RC
Sbjct: 582 ELLSGQKPISYERSEERGSLATHFILLVEENKIFDILDERLMGQDREEEVIAVANLARRC 641
Query: 649 LNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQ-----ESVESDIAESYETGESFTE---- 699
LNL G+KRPTM+EVA+ L I+ G + Q E++ ++ +E T
Sbjct: 642 LNLIGRKRPTMREVAIELEQIRLSKGALHPQQCSKELENIWDEVPNVWEIAGPPTSVTIG 701
Query: 700 SYTDSVTIPVDADPLIS 716
+ + +D PLIS
Sbjct: 702 DFRNGTAPSLDVQPLIS 718
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224143699|ref|XP_002336072.1| predicted protein [Populus trichocarpa] gi|222869913|gb|EEF07044.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1421), Expect = e-154, Method: Compositional matrix adjust.
Identities = 317/651 (48%), Positives = 410/651 (62%), Gaps = 53/651 (8%)
Query: 28 DQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVFQKGLIAV 87
D+CGD S YPFGI + CY ++ F + C+ S + + IN+ +LN ++ V
Sbjct: 29 DRCGDI-SIPYPFGIRKDCYMNEWFAIECNASVNPARAFISRINME-VLNISAERATATV 86
Query: 88 EAPVISLNSSKSMGNAKGV--NLTGTPFSFSQKNNKFTTAGCDSYAKLNQKNDSSNSGKC 145
++P+IS N + G GV NLTGTPF FS+ +N F GC++ A + + N C
Sbjct: 87 KSPIISSNCT---GREDGVPLNLTGTPFVFSRYDNVFIAVGCNTQALMT--GITPNLIGC 141
Query: 146 QSVCTCDPTQYADCCDLLCTVPPNTKVFDTNSSYKYYQSIPQECSVVFVVEQEWLFNNYQ 205
V TC + + C+ L +P + +VF+ + C + F+V W F +
Sbjct: 142 --VSTCSDVKSKNFCEAL--LPSSLQVFNPRIEATDDNQDREGCKLAFLVNHTW-FESNV 196
Query: 206 TNSVVLKDQEQVPAVLEWGKYKGT-----CTEEYN-SHTKMCNKDNHCLLQLGTGHFCLC 259
++ L+ ++ VPA L W C YN S C D G +
Sbjct: 197 SDPFSLQSRDYVPAELGWAMSVNDDDPVYCRGYYNRSFGSECECDGG---YEGIPYLGCI 253
Query: 260 DYTRSVASRH-CAGDLICSTTSGHNCSECPQGYYLSSYNSDQEPLCSRSTQLTFGKKSRN 318
D S+H C G L C T G+ E + Y
Sbjct: 254 DVDECKESKHSCRGLLKCVNTRGYFNCEINKLYI-------------------------- 287
Query: 319 KYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNI 378
IVIG L LL G WW+YK +K+ +I LK+KFFKRNGGLLLQQEL + EG +
Sbjct: 288 ALIVIGAVVLA---LSLLMGIWWLYKLVKKWKKIELKKKFFKRNGGLLLQQELRAAEGWV 344
Query: 379 DKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFI 438
K+K+++SKELE ATD +N NRILGQGGQGTVYKGMLADGRIVA+KKS V+DE K++EFI
Sbjct: 345 QKTKIYSSKELEVATDRFNVNRILGQGGQGTVYKGMLADGRIVAVKKSMVVDEGKLEEFI 404
Query: 439 NEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI 498
NEV +LSQINHRNVVKLLGCCLETEVPLLVYEFI NG L++Y+HD NE+F ++WE+RLRI
Sbjct: 405 NEVVVLSQINHRNVVKLLGCCLETEVPLLVYEFIPNGNLYKYIHDPNEDFLLSWEMRLRI 464
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
AIEV+ A+SYLHSA SIPIYHRDIKSTNILLD KYRAKVSDFG+SRS++IDQTH+TT VQ
Sbjct: 465 AIEVAGALSYLHSATSIPIYHRDIKSTNILLDEKYRAKVSDFGSSRSISIDQTHLTTLVQ 524
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
GTFGYLDPEYF+SS+FTEKSDVYSFGVVL EL++G++ I + E +SLA +F+ M++
Sbjct: 525 GTFGYLDPEYFQSSQFTEKSDVYSFGVVLVELISGQKPIFSVSQTETRSLATHFIMLMED 584
Query: 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+ L ++LDA V + E++++VA L RCLNLNGK RPTM+EV L I
Sbjct: 585 NRLSDVLDARVKEGCQNEEVISVANLAKRCLNLNGKNRPTMREVTSELERI 635
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 721 | ||||||
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.528 | 0.481 | 0.579 | 3.9e-136 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.654 | 0.613 | 0.481 | 4e-136 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.823 | 0.755 | 0.437 | 3.6e-135 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.619 | 0.563 | 0.517 | 8.2e-132 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.533 | 0.534 | 0.560 | 6.1e-131 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.937 | 0.900 | 0.413 | 7.3e-130 | |
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.556 | 0.536 | 0.546 | 8.8e-130 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.624 | 0.589 | 0.508 | 1.4e-129 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.814 | 0.804 | 0.427 | 2.4e-122 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.852 | 0.780 | 0.439 | 1.7e-121 |
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1169 (416.6 bits), Expect = 3.9e-136, Sum P(3) = 3.9e-136
Identities = 223/385 (57%), Positives = 298/385 (77%)
Query: 316 SRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTE 375
+ ++ + IG FG L + G + +YKF+K++ ++ K+KFFKRNGGLLLQQ+L ST
Sbjct: 368 NNHRPLAIGL-GASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTV 426
Query: 376 GNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVD 435
G ++K+ +F+S+ELE AT+++++NRILGQGGQGTVYKGML DGRIVA+KKSKV+DE K++
Sbjct: 427 GMVEKTIVFSSRELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLE 486
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEI 494
EFINEV ILSQINHRN+VKLLGCCLET+VP+LVYEFI NG LF++LHD+ +E TW I
Sbjct: 487 EFINEVVILSQINHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNI 546
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554
RLRIAI+++ A+SYLHS+AS PIYHRD+KSTNI+LD KYRAKVSDFG SR++ +D TH+T
Sbjct: 547 RLRIAIDIAGALSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLT 606
Query: 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614
T V GT GY+DPEYF+SS+FT+KSDVYSFGVVL EL+TGE++I +E+++LA YF+
Sbjct: 607 TVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFIL 666
Query: 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674
AMKE+ LF+I+DA + + AK+ +CLNL G+KRP+M+EV++ L I+ G
Sbjct: 667 AMKENKLFDIIDARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCG 726
Query: 675 TSNIIQESVESDIAESYETGESFTE 699
+ QE V S+ E E + E
Sbjct: 727 DMQL-QECV-SENEEGEEQNKGLVE 749
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1201 (427.8 bits), Expect = 4.0e-136, Sum P(2) = 4.0e-136
Identities = 240/498 (48%), Positives = 341/498 (68%)
Query: 189 CSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYNSHTKMCNKDNHCL 248
C V F+ ++E+ +N ++ L L W + T + + D + +
Sbjct: 223 CKVAFITDEEYFLSN-GSDPERLHANGYDTVDLRW--FIHTANHSFIGSLGCKSIDEYTI 279
Query: 249 LQLGTGHF---CLCDY---TRSVASRHCAGDLICSTTSGHNC---SECPQGYYLSSYNSD 299
L+ + CLCDY T A+ CA + C +EC +G D
Sbjct: 280 LRRDNREYGIGCLCDYNSTTTGYATCSCASGFEGNPYIPGECKDINECVRGI-------D 332
Query: 300 QEPLCS--RSTQLTFG---KKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIML 354
P+C+ + L G + + ++ +VIG ++ F L + G +W+YKF++R+ +
Sbjct: 333 GNPVCTAGKCVNLLGGYTCEYTNHRPLVIGLSTS-FSTLVFIGGIYWLYKFIRRQRRLNQ 391
Query: 355 KQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM 414
K+KFFKRNGGLLLQQ+L +TEGN+D +++F S+ELE AT++++ RILG+GGQGTVYKGM
Sbjct: 392 KKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGM 451
Query: 415 LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474
L DGRIVA+KKSKV+DE K++EFINEV ILSQINHRN+VKLLGCCLET+VP+LVYEFI N
Sbjct: 452 LVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPN 511
Query: 475 GTLFQYLHDQNEEFPIT-WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533
G LF++LHD ++++ +T WE+RLRIA++++ A+SYLHSAAS PIYHRDIKSTNI+LD K+
Sbjct: 512 GNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKH 571
Query: 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
RAKVSDFG SR++ +D TH+TT V GT GY+DPEYF+SS+FT+KSDVYSFGVVLAEL+TG
Sbjct: 572 RAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITG 631
Query: 594 ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNG 653
E+++ +E ++LA YF AMKE+ L +I+DA + + AK+ +CLN+ G
Sbjct: 632 EKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKG 691
Query: 654 KKRPTMKEVAVVLAGIKA 671
+KRP+M++V++ L I++
Sbjct: 692 RKRPSMRQVSMELEKIRS 709
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1176 (419.0 bits), Expect = 3.6e-135, Sum P(2) = 3.6e-135
Identities = 284/649 (43%), Positives = 381/649 (58%)
Query: 92 ISLNSSKSMGNAKGVNLTGTPFSFSQKNNK--FTTAGCD-SY--AKLNQKNDSSNSGKCQ 146
+SL K N G L + + S N+ F GC SY A++ N + G
Sbjct: 145 VSLEHIKQ--NMVGCELNCSTTNASDSNSIPFFDKTGCSFSYTFAQVCTGNKPEDMG--- 199
Query: 147 SVCTCDPTQYADCCDLLCTVPPNTKVFDTNSSYKYYQSIPQECSVVFVVEQEWLFNNYQT 206
CD CC P + S + +C V F+ ++ + + T
Sbjct: 200 ----CDGR---GCCQASLPREPQQVIGIRIESNDGKSTTSGDCRVAFLTDEFFSLSKL-T 251
Query: 207 NSVVLKDQEQVPAVLEWGKYKGTCTEEYNSHTKMCNKDNHCLLQLGTGHFCLCDYTRSVA 266
L + L W T NS KD C+CDYT S+
Sbjct: 252 KPEQLHAKRYATLSLGWIMQTRN-TSFVNSLACKIRKDTDTAYSNDQSIKCICDYTMSII 310
Query: 267 SRHCAGDLICSTTSGHNCSECPQGYYLSSYNSD---------QEP-LCSRS-TQLTF--G 313
S D+ + NC EC GY + Y+SD + P C + T + F G
Sbjct: 311 S-----DIRYA-----NC-ECNLGYKGNPYDSDGCRDIDECKENPKYCKETDTCVNFEGG 359
Query: 314 KK---SRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQE 370
+ + K I+IG +G FG+L L+ G WW+ KFL ++ K+KFFKRNGGLLLQQE
Sbjct: 360 YRCVGDKTKAIMIGAGTG-FGVLVLVGGVWWLRKFLVKRRMAKRKKKFFKRNGGLLLQQE 418
Query: 371 LASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID 430
L + +G ++K+++FTSKELE AT++++ NR+LG GGQGTVYKGML DGR VA+KKSKVID
Sbjct: 419 LNTRQGVVEKARIFTSKELEKATENFSENRVLGHGGQGTVYKGMLVDGRTVAVKKSKVID 478
Query: 431 ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN-EEFP 489
E K+ EFINEV ILSQINHR+VVKLLGCCLETEVP+LVYEFIING LF+++H++ +++
Sbjct: 479 EDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPILVYEFIINGNLFKHIHEEEADDYT 538
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549
+ W +RLRIA++++ A+SYLHSAAS PIYHRDIKSTNILLD KYRAKV+DFG SRS+ ID
Sbjct: 539 MIWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRAKVADFGTSRSVTID 598
Query: 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER-AIRVTNFEEDKSL 608
QTH TT + GT GY+DPEY+RSS++TEKSDVYSFGV+LAEL+TG++ I V N +E +L
Sbjct: 599 QTHWTTVISGTVGYVDPEYYRSSQYTEKSDVYSFGVILAELITGDKPVIMVQNTQEIIAL 658
Query: 609 AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668
A +F AMKE L +I+DA + ++ E ++ VA L +CL+ G+ RP M+EV L
Sbjct: 659 AEHFRVAMKERRLSDIMDARIRDDSKPEQVMAVANLAMKCLSSRGRNRPNMREVFTELER 718
Query: 669 IKACDGTSNI---IQESVESDIAESYETGESFT---ESYTDSVTIPVDA 711
I S + I E E D E E + +S++ VT P +
Sbjct: 719 ICTSPEDSQVQNRIDEEEEEDGVEEEEEVVTIVHRGDSWSIGVTAPASS 767
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1149 (409.5 bits), Expect = 8.2e-132, Sum P(3) = 8.2e-132
Identities = 245/473 (51%), Positives = 327/473 (69%)
Query: 260 DYTRSV-ASRHCA-GDLICSTTSGHNCSECPQGYYLSSY--NSDQE--------PLCSRS 307
DY + R C G + S TS NC C GY + Y N ++ C ++
Sbjct: 301 DYRNTTNLERKCTCGRITISETSYANCG-CTYGYTGNPYVLNGCKDIDECKVKFEYCGKT 359
Query: 308 -TQLTF--GK---KSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKR 361
T + F G + + K I+IG +G FG+L L+ G WW+ KFL ++ K+KFFKR
Sbjct: 360 ETCVNFEGGYRCVRDKTKAIMIGAGTG-FGVLVLVGGLWWLRKFLIKRRITKRKKKFFKR 418
Query: 362 NGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIV 421
NGGLLL QEL + EG ++K+++F S+ELE AT++++ NR+LG GGQGTVYKGML DGR V
Sbjct: 419 NGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRVLGHGGQGTVYKGMLVDGRTV 478
Query: 422 AIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL 481
A+KKSKVIDE K+ EFINEV ILSQINHR+VVKLLGCCLETEVP+LVYEFIING LF+++
Sbjct: 479 AVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLETEVPMLVYEFIINGNLFKHI 538
Query: 482 HDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540
H++ ++++ + W +RLRIA++++ A+SYLHS+AS PIYHRDIKSTNILLD KYRAKV+DF
Sbjct: 539 HEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRDIKSTNILLDEKYRAKVADF 598
Query: 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER-AIRV 599
G SRS+ IDQTH TT + GT GY+DPEY++SS++TEKSDVYSFGV+LAEL+TG++ I V
Sbjct: 599 GTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVYSFGVILAELITGDKPVIMV 658
Query: 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659
N +E +LA +F AMKE L +I+DA + + E ++ VAK+ +CL+ GKKRP M
Sbjct: 659 QNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQVMAVAKVAMKCLSSKGKKRPNM 718
Query: 660 KEVAVVLAGIKACDGTSN----IIQESVESDIAESYETGESFTESYTDSVTIP 708
+EV L I S I +E E + E T + +S++ SVT P
Sbjct: 719 REVFTELERICTSPEDSQVHNRIDEEEEEEEEEEEVVTTINRGDSWSISVTAP 771
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1118 (398.6 bits), Expect = 6.1e-131, Sum P(2) = 6.1e-131
Identities = 219/391 (56%), Positives = 290/391 (74%)
Query: 331 GMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELE 390
G+L L+ G W + K +++ K+KFF+RNGGLLLQQ+ + G+++++K+F+S +LE
Sbjct: 325 GLLLLIFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLE 384
Query: 391 TATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHR 450
ATD +N +RILGQGGQGTVYKGML DG IVA+KKSK + E ++EFINE+ +LSQINHR
Sbjct: 385 NATDRFNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHR 444
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
NVVK+LGCCLETEVP+LVYEFI N LF +LH+ +E+FP++WE+RL IA EV+DA+SYLH
Sbjct: 445 NVVKILGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLH 504
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
SA SIPIYHRD+KSTNILLD K+RAKVSDFG SRS+AID TH+TT VQGT GY+DPEY +
Sbjct: 505 SAVSIPIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQ 564
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
S+ FT KSDVYSFGV+L ELLTGE+ + + +E + L AYFL AM+ D L EILDA +
Sbjct: 565 SNHFTGKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIK 624
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC-DGTSNIIQESVES---D 686
+E +E+++ VAKL RCL+LN + RPTM++V + L +++ GT + Q E
Sbjct: 625 EECDREEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQ 684
Query: 687 IA--ESYETGESFTESYTDSVTIPVDADPLI 715
IA ES S ++ + +D PL+
Sbjct: 685 IAMPESMSLSYSSPNIVVENSSFSLDTKPLM 715
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 7.3e-130, P = 7.3e-130
Identities = 303/733 (41%), Positives = 437/733 (59%)
Query: 22 SEPLMCDQ-CGDFGSDDYPFGIGE-GCYFDKSFEVFCDNS-SG-SPKPLLKSIN---LNM 74
S C++ CG +PFGIG C+ + +EV C+++ SG S P L IN +++
Sbjct: 32 SSSTSCNRICGGI-EIPFPFGIGRRDCFLNDWYEVVCNSTTSGKSLAPFLYKINRELVSI 90
Query: 75 LLNFVFQK--GLIAVEAPVISLNSSKSMGNAKGVNLTG--TPFSFSQKNNKFTTAGCDSY 130
L G++ +++PV S S+ +NLTG +PF F +N+ + GCD+
Sbjct: 91 TLRSSIDSSYGVVHIKSPVTSSGCSQRPVKPLPLNLTGKGSPF-FITDSNRLVSVGCDNR 149
Query: 131 AKLNQKNDSSNSGKCQSVCTCDPTQYADCCD--LLCT--VP---PNTKVFDTNSSYKYYQ 183
A + +S +G C+S C D ++ C C +P P D SS
Sbjct: 150 ALITDI-ESQITG-CESSCDGDKSRLDKICGGYTCCQAKIPADRPQVIGVDLESSGGNTT 207
Query: 184 SIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPA--VLEWGKYKGTCTEEYNSHTKMC 241
C V F+ + Y +V +Q V+E G Y T S +++
Sbjct: 208 Q-GGNCKVAFLTNE-----TYSPANVTEPEQFYTNGFTVIELGWYFDT------SDSRLT 255
Query: 242 NKDNHCLLQLGTGHF-----CLCDYTR--SVASRHCAGDLICSTTSGH---NC---SECP 288
N C+ TG + C+C+Y +C + I + + C EC
Sbjct: 256 NPVG-CVNLTETGIYTSAPSCVCEYGNFSGFGYSNCYCNQIGYRGNPYLPGGCIDIDECE 314
Query: 289 QGYYLSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKR 348
+G LSS S + + K + G G F +L L+ G W + KF+K+
Sbjct: 315 EGKGLSSCGELTCVNVPGSWRCELNGVGKIKPLFPGLVLG-FPLLFLVLGIWGLIKFVKK 373
Query: 349 KMEIMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQG 408
+ +I+ K+ FFKRNGGLLL+Q+L + GN+ SK+F+SKELE ATD++N NR+LGQGGQG
Sbjct: 374 RRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQG 433
Query: 409 TVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468
TVYKGML DGRIVA+K+SKV+DE KV+EFINEV +LSQINHRN+VKL+GCCLETEVP+LV
Sbjct: 434 TVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILV 493
Query: 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNIL 528
YE I NG LF+ LH ++++ +TW++RLRI++E++ A++YLHSAAS P+YHRD+K+TNIL
Sbjct: 494 YEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNIL 553
Query: 529 LDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLA 588
LD KYRAKVSDFG SRS+ +DQTH+TT V GTFGYLDPEYF++S+FT+KSDVYSFGVVL
Sbjct: 554 LDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLV 613
Query: 589 ELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRC 648
EL+TGE+ V EE++ L ++F AMK++ + +I+D+ + + + E ++ VAKL RC
Sbjct: 614 ELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRIKEGCTLEQVLAVAKLARRC 673
Query: 649 LNLNGKKRPTMKEVAVVLAGIKACDGTSNI-IQESVESDIAESYETGESFTESYTDSVTI 707
L+L GKKRP M+EV+V L I++ + I+E E + A +S++ T ++
Sbjct: 674 LSLKGKKRPNMREVSVELERIRSSPEDLELHIEEEDEEECAMEINMDDSWSVDMTAPASL 733
Query: 708 ----P-VDADPLI 715
P +D +PL+
Sbjct: 734 FDLSPKLDVEPLV 746
|
|
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1174 (418.3 bits), Expect = 8.8e-130, Sum P(2) = 8.8e-130
Identities = 224/410 (54%), Positives = 310/410 (75%)
Query: 314 KKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELAS 373
K + K ++ G G +L G + +YKF++++ +++ +KFF+RNGG+LL+Q+LA
Sbjct: 335 KPEQLKRVIQGVLIGS-ALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLAR 393
Query: 374 TEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESK 433
EGN++ S++F+S ELE ATD++N NR+LGQGGQGTVYKGML DGRIVA+K+SK +DE +
Sbjct: 394 KEGNVEMSRIFSSHELEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDR 453
Query: 434 VDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWE 493
V+EFINEV +L+QINHRN+VKLLGCCLETEVP+LVYEF+ NG L + LHD+++++ +TWE
Sbjct: 454 VEEFINEVVVLAQINHRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWE 513
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
+RL IAIE++ A+SYLHSAAS PIYHRDIK+TNILLD + RAKVSDFG SRS+ IDQTH+
Sbjct: 514 VRLHIAIEIAGALSYLHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHL 573
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613
TTQV GTFGY+DPEYF+SS+FTEKSDVYSFGVVL ELLTGE+ EE++ LAA+F+
Sbjct: 574 TTQVAGTFGYVDPEYFQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFV 633
Query: 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673
A+KE+ + +I+D + E + + +++VA L RCLN GKKRP M+EV++ L I++
Sbjct: 634 EAVKENRVLDIVDDRIKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSH 693
Query: 674 GTSNI-IQESVESD-------IAESYETGESFTESYTDSVTIPVDADPLI 715
S I I++ E D +++E G + S ++ + DA+PL+
Sbjct: 694 YDSGIHIEDDDEEDDQAMELNFNDTWEVGATAPASMFNNASPTSDAEPLV 743
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 1.4e-129, Sum P(2) = 1.4e-129
Identities = 242/476 (50%), Positives = 313/476 (65%)
Query: 238 TKMCNKDNHCLLQLGTGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYN 297
T+ C DNH +G C C AS + + N EC + Y +
Sbjct: 305 TRQCTCDNHIASGMGYAS-CAC------ASGYKGNPYVSDDCQDIN--ECTE--YKNPCG 353
Query: 298 SDQEPLCSRSTQL-TFGKKSRNKY----IVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEI 352
+ + R+T + T G Y +++G GF +L + G WW K L+++
Sbjct: 354 DTR--ILYRNTCINTSGGHRCIDYHIPEVMLGL-GAGFFVLIVGGGIWWWRKLLRKRRMT 410
Query: 353 MLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYK 412
K+KFFKRNGGLLLQQ+L +T+G ++K+KLF+S+ELE ATD++N NR++GQGGQGTVYK
Sbjct: 411 NRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVIGQGGQGTVYK 470
Query: 413 GMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472
GML DGR VA+KKS V+DE K+ EFINEV ILSQINHR+VVKLLGCCLETEVP+LVYEFI
Sbjct: 471 GMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLETEVPILVYEFI 530
Query: 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532
NG LFQ+LH++ +++ W +R+RIA+++S A SYLH+AA PIYHRDIKSTNILLD K
Sbjct: 531 PNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDIKSTNILLDEK 590
Query: 533 YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
YRAKVSDFG SRS++ID TH TT + GT GY+DPEY+ SS FTEKSDVYSFGVVL EL+T
Sbjct: 591 YRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYSFGVVLVELIT 650
Query: 593 GER-AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNL 651
GE+ I ++ +E LA YF AM+E+ LFEI+DA + + E ++ VA L RCL
Sbjct: 651 GEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAVANLALRCLKK 710
Query: 652 NGKKRPTMKEVAVVLAGIKACDGTSNIIQESVESDIAESYETGESFTESYTDSVTI 707
GK RP M+EV+ L I C + V+ I E ET + F Y+ S I
Sbjct: 711 TGKTRPDMREVSTALERI--CSAPEDF---QVQIQIDEEDETTKLF-RGYSGSTEI 760
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1203 (428.5 bits), Expect = 2.4e-122, P = 2.4e-122
Identities = 271/634 (42%), Positives = 389/634 (61%)
Query: 83 GLIAVEAPVISL----NSSKSMGNAKGV-NLTG--TPFSFSQKNNKFTTAGCDSYAKLNQ 135
GL+ ++ PV SL N+S+ N+ V N+TG +P+ F N+ GC A +
Sbjct: 103 GLVQIKGPVTSLGCSSNTSEGPQNSLPVLNVTGKGSPY-FLTDENRLVAVGCGIKALMTD 161
Query: 136 KNDSSNSGKCQSVCTCDPTQYADCCDLLCT--------VPPNTKVFDTNSSYKYYQSIPQ 187
+S G C+S C + + +L+CT +P T + + +
Sbjct: 162 -TESEILG-CESSCEHRKSG-EEVTNLICTGYRCCQARLPVGRPQAIT-VNIENSSGGEE 217
Query: 188 ECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTEEYNSH---TKMCNK- 243
C V F+ ++ + +N T + V VLE G Y T + S T M K
Sbjct: 218 TCKVAFLTDKRYSPSNV-TEPEQFHNNGYV--VLELGWYFATSNSRFKSLLGCTNMSRKG 274
Query: 244 ----DNHCLLQL----GTGHF-CLCDYTRSVASRHCAGDLIC--STTSGHNCSECPQGYY 292
D++C + G + C CDY + + + G + S HNC E
Sbjct: 275 SGFSDDNCSCEYDYFSGMSYRNCYCDYGYT-GNPYLRGGCVDTDSCEGNHNCGEDAHCVN 333
Query: 293 LSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEI 352
+ S +C + ++T K ++ G G G++ G +W++K +K++ I
Sbjct: 334 MPGPMS----MCRPNPKIT---KPTKPPVLQGILIGLSGLV-FFVGLFWLFKLIKKRRNI 385
Query: 353 MLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYK 412
+KFFKRNGGLLL+Q+L + +GN++ SK+F+SKEL ATD+++ +R+LGQGGQGTVYK
Sbjct: 386 NRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLGQGGQGTVYK 445
Query: 413 GMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472
GML DG IVA+K+SKV+DE K++EFINE+ +LSQINHRN+VKLLGCCLETEVP+LVYE+I
Sbjct: 446 GMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETEVPILVYEYI 505
Query: 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532
NG LF+ LHD+++++ +TWE+RLRIAIE++ A++Y+HSAAS PI+HRDIK+TNILLD K
Sbjct: 506 PNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIKTTNILLDEK 565
Query: 533 YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
YRAKVSDFG SRS+ +DQTH+TT V GTFGY+DPEYF SS++T KSDVYSFGVVL EL+T
Sbjct: 566 YRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSFGVVLVELIT 625
Query: 593 GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLN 652
GE+ + EE + LA +FL AMKE+ + +I+D + E+ E ++ VAKL +CLN
Sbjct: 626 GEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAKLARKCLNRK 685
Query: 653 GKKRPTMKEVAVVLAGIKACDGTSNIIQESVESD 686
GK RP MKEV+ L I++ ++ E+ + +
Sbjct: 686 GKNRPNMKEVSNELERIRSSPEDLDVRTENEDEE 719
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1195 (425.7 bits), Expect = 1.7e-121, P = 1.7e-121
Identities = 287/653 (43%), Positives = 387/653 (59%)
Query: 78 FVFQKGLIAV----EAPVISLNSSKSMGNAKGVNLTGTPFSFSQKNNKF-TTAGCDSYAK 132
F L+AV +A + ++N SK +G +N T + + K+ F GC S K
Sbjct: 129 FGIGNSLVAVGCNSKASLTNINPSK-VGCE--LNCTASKETLPSKSIPFFDKTGC-SNNK 184
Query: 133 LNQKNDSSNSGKCQSVCTCDPTQYADCC--DLLCTVPPNTKVFDTN-SSYKYYQSIPQEC 189
L + + +CD CC LL + P +V N S+ + S EC
Sbjct: 185 LPYYSSLCTKNNGEDERSCDGN---GCCIAGLLDSEAP--QVIGINIESFDHGNSTKLEC 239
Query: 190 SVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWG-KYKG-------TC--TEEYNSHTK 239
V F+ + F+N + L + L W + K +C T+EY++ T
Sbjct: 240 RVAFLTDDVSPFSN-ASEPKRLFAKRYATVSLGWVIQTKNLSFVNSLSCKNTKEYDNSTY 298
Query: 240 MCNKDNHCLLQLGTGHFCLCDYTRSVASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSD 299
C+ T DY S+ G+ + +EC + Y N
Sbjct: 299 NIKLVTSCICNNVT--ISGTDYANCGCSQGYEGNPYLPGGC-KDINECLRNSYGQRQNCR 355
Query: 300 QEPLCSR--STQLTFGKKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQK 357
+ C T G K+R I +G FG+L L+ G WW+ KFLK++ K+K
Sbjct: 356 ESDTCVNLPGTFNCIGNKTRVTMIGVG---SAFGILVLVVGIWWLRKFLKKRRMSKRKRK 412
Query: 358 FFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLAD 417
FFKRNGGLLLQQ+L + +GN++K+++F+S+ELE ATD+++ +RILGQGGQGTVYKGML D
Sbjct: 413 FFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRILGQGGQGTVYKGMLVD 472
Query: 418 GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477
GR VA+KKSKV+DE K++EFINEV ILSQINHR+VVKLLGCCLETEVP LVYEFI NG L
Sbjct: 473 GRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLETEVPTLVYEFIPNGNL 532
Query: 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537
FQ++H++++++ TW +RLRIA++++ A+SYLHSAAS PIYHRDIKSTNILLD KYR KV
Sbjct: 533 FQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNILLDEKYRTKV 592
Query: 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER-A 596
SDFG SRS+ ID TH TT + GT GY+DPEY+ SS++T+KSDVYSFGVVL EL+TGE+
Sbjct: 593 SDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYSFGVVLVELITGEKPV 652
Query: 597 IRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKR 656
I V+N +E + LA +F AMKE+ FEI+DA + E ++ VA L RCLN GKKR
Sbjct: 653 ITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAVANLARRCLNSKGKKR 712
Query: 657 PTMKEVAVVLAGIKACDGTSNI-IQESVESDIAESYETGESFTESYTDSVTIP 708
P M++V L I A S + I+ +D E T + +S T VT P
Sbjct: 713 PCMRKVFTDLEKILASQEDSLVNIENDDGADDEEEGMTMINIDDSQTIYVTAP 765
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005801001 | SubName- Full=Chromosome chr3 scaffold_158, whole genome shotgun sequence; (791 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 721 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-52 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-50 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-48 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-46 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 3e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 6e-45 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-30 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-28 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-28 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-28 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-26 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-26 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 6e-26 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-26 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-25 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-25 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-25 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-24 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-24 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-23 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 7e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-23 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 8e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-22 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-22 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 8e-22 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-22 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-21 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-21 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-21 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-21 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 9e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-20 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-20 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-20 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-19 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-19 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-19 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-18 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-18 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-18 | |
| pfam13947 | 106 | pfam13947, GUB_WAK_bind, Wall-associated receptor | 4e-18 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-18 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-18 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-18 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-17 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-17 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-17 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-16 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-16 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-16 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-16 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-16 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-16 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-16 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-15 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-15 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-15 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-15 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 5e-15 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-15 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-14 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 5e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-14 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 6e-14 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-14 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-13 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-13 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 8e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 9e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 9e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-12 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-12 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-12 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-12 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-12 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-12 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-12 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-11 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-11 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-11 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 8e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 9e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-10 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-10 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 7e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 9e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-09 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 7e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-08 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-08 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-08 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 1e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.003 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 5e-55
Identities = 87/273 (31%), Positives = 130/273 (47%), Gaps = 25/273 (9%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNV 452
Y R LG G GTVYK G+IVA+K K K E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
V+L+ + + LV E+ G LF YL P++ + +IA+++ + YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRS 571
I HRD+K NILLD K++DFG ++ + + +TT V GT Y+ PE
Sbjct: 118 G---IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 572 SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631
+ + K DV+S GV+L ELLTG+ F + L L + IL +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK-----PPFSGENILDQLQL-------IRRILGPPLEF 221
Query: 632 EASQEDIV--TVAKLTNRCLNLNGKKRPTMKEV 662
+ + L +CLN + KRPT +E+
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 4e-53
Identities = 81/269 (30%), Positives = 122/269 (45%), Gaps = 23/269 (8%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQINHRNVV 453
Y LG+G G VY G++VAIK K + + + E+ IL ++ H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+L + + LV E+ G LF L + E R ++ A+ YLHS
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-RLSE-DEAR-FYLRQILSALEYLHSK- 116
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I HRD+K NILLD K++DFG +R + +TT V GT Y+ PE
Sbjct: 117 --GIVHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKG 172
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
+ + D++S GV+L ELLTG+ F D L F + K F + + EA
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP-----FPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+D++ + L + +KR T +E
Sbjct: 228 --KDLI------RKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 2e-52
Identities = 73/193 (37%), Positives = 109/193 (56%), Gaps = 10/193 (5%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG+GG GTVY G+ VAIK K S ++E + E+ IL ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ LV E+ G+L L + E ++ + LRI +++ + + YLH S I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 520 RDIKSTNILLD-GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR-FTEK 577
RD+K NILLD + K++DFG S+ + D++ + T V GT Y+ PE ++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174
Query: 578 SDVYSFGVVLAEL 590
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 6e-50
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 31/273 (11%)
Query: 399 NRILGQGGQGTVYKGML----ADGRI-VAIKKSKVI-DESKVDEFINEVAILSQINHRNV 452
+ LG+G G VYKG L + VA+K K E +++EF+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
VKLLG C E E ++V E++ G L YL N ++ L A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
S HRD+ + N L+ K+SDFG SR + D + + ++ PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 573 RFTEKSDVYSFGVVLAELLT-GER-AIRVTNFE-EDKSLAAYFLRAMKEDSLFEILDAHV 629
+FT KSDV+SFGV+L E+ T GE ++N E + Y L
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCP--------- 230
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
++ + +C + + RPT E+
Sbjct: 231 ------PELYKLML---QCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 1e-48
Identities = 79/273 (28%), Positives = 126/273 (46%), Gaps = 32/273 (11%)
Query: 399 NRILGQGGQGTVYKGML-----ADGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNV 452
+ LG+G G VYKG L VA+K K E +++EF+ E I+ +++H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
VKLLG C E E +V E++ G L YL + ++ L A++++ + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
S HRD+ + N L+ K+SDFG SR + D + + ++ PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 573 RFTEKSDVYSFGVVLAELLT-GER-AIRVTNFE-EDKSLAAYFLRAMKEDSLFEILDAHV 629
+FT KSDV+SFGV+L E+ T GE+ ++N E + Y L
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCP--------- 229
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
++ + +C + + RPT E+
Sbjct: 230 ------PELYDLML---QCWAEDPEDRPTFSEL 253
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 165 bits (421), Expect = 1e-46
Identities = 82/280 (29%), Positives = 125/280 (44%), Gaps = 40/280 (14%)
Query: 400 RILGQGGQGTVYKGMLADG----RIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVK 454
+ LG+G G VYKG L VA+K K E + +F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFP------ITWEIRLRIAIEVSDAVSY 508
LLG C E E LV E++ G L YL FP ++ + L AI+++ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDP 566
L S HRD+ + N L+ K+SDFG SR + D + G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE-IL 625
E + FT KSDV+SFGV+L E+ T L A + + + E +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT---------------LGATPYPGLSNEEVLEYLR 221
Query: 626 DAHVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ L + E + +L C L+ + RPT E+
Sbjct: 222 KGYRLPKPEYCPDE----LYELMLSCWQLDPEDRPTFSEL 257
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 164 bits (419), Expect = 3e-46
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 39/281 (13%)
Query: 399 NRILGQGGQGTVYKGML-----ADGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNV 452
+ LG+G G VYKG L VA+K K E + +EF+ E +I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
V+LLG C + E +V E++ G L +L E+ + L++A++++ + YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD--LLQMALQIAKGMEYLE-- 119
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLD-----PE 567
S HRD+ + N L+ K+SDFG ++ D + G L PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFG----LSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERA--IRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625
+ +FT KSDV+SFGV+L E+ T ++N E L +++ L
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE--------VLELLEDG---YRL 223
Query: 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ E + +L +C + + RPT E+ L
Sbjct: 224 PRP--ENCPDE----LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 6e-45
Identities = 75/265 (28%), Positives = 131/265 (49%), Gaps = 26/265 (9%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLL 456
+LG+G G+VY + D G ++A+K ++ E +++ E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 457 GCCL-ETEVPLLVY-EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
G E + L ++ E++ G+L L + + P IR + ++ + ++YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK-KFGKLPEP-VIR-KYTRQILEGLAYLHSNG- 121
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA-IDQTHMTTQVQGTFGYLDPEYFRSSR 573
I HRDIK NIL+D K++DFG ++ + I+ T V+GT ++ PE R
Sbjct: 122 --IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
+ +D++S G + E+ TG+ + E + A + EI H+ +EA
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPP-----WSELGNPMAALYKIGSSGEPPEI-PEHLSEEA 233
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPT 658
+D + +CL + KKRPT
Sbjct: 234 --KDFL------RKCLRRDPKKRPT 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 77/267 (28%), Positives = 129/267 (48%), Gaps = 24/267 (8%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLL 456
+ +G+G G VY +DG++ +K+ + + E + ++ +NEV IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSDAVSYLHSAASI 515
E +V E+ G L Q + Q +E P E L +++ A+ YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
I HRDIK NI L K+ DFG S+ ++ T V GT YL PE ++ +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQNKPYN 181
Query: 576 EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635
KSD++S G VL EL T + F E ++L L+ +K + + + S
Sbjct: 182 YKSDIWSLGCVLYELCTLKHP-----F-EGENLLELALKILKGQ--YPPIPSQY----SS 229
Query: 636 EDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E + L + L + ++RP++ ++
Sbjct: 230 E----LRNLVSSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 81/269 (30%), Positives = 120/269 (44%), Gaps = 38/269 (14%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+G+GG G VYK G+ VAIK K+ + K ++ INE+ IL + H N+VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 461 ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIA---IEVSDAVSYLHSAASIPI 517
+ + +V EF G+L L N+ + IA E+ + YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG---I 119
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRDIK+ NILL K+ DFG S ++ + T GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYDYK 177
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE---AS 634
+D++S G+ EL G+ + E + A F A L+ S
Sbjct: 178 ADIWSLGITAIELAEGKPP-----YSELPPMKALFKIATN--------GPPGLRNPEKWS 224
Query: 635 QE--DIVTVAKLTNRCLNLNGKKRPTMKE 661
E D + +CL N +KRPT ++
Sbjct: 225 DEFKDFL------KKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 9e-33
Identities = 78/281 (27%), Positives = 122/281 (43%), Gaps = 24/281 (8%)
Query: 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH-R 450
Y R LG+G G VY D ++VA+K K +V+ F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+VKL + LV E++ G+L L + P++ L I ++ A+ YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 511 SAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQTHMTTQVQ-----GTFGYL 564
S I HRDIK NILLD K+ DFG ++ + + + GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 565 DPEYFRSSRF---TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF-LRAMKEDS 620
PE + SD++S G+ L ELLTG FE +K+ +A + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP-----FEGEKNSSATSQTLKIILEL 230
Query: 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
L + + + + L + L + K R +
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 82/275 (29%), Positives = 130/275 (47%), Gaps = 39/275 (14%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESK-VDEFINEVAILSQINHRNVVKLLGCCL 460
+G+G G V G G+ VA+K K D+S F+ E ++++ + H N+V+LLG L
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 461 ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHR 520
+ +V E++ G+L YL + IT +L A++V + + YL HR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 521 DIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDV 580
D+ + N+L+ AKVSDFG ++ + Q V+ T PE R +F+ KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182
Query: 581 YSFGVVLAELLTGERA--IRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK----EAS 634
+SFG++L E+ + R R+ L +++ HV K EA
Sbjct: 183 WSFGILLWEIYSFGRVPYPRI--------------------PLKDVVP-HVEKGYRMEAP 221
Query: 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+ V K+ C L+ KRPT K++ LA I
Sbjct: 222 EGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 79/279 (28%), Positives = 124/279 (44%), Gaps = 40/279 (14%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
+ Y +G+G G VYK A G+ VAIKK ++ ++K + INE+ I+ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNK-ELIINEILIMKDCKHPN 76
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+V L + +V E++ G+L + QN + + EV + YLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS 134
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
I HRDIKS NILL K++DFG + + +++ + V GT ++ PE +
Sbjct: 135 QNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPEVIKR 190
Query: 572 SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF----LRAMKEDSLFEILDA 627
+ K D++S G++ E+ GE Y LRA+ L
Sbjct: 191 KDYGPKVDIWSLGIMCIEMAEGE--------------PPYLREPPLRALF---LITTKGI 233
Query: 628 HVLKEA---SQE--DIVTVAKLTNRCLNLNGKKRPTMKE 661
LK S E D + N+CL + +KRP+ +E
Sbjct: 234 PPLKNPEKWSPEFKDFL------NKCLVKDPEKRPSAEE 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 77/262 (29%), Positives = 128/262 (48%), Gaps = 30/262 (11%)
Query: 402 LGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVD-----EFINEVAILSQINHRNVVKL 455
+G+G G V+K + AD R+ A+K+ ID SK++ E I+E +L++++ +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQ---IDLSKMNRREREEAIDEARVLAKLDSSYIIRY 64
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
L+ +V E+ NG L + L Q P+ + R I++ +++LHS
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK-- 121
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
I HRDIKS N+ LD K+ D G ++ ++ D T+ + GT YL PE +
Sbjct: 122 -ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYN 179
Query: 576 EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635
EKSDV++ GVVL E TG+ N A L+ ++ V SQ
Sbjct: 180 EKSDVWALGVVLYECCTGKHPFDANN------QGALILKIIR----------GVFPPVSQ 223
Query: 636 EDIVTVAKLTNRCLNLNGKKRP 657
+A+L ++CL + ++RP
Sbjct: 224 MYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 70/197 (35%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLG 457
LG+G G V G++ A+K K K+I +V+ + E ILS+INH +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 458 CCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
+TE L LV E+ G LF +L + F R A E+ A+ YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS-KEGRFSEER-ARFYAA-EIVLALEYLHSLG--- 113
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE 576
I +RD+K NILLD K++DFG ++ + T GT YL PE + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGK 172
Query: 577 KSDVYSFGVVLAELLTG 593
D +S GV+L E+LTG
Sbjct: 173 AVDWWSLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 4e-30
Identities = 64/203 (31%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRN 451
+Y ++G+G G VYKG+ L G VAIK+ + I E + + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVSYLH 510
+VK +G ++ ++ E+ NG+L Q + + FP E + + + +V ++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFP---ESLVAVYVYQVLQGLAYLH 116
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I HRDIK+ NIL K++DFG + + D + V GT ++ PE
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVATKLN-DVSKDDASVVGTPYWMAPEVIE 172
Query: 571 SSRFTEKSDVYSFGVVLAELLTG 593
S + SD++S G + ELLTG
Sbjct: 173 MSGASTASDIWSLGCTVIELLTG 195
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-29
Identities = 75/221 (33%), Positives = 110/221 (49%), Gaps = 29/221 (13%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIK--KSKVIDESKVD 435
ID S+L KEL G G G V+ G VAIK + + E D
Sbjct: 1 IDPSELTFLKEL-------------GSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---D 44
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIR 495
+FI E ++ +++H N+V+L G C + +V E++ NG L YL ++ + E
Sbjct: 45 DFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWL 102
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
L + +V +A+ YL S I HRD+ + N L+ KVSDFG +R + DQ T
Sbjct: 103 LDMCSDVCEAMEYLESNGFI---HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YT 156
Query: 556 QVQGT---FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
QGT + PE F SRF+ KSDV+SFGV++ E+ +
Sbjct: 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 71/276 (25%), Positives = 116/276 (42%), Gaps = 32/276 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFI-NEVAILSQINHRN 451
++LGQG G VYK G+I A+KK V + + + + E+ L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRL-RIAIEVSDAVSYLH 510
VVK G + +V E++ G+L L + + P E L IA ++ + YLH
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLH 116
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA-IDQTHMTTQVQGTFGYLDPEYF 569
+ I HRDIK +N+L++ K K++DFG S+ + T GT Y+ PE
Sbjct: 117 TKRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGTVTYMSPERI 172
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
+ ++ +D++S G+ L E G+ + + S FE++ A
Sbjct: 173 QGESYSYAADIWSLGLTLLECALGK----------------FPFLPPGQPSFFELMQAIC 216
Query: 630 LKEA-SQEDIVTVAKLTN---RCLNLNGKKRPTMKE 661
S + + CL + KKRP+ E
Sbjct: 217 DGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 68/212 (32%), Positives = 109/212 (51%), Gaps = 12/212 (5%)
Query: 395 HYNTNRILGQG--GQGTVYKGMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHR 450
HY R+LG+G G+ T+Y+ D +V K+ + + E + + +NE+ ILS + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYL 509
N++ ++ L+ E+ GTL+ + + + F E+ L ++ AVSY+
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE--EEMVLWYLFQIVSAVSYI 117
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
H A I HRDIK+ NI L K+ DFG S+ + + M V GT Y+ PE
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILG-SEYSMAETVVGTPYYMSPELC 173
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601
+ ++ KSD+++ G VL ELLT +R TN
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 30/219 (13%)
Query: 400 RILGQGGQGTVYKGML-ADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN-HRNVVK 454
+I+G+G TV + AIK K ++I E KV E +L+++N H ++K
Sbjct: 7 KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L + E V E+ NG L QY+ + R A E+ A+ YLHS
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIR-KYGSLDEKC-TRFYAA-EILLALEYLHS--- 120
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ---------------- 558
I HRD+K NILLD K++DFG ++ + + + + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180
Query: 559 ---GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
GT Y+ PE + SD+++ G ++ ++LTG+
Sbjct: 181 SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 36/219 (16%)
Query: 400 RILGQGGQGTVYKGMLA------DGRIVAIK--KSKVIDESKVDEFINEVAILSQINHRN 451
R LG+G G V+ G D +VA+K K ++++ D F E +L+ H N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD-FEREAELLTNFQHEN 69
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL--HD---------QNEEFPITWEIRLRIAI 500
+VK G C E + P++V+E++ +G L ++L H + +T L+IA+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT---QV 557
+++ + YL AS HRD+ + N L+ K+ DFG SR + TT +V
Sbjct: 130 QIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRV 180
Query: 558 QGT----FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
G ++ PE +FT +SDV+SFGVVL E+ T
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 66/202 (32%), Positives = 111/202 (54%), Gaps = 14/202 (6%)
Query: 400 RILGQGGQGTVYKGMLADG----RIVAIKK-SKVIDESKVDEFINEVAILSQINHRNVVK 454
R++G+G G VY G L D A+K +++ D +V++F+ E I+ +H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 455 LLGCCLETE-VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
LLG CL +E PL+V ++ +G L ++ ++E T + + ++V+ + YL A
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFI--RSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM---AIDQTHMTTQVQGTFGYLDPEYFR 570
S HRD+ + N +LD + KV+DFG +R + H T + ++ E +
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 571 SSRFTEKSDVYSFGVVLAELLT 592
+ +FT KSDV+SFGV+L EL+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 401 ILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILSQINHRNVVKL 455
LG+G G VYK G IVA+KK ++ +E + + E+++L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
L LV+E+ + L +YL + I+ I ++ ++Y HS
Sbjct: 64 LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPN-LIK-SIMYQLLRGLAYCHSHR-- 118
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
I HRD+K NIL++ K++DFG +R+ I T +V T Y PE S+
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 576 EKS-DVYSFGVVLAELLTGE 594
+ D++S G + AE++TG+
Sbjct: 177 STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 81/265 (30%), Positives = 127/265 (47%), Gaps = 27/265 (10%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
LG G G VY+G+ VA+K K D +V+EF+ E A++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 461 ETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
E P ++ EF+ G L YL + N + + + L +A ++S A+ YL I H
Sbjct: 73 R-EPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---H 127
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRFTEK 577
RD+ + N L+ + KV+DFG SR M D T F + PE ++F+ K
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSIK 185
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637
SDV++FGV+L E+ T ++ Y + ++E+L+ E +
Sbjct: 186 SDVWAFGVLLWEIAT-------------YGMSPY--PGIDLSQVYELLEKGYRMERPEGC 230
Query: 638 IVTVAKLTNRCLNLNGKKRPTMKEV 662
V +L C N RP+ E+
Sbjct: 231 PPKVYELMRACWQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 73/276 (26%), Positives = 116/276 (42%), Gaps = 39/276 (14%)
Query: 401 ILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDE-----FINEVAILSQINHRNVVK 454
+G+G GTV K +DG+I+ K+ ID + E ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKE---IDYGNMTEKEKQQLVSEVNILRELKHPNIVR 63
Query: 455 LLGCCL--ETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYLH- 510
+ + +V E+ G L Q + + E I E RI ++ A+ H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 511 -SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
S + HRD+K NI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQL 182
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--FLR--AMKEDSLFEIL 625
+ EKSD++S G ++ EL N + S F R L E++
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI 242
Query: 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
+ LN++ KRP+ +E
Sbjct: 243 KS--------------------MLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 63/200 (31%), Positives = 104/200 (52%), Gaps = 16/200 (8%)
Query: 402 LGQGGQGTVYKG--MLADGRI--VAIK--KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
LG G G V +G + G++ VA+K KS + + +D+F+ E AI+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
G L T ++V E G+L L F I+ A+++++ + YL S
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH--MTTQVQGTFGYLDPEYFRSS 572
I HRD+ + NILL + K+ DFG R++ ++ H M ++ F + PE R+
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 573 RFTEKSDVYSFGVVLAELLT 592
F+ SDV+ FGV L E+ T
Sbjct: 176 TFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 76/276 (27%), Positives = 130/276 (47%), Gaps = 31/276 (11%)
Query: 402 LGQGGQGTVYKG--MLADGRI--VAIK--KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
LG G G+V KG ++ G+ VA+K K + I K EF+ E ++++Q++H +V+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRL 61
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
+G C E +LV E G L +YL E P++ +++ +A +V+ ++YL S +
Sbjct: 62 IGVCKG-EPLMLVMELAPLGPLLKYLKK-RREIPVS-DLKE-LAHQVAMGMAYLESKHFV 117
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSR 573
HRD+ + N+LL +++AK+SDFG SR++ + G + + PE +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
F+ KSDV+S+GV L E S A MK + +L++
Sbjct: 175 FSSKSDVWSYGVTLWEAF---------------SYGAKPYGEMKGAEVIAMLESGERLPR 219
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+E + + C + RPT E+
Sbjct: 220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 65/191 (34%), Positives = 107/191 (56%), Gaps = 6/191 (3%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461
+G G G V+ G + R VAIK + S+ ++FI E ++ +++H +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521
LV+EF+ +G L YL Q +F + E L + ++V + ++YL S+ I HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---HRD 125
Query: 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVY 581
+ + N L+ KVSDFG +R + DQ +T + + PE F S+++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 582 SFGVVLAELLT 592
SFGV++ E+ +
Sbjct: 186 SFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 44/277 (15%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRNVVKLLGC 458
+G G G VY + L G ++A+K+ ++ D + E +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 459 CLETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIP 516
+ E + E+ GTL + L H + + E +R+ +++ + ++YLHS
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILD-----EHVIRVYTLQLLEGLAYLHSHG--- 119
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG---YLDPEYFRSSR 573
I HRDIK NI LD K+ DFG + + + T M +VQ G Y+ PE +
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 574 FTEK---SDVYSFGVVLAELLTGERAIRVTNFEE-DKSLAAYFLRAMKE-----DSLFEI 624
+D++S G V+ E+ TG+R + E D F DSL
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGKRP-----WSELDNEFQIMFHVGAGHKPPIPDSL--- 231
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
+ S E +RCL + KKRPT E
Sbjct: 232 -------QLSPEGK----DFLDRCLESDPKKRPTASE 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 58/193 (30%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
R LG G G V++G+ + VAIK K D K +F EV L ++ H++++ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
E ++ E + G+L +L E + + +A +V++ ++YL SI H
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQNSI---H 127
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RD+ + NIL+ KV+DFG +R + + ++++ + + + PE F+ KSD
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 580 VYSFGVVLAELLT 592
V+SFG++L E+ T
Sbjct: 187 VWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 23/208 (11%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN--EVAILSQINHRNV 452
Y +G+G G VYK G IVAIKK K+ ES+ E+ +L ++NH N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFP------ITWEIRLRIAIEVSDAV 506
+KLL LV+EF+ + L++ + D+ P +++ L+ +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GL 111
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
++ HS I HRD+K N+L++ + K++DFG +RS T V T Y P
Sbjct: 112 AFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 567 E-YFRSSRFTEKSDVYSFGVVLAELLTG 593
E ++ D++S G + AELL+
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-26
Identities = 61/207 (29%), Positives = 111/207 (53%), Gaps = 18/207 (8%)
Query: 399 NRILGQGGQGTVYKGMLA----DGRIVAIK--KSKVIDESKVDEFINEVAILSQINHRNV 452
+++G G G V +G L VAIK K+ D+ ++D F+ E +I+ Q +H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
++L G ++ +++ E++ NG+L ++L + + +F T + + ++ + YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEM 125
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG---TFGYLDPEYF 569
+ HRD+ + NIL++ KVSDFG SR ++ + T +G + PE
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSR--RLEDSEATYTTKGGKIPIRWTAPEAI 180
Query: 570 RSSRFTEKSDVYSFGVVLAELLT-GER 595
+FT SDV+SFG+V+ E+++ GER
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 2e-25
Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQINH 449
Y + LG+G VYK GRIVAIKK K+ + + + IN E+ +L ++ H
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR------IAIEVS 503
N++ LL LV+EF+ L + + D++ I L +
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--------IVLTPADIKSYMLMTL 112
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
+ YLHS I HRD+K N+L+ K++DFG +RS MT QV T Y
Sbjct: 113 RGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWY 168
Query: 564 LDPE-YFRSSRFTEKSDVYSFGVVLAELL 591
PE F + + D++S G + AELL
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 17/204 (8%)
Query: 400 RILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKV-DEFINEVAILSQINHRNVV 453
+ LG+G G V G VA+K E + +F E+ IL ++H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 454 KLLGCCLET--EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
K G C + L+ E++ +G+L YL ++ I + L + ++ + YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG---TFGYLDPEY 568
I HRD+ + NIL++ + K+SDFG ++ + D+ + + G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 569 FRSSRFTEKSDVYSFGVVLAELLT 592
R+S+F+ SDV+SFGV L EL T
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 70/215 (32%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESK----VDEFINEVAILSQIN 448
D Y ++G G VY + L + VAIK+ ID K VDE EV +SQ N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKR---IDLEKCQTSVDELRKEVQAMSQCN 57
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTL-----FQYLHDQNEEFPITWEIRLRIAIEVS 503
H NVVK + + LV ++ G+L Y +E I ++ EV
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVL 112
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA---IDQTHMTTQVQGT 560
+ YLHS I HRDIK+ NILL K++DFG S S+A + GT
Sbjct: 113 KGLEYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
Query: 561 FGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGE 594
++ PE + K+D++SFG+ EL TG
Sbjct: 170 PCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 58/199 (29%), Positives = 100/199 (50%), Gaps = 13/199 (6%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDE-FINEVAILSQINHRNVVKLLGC 458
+G+G G VYKG+L VA+K + + F+ E IL Q +H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
C++ + +V E + G+L +L + + + L+++++ + + YL S I
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI--- 115
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT----FGYLDPEYFRSSRF 574
HRD+ + N L+ K+SDFG SR ++ + T G + PE R+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRE---EEGGIYTVSDGLKQIPIKWTAPEALNYGRY 172
Query: 575 TEKSDVYSFGVVLAELLTG 593
T +SDV+S+G++L E +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 69/215 (32%), Positives = 115/215 (53%), Gaps = 15/215 (6%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGML-ADGR---IVAIKKSKV-IDESKVDEFINEVAIL 444
E H +++G G G V++G+L GR VAIK K E + +F++E +I+
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIM 60
Query: 445 SQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVS 503
Q +H N+++L G + + +++ E++ NG L +YL D + EF LR ++
Sbjct: 61 GQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIA 117
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID--QTHMTTQVQGTF 561
+ YL + + HRD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPI 174
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GER 595
+ PE +FT SDV+SFG+V+ E+++ GER
Sbjct: 175 RWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 82/289 (28%), Positives = 125/289 (43%), Gaps = 45/289 (15%)
Query: 400 RILGQGGQGTVYKGMLAD------GRIVAIKKSKVIDESKVD--EFINEVAILSQINHRN 451
R LGQG G VY+G+ VAIK + + S + EF+NE +++ + N +
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIK-TVNENASMRERIEFLNEASVMKEFNCHH 70
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL--HDQNEEF-----PITWEIRLRIAIEVSD 504
VV+LLG + L+V E + G L YL E P T + +++A E++D
Sbjct: 71 VVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
++YL A+ HRD+ + N ++ K+ DFG M D +G G L
Sbjct: 131 GMAYL---AAKKFVHRDLAARNCMVAEDLTVKIGDFG----MTRDIYETDYYRKGGKGLL 183
Query: 565 -----DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619
PE + FT KSDV+SFGVVL E+ T LA + + +
Sbjct: 184 PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMAT---------------LAEQPYQGLSNE 228
Query: 620 SLFE-ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667
+ + ++D L + +L C N K RPT E+ L
Sbjct: 229 EVLKFVIDGGHLDLPENCP-DKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 14/206 (6%)
Query: 395 HYNTNRILGQGGQGTVYKGMLADGRIV-AIK---KSKVIDESKVDEFINEVAILSQINHR 450
H+ R++G+G G V D + + A+K K K +++ V +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVSYL 509
+V L + E LV + ++ G L +Y Q +F E +++ I E+ A+ YL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDL-RYHLSQKVKFS---EEQVKFWICEIVLALEYL 116
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS I HRDIK NILLD + ++DF + + D +TT GT GY+ PE
Sbjct: 117 HSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVL 171
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGER 595
++ D +S GV E L G+R
Sbjct: 172 CRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 61/196 (31%), Positives = 97/196 (49%), Gaps = 9/196 (4%)
Query: 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
R LG G G V+ G VA+K K S F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEA-FLQEAQIMKKLRHDKLVQLYAV 69
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
C E E +V E++ G+L +L E + + +A ++++ ++YL S I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQIAEGMAYLESRNYI--- 125
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRFTE 576
HRD+ + NIL+ K++DFG +R I+ T + F + PE RFT
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 577 KSDVYSFGVVLAELLT 592
KSDV+SFG++L E++T
Sbjct: 184 KSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 60/205 (29%), Positives = 106/205 (51%), Gaps = 17/205 (8%)
Query: 401 ILGQGGQGTVYKGMLADGRIVAIKK------SKVIDESKVDEFINEVAILSQINHRNVVK 454
+LG+G GTVY G+ G+++A+K+ + + E + ++ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
LG CL+ + EF+ G++ L N P+ + + ++ D V+YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA-----IDQTHMTTQVQGTFGYLDPEYF 569
+ HRDIK N++L K+ DFG +R +A ++M + GT ++ PE
Sbjct: 124 V---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGE 594
S + KSD++S G + E+ TG+
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 13/199 (6%)
Query: 399 NRILGQGGQGTVYKGM---LADGRI-VAIKKSKVIDESKVDE-FINEVAILSQINHRNVV 453
R +G+G G VY+G+ + +I VA+K K V E F+ E I+ Q +H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 454 KLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
KL+G TE P+ +V E G L YL + + + ++S A++YL S
Sbjct: 71 KLIGVI--TENPVWIVMELAPLGELRSYLQVNKYSLDL--ASLILYSYQLSTALAYLES- 125
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
HRDI + N+L+ K+ DFG SR + + + ++ + ++ PE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 573 RFTEKSDVYSFGVVLAELL 591
RFT SDV+ FGV + E+L
Sbjct: 184 RFTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 55/193 (28%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
R LG G G V++G+ + VA+K K +F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
E +V E + G+L +YL + + +A +V+ ++YL + I H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG-GAGRALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RD+ + N+L+ KV+DFG +R + D + + PE +RF+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 580 VYSFGVVLAELLT 592
V+SFG++L E++T
Sbjct: 187 VWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 20/201 (9%)
Query: 402 LGQGGQGTVYK-GMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVK---- 454
LG+G G+VYK L+D + A+K+ + + + + ++ +NE+ IL+ +NH N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 455 -LLGCCLETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
L G L +V E+ G L + + + + I + RI I++ + LH
Sbjct: 68 FLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
I HRD+KS NILL K+ D G S+ + + TQ+ GT Y+ PE ++
Sbjct: 123 K---ILHRDLKSANILLVANDLVKIGDLGISKVLK--KNMAKTQI-GTPHYMAPEVWKGR 176
Query: 573 RFTEKSDVYSFGVVLAELLTG 593
++ KSD++S G +L E+ T
Sbjct: 177 PYSYKSDIWSLGCLLYEMATF 197
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 64/209 (30%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 401 ILGQGGQGTVYKGMLA-DGRIVAIK---------KSKVIDESKVDEFINEVAILSQINHR 450
++G G G+VY GM A G ++A+K SK S +D E+A+L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVSYL 509
N+V+ LG L+ + + E++ G++ L + F E +R + ++ ++YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ-----VQGTFGYL 564
H+ I HRDIK NIL+D K K+SDFG S+ + + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
PE + + +T K+D++S G ++ E+LTG
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTG 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 28/272 (10%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF--INEVAILSQINHRNV 452
Y R++G+G G V+ AD ++V IK+ V +K + NE +L ++H N+
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHS 511
++ LE + ++V E+ GTL +Y+ + N + L +++ A+ ++H+
Sbjct: 62 IEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLD--EDTILHFFVQILLALHHVHT 119
Query: 512 AASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I HRD+K+ NILLD K K+ DFG S+ ++ T V GT Y+ PE
Sbjct: 120 KL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCE 174
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
+ +KSD+++ G VL EL + +RA N L A L+ M F +
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEAAN------LPALVLKIMS--GTFAPISDRYS 226
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ Q L LNL+ KRP + ++
Sbjct: 227 PDLRQ--------LILSMLNLDPSKRPQLSQI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 75/275 (27%), Positives = 131/275 (47%), Gaps = 31/275 (11%)
Query: 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
I+G+G G V +G G+ VA+K K + F+ E A++++++H+N+V+
Sbjct: 7 KLTLGEIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTKLHHKNLVR 63
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
LLG L + +V E + G L +L + ++ L+ +++V++ + YL S
Sbjct: 64 LLGVILHNGL-YIVMELMSKGNLVNFLRTRGRALVSVIQL-LQFSLDVAEGMEYLESKK- 120
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASR--SMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
+ HRD+ + NIL+ AKVSDFG +R SM +D + + + + PE +
Sbjct: 121 --LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632
+F+ KSDV+S+GV+L E+ + R A Y ++KE E ++ E
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGR-------------APYPKMSLKEVK--ECVEKGYRME 217
Query: 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667
+ V L C KKRP+ ++ L
Sbjct: 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 70/262 (26%), Positives = 123/262 (46%), Gaps = 36/262 (13%)
Query: 419 RIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477
+VA+K + ++ ++F+ EV ILS+++ N+ +LLG C ++ E++ NG L
Sbjct: 47 VLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 478 FQYLH--------DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529
Q+L +++ L +A +++ + YL S+ HRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLV 163
Query: 530 DGKYRAKVSDFGASRSMAIDQTHMTTQVQGT----FGYLDPEYFRSSRFTEKSDVYSFGV 585
Y K++DFG SR++ + +VQG ++ E +FT KSDV++FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYY---RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220
Query: 586 VLAELLTGERAIRVTNFEE--DKSL---AAYFLRAMKEDSLFEILDAHVLKEASQEDIVT 640
L E+LT R +E D+ + A +F R +D L +DI
Sbjct: 221 TLWEILTLCRE---QPYEHLTDQQVIENAGHFFR---DDGRQIYLP---RPPNCPKDIY- 270
Query: 641 VAKLTNRCLNLNGKKRPTMKEV 662
+L C + + RPT +E+
Sbjct: 271 --ELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 65/210 (30%), Positives = 104/210 (49%), Gaps = 24/210 (11%)
Query: 402 LGQGGQGTVYKGML------ADGRIVAIKKSKVIDESKV-DEFINEVAILSQINHRNVVK 454
LG+G G VYKG L VAIK K E KV EF E ++S + H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYL--HDQNEEFPITWEIR-----------LRIAIE 501
LLG C + + +++E++ +G L ++L + + + L IAI+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGT 560
++ + YL +S HRD+ + N L+ K+SDFG SR + + D + ++
Sbjct: 133 IAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAEL 590
++ PE +FT +SD++SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 7e-23
Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 36/283 (12%)
Query: 401 ILGQGGQGTVYKGML------ADGRIVAIKK-SKVIDESKVDEFINEVAILSQINHRNVV 453
LG+G G V+ +V +K K DE+ EF E+ + +++H+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYL------HDQNEEFPITWEIRLRIAIEVSDAVS 507
+LLG C E E ++ E+ G L Q+L ++ + P++ + ++ + +++ +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
+L +A + HRD+ + N L+ + KVS S+ + + + +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
+ F+ KSDV+SFGV++ E+ T GE + EE L ++ L
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAGKL----- 236
Query: 627 AHVLKEASQEDIV--TVAKLTNRCLNLNGKKRPTMKEVAVVLA 667
E + + KL RC +N K RP+ E+ L
Sbjct: 237 -----ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 8e-23
Identities = 57/204 (27%), Positives = 105/204 (51%), Gaps = 21/204 (10%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKS-KVIDESK----VDEFINEVAILSQINHRNVV 453
++LG G GTVYKG+ + +G V I + KV+ E E ++E +++ ++H +VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG CL + L+ + + G L Y+ + + I + L ++++ +SYL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG-----YLDPEY 568
+ HRD+ + N+L+ K++DFG ++ + +D+ G ++ E
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE----YHAEGGKVPIKWMALES 182
Query: 569 FRSSRFTEKSDVYSFGVVLAELLT 592
+T KSDV+S+GV + EL+T
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 8e-23
Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 23/269 (8%)
Query: 401 ILGQGGQGTVYKGMLADGRIVAIK--KSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
+LG+G G V+KG L D VA+K K + E K+ +F++E IL Q +H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
C + + +V E + G +L + +E + ++ A++ + ++YL S I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKS 578
HRD+ + N L+ K+SDFG SR + Q + PE R++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 579 DVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDI 638
DV+S+G++L E SL M E ++ Q+
Sbjct: 176 DVWSYGILLWETF---------------SLGVCPYPGMTNQQAREQVEKGYRMSCPQKCP 220
Query: 639 VTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667
V K+ RC + + RP E+ LA
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 63/199 (31%), Positives = 110/199 (55%), Gaps = 16/199 (8%)
Query: 400 RILGQGGQGTVYKGMLAD--GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLG 457
+ +G+G G V ML D G VA+K K +++ F+ E ++++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 458 CCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
+E + L +V E++ G+L YL + + + L+ +++V +A+ YL + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV- 124
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE 576
HRD+ + N+L+ AKVSDFG ++ + Q V+ T PE R +F+
Sbjct: 125 --HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 577 KSDVYSFGVVLAELLTGER 595
KSDV+SFG++L E+ + R
Sbjct: 179 KSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 1e-22
Identities = 66/193 (34%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461
LG G G V G VAIK K S+ DEFI E ++ +++H +V+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521
+V E++ NG L YL + + F L + +V + ++YL S I HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---HRD 125
Query: 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRFTEKSD 579
+ + N L+D + KVSDFG SR + D+ T+ V F + PE S+F+ KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 580 VYSFGVVLAELLT 592
V++FGV++ E+ +
Sbjct: 184 VWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 60/195 (30%), Positives = 104/195 (53%), Gaps = 10/195 (5%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKV--DEFINEVAILSQINHRNVVKLLG 457
+ LG G G V+ G VAIK I+E + ++FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
C + + +V EF+ NG L YL + + + ++ L + +V + + YL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRD+ + N L+ KVSDFG +R + D+ ++ + + PE F S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 578 SDVYSFGVVLAELLT 592
SDV+SFGV++ E+ T
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-22
Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 29/214 (13%)
Query: 400 RILGQGGQGTVYKGMLA--DGRI--VAIKKSKV--IDESKVDEFINEVAILSQINHRNVV 453
+ILG+G G+V +G L+ DG VA+K K+ S+++EF++E A + +H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 454 KLLGCCLETE------VPLLVYEFIINGTLFQYL-----HDQNEEFPITWEIRLRIAIEV 502
KL+G C E P+++ F+ +G L +L E+ P+ + L+ +++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKFMVDI 122
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID----QTHMTTQVQ 558
+ + YL + I HRD+ + N +L V+DFG S+ + Q +
Sbjct: 123 ALGMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM-- 177
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ E +T KSDV++FGV + E+ T
Sbjct: 178 -PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 2e-22
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILSQINHRNVVK 454
+G+G G VYK G +VA+KK ++ E++ + F I E+ +L ++ H N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHPNIVR 62
Query: 455 LLGCCLETEVPLLVYEFIINGT--LFQYL-HD-----QNEEFPITW-EIRLRIAIEVSDA 505
L E+ V +F+Y+ HD + E T +I+ ++ +
Sbjct: 63 LK------EI---VTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK-CYMKQLLEG 112
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLD 565
+ YLHS I HRDIK +NIL++ K++DFG +R + T T Y
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169
Query: 566 PE-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE ++R+ + D++S G +LAEL G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-22
Identities = 75/276 (27%), Positives = 131/276 (47%), Gaps = 24/276 (8%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV---IDESKVDEFINEVAILSQIN 448
++ + +G+G VYK + L DGR+VA+KK ++ +D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVS 507
H NV+K L +E +V E G L + + H + ++ I + +++ A+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
++HS I HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK-SLAAYFLRAMKEDSLFEILD 626
+ + KSD++S G +L E+ A + F DK +L + + K D + L
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM-----AALQSPFYGDKMNLYSLCKKIEKCD--YPPLP 229
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
A E ++ L +RC+N + +KRP + V
Sbjct: 230 ADHYSEELRD-------LVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 71/294 (24%), Positives = 126/294 (42%), Gaps = 47/294 (15%)
Query: 399 NRILGQGGQGTVYKGM------LADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRN 451
+ LG+G G V K A VA+K K S++ + ++E +L Q+NH +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLH---------------------DQNEEFPI 490
V+KL G C + LL+ E+ G+L +L D +E +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 491 TWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550
T + A ++S + YL A + + HRD+ + N+L+ + K+SDFG SR + +
Sbjct: 125 TMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 551 THMT-TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609
+++ ++ + ++ E +T +SDV+SFGV+L E++T L
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------------LG 226
Query: 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA 663
+ + LF +L E + + L C KRPT +++
Sbjct: 227 GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 6e-22
Identities = 73/215 (33%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 400 RILGQGGQGTVYKGMLAD------GRI-VAIK--KSKVIDESKVDEFINEVAILSQINHR 450
LG G G VY+G D G I VA+K + D+ K EF+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK-EFLKEAHLMSNFNHP 59
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD-QNEEFP---ITWEIRLRIAIEVSDAV 506
N+VKLLG CL E ++ E + G L YL D + E F +T + L I ++V+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGK-YRA----KVSDFGASRSMAIDQTHMTTQVQG-- 559
YL I HRD+ + N L+ K Y A K+ DFG +R + + + +G
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY---RKEGEG 173
Query: 560 --TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +FT +SDV+SFGV++ E+LT
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 76/256 (29%), Positives = 124/256 (48%), Gaps = 31/256 (12%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+GQG GTVY + +A G+ VAIK+ + + K + INE+ ++ + H N+V L L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 461 ETEVPLLVYEFIINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ +V E++ G+L + + +E I R E A+ +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVI---H 138
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 580 VYSFGVVLAELLTGE---------RAIRV--TN----FEEDKSLAAYFLRAMKEDSLFEI 624
++S G++ E++ GE RA+ + TN + + L+A F D L
Sbjct: 198 IWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF-----RDFLNRC 252
Query: 625 LDAHVLKEASQEDIVT 640
L+ V K S ++++
Sbjct: 253 LEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 8e-22
Identities = 81/280 (28%), Positives = 128/280 (45%), Gaps = 32/280 (11%)
Query: 402 LGQGGQGTVYK---GMLAD--GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLL 456
LG+G G+V L D G +VA+KK + + +F E+ IL + H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 457 GCCLETEVP--LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
G C LV E++ G+L YL Q + L A ++ + YL S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL--QKHRERLDHRKLLLYASQICKGMEYLGSKRY 129
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG---TFGYLDPEYFRS 571
+ HRD+ + NIL++ + R K+ DFG ++ + D+ + + G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 572 SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH--- 628
S+F+ SDV+SFGVVL EL T ++ S A F+R M D +++ H
Sbjct: 186 SKFSVASDVWSFGVVLYELF--------TYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237
Query: 629 VLKEASQ----EDIVT-VAKLTNRCLNLNGKKRPTMKEVA 663
+LK + + + C N + +RP+ E+A
Sbjct: 238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 9e-22
Identities = 59/200 (29%), Positives = 112/200 (56%), Gaps = 13/200 (6%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKS-KVIDES---KVD-EFINEVAILSQINHRNVV 453
++LG G GTVYKG+ + +G V I + K+++E+ K + EF++E I++ ++H ++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG CL + LV + + +G L Y+H+ + I ++ L ++++ + YL
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEERR 129
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ-VQGTFGYLDPEYFRSS 572
+ HRD+ + N+L+ K++DFG +R + D+ + ++ E
Sbjct: 130 ---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186
Query: 573 RFTEKSDVYSFGVVLAELLT 592
+FT +SDV+S+GV + EL+T
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 1e-21
Identities = 65/207 (31%), Positives = 102/207 (49%), Gaps = 20/207 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD----GRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
D + + LG G G V ML G+ A+K K+K++ +V+ +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
I H +V L G + LV E++ G LF +L ++ FP R A +V A+
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPV-ARFYAA-QVVLAL 114
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
YLHS I +RD+K N+LLD K++DFG ++ + +T+ GT YL P
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLAP 167
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTG 593
E S + + D ++ G+++ E+L G
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)
Query: 402 LGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455
LG+G G V+ D +VA+K K ES +F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLH---------DQNEEFP---ITWEIRLRIAIEVS 503
G C E L+V+E++ +G L ++L E+ +T L IA +++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFG 562
+ YL AS+ HRD+ + N L+ K+ DFG SR + + D + +
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +FT +SD++SFGVVL E+ T
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-21
Identities = 62/195 (31%), Positives = 106/195 (54%), Gaps = 14/195 (7%)
Query: 402 LGQGGQGTVYKG---MLADGRIVAIK--KSKVIDESKVDEFINEVAILSQINHRNVVKLL 456
LG G GTV KG M + VA+K K+ D + DE + E ++ Q+++ +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
G C E E +LV E G L ++L +N+ +T + + +VS + YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQ-KNKH--VTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRF 574
HRD+ + N+LL ++ AK+SDFG S+++ D+ + + G + + PE +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 575 TEKSDVYSFGVVLAE 589
+ KSDV+SFGV++ E
Sbjct: 176 SSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 66/208 (31%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 400 RILGQGGQGTVYKGMLA--DGRIVAIK---KSKVIDESKVDE--FINEVAILSQINHRNV 452
R LG G G VY+G+ DG V ++ K+ S+ DE F+ E I+S+ NH+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHD----QNEEFPITWEIRLRIAIEVSDAVSY 508
V+L+G E ++ E + G L +L + +T + L A +V+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 509 LHSAASIPIYHRDIKSTNILLD--GKYR-AKVSDFGASRSM-AIDQTHMTTQVQGTFGYL 564
L I HRDI + N LL G R AK++DFG +R + + ++
Sbjct: 132 LEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
PE F FT K+DV+SFGV+L E+ +
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 37/209 (17%)
Query: 401 ILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG+G G+VYK + G++VAIK V E + E I E++IL Q + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVKYYGSY 67
Query: 460 LETEVPLLVYEF-----------IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV-- 506
+ +V E+ I N TL EE IA + +
Sbjct: 68 FKNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEE---------EIAAILYQTLKG 111
Query: 507 -SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLD 565
YLHS I HRDIK+ NILL+ + +AK++DFG S + D V GT ++
Sbjct: 112 LEYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVSGQL-TDTMAKRNTVIGTPFWMA 167
Query: 566 PEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + + K+D++S G+ E+ G+
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-21
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVI----DESKVDEFINEVAILSQINH- 449
Y ++G+G G VY+G + GR+VA+K +I + V + EVA+LSQ+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK---IINLDTPDDDVSDIQREVALLSQLRQS 59
Query: 450 --RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
N+ K G L+ ++ E+ G++ + PI + I EV A+
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALK 115
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
Y+H + HRDIK+ NIL+ K+ DFG + + + + +T V GT ++ PE
Sbjct: 116 YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPE 171
Query: 568 YFRSSR-FTEKSDVYSFGVVLAELLTGE 594
+ + K+D++S G+ + E+ TG
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGN 199
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 53/197 (26%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 402 LGQGGQGTVYK-GMLADGRIVAIKK--SKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
+G+G G V+K G VA+KK + ++ ++ + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+LV E++ L + L D+ P +++ + V+Y+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEA-QVK-SYMRMLLKGVAYMHANG---IM 121
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPE-YFRSSRFTE 576
HRD+K N+L+ K++DFG +R + ++ + QV T Y PE + + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPELLYGARKYDP 180
Query: 577 KSDVYSFGVVLAELLTG 593
D+++ G + AELL G
Sbjct: 181 GVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 4e-21
Identities = 77/273 (28%), Positives = 123/273 (45%), Gaps = 47/273 (17%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVID----ESKVDEFINEVAILSQINHRNVVKLL 456
+G+G G VYK + ++VAIK VID E ++++ E+ LSQ + K
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIK---VIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYY 65
Query: 457 GCCLETEVPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
G L+ ++ E+ G+ L +E I + +R EV + YLH I
Sbjct: 66 GSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVLLGLEYLHEEGKI 120
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
HRDIK+ NILL + K++DFG S + + T V GT ++ PE + S +
Sbjct: 121 ---HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYD 176
Query: 576 EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI-------LDAH 628
EK+D++S G+ EL GE L+ M+ LF I L+ +
Sbjct: 177 EKADIWSLGITAIELAKGE-----------PPLSDL--HPMR--VLFLIPKNNPPSLEGN 221
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
+ ++ + + CLN + K+RP+ KE
Sbjct: 222 KFSKPFKDFV-------SLCLNKDPKERPSAKE 247
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 71/269 (26%), Positives = 117/269 (43%), Gaps = 25/269 (9%)
Query: 402 LGQGGQGTVYKGML-ADGRIVAIKKSK-VIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+G+G G V+ G L AD VA+K + + +F+ E IL Q +H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ + +V E + G +L + E + + +++ + + YL S I H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT--QVQGTFGYLDPEYFRSSRFTEK 577
RD+ + N L+ K K+SDFG SR D + +T Q + PE R++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSREEE-DGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637
SDV+SFG++L E SL A + E ++ V +
Sbjct: 177 SDVWSFGILLWEAF---------------SLGAVPYANLSNQQTREAIEQGVRLPCPELC 221
Query: 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
V +L RC + +RP+ V L
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 4e-21
Identities = 61/197 (30%), Positives = 107/197 (54%), Gaps = 12/197 (6%)
Query: 402 LGQGGQGTVYKGM--LADGRI-VAIKKSKVIDESKV-DEFINEVAILSQINHRNVVKLLG 457
LG G G V KG+ + +I VAIK K +E V DE + E I+ Q+++ +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
C E E +LV E G L ++L + +E ++ + L +VS + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSMGMKYLEGKNFV-- 117
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRFT 575
HRD+ + N+LL ++ AK+SDFG S+++ D ++ + G + + PE +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 576 EKSDVYSFGVVLAELLT 592
+SDV+S+G+ + E +
Sbjct: 177 SRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 16/206 (7%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESK-VDEFI-NEVAILSQINHRNV 452
Y ++G+G G V K A G IVAIKK K ++ + V + EV +L Q+ H N+
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFP--ITWEIRLRIAIEVSDAVSYLH 510
V L LV+E++ TL + L E P + + ++ A++Y H
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELL----EASPGGLPPDAVRSYIWQLLQAIAYCH 117
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID-QTHMTTQVQGTFGYLDPEYF 569
S I HRDIK NIL+ K+ DFG +R++ + +T V T Y PE
Sbjct: 118 SHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELL 173
Query: 570 RSSRFTEKS-DVYSFGVVLAELLTGE 594
K DV++ G ++AELL GE
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 6e-21
Identities = 64/279 (22%), Positives = 119/279 (42%), Gaps = 29/279 (10%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKK------SKVIDESKVDEFINEVAILSQI 447
+ + LG G + Y+ + G ++A+K+ + E V+ E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
NH +++++LG E L E++ G++ L + + ++ +S
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLS 117
Query: 508 YLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQT---HMTTQVQGTFGY 563
YLH I HRD+K N+L+D R +++DFGA+ +A T Q+ GT +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
+ PE R ++ DV+S G V+ E+ T + +L A S+ E
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPE 234
Query: 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
L + D+ RCL L + RP +E+
Sbjct: 235 HLSPGL------RDVTL------RCLELQPEDRPPSREL 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 9e-21
Identities = 84/355 (23%), Positives = 154/355 (43%), Gaps = 31/355 (8%)
Query: 314 KKSRNKYIVIGCTSGGFGMLCLLTGAWWMYKFLKRKMEIMLKQKFFKRNGGLLLQQELAS 373
+K+ + + I CT G F +L L+ + F++ + + LK+ ++ E +
Sbjct: 623 RKTPSWWFYITCTLGAFLVLALVAFG---FVFIRGRNNLELKR----------VENEDGT 669
Query: 374 TEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESK 433
E SK+ S + ++ +G +G YKG + + K ++ D +
Sbjct: 670 WELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVK-EINDVNS 728
Query: 434 VDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWE 493
+ +E+A + ++ H N+VKL+G C + L++E+I L + L + ++WE
Sbjct: 729 IPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWE 780
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
R +IAI ++ A+ +LH S + ++ I++DGK + + D
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCF 839
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613
+ Y+ PE + TEKSD+Y FG++L ELLTG+ F S+ +
Sbjct: 840 ISS-----AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWAR 893
Query: 614 RAMKEDSLFEILDAHVLKEAS--QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ L +D + + S Q +IV V L C + RP +V L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 66/208 (31%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 402 LGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVK 454
+ +G G V+ LA G I AIK K+ +I +++VD+ + E ILSQ VVK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 455 LLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
L + + L LV E++ G L L + R+ IA E+ A+ YLHS
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDV-ARIYIA-EIVLALEYLHS-- 111
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASR-------SMAIDQTHMTTQVQGTFGYLDP 566
I HRD+K NIL+D K++DFG S+ D ++ GT Y+ P
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGE 594
E ++ D +S G +L E L G
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGI 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 37/271 (13%)
Query: 402 LGQGGQGTVYKGML--ADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGC 458
LG G G V K +L G+I+A+K ++ I+E+ + + E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 459 CL-ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
++ + + E++ G+L + L + P I +IA+ V ++YLH I
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPE--RILGKIAVAVLKGLTYLHEKHKI-- 122
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRD+K +NIL++ + + K+ DFG S + ++ T GT Y+ PE + + ++ K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF--VGTSSYMAPERIQGNDYSVK 179
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ-- 635
SD++S G+ L EL TG F D +FE+L V + +
Sbjct: 180 SDIWSLGLSLIELATGR-------FPYPPENDPP-------DGIFELLQYIVNEPPPRLP 225
Query: 636 -----EDIVTVAKLTNRCLNLNGKKRPTMKE 661
D N CL + ++RP+ KE
Sbjct: 226 SGKFSPDFQ---DFVNLCLIKDPRERPSYKE 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 81/293 (27%), Positives = 140/293 (47%), Gaps = 43/293 (14%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGMLADGRI-------VAIKKSKVIDES----KVDEFI 438
E A + +R LGQG G VY+G +A G + VAIK ++E+ + EF+
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIK---TVNEAASMRERIEFL 57
Query: 439 NEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-------PIT 491
NE +++ + N +VV+LLG + + L++ E + G L YL E P +
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQ 550
+ +++A E++D ++YL++ + HRD+ + N ++ + K+ DFG +R + D
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLA 609
+ ++ PE + FT SDV+SFGVVL E+ T E+ + + E+
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ----- 229
Query: 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
LR + E L + K + D++ +L C N K RP+ E+
Sbjct: 230 --VLRFVMEGGLLD-------KPDNCPDMLF--ELMRMCWQYNPKMRPSFLEI 271
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 91.4 bits (227), Expect = 3e-20
Identities = 72/296 (24%), Positives = 136/296 (45%), Gaps = 49/296 (16%)
Query: 400 RILGQGGQGTVYK----GMLA--DGRIVAIKKSKVIDESKVD---EFINEVAILSQINHR 450
R +GQG G V++ G+L +VA+K K +E+ D +F E A++++ +H
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHP 68
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN-------------------EEFPIT 491
N+VKLLG C + L++E++ G L ++L ++ P++
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQ 550
+L IA +V+ ++YL + HRD+ + N L+ K++DFG SR++ + D
Sbjct: 129 CTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 185
Query: 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA 610
+ ++ PE +R+T +SDV+++GVVL E+ + +
Sbjct: 186 YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS-------------YGMQP 232
Query: 611 YFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
Y+ A E+ ++ + D +VL + + L C + RP+ + +L
Sbjct: 233 YYGMA-HEEVIYYVRDGNVLS-CPDNCPLELYNLMRLCWSKLPSDRPSFASINRIL 286
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 3e-20
Identities = 71/271 (26%), Positives = 129/271 (47%), Gaps = 34/271 (12%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESK-----VDEFINEVAILSQINHRNVV 453
+LG G G+VY+G+ L DG A+K+ + D+ + V + E+A+LS++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 454 KLLGCCLETEVPLLVY-EFIINGTLFQYLHDQNEEFPITWEIRLRIAIE-VSDAVSYLHS 511
+ LG E + L ++ E + G+L +++ E +R+ + + YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGSL----AKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
++ HRDIK NIL+D K++DFG ++ + + +G+ ++ PE
Sbjct: 121 RNTV---HRDIKGANILVDTNGVVKLADFGMAKQ--VVEFSFAKSFKGSPYWMAPEVIAQ 175
Query: 572 S-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
+ +D++S G + E+ TG+ + + + +AA F + + L I D H+
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP-----WSQLEGVAAVF-KIGRSKELPPIPD-HLS 228
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
EA D + +CL + RPT E
Sbjct: 229 DEAK--DFIL------KCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 4e-20
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 15/205 (7%)
Query: 401 ILGQGGQGTVYKGML-ADGR---IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKL 455
++G G G V +G L G+ VAIK K E + +F++E +I+ Q +H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
G ++ +++ EF+ NG L +L + +F + + + I + + YL + +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI--AAGMKYL---SEM 125
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-TQVQG---TFGYLDPEYFRS 571
HRD+ + NIL++ KVSDFG SR + D + T T G + PE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 572 SRFTEKSDVYSFGVVLAELLT-GER 595
+FT SDV+S+G+V+ E+++ GER
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 6e-20
Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 33/273 (12%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESK-----VDEFINEVAILSQINHRNVV 453
++LGQG G VY D GR +A+K+ +S V+ E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSDAVSYLHSA 512
+ GC + E + E++ G++ DQ + + +T + + ++ + V YLHS
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASR---SMAIDQTHMTTQVQGTFGYLDPEYF 569
I HRDIK NIL D K+ DFGAS+ ++ T M + V GT ++ PE
Sbjct: 124 M---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPEVI 179
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
+ K+DV+S G + E+LT + FE ++AA F A + + L +HV
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPPW--AEFE---AMAAIFKIATQPTN--PQLPSHV 232
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+A R N KKRP+ +E+
Sbjct: 233 SPDARN--------FLRRTFVENAKKRPSAEEL 257
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 17/206 (8%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN--EVAILSQIN-HRN 451
Y + LG G G+VY G +VAIKK K S +E +N EV L ++N H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPN 59
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEE-FPITWEIRLR-IAIEVSDAVSYL 509
+VKL E + V+E++ G L+Q + D+ + F E +R I ++ ++++
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS---ESVIRSIIYQILQGLAHI 115
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
H +HRD+K N+L+ G K++DFG +R + + T V T Y PE
Sbjct: 116 HKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYV-STRWYRAPEIL 170
Query: 570 -RSSRFTEKSDVYSFGVVLAELLTGE 594
RS+ ++ D+++ G ++AEL T
Sbjct: 171 LRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 13/204 (6%)
Query: 400 RILGQGGQGTVYKGMLA-DGR---IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVK 454
+++G G G V G L G+ VAIK K E + +F++E +I+ Q +H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L G +++ ++V E++ NG+L +L + +F + + + I + + YL +
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI--ASGMKYL---SD 124
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG--YLDPEYFRSS 572
+ HRD+ + NIL++ KVSDFG SR + D T G + PE
Sbjct: 125 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 573 RFTEKSDVYSFGVVLAELLT-GER 595
+FT SDV+S+G+V+ E+++ GER
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-19
Identities = 72/280 (25%), Positives = 131/280 (46%), Gaps = 39/280 (13%)
Query: 401 ILGQGGQGTVYKGMLAD-GRIVAIKKSKV----------IDESKVDEFINEVAILSQINH 449
++G+G G VY + G ++A+K+ ++ + V +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 450 RNVVKLLGCCLETEVPLLVY-EFIINGTLFQYL--HDQNEEFPITWEIRLRIAIEVSDAV 506
N+V+ LG TE L ++ E++ G++ L + + EE + + +V + +
Sbjct: 68 LNIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-----QVLEGL 121
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR-SMAIDQTHMTTQVQGTFGYLD 565
+YLHS I HRD+K+ N+L+D K+SDFG S+ S I +QG+ ++
Sbjct: 122 AYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMA 178
Query: 566 PEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
PE S ++ K D++S G V+ E+ G R + +++++AA F L
Sbjct: 179 PEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-----WSDEEAIAAMF-------KLGN 226
Query: 624 ILDAHVLKEASQEDIVTVA-KLTNRCLNLNGKKRPTMKEV 662
A + ++ VA N C +N RPT +E+
Sbjct: 227 KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 3e-19
Identities = 72/270 (26%), Positives = 124/270 (45%), Gaps = 28/270 (10%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVID-ESKVDEFI-NEVAILSQINHRNVVKLLGCC 459
LG G G+V K V KK I +S V + I E+ I+ + +V G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
L + EF+ G+L + + PI EI +IA+ V + ++YL++ I H
Sbjct: 73 LNENNICMCMEFMDCGSLDRIY---KKGGPIPVEILGKIAVAVVEGLTYLYNVHRI--MH 127
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSM--AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
RDIK +NIL++ + + K+ DFG S + +I T + GT Y+ PE + ++T K
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYTVK 182
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS--- 634
SDV+S G+ + EL G+ +N ++D + ++L +++E
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM--------GILDLLQ-QIVQEPPPRL 233
Query: 635 -QEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
D + + CL + +RPT +++
Sbjct: 234 PSSDFPEDLRDFVDACLLKDPTERPTPQQL 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 3e-19
Identities = 76/289 (26%), Positives = 123/289 (42%), Gaps = 50/289 (17%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVID----ESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G G V+KG+ D R + K+ID E ++++ E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
L+ ++ E++ G+ L +EF I ++ E+ + YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK-----EILKGLDYLHSEKKI- 123
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE 576
HRDIK+ N+LL + K++DFG + + Q T V GT ++ PE + S +
Sbjct: 124 --HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 577 KSDVYSFGVVLAELLTGE---------RAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627
K+D++S G+ EL GE R + + +L F + KE
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKE--------- 231
Query: 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTS 676
+ CLN + RPT KE+ +K TS
Sbjct: 232 ----------------FIDACLNKDPSFRPTAKELLKHKFIVKNAKKTS 264
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 74/279 (26%), Positives = 128/279 (45%), Gaps = 39/279 (13%)
Query: 402 LGQGGQGTVYKGMLADG--RIVAIK----------KSKVIDESKVDEFINEVAIL-SQIN 448
LG G G VYK + ++A+K K K + + + ++EV I+ Q+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIIN---GTLFQYLHDQNEEFPITWEIRL-RIAIEVSD 504
H N+V+ LE + +V + I G F L ++ + F E R+ I +++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWNIFVQMVL 124
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
A+ YLH I HRD+ NI+L + ++DFG ++ ++ +T+ V GT Y
Sbjct: 125 ALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVV-GTILYS 180
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE ++ + EK+DV++FG +L ++ T + TN SLA + A+ E
Sbjct: 181 CPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVYEP----- 232
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA 663
L E + VT + CL + + RP + +V+
Sbjct: 233 -----LPEGMYSEDVTD--VITSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-19
Identities = 67/206 (32%), Positives = 103/206 (50%), Gaps = 23/206 (11%)
Query: 400 RILGQGGQGTV--YKGMLAD---GRIVAIKKSKVIDESKVDE-FINEVAILSQINHRNVV 453
R+LG+G G V Y A+ G +VA+K K + + E+ IL + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 454 KLLGCCLET--EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
K GCC E + L+ E++ G+L YL + L A ++ + ++YLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS 125
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG-----TFGYLDP 566
I HRD+ + N+LLD K+ DFG ++ A+ + H +V+ F Y
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAK--AVPEGHEYYRVREDGDSPVFWYA-V 179
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLT 592
E + ++F+ SDV+SFGV L ELLT
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-19
Identities = 70/242 (28%), Positives = 109/242 (45%), Gaps = 37/242 (15%)
Query: 418 GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLL--GCCLETEVPLL--VYE 470
G VAIK +E + F E A+ +++ H N+V LL G E LL V+E
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG---EAPPGLLFAVFE 59
Query: 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL- 529
++ TL + L + R+ ++V DA++ H+ I HRD+K NI++
Sbjct: 60 YVPGRTLREVLAADG---ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVS 113
Query: 530 --DGKYRAKVSDFGAS------RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVY 581
+ AKV DFG R + TT+V GT Y PE R T SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 582 SFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED--SLFEILDAH----VLKEASQ 635
++G++ E LTG+R + + S+A + + SL + H VL++A
Sbjct: 174 AWGLIFLECLTGQRVV------QGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALN 227
Query: 636 ED 637
+D
Sbjct: 228 KD 229
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-19
Identities = 77/283 (27%), Positives = 134/283 (47%), Gaps = 25/283 (8%)
Query: 382 KLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINE 440
KL T + Y +GQG GTV+ + +A G+ VAIK+ + + K + INE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 441 VAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIA 499
+ ++ ++ + N+V L L + +V E++ G+L + + +E I R
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR---- 122
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG 559
E A+ +LH+ I HRDIKS N+LL K++DFG + +Q+ +T V G
Sbjct: 123 -ECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 177
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619
T ++ PE + K D++S G++ E++ GE + + L A +L A +
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP-----YLNENPLRALYLIAT--N 230
Query: 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E+ + L ++ NRCL ++ +KR + KE+
Sbjct: 231 GTPELQNPEKLSPIFRD-------FLNRCLEMDVEKRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 5e-19
Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 22/206 (10%)
Query: 399 NRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILSQINHRNVV 453
NRI G+G G VY+ G IVA+KK + +D + D + E+ +L + H N+V
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVR-MDNER-DGIPISSLREITLLLNLRHPNIV 69
Query: 454 KLL----GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
+L G L++ LV E+ L L + F + +++ + +++ + YL
Sbjct: 70 ELKEVVVGKHLDS--IFLVMEYC-EQDLASLLDNMPTPFSES-QVKC-LMLQLLRGLQYL 124
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-Y 568
H I HRD+K +N+LL K K++DFG +R+ + MT +V T Y PE
Sbjct: 125 HENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELL 180
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGE 594
+ +T D+++ G +LAELL +
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 87.9 bits (217), Expect = 5e-19
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 25/263 (9%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+GQG GTVY + +A G+ VAIK+ + + K + INE+ ++ + + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 461 ETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ +V E++ G+L + + +E I R E A+ +LHS I H
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLHSNQVI---H 138
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 197
Query: 580 VYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIV 639
++S G++ E++ GE + + L A +L A + E+ + L ++
Sbjct: 198 IWSLGIMAIEMVEGEPP-----YLNENPLRALYLIAT--NGTPELQNPERLSAVFRD--- 247
Query: 640 TVAKLTNRCLNLNGKKRPTMKEV 662
NRCL ++ +R + KE+
Sbjct: 248 ----FLNRCLEMDVDRRGSAKEL 266
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 61/200 (30%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 400 RILGQGGQGTVYKGMLA-DGRIVAIKKS-KVIDESKV----DEFINEVAILSQINHRNVV 453
++LG G GTVYKG+ DG V I + KV+ E+ E ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG CL + V L V + + G L Y+ + + I + L ++++ +SYL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSS 572
+ + HRD+ + N+L+ K++DFG +R + ID+T + + ++ E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 573 RFTEKSDVYSFGVVLAELLT 592
RFT +SDV+S+GV + EL+T
Sbjct: 187 RFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 87.5 bits (216), Expect = 6e-19
Identities = 76/263 (28%), Positives = 129/263 (49%), Gaps = 25/263 (9%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+GQG GTVY M +A G+ VAI++ + + K + INE+ ++ + + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 461 ETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ +V E++ G+L + + +E I R E A+ +LHS I H
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVI---H 139
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RDIKS NILL K++DFG + +Q+ +T V GT ++ PE + K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVD 198
Query: 580 VYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIV 639
++S G++ E++ GE + + L A +L A + E+ + L ++
Sbjct: 199 IWSLGIMAIEMIEGEPP-----YLNENPLRALYLIAT--NGTPELQNPEKLSAIFRD--- 248
Query: 640 TVAKLTNRCLNLNGKKRPTMKEV 662
NRCL+++ +KR + KE+
Sbjct: 249 ----FLNRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 7e-19
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQ 446
E E D +LG+G G VY L+ +AIK+ D V E+A+ S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-----NEEFPITWEIRLRIAIE 501
+ HRN+V+ LG E + E + G+L L + + E I + + +
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTK-----Q 116
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA--KVSDFGASRSMAIDQTHMTTQVQG 559
+ + + YLH I HRDIK N+L++ Y K+SDFG S+ +A T G
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLA-GINPCTETFTG 171
Query: 560 TFGYLDPEYF-RSSR-FTEKSDVYSFGVVLAELLTGE 594
T Y+ PE + R + +D++S G + E+ TG+
Sbjct: 172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-18
Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461
LG G G V+ G VAIK K S + F+ E ++ Q+ H +V+L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV-- 70
Query: 462 TEVPL-LVYEFIINGTLFQYLH-DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
T+ P+ ++ E++ NG+L +L + + I I + A ++++ ++++ I H
Sbjct: 71 TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDM--AAQIAEGMAFIERKNYI---H 125
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRFTEK 577
RD+++ NIL+ K++DFG +R I+ T + F + PE FT K
Sbjct: 126 RDLRAANILVSETLCCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183
Query: 578 SDVYSFGVVLAELLTGER 595
SDV+SFG++L E++T R
Sbjct: 184 SDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 79/297 (26%), Positives = 131/297 (44%), Gaps = 43/297 (14%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGMLAD---GRIVAIKKSKVIDES----KVDEFINEVA 442
E + + R LGQG G VY+G D G K ++ES + EF+NE +
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 443 ILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEE-------FPITWEIR 495
++ +VV+LLG + + L+V E + +G L YL E P T +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
+++A E++D ++YL++ + HRD+ + N ++ + K+ DFG +R D
Sbjct: 122 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDY 174
Query: 556 QVQGTFG-----YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA 610
+G G ++ PE + FT SD++SFGVVL E+ SLA
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAE 219
Query: 611 YFLRAMKEDSLFE-ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ + + + + ++D L + V L C N K RPT E+ +L
Sbjct: 220 QPYQGLSNEQVLKFVMDGGYLDQPDNCP-ERVTDLMRMCWQFNPKMRPTFLEIVNLL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 26/210 (12%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEF-INEVAILSQI---NH 449
Y +G+G GTVYK L GR VA+KK +V + E + + E+A+L Q+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 450 RNVVKLLGCC----LETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
N+V+LL C + E+ L LV+E + + L YL + I+ + ++
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIK-DLMRQLLR 118
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR----SMAIDQTHMTTQVQGT 560
V +LHS I HRD+K NIL+ + K++DFG +R MA+ T V T
Sbjct: 119 GVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL------TSVVVT 169
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAEL 590
Y PE S + D++S G + AEL
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 2e-18
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 400 RILGQGGQGTVYKGML------ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
R LG+G G V+ D +VA+K K ++ +F E +L+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLH----------DQNEEFPITWEIRLRIAIEVS 503
K G C+E + ++V+E++ +G L ++L + N +T L IA +++
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFG 562
+ YL AS HRD+ + N L+ K+ DFG SR + + D +
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +FT +SDV+S GVVL E+ T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 66/237 (27%), Positives = 116/237 (48%), Gaps = 25/237 (10%)
Query: 373 STEGN----IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRI-------V 421
S GN ID ++L + E ++ + + LG G G V + A G V
Sbjct: 10 SINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEAT-AYGLSKSDAVMKV 68
Query: 422 AIKKSK-VIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQ 479
A+K K S+ + ++E+ I+S + NH N+V LLG C L++ E+ G L
Sbjct: 69 AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLN 128
Query: 480 YLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSD 539
+L + E F ++ L + +V+ +++L S I HRD+ + N+LL K+ D
Sbjct: 129 FLRRKRESFLTLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVKICD 184
Query: 540 FGASRSMAIDQTHMTTQVQGT----FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
FG +R + D ++ V+G ++ PE + +T +SDV+S+G++L E+ +
Sbjct: 185 FGLARDIMNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 51/187 (27%), Positives = 101/187 (54%), Gaps = 20/187 (10%)
Query: 420 IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLF 478
+VA+K + + ++ ++F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 479 QYLHDQ---------NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529
Q+L + N ++ L +A++++ + YL AS+ HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 530 DGKYRAKVSDFGASRSMAIDQTHMTTQVQG----TFGYLDPEYFRSSRFTEKSDVYSFGV 585
Y K++DFG SR++ + ++QG ++ E +FT SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 586 VLAELLT 592
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 3e-18
Identities = 75/265 (28%), Positives = 114/265 (43%), Gaps = 30/265 (11%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVID----ESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G G V+KG+ D R + K+ID E ++++ E+ +LSQ + V K G
Sbjct: 12 IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYG 69
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
L+ ++ E++ G+ L E P+ I E+ + YLHS I
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEKKI-- 123
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRDIK+ N+LL K++DFG + + Q T V GT ++ PE + S + K
Sbjct: 124 -HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDSK 181
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637
+D++S G+ EL GE E + FL E + LKE
Sbjct: 182 ADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKNNPPTLEGNYSKPLKE----- 231
Query: 638 IVTVAKLTNRCLNLNGKKRPTMKEV 662
CLN RPT KE+
Sbjct: 232 ------FVEACLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|222467 pfam13947, GUB_WAK_bind, Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 4e-18
Identities = 38/103 (36%), Positives = 55/103 (53%), Gaps = 3/103 (2%)
Query: 28 DQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVFQKGLIAV 87
D+CG+ S YPFGIG GC D FE+ C+N++ P+ LL + N +L+ G + V
Sbjct: 6 DRCGNV-SIPYPFGIGPGCARDPGFELTCNNTTSPPRLLLGNGNYE-VLSISLANGTVRV 63
Query: 88 EAPVISLNSSKSMGNAKGVNLT-GTPFSFSQKNNKFTTAGCDS 129
P+ S + S +L+ G PF FS NKF GC++
Sbjct: 64 LDPISSNCYNSSGKRTDNGSLSLGGPFFFSSSRNKFVVVGCNT 106
|
This cysteine-rich GUB_WAK_bind domain is the extracellular part of this serine/threonine kinase that binds to the cell-wall pectins. Length = 106 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 5e-18
Identities = 66/222 (29%), Positives = 107/222 (48%), Gaps = 30/222 (13%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEF----INEVAIL 444
+ D ++ +G+G G VYK D G +VA+KK ++ +E + F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 445 SQINHRNVVKLLGCCLETEVPL----------LVYEFI---INGTLFQYLHDQNEEFPIT 491
Q+NHRN+V L + + L LV+E++ + G L L +E+
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSED---- 116
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551
I+ ++ + ++Y H + HRDIK +NILL+ K + K++DFG +R +++
Sbjct: 117 -HIK-SFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEES 171
Query: 552 HMTTQVQGTFGYLDPEYFR-SSRFTEKSDVYSFGVVLAELLT 592
T T Y PE R+ DV+S G +L EL T
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 5e-18
Identities = 70/286 (24%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 402 LGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKV-DEFINEVAILSQINHRNVVKL 455
LG+ G +YKG L ++VAIK K I+ + EF E +++++++H N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYL-----H-----DQNEEFPITWEIR----LRIAIE 501
LG + + +++E++ G L ++L H +E+ + + L IAI+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGT 560
++ + YL S + H+D+ + NIL+ + K+SD G SR + + D + +
Sbjct: 133 IAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620
++ PE +F+ SD++SFGVVL E+ + L Y+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS-------------FGLQPYY--GFSNQE 234
Query: 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ E++ L S++ + L C +RP K++ L
Sbjct: 235 VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 54/206 (26%), Positives = 108/206 (52%), Gaps = 17/206 (8%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADG---RI-VAIKKSKVIDESKVD-EFINEVAILSQINH 449
+ ++LG G GTVYKG+ + +G +I VAIK+ + K + E ++E +++ +++
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
+V +LLG CL + V L + + + G L Y+ + + + L ++++ ++YL
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYL 125
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG---TFGYLDP 566
+ HRD+ + N+L+ K++DFG ++ + D+ +G ++
Sbjct: 126 EERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY--HAEGGKVPIKWMAL 180
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLT 592
E +T +SDV+S+GV + EL+T
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 72/205 (35%), Positives = 112/205 (54%), Gaps = 23/205 (11%)
Query: 400 RILGQGGQGTVY---KGMLAD-GRIVA---IKKS--KVIDESKVDEFINEVAILSQINHR 450
++LGQG G V+ K D G++ A +KK+ KV D + E IL+++NH
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTK---MERDILAEVNHP 58
Query: 451 NVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWE-IRLRIAIEVSDAVSY 508
+VKL +TE L L+ +F+ G LF L ++E T E ++ +A E++ A+ +
Sbjct: 59 FIVKL-HYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLA-ELALALDH 113
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHS + I +RD+K NILLD + K++DFG S+ +ID GT Y+ PE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEV 169
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTG 593
T+ +D +SFGV++ E+LTG
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 7e-18
Identities = 65/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 395 HYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDES-----KVDEFINEVAILSQIN 448
++ ++LGQG G VY AD GR +A+K+ + ES +V+ E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 449 HRNVVKLLGCCLET-EVPLLVY-EFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSDA 505
H +V+ GC + E L ++ E + G++ DQ + + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQILEG 118
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR---SMAIDQTHMTTQVQGTFG 562
VSYLHS I HRDIK NIL D K+ DFGAS+ ++ + T M + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE + K+D++S G + E+LT
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 36/275 (13%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDES-----KVDEFINEVAILSQINHRNVV 453
++LGQG G VY D GR +A K+ + ES +V E+ +L + H +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 454 KLLGCCLE-TEVPLLVY-EFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSDAVSYLH 510
+ GC + E L ++ E++ G++ DQ + + +T + + ++ + +SYLH
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILEGMSYLH 123
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR---SMAIDQTHMTTQVQGTFGYLDPE 567
S I HRDIK NIL D K+ DFGAS+ ++ + T + + V GT ++ PE
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPYWMSPE 179
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627
+ K+DV+S G + E+LT + + E +++AA F A + + L +
Sbjct: 180 VISGEGYGRKADVWSLGCTVVEMLTEKPP-----WAEYEAMAAIFKIATQPTN--PQLPS 232
Query: 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
H+ + A D + C+ + + RP+ +E+
Sbjct: 233 HISEHA--RDFL-------GCIFVEARHRPSAEEL 258
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 1e-17
Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 30/265 (11%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVID----ESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G G VYKG+ D R + K+ID E ++++ E+ +LSQ + + + G
Sbjct: 12 IGKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
L+ ++ E++ G+ L + P+ I E+ + YLHS I
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSERKI-- 123
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRDIK+ N+LL + K++DFG + + Q T V GT ++ PE + S + K
Sbjct: 124 -HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFK 181
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637
+D++S G+ EL GE + + FL E + KE
Sbjct: 182 ADIWSLGITAIELAKGEPP-----NSDLHPMRVLFLIPKNSPPTLEGQYSKPFKE----- 231
Query: 638 IVTVAKLTNRCLNLNGKKRPTMKEV 662
CLN + + RPT KE+
Sbjct: 232 ------FVEACLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 16/211 (7%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINH 449
E + + LG G G V+ G VA+K K S + F+ E I+ ++ H
Sbjct: 2 EIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRH 60
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD---QNEEFPITWEIRLRIAIEVSDAV 506
+V+L E + +V E++ G+L +L D + + P + +A +V+ +
Sbjct: 61 DKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKDGEGRALKLPNL----VDMAAQVAAGM 115
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYL 564
+Y+ I HRD++S NIL+ K++DFG +R I+ T + F +
Sbjct: 116 AYIERMNYI---HRDLRSANILVGDGLVCKIADFGLAR--LIEDNEYTARQGAKFPIKWT 170
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGER 595
PE RFT KSDV+SFG++L EL+T R
Sbjct: 171 APEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-17
Identities = 58/195 (29%), Positives = 97/195 (49%), Gaps = 11/195 (5%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+G+G G V + GR VA+KK + + + + NEV I+ H N+V++ L
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 461 ETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ +V EF+ G L + H + E I + + V A+S+LH+ I H
Sbjct: 87 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLAVLKALSFLHAQGVI---H 138
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RDIKS +ILL R K+SDFG ++ + + V GT ++ PE + + D
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRLPYGTEVD 197
Query: 580 VYSFGVVLAELLTGE 594
++S G+++ E++ GE
Sbjct: 198 IWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 2e-17
Identities = 55/180 (30%), Positives = 96/180 (53%), Gaps = 10/180 (5%)
Query: 418 GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLLVYEFIIN 474
G VA+K K + + + E+ IL + H N+VK G C E L+ EF+ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR 534
G+L +YL + I + +L+ A+++ + YL S + HRD+ + N+L++ +++
Sbjct: 93 GSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 147
Query: 535 AKVSDFGASRSMAIDQTHMTTQ--VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
K+ DFG ++++ D+ + T + + + PE S+F SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 83.4 bits (207), Expect = 3e-17
Identities = 85/317 (26%), Positives = 139/317 (43%), Gaps = 97/317 (30%)
Query: 402 LGQGGQGTVYKGMLAD---GRIVAIKKSKVIDESKVDEFIN---------EVAILSQI-N 448
LG+G G V+K + D +VA+KK D F N E+ L ++ +
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGD 65
Query: 449 HRNVVKLLGCCLETEVP--------LLVYEFI-------INGTLFQYLHDQNEEFPITWE 493
H N+VKLL V LV+E++ I + + +H + I ++
Sbjct: 66 HPNIVKLL------NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRY----IMYQ 115
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA-IDQTH 552
+ L+ A+ Y+HS I HRD+K +NILL+ R K++DFG +RS++ +++
Sbjct: 116 L-LK-------ALKYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164
Query: 553 ----MTTQVQGTFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTG-------------E 594
+T V T Y PE S+R+T+ D++S G +L E+L G E
Sbjct: 165 ENPVLTDYV-ATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE 223
Query: 595 RAIRVT---NFEEDKSLAAYFLRAM-------KEDSLFEILDAHVLKEASQEDIVTVAKL 644
+ I V + E+ +S+ + F M L E+ L +AS + + L
Sbjct: 224 KIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL-----LPKASDDAL----DL 274
Query: 645 TNRCLNLNGKKRPTMKE 661
+ L N KR T +E
Sbjct: 275 LKKLLVFNPNKRLTAEE 291
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 400 RILGQGGQGTVYKGM------LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
R LG+G G V+ D +VA+K K + +F E +L+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIR-------------LRIAI 500
K G C + + ++V+E++ +G L ++L + I + + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQG 559
+++ + YL AS HRD+ + N L+ K+ DFG SR + + D +
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +FT +SDV+SFGV+L E+ T
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 11/195 (5%)
Query: 402 LGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+G+G G V + + G++VA+KK + + + + NEV I+ H NVV++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 461 ETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ +V EF+ G L + H + E I + + V A+S LH+ I H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVI---H 139
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RDIKS +ILL R K+SDFG ++ + + V GT ++ PE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 580 VYSFGVVLAELLTGE 594
++S G+++ E++ GE
Sbjct: 199 IWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 4e-17
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 400 RILGQGGQGTVY----KGMLADGRIVAIK---KSKVIDESKVDEFI-NEVAILSQINHRN 451
R+LG G G V+ G G++ A+K K+ ++ ++K E E +L +
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 452 VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+ L +T+ L L+ +++ G LF +L+ Q E F + E+R+ IA E+ A+ +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLALDHLH 122
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
+ I +RDIK NILLD + ++DFG S+ ++ GT Y+ PE R
Sbjct: 123 Q---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 571 --SSRFTEKSDVYSFGVVLAELLTG 593
S + D +S GV+ ELLTG
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 4e-17
Identities = 58/200 (29%), Positives = 90/200 (45%), Gaps = 24/200 (12%)
Query: 402 LGQGGQGTVYKG-MLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+G G G VYK +A G +VAIK K+ + E+++L + H N+V G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 461 ETEVPLLVYEFIINGTL---FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
+ +V E+ G+L +Q E I + R E ++YLH I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHETGKI-- 123
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGAS----RSMAIDQTHMTTQVQGTFGYLDPEYF---R 570
HRDIK NILL K++DFG S ++A ++ + GT ++ PE R
Sbjct: 124 -HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVER 177
Query: 571 SSRFTEKSDVYSFGVVLAEL 590
+ K D+++ G+ EL
Sbjct: 178 KGGYDGKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 4e-17
Identities = 64/242 (26%), Positives = 110/242 (45%), Gaps = 39/242 (16%)
Query: 400 RILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
++LG+G G V +LA+ + + +KK ++ + V+ + E +L+
Sbjct: 1 KVLGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPF 57
Query: 453 VKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLH 510
+ L C +T+ L V E++ G L ++ ++ F E R R A E+ + +LH
Sbjct: 58 LTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFD---EPRARFYAAEIVLGLQFLH 113
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR-SMAIDQTHMTTQVQGTFGYLDPEYF 569
I +RD+K N+LLD + K++DFG + + T T+ GT Y+ PE
Sbjct: 114 ERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEIL 168
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE-ILDAH 628
+ D ++ GV+L E+L G+ + FE D ED LF+ IL+
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLAGQ-----SPFEGD-----------DEDELFQSILEDE 212
Query: 629 VL 630
V
Sbjct: 213 VR 214
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 4e-17
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 19/209 (9%)
Query: 400 RILGQGGQGTVYKGML----ADGRIVAIK--KSKVIDESKVDEFINEVAILSQINHRNVV 453
R+LG+G G+V + L + VA+K K+ + S ++EF+ E A + + +H NV+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 454 KLLGCCLETE------VPLLVYEFIINGTLFQYL---HDQNEEFPITWEIRLRIAIEVSD 504
KL+G L + +P+++ F+ +G L +L E F + + +R I+++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFGY 563
+ YL S I HRD+ + N +L+ V+DFG S+ + + D + +
Sbjct: 125 GMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
L E + +T SDV++FGV + E++T
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 60/205 (29%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFI--NEVAILSQINHRNV 452
Y ++G+G G V K + G+IVAIKK ++ K+ + I E+ +L Q+ H N+
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFP--ITWEIRLRIAIEVSDAVSYLH 510
V L+ + LV+EF+ + L D E++P + + ++ + + H
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDHTVL-----DDLEKYPNGLDESRVRKYLFQILRGIEFCH 117
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF- 569
S I HRDIK NIL+ K+ DFG +R++A T V T Y PE
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLV 173
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGE 594
+++ D+++ G ++ E+LTGE
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 57/194 (29%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461
LGQG G V+ G VAIK K + F+ E I+ ++ H +V L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVSE 72
Query: 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521
+ +V EF+ G+L +L + + ++ + + +A +++D ++Y+ I HRD
Sbjct: 73 EPI-YIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HRD 127
Query: 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVY 581
+++ NIL+ K++DFG +R + ++ + + PE RFT KSDV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 582 SFGVVLAELLTGER 595
SFG++L EL+T R
Sbjct: 188 SFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 5e-17
Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461
LGQG G V+ G VAIK K S + F+ E ++ ++ H +V+L E
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVSE 72
Query: 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRL----RIAIEVSDAVSYLHSAASIPI 517
+ +V E++ G+L +L + ++ +RL +A +++ ++Y+ +
Sbjct: 73 EPI-YIVTEYMSKGSLLDFLKGEMGKY-----LRLPQLVDMAAQIASGMAYVERMNYV-- 124
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRD+++ NIL+ KV+DFG +R + ++ + + PE RFT K
Sbjct: 125 -HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 578 SDVYSFGVVLAELLTGER 595
SDV+SFG++L EL T R
Sbjct: 184 SDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 1e-16
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGC 458
+G+G G VYKG G+IVA+KK ++ +E I E+++L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
++ L++EF+ + L +YL + + E+ ++ + + HS +
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VL 123
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR-SSRFTEK 577
HRD+K N+L+D K K++DFG +R+ I T +V T Y PE S R++
Sbjct: 124 HRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTP 182
Query: 578 SDVYSFGVVLAELLT 592
D++S G + AE+ T
Sbjct: 183 VDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 60/197 (30%), Positives = 96/197 (48%), Gaps = 15/197 (7%)
Query: 402 LGQGGQGTVYKGMLA----DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G G V +A GR VA+K + + + + NEV I+ H+NVV++
Sbjct: 29 IGEGSTGIV---CIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYK 85
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
L E ++ EF+ G L D + + E + V A+ YLHS I
Sbjct: 86 SYLVGEELWVLMEFLQGGAL----TDIVSQTRLNEEQIATVCESVLQALCYLHSQGVI-- 139
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRDIKS +ILL R K+SDFG ++ D + V GT ++ PE + + +
Sbjct: 140 -HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTE 197
Query: 578 SDVYSFGVVLAELLTGE 594
D++S G+++ E++ GE
Sbjct: 198 VDIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 74/273 (27%), Positives = 129/273 (47%), Gaps = 22/273 (8%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVID--ESKV-DEFINEVAILSQINHR 450
++ + +G+G VY+ L DG VA+KK ++ D ++K + I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYL 509
NV+K +E +V E G L + + H + ++ I + + +++ A+ ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
+ + KSD++S G +L E+ A + F DK + Y L E + L +
Sbjct: 179 HENGYNFKSDIWSLGCLLYEM-----AALQSPFYGDK-MNLYSLCKKIEQCDYPPLPS-- 230
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
S+E + +L N C+N + +KRP + V
Sbjct: 231 -DHYSEE----LRQLVNMCINPDPEKRPDITYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 1e-16
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 5/193 (2%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+ LG G G V+ G + VA+K K S V F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ E ++ E++ G+L +L E + + + ++++ ++Y+ I H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RD+++ N+L+ K++DFG +R + ++ + + PE FT KSD
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 186
Query: 580 VYSFGVVLAELLT 592
V+SFG++L E++T
Sbjct: 187 VWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 37/211 (17%)
Query: 399 NRILGQGGQGTVYKGM-LADGRIVAIKKSKVI----DESKVDEFINEVAILSQINHRNVV 453
NRI G G GTVYK + GR+ A+K VI +++ + E+ IL +NH NVV
Sbjct: 80 NRI-GSGAGGTVYKVIHRPTGRLYALK---VIYGNHEDTVRRQICREIEILRDVNHPNVV 135
Query: 454 KLLGCCLET-----EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR-IAIEVSDAVS 507
K C + E+ +L+ EF+ G+L E I E L +A ++ ++
Sbjct: 136 K----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLADVARQILSGIA 182
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
YLH I HRDIK +N+L++ K++DFG SR +A + V GT Y+ PE
Sbjct: 183 YLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPE 238
Query: 568 YFRSSRFTEK-----SDVYSFGVVLAELLTG 593
+ D++S GV + E G
Sbjct: 239 RINTDLNHGAYDGYAGDIWSLGVSILEFYLG 269
|
Length = 353 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 77/322 (23%), Positives = 125/322 (38%), Gaps = 85/322 (26%)
Query: 399 NRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDES--------KVDE------FINEVAI 443
LG+G G V K G+IVAIKK K+I+ S V + E+ I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 444 LSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR------ 497
+++I H N++ L+ +E + LV + I+ L + + + IRL
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRK---------IRLTESQVKC 123
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID-------- 549
I +++ + ++ LH HRD+ NI ++ K K++DFG +R
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 550 ------QTHMTTQVQGTFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLT------GERA 596
+ MT++V T Y PE + ++ D++S G + AELLT GE
Sbjct: 181 DETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239
Query: 597 IR-------------VTNFEEDKSLAAY--FLRAMKED--SLFEILDAHVLKEASQEDIV 639
I N+ + K L Y F +D ++F +
Sbjct: 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAI--------- 290
Query: 640 TVAKLTNRCLNLNGKKRPTMKE 661
L L LN +R + KE
Sbjct: 291 ---DLLQSLLKLNPLERISAKE 309
|
Length = 335 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 57/207 (27%), Positives = 105/207 (50%), Gaps = 10/207 (4%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG+G TVYKG G IVA+K+ + +E I E++++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV- 66
Query: 460 LETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+ TE L LV+E++ + L +Y+ + ++ +++ H +
Sbjct: 67 IHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VL 122
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR-FTEK 577
HRD+K N+L++ + K++DFG +R+ I + +V T Y P+ SR ++
Sbjct: 123 HRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTS 181
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEE 604
D++S G ++AE++TG TN E+
Sbjct: 182 IDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 65/214 (30%), Positives = 104/214 (48%), Gaps = 15/214 (7%)
Query: 385 TSKELETATDHYNTNRILGQGGQGTVYKGMLADGRI--VAIK---KSKVIDESKVDEFIN 439
++ + + +N R LG G G V + VAIK KSK+I + +VD +
Sbjct: 21 PKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIA 499
E IL+ INH V L G + LV EF+I G F +L +N+ FP ++ A
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLR-RNKRFPN--DVGCFYA 137
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG 559
++ YL S+ I +RD+K N+LLD K++DFG ++ + T T + G
Sbjct: 138 AQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK---VVDTRTYT-LCG 190
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
T Y+ PE + + +D ++ G+ + E+L G
Sbjct: 191 TPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 48/174 (27%), Positives = 91/174 (52%), Gaps = 20/174 (11%)
Query: 435 DEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL-HDQNEE------ 487
++F+ EV ILS++ N+++LLG C++ + ++ E++ NG L Q+L ++
Sbjct: 64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123
Query: 488 ---------FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS 538
I++ L +A++++ + YL +S+ HRD+ + N L+ K++
Sbjct: 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 539 DFGASRSM-AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591
DFG SR++ A D + + ++ E +FT SDV++FGV L E+L
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 2e-16
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 40/231 (17%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD------EFINEVAILSQI 447
Y+ R++G+GG G VY R VA+KK I E + F+ E I + +
Sbjct: 3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKK---IREDLSENPLLKKRFLREAKIAADL 59
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD--QNEEFPITWEIR------LRIA 499
H +V + C + + +I TL L Q E + L I
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQ-------- 550
++ + Y+HS + HRD+K NILL G + + D+GA+ +++
Sbjct: 120 HKICATIEYVHSKG---VLHRDLKPDNILL-GLFGEVVILDWGAAIFKKLEEEDLLDIDV 175
Query: 551 -------THMTT--QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ MT ++ GT Y+ PE +E +D+Y+ GV+L ++LT
Sbjct: 176 DERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 3e-16
Identities = 59/198 (29%), Positives = 99/198 (50%), Gaps = 16/198 (8%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDE-----FINEVAILSQINHRNVVKL 455
+G+G G VYK G IVA+KK ++ E DE I E+++L ++NH N+V+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIVRL 63
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
L LV+EF+ + L +Y+ D + + + ++ ++Y HS
Sbjct: 64 LDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR-- 119
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
+ HRD+K N+L+D + K++DFG +R+ + T +V T Y PE SR
Sbjct: 120 -VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQY 177
Query: 576 EKS-DVYSFGVVLAELLT 592
D++S G + AE++
Sbjct: 178 STPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-16
Identities = 57/196 (29%), Positives = 105/196 (53%), Gaps = 12/196 (6%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESK--VDEFINEVAILSQINHRNVVKLLGC 458
+G+G G VYK G +VA+KK ++ E++ I E+++L ++NH N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 459 CLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
+ TE L LV+EF+ + L +++ D + I + ++ +++ HS +
Sbjct: 68 -IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL-- 122
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF-TE 576
HRD+K N+L++ + K++DFG +R+ + T +V T Y PE ++ +
Sbjct: 123 -HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180
Query: 577 KSDVYSFGVVLAELLT 592
D++S G + AE++T
Sbjct: 181 AVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 40/231 (17%)
Query: 391 TATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILS 445
+ Y LG+G G VYK + GR+VA+KK ++ ++ D F + E+ IL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKK--ILMHNEKDGFPITALREIKILK 62
Query: 446 QINHRNVVKLLGCCLE-----TEVPLLVYEFIINGTLFQYL-HD-----QNEEFPITW-E 493
++ H NVV L+ +E VY + Y+ HD +N +T +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVY------MVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM------- 546
I+ +++ + ++YLH I HRDIK+ NIL+D + K++DFG +R
Sbjct: 117 IKC-YMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNP 172
Query: 547 ---AIDQTHMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTG 593
T T + T Y PE R +T D++ G V AE+ T
Sbjct: 173 KGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 61/227 (26%), Positives = 103/227 (45%), Gaps = 25/227 (11%)
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGMLAD-----GRI-VAIKKSKV-IDESKVDEFINE 440
E E D + LG+G G V K VA+K K E + + ++E
Sbjct: 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSE 65
Query: 441 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD---QNEEF-------- 488
+ ++ I H+N++ LLG C + +V E+ +G L +L E
Sbjct: 66 MEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125
Query: 489 --PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546
+T + + A +V+ + +L S I HRD+ + N+L+ + K++DFG +R +
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDI 182
Query: 547 -AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
ID TT + ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 5e-16
Identities = 61/230 (26%), Positives = 101/230 (43%), Gaps = 58/230 (25%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINHRN 451
Y + +G G G V + GR VAIKK + + +D + E+ +L + H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 452 VVKLLGCCLETEVPL-----------LVYEF-------IINGTLFQYLHDQNEEFPITWE 493
++ LL ++ +V E +I Q L D + ++ ++
Sbjct: 61 IIGLL------DILRPPSPEDFNDVYIVTELMETDLHKVIKSP--QPLTDDHIQY-FLYQ 111
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID---Q 550
I LR + YLHSA + HRD+K +NIL++ K+ DFG +R + D +
Sbjct: 112 I-LR-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEK 160
Query: 551 THMTTQVQGTFGYLDPEYFR-------SSRFTEKSDVYSFGVVLAELLTG 593
+T Y+ ++R SSR+T+ D++S G + AELLT
Sbjct: 161 GFLT-------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 61/196 (31%), Positives = 98/196 (50%), Gaps = 13/196 (6%)
Query: 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+G+G G V G+ VA+KK + + + + NEV I+ +H NVV + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 461 ETEVPLLVYEFIINGTLFQYL-HDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+ +V EF+ G L + H + NEE T + + V A+SYLH+ I
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT------VCLSVLRALSYLHNQGVI--- 140
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKS 578
HRDIKS +ILL R K+SDFG ++ + + V GT ++ PE + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEV 199
Query: 579 DVYSFGVVLAELLTGE 594
D++S G+++ E++ GE
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 29/213 (13%)
Query: 401 ILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGC 458
++G+G G VYK G++VAIK +I++ + +E E IL + NH N+ G
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEE-EEIKEEYNILRKYSNHPNIATFYGA 71
Query: 459 CLETEVPL------LVYEFIINGT---LFQYLHDQNEEFPITWEIRLRIAI---EVSDAV 506
++ P LV E G+ L + L + + W IA E +
Sbjct: 72 FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETLRGL 126
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
+YLH I HRDIK NILL K+ DFG S + T + GT ++ P
Sbjct: 127 AYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAP 182
Query: 567 E-----YFRSSRFTEKSDVYSFGVVLAELLTGE 594
E + + +SDV+S G+ EL G+
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 395 HYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESK-----VDEFINEVAILSQIN 448
++ ++LG+G G VY AD GR +A+K+ +S+ V+ E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 449 HRNVVKLLGCCLE-TEVPLLVY-EFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSDA 505
H +V+ GC + E L ++ E++ G++ DQ + + +T + R ++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTRQILQG 118
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT----TQVQGTF 561
VSYLHS I HRDIK NIL D K+ DFGAS+ I M+ V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR--IQTICMSGTGIKSVTGTP 173
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE + K+DV+S + E+LT
Sbjct: 174 YWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 69/198 (34%), Positives = 96/198 (48%), Gaps = 19/198 (9%)
Query: 406 GQGTVYKGMLA----DGRIVAIK--KSKVIDESKVDEFI--NEVAILSQINHRNVVKLLG 457
G+G+ K +LA DG+ A+K + K++ K + I +L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEE-FPITWEIRLRI-AIEVSDAVSYLHSAASI 515
TE V +F+ G LF H Q E FP E R R A E++ A+ YLHS I
Sbjct: 64 SFQTTEKLYFVLDFVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS---I 115
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
I +RD+K NILLD + ++DFG + I Q+ TT GT YL PE R +
Sbjct: 116 NIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 576 EKSDVYSFGVVLAELLTG 593
D + G VL E+L G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G VY+ L D + VA+KK ++ +D + + E+ +L Q+NH NV+K L
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 458 CCLETEVPLLVYEFIINGTLFQ---YLHDQNEEFP--ITWEIRLRIAIEVSDAVSYLHSA 512
+E +V E G L Q Y Q P W + +++ AV ++HS
Sbjct: 70 SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSAVEHMHSR 125
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
+ HRDIK N+ + K+ D G R + T + V GT Y+ PE +
Sbjct: 126 R---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHEN 181
Query: 573 RFTEKSDVYSFGVVLAEL 590
+ KSD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 2e-15
Identities = 68/273 (24%), Positives = 130/273 (47%), Gaps = 52/273 (19%)
Query: 420 IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLF 478
+VA+K + +++ ++F+ E+ I+S++ N+++LL C+ ++ ++ E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 479 QYLH--------DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD 530
Q+L ++ + I++ + +A +++ + YL +S+ HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 531 GKYRAKVSDFGASRSMAIDQTHMTTQVQG----TFGYLDPEYFRSSRFTEKSDVYSFGVV 586
Y K++DFG SR++ + ++QG ++ E +FT SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 587 LAELLT-----------GERAIRVT-NFEEDKSLAAYFLR-AMKEDSLFEILDAHVLKEA 633
L E+LT E+ I T F D+ Y + A+ DSL+
Sbjct: 222 LWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLY----------- 270
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
KL C N K+RP+ +E+ L
Sbjct: 271 ---------KLMLSCWRRNAKERPSFQEIHATL 294
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 2e-15
Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEF--------INEVAILSQINHRNVV 453
LG+G GTVY ++ D + VA ++ KV+ E V E E +LS+++H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 454 KLLGCCLETEVPLLVYEFIINGTL---FQYLHDQNEEFP----ITWEIRLRIAIEVSDAV 506
K LE + ++ E+ L + L + W I+L + V
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG------V 119
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
Y+H I HRD+K+ NI L K+ DFG SR + + + T GT Y+ P
Sbjct: 120 HYMHQRR---ILHRDLKAKNIFLK-NNLLKIGDFGVSR-LLMGSCDLATTFTGTPYYMSP 174
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602
E + + KSD++S G +L E+ A NF
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 2e-15
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 27/227 (11%)
Query: 390 ETATDHYNTNRILGQG--GQGTVYKGMLAD----GRI--VAIKKSKV-IDESKVDEFINE 440
E D + LG+G GQ + + + D R+ VA+K K E + + I+E
Sbjct: 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISE 73
Query: 441 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLH-------------DQNE 486
+ ++ I H+N++ LLG C + ++ E+ G L +YL Q
Sbjct: 74 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVP 133
Query: 487 EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546
E ++++ + A +V+ + YL S I HRD+ + N+L+ K++DFG +R +
Sbjct: 134 EEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDI 190
Query: 547 A-IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
ID TT + ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 191 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 65/260 (25%), Positives = 106/260 (40%), Gaps = 60/260 (23%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
D + +++G+G G V+ L G++ A+K KS +I +++ E IL+
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
+ +VKL + E L LV E++ G L L ++ FP R IA E+ A
Sbjct: 58 ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDV-FPEET-ARFYIA-ELVLA 113
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ------- 558
+ +H I HRDIK NIL+D K++DFG +++
Sbjct: 114 LDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLC--KKMNKAKDREYYLNDSHNLL 168
Query: 559 -----------------------GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG-- 593
GT Y+ PE R + + + D +S GV+L E+L G
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 594 --------ERAIRVTNFEED 605
E ++ N++E
Sbjct: 229 PFYSDTLQETYNKIINWKES 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 2e-15
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 19/197 (9%)
Query: 401 ILGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGC 458
ILG G GTVYK L RI+A+K + I + ++E+ IL + + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+ EF+ G+L Y I + RIA+ V ++YL S + I
Sbjct: 68 FFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWS---LKIL 117
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSM--AIDQTHMTTQVQGTFGYLDPEYFRSSRFTE 576
HRD+K +N+L++ + + K+ DFG S + +I +T++ GT Y+ PE ++
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGI 172
Query: 577 KSDVYSFGVVLAELLTG 593
SDV+S G+ EL G
Sbjct: 173 HSDVWSLGISFMELALG 189
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 30/210 (14%)
Query: 399 NRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILSQINHRNVV 453
NRI +G G VY+ G IVA+KK K+ E + + F + E+ IL ++ H N+V
Sbjct: 11 NRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKLQHPNIV 67
Query: 454 KLLGCCLETEVPL--------LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
+ EV + +V E++ + L + + F + E++ + +++
Sbjct: 68 TV------KEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQS-EVKC-LMLQLLSG 118
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLD 565
V++LH I HRD+K++N+LL+ + K+ DFG +R T V T Y
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRA 174
Query: 566 PE-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + ++ D++S G + AELLT +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 69/280 (24%), Positives = 131/280 (46%), Gaps = 37/280 (13%)
Query: 400 RILGQGGQGTVYKGML-ADGRI--VAIKKSKV--IDESKVDEFINEVAILSQINHRNVVK 454
+ LG+G G+V +G L D I VA+K K+ S++++F++E + + +H NV++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 455 LLGCCLETE------VPLLVYEFIINGTLFQY-----LHDQNEEFPITWEIRLRIAIEVS 503
L+G CL+T P+++ F+ +G L + L D + P ++ ++ +++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIA 122
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV-QGTFG 562
+ YL S + I HRD+ + N +L+ V+DFG S+ + + ++ +
Sbjct: 123 SGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
++ E +T KSDV+SFGV + E+ T R E+ + Y + +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIAT--RGQTPYPGVENSEIYDYLRQGNRLKQPP 237
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ LD + L + C LN K RP+ + +
Sbjct: 238 DCLDG-------------LYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-15
Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 400 RILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNV 452
R+LG+G G V MLA GR+ A+K K ++ + V+ + E ILS +
Sbjct: 1 RVLGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 453 VKLLGCCLET-EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLH 510
+ L CC +T + V EF+ G L ++ ++ F E R R A E++ A+ +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLH 113
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I +RD+K N+LLD + K++DFG + I T+ GT Y+ PE +
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL--DAH 628
+ D ++ GV+L E+L G FE A ED LFE + D
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGH-----APFE-----------AENEDDLFEAILNDEV 213
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
V +D V + K K PTM+ ++ L G +A
Sbjct: 214 VYPTWLSQDAVDILKAFM-------TKNPTMRLGSLTLGGEEA 249
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 64/216 (29%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRI-VAIKKSKVIDESKVD--EFINEVAILSQINHR 450
D Y +G G G V VAIKK +S + E+ +L ++H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 451 NVVKLLGC-----CLE--TEVPLLVYEFI---INGTL-FQYLHDQNEEFPITWEIRLRIA 499
NV+ LL LE +V LV + +N + Q L D + +F + ++I LR
Sbjct: 75 NVIGLLDVFTPASSLEDFQDV-YLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQI-LR-- 129
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG 559
+ Y+HSA I HRD+K +NI ++ K+ DFG +R MT V
Sbjct: 130 -----GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTD---DEMTGYVA- 177
Query: 560 TFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
T Y PE + + D++S G ++AELLTG+
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 5e-15
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 423 IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLH 482
+KK +++ +V E +IL +++H +V ++ + + EF++ G LF +L
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 483 DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
FP ++ E+ A YLHS I +RD+K N+LLD K KV+DFG
Sbjct: 111 KAGR-FPN--DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164
Query: 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
++ + T + GT YL PE +S + D ++ GV+L E + G
Sbjct: 165 AKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 6e-15
Identities = 65/234 (27%), Positives = 104/234 (44%), Gaps = 19/234 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFI-NEVAILSQINHRN 451
++LG G G V+ G + +KK+ ++ ++K E E +L I
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 452 VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+ L +T+ L L+ ++I G LF +L Q E F E+++ E+ A+ +LH
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK-EQEVQIYSG-EIVLALEHLH 122
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
+ I +RDIK NILLD ++DFG S+ D+ GT Y+ P+ R
Sbjct: 123 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 571 --SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
+ D +S GV++ ELLTG V E S A R +K + +
Sbjct: 180 GGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG--EKNSQAEISRRILKSEPPY 231
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 22/208 (10%)
Query: 401 ILGQGGQGTVYKGMLADG-----RIVAIKKSKVID---ESKVDEFINEVAILSQINHRNV 452
+L +G G ++ G+L D V +K V D E +V + E +L ++H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 453 VKLLGCCLE-TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR------IAIEVSDA 505
+ +L C+E E P ++Y ++ G L +L Q L +AI+++
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYL 564
+SYLH + H+DI + N ++D + + K++D SR + H + ++
Sbjct: 130 MSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
E + ++ SDV+SFGV+L EL+T
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 26/215 (12%)
Query: 393 TDHYNTNRILGQGGQGTVYK------GMLADGRIVAIKKSKVIDESKVDEFINEVAILSQ 446
D + LG G G VYK G+ A +I+ I+ E ++++F+ E+ ILS+
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-----SEEELEDFMVEIDILSE 58
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITW-EIRLRIAIEVSDA 505
H N+V L ++ EF G L + + E +T +IR + ++ +A
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGAL-DSIMLELER-GLTEPQIRY-VCRQMLEA 115
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS-RSMAIDQTHMTTQVQGTFGYL 564
+++LHS I HRD+K+ NILL K++DFG S ++ + Q T GT ++
Sbjct: 116 LNFLHSHKVI---HRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWM 170
Query: 565 DPEY-----FRSSRFTEKSDVYSFGVVLAELLTGE 594
PE F+ + + K+D++S G+ L EL E
Sbjct: 171 APEVVACETFKDNPYDYKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 1e-14
Identities = 61/223 (27%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 396 YNTNRILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQIN 448
Y + +G+G G +Y LA + I I +K+ + K + EV +L+++
Sbjct: 2 YEIIKKIGEGSFGKIY---LAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMK 57
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-----NEEFPITWEIRLRIAIEVS 503
H N+V E +V E+ G L + ++ Q +E+ ++W +++S
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQIS 111
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILL--DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
+ ++H I HRDIKS NI L +G AK+ DFG +R + D + GT
Sbjct: 112 LGLKHIHDRK---ILHRDIKSQNIFLSKNGMV-AKLGDFGIARQLN-DSMELAYTCVGTP 166
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604
YL PE ++ + K+D++S G VL EL T + N +
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 66/202 (32%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 400 RILGQGGQGTVYKGML-ADGRIVAIKK--SKVIDESKVDEF-INEVAILSQINHRNVVKL 455
R+LG+GG G V + A G++ A KK K I + K + +NE IL ++N R VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 456 LGCCLETEVPLLVYEFIING--TLFQYLHDQNEEFPITWEIR-LRIAIEVSDAVSYLHSA 512
ET+ L + ++NG F H F E R + A E+ + LH
Sbjct: 66 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICCGLEDLHQE 121
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
I +RD+K NILLD ++SD G + + QT + +V GT GY+ PE ++
Sbjct: 122 R---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNE 176
Query: 573 RFTEKSDVYSFGVVLAELLTGE 594
R+T D ++ G +L E++ G+
Sbjct: 177 RYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 61/215 (28%), Positives = 98/215 (45%), Gaps = 13/215 (6%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKK--SKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG G G V K ++ +K I + ++ I E+ +L + N +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ E + G+L Q L + I EI +++I V ++YL I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQI--MH 127
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579
RD+K +NIL++ + K+ DFG S + ID M GT Y+ PE + + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 580 VYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614
++S G+ L EL G I + +E L A F R
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGR 216
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 61/203 (30%), Positives = 97/203 (47%), Gaps = 21/203 (10%)
Query: 402 LGQGGQGTVYKG--MLADGRIVAIKKSKV--IDESKVDEFINEVAILSQIN---HRNVVK 454
+G+G G V+K + GR VA+K+ +V +E I EVA+L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 455 LLGCCL------ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
L C ET++ L V+E + + L YL D+ E + E + ++ + +
Sbjct: 69 LFDVCTVSRTDRETKLTL-VFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHS + HRD+K NIL+ + K++DFG +R + T V T Y PE
Sbjct: 126 LHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEV 180
Query: 569 FRSSRFTEKSDVYSFGVVLAELL 591
S + D++S G + AE+
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 55/200 (27%), Positives = 98/200 (49%), Gaps = 9/200 (4%)
Query: 396 YNTNRILGQG--GQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
YN R++G+G G+ + + + +D + + S V++ E +L+++ H N+V
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61
Query: 454 KLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
E + L +V E+ G L Q + Q + + L+ +++ V ++H
Sbjct: 62 AFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKL-FPEDTILQWFVQMCLGVQHIHEK 119
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
+ HRDIKS NI L + K+ DFG++R + + T V GT Y+ PE + +
Sbjct: 120 R---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 573 RFTEKSDVYSFGVVLAELLT 592
+ KSD++S G +L EL T
Sbjct: 176 PYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 61/273 (22%), Positives = 124/273 (45%), Gaps = 32/273 (11%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKS-KVIDESKVDEFINEVA----ILSQINHRNVV 453
++LG G GTV+KG+ + +G + I + K I + + E+ + ++H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG C + L V + G+L ++ + + + L ++++ + YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFG-ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
+ HR++ + NILL +++DFG A D+ + ++ + ++ E
Sbjct: 130 MV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632
R+T +SDV+S+GV + E+++ A M+ + ++L+ +
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS---------------YGAEPYAGMRPHEVPDLLEKG--ER 229
Query: 633 ASQEDIVT--VAKLTNRCLNLNGKKRPTMKEVA 663
+Q I T V + +C ++ RPT KE+A
Sbjct: 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELA 262
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 4e-14
Identities = 64/196 (32%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 402 LGQGGQGTVYKGMLA-DGRIVAIK--KSKVIDESKVDEFI-NEVAILSQINHRNVVKLLG 457
LG GG G V + R A+K K + I E+ E I +E IL + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
+ + ++ E+ + G L+ L D+ F + R IA V A YLH+ I
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL-FD-EYTARFYIACVVL-AFEYLHN---RGI 114
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
+RD+K N+LLD K+ DFG ++ + Q T GT Y+ PE + +
Sbjct: 115 IYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYDFS 172
Query: 578 SDVYSFGVVLAELLTG 593
D +S G++L ELLTG
Sbjct: 173 VDYWSLGILLYELLTG 188
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 65/293 (22%), Positives = 129/293 (44%), Gaps = 32/293 (10%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIV--AIKKSKVIDESKVD 435
I +S + K +E+ T+ ++ + Q ++YKG+ + ++ KK + +D
Sbjct: 4 ITRSYINDIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLID 63
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPL----LVYEFIINGTLFQYLHDQNEEFPIT 491
NE+ L +I+ N++K+ G ++ L L+ E+ G L + L ++E ++
Sbjct: 64 ITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL---DKEKDLS 120
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551
++ +L +AI+ + L+ + P ++++ S + L+ Y+ K+ G + ++
Sbjct: 121 FKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPF 178
Query: 552 HMTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609
Y + S +T K D+YS GVVL E+ TG+ FE +
Sbjct: 179 KNVN----FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK-----IPFENLTTKE 229
Query: 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
Y L K +SL LD + + + C + + KRP +KE+
Sbjct: 230 IYDLIINKNNSLKLPLDCPLE----------IKCIVEACTSHDSIKRPNIKEI 272
|
Length = 283 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 14/204 (6%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK---SKVIDESKVDEFINEVAILSQINH 449
D + +G G G V+ A+K +VI + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
+++L + ++ E++ G LF YL + + L A E+ A+ YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS I +RD+K NILLD + K++DFG ++ + D+T + GT YL PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT---LCGTPEYLAPEVI 170
Query: 570 RSSRFTEKSDVYSFGVVLAELLTG 593
+S + D ++ G+++ E+L G
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 5e-14
Identities = 53/198 (26%), Positives = 97/198 (48%), Gaps = 8/198 (4%)
Query: 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
+ LG G G V+ VA+K K S V+ F+ E ++ + H +VKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 459 CLETEVPLLVYEFIINGTLFQYLH-DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
+ E ++ EF+ G+L +L D+ + P+ I + ++++ ++++ I
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF--SAQIAEGMAFIEQRNYI-- 124
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRD+++ NIL+ K++DFG +R + ++ + + PE FT K
Sbjct: 125 -HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 578 SDVYSFGVVLAELLTGER 595
SDV+SFG++L E++T R
Sbjct: 184 SDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 62/201 (30%), Positives = 97/201 (48%), Gaps = 16/201 (7%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQ-INHRNVVK 454
+++G+G G V ADG+ A+K K ++ + + + E +L + + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEE-FPITWEIRLRI-AIEVSDAVSYLHSA 512
L + V +++ G LF H Q E FP E R R A E++ A+ YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELF--FHLQRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
+ I +RD+K NILLD + ++DFG + I+ + T+ GT YL PE R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 573 RFTEKSDVYSFGVVLAELLTG 593
+ D + G VL E+L G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 401 ILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQIN---HR 450
+LG+G G V +LA+ + I A+KK +I +V+ + E I N H
Sbjct: 6 VLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 451 NVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSY 508
+V L C +TE + V E+ G L +H + F E R A V + Y
Sbjct: 63 FLVNLF-ACFQTEDHVCFVMEYAAGGDLM--MHIHTDVFS---EPRAVFYAACVVLGLQY 116
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS-MAIDQTHMTTQVQGTFGYLDPE 567
LH I +RD+K N+LLD + K++DFG + M T+ GT +L PE
Sbjct: 117 LHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPE 171
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ +T D + GV++ E+L GE
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGE 198
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 12/204 (5%)
Query: 400 RILGQGGQGTVYKGML-ADGRIVAIKK--SKVIDESKVDEF-INEVAILSQINHRNVVKL 455
R+LG+GG G V + A G++ A K+ K I + K + +NE IL ++N + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIR-LRIAIEVSDAVSYLHSAAS 514
ET+ L + I+NG ++ H N P E R L A E+ + LH +
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
+ +RD+K NILLD ++SD G + + I + GT GY+ PE + R+
Sbjct: 124 V---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 575 TEKSDVYSFGVVLAELLTGERAIR 598
T D + G ++ E++ G+ R
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 27/227 (11%)
Query: 390 ETATDHYNTNRILGQGGQGTVY--------KGMLADGRIVAIKKSK-VIDESKVDEFINE 440
E + D + LG+G G V K + VA+K K E + + ++E
Sbjct: 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSE 70
Query: 441 VAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN-------------E 486
+ ++ I H+N++ LLG C + ++ E+ G L +YL +
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 487 EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546
+ +T++ + +V+ + YL S I HRD+ + N+L+ K++DFG +R +
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDV 187
Query: 547 -AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
ID TT + ++ PE +T +SDV+SFGV++ E+ T
Sbjct: 188 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 6e-14
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 23/208 (11%)
Query: 406 GQGTVYKGMLA----DGRIVAIKK---SKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
G+G+ K +L DG+ IK+ SK+ + + +E EVA+LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKER-EESRKEVAVLSNMKHPNIVQYQES 67
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQN-----EEFPITWEIRLRIAIEVSDAVSYLHSAA 513
E +V ++ G L++ ++ Q E+ + W +++ +A++ ++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK------HVHDRK 121
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I HRDIKS NI L K+ DFG +R + + GT YL PE +
Sbjct: 122 ---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRP 177
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTN 601
+ KSD+++ G VL E+ T + A N
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 8e-14
Identities = 74/242 (30%), Positives = 111/242 (45%), Gaps = 39/242 (16%)
Query: 400 RILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
++LG+G G V MLA+ + I +KK ++ + VD + E IL+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 453 VKLLGCCLETEVPLL-VYEFIINGTL-FQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYL 509
+ L CC +T+ L V E++ G L FQ + + E R R A EV+ A+ +L
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD-----EPRSRFYAAEVTLALMFL 112
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
H I +RD+K NILLD + K++DFG + I TT GT Y+ PE
Sbjct: 113 HRHGVI---YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEIL 168
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE-ILDAH 628
+ + D ++ GV++ E++ G+ FE D ED LFE IL
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPP-----FEAD-----------NEDDLFESILHDD 212
Query: 629 VL 630
VL
Sbjct: 213 VL 214
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 21/201 (10%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKV--DEFINEVAILSQINHRNVVKLLG 457
LG+G G+V K L + ++ K+ D + + + E+ I +VK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 458 CCL---ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWE-IRLRIAIEVSDAVSYLHSAA 513
L + + + + E+ G+L + E + +IA V +SYLHS
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGAS----RSMAIDQTHMTTQVQGTFGYLDPEYF 569
I HRDIK +NILL K + K+ DFG S S+A T GT Y+ PE
Sbjct: 126 II---HRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-------GTSFYMAPERI 175
Query: 570 RSSRFTEKSDVYSFGVVLAEL 590
+ ++ SDV+S G+ L E+
Sbjct: 176 QGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 57/193 (29%), Positives = 83/193 (43%), Gaps = 40/193 (20%)
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
+I+I V ++YL I HRD+K +NIL++ + K+ DFG S ID M
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS-GQLIDS--MANS 157
Query: 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616
GT Y+ PE + + +T +SD++S G+ L E+ G I + K L A F R +
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD---AKELEAMFGRPV 214
Query: 617 KEDS--------------------LFEILDAHVLKEA--------SQEDIVTVAKLTNRC 648
E +FE+LD V + S E V K C
Sbjct: 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK----C 270
Query: 649 LNLNGKKRPTMKE 661
L N K+R +KE
Sbjct: 271 LKKNPKERADLKE 283
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 60/217 (27%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 401 ILGQGGQGTVYK------GMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVV 453
++G+G G V K G+ D I +K+ D+ + +F E+ +L ++ H N++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNII 71
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLH-----DQNEEFPI--------TWEIRLRIAI 500
LLG C L E+ +G L +L + + F I + + L A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
+V+ + YL I HRD+ + NIL+ Y AK++DFG SR + V+ T
Sbjct: 132 DVARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 181
Query: 561 FG-----YLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
G ++ E S +T SDV+S+GV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 11/204 (5%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHR 450
D Y +G+G G VYK +A+KK ++ DE I E+++L ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+V+L + LV+E+ ++ L +++ D + +F + ++ ++Y H
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEY-LDLDLKKHM-DSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 511 SAASIPIYHRDIKSTNILLDGKYRA-KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
S + HRD+K N+L+D + A K++DFG +R+ I T +V T Y PE
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 570 RSSR-FTEKSDVYSFGVVLAELLT 592
SR ++ D++S G + AE++
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 23/190 (12%)
Query: 421 VAIK--KSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLV-YEFIINGT 476
VA+K K D+ D I+E+ ++ I H+N++ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDKDLAD-LISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 477 LFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523
L ++L + E ++++ + A +V+ + YL S I HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 524 STNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYS 582
+ N+L+ K++DFG +R + ID T+ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 583 FGVVLAELLT 592
FG+++ E+ T
Sbjct: 222 FGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 22/200 (11%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKK---SKVIDESKVDEFINEVAILSQINHRNVVKL 455
R +G G G VY + +VAIKK S K + I EV L Q+ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80
Query: 456 LGCCLETEVPLLVYEFIINGT--LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
GC L LV E+ + + + +E I I ++YLHS
Sbjct: 81 KGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIA-----AICHGALQGLAYLHSHE 135
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-- 571
I HRDIK+ NILL K++DFG++ ++ + + GT ++ PE +
Sbjct: 136 RI---HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMD 187
Query: 572 -SRFTEKSDVYSFGVVLAEL 590
++ K DV+S G+ EL
Sbjct: 188 EGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFIN-----EVAILSQINHRNVVKL 455
+G+G G V+K + G+IVAIKK ES+ D I E+ +L Q+ H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKK---FVESEDDPVIKKIALREIRMLKQLKHPNLVNL 65
Query: 456 LGCCLETEVPLLVYEFIIN---GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
+ LV+E+ + L + E I+ +I + AV++ H
Sbjct: 66 IEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-----LIK-KIIWQTLQAVNFCHKH 119
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF-RS 571
I HRD+K NIL+ + + K+ DFG +R + T T Y PE
Sbjct: 120 NCI---HRDVKPENILITKQGQIKLCDFGFAR-ILTGPGDDYTDYVATRWYRAPELLVGD 175
Query: 572 SRFTEKSDVYSFGVVLAELLTGE 594
+++ DV++ G V AELLTG+
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 1e-13
Identities = 52/215 (24%), Positives = 102/215 (47%), Gaps = 20/215 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKV-DEFINEVAILSQINHR 450
D Y +G+G G VYK G++VA+KK+++ +DE + + E+++L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 451 N-VVKLLGCCLETEVPL------LVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAIE 501
+V+LL E LV+E++ + L +++ + + P+ + +
Sbjct: 61 IYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
+ V++ H + HRD+K N+L+D K K++D G R+ +I T ++ T
Sbjct: 119 LLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-T 174
Query: 561 FGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGE 594
Y PE S ++ D++S G + AE+ +
Sbjct: 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ 209
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 64/203 (31%), Positives = 87/203 (42%), Gaps = 28/203 (13%)
Query: 404 QGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAIL-SQINHRNVVKL 455
+G G+VY LA R I +KKS +I +++V E AI+ Q V KL
Sbjct: 6 KGAFGSVY---LAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62
Query: 456 LGCCLETEVPLLVYEFIING---TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
+ LV E++ G +L + L P W + IA EV V LH
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLG----GLPEDW-AKQYIA-EVVLGVEDLHQR 116
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
I HRDIK N+L+D K++DFG SR+ + GT YL PE
Sbjct: 117 G---IIHRDIKPENLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGV 168
Query: 573 RFTEKSDVYSFGVVLAELLTGER 595
+ SD +S G V+ E L G
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYP 191
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 54/172 (31%), Positives = 81/172 (47%), Gaps = 7/172 (4%)
Query: 422 AIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL 481
I+K+ ++ S+V + E +L+Q+N +V L E LV FI G LF +L
Sbjct: 25 TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84
Query: 482 HDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541
Q E R A E+ A+ LH + +RD+K NILLD + + DFG
Sbjct: 85 --QREGRFDLSRARFYTA-ELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
+ + + T GT YL PE +T+ D ++ GV+L E+LTG
Sbjct: 139 LCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 18/205 (8%)
Query: 400 RILGQGGQGTVY---KGMLAD-GRIVAIK---KSKVIDESKVDEFI-NEVAILSQINHRN 451
++LG G G V+ K D G++ A+K K+ ++ ++K E E +L +
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 452 VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVSYL 509
+ L +TE L L+ +++ G +F +L+ Q + F E +R E+ A+ +L
Sbjct: 66 FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIILALEHL 121
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
H + I +RDIK NILLD + ++DFG S+ ++ T GT Y+ PE
Sbjct: 122 HK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 570 RSSRFTEKS-DVYSFGVVLAELLTG 593
R K+ D +S G+++ ELLTG
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 57/204 (27%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVI-DESKVDEFINEV-AILSQINHRNVVKLLGC 458
+G+G GTV K + G I+A+K+ + DE + + ++ ++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 459 CLETEVPLLVYEF--IINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
+ E I ++Y+++ P EI +IA+ A++YL +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNYLKE--EL 127
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSM--AIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I HRD+K +NILLD K+ DFG S + +I +T G Y+ PE S
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDA----GCRPYMAPERIDPSA 183
Query: 574 ---FTEKSDVYSFGVVLAELLTGE 594
+ +SDV+S G+ L E+ TG+
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 401 ILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILSQINHRNVVKL 455
+GQG G V+K +IVA+KK V+ E++ + F + E+ IL + H NVV L
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK--VLMENEKEGFPITALREIKILQLLKHENVVNL 76
Query: 456 LGCCLETEVP--------LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
+ C P LV+EF L L ++N +F ++ EI+ ++ + + +
Sbjct: 77 IEICRTKATPYNRYKGSFYLVFEFC-EHDLAGLLSNKNVKFTLS-EIK-KVMKMLLNGLY 133
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI----DQTHMTTQVQGTFGY 563
Y+H I HRD+K+ NIL+ K++DFG +R+ ++ T +V T Y
Sbjct: 134 YIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-TLWY 189
Query: 564 LDPEYFRSSR-FTEKSDVYSFGVVLAELLT 592
PE R + D++ G ++AE+ T
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 66/280 (23%), Positives = 118/280 (42%), Gaps = 47/280 (16%)
Query: 402 LGQGGQGTVYKGML---ADGRIVAIKKS-----KVIDESKVD--EFINEVAILSQINHRN 451
LGQG +YKG+L +D IV + KV+ D F +++SQ++H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+VKL G C+ E ++V E++ G L +LH + + W +L +A +++ A+ YL
Sbjct: 63 LVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 512 AASIPIYHRDIKSTNILL-----DGKYR--AKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ H ++ NIL+ + Y K+SD G ++ + ++
Sbjct: 120 KKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL-----SREERVERIPWI 171
Query: 565 DPEYFR--SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
PE R + T +D +SFG L E+ ++ L+ +
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEIC----------SNGEEPLSTLSSSEKER---- 217
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
D H L +A L N+C + KRP+ + +
Sbjct: 218 FYQDQHRLPMPDCA---ELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-13
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 12/202 (5%)
Query: 402 LGQGGQGTVYK-GMLADGRIVAIKK--SKVIDESKVDEF-INEVAILSQINHRNVVKLLG 457
LG+GG G V + A G++ A KK K + + K ++ +NE IL +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIP 516
ET+ L + ++NG +Y H N P E R A ++ + +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKY-HIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--- 115
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE 576
I +RD+K N+LLD ++SD G + + + GT GY+ PE + +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGEVYDF 173
Query: 577 KSDVYSFGVVLAELLTGERAIR 598
D ++ G L E++ G R
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 4e-13
Identities = 63/199 (31%), Positives = 91/199 (45%), Gaps = 20/199 (10%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLG 457
+GQGG G V+ D G IVA+K KS + ++V + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 458 CCLETEVPLLVYEFIING---TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
+ E L E++ G TL L +E+ R +A E+ +AV LH
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-----HARFYMA-EMFEAVDALHELGY 122
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
I HRD+K N L+D K++DFG S + + V G+ Y+ PE R +
Sbjct: 123 I---HRDLKPENFLIDASGHIKLTDFGLS-KGIVTYAN---SVVGSPDYMAPEVLRGKGY 175
Query: 575 TEKSDVYSFGVVLAELLTG 593
D +S G +L E L G
Sbjct: 176 DFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 61/215 (28%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 401 ILGQGGQGTVYKGMLA-DGRIV--AIKKSK-VIDESKVDEFINEVAILSQI-NHRNVVKL 455
++G+G G V + M+ DG + AIK K E+ +F E+ +L ++ +H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQN--EEFP-----------ITWEIRLRIAIEV 502
LG C + E+ G L +L E P +T + L+ A +V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
+ + YL I HRD+ + N+L+ +K++DFG SR + V+ T G
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV-------YVKKTMG 178
Query: 563 -----YLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ E S +T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 6e-13
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 402 LGQGGQGTVYK------GMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455
LG G G VYK G LA +++ K E ++++++ E+ IL+ NH +VKL
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETK-----SEEELEDYMVEIEILATCNHPYIVKL 74
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLH--DQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
LG ++ EF G + + D+ P +I++ I ++ +A+ YLHS
Sbjct: 75 LGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS-- 128
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY----- 568
+ I HRD+K+ N+LL K++DFG S + + GT ++ PE
Sbjct: 129 -MKIIHRDLKAGNVLLTLDGDIKLADFGVS-AKNVKTLQRRDSFIGTPYWMAPEVVMCET 186
Query: 569 FRSSRFTEKSDVYSFGVVLAEL 590
+ + + K+D++S G+ L E+
Sbjct: 187 MKDTPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 7e-13
Identities = 64/218 (29%), Positives = 100/218 (45%), Gaps = 36/218 (16%)
Query: 401 ILGQGGQGT---VYKGML---ADGRIVAIKKSKVIDESKVDEF----INEVAILSQINHR 450
I G G+GT VYK DG+ AIKK K D+ + E+A+L ++ H
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKG-DKEQYTGISQSACREIALLRELKHE 62
Query: 451 NVVKLLGCCLE-TEVPL-LVYEF-------IINGTLFQYLHDQNEEFPITWEIRLRIAIE 501
NVV L+ LE + + L++++ II H Q + I + + +
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIK------FHRQAKRVSIPPSMVKSLLWQ 116
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILL--DGKYRA--KVSDFGASR--SMAIDQTHMTT 555
+ + V YLHS + HRD+K NIL+ +G R K+ D G +R + +
Sbjct: 117 ILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD 173
Query: 556 QVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLT 592
V T Y PE +R +T+ D+++ G + AELLT
Sbjct: 174 PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 8e-13
Identities = 67/211 (31%), Positives = 105/211 (49%), Gaps = 19/211 (9%)
Query: 395 HYNTNRILGQGGQGTVYKGML-ADGRIVAIKK--SKVIDESKVDEF-INEVAILSQINHR 450
HY R+LG+GG G V + A G++ A KK K I + K + +NE IL ++N R
Sbjct: 4 HY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 60
Query: 451 NVVKLLGCCLETEVPLLVYEFIING--TLFQYLHDQNEEFPITWEIR-LRIAIEVSDAVS 507
VV L ET+ L + ++NG F + N F E R + A E++ +
Sbjct: 61 FVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLE 116
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
LH I +RD+K NILLD ++SD G + + +T + +V GT GY+ PE
Sbjct: 117 DLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPE 171
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIR 598
++ R+T D + G ++ E++ G+ R
Sbjct: 172 VVKNERYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 8e-13
Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 18/214 (8%)
Query: 390 ETATDHYNTNRILGQGGQGTVYK------GMLADGRIVAIKKSKVIDESKVDEFINEVAI 443
E D + LG G G V+K G++ +++ ++ I ++ I E+ +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIR----NQIIRELQV 56
Query: 444 LSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVS 503
L + N +V G + E + G+L Q L I +I +++I V
Sbjct: 57 LHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVI 113
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
++YL I HRD+K +NIL++ + K+ DFG S + ID M GT Y
Sbjct: 114 KGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSY 168
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597
+ PE + + ++ +SD++S G+ L E+ G I
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 9e-13
Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 53/226 (23%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
R LG G G V+ + +D + VA+KK + D V + E+ I+ +++H N+VK
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK---- 66
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIR-LRIAIEVSDA------------ 505
VYE L D E+ E+ + I E +
Sbjct: 67 ---------VYE-----VLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLS 112
Query: 506 --------------VSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQ 550
+ Y+HSA + HRD+K N+ ++ + K+ DFG +R +
Sbjct: 113 EEHARLFMYQLLRGLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHY 169
Query: 551 THMTTQVQG--TFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTG 593
+H +G T Y P S +T+ D+++ G + AE+LTG
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 9e-13
Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 18/203 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR-----IVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
++LG+G G V L G+ + A+KK V+ + V+ + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAEL-KGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT 59
Query: 455 LLGCCLETEVPLL-VYEFIINGTLFQYLHDQN--EEFPITWEIRLRIAIEVSDAVSYLHS 511
L C +T+ L V EF+ G L ++ D+ + + T+ A E+ + +LHS
Sbjct: 60 HLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHS 114
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
I +RD+K N++LD K++DFG + +T GT Y+ PE +
Sbjct: 115 KGII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQG 170
Query: 572 SRFTEKSDVYSFGVVLAELLTGE 594
++T D +SFGV+L E+L G+
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 39/225 (17%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK----SKVIDESKVDEFINEVAILSQIN 448
Y +G G G V + G+ VAIKK V +K + E+ IL
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAK--RTLRELKILRHFK 62
Query: 449 HRNVVKLLGCCLETEVPL-----LVYEFIINGTLFQYLHDQNEEFPITWE-IR------L 496
H N++ + L +V + ++ L +H P+T E IR L
Sbjct: 63 HDNIIAIRDI-LRPPGADFKDVYVVMD-LMESDLHHIIHSDQ---PLTEEHIRYFLYQLL 117
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA---IDQTHM 553
R + Y+HSA + HRD+K +N+L++ ++ DFG +R ++ + +
Sbjct: 118 R-------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF 167
Query: 554 TTQVQGTFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTGERAI 597
T+ T Y PE +T D++S G + AE+L G R +
Sbjct: 168 MTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 86/295 (29%), Positives = 136/295 (46%), Gaps = 43/295 (14%)
Query: 387 KELETATDHYNTNRILGQGGQGTV----YKGMLADGRIVAIK---KSKVIDESKVDEFIN 439
++L+ + Y+ +++G+G G V +K + ++ A+K K ++I S F
Sbjct: 36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHK---SSQKVYAMKLLSKFEMIKRSDSAFFWE 92
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI 498
E I++ N VV+L C + + L +V E++ G L + N + P W +
Sbjct: 93 ERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-KFYT 148
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT---T 555
A EV A+ +HS I HRD+K N+LLD K++DFG M +D+T M T
Sbjct: 149 A-EVVLALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDT 202
Query: 556 QVQGTFGYLDPEYFRSS----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611
V GT Y+ PE +S + + D +S GV L E+L G+ T F D + Y
Sbjct: 203 AV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD-----TPFYADSLVGTY 256
Query: 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNL--NG----KKRPTMK 660
++SL D + K A + A LT+R + L NG K+ P K
Sbjct: 257 SKIMDHKNSLNFPEDVEISKHAKN---LICAFLTDREVRLGRNGVEEIKQHPFFK 308
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 400 RILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
++LG+G G V MLA+ + I A+KK V+++ V+ + E +L+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPF 57
Query: 453 VKLLGCCLETEVPLL-VYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLH 510
+ L C +T+ L V E++ G L ++ F E R R A E+ + +LH
Sbjct: 58 LTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR-FD---EARARFYAAEIICGLQFLH 113
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I +RD+K N+LLD K++DFG + + + GT Y+ PE +
Sbjct: 114 KKGII---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-KASTFCGTPDYIAPEILK 169
Query: 571 SSRFTEKSDVYSFGVVLAELLTGE 594
++ E D +SFGV+L E+L G+
Sbjct: 170 GQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 60/202 (29%), Positives = 98/202 (48%), Gaps = 11/202 (5%)
Query: 400 RILGQGGQGTV-YKGMLADGRIVAIKKSKVIDESKVDEFI--NEVAILSQINHRNVVKLL 456
R++G+G G V DG+ IKK + + S+ + E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 457 GCCLETEVPLL--VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
E E LL V F G L+ L +Q + ++ + ++++ A+ YLH
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV-VEWFVQIAMALQYLHEKH- 122
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
I HRD+K+ N+ L KV D G +R + +Q M + + GT Y+ PE F + +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 575 TEKSDVYSFGVVLAELLTGERA 596
KSDV++ G + E+ T + A
Sbjct: 180 NYKSDVWALGCCVYEMATLKHA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 21/189 (11%)
Query: 421 VAIK--KSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTL 477
VA+K K D+ + + ++E+ ++ I H+N++ LLG C + ++ E+ G L
Sbjct: 47 VAVKMLKDDATDKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 478 FQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524
+YL + E +T++ + A +V+ + YL S I HRD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAA 162
Query: 525 TNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSF 583
N+L+ K++DFG +R + ID TT + ++ PE +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 584 GVVLAELLT 592
GV+L E+ T
Sbjct: 223 GVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 63/197 (31%), Positives = 90/197 (45%), Gaps = 17/197 (8%)
Query: 406 GQGTVYKGMLA----DGRIVAIK--KSKVIDESKVDEFI--NEVAILSQINHRNVVKLLG 457
G+G+ K +LA DG A+K + K I + K I +L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIP 516
E V +++ G LF H Q E E R R A EV+ A+ YLHS +
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE 576
I +RD+K NILLD + ++DFG + ++ T+ GT YL PE R +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 577 KSDVYSFGVVLAELLTG 593
D + G VL E+L G
Sbjct: 176 TVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 26/202 (12%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGC 458
LG G G VYK + ++A +KVID E ++++++ E+ IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLA--AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVS-DAVSYLHSAASIPI 517
++ EF G + + + E P+T E ++R+ + + +A++YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLT-EPQIRVVCKQTLEALNYLHENK---I 124
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ----GTFGYLDPEYF---- 569
HRD+K+ NIL K++DFG S + T Q + GT ++ PE
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSA-----KNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 570 -RSSRFTEKSDVYSFGVVLAEL 590
+ + K+DV+S G+ L E+
Sbjct: 180 SKDRPYDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 68/263 (25%), Positives = 116/263 (44%), Gaps = 22/263 (8%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVA---IKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455
R++G+G V L RI A +KK V D+ +D E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 456 LGCCLETEVPLL-VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L C +TE L V E++ G L ++ Q + + E + E+S A++YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG- 116
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE R +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 575 TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE-ILDAHVLKEA 633
D ++ GV++ E++ G + ++ ED LF+ IL+ +
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD-------QNTEDYLFQVILEKQIRIPR 226
Query: 634 SQEDIVTVAKLTNRCLNLNGKKR 656
S V A + LN + K+R
Sbjct: 227 SLS--VKAASVLKSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 3e-12
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 42/223 (18%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKV-DEFINEVAILSQINHRN 451
Y +G+G G V G VAIKK + + E+ IL + H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 452 VVKLLG-----------------CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEI 494
++ +L +ET++ L+ Q+L + + ++ ++I
Sbjct: 65 IIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--------QHLSNDHIQY-FLYQI 115
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI--DQTH 552
LR + Y+HSA + HRD+K +N+LL+ K+ DFG +R D T
Sbjct: 116 -LR-------GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTG 164
Query: 553 MTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGE 594
T+ T Y PE +S+ +T+ D++S G +LAE+L+
Sbjct: 165 FLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG+G G+VYK + G +A+K+ ++ +DESK ++ I E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRL-RIAIEVSDAVSYLHSAASIPIY 518
+ E++ G+L L+ E L RI V + +L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--I 125
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSM--AIDQTHMTTQVQGTFGYLDPEYFRS----- 571
HRD+K TN+L++G + K+ DFG S ++ ++ +T++ Q Y+ PE +S
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQ-----SYMAPERIKSGGPNQ 180
Query: 572 -SRFTEKSDVYSFGVVLAELLTG 593
+T +SDV+S G+ + E+ G
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALG 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 3e-12
Identities = 60/243 (24%), Positives = 104/243 (42%), Gaps = 19/243 (7%)
Query: 400 RILGQGGQGTVYKGMLADGRIV----AIKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455
R++G+G V L + +KK V D+ +D E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 456 LGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAA 513
L C +T L LV E++ G L ++ Q + P E R A E+ A+++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYAAEICIALNFLHERG 116
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I +RD+K N+LLD K++D+G + + T+ GT Y+ PE R
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL-----FEILDAH 628
+ D ++ GV++ E++ G + D + Y + + E + + +H
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232
Query: 629 VLK 631
VLK
Sbjct: 233 VLK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 28/206 (13%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVI--DESKVDEFINEVAIL---SQINHRNVVKL 455
+G G GTVYK G VA+K +V ++ + EVA+L +H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 456 LGCCL------ETEVPLLVYEFIINGTLFQYLHDQNEEFP---ITWEIRLRIAIEVSDAV 506
+ C ET+V L V+E + + L YL ++ P + E + + +
Sbjct: 68 MDVCATSRTDRETKVTL-VFEHV-DQDLRTYL----DKVPPPGLPAETIKDLMRQFLRGL 121
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-TQVQGTFGYLD 565
+LH+ I HRD+K NIL+ + K++DFG +R I M T V T Y
Sbjct: 122 DFLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR---IYSCQMALTPVVVTLWYRA 175
Query: 566 PEYFRSSRFTEKSDVYSFGVVLAELL 591
PE S + D++S G + AE+
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 66/209 (31%), Positives = 104/209 (49%), Gaps = 15/209 (7%)
Query: 395 HYNTNRILGQGGQGTVYKGML-ADGRIVAIKK--SKVIDESKVDEF-INEVAILSQINHR 450
HY R+LG+GG G V + A G++ A KK K I + K + +NE IL ++N R
Sbjct: 4 HY---RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSR 60
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIR-LRIAIEVSDAVSYL 509
VV L ET+ L + I+NG ++ H N P E R + A E+ + L
Sbjct: 61 FVVSL-AYAYETKDALCLVLTIMNGGDLKF-HIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
I +RD+K NILLD + ++SD G + + +T + +V GT GY+ PE
Sbjct: 119 QRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVI 173
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIR 598
+ ++T D + G ++ E++ G+ R
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 78/244 (31%), Positives = 114/244 (46%), Gaps = 42/244 (17%)
Query: 396 YNTNRILGQGGQGTV-YKGMLADGRIVAIKKSKVID-----ESKVDEFINEVAILSQINH 449
Y +R+LG G GTV ++DG A+K V+D E+ + EV L +
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 450 RNVVKLLGCCLE------------TEVPLLVYEFIINGTLFQYLHDQ---NEEFPITWEI 494
++VK C E + LV ++ G L Q + + N F E
Sbjct: 91 FSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF-REHEA 145
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554
L + I+V AV ++HS I HRDIKS NILL K+ DFG S+ A ++
Sbjct: 146 GL-LFIQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYA---ATVS 198
Query: 555 TQVQGTFG----YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE--DKSL 608
V TF Y+ PE +R +++K+D++S GV+L ELLT +R N EE K+L
Sbjct: 199 DDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258
Query: 609 AAYF 612
A +
Sbjct: 259 AGRY 262
|
Length = 496 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 61/214 (28%), Positives = 104/214 (48%), Gaps = 27/214 (12%)
Query: 392 ATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD-EFINEVAILSQINH 449
AT + N + LG+G TVYKG+ +G++VA+K + E V I E ++L + H
Sbjct: 4 ATSYLNLEK-LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQY-------LHDQNEEFPITWEIRLRIAIEV 502
N+V L E V+E++ + L QY LH N +RL ++
Sbjct: 63 ANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYN--------VRL-FMFQL 112
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI-DQTHMTTQVQGTF 561
++Y+H I HRD+K N+L+ K++DFG +R+ +I QT+ + V T
Sbjct: 113 LRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TL 167
Query: 562 GYLDPEYFR-SSRFTEKSDVYSFGVVLAELLTGE 594
Y P+ ++ ++ D++ G + E+L G+
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 5e-12
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 24/213 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVD-EFINEVAILSQINHRN 451
D Y LG+G TVYKG +G++VA+K ++ +E I E ++L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQY-------LHDQNEEFPITWEIRLRIAIEVSD 504
+V L E LV+E++ + L QY LH +N + + +R
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR--------- 114
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+SY+H I HRD+K N+L+ K++DFG +R+ ++ +H + T Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYR 170
Query: 565 DPE-YFRSSRFTEKSDVYSFGVVLAELLTGERA 596
P+ S+ ++ D++ G + E++ G A
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 401 ILGQGGQGTVYKGMLA-DGRIV--AIKKSK-VIDESKVDEFINEVAILSQINHR-NVVKL 455
++G+G G V K + DG + AIK+ K + +F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQN--EEFP-----------ITWEIRLRIAIEV 502
LG C L E+ +G L +L E P ++ + L A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
+ + YL I HRD+ + NIL+ Y AK++DFG SR + V+ T G
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 171
Query: 563 -----YLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ E S +T SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-12
Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 11/203 (5%)
Query: 402 LGQGGQGTVYK-GMLADGRIVAIKK--SKVIDESKVDE-FINEVAILSQINHRNVVKLLG 457
LG+GG G V M A G++ A KK K + + K E + E IL++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 458 CCLETEVPLLVYEFIINGTLFQY-LHDQNEEFPITWEIR-LRIAIEVSDAVSYLHSAASI 515
+T+ L + I+NG +Y +++ +EE P E R ++ + +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT 575
I +RD+K N+LLD ++SD G + + Q+ T GT G++ PE + +
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 576 EKSDVYSFGVVLAELLTGERAIR 598
D ++ GV L E++ R
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFR 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 6e-12
Identities = 49/202 (24%), Positives = 92/202 (45%), Gaps = 11/202 (5%)
Query: 400 RILGQGGQGTVYKGMLA-DGR---IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVK 454
RILG G G + +G L + VAI + + + F+ E L Q +H N+V+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L G ++V E++ NG L +L + E + + + ++ + YL
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQLVAGQLMGMLPGLASGMKYLSEMGY 128
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
+ H+ + + +L++ K+S F + + + T + + PE + F
Sbjct: 129 V---HKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185
Query: 575 TEKSDVYSFGVVLAELLT-GER 595
+ SDV+SFG+V+ E+++ GER
Sbjct: 186 SSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 71/282 (25%), Positives = 115/282 (40%), Gaps = 49/282 (17%)
Query: 407 QGTVYKGMLADGRIVA--IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464
G ++GM + R+V ++ S DE F+ EV ++NH NV++ LG C+E+
Sbjct: 13 LGEAHRGM-SKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQCLGQCIESIP 69
Query: 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRL--RIAIEVSDAVSYLHSAASIPIYHRDI 522
LLV EF G L YL + + R+A EV+ + +LH A I H D+
Sbjct: 70 YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI---HSDL 126
Query: 523 KSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT-FGYLDPEYFRS-------SRF 574
N L K+ D+G + + ++T +L PE
Sbjct: 127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQ 186
Query: 575 TEKSDVYSFGVVLAEL----------LTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
T+KS+++S GV + EL L+ E+ ++ E+D L L D +E+
Sbjct: 187 TKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEV 246
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ C L+ + RPT +EV +L
Sbjct: 247 MQF--------------------CW-LDPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 7e-12
Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 19/218 (8%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGMLADGRIV-AIK---KSKVIDESKVDEFINEVA 442
+L + ++ +++G+G G V + V A+K K ++I S F E
Sbjct: 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 443 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIE 501
I++ N +V+L + + L +V E++ G L + N + P W R A E
Sbjct: 96 IMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWA-RFYTA-E 150
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID-QTHMTTQVQGT 560
V A+ +HS I HRD+K N+LLD K++DFG M + T V GT
Sbjct: 151 VVLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GT 206
Query: 561 FGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGE 594
Y+ PE +S + + D +S GV L E+L G+
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 54/201 (26%), Positives = 100/201 (49%), Gaps = 17/201 (8%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFI-----NEVAILSQINHRNVVKL 455
+G+G GTV+K + IVA+K+ ++ D+ DE + E+ +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIVRL 64
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
+ LV+E+ + L +Y N + I EI ++ +++ HS
Sbjct: 65 YDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSHN-- 119
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRSSRF 574
+ HRD+K N+L++ K++DFG +R+ I + +V T Y P+ F + +
Sbjct: 120 -VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLY 177
Query: 575 TEKSDVYSFGVVLAELLTGER 595
+ D++S G + AEL R
Sbjct: 178 STSIDMWSAGCIFAELANAGR 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 57/196 (29%), Positives = 88/196 (44%), Gaps = 16/196 (8%)
Query: 406 GQGTVYKGML----ADGRIVA---IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
G+GT K +L A G+ A +KK +I + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIPI 517
+ V E++ G LF +L + + E R R E+ A+ YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---I 116
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
+RD+K N++LD K++DFG + D M T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 578 SDVYSFGVVLAELLTG 593
D + GVV+ E++ G
Sbjct: 176 VDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 23/273 (8%)
Query: 387 KELETATDHYNTNRILGQGGQGTV----YKGMLADGRIVAIKKSKVIDESKVDEFINEVA 442
++L + Y +++G+G G V +K + + K ++I S F E
Sbjct: 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERD 95
Query: 443 ILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
I++ N VV+L + +V E++ G L + N + P W R A EV
Sbjct: 96 IMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWA-RFYTA-EV 151
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
A+ +HS I HRD+K N+LLD K++DFG M + GT
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 563 YLDPEYFRSS----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
Y+ PE +S + + D +S GV L E+L G+ T F D + Y +
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD-----TPFYADSLVGTYSKIMNHK 263
Query: 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNL 651
+SL D + KEA + A LT+R + L
Sbjct: 264 NSLTFPDDNDISKEAKN---LICAFLTDREVRL 293
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 22/204 (10%)
Query: 400 RILGQGGQGT---VYKGM-LADGRIVAIKKSKVIDESKVDEFIN--EVAILSQIN-HRNV 452
+ILG+ G+GT V K G+ AIK K +S +++ N E+ L +++ H N+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNI 60
Query: 453 VKLLGCCLE--TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR-IAIEVSDAVSYL 509
++L+ + T LV+E +++ L++ + + P E R++ ++ ++ ++
Sbjct: 61 LRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHM 116
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
H I+HRDIK NIL+ K++DFG+ R I T+ T Y PE
Sbjct: 117 HRNG---IFHRDIKPENILIK-DDILKLADFGSCRG--IYSKPPYTEYISTRWYRAPECL 170
Query: 570 RSS-RFTEKSDVYSFGVVLAELLT 592
+ + K D+++ G V E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 64/233 (27%), Positives = 99/233 (42%), Gaps = 27/233 (11%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKK---SKVIDESKVDEFINEVAILSQINHRNVVKL 455
R +G G G VY + + +VAIKK S K + I EV L ++ H N ++
Sbjct: 21 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 456 LGCCLETEVPLLVYEFIINGT--LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
GC L LV E+ + L + +E I + ++YLHS
Sbjct: 81 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AVTHGALQGLAYLHSHN 135
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-- 571
I HRD+K+ NILL K+ DFG++ MA + GT ++ PE +
Sbjct: 136 MI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMD 187
Query: 572 -SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
++ K DV+S G+ EL ER + N +++A + A E +
Sbjct: 188 EGQYDGKVDVWSLGITCIEL--AERKPPLFNM---NAMSALYHIAQNESPALQ 235
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 73/279 (26%), Positives = 129/279 (46%), Gaps = 29/279 (10%)
Query: 402 LGQGGQGTVYKG--MLADGRIVAIKKSKVIDESKVD-EFINEVAILSQINHRNVVKLLGC 458
LG+G TVYKG L D +VA+K+ ++ E I EV++L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 459 CLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
+ TE L LV+E++ + L QYL D + ++L + ++ ++Y H +
Sbjct: 73 -IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFL-FQLLRGLNYCHRRK---V 125
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRSSRFTE 576
HRD+K N+L++ + K++DFG +R+ +I + +V T Y P+ S+ ++
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184
Query: 577 KSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH-------- 628
+ D++ G + E+ TG + EE L E++ IL
Sbjct: 185 QIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244
Query: 629 ------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
+ A + D A+L ++ L G+KR + +E
Sbjct: 245 KYRADCLHNHAPRLD-SDGAELLSKLLQFEGRKRISAEE 282
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 37/217 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK------SKVIDESKVDEFINEVAILS 445
T+ Y + +G G G V G+ VAIKK + V+ + E+ +L
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAK----RTYRELKLLK 64
Query: 446 QINHRNVVKLLGCCLE-TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
+ H N++ L + E V E + GT LH P+ + ++
Sbjct: 65 HLRHENIISLSDIFISPLEDIYFVTELL--GT---DLHRLLTSRPLEKQFIQYFLYQILR 119
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ Y+HSA + HRD+K +NIL++ K+ DFG +R I MT GY+
Sbjct: 120 GLKYVHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYV 166
Query: 565 DPEYFRS-------SRFTEKSDVYSFGVVLAELLTGE 594
Y+R+ ++ + D++S G + AE+L G+
Sbjct: 167 STRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 18/211 (8%)
Query: 391 TATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK--SKVIDESKVDEFINEVAILSQI 447
T Y + +G G QG V G VA+KK +++ E+ +L +
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 448 NHRNVVKLLGC-----CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
NH+N++ LL LE + + +++ L Q +H + + +++ + ++
Sbjct: 78 NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-----LLYQM 132
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
+ +LHSA I HRD+K +NI++ K+ DFG +R+ + M T T
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRY 187
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
Y PE + E D++S G ++ EL+ G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 3e-11
Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 14/162 (8%)
Query: 439 NEVAILSQINHRNVVKL---LGCCLETEVPLLVYEFIINGTLFQYLHD---QNEEFPITW 492
NE+ L ++NH N++K+ L T + Y+F L+ +++D ++ P+
Sbjct: 212 NEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRPLLK 267
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552
+ R I ++ AV Y+H I HRDIK NI L+ + + DFG + ++
Sbjct: 268 QTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA 323
Query: 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
GT PE + E +D++S G++L ++L+ +
Sbjct: 324 FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHD 365
|
Length = 501 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 400 RILGQGGQGTVYKGML-ADGRIVA---IKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455
R++G+G V L RI A IKK V D+ +D E + ++ +
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 456 LGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAA 513
L C +TE L V EF+ G L ++ Q + P E R + E+S A+++LH
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLP---EEHARFYSAEISLALNFLHERG 116
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I +RD+K N+LLD + K++D+G + I T+ GT Y+ PE R
Sbjct: 117 ---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 574 FTEKSDVYSFGVVLAELLTG 593
+ D ++ GV++ E++ G
Sbjct: 173 YGFSVDWWALGVLMFEMMAG 192
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 6/90 (6%)
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT-HMTTQVQGTFGYL 564
+ YLHSA I HRDIK N+L++ K+ DFG +R D++ HMT +V + Y
Sbjct: 116 LKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 565 DPEYFRSSR-FTEKSDVYSFGVVLAELLTG 593
PE SR +T D++S G + AELL
Sbjct: 172 APEILMGSRHYTSAVDIWSVGCIFAELLGR 201
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 60/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIK--KSKVIDESKVDEFI--NEVAILSQINHRNVVK 454
+++G+G G V A+ + A+K + K I + K ++ I +L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAA 513
L + V ++I G LF +L Q E + E R R A E++ A+ YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFL--EPRARFYAAEIASALGYLHS-- 114
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
+ I +RD+K NILLD + ++DFG + I+ T+ GT YL PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 574 FTEKSDVYSFGVVLAELLTG 593
+ D + G VL E+L G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 58/199 (29%), Positives = 90/199 (45%), Gaps = 24/199 (12%)
Query: 402 LGQGGQGTVYKGMLA-DGRIVAIKK----SKVIDESKVDEFINEVAILSQINHRNVVKLL 456
+G G G VY + +VA+KK K +E K + I EV L Q+ H N ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNE-KWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 457 GCCLETEVPLLVYEFIINGT--LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
GC L+ LV E+ + L + +E I I ++YLHS
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHSHNM 142
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS--- 571
I HRDIK+ NILL + K++DFG++ + + + GT ++ PE +
Sbjct: 143 I---HRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDE 194
Query: 572 SRFTEKSDVYSFGVVLAEL 590
++ K DV+S G+ EL
Sbjct: 195 GQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 5e-11
Identities = 58/196 (29%), Positives = 87/196 (44%), Gaps = 16/196 (8%)
Query: 406 GQGTVYKGML----ADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
G+GT K +L A GR A+K K +I + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIPI 517
+ V E+ G LF +L + + E R R E+ A+ YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
+RDIK N++LD K++DFG + D M T GT YL PE + +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 578 SDVYSFGVVLAELLTG 593
D + GVV+ E++ G
Sbjct: 176 VDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 400 RILGQGGQGTVYKGMLADG----RIVAIK---KSKVIDESKVDEFIN-EVAILSQINHRN 451
++LG+GG G V++ G +I A+K K+ ++ K E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 452 VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+V L+ +T L L+ E++ G LF +L + T L E+S A+ +LH
Sbjct: 62 IVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---EISLALEHLH 117
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I +RD+K NILLD + K++DFG + +I + +T GT Y+ PE
Sbjct: 118 QQG---IIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMAPEILM 173
Query: 571 SSRFTEKSDVYSFGVVLAELLTG 593
S + D +S G ++ ++LTG
Sbjct: 174 RSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 64.0 bits (155), Expect = 6e-11
Identities = 64/202 (31%), Positives = 88/202 (43%), Gaps = 26/202 (12%)
Query: 400 RILGQGGQGTVYKGMLADGR---IVAIKK---SKVIDESKVDEFINEVAILSQINHRNVV 453
R +G G G VY D R +VAIKK S K + I EV L +I H N +
Sbjct: 31 REIGHGSFGAVY--FARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSI 88
Query: 454 KLLGCCLETEVPLLVYEFIINGT--LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+ GC L LV E+ + L + +E I I ++YLHS
Sbjct: 89 EYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA-----AITHGALQGLAYLHS 143
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
I HRDIK+ NILL + K++DFG S S+A GT ++ PE +
Sbjct: 144 HNMI---HRDIKAGNILLTEPGQVKLADFG-SASIASPANSFV----GTPYWMAPEVILA 195
Query: 572 ---SRFTEKSDVYSFGVVLAEL 590
++ K DV+S G+ EL
Sbjct: 196 MDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 16/195 (8%)
Query: 423 IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLH 482
+KKS ++ + V F E ILS N + +L + + LV E+ G L L+
Sbjct: 34 MKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLN 93
Query: 483 DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
++F + +A E+ A+ +H + HRDIK N+L+D K++DFG+
Sbjct: 94 RYEDQFDEDM-AQFYLA-ELVLAIHSVHQMGYV---HRDIKPENVLIDRTGHIKLADFGS 148
Query: 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKS------DVYSFGVVLAELLTGERA 596
+ + ++ + GT Y+ PE + K D +S GV+ E++ G
Sbjct: 149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR-- 206
Query: 597 IRVTNFEEDKSLAAY 611
+ F E S Y
Sbjct: 207 ---SPFHEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 28/214 (13%)
Query: 402 LGQGGQGTVYKGML---ADG---RIVAIKKSKVIDESKV---DEFINEVAILSQINHRNV 452
LG+ G VYKG L A G + VAIK K D+++ +EF +E + S++ H N+
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNI 70
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYL-----------HDQNEEFPITWEIR--LRIA 499
V LLG + + +++ + + L ++L D ++ T E + I
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQ 558
+++ + +L S + H+D+ + N+L+ K K+SD G R + A D +
Sbjct: 131 TQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSL 187
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +F+ SD++S+GVVL E+ +
Sbjct: 188 LPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 9e-11
Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 8/152 (5%)
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIA 499
E +L +NH +V+++ + + +V + L+ YL P+ + L I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYL--TKRSRPLPIDQALIIE 163
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG 559
++ + + YLH+ I HRD+K+ NI ++ + + D GA++ + + G
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP--AFLGLAG 218
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591
T PE ++ K+D++S G+VL E+L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 61/223 (27%), Positives = 109/223 (48%), Gaps = 12/223 (5%)
Query: 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG+G TV+KG +VA+K+ ++ +E I EV++L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI- 71
Query: 460 LETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+ TE L LV+E++ + L QYL D +++ ++ +SY H I
Sbjct: 72 IHTERCLTLVFEYL-DSDLKQYL-DNCGNLMSMHNVKI-FMFQLLRGLSYCHKRK---IL 125
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRSSRFTEK 577
HRD+K N+L++ K K++DFG +R+ ++ + +V T Y P+ S+ ++
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTP 184
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620
D++ G +L E+ TG + +E+ L L E++
Sbjct: 185 IDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEET 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 56/196 (28%), Positives = 87/196 (44%), Gaps = 16/196 (8%)
Query: 406 GQGTVYKGML----ADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
G+GT K +L A G+ A+K K +I + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIPI 517
+ V E+ G LF +L + + E R R E+ A+ YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---V 116
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
+RD+K N++LD K++DFG + D M T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDNDYGRA 175
Query: 578 SDVYSFGVVLAELLTG 593
D + GVV+ E++ G
Sbjct: 176 VDWWGLGVVMYEMMCG 191
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 14/211 (6%)
Query: 400 RILGQGGQGTVY----KGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455
++LG+G G V+ KG I A+KK V+ + V+ + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 456 LGCCLETEVPLL-VYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAA 513
L C +T+ L V E++ G L H Q+ +F + A E+ + +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLM--FHIQSCHKFDLPRATFY--AAEIICGLQFLHSKG 116
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I +RD+K NILLD K++DFG + + T GT Y+ PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQK 172
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604
+ D +SFGV+L E+L G+ + EE
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 11/193 (5%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL 460
+G G G VYK + G + AIK K+ E+ ++ H N+V G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 461 ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHR 520
+ + EF G+L H P++ ++ E + YLHS + HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKM---HR 130
Query: 521 DIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF---RSSRFTEK 577
DIK NILL K++DFG S + + + GT ++ PE R + +
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQL 189
Query: 578 SDVYSFGVVLAEL 590
D+++ G+ EL
Sbjct: 190 CDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 2e-10
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 30/208 (14%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLG 457
+G G G VYK G ++A+K ++ +E+K +V + S + +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSH-DCPYIVKCYG 81
Query: 458 CCL-ETEVPLLVYEFI---INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL---H 510
+ +++V FI + T L + + PI +I ++ + + A+ YL H
Sbjct: 82 YFITDSDV------FICMELMSTCLDKLLKRIQG-PIPEDILGKMTVAIVKALHYLKEKH 134
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
+ HRD+K +NILLD K+ DFG S + + T+ G Y+ PE
Sbjct: 135 G-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPERID 187
Query: 571 SSRFTEK----SDVYSFGVVLAELLTGE 594
K +DV+S G+ L EL TG+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 46/205 (22%), Positives = 78/205 (38%), Gaps = 17/205 (8%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKS--KVIDESKVDEFINEVAILSQINHRNVVKLLG 457
+ + K +VA+KK + + E+ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
+ +V + G+ L E P I I +V +A+ Y+HS I
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPEL-AIAF-ILKDVLNALDYIHSKGFI- 123
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTH-----MTTQVQGTFGYLDPEYFR 570
HR +K+++ILL G + +S S SM + +L PE +
Sbjct: 124 --HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQ 181
Query: 571 SSR--FTEKSDVYSFGVVLAELLTG 593
+ + EKSD+YS G+ EL G
Sbjct: 182 QNLQGYNEKSDIYSVGITACELANG 206
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 3e-10
Identities = 67/278 (24%), Positives = 130/278 (46%), Gaps = 44/278 (15%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKS----KVIDESK---VDEFINEVAILSQINHRNVV 453
LGQG ++KG+ + G + K+ KV+D+S + F +++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
G C+ + ++V E++ G+L YL I+W +L +A +++ A+ +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 514 SIPIYHRDIKSTNILL----DGKYRA----KVSDFGASRSMAIDQTHMTTQVQGTFGYLD 565
+ H ++ + N+LL D K K+SD G S+ + + + ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLE---RIPWVP 172
Query: 566 PEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE + + + +D +SFG L E+ +G DK L+A L + K+ +E
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG----------GDKPLSA--LDSQKKLQFYE- 219
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
D H L ++ A L N+C++ RP+ + +
Sbjct: 220 -DRHQLPAPKWTEL---ANLINQCMDYEPDFRPSFRAI 253
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 3e-10
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 19/211 (9%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINHRNV 452
Y ++G+G G V + G VAIKK + E D + E+ +L + H ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 453 VKLLGCCL-----ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
V++ L E + +V+E ++ L Q + ++ P + L ++ A+
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFL---YQLLRALK 117
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID--QTHMTTQVQGTFGYLD 565
Y+H+A ++HRD+K NIL + + K+ DFG +R D T T Y
Sbjct: 118 YIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 566 PEYFRS--SRFTEKSDVYSFGVVLAELLTGE 594
PE S S++T D++S G + AE+LTG+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 54/223 (24%), Positives = 109/223 (48%), Gaps = 12/223 (5%)
Query: 402 LGQGGQGTVYKG--MLADGRIVAIKKSKVIDESKVD-EFINEVAILSQINHRNVVKLLGC 458
LG+G TV+KG L + +VA+K+ ++ E I EV++L + H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+ LV+E++ + L QY+ D + +++ + ++ ++Y H +
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMH-NVKIFL-YQILRGLAYCHRRK---VL 126
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR-SSRFTEK 577
HRD+K N+L++ + K++DFG +R+ ++ + +V T Y P+ SS ++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYSTQ 185
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620
D++ G + E+ +G + E++ L L E++
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 73/264 (27%), Positives = 116/264 (43%), Gaps = 39/264 (14%)
Query: 396 YNTNRILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQIN 448
+N +LG+G G V MLA+ + I +KK VI + V+ + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG 58
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
+ L C +T L V E++ NG Y Q F + A E++ +
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYV-NGGDLMYQIQQVGRFKEPHAVFY--AAEIAIGLF 115
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
+LHS I +RD+K N++LD + K++DFG + D T GT Y+ PE
Sbjct: 116 FLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV-TTKTFCGTPDYIAPE 171
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFE-EDKSLAAYFLRAMKEDSLFE-IL 625
+ + D ++FGV+L E+L G+ FE ED ED LF+ I+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ-----APFEGED------------EDELFQSIM 214
Query: 626 DAHVL--KEASQEDIVTVAKLTNR 647
+ +V K S+E + L +
Sbjct: 215 EHNVAYPKSMSKEAVAICKGLMTK 238
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 31/209 (14%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVD--EFINEVAILSQINHRNVVKLLGC 458
+G+G G V ++ VAIKK ++++D + E+ +L ++H NV+ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 459 CLET-----EVPLLVYEF-------IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
+VYE II + Q L D + ++ + +R +
Sbjct: 73 MPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQYFLYQLLR---------GL 121
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
Y+HSA + HRD+K +N+LL+ K+ DFG +R+ + MT V T Y P
Sbjct: 122 KYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAP 177
Query: 567 E-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
E S +T DV+S G + AELL +
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 5e-10
Identities = 59/223 (26%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 395 HYNTNRILGQGGQGTV----YKGMLADGRIVAIKK-----SKVIDESKVDEFINEVAILS 445
Y + LGQG G V ++ VAIKK SK I + + E+ +L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNVFSKKILAKRA---LRELKLLR 56
Query: 446 QI-NHRNVVKLLGCCLETEVP-------LLVYEFIINGTLFQYLHD--QNEEFPITWEIR 495
H+N+ C + ++ L +YE ++ L Q + + I
Sbjct: 57 HFRGHKNIT----CLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFI- 111
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID----QT 551
++ + Y+HSA + HRD+K N+L++ K+ DFG +R + +
Sbjct: 112 ----YQILCGLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAG 164
Query: 552 HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTG 593
MT V T Y PE S +T+ DV+S G +LAELL
Sbjct: 165 FMTEYV-ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 7e-10
Identities = 44/169 (26%), Positives = 76/169 (44%), Gaps = 13/169 (7%)
Query: 427 KVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNE 486
K+I + V L + ++ N +KL + +L+ ++I +G LF L + E
Sbjct: 47 KIIKAKNFNAIEPMVHQLMK-DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKE 103
Query: 487 EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRS 545
E++ I ++ +A++ LH I H DIK N+L D K R + D+G +
Sbjct: 104 GKLSEAEVKK-IIRQLVEALNDLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKI 159
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ + GT Y PE + + D ++ GV+ ELLTG+
Sbjct: 160 IGTPSCY-----DGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 69/288 (23%), Positives = 127/288 (44%), Gaps = 60/288 (20%)
Query: 402 LGQGGQGTVYKGMLAD---------GRIVAIKKS-KVIDESKVD---EFINEVAILSQIN 448
LG+G + +Y G+L IK KV+D S D F +++ Q++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
H+++V L G C+ ++V EF+ G L ++H +++ W + ++A +++ A+SY
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 509 LHSAASIPIYHRDIKSTNILL-----DGKYRA--KVSDFGA-----SRSMAIDQTHMTTQ 556
L + H ++ + NILL DG+ K+SD G SR +++
Sbjct: 121 LEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER------ 171
Query: 557 VQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAEL-LTGERAIRVTNFEEDKSLAAYFLR 614
++ PE S+ + +D +SFG L E+ GE ++ DK+LA
Sbjct: 172 ----IPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKTLA----- 216
Query: 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E F ++ + +E +A L C+N + +RP + +
Sbjct: 217 ---EKERFYEGQCMLVTPSCKE----LADLMTHCMNYDPNQRPFFRAI 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 401 ILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINH-RNVVKLLGC 458
++G G G VYKG + G++ AIK V + + +E E+ +L + +H RN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIKQEINMLKKYSHHRNIATYYGA 71
Query: 459 CLETEVP------LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
++ P LV EF G++ + + + E I E+ +S+LH
Sbjct: 72 FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQH 130
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR-- 570
I HRDIK N+LL K+ DFG S + T + GT ++ PE
Sbjct: 131 KVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACD 186
Query: 571 ---SSRFTEKSDVYSFGVVLAELLTG 593
+ + KSD++S G+ E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 1e-09
Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 46/220 (20%)
Query: 396 YNTNRILGQGGQGTV---YKGMLADGRIVAIKK-SKVIDESKVDEFIN---------EVA 442
Y + +G G QG V Y + G+ VAIKK S+ F N E+
Sbjct: 18 YQNLKPIGSGAQGIVCAAYDTVT--GQNVAIKKLSR--------PFQNVTHAKRAYRELV 67
Query: 443 ILSQINHRNVVKLLGC-----CLET--EVPLLVYEFIINGTLFQYLH-DQNEEFPITWEI 494
++ +NH+N++ LL LE +V LV E + + L Q + D + E
Sbjct: 68 LMKLVNHKNIIGLLNVFTPQKSLEEFQDV-YLVMELM-DANLCQVIQMDLDHE------- 118
Query: 495 RLRIAI-EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
R+ + ++ + +LHSA I HRD+K +NI++ K+ DFG +R+ A M
Sbjct: 119 RMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART-AGTSFMM 174
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
T V T Y PE + E D++S G ++ E++ G
Sbjct: 175 TPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 53/213 (24%), Positives = 97/213 (45%), Gaps = 22/213 (10%)
Query: 391 TATDHYNTNRILGQGGQGTV---YKGMLADGRIVAIKK--SKVIDESKVDEFINEVAILS 445
T Y + +G G QG V Y +L R VAIKK +++ E+ ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 446 QINHRNVVKLLGC-----CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI 500
+NH+N++ LL LE + + +++ L Q + + + +++ +
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY-----LLY 133
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
++ + +LHSA I HRD+K +NI++ K+ DFG +R+ + M T T
Sbjct: 134 QMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVT 188
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
Y PE + E D++S G ++ E++ G
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 391 TATDHYNTNRILGQGGQGTV---YKGMLADGRIVAIKK--SKVIDESKVDEFINEVAILS 445
T Y + +G G QG V Y +L R VAIKK +++ E+ ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMK 71
Query: 446 QINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEI---RLRIAI-E 501
+NH+N++ LL P E + L L D N I E+ R+ + +
Sbjct: 72 CVNHKNIISLL----NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQ 127
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
+ + +LHSA I HRD+K +NI++ K+ DFG +R+ + M T T
Sbjct: 128 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTR 182
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591
Y PE + E D++S G ++ E++
Sbjct: 183 YYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 59/210 (28%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 396 YNTNRILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQIN 448
+N +LG+G G V MLA+ + I +KK +I + V+ + E +L+
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPG 58
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEF--PITWEIRLRIAIEVSDA 505
+ L C +T L V E++ NG Y Q +F P + A E++
Sbjct: 59 KPPFLTQLHSCFQTMDRLYFVMEYV-NGGDLMYHIQQVGKFKEPHA----VFYAAEIAIG 113
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR-SMAIDQTHMTTQVQGTFGYL 564
+ +LHS I +RD+K N++LD + K++DFG + ++ +T T GT Y+
Sbjct: 114 LFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT--TRTFCGTPDYI 168
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + + D ++FGV+L E+L G+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 17/201 (8%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G G VY+ D RI A+K K +++ + +V I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 458 CCLETEVP---LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVSYLHSAA 513
+ LV +++ G LF +L + F E R + I E+ A+ +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FS---EDRAKFYIAELVLALEHLHKY- 115
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I +RD+K NILLD + DFG S++ D T GT YL PE +
Sbjct: 116 --DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTNTFCGTTEYLAPEVLLDEK 172
Query: 574 -FTEKSDVYSFGVVLAELLTG 593
+T+ D +S GV++ E+ G
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 56/196 (28%), Positives = 88/196 (44%), Gaps = 15/196 (7%)
Query: 406 GQGTVYKGML----ADGRIVA---IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
G+GT K +L A GR A +KK ++ + +V + E +L H + L
Sbjct: 4 GKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 63
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIPI 517
+ V E+ G LF +L + + E R R E+ A+ YLHS ++
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKNV-- 117
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
+RD+K N++LD K++DFG + D M T GT YL PE + +
Sbjct: 118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRA 176
Query: 578 SDVYSFGVVLAELLTG 593
D + GVV+ E++ G
Sbjct: 177 VDWWGLGVVMYEMMCG 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 61/256 (23%), Positives = 102/256 (39%), Gaps = 68/256 (26%)
Query: 394 DHYNTNRILGQGGQGTV-YKGMLADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ ++T +++G+G G V G+I A+K KS++ + ++ E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEI------RLRIAIEVS 503
VV L + + L+ EF+ G L L I ++ R +A E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECV 111
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS-------------------- 543
A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 112 LAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 544 --------RSMAIDQTHMTT----QVQ--------------GTFGYLDPEYFRSSRFTEK 577
S+A+D ++T Q+ GT Y+ PE F + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 578 SDVYSFGVVLAELLTG 593
D +S G ++ E L G
Sbjct: 229 CDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 396 YNTNRILGQGGQGTVYKGMLADGR-------IVAIKKSKVIDESKVDEFINEVAILSQIN 448
+N +LG+G G V MLA+ + I +KK VI + V+ + E +L+ +
Sbjct: 2 FNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
+ L C +T L V E++ G L ++ Q +F + A E+S +
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAVFY--AAEISVGLF 115
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV-QGTFGYLDP 566
+LH I +RD+K N++LD + K++DFG + +D +TT+ GT Y+ P
Sbjct: 116 FLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIAP 170
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGE 594
E + + D +++GV+L E+L G+
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 52/175 (29%), Positives = 89/175 (50%), Gaps = 13/175 (7%)
Query: 430 DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-NEEF 488
DE + +E+ L+ +H +VK + LL+ E+ G L + + + E
Sbjct: 105 DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL 164
Query: 489 PIT-WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR--- 544
P +E+ L + ++ A+ +HS + HRD+KS NI L K+ DFG S+
Sbjct: 165 PFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220
Query: 545 -SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIR 598
S+++D + + GT YL PE + R+++K+D++S GV+L ELLT R +
Sbjct: 221 DSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 65/252 (25%), Positives = 123/252 (48%), Gaps = 29/252 (11%)
Query: 359 FKRNGGLLLQQELASTE---GNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGML 415
F+ N L ++E + + D+ K+ + + Y I+G G G VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 416 AD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKL-----LGCCLETEVPL--- 466
D VAIKK V+ + + E+ I+ +NH N++ L C + E +
Sbjct: 88 IDTSEKVAIKK--VLQDPQYKN--RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLN 143
Query: 467 LVYEFIINGTLFQYLH---DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523
+V EFI T+ +Y+ N P+ + ++L + ++ A++Y+HS I HRD+K
Sbjct: 144 VVMEFIPQ-TVHKYMKHYARNNHALPL-FLVKL-YSYQLCRALAYIHSKF---ICHRDLK 197
Query: 524 STNILLDGK-YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRSSRFTEKSDVY 581
N+L+D + K+ DFG+++++ Q ++ + F Y PE ++ +T D++
Sbjct: 198 PQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVS-YICSRF-YRAPELMLGATNYTTHIDLW 255
Query: 582 SFGVVLAELLTG 593
S G ++AE++ G
Sbjct: 256 SLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINH-RNVVKLLG 457
++G G G VYKG + G++ AIK V ++ + +E E+ +L + +H RN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIATYYG 80
Query: 458 CCLETEVP------LLVYEFIINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLH 510
++ P LV EF G++ + + + W I E+ +++LH
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW--IAYICREILRGLAHLH 138
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
+ I HRDIK N+LL K+ DFG S + T + GT ++ PE
Sbjct: 139 AHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIA 194
Query: 571 -----SSRFTEKSDVYSFGVVLAELLTG 593
+ + +SD++S G+ E+ G
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 63/235 (26%), Positives = 96/235 (40%), Gaps = 40/235 (17%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
H+ ++LG+G G V+ L G++ A+K K ++I +KV + E IL+ ++H
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEE-FPITWEIRLRIAIEVSDAVS 507
+ L +TE L LV ++ G LF+ L Q + R A EV A+
Sbjct: 61 PFLPTLY-ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA-EVLLALE 117
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF-------------------GASRSMAI 548
YLH I +RD+K NILL +SDF G+ RS
Sbjct: 118 YLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVN 174
Query: 549 DQTHMTTQVQ---------GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
T + GT Y+ PE D ++ G++L E+L G
Sbjct: 175 SIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 65/239 (27%), Positives = 105/239 (43%), Gaps = 55/239 (23%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
+++G+G G V D G I A+K KS+++++ +V E IL++ ++ VVKL
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66
Query: 456 LGCCLETEVPL-LVYEFIINGTLFQYLHDQN---EEFPITWEIRLRIAIEVSDAVSYLHS 511
+ E L L+ E++ G + L ++ EE E R IA E A+ +H
Sbjct: 67 Y-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIA-ETILAIDSIHK 119
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFG---------------------ASRSMAIDQ 550
I HRDIK N+LLD K K+SDFG S +
Sbjct: 120 LGYI---HRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176
Query: 551 THMTTQVQ----------------GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
M+++ + GT Y+ PE F + + ++ D +S GV++ E+L G
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 50/176 (28%), Positives = 78/176 (44%), Gaps = 34/176 (19%)
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS----RSMAIDQTH 552
+IA+ + A+ YLHS S+ HRD+K +N+L++ + K+ DFG S S+A
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA----- 159
Query: 553 MTTQVQGTFGYLDPEYF----RSSRFTEKSDVYSFGVVLAELLTGE--RAIRVTNFEEDK 606
T G Y+ PE + KSDV+S G+ + EL TG T F++ K
Sbjct: 160 -KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLK 218
Query: 607 SLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ ++E S + E + N+CL N K+RP E+
Sbjct: 219 -------QVVEEPS------PQLPAEKFSPEFQ---DFVNKCLKKNYKERPNYPEL 258
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 58/215 (26%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 401 ILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
I+G+GG G VY AD G++ A+K +D+ ++ E L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLAL---NERIMLSLVST- 53
Query: 460 LETEVPLLV---YEF-----------IINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSD 504
+ P +V Y F ++NG Y Q+ F E +R A E+
Sbjct: 54 --GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS---EKEMRFYATEIIL 108
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ ++H+ + +RD+K NILLD ++SD G + + + H + GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 565 DPEYF-RSSRFTEKSDVYSFGVVLAELLTGERAIR 598
PE + + + +D +S G +L +LL G R
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 7e-09
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 394 DHYNTNRILGQG--GQGTVYKGMLADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
D + +++G+G G+ V K M G++ A+K K +++ ++ F E +L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVK-MKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
R + L + LV ++ + G L L + P R +A E+ A+
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYLA-EMVLAIDS 117
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
+H + HRDIK N+LLD +++DFG+ + D T + GT Y+ PE
Sbjct: 118 VHQLGYV---HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 569 FRS-----SRFTEKSDVYSFGVVLAELLTGE 594
++ R+ + D +S GV + E+L GE
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 7e-09
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 14/210 (6%)
Query: 394 DHYNTNRILGQGGQGTV-YKGMLADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
D + +++G+G G V M RI A+K K +++ ++ F E +L +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
+ + L + LV ++ + G L L + P E R I ++ V +
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFYI--AEMVLAI 115
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS + HRDIK N+LLD +++DFG+ M D T ++ GT Y+ PE
Sbjct: 116 HSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 570 RS-----SRFTEKSDVYSFGVVLAELLTGE 594
++ ++ + D +S GV + E+L GE
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 401 ILGQGGQGTVYKGMLADGR-IVAIKKSKVIDESK-VDEF-INEVAILSQINHRNVVKLLG 457
++G+G G V K + + IVAIKK K +E++ V E + E+ +L + N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
LV+E++ L + EE P ++ + + +H I
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRDIK N+L+ K+ DFG +R+++ T+ T Y PE + + +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 578 SDVYSFGVVLAELLTGE 594
D++S G +L EL G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 53/198 (26%), Positives = 86/198 (43%), Gaps = 21/198 (10%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFI---NEVAILSQINHRNVVKLLG 457
+G G G VYK L G + A+K +I D+F E+ ++ + H N+V G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK---IIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFG 73
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQN--EEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
L E + E+ G+L H E I + R E ++YLHS +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKM 128
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF---RSS 572
HRDIK NILL K++DFG + + + + GT ++ PE ++
Sbjct: 129 ---HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNG 184
Query: 573 RFTEKSDVYSFGVVLAEL 590
+ + D+++ G+ EL
Sbjct: 185 GYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 69/298 (23%), Positives = 123/298 (41%), Gaps = 68/298 (22%)
Query: 402 LGQGGQGTVYKGML--------------------------ADGRIVAIKKSKVIDESKVD 435
LGQG + +Y G L + R+V KV+D S D
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVL----KVLDPSHRD 58
Query: 436 ---EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITW 492
F +++SQ++H ++ + G C+ ++V EF+ +G L L + P+ W
Sbjct: 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW 118
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA-------KVSDFGASRS 545
+I +A +++ A+SYL + H ++ + NILL A K+SD G S +
Sbjct: 119 KI--TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFT 173
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604
A+ + ++ ++ PE + + +D +SFG L E+ F+
Sbjct: 174 -ALSREERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEIC----------FDG 218
Query: 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ L R E F H L E S +++ A L ++CL +RP+ + +
Sbjct: 219 EVPLKE---RTPSEKERF-YEKKHRLPEPSCKEL---ATLISQCLTYEPTQRPSFRTI 269
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGR----IVAIKKSKVIDESKVDEFINEVAILSQINH 449
+ + T +++ G G VY + R + I K +I +++ + E IL+ +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEI-RLRIAIEVSDAVS 507
VV + C ET+ L +V E++ G L + + ++ R+ A E A+
Sbjct: 61 PFVVSMF-CSFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFA-ETVLALE 115
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR----SMAID----------QTHM 553
YLH+ I HRD+K N+L+ K++DFG S+ S+ + + +
Sbjct: 116 YLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFL 172
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
QV GT Y+ PE + + D ++ G++L E L G
Sbjct: 173 DKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 1e-08
Identities = 56/209 (26%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVD-EFINEVAILSQINHRNVVKLLGCCL 460
+G+G G VYK DG+ K I+ + + E+A+L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 461 ---ETEVPLLVYEF----IINGTLFQYLHDQNEE-FPITWEIRLRIAIEVSDAVSYLHSA 512
+ +V LL +++ + + F N++ + + + ++ D + YLH+
Sbjct: 69 SHSDRKVWLL-FDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 513 ASIPIYHRDIKSTNILLDG----KYRAKVSDFGASR--SMAIDQTHMTTQVQGTFGYLDP 566
+ HRD+K NIL+ G + R K++D G +R + + V TF Y P
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 567 EYFRSSR-FTEKSDVYSFGVVLAELLTGE 594
E +R +T+ D+++ G + AELLT E
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 57/210 (27%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVD-EFINEVAILSQINHRNVVKLLGCCL 460
+G+G G VYK DG+ K I+ + + E+A+L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 461 ---ETEVPLLVYEF----IINGTLFQYLHDQNEEFPITWEIRL--RIAIEVSDAVSYLHS 511
+ +V LL +++ + + F N++ P+ + + ++ D + YLH+
Sbjct: 69 SHADRKVWLL-FDYAEHDLWHIIKFHRASKANKK-PVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 512 AASIPIYHRDIKSTNILLDG----KYRAKVSDFGASR--SMAIDQTHMTTQVQGTFGYLD 565
+ HRD+K NIL+ G + R K++D G +R + + V TF Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 566 PEYFRSSR-FTEKSDVYSFGVVLAELLTGE 594
PE +R +T+ D+++ G + AELLT E
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 55/229 (24%), Positives = 110/229 (48%), Gaps = 18/229 (7%)
Query: 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDE------FINEVAILSQINHRNVVK 454
LG+GG G V + + G++ A KK +D+ ++ + + E IL ++N +V
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKK---LDKKRLKKKSGEKMALLEKEILEKVNSPFIVN 57
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L E++ L + ++NG +Y E + E + + +++ + +LHS
Sbjct: 58 L-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHS--- 113
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
+ I +RD+K N+LLD + ++SD G + + +T TQ GT GY+ PE + +
Sbjct: 114 MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 575 TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
+ D ++ G + E++ G + + +E + R ++++ FE
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFK--DHKEKVAKEELKRRTLEDEVKFE 218
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 80/296 (27%), Positives = 123/296 (41%), Gaps = 58/296 (19%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN-EVAILSQI-NH 449
+D + +G+G G V+K + +G A+K I + +DE I E IL + +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDH 74
Query: 450 RNVVKLLGCCLETEVP-----LLVYEFIINGTL------FQYLHDQNEEFPITWEIRLRI 498
NVVK G + +V LV E G++ F ++ EE I + I
Sbjct: 75 PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----I 129
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
E + +LH +I HRD+K NILL + K+ DFG S + + T V
Sbjct: 130 LHEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 185
Query: 559 GTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613
GT ++ PE S + + DV+S G+ EL G D LA L
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG-----------DPPLAD--L 232
Query: 614 RAMKEDSLFEI-------LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
M+ +LF+I L L D + +CL + +KRPT+ ++
Sbjct: 233 HPMR--ALFKIPRNPPPTLHQPELWSNEFNDFI------RKCLTKDYEKRPTVSDL 280
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 65/234 (27%), Positives = 100/234 (42%), Gaps = 30/234 (12%)
Query: 380 KSKLFTSKELETATDHYNTNRILGQGGQGTVYK-GMLADGRIVAIKKSKVIDE-SKVDEF 437
S + + L TD + +G+G G VYK DG + A+K ++D S VDE
Sbjct: 8 NSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK---ILDPISDVDEE 64
Query: 438 IN-EVAILSQI-NHRNVVKLLGCCLETEVPL-----LVYEFIINGTLFQYLHD-----QN 485
I E IL + NH NVVK G + + + LV E G++ + + Q
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 486 EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545
+ + I+ + A+ L + I HRD+K NILL + K+ DFG S
Sbjct: 125 LDEAM-------ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ 177
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGE 594
+ + T V GT ++ PE + + DV+S G+ EL G+
Sbjct: 178 LTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD 230
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 400 RILGQGGQGTVYKGMLADG-RIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
+++G+G G V L + ++ A+K K +++ ++ F E +L +++ + L
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPIT----WEIRLRIAIEVSDAVSYLHS 511
+ LV ++ + G L L + P + + IAI D+V LH
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAI---DSVHQLHY 123
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
HRDIK NIL+D +++DFG+ + D T ++ GT Y+ PE ++
Sbjct: 124 V------HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 572 -----SRFTEKSDVYSFGVVLAELLTGE 594
++ + D +S GV + E+L GE
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 50/241 (20%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
D + + +++G+G G V D G I A+K K+ ++++ +V E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN---EEFPITWEIRLRIAIEVSDAV 506
VVK+ + L+ EF+ G + L ++ EE + IA E A+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE-----ATQFYIA-ETVLAI 114
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG------------------------- 541
+H I HRDIK N+LLD K K+SDFG
Sbjct: 115 DAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 542 ---------ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ + ++ + GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 593 G 593
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 5e-08
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 401 ILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
I+G+GG G VY AD G++ A+K +D+ ++ E L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK---CLDKKRIKMKQGETLAL---NERIMLSLVST- 53
Query: 460 LETEVPLLV---YEF-----------IINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSD 504
+ P +V Y F ++NG Y Q+ F E +R A E+
Sbjct: 54 --GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---EAEMRFYAAEIIL 108
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ ++H+ + +RD+K NILLD ++SD G + + + H + GT GY+
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYM 162
Query: 565 DPEYF-RSSRFTEKSDVYSFGVVLAELLTGERAIR 598
PE + + +D +S G +L +LL G R
Sbjct: 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 66/271 (24%), Positives = 98/271 (36%), Gaps = 70/271 (25%)
Query: 390 ETATDHYNTNRILGQGGQGTV--------YKGMLADGRIVAIKKSKV-IDESKVDEFINE 440
E D ++LG G G V K + VA+K K S+ ++E
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSE 60
Query: 441 VAILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIINGTLFQYLHDQNEEFPITWE----- 493
+ IL I NH NVV LLG C + PL+V EF G L +L + E F E
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 494 -IRLRIAIEVSDAVSYLHSAASIPIYHRDIKST--------------------------- 525
R R +E S + + + ++ R ST
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 526 -----------------------NILLDGKYRAKVSDFGASRSMAIDQTHMTT-QVQGTF 561
NILL K+ DFG +R + D ++ +
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +T +SDV+SFGV+L E+ +
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 60/257 (23%), Positives = 113/257 (43%), Gaps = 46/257 (17%)
Query: 429 IDESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFIINGTLFQYLHDQNE 486
+ E + + + EV ++ ++ H+N+V+ + L + ++ EF G L + + +
Sbjct: 51 LKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYK 110
Query: 487 EF-PITWEIRLRIAIEVSDAVSYLHSAASIP----IYHRDIKSTNILL------------ 529
F I + I ++ A++Y H+ P + HRD+K NI L
Sbjct: 111 MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITA 170
Query: 530 -----DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF--RSSRFTEKSDVYS 582
+G+ AK+ DFG S+++ I+ M GT Y PE + + +KSD+++
Sbjct: 171 QANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 583 FGVVLAELLTGERAI-RVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTV 641
G ++ EL +G+ + NF + + +K I K S+E + +
Sbjct: 229 LGCIIYELCSGKTPFHKANNFSQ-------LISELKRGPDLPI------KGKSKELNILI 275
Query: 642 AKLTNRCLNLNGKKRPT 658
L LNL+ K+RP+
Sbjct: 276 KNL----LNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 51/162 (31%), Positives = 77/162 (47%), Gaps = 26/162 (16%)
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPLLV---YEFIINGTLFQYLHDQNEEFP----ITW 492
E+ IL I+HR ++ L+ +V Y+ LF Y+ D++ P IT
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC----DLFTYV-DRSGPLPLEQAITI 190
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552
+ RL +A++YLH I HRD+K+ NI LD A + DFGA + +D
Sbjct: 191 QRRLL------EALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA--ACKLDAHP 239
Query: 553 MTTQVQGTFGYLD---PEYFRSSRFTEKSDVYSFGVVLAELL 591
T Q G G L+ PE + K+D++S G+VL E+
Sbjct: 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281
|
Length = 392 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 33/114 (28%), Positives = 61/114 (53%), Gaps = 10/114 (8%)
Query: 483 DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
D + +P+ + LR + +V+ + +L S I HRD+ + N+LL AK+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGL 258
Query: 543 SRSMAIDQTHMTTQVQGT----FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+R + D ++ V+G ++ PE +T +SDV+S+G++L E+ +
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 58/238 (24%), Positives = 98/238 (41%), Gaps = 44/238 (18%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ + + +++G+G G V D G + A+K K+ ++++ +V E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
VVK+ + L+ EF+ G + L ++ +T E E A+ +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTEEETQFYIAETVLAIDSI 117
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFG----------------ASRSMAIDQT-- 551
H I HRDIK N+LLD K K+SDFG + S+ D T
Sbjct: 118 HQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQ 174
Query: 552 ----------------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
+ GT Y+ PE F + + + D +S GV++ E+L G
Sbjct: 175 NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 13/169 (7%)
Query: 438 INEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR 497
E IL INH ++++L G + L+ L+ YL + I +I L
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAK-RNIAIC-DI-LA 186
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS-RSMAIDQTHMTTQ 556
I V A+ YLH I HRDIK+ NI ++ + DFGA+ + I+
Sbjct: 187 IERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW 243
Query: 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605
GT PE + D++S G+VL E+ T ++ FE+D
Sbjct: 244 A-GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL----FEKD 287
|
Length = 391 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 402 LGQGGQGTVYKGMLADGRIVA---IKKSKVIDESK-VDEFINEVAILSQINHRNVVKLLG 457
+G G G V + VA +K+ K SK +EF+ + + H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRL-RIAIEVSDAVSYLHSAASIP 516
C+E LLV+E+ G L YL + + + L R+A E++ V+++H +
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFL- 121
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG--YLDPEYFRS--- 571
H D+ N L KV D+G S + ++ T+ +L PE
Sbjct: 122 --HSDLALRNCFLTSDLTVKVGDYGIGPS-RYKEDYIETEDDKCVPLRWLAPELVGEFHG 178
Query: 572 ----SRFTEKSDVYSFGVVLAELL 591
+ T+ S+V++ GV L EL
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 30/215 (13%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRI---VAIKKSKVIDESKV--DEFINEVAILSQIN 448
D Y + +G G GTV + D R VAIKK +S++ E+ +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSAL--DRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK 72
Query: 449 HRNVVKLLGCCLETEVP------LLVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAI 500
H NV+ LL LV F+ GT L H++ E I + +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQF-----LVY 125
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
++ + Y+H+A I HRD+K N+ ++ K+ DFG +R + MT V T
Sbjct: 126 QMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQT---DSEMTGYVV-T 178
Query: 561 FGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGE 594
Y PE + +T+ D++S G ++AE+LTG+
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 13/166 (7%)
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIR 495
+F+ E + H N+++ LG C E LLV EF G L YL + +T +
Sbjct: 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPT 100
Query: 496 L--RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
R+A E++ + +LH I H D+ N LL K+ D+G S + + ++
Sbjct: 101 TLQRMACEIALGLLHLHKNNFI---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157
Query: 554 TT-QVQGTFGYLDPEYFRSSRF-------TEKSDVYSFGVVLAELL 591
T Q+ ++ PE T++S+V+S GV + EL
Sbjct: 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 6e-07
Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 386 SKELETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKV--DEFINEVA 442
+K + + Y +G G G+V G VA+KK +S + E+
Sbjct: 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELR 68
Query: 443 ILSQINHRNVVKLL-----GCCLE--TEVPLLVYEF---IINGTLFQYLHDQNEEFPITW 492
+L + H NV+ LL LE +V L+ + + N Q L D + +F I
Sbjct: 69 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 128
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552
+R + Y+HSA I HRD+K +N+ ++ K+ DFG +R + T
Sbjct: 129 ILR---------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT- 175
Query: 553 MTTQVQGTFGYLDPEYFRSSR-------FTEKSDVYSFGVVLAELLTG 593
GY+ ++R+ + + D++S G ++AELLTG
Sbjct: 176 ---------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 6e-07
Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 36/121 (29%)
Query: 489 PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548
P+T E + + +V+ + +L S I HRD+ + NILL K+ DFG +R +
Sbjct: 169 PLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDI-- 223
Query: 549 DQTHMTTQVQGTFGYLDPEYFRSSR-----------------FTEKSDVYSFGVVLAELL 591
Y DP+Y R +T +SDV+SFGV+L E+
Sbjct: 224 --------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF 269
Query: 592 T 592
+
Sbjct: 270 S 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKV--DEFINEVAILSQINHRNV 452
Y + + +G G G+V + G VAIKK +S++ E+ +L + H NV
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 453 VKLLGCCLETEVPLL--VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+ LL + T +F + Q + P++ + + ++ + Y+H
Sbjct: 77 IGLLD--VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIH 134
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
SA I HRD+K N+ ++ K+ DFG +R MT V T Y PE
Sbjct: 135 SAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV-TRWYRAPEVIL 187
Query: 571 S-SRFTEKSDVYSFGVVLAELLTGE 594
+ + + D++S G ++AE+LTG+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 52/195 (26%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD-EFINEVAILSQINHRNVVKLLGCC 459
LG+G TVYKG G++VA+K+ ++ E I E ++L + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ LV+E++ + L QY+ D + +RL ++ ++Y H + H
Sbjct: 73 HTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMH-NVRL-FLFQLLRGLAYCHQRR---VLH 126
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR-FTEKS 578
RD+K N+L+ + K++DFG +R+ ++ + +V T Y P+ S ++
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV-TLWYRPPDVLLGSTEYSTSL 185
Query: 579 DVYSFGVVLAELLTG 593
D++ G + E+ TG
Sbjct: 186 DMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 42/221 (19%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGR-IVAIKKSKVIDESKVD--EFINEVAILSQINHR 450
+ Y +G G G+V R VA+KK +S + E+ +L + H
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 451 NVVKLL-----GCCLE--TEVPL---LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI 500
NV+ LL +E EV L L+ + N Q L D++ +F I +R
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR----- 129
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
+ Y+HSA I HRD+K +N+ ++ ++ DFG +R + T
Sbjct: 130 ----GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--------- 173
Query: 561 FGYLDPEYFRSSR-------FTEKSDVYSFGVVLAELLTGE 594
GY+ ++R+ + + D++S G ++AELL G+
Sbjct: 174 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 31/105 (29%), Positives = 54/105 (51%), Gaps = 4/105 (3%)
Query: 489 PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548
+T E + + +V+ + +L S I HRD+ + NILL K+ DFG +R +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 549 DQTHMTT-QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
D ++ + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 48/214 (22%)
Query: 423 IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLH 482
++K+ V+ ++ E IL++ ++ VVKL + + V ++I G + L
Sbjct: 34 LRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92
Query: 483 DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
+ F R IA E++ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 93 IRLGIFEEDLA-RFYIA-ELTCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGL 147
Query: 543 ---------SR-----------SM-------AIDQTHMTT-------QVQ--------GT 560
S+ SM ID+ + Q Q GT
Sbjct: 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGT 207
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
Y+ PE + +T+ D +S GV+L E+L G+
Sbjct: 208 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 33/113 (29%), Positives = 60/113 (53%), Gaps = 10/113 (8%)
Query: 484 QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543
+ +E + E L + +V+ +S+L S I HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261
Query: 544 RSMAIDQTHMTTQVQGT----FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
R + D ++ V+G ++ PE + +T +SDV+S+G++L E+ +
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 60/239 (25%), Positives = 95/239 (39%), Gaps = 66/239 (27%)
Query: 423 IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLH 482
++K V++ ++V E IL++ ++ VVKL + + V ++I G + L
Sbjct: 34 LRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL- 92
Query: 483 DQNEEFPITWEIRLRIAI-EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541
+ E FP E+ R I E++ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 93 IRMEVFP---EVLARFYIAELTLAIESVHKMGFI---HRDIKPDNILIDLDGHIKLTDFG 146
Query: 542 ---------------------------------------ASRSMAIDQTHMTTQVQ---- 558
R ++Q T Q Q
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQ-RATKQHQRCLA 205
Query: 559 ----GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG----------ERAIRVTNFE 603
GT Y+ PE +T+ D +S GV+L E+L G E ++V N+E
Sbjct: 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWE 264
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 1e-05
Identities = 32/112 (28%), Positives = 63/112 (56%), Gaps = 10/112 (8%)
Query: 485 NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-DGKYRAKVSDFGAS 543
NE +++ + + +V++ + +L S + HRD+ + N+L+ +GK K+ DFG +
Sbjct: 231 NESPALSYMDLVGFSYQVANGMEFLASKNCV---HRDLAARNVLICEGKL-VKICDFGLA 286
Query: 544 RSMAIDQTHMTTQVQGTF---GYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
R + D +++ TF ++ PE ++ +T SDV+SFG++L E+ T
Sbjct: 287 RDIMRDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 41/150 (27%), Positives = 70/150 (46%), Gaps = 20/150 (13%)
Query: 404 QGGQGTVYKGMLA-DGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+G G VY G + ++ A+K K+ +I+++ V + E L+ +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 460 LETEVPLLVYEFIINGTLFQYLH-----DQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
LV E++I G + LH D+ E+ ++ EV+ A+ YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKYISEVALALDYLHRHG- 124
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASR 544
I HRD+K N+L+ + K++DFG S+
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 44/182 (24%), Positives = 81/182 (44%), Gaps = 32/182 (17%)
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
L +V+ + +L S + HRD+ + N+LL K+ DFG +R + D +++
Sbjct: 240 LSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296
Query: 556 QVQGTF---GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612
TF ++ PE + +T SDV+S+G++L E+ SL
Sbjct: 297 --GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIF---------------SLGGTP 339
Query: 613 LRAMKEDSLF--EILDAHVLKE---ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667
M DS F +I + + + A+QE V + +C N +KRP+ ++ ++
Sbjct: 340 YPGMIVDSTFYNKIKSGYRMAKPDHATQE----VYDIMVKCWNSEPEKRPSFLHLSDIVE 395
Query: 668 GI 669
+
Sbjct: 396 SL 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 36/108 (33%), Positives = 48/108 (44%), Gaps = 9/108 (8%)
Query: 390 ETATDHYNTNRILGQGGQGTVYK------GMLADGRIVAIKKSKV-IDESKVDEFINEVA 442
E D + LG+G G V + A R VA+K K S+ + E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELK 62
Query: 443 ILSQI-NHRNVVKLLGCCLETEVPLLV-YEFIINGTLFQYLHDQNEEF 488
IL I +H NVV LLG C + PL+V E+ G L YL + E F
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 40/150 (26%), Positives = 59/150 (39%), Gaps = 24/150 (16%)
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+V L + + LV + G L+ ++ I E R A E+ A+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF---LNIPEECVKRWAAEMVVALDALH 102
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-------AIDQTHMTTQVQGTFGY 563
I RD+ NILLD + +++ F + A++ Y
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----------Y 148
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
PE S TE D +S G +L ELLTG
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 14/98 (14%)
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA------SRSMAIDQT 551
+A ++ A+ Y+H I HRDIK+ N+L++G + DFGA S S T
Sbjct: 265 VARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS-----T 316
Query: 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAE 589
+ GT PE +T D++S G+V+ E
Sbjct: 317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM---LADGR---IVAIKKSK-VID 430
+D +L E D RILG G G V +G L+ + VA+K K
Sbjct: 21 VDPMQLPYDSRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR 80
Query: 431 ESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF 488
S+ ++E+ I++ + H N+V LLG C ++ ++ E+ G L YLH + F
Sbjct: 81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 36/128 (28%), Positives = 62/128 (48%), Gaps = 12/128 (9%)
Query: 373 STEGN----IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYK----GMLADGRI--VA 422
+ EGN ID ++L +++ E D+ + LG G G V + G+ + + VA
Sbjct: 13 AAEGNNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVA 72
Query: 423 IKKSKV-IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQY 480
+K K + + ++E+ ILS + H+N+V LLG C L++ E+ G L +
Sbjct: 73 VKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNF 132
Query: 481 LHDQNEEF 488
L + E F
Sbjct: 133 LRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 37/108 (34%), Positives = 48/108 (44%), Gaps = 9/108 (8%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKG------MLADGRIVAIKKSKV-IDESKVDEFINEVA 442
E D + LG+G G V + A R VA+K K S+ ++E+
Sbjct: 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELK 62
Query: 443 ILSQINHR-NVVKLLGCCLETEVPLLV-YEFIINGTLFQYLHDQNEEF 488
IL I H NVV LLG C + PL+V EF G L YL + EF
Sbjct: 63 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 33/119 (27%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQG-----TVYKGMLADGRI-VAIKKSKVIDE 431
ID ++L + E + + + LG G G T Y +D + VA+K K
Sbjct: 19 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 432 SKVDE-FINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF 488
E ++E+ +LS + NH N+V LLG C L++ E+ G L +L + + F
Sbjct: 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 30/101 (29%), Positives = 44/101 (43%), Gaps = 17/101 (16%)
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF---------GASRSMAIDQTHMTT 555
++YLH I HR+IK+++IL+ G +S G + D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 556 QVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGE 594
V +L PE R + KSD+YS G+ EL TG
Sbjct: 170 SVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 47/183 (25%), Positives = 72/183 (39%), Gaps = 44/183 (24%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQI 447
D + + LG+G G VYK L +G+ V +KK+ + V+ ++NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYV-LKKAT--EYGAVEIWMNERV---RR 185
Query: 448 NHRN-VVKLLGCCLET-----EVPL-LVYEFIINGTLFQYLHDQNEEFPITWE------- 493
N + LE E LV+ + TL + Q++EFP E
Sbjct: 186 ACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPYLLGKV 243
Query: 494 ------------IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDF 540
I I ++ A+ LHS I HRD+K NI+ G K+ D
Sbjct: 244 QDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDL 300
Query: 541 GAS 543
GA+
Sbjct: 301 GAA 303
|
Length = 566 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 52/218 (23%)
Query: 423 IKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLH 482
++K V+ ++V E IL++ ++ VV+L + + V ++I G + L
Sbjct: 34 LRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI 93
Query: 483 DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
FP R IA E++ AV +H I HRDIK NIL+D K++DFG
Sbjct: 94 RMGI-FPEDLA-RFYIA-ELTCAVESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGL 147
Query: 543 S------------------RSMAID----------------------------QTHMTTQ 556
R ++D Q +
Sbjct: 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHS 207
Query: 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ GT Y+ PE + +T+ D +S GV+L E+L G+
Sbjct: 208 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 721 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| PF13947 | 106 | GUB_WAK_bind: Wall-associated receptor kinase gala | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.79 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.75 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.67 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.63 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.55 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PF08488 | 103 | WAK: Wall-associated kinase; InterPro: IPR013695 T | 99.47 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.26 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.08 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.05 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.9 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.84 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.84 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.61 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.6 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.6 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.26 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.24 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.09 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.06 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.05 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.05 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.77 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.76 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.63 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.62 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.33 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.25 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.24 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.09 | |
| PLN02236 | 344 | choline kinase | 97.01 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.98 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.98 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.86 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.67 | |
| KOG1219 | 4289 | consensus Uncharacterized conserved protein, conta | 96.6 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.57 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.0 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.91 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.39 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.25 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.05 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.77 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.53 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 94.49 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.17 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.07 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.02 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=462.54 Aligned_cols=291 Identities=45% Similarity=0.741 Sum_probs=258.4
Q ss_pred CccccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEE
Q 036483 380 KSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459 (721)
Q Consensus 380 ~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~ 459 (721)
..+.|+++|+..+|++|...++||+|+||.||+|.+.+++.||||++.........+|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988764443145699999999999999999999999
Q ss_pred EeCCc-ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEe
Q 036483 460 LETEV-PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 460 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
.+.+. .+||||||++|+|.++|+..... +++|..|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99994 99999999999999999987654 79999999999999999999999998899999999999999999999999
Q ss_pred eccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc
Q 036483 539 DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 539 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
|||+++..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+++...........+..|....+.+
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999766441222222117999999999999999999999999999999999999998776655566789999888988
Q ss_pred cchhhhhhhhhc-ccCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 619 DSLFEILDAHVL-KEASQ-EDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 619 ~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
..+.+++|+.+. .+... +....+..++.+|++.+|++||+|.||+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 899999999987 55554 678889999999999999999999999999966544
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-47 Score=400.01 Aligned_cols=258 Identities=35% Similarity=0.541 Sum_probs=214.6
Q ss_pred CCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCc--hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-cceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRNVVKLLGCCLETE-VPLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-~~~lv~e~~ 472 (721)
+...+.||+|+||+||+|.++....||||++...+. ...++|.+|+.+|++++|||||+++|++.+.. ...|||||+
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 344566999999999999998666699998876432 23669999999999999999999999999887 789999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCccccccCCc
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~~~~~~ 551 (721)
++|+|.++++.. ....+++..+++|+.|||+||.|||+.+. ||||||||+||||+.++ ++||+|||+++......
T Consensus 123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 999999999874 23479999999999999999999999984 99999999999999997 99999999998765332
Q ss_pred eeeeeeecCCCCCCccccc--cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFR--SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
...+...||+.|||||++. ...|+.|+||||||++||||+||+.||...... ..... +.....
T Consensus 199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~------~~~~~---------v~~~~~ 263 (362)
T KOG0192|consen 199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV------QVASA---------VVVGGL 263 (362)
T ss_pred ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH------HHHHH---------HHhcCC
Confidence 2334467999999999999 569999999999999999999999999654431 11111 111222
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
+...+...+..+..|+.+||+.||+.||++.+|+..|+.+...
T Consensus 264 Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~ 306 (362)
T KOG0192|consen 264 RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH 306 (362)
T ss_pred CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence 3334445777899999999999999999999999999988654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-46 Score=394.02 Aligned_cols=255 Identities=29% Similarity=0.444 Sum_probs=221.0
Q ss_pred CCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 396 YNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+...+.||+|-||+||.|.++....||+|.++.. ....++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3455789999999999999988889999988765 334478999999999999999999999999999999999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeee
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 555 (721)
+|.++|+.. .+..+...+.+.++.|||+||+||++++ +|||||.++||||++++.+||+||||++....+......
T Consensus 287 sLl~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 287 SLLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cHHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999973 2336999999999999999999999999 999999999999999999999999999966555555555
Q ss_pred eeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
...-...|.|||.+..+.++.|||||||||+||||+| |+.|+..... ..+.+.++...+...+
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn----------------~ev~~~le~GyRlp~P 426 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN----------------EEVLELLERGYRLPRP 426 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH----------------HHHHHHHhccCcCCCC
Confidence 5556788999999999999999999999999999999 8877643322 2234455556666678
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
..++.++.+||..||+.+|++|||++.+...|+.+..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 8899999999999999999999999999999887754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=369.76 Aligned_cols=251 Identities=27% Similarity=0.391 Sum_probs=209.1
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-ceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV-PLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~-~~lv~e~~ 472 (721)
.+..+.||+|..|+|||++++ +++.+|+|.+.. .++...+++.+|++++.+.+||+||+++|.|..... ..|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 445578999999999999977 588999998744 456677899999999999999999999999999995 99999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
++|+|++++...+ .+++...-+|+.+|++||.|||+ ++ ||||||||+||||+..|++||+|||.+..+...
T Consensus 161 DgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 161 DGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred CCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998763 59999999999999999999996 66 999999999999999999999999999877543
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
....+.||..|||||.+.+..|+.++||||||++++|+.+|+.|+..... ......+.+. .|++.. ..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~---------~Iv~~p-pP 300 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLC---------AIVDEP-PP 300 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHH---------HHhcCC-CC
Confidence 45667899999999999999999999999999999999999999865411 1111222111 122211 11
Q ss_pred cCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 632 EASQ-EDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 632 ~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
..+. ...++++.++..||+.||.+||+++|++++=
T Consensus 301 ~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp 336 (364)
T KOG0581|consen 301 RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP 336 (364)
T ss_pred CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence 1222 3567799999999999999999999998763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=365.00 Aligned_cols=202 Identities=30% Similarity=0.499 Sum_probs=182.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..+|...+.||+|+|++||+|+++ ++..||||.+... ..+..+.+..|+.+|+.++|||||.|++++..++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 367888999999999999999976 4889999987554 5667788899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC------CcEEEeeccCc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK------YRAKVSDFGAS 543 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~------~~~kl~DFGls 543 (721)
||+++|+|.+|+++.. .+++.++..++.|||.||++||+++ ||||||||.||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 9999999999999775 6999999999999999999999999 9999999999999764 46899999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCc
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~ 602 (721)
|.+.. ........|++.|||||+++.++|+.|+|+||+|++|||+++|+.||.....
T Consensus 163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 98863 3344567899999999999999999999999999999999999999975443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=401.39 Aligned_cols=263 Identities=28% Similarity=0.455 Sum_probs=221.8
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
..+.+....+.||+|.||+||+|+.. +...||||.++..... ..++|++|+++|+.++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33456667789999999999999843 2457999999886655 7889999999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCC-----------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNE-----------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~ 532 (721)
..++|+|||..|||.++|+.... ..+|+..+.+.||.|||.||.||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999975321 234899999999999999999999999 9999999999999999
Q ss_pred CcEEEeeccCccccccCCceeee-eeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHH
Q 036483 533 YRAKVSDFGASRSMAIDQTHMTT-QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAA 610 (721)
Q Consensus 533 ~~~kl~DFGls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~ 610 (721)
..+||+||||+|.+...+.+... ...-..+||+||.+..+++|++||||||||+|||+++ |+.|+.+...++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 99999999999987644433322 3345789999999999999999999999999999999 999986443222
Q ss_pred HHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 611 YFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
+...++.++ .-+.+..++.++..||..||+.+|++||+++||-..|+.....
T Consensus 714 -VIe~i~~g~---------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 714 -VIECIRAGQ---------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred -HHHHHHcCC---------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 222333332 3456778889999999999999999999999999999877543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=380.53 Aligned_cols=248 Identities=25% Similarity=0.428 Sum_probs=213.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.+|...++||+|||..+|.++. ..|+.||+|.+.. ....+.+...+||+|.++|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5699999999999999999997 6799999998644 34566788999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
|++++++|.+++++.+ ++++.+++.+..||+.||.|||+++ |+|||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krrk---~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK---PLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhcC---CCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999998544 7999999999999999999999999 999999999999999999999999999988755
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ...+..||+.|+|||++.....+..+||||+|||||-||.|++||+.....+ .+..++....
T Consensus 172 ~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~~Y-------- 235 (592)
T KOG0575|consen 172 GE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLNEY-------- 235 (592)
T ss_pred cc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhcCc--------
Confidence 33 3445789999999999999999999999999999999999999996433221 2222222211
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.....+..+||.++|+.||.+|||+.+|+..
T Consensus 236 --~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 236 --SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 1122344568899999999999999999999875
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=358.98 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=205.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-------chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-------ESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
..+.|.+.+.||+|+||.|-+|+.+ +|+.||||+++... ........+|++||++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 5677889999999999999999954 69999999875521 112334579999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC---CcEEEeec
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDF 540 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DF 540 (721)
..|+||||++||+|.+.+-.++ .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 9999999999999999998765 5777778889999999999999999 9999999999999765 78999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCC---CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
|+|+... ....+.+..||+.|.|||++.+.. +..|.|+||+||+||-+|+|.+||...... .++.+ .+.
T Consensus 324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--~sl~e----QI~ 395 (475)
T KOG0615|consen 324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--PSLKE----QIL 395 (475)
T ss_pred chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--ccHHH----HHh
Confidence 9999775 445567788999999999998764 334889999999999999999999643321 11221 111
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.++... ....-.+..++..+||.+||..||++|||+.|+++.=
T Consensus 396 ~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hp 438 (475)
T KOG0615|consen 396 KGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNHP 438 (475)
T ss_pred cCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcCh
Confidence 111100 0011234556789999999999999999999997753
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=349.53 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=208.5
Q ss_pred cCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEE-EEEeCC-cceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLG-CCLETE-VPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g-~~~~~~-~~~lv 468 (721)
.+|.+.++||+|.||+||++. +.+|..+|.|.++. .+.+..++...|+.+|++|+|||||++++ .+.++. ...||
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457788899999999999998 66899999998764 45667788999999999999999999998 454444 47899
Q ss_pred EeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCC-CCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 469 YEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAAS-IPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~-~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
||++..|+|...++..+ .+..+++..+++++.|++.||.++|+.-+ ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999997533 34579999999999999999999998321 13999999999999999999999999999988
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
..... .....+|||.||+||.+....|+.||||||+||++|||..-+.||.+.+. .. .-+++..+...
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~------~~-L~~KI~qgd~~---- 246 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL------LS-LCKKIEQGDYP---- 246 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH------HH-HHHHHHcCCCC----
Confidence 65433 34556799999999999999999999999999999999999999975432 21 22333333221
Q ss_pred hhhcccCC-HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 627 AHVLKEAS-QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 627 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+ .-.+..+..||..|+..||+.||+.-.++..+.
T Consensus 247 -----~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 247 -----PLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----CCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 122 335567999999999999999999655544443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=353.42 Aligned_cols=242 Identities=27% Similarity=0.399 Sum_probs=204.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|++.++||+|+||+||.++.++ ++.+|+|.++. ......+...+|..||.+++||+||+++-.|.+.+..|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4789999999999999999999665 88999997754 3445678899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
+||+.||.|..+|+++. .+++..+.-++.+|+.||.|||+++ ||||||||+|||||++|+++|+||||++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998765 6999999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. ...+..+.||+.|||||++.+..|+..+|+||||+++|||++|.+||...+.. . ..+.+..++
T Consensus 178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~-~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------K-MYDKILKGK-------- 241 (357)
T ss_pred C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------H-HHHHHhcCc--------
Confidence 3 23344578999999999999999999999999999999999999999654321 1 222222222
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCC
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRP 657 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP 657 (721)
....+.-...+.++++.+.|+.+|++|-
T Consensus 242 -~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 -LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1112222445688999999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=381.67 Aligned_cols=256 Identities=25% Similarity=0.417 Sum_probs=222.0
Q ss_pred CCCCceEeeeCcEEEEEEEEcC----CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..+.++||.|.||+|++|+++- ...||||.++... +++..+|+.|+.||.+++||||++|.|+.......+||+|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 4467899999999999999763 3479999998854 5567899999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
||++|+|+.+|+.+.. .+++.+..-++++||.||+||.+.+ +|||||.++|||++.++.+||+||||+|.+..+.
T Consensus 711 yMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 9999999999998765 4999999999999999999999999 9999999999999999999999999999876554
Q ss_pred ceeeee--eecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 551 THMTTQ--VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 551 ~~~~~~--~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
....+. -.-..+|.|||.+...++|.+|||||||++|||.++ |.+|+=. |.+..+...++.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWd----------------mSNQdVIkaIe~ 849 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWD----------------MSNQDVIKAIEQ 849 (996)
T ss_pred CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccc----------------cchHHHHHHHHh
Confidence 332222 234578999999999999999999999999999988 8888521 222334455566
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.++...+.+++..|.+|++.||++|-.+||.+.+|+..|+++.+.
T Consensus 850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 677778889999999999999999999999999999999988653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=391.43 Aligned_cols=264 Identities=27% Similarity=0.474 Sum_probs=219.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC--Cc----EEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD--GR----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++....+.||+|.||.||.|...+ +. .||||.++. .+.++..+|.+|..+|+.++|||||+++|++.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4556677899999999999999664 43 499998866 4567788999999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccC----CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 466 LLVYEFIINGTLFQYLHDQN----EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
+|++|||++|+|..+|++.. ....|+....+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998752 1346999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeee-ecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhcc
Q 036483 542 ASRSMAIDQTHMTTQV-QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
||+.+........... .-..+|||||.+..+.++.|+|||||||+||||+| |..|+...... +.+...+..+
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~------~v~~~~~~gg 921 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF------EVLLDVLEGG 921 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH------HHHHHHHhCC
Confidence 9996554443333222 34578999999999999999999999999999999 88887543322 1111122222
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
+.+.+..++..+.++|.+||+.+|++||++..|++.+..+......
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 3345677888899999999999999999999999988877654433
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.00 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=207.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC--cceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE--VPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~--~~~lv~ 469 (721)
..++...+.||+|.||+||++...+ |...|||.....+....+.+.+|+.+|++++|||||+++|.....+ ...+.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 3557788999999999999999765 8999999876654444778999999999999999999999855444 588999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~~~ 548 (721)
||+++|+|.+++.+... .|++..+.+++.||++||+|||+++ |+|+||||+||||+. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999987654 5999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CCceeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 549 --DQTHMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 549 --~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..........||+.|||||++..+. ...++|||||||++.||+||++||... .....+........
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~------ 239 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED------ 239 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC------
Confidence 2222344578999999999999643 335999999999999999999999643 11111111111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
....++...+.+..+++.+|++.+|++|||+.++++...
T Consensus 240 ---~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 240 ---SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred ---CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 122344456667899999999999999999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=333.40 Aligned_cols=264 Identities=24% Similarity=0.346 Sum_probs=207.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCc--hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
+.|+...++|+|+||+|||.+.++ |+.||||++....+ ...+-.++|+++|++++|+|+|.|+.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 457788899999999999999775 99999999866433 334567899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|++..-|++ |.+... .++.+.+.+++.|++.|+.|+|+++ +|||||||+||||+.++.+||+|||+||.+.. .
T Consensus 82 ~~dhTvL~e-Le~~p~--G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p 154 (396)
T KOG0593|consen 82 YCDHTVLHE-LERYPN--GVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P 154 (396)
T ss_pred ecchHHHHH-HHhccC--CCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence 997655554 443332 4889999999999999999999999 99999999999999999999999999998864 3
Q ss_pred ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHH--------HHHhhccch
Q 036483 551 THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF--------LRAMKEDSL 621 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 621 (721)
....+.++.|.+|+|||.+.+ .+|....|||+.||++.||++|.+.|.+....+.--++... ......+..
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~ 234 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF 234 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence 445677789999999999988 68999999999999999999999999876544322111111 111111111
Q ss_pred hh------hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 622 FE------ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 622 ~~------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
+. .-+....+..-+....-+.++++.||+.||.+|++-++++.
T Consensus 235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 11111111112233346889999999999999999998864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=356.29 Aligned_cols=250 Identities=26% Similarity=0.417 Sum_probs=212.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
..|....+||+|+.|.||.++. ..++.||||++........+-+.+|+.+|+..+|+|||++++.+...+..|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 4577778999999999999984 468899999998877777788999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|.+.+... .+++.++..|..++++||+|||.++ |+|||||++|||++.++.+||+|||++..+......
T Consensus 353 ~ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 999999998765 4999999999999999999999999 999999999999999999999999999988765543
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....||+.|||||+.....|.+|.||||||++++||+-|++||-... .+.. .+ .+..+... ...
T Consensus 426 -R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~-----PlrA-ly-LIa~ng~P-------~lk 490 (550)
T KOG0578|consen 426 -RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN-----PLRA-LY-LIATNGTP-------KLK 490 (550)
T ss_pred -cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC-----hHHH-HH-HHhhcCCC-------CcC
Confidence 344569999999999999999999999999999999999999985311 1111 11 11111111 112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+.....++.+++.+||..|+++||++.|++++
T Consensus 491 ~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 491 NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 334455679999999999999999999999875
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=359.48 Aligned_cols=265 Identities=29% Similarity=0.455 Sum_probs=217.8
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcC--C--cE-EEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLAD--G--RI-VAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCL 460 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~-vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~ 460 (721)
++...++....++||+|+||.||+|.+.. + .. ||||..+. ....+..+|++|+++|++++|||||+++|++.
T Consensus 152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV 231 (474)
T ss_pred cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 33344555667899999999999999653 2 23 89998774 44678899999999999999999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
.....+||||++.||+|.++|+.... .++..++++++.+.|.||+|||+++ ++||||.++|+|++.++.+||+||
T Consensus 232 ~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 232 LEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 99999999999999999999987664 5999999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCceeee-eeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhc
Q 036483 541 GASRSMAIDQTHMTT-QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 541 Gls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
||++... ...... .-.-..+|+|||.+....|++++|||||||++||+++ |..|+......+ ...
T Consensus 307 GLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~-------v~~---- 373 (474)
T KOG0194|consen 307 GLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE-------VKA---- 373 (474)
T ss_pred ccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH-------HHH----
Confidence 9997653 111111 2235689999999999999999999999999999999 888876543221 111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
.++........+...+.++..++.+||..+|++||+|.++.+.|+.+......
T Consensus 374 ----kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 ----KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ----HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 12122233344556677899999999999999999999999999998766554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=358.71 Aligned_cols=262 Identities=27% Similarity=0.454 Sum_probs=206.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEE------cCCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE 463 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~ 463 (721)
..++|.+.++||+|+||.||+|.. ..++.||||+++... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 356899999999999999999974 235689999886532 33456799999999999 8999999999887654
Q ss_pred -cceEEEeeccCCCcchhccccCC--------------------------------------------------------
Q 036483 464 -VPLLVYEFIINGTLFQYLHDQNE-------------------------------------------------------- 486 (721)
Q Consensus 464 -~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 486 (721)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 56899999999999999875321
Q ss_pred ---CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-eeeeecCCC
Q 036483 487 ---EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFG 562 (721)
Q Consensus 487 ---~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~ 562 (721)
..++++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++......... .....++..
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 135888999999999999999999998 9999999999999999999999999998654322211 122345678
Q ss_pred CCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHH
Q 036483 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTV 641 (721)
Q Consensus 563 y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 641 (721)
|+|||++.+..++.++||||||++||||++ |..||......+ .+...+..+.. ...+...+..+
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~l 306 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKDGTR---------MRAPENATPEI 306 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhcCCC---------CCCCCCCCHHH
Confidence 999999999999999999999999999997 999986433211 11112221111 11122334568
Q ss_pred HHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 642 AKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 642 ~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=353.17 Aligned_cols=267 Identities=27% Similarity=0.358 Sum_probs=209.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhH-HHHHHHHHHhhcC-CCceeeEEEEEEeCC-cceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVD-EFINEVAILSQIN-HRNVVKLLGCCLETE-VPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-~~~~E~~il~~l~-h~niv~l~g~~~~~~-~~~l 467 (721)
.-++|.+.++||.|.||.||+|+.. .+..||||+++..-....+ .=.+|++.|++|+ ||||++|..++.+.+ ..++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4578999999999999999999954 6899999998764333222 2368999999998 999999999999988 8999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||| ..+|.+++++. +..+++..++.|+.||++||+|+|.+| ++|||+||+|||+..+..+||+|||+||.+.
T Consensus 88 VfE~M-d~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFM-DCNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhh-hhhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 99999 56899999876 347999999999999999999999999 9999999999999999999999999999875
Q ss_pred cCCceeeeeeecCCCCCCccccc-cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh---
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFR-SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE--- 623 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 623 (721)
.. ...+.++.|.+|+|||++. .+-|+.+.|+|++|+|++||.+-++.|.+.+..++-..+-.+........+.+
T Consensus 162 Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 162 SK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN 239 (538)
T ss_pred cC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence 33 3456677899999999875 46799999999999999999999998876554332111111111111111111
Q ss_pred ---hhhhhh-------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 624 ---ILDAHV-------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 624 ---~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.+.-.+ ....-.....+..+|+.+|+++||++|||+.|.+++-
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 000000 1111223557789999999999999999999998763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=349.22 Aligned_cols=266 Identities=27% Similarity=0.351 Sum_probs=209.6
Q ss_pred cCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~lv 468 (721)
+.|+..++||+|.||.||+|+ ..+|+.||+|++.... +....-..+||.||++|+||||++|.+...+. ...|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 457777899999999999999 4569999999986644 44566778999999999999999999999887 578999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
+|||+. +|.-++.... ..++..++..++.|+++||.|+|+++ |+|||||.+|||||.+|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999954 6777776532 35999999999999999999999999 99999999999999999999999999999887
Q ss_pred CCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh-----
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF----- 622 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----- 622 (721)
......+..+-|++|+|||.+.+. .|+.+.|+||.||||.||++|++.+++....++-..+-.+-....++.+.
T Consensus 271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 777667777889999999999886 79999999999999999999999988765443221111111001111111
Q ss_pred --hhhhh-----hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 623 --EILDA-----HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 623 --~~~~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.+ +...+.....+....+|+..+|..||.+|.|+.++++.
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 01100 00111122234567899999999999999999998754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=356.54 Aligned_cols=269 Identities=27% Similarity=0.465 Sum_probs=215.9
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
.+.++++...+.+.+...||+|.||+||+|++.+ .||||.++.. ..++.+.|++|+.++++-+|.||+-+.|++..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 3446777777888899999999999999999864 3999998774 35578999999999999999999999999998
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
... .||+.+++|.+|+.+||.... .+...+.+.||.|||+|+.|||.++ |||||||+.||+|.+++++||+|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred Cce-eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence 877 999999999999999998764 5888999999999999999999999 9999999999999999999999999
Q ss_pred CccccccC-CceeeeeeecCCCCCCccccccC---CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 542 ASRSMAID-QTHMTTQVQGTFGYLDPEYFRSS---RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 542 ls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
|+..-..- ........-|...|||||+++.+ +|++.+||||||+++|||++|..|+.....+ +.+. .+.
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d--qIif-----mVG 606 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD--QIIF-----MVG 606 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh--heEE-----Eec
Confidence 98643211 11112223377889999998754 6899999999999999999999998722211 1110 011
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.+.++ .| ........++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus 607 rG~l~--pd---~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 607 RGYLM--PD---LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred ccccC--cc---chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 11000 00 1122345667899999999999999999999999988888664
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=346.25 Aligned_cols=252 Identities=28% Similarity=0.384 Sum_probs=212.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcce
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~ 466 (721)
-.++|.+.++||+|+|++|++|+.+ .++.+|||++.. ..+...+-...|-.+|.+| .||.|++|+-.|.++...|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3467999999999999999999955 589999998644 3455667788999999999 8999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+|+||.++|+|.++|++.. .+++...+.++.||+.||+|||+.| ||||||||+|||||+++++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999998775 6999999999999999999999999 999999999999999999999999999887
Q ss_pred ccCCce----------e--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH
Q 036483 547 AIDQTH----------M--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 547 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 614 (721)
...... . ...++||..|.+||++.....+..+|||+|||+||+|+.|++||...+.. ..|.+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------liFqk 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------LIFQK 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH------HHHHH
Confidence 532221 1 14578999999999999999999999999999999999999999754421 11222
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.+ +-. -+++...++.+.+|+.+.|..||.+|+|.++|-++.
T Consensus 299 I~---------~l~--y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 299 IQ---------ALD--YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred HH---------Hhc--ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 21 111 123334446689999999999999999998886653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=338.48 Aligned_cols=268 Identities=25% Similarity=0.390 Sum_probs=204.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhh--cCCCceeeEEEEEEeCC----cceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQ--INHRNVVKLLGCCLETE----VPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~g~~~~~~----~~~l 467 (721)
+...+.++||+|+||.||||.+. ++.||||++. .++.+.|++|-.|.+. ++|+||+++++.-.... .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 33456689999999999999996 4899999876 4566889999999876 48999999999866544 7899
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc------CCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA------ASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~------~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
|+||.+.|+|.+||..+ .++|....+|+..+++||+|||+. .+++|+|||||++||||.+|+++.|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~n----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKAN----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHhc----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 99999999999999876 599999999999999999999974 35789999999999999999999999999
Q ss_pred CccccccCCcee-eeeeecCCCCCCccccccCC-CC-----ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH
Q 036483 542 ASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSR-FT-----EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 542 ls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~t-----~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 614 (721)
+|..+....... ....+||.+|||||++.+.. +. .+.||||+|.|||||+++...+......+-+. -|..
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql---pfe~ 438 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL---PFEA 438 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC---chhH
Confidence 999887554433 23357999999999998752 22 25899999999999999876553211111110 0111
Q ss_pred Hhhcc----chhhhhhhhh-cccCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 615 AMKED----SLFEILDAHV-LKEAS-----QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 615 ~~~~~----~~~~~~~~~~-~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.+... ++.+.+.... +..++ ...+..+.+.+..||..|++.|.|+.=|.+.+.++...
T Consensus 439 evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 439 EVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred HhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 11111 1111111111 11111 13445688999999999999999999999999888654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=339.90 Aligned_cols=247 Identities=21% Similarity=0.358 Sum_probs=200.6
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchh---hHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcceEEEee
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESK---VDEFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVYEF 471 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~~lv~e~ 471 (721)
...||+|++|.||+|.. +|+.||||+++...... .+.|.+|+.+|++++||||+++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36899999999999998 68899999886543322 5778899999999999999999999877 3456899999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++|+|.+++.... .+++..+++++.|++.||.|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 104 ~~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 104 CTRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred CCCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999997643 589999999999999999999985 6 7899999999999999999999999998653221
Q ss_pred ceeeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
....++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ..+......+.
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~-------- 239 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNN-------- 239 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC--------
Confidence 12347889999999976 68999999999999999999999999643211 11111111110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+.++.+++.+||+.||++|||+.||++.|+.++.
T Consensus 240 -~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 -SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred -CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 111222345679999999999999999999999999988753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=333.76 Aligned_cols=263 Identities=24% Similarity=0.368 Sum_probs=210.0
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..+.|++..+||.|..++||+|+. ..+..||||++.... ....+.+.+|+..|+.++||||++++..|..+...|+||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 457899999999999999999994 457999999976533 334789999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
.||.+|++.+++...-.. .+++..+..|++++++||.|||.+| .||||||+.||||+++|.+||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 999999999999875443 4999999999999999999999999 999999999999999999999999998766433
Q ss_pred Ccee---eeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 550 QTHM---TTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 550 ~~~~---~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.... ...+.||+.|||||+++. ..|+.|+||||||++..||.+|..||.....- ......+..... ..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm------kvLl~tLqn~pp-~~ 252 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM------KVLLLTLQNDPP-TL 252 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH------HHHHHHhcCCCC-Cc
Confidence 2211 145679999999999544 46999999999999999999999998643321 111222222111 00
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.-.....+........+.+++..||..||.+|||+.++++.
T Consensus 253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 01111112223344579999999999999999999998764
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=315.03 Aligned_cols=262 Identities=27% Similarity=0.347 Sum_probs=207.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCch--hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDES--KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|...++||+|.||.||+|+. ..|+.||||+++..+.. ......+|++.|+.++|+||+.++++|...+..-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999995 46999999998765332 34567899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|| ..+|+..++... ..++...+..++.++++||+|+|++. |+||||||.|+|++++|.+||+|||+++.+....
T Consensus 82 fm-~tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FM-PTDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ec-cccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99 568998887654 36899999999999999999999999 9999999999999999999999999999987554
Q ss_pred ceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh---ccchhh---
Q 036483 551 THMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK---EDSLFE--- 623 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 623 (721)
...... +-|.+|+|||.+.+. .|+...|+||.||++.||+-|.+-|.+...-++ +...| +.+. ++.+.+
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If-~~LGTP~~~~WP~~~~ 231 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIF-RALGTPTPDQWPEMTS 231 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHH-HHcCCCCcccCccccc
Confidence 433332 578999999998875 699999999999999999999887766543332 22222 2221 111111
Q ss_pred hhhhh--------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 ILDAH--------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~~~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+.|-. .....-........+|+.++|..||.+|+|+.|++++
T Consensus 232 lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 232 LPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 11110 0111223344567999999999999999999999775
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=346.54 Aligned_cols=246 Identities=28% Similarity=0.484 Sum_probs=205.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
+.....+-||.|+.|.||+|++. ++.||||+++...+ .+|+-|++|+|+||+.|.|+|...--++|||||++
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 33445578999999999999996 67899998764433 46888999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
.|-|...|+..+ +++......|..+||.|+.|||.+. |||||||+-||||..+..+||+|||.++..... ..
T Consensus 196 ~GqL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST 267 (904)
T KOG4721|consen 196 QGQLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST 267 (904)
T ss_pred cccHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence 999999998755 6888999999999999999999999 999999999999999999999999999876432 23
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
.-.+.||..|||||++.+.+.++|+|||||||||||||||.-|+....... + ...+.. ..+....
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I---IwGVGs--------NsL~Lpv 332 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I---IWGVGS--------NSLHLPV 332 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e---EEeccC--------CcccccC
Confidence 345679999999999999999999999999999999999999985332110 0 000111 1122334
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+..++..+.-|+++||+..|..||++++|+.+|+-..
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 5667778999999999999999999999999997554
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=315.20 Aligned_cols=236 Identities=27% Similarity=0.366 Sum_probs=202.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|+..+.||.|+||+|.+++.+ +|..+|+|.+.. ....+.+...+|..+|+.+.||++++|++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 56888999999999999999966 588999998765 34556778899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||++||.|..+|++.. .+++..++.+|.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||.|+.+..
T Consensus 124 eyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 9999999999998765 5999999999999999999999999 99999999999999999999999999987643
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.+-+..||+.|+|||.++...+..++|.|+|||++|||+.|.+||...+. ...+.++-+..+
T Consensus 197 ---rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-------~~iY~KI~~~~v-------- 258 (355)
T KOG0616|consen 197 ---RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-------IQIYEKILEGKV-------- 258 (355)
T ss_pred ---cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-------HHHHHHHHhCcc--------
Confidence 24567899999999999999999999999999999999999999975443 112222222221
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCC
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKR 656 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~R 656 (721)
.++.-....+.+|+...|+.|-.+|
T Consensus 259 --~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 --KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 1233344568899999999998888
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=334.10 Aligned_cols=256 Identities=21% Similarity=0.357 Sum_probs=205.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|++.++||+|+||.||+|.++ .+..||+|.++... ....+.|.+|+.++++++||||+++++++...+..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999854 35689999887642 3445679999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 999999999999997643 25899999999999999999999998 9999999999999999999999999876543
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~------ 225 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD-------VIKAVEDGF------ 225 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCCC------
Confidence 222111112235678999999999999999999999999999875 999985432211 111121111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
....+...+..+.+++.+||+.+|++||++.+|.+.|..+
T Consensus 226 ---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 ---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1112333456799999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=338.22 Aligned_cols=263 Identities=24% Similarity=0.387 Sum_probs=202.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-----------------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-----------------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVK 454 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~ 454 (721)
.++|.+.++||+|+||.||++.+.+ +..||+|.+.... .....+|.+|+.++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3678899999999999999998542 3369999876532 334568999999999999999999
Q ss_pred EEEEEEeCCcceEEEeeccCCCcchhccccC----------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCee
Q 036483 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQN----------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518 (721)
Q Consensus 455 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~iv 518 (721)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999886432 1125788999999999999999999998 99
Q ss_pred eccCcCccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhC--Cc
Q 036483 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG--ER 595 (721)
Q Consensus 519 HrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG--~~ 595 (721)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++....++.++||||||+++|||+++ ..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433221 12223457889999999989999999999999999999874 45
Q ss_pred ccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 596 AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 596 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
||...... ............... ......+...+..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 55432211 111111111111000 0001112234467899999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=342.09 Aligned_cols=256 Identities=25% Similarity=0.383 Sum_probs=209.4
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc----Cc-hhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCC
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI----DE-SKVDEFINEVAILSQIN-HRNVVKLLGCCLETE 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~----~~-~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~ 463 (721)
...++|.+.+.||+|.||+|+.|... .+..||+|..... .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44578999999999999999999854 6899999965442 11 33456778999999998 999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeeccC
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGA 542 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGl 542 (721)
..++||||+.+|+|.+++.+.. .+.+..+.+++.|++.|++|+|+++ |+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 9999999999999999998733 6889999999999999999999999 9999999999999999 9999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCC-CC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR-FT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+.... ..........||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. ......+.. +..+.
T Consensus 168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d------~~~~~l~~k-i~~~~ 239 (370)
T KOG0583|consen 168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD------SNVPNLYRK-IRKGE 239 (370)
T ss_pred ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC------ccHHHHHHH-HhcCC
Confidence 98774 2233456678999999999999987 87 679999999999999999999964 222222222 22221
Q ss_pred hhhhhhhhhcccCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 621 LFEILDAHVLKEASQED-IVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
. .++.-. ..++..|+.+||..+|.+|+|+.+|+ .-..++.
T Consensus 240 ~----------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 240 F----------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred c----------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 1 111111 55689999999999999999999998 4444443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=383.24 Aligned_cols=265 Identities=25% Similarity=0.428 Sum_probs=211.7
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
+.....|...++||+|+||.||+|+. .+++.||||+++.... ...+|++++++++||||+++++++.+.+..++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 33445678889999999999999996 4689999998764332 223568899999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.++++ .++|..+.+|+.|+++||+|||+...++|+||||||+||+++.++..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 99999999999995 38999999999999999999997655569999999999999999888876 666543321
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
+ ....++..|+|||++.+..++.++||||||+++|||++|+.|+.... ........+............++++.
T Consensus 835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhcCccchhheeCcc
Confidence 1 12357899999999999999999999999999999999999984322 22334445544433333344445544
Q ss_pred hcc--cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 629 VLK--EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 629 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
... ....++..++.+++.+||+.+|++||||+||++.|+++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 432 2345667788999999999999999999999999998855
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=350.18 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=206.9
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEE------cCCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCL 460 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~ 460 (721)
+....++|++.+.||+|+||.||+|+. ..+..||||+++... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus 30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~ 109 (375)
T cd05104 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT 109 (375)
T ss_pred cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence 334456799999999999999999973 235689999886432 33456789999999999 8999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCC------------------------------------------------------
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNE------------------------------------------------------ 486 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------ 486 (721)
+.+..++||||+++|+|.++++....
T Consensus 110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 189 (375)
T cd05104 110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV 189 (375)
T ss_pred cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence 99999999999999999999865321
Q ss_pred ------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 487 ------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 487 ------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
...+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 125789999999999999999999998 99999999999999999999999999986643
Q ss_pred CCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 549 DQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 549 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
..... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... ..+...+..+.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~~------ 334 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD------SKFYKMIKEGY------ 334 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch------HHHHHHHHhCc------
Confidence 32211 112335667999999999999999999999999999998 88887543211 11111222111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
....+...+.++.+|+.+||+.+|++||++.||++.|++.
T Consensus 335 ---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 ---RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 1111122345689999999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.08 Aligned_cols=249 Identities=25% Similarity=0.383 Sum_probs=208.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..|...+.||+|.||.||+|... .++.||+|.+.. ..+...++++.|+.+|++++++||.++++.+..+...|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666789999999999999965 588999998765 3455678999999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+.+|++.++|.... .+.+..+.-|+.+++.||.|||+++ .+|||||+.|||+..++.+||+|||.+-.+.....
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999998654 4577888889999999999999999 99999999999999999999999999988765544
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.. .+++||+.|||||++....|+.|+||||||++.+||.+|.+|+...... +..-++-.....
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEEeccCCCCC
Confidence 44 5678999999999999989999999999999999999999998643321 111111111111
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.........+.+++..||..||+.||++.+++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2222344569999999999999999999999765
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=330.49 Aligned_cols=256 Identities=21% Similarity=0.392 Sum_probs=208.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|++.++||+|+||.||+|...+++.||+|.+... ....+.+.+|+.++++++|+||+++++.+.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3678899999999999999999888889999987643 234578999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.++++.... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999976432 36899999999999999999999998 999999999999999999999999999876433222
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||++....++.++||||||+++|||++ |+.||....... ....+.... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSALQRGY---------RM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHHHHcCC---------CC
Confidence 2223345678999999999999999999999999999998 999985432111 111111110 00
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
......+.++.+++.+||+.+|++||+++++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 11112345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=339.32 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=210.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|.+.+.||+|.||.||||+.+ +.+.||+|.+.. ..+++.+.+.+|++|+++++||||+.+++.|....+.|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56888899999999999999966 588999997644 334567789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+.+ +|..+|.... .++++.+..|+.|+..||.|||+.+ |+|||+||.||||+..+.+|++|||+++.... .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9966 9999998654 6999999999999999999999999 99999999999999999999999999998764 4
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
..+.+.+.||+-|||||...+..|+..+|.||+||+|||+++|++||.... +.. ..+.+..+..
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~-Lv~~I~~d~v--------- 217 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQ-LVKSILKDPV--------- 217 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHH-HHHHHhcCCC---------
Confidence 556777889999999999999999999999999999999999999985322 111 1122211111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+......+..+++..|..||.+|.|..+++.+
T Consensus 218 -~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 -KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred -CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 1233556679999999999999999999888654
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=349.62 Aligned_cols=262 Identities=25% Similarity=0.444 Sum_probs=206.5
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLE 461 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~ 461 (721)
....++|++.+.||+|+||.||+++.. ++..||+|+++.. .....+.+.+|+.+++.+ +|+||+++++.+.+
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 344568999999999999999998842 2357999988653 233456789999999999 89999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCC-------------------------------------------------------
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNE------------------------------------------------------- 486 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 486 (721)
....++||||+++|+|.++++....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999998864211
Q ss_pred ------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-
Q 036483 487 ------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM- 553 (721)
Q Consensus 487 ------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~- 553 (721)
..++++..+++++.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~ 270 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence 124788999999999999999999998 9999999999999999999999999997654332211
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||....... .+....... ....
T Consensus 271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~------~~~~~~~~~---------~~~~ 335 (374)
T cd05106 271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS------KFYKMVKRG---------YQMS 335 (374)
T ss_pred ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH------HHHHHHHcc---------cCcc
Confidence 112235678999999999999999999999999999997 999986432111 111111111 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.+...+.++.+++.+||+.+|++|||+.+|++.|+++
T Consensus 336 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1112245689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=343.04 Aligned_cols=263 Identities=28% Similarity=0.454 Sum_probs=226.9
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
++++.-..+....++||-|.||.||.|.|+. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|..+-..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555556667778999999999999999875 567999988753 45678999999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
|||+|||..|+|.+||++.+.. .++....+.+|.||+.||.||..++ +|||||..+|+|+.++..+||+||||+|+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999986543 5778888999999999999999999 99999999999999999999999999999
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
+..+....-....-...|.|||-+....++.|+|||+|||+||||.| |-.|+.+.+.. .+.++
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS----------------qVY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH----------------HHHHH
Confidence 87654433333345678999999999999999999999999999998 88887643321 23456
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+...++.+.+..+++.+.+|+++||+++|.+||++.|+-+.++.+-
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 6666777778889999999999999999999999999999988654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.97 Aligned_cols=249 Identities=28% Similarity=0.413 Sum_probs=213.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.-|.+.+-||.|+.|.|-.|++. .|+.+|||++... .......+.+|+.||+.+.|||++++++++.+...+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 44778899999999999999965 5999999987543 3445667889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|.|+++|.+.+ ++++.++.+++.||+.|+.|.|..+ |+||||||+|+|||.++++||+|||+|.+-..+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999998765 6999999999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeeeeecCCCCCCccccccCCCC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
....+..|.++|.+||++++.+|+ .++||||.|||||.||+|+.||. ++++. ..+.++..+..
T Consensus 166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd------DdNir-~LLlKV~~G~f------- 229 (786)
T KOG0588|consen 166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD------DDNIR-VLLLKVQRGVF------- 229 (786)
T ss_pred --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC------CccHH-HHHHHHHcCcc-------
Confidence 234556799999999999999987 58999999999999999999995 22332 23334444332
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
+.+...+.+.++|+.+||..||+.|.|++||+++-.
T Consensus 230 ---~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 ---EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred ---cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 345566677999999999999999999999988753
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=332.65 Aligned_cols=250 Identities=25% Similarity=0.319 Sum_probs=200.3
Q ss_pred CCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 396 YNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
|...+.||+|+||+||++.. .+++.||+|.+.... ......+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67789999999999999986 468999999865422 22345678999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++|+|..++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 999999888764332 25899999999999999999999999 9999999999999999999999999998653222
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......||..|+|||++.+..++.++||||||+++|||++|+.||........ ........... ..
T Consensus 157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~---~~~~~~~~~~~----------~~ 222 (285)
T cd05631 157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK---REEVDRRVKED----------QE 222 (285)
T ss_pred -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh---HHHHHHHhhcc----------cc
Confidence 12334689999999999999999999999999999999999999975432211 11111111110 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAV 664 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 664 (721)
..+...+..+.+|+.+||+.+|++||+ +.++++
T Consensus 223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 122234456899999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=335.59 Aligned_cols=265 Identities=22% Similarity=0.253 Sum_probs=202.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|.+.+.||+|+||.||+++.+ +++.+|+|+++.. .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46889999999999999999976 5789999987643 23345678899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|++++.|..+.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99988776554322 25899999999999999999999998 9999999999999999999999999998764333
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH--------HHhhccc-h
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL--------RAMKEDS-L 621 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~-~ 621 (721)
........|++.|+|||++.+..++.++||||||+++|||++|+.||......+......... ....... .
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 222334568999999999999999999999999999999999999986543211100000000 0000000 0
Q ss_pred hhhhhhhhc------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 622 FEILDAHVL------KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 622 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+... .......+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0011123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=327.15 Aligned_cols=251 Identities=26% Similarity=0.410 Sum_probs=203.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|++.+.||+|+||.||++.++++..+|+|..+.. ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999988889999987643 2334678999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999875432 5899999999999999999999998 9999999999999999999999999998654322222
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ... ..+..+.. ..
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~------~~~-~~i~~~~~---------~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY------EVV-EMISRGFR---------LY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HHHHCCCC---------CC
Confidence 222335668999999998899999999999999999999 88888533211 111 11111110 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.+...+..+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1112335689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=330.48 Aligned_cols=257 Identities=25% Similarity=0.418 Sum_probs=212.4
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
...+|.+.++||+|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34668889999999999999999888999999998776665677899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999986533 36899999999999999999999998 99999999999999999999999999976643221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
......++..|+|||.+....++.++||||||+++++|++ |+.||...... ..+. .+.. ...
T Consensus 160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~-~~~~---------~~~ 222 (261)
T cd05148 160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYD-QITA---------GYR 222 (261)
T ss_pred -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHH-HHHh---------CCc
Confidence 1223345678999999998899999999999999999998 88888543211 1111 1111 111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
...+...+..+.+++.+||+.+|++|||++++++.|+++
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 223 MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 122234456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=327.79 Aligned_cols=255 Identities=29% Similarity=0.455 Sum_probs=207.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.+|.+.+.||+|+||.||+|... .++.||+|..+.. ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45778899999999999999965 4888999987643 334578999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++........
T Consensus 85 ~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999875432 35899999999999999999999998 999999999999999999999999999876433222
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||.+.+..++.++||||||+++|||++ |..|+...... ..+ ..+.. ....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~-~~~~~---------~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVY-ELLEK---------GYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH-HHHHC---------CCCC
Confidence 2222234668999999999999999999999999999998 88887543221 111 11111 1111
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
+.+...+.++.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 22233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=333.78 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=201.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
-.++|++.++||+|+||.||+++.++ |..+|+|+++.. ...+++..+.|-.+|...++|+||+|+-.|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 34789999999999999999999664 999999998764 35567788999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||++||++..+|.+.. .|++..+..++.+++-|+.-||+.| ||||||||+|+|||..|++||+||||+.-+.
T Consensus 219 iMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 999999999999998765 7999999999999999999999999 9999999999999999999999999985321
Q ss_pred c-----------------------CCc-----e------------------eeeeeecCCCCCCccccccCCCCccccch
Q 036483 548 I-----------------------DQT-----H------------------MTTQVQGTFGYLDPEYFRSSRFTEKSDVY 581 (721)
Q Consensus 548 ~-----------------------~~~-----~------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~ 581 (721)
. +.. . .....+|||.|||||++.+..|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 1 000 0 00124599999999999999999999999
Q ss_pred hHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC
Q 036483 582 SFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT 658 (721)
Q Consensus 582 SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 658 (721)
|||+|+||||.|.+||......+- +.+.+ ..+. .+..........+..+||.++|. ||++|--
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T------~rkI~-nwr~------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET------YRKIV-NWRE------TLKFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH------HHHHH-HHhh------hccCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999975544331 11111 1110 00011111223568899999998 9999965
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=326.88 Aligned_cols=257 Identities=24% Similarity=0.381 Sum_probs=208.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++|++.+.||+|++|.||+|...+++.||+|..+... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346788999999999999999998888889999876533 3356799999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997644 236899999999999999999999998 99999999999999999999999999987653221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
........+..|+|||++.+..++.++||||||++++||++ |+.||...... . ....+... ..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~-~~~~~~~~---------~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------E-VLQQVDQG---------YR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHcC---------CC
Confidence 11111223457999999999999999999999999999999 98888533211 0 11111111 00
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
...+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 111223446789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=342.98 Aligned_cols=251 Identities=27% Similarity=0.477 Sum_probs=211.6
Q ss_pred CCceEeeeCcEEEEEEEEc-CCc----EEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 398 TNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++||+|+||+||+|.+- .|+ +||||.+.. ...+..+++.+|+-+|.+|+|||+++|+|+|.... +.||++|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 4579999999999999853 343 688887644 44556789999999999999999999999998776 7899999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
|+.|+|.+|++.++. .+..+..+.|..|||+||.|||.+. ++||||..+||||..-..+||.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999988654 5889999999999999999999998 99999999999999999999999999999887655
Q ss_pred eeeee-eecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 552 HMTTQ-VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 552 ~~~~~-~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
..... ..-.+.|||-|.+....|+.++|||||||.+|||+| |.+|+.....++ +.+++....
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccc
Confidence 44332 234578999999999999999999999999999999 999976544332 333344444
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+...++.+...+..++.+||..|++.||+++++...+....
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 44556777788999999999999999999999999887654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=330.42 Aligned_cols=249 Identities=35% Similarity=0.579 Sum_probs=194.9
Q ss_pred CCceEeeeCcEEEEEEEEc-----CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 398 TNRILGQGGQGTVYKGMLA-----DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+.+.||.|.||.||+|.+. .+..|+||.++... ....+.|.+|++++++++||||++++|++.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999977 25689999986643 34578999999999999999999999999988889999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++|+|.++|+.... ..+++..+++|+.||++||.|||+.+ |+|+||+++||++++++.+||+|||+++.......
T Consensus 83 ~~~g~L~~~L~~~~~-~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNK-EPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTCT-TTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccccc-cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 999999999988622 36999999999999999999999998 99999999999999999999999999987632222
Q ss_pred -eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 552 -HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 552 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
...........|+|||.+....++.++||||||+++|||++ |+.|+...... . +...+.+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~-~~~~~~~~~~-------- 223 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------E-IIEKLKQGQR-------- 223 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------H-HHHHHHTTEE--------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------c-cccccccccc--------
Confidence 22233446788999999999999999999999999999999 67886433211 1 1122222211
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+...+..+.+++.+||+.+|++|||+.+|++.|
T Consensus 224 -~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 224 -LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp -TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred -ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 112223455689999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=338.84 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=204.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999976 4889999987643 2234567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 5899999999999999999999999 99999999999999999999999999976532
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. +......... +....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~~~~~~---~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET------WENLKYWKET---LQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH------HHHHHhcccc---ccCCC
Confidence 22345689999999999999999999999999999999999999865432211 1111110000 00000
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........+.++.+++.+||..+|++||+++++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011234568899999999999999999999876
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=336.53 Aligned_cols=265 Identities=23% Similarity=0.379 Sum_probs=215.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchh-hHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESK-VDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..+...+.++||+|-||+|.+.....+..||||+++...... ..+|.+|+++|.+++||||++|+|+|..++..++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 345667789999999999999999888999999998866554 4899999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
||++|+|.+++.++... .+.-....+|+.|||.||+||.+.+ +|||||.++|+|+|+++++||+|||++|.+....
T Consensus 616 YmEnGDLnqFl~aheap-t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELP-TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHhcCcHHHHHHhccCc-ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 99999999999876533 2445566779999999999999998 9999999999999999999999999999776544
Q ss_pred cee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh--CCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 551 THM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT--GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 551 ~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.+. .....-..+|||||.+..+++|.+||||+||++|||+++ ..+|+.....+ ...+......... ..
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~------~~ 762 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQ------GR 762 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCC------Cc
Confidence 433 334556789999999999999999999999999999876 67776433221 1111111111111 11
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
......+..++.++.+++.+||+.+-++||+++++...|++.
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 112234556777899999999999999999999999988754
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.21 Aligned_cols=257 Identities=28% Similarity=0.448 Sum_probs=207.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
++|++.+.||+|+||.||+|.... ...||+|.++... ....+.|.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468889999999999999998643 2579999876433 334567999999999999999999999999988999
Q ss_pred EEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 467 LVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999975321 135889999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHH
Q 036483 534 RAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 611 (721)
.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999976543221 12223346788999999999999999999999999999998 999986433211
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
....+.... ....+...+.++.+|+.+||+.+|++||++.||++.|+++
T Consensus 235 ~~~~i~~~~---------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 235 VIEMIRSRQ---------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHcCC---------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 111222211 1222344567799999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=341.12 Aligned_cols=245 Identities=27% Similarity=0.363 Sum_probs=207.0
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCc
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEV 464 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~ 464 (721)
....++|.+.++||+|.||+|+++..+ +++.+|||.++. .....++..+.|..|+... +||.+++|+.+|...++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 344578999999999999999999976 478999998876 3456778899999999888 59999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+.||++..+.+.. .+++..+..+|.+|+.||+|||+++ ||+||||.+|||||.+|.+||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999966555543 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.... ....+.++.||+.|||||++.+..|+.++|.|+|||+|||||.|..||.+.+.++ .|...+.++..
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~~~--- 586 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDEVR--- 586 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCCCC---
Confidence 6542 2335667899999999999999999999999999999999999999997544332 23333222221
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
++.-.+.+...+++++|..+|++|.-+
T Consensus 587 --------yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 587 --------YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --------CCCcccHHHHHHHHHHhccCcccccCC
Confidence 233445668899999999999999866
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=324.40 Aligned_cols=255 Identities=25% Similarity=0.417 Sum_probs=206.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++|++.+.||+|+||+||+|.+.. ...||||..+.. ......+|.+|+.++++++||||+++++.+.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568899999999999999999753 357999987653 334456899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++..... .+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 999999999999976443 5899999999999999999999998 99999999999999999999999999987752
Q ss_pred CCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 549 DQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 549 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
... .......++..|+|||.+.+..++.++||||||++++||++ |..||...... .+...+....
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~-------~~~~~~~~~~------ 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ-------DVIKAVEDGY------ 225 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH-------HHHHHHHcCC------
Confidence 221 12222335678999999999999999999999999999998 98887432211 1111111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
....+...+..+.+++.+||+.+|++||++.||++.|+.+
T Consensus 226 ---~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ---RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0111223445689999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.05 Aligned_cols=268 Identities=23% Similarity=0.341 Sum_probs=220.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCC-cEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEE-EEEeC------
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADG-RIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLG-CCLET------ 462 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g-~~~~~------ 462 (721)
...++++.+.|-+|||+.||.|....+ ..+|+|++-..++...+...+|+.+|++|+ |+|||.+++ .....
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 345677889999999999999998776 999999987778889999999999999996 999999999 33221
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
-+.+|.||||.+|.|-+++...... .|++.++++|+.|+++|+++||... +||||||||.+||||+.+++.||+|||.
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccc
Confidence 2457999999999999999865444 4999999999999999999999986 5799999999999999999999999999
Q ss_pred ccccccCCc--eee------eeeecCCCCCCcccc---ccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH
Q 036483 543 SRSMAIDQT--HMT------TQVQGTFGYLDPEYF---RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 543 s~~~~~~~~--~~~------~~~~gt~~y~aPE~~---~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~ 611 (721)
+.-...... ... ....-|+.|+|||++ .+...++|+|||+|||+||-|+....||....
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 864332211 100 112268999999987 46789999999999999999999999996432
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCCCcccc
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQ 680 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~~~~~ 680 (721)
...|+...+.....+.....+.+||..||+.||++||++-+|+..+..+.....+...++
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 233555555555556788889999999999999999999999999998887666555544
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=323.58 Aligned_cols=250 Identities=25% Similarity=0.404 Sum_probs=211.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
...+|++.+.||+|.||.|-+|+. ..|+.||||.++. .+++..-.+.+|++||+.|+||||+.++.+|...+..+|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 346788889999999999999995 6799999996543 456667788999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||..+|.|++|+.+.. .|++.++++++.||..|+.|.|.++ ++|||||.+|||||.++++||+||||+.++.
T Consensus 131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999998765 6999999999999999999999999 9999999999999999999999999998875
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.+ ....++.|++-|.+||.+.+.+|. +..|-|||||+||-|+.|.-||.+.+.. ...+.+..+...+
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-------~lvrQIs~GaYrE--- 272 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-------RLVRQISRGAYRE--- 272 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-------HHHHHhhcccccC---
Confidence 33 334567899999999999999986 5799999999999999999999754321 1222222222221
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
++.+....-||++||..||++|.|+.+|+..-.
T Consensus 273 --------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 --------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred --------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 223345678999999999999999999987753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=335.72 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=198.0
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
++||+|+||.||++... +|+.||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999865 6889999987642 2344567889999999999999999999999999999999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeee
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 555 (721)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9999887543 6899999999999999999999999 9999999999999999999999999987542221 2233
Q ss_pred eeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCH
Q 036483 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635 (721)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (721)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+.... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~-~~~~~~~----------~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLF-ELILMEE----------IRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHH-HHHHcCC----------CCCCC
Confidence 456999999999999999999999999999999999999998543211 111 1111111 11222
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 636 EDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 636 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
....++.+++.+||+.||++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 3445689999999999999999 78888654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=337.45 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=201.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+++.. +++.||+|.++.. .....+.+.+|+.++++++||||+++++.+.+.+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 67889999999999999999976 5889999987542 2344567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 9999999999997643 5889999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. ....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~-~~~~i~~~~~-------- 232 (329)
T PTZ00263 172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------R-IYEKILAGRL-------- 232 (329)
T ss_pred c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------H-HHHHHhcCCc--------
Confidence 1 2346899999999999999999999999999999999999998543211 1 1111211111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
..+......+.+|+.+||+.||++||+ +++++.+
T Consensus 233 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 233 --KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 111123345889999999999999997 5666544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=332.63 Aligned_cols=245 Identities=24% Similarity=0.326 Sum_probs=201.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999976 5889999987542 2234567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997643 5899999999999999999999999 999999999999999999999999999765322
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~~-------- 215 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------G-IYEKILAGKL-------- 215 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCc--------
Confidence 12345899999999999999999999999999999999999998643221 1 1111111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
..+......+.+|+.+||+.||.+||+ +.++++.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 216 --EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 112223456899999999999999995 7776544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=333.94 Aligned_cols=256 Identities=23% Similarity=0.457 Sum_probs=204.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.+|+..+.||+|+||.||+|++. +++ .||+|.++.. .....+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46889999999999999999854 333 4899988653 334567899999999999999999999999764 5689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
++||+++|+|.+++..... .+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 9999999999999986543 4889999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCceee-eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHMT-TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
....... ....++..|+|||++.+..++.++||||||+++|||++ |+.||......+ +........
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~----- 228 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGE----- 228 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHhCCC-----
Confidence 4332221 12234678999999999999999999999999999998 999985432111 111111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+......+.+++.+||+.+|++||++.+++..|..+..
T Consensus 229 ----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 ----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 011112233568999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=323.73 Aligned_cols=252 Identities=27% Similarity=0.401 Sum_probs=203.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|.+.+.||+|+||+||+|...++..+|+|.++... ...++|.+|+.++++++||||+++++++.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777789999876432 334679999999999999999999999999888999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... .+++..+++++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999876432 5899999999999999999999998 9999999999999999999999999988664332222
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++..|++||.+.+..++.++||||||+++|||++ |+.||......+ .......... ..
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~-------~~~~~~~~~~---------~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE-------TVEKVSQGLR---------LY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHhcCCC---------CC
Confidence 222335678999999998889999999999999999998 998875332211 1111111110 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
.+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11123457899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=330.34 Aligned_cols=261 Identities=23% Similarity=0.338 Sum_probs=199.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|.+.++||+|+||+||+|... +++.||+|.++... ......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56889999999999999999965 58899999876432 23345788999999999999999999999998899999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++ +|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 974 89888865432 4789999999999999999999999 99999999999999999999999999976532221
Q ss_pred eeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc------------
Q 036483 552 HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE------------ 618 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------ 618 (721)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||......+. + .........
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--L-HLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--H-HHHHHHhCCCChHHhhccccc
Confidence 1223457899999999875 5689999999999999999999999865433221 1 111111100
Q ss_pred cchhhhhhhhhcc----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 DSLFEILDAHVLK----EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
........+.... ........+..+|+.+||+.||.+|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000000 000112346789999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=328.92 Aligned_cols=264 Identities=29% Similarity=0.460 Sum_probs=205.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-----CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-----DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~ 466 (721)
++|.+.+.||+|+||.||++... +++.||+|+++.......+.|.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57888999999999999999743 4789999998776666678899999999999999999999987543 4578
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999997543 25899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCceee--eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc----
Q 036483 547 AIDQTHMT--TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS---- 620 (721)
Q Consensus 547 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---- 620 (721)
........ ....++..|+|||++.+..++.++||||||++++||++|..++...... +...+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--------~~~~~~~~~~~~~ 230 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQM 230 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh--------hhhhccccccccc
Confidence 43322111 1112345699999999989999999999999999999987765322110 111111110
Q ss_pred ----hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 621 ----LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 621 ----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+.+.+............+.++.+++.+||+.+|++|||+.||++.|+.++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 01111111111112233457999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=327.49 Aligned_cols=255 Identities=27% Similarity=0.454 Sum_probs=206.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
++|.+.+.||+|+||.||+|...+ ++.||+|.++..... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 568888999999999999998643 478999988664433 4678999999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccC-----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 467 LVYEFIINGTLFQYLHDQN-----------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
+||||+++++|.++++... ....+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999997542 1245889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 613 (721)
||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE-------VI 234 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH
Confidence 99999999765332211 1222345788999999999999999999999999999998 999985433211 11
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+..+. ....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 235 ~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 235 ECITQGR---------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHHcCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111111 11112234466899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=328.35 Aligned_cols=261 Identities=25% Similarity=0.427 Sum_probs=210.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
.++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 356888999999999999999842 24568999887666666778999999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccC----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 467 LVYEFIINGTLFQYLHDQN----------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
+||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence 9999999999999987542 1235899999999999999999999998 99999999999999999999
Q ss_pred EeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHH
Q 036483 537 VSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 537 l~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 614 (721)
|+|||+++........ ......++..|+|||++.+..++.++||||||++++||++ |..||......+ ...
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~ 233 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIE 233 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 9999999865432211 1122335678999999999999999999999999999998 888875432211 112
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.+..+... ..+...+.++.+++.+||+.+|.+|||+.+|.+.|+++...
T Consensus 234 ~i~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 234 CITQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHHcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 22222111 11112345689999999999999999999999999988643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=321.57 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=204.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|++.++||+|+||.||++...++..+|+|.++.... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457889999999999999999988888899998765332 3467999999999999999999999875 45678999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.++++.... ..+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999976432 25899999999999999999999998 999999999999999999999999999766433222
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||.+.+..++.++||||||++++||++ |..||...... . ....+.. ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~-~~~~~~~---------~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------E-VLEQVER---------GYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------H-HHHHHHc---------CCCC
Confidence 2222335668999999998899999999999999999999 88888542211 1 1111111 1111
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
..+...+..+.+++.+||..+|++|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1223345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=333.75 Aligned_cols=263 Identities=27% Similarity=0.403 Sum_probs=205.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|++.+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 467999999999999999999976 5788999987653 23445689999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ .|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997643 5899999999999999999999863 2999999999999999999999999998765322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc------------
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE------------ 618 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------------ 618 (721)
......|+..|+|||++.+..++.++||||||+++|||++|+.||......+ +...+......
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 232 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR 232 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence 1233458999999999999999999999999999999999999986433211 11110000000
Q ss_pred ------------------cchhhhhhhh---hccc-CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 619 ------------------DSLFEILDAH---VLKE-ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 619 ------------------~~~~~~~~~~---~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
....+..+.. .... .......++.+|+.+||+.||++|||++|+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 0000000100 0000 1112446799999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=342.59 Aligned_cols=263 Identities=25% Similarity=0.404 Sum_probs=208.4
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcC-CCceeeEEEEEEe
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQIN-HRNVVKLLGCCLE 461 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~ 461 (721)
....++|.+.++||+|+||.||+|.... +..||||+++... ....+.+.+|++++++++ ||||+++++++.+
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 3445788999999999999999998531 3469999886533 334568999999999996 9999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCC-------------------------------------------------------
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNE------------------------------------------------------- 486 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------- 486 (721)
....+|||||+++|+|.++++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 9999999999999999998865311
Q ss_pred --------------------------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEE
Q 036483 487 --------------------------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNIL 528 (721)
Q Consensus 487 --------------------------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIl 528 (721)
...+++..+++++.|+++||+|||+.+ |+||||||+|||
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil 269 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL 269 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence 124788899999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccc
Q 036483 529 LDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDK 606 (721)
Q Consensus 529 l~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~ 606 (721)
+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--- 346 (400)
T cd05105 270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--- 346 (400)
T ss_pred EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh---
Confidence 9999999999999998664332211 222346788999999999999999999999999999997 88887543211
Q ss_pred cHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 607 SLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..+...+... .....+...+..+.+++.+||+.+|++|||+.+|.+.|+.+.
T Consensus 347 ---~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 347 ---STFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ---HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1111111111 111122334567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=322.42 Aligned_cols=255 Identities=23% Similarity=0.397 Sum_probs=206.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++|++.++||+|+||.||+|...+++.+|+|.+.... ...++|.+|+.++++++|+||+++++++. .+..+++|||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 346788999999999999999998889999999876433 33568999999999999999999999874 5568999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 82 MENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999999875432 36899999999999999999999998 99999999999999999999999999976653322
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......++..|+|||++....++.++||||||++++||++ |+.||......+ ....+... ..
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~ 221 (260)
T cd05067 158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE-------VIQNLERG---------YR 221 (260)
T ss_pred ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH-------HHHHHHcC---------CC
Confidence 22223345678999999999999999999999999999999 999986432111 11111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
...+...+.++.+++.+||+.+|++||++++++..|+.
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 222 MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11122234569999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.41 Aligned_cols=242 Identities=24% Similarity=0.320 Sum_probs=197.4
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
++||+|+||.||++... +++.||+|.+... .......+.+|+.+++.++||||+++++.+...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999965 5899999987542 3345678899999999999999999999999999999999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeee
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 555 (721)
+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~ 153 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK 153 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence 9998886543 5899999999999999999999999 9999999999999999999999999987543221 1223
Q ss_pred eeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCH
Q 036483 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635 (721)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (721)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+.... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~-~~~~~~~----------~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLF-ELILMED----------IKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHH-HHhccCC----------ccCCC
Confidence 356899999999999999999999999999999999999998643221 111 1111110 01122
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 636 EDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 636 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
....++.+++.+||+.+|++|| ++.|+++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 3345688999999999999997 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=327.24 Aligned_cols=257 Identities=28% Similarity=0.446 Sum_probs=204.5
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
..++|++.+.||+|+||.||+|... .+..||+|+..... .....+|.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999753 24679999875432 2345678999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCC-------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 465 PLLVYEFIINGTLFQYLHDQNE-------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
.++||||+++++|.++++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999875322 234688999999999999999999998 999999999999999999999
Q ss_pred eeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHH
Q 036483 538 SDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 538 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-------~~~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-------QVLRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-------HHHHH
Confidence 9999987654322211 112235678999999999999999999999999999999 68887543221 11111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
...... ...+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111111 1112233456899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=302.38 Aligned_cols=249 Identities=24% Similarity=0.344 Sum_probs=208.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|++.+.||+|.||.||.|+.+ ++..||+|.+... ......++.+|++|-+.|+||||++++++|.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 477999999999999999999965 5778999976442 233356789999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
+||.++|.|...|+.+... .+++.....++.|+|.||.|+|..+ ++||||||+|+|++.++.+||+|||.+..-.
T Consensus 101 lEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999999865433 6888899999999999999999999 9999999999999999999999999997543
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
........||..|.+||+..+...+.+.|+|++|++.||++.|.+||...... + .++.+..-. +
T Consensus 176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------e-tYkrI~k~~---~---- 239 (281)
T KOG0580|consen 176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------E-TYKRIRKVD---L---- 239 (281)
T ss_pred --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------H-HHHHHHHcc---c----
Confidence 22334567999999999999999999999999999999999999999643311 1 111121111 1
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.++.......+++|.+|+..+|.+|.+..|+++.
T Consensus 240 ---~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 240 ---KFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ---cCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1223445568999999999999999999999875
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=320.34 Aligned_cols=269 Identities=25% Similarity=0.356 Sum_probs=211.7
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecc--ccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-----
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSK--VIDESKVDEFINEVAILSQINHRNVVKLLGCCLE----- 461 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----- 461 (721)
..+...|...+.||+|+||.|..+..+ +|+.||||++. .......++..+|+++|+.++|+||+.+++.+..
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 344566777899999999999999965 58999999987 3556678889999999999999999999999875
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
-+..|+|+|+| +.+|...++.+. .|+......+..|+++||+|+|+.+ |+||||||+|+|++.+..+||+|||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 34669999999 778999998664 5999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccC-CceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 542 ASRSMAID-QTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 542 ls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+||..... .....+.+..|.+|.|||.+.. ..||.+.||||.||+|.||++|++.|.+.+..++-.+.........++
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987532 2223466778999999998865 579999999999999999999999998877554433333222211111
Q ss_pred chhhhhhhhh---c-----------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 SLFEILDAHV---L-----------KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~~~~~~~~~~---~-----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+..+-.... . ...-+...+...+|+.+||..||.+|+|++|.++.
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111110000 0 00111233567899999999999999999999775
|
|
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=321.39 Aligned_cols=251 Identities=28% Similarity=0.425 Sum_probs=202.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
.+|.+.+.||+|+||.||++..+++..+|+|...... ...+.|.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3477889999999999999998877789999875422 234578899999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999975433 5899999999999999999999999 9999999999999999999999999997654322211
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ........ ....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAG---------YRLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH-------HHHHHHcC---------CcCC
Confidence 122224467999999999999999999999999999999 788885432211 11111111 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.+...+.++.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1223456799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=331.72 Aligned_cols=241 Identities=25% Similarity=0.306 Sum_probs=195.2
Q ss_pred EeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||+|+||.||++... +++.||+|.++.. .......+.+|+.++.+++||||+++++.+.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 4789999987542 344567788999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 557 (721)
.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 99997643 5899999999999999999999999 9999999999999999999999999997543222 223345
Q ss_pred ecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 558 ~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
.||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+..... .. ...+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~-~~----------~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ-EP----------LRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc-CC----------CCCCCcC
Confidence 689999999999999999999999999999999999999864321 111111111 11 1122234
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
+.++.+++.+||+.+|++||++..+.+.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 45689999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=320.89 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=204.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|.+.++||+|+||.||+|...+...||+|+++... ...+.|.+|++++++++|+||+++++.+. .+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35689999999999999999998777789999887532 23467899999999999999999999875 45679999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... ..+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999976432 25899999999999999999999998 999999999999999999999999999866433322
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||++.+..++.++||||||+++|||++ |+.||...... .. ....... ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~----~~~~~~~---------~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EV----LDQVERG---------YRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HH----HHHHhcC---------CCC
Confidence 2223346678999999999999999999999999999999 77787533211 11 1111110 011
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
..+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12234556789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.19 Aligned_cols=259 Identities=25% Similarity=0.416 Sum_probs=210.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.+|.+.+.||+|+||.||++... ++..+++|..+.......+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999743 345789998876666666789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc
Q 036483 468 VYEFIINGTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR 534 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 534 (721)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999997532 1235899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHH
Q 036483 535 AKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 535 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 612 (721)
+||+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||......+ .
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~ 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------H
Confidence 99999999976543221 11223346788999999999999999999999999999999 999875432211 1
Q ss_pred HHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 613 LRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
...+...... ......+..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 235 IECITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HHHHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 1122222111 1122345678999999999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=326.90 Aligned_cols=261 Identities=26% Similarity=0.373 Sum_probs=195.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc--CCcEEEEeeccccC--chhhHHHHHHHHHHhhc---CCCceeeEEEEEEe-----
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA--DGRIVAIKKSKVID--ESKVDEFINEVAILSQI---NHRNVVKLLGCCLE----- 461 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~----- 461 (721)
++|.+.+.||+|+||+||+|... +++.||+|+++... ......+.+|+.+++++ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46889999999999999999863 46889999875432 22344667788877766 69999999999863
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
....++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345789999996 689888875432 25899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE--- 618 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 618 (721)
+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ ...........
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~---~~~~i~~~~~~~~~ 230 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLPGE 230 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH---HHHHHHHHhCCCCh
Confidence 99765432 22334568999999999999999999999999999999999999987543321 11111111100
Q ss_pred cchh-------hhhhhh---hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 DSLF-------EILDAH---VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ~~~~-------~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.... ...... .........+..+.+++.+||+.+|++|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 000000 000111123456789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=324.52 Aligned_cols=256 Identities=25% Similarity=0.435 Sum_probs=204.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-----cCCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
+.|++.+.||+|+||.||+|.. .+++.+++|.++... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4578889999999999999984 246789999886533 3345788999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCC--------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 468 VYEFIINGTLFQYLHDQNE--------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+++ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 235889999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHH
Q 036483 534 RAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 611 (721)
.+||+|||+++....... .......++..|+|||++.+..++.++||||||++++||++ |..||...... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~ 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------E 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------H
Confidence 999999999986543221 11222335678999999998899999999999999999998 88887533211 1
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
.......... ...+...+..+.+++.+||+.+|++||++.+|++.|..
T Consensus 235 ~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 VIEMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 11222334568999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=317.78 Aligned_cols=269 Identities=24% Similarity=0.353 Sum_probs=204.5
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhh--cCCCceeeEEEEEEeCC----
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQ--INHRNVVKLLGCCLETE---- 463 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~g~~~~~~---- 463 (721)
..+..+..+.+.||+|.||+||+|.++ |..||||++...++ +.|.+|.+|.+. |+|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 455677888999999999999999996 78899999875543 678899999886 49999999998865443
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-----cCCCCeeeccCcCccEEECCCCcEEEe
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-----AASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-----~~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
..|||++|.+.|+|++||.+. .++....++++..+|.||++||- +|.|.|.|||||+.|||+..++..-|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 568999999999999999874 59999999999999999999995 578889999999999999999999999
Q ss_pred eccCccccccCCcee---eeeeecCCCCCCccccccCC----CC--ccccchhHHHHHHHHHhCC----------ccccc
Q 036483 539 DFGASRSMAIDQTHM---TTQVQGTFGYLDPEYFRSSR----FT--EKSDVYSFGVVLAELLTGE----------RAIRV 599 (721)
Q Consensus 539 DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~t--~ksDV~SlGvll~elltG~----------~p~~~ 599 (721)
|+|||.....+.... .....||.+|||||++.... +. ..+||||||.++||+.-+. .||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999997665443222 23456999999999987542 21 2589999999999997542 23221
Q ss_pred CCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.-.. +...+...+.+-.+++...+. ....+.+....+.+|++.||..||..|-|+--|-+.|.++..
T Consensus 439 ~Vp~--DPs~eeMrkVVCv~~~RP~ip---nrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPS--DPSFEEMRKVVCVQKLRPNIP---NRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCC--CCCHHHHhcceeecccCCCCC---cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 1111 111111111111111111111 122456677889999999999999999999999999988753
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=334.87 Aligned_cols=262 Identities=29% Similarity=0.453 Sum_probs=205.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC-
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCLET- 462 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~- 462 (721)
..++|.+.+.||+|+||.||+|... .++.||+|+++... ....+.+.+|+.++.++ +|+||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3467999999999999999999742 24789999876432 33456788999999999 899999999988754
Q ss_pred CcceEEEeeccCCCcchhccccCC--------------------------------------------------------
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNE-------------------------------------------------------- 486 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------------------------------------------- 486 (721)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 456799999999999998864221
Q ss_pred --CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-eeeeecCCCC
Q 036483 487 --EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGY 563 (721)
Q Consensus 487 --~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y 563 (721)
...++|..+.+++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 126899999999999999999999998 9999999999999999999999999998764332222 2233466789
Q ss_pred CCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHH
Q 036483 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVA 642 (721)
Q Consensus 564 ~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (721)
+|||++.+..++.++||||||++|+||++ |..||......+ .+...+..... ...+.....++.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLKEGTR---------MRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHhccCC---------CCCCccCCHHHH
Confidence 99999999999999999999999999998 999986432211 11112211111 111223345689
Q ss_pred HHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 643 KLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 643 ~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+++.+||+.+|++||++.||+++|+.+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=333.56 Aligned_cols=260 Identities=27% Similarity=0.474 Sum_probs=220.6
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcC---C--cEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLAD---G--RIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
+...+.....++||+|.||.||+|...+ | -.||||..+. ......+.|+.|..+|++++||||++|+|+|.+.
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence 3334455567899999999999998543 2 2589998877 4556688999999999999999999999999764
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..|||||..+.|.|..||+.++. .|+......++.||..||+|||+.. +|||||..+|||+...--+||+|||++
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchh
Confidence 56999999999999999998765 4899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchh
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
|.+..+..+......-...|||||.+.-.+++.+||||.|||.+||++. |.+||.+....+ +.
T Consensus 539 R~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI 602 (974)
T KOG4257|consen 539 RYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VI 602 (974)
T ss_pred hhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eE
Confidence 9987766655555556788999999999999999999999999999988 999997543221 12
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
-.++.+-+...++.+++.+..|+.+||..+|.+||.+.|+...|..+..
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 2233334456678889999999999999999999999999999987764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.49 Aligned_cols=252 Identities=23% Similarity=0.303 Sum_probs=200.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc----CCcEEEEeecccc----CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVI----DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
+|++.+.||+|+||.||+++.. +++.||+|.+... .....+.+.+|+.++.++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4788899999999999998853 5789999987542 223456788999999999 599999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999987543 5899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
+............||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ...+...+...
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~~~~~~~~~----- 226 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT---QSEVSRRILKC----- 226 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC---HHHHHHHHhcC-----
Confidence 544333333445699999999999875 478899999999999999999999864332211 11111111110
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
+ ...+......+.+++.+||+.||++|| +++++++.
T Consensus 227 -~----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 -D----PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred -C----CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 0 111223345688999999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=320.23 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=209.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+|+.. +++.||||.++. .+......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57899999999999999999965 688999997654 23344567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998886432 2235889999999999999999999998 99999999999999999999999999886643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .... ...+.....
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~-~~~~~~~~~------- 225 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSL-CQKIEQCDY------- 225 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHH-HHHHhcCCC-------
Confidence 221 112345788999999999888999999999999999999999998532211 1111 111111110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
........+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 226 -~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 -PPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred -CCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 01112234467899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=333.53 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC--CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD--GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|.+.+.||+|+||.||+|...+ +..||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568999999999999999998543 368999987542 23456678999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 109 v~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999997654 5899999999999999999999999 9999999999999999999999999998653
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~------~-~~~~i~~~~~------ 245 (340)
T PTZ00426 183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL------L-IYQKILEGII------ 245 (340)
T ss_pred CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH------H-HHHHHhcCCC------
Confidence 22 23356899999999999999999999999999999999999998643211 1 1111111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+......+.+++.+||+.+|++|+ +++++++.
T Consensus 246 ----~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 246 ----YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 11222334578999999999999995 78887665
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=321.85 Aligned_cols=268 Identities=24% Similarity=0.309 Sum_probs=207.4
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--------------chhhHHHHHHHHHHhhcC
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--------------ESKVDEFINEVAILSQIN 448 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------~~~~~~~~~E~~il~~l~ 448 (721)
+...+-.+..++|.+.+.||+|.||.|-+|+.. +++.||||++.... ....+...+||.||++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 333344455688999999999999999999954 68999999764321 112457899999999999
Q ss_pred CCceeeEEEEEEe--CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 449 HRNVVKLLGCCLE--TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 449 h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
|||||+|+.+..+ .+..|||+||+..|.+.+.-.... .+++.++++++.++..||.|||.++ ||||||||+|
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~---els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsN 240 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP---ELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSN 240 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcc---cccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhh
Confidence 9999999999875 457899999999998766443221 2999999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCC----ceeeeeeecCCCCCCccccccCC----CCccccchhHHHHHHHHHhCCcccc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQ----THMTTQVQGTFGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGERAIR 598 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SlGvll~elltG~~p~~ 598 (721)
+||++++++||+|||.+....... ........||+.|+|||...++. .+.+.||||+||+||-|+.|+.||.
T Consensus 241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 999999999999999997663211 11112256999999999998742 3467899999999999999999985
Q ss_pred cCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 599 VTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.. .....+. ++..+. +.....++.-+.+.+||+++|..||++|.+..+|..+..-.+..
T Consensus 321 ~~------~~~~l~~-KIvn~p--------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 321 DD------FELELFD-KIVNDP--------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred cc------hHHHHHH-HHhcCc--------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 32 2222222 222222 22222334556789999999999999999999998888655543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.90 Aligned_cols=269 Identities=27% Similarity=0.413 Sum_probs=204.1
Q ss_pred cCC-CCCceEeeeCcEEEEEEEE-----cCCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC--c
Q 036483 394 DHY-NTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE--V 464 (721)
Q Consensus 394 ~~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~--~ 464 (721)
++| ...+.||+|+||+||++.. .+++.||+|..+... ....+.|.+|++++++++||||+++++++.+.+ .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 7889999999999988652 357789999876533 234578899999999999999999999987643 5
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 68999999999999998754 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 545 SMAIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 545 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
......... .....++..|+|||.+....++.++||||||++++||++|..|+........ ..............+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence 664322111 1122356679999999988999999999999999999999998754321100 0000000000011111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+.++.......+...+.++.+++.+||+.+|++|||+++|++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 122222112223334567999999999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=331.03 Aligned_cols=242 Identities=25% Similarity=0.312 Sum_probs=196.9
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
++||+|+||.||+++.. +|+.||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999965 5899999987642 3345567889999999999999999999999999999999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeee
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 555 (721)
+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9998887543 5899999999999999999999998 9999999999999999999999999987542221 1223
Q ss_pred eeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCH
Q 036483 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635 (721)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (721)
...||+.|+|||++.+..++.++||||||+++|||++|+.||....... .+.... ... ...+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~-~~~----------~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELIL-MEE----------IRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCC----------CCCCC
Confidence 3568999999999999999999999999999999999999985432211 111111 110 01122
Q ss_pred HHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 636 EDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 636 ~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+.++.+++.+||+.+|++|| ++.++++.
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 3345689999999999999998 78887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=326.15 Aligned_cols=263 Identities=27% Similarity=0.408 Sum_probs=209.6
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCL 460 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~ 460 (721)
++...++|++.+.||+|+||.||++...+ ...+|+|..... ......++.+|+.++.++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 44455678899999999999999998642 367999987653 334456789999999999 8999999999999
Q ss_pred eCCcceEEEeeccCCCcchhcccc-------------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQ-------------NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
..+..+++|||+++++|.++++.. .....+++..+++++.|++.||+|||+.+ |+||||||+||
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Ni 163 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNV 163 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeE
Confidence 999999999999999999998653 12346899999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEED 605 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~ 605 (721)
|+++++.+||+|||+++.+....... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 242 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE- 242 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence 99999999999999998764332211 122235678999999999999999999999999999998 888875332211
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
....+.... ....+...+..+.+|+.+||..+|++|||+.|+++.|+.+.
T Consensus 243 ------~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 ------LFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred ------HHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111111111 11122334456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=302.59 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=213.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-----c
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV-----P 465 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~-----~ 465 (721)
..++|.+.+.||+|||+-||.++ ..+++.+|+|++.....++.+..++|++..++++|||+++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 45789999999999999999999 66789999999988777888999999999999999999999988765443 7
Q ss_pred eEEEeeccCCCcchhccccCCC-CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEE-FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
||+++|...|+|.+.+...+.+ ..+++.+.++|+.+|.+||++||+..+ |++||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999864433 379999999999999999999999875 69999999999999999999999999987
Q ss_pred ccccCCceee--------eeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 545 SMAIDQTHMT--------TQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 545 ~~~~~~~~~~--------~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
.....-.... ..-.-|..|.|||.+. +...++++|||||||+||+|+.|..||...-.
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~----------- 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ----------- 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----------
Confidence 6542211110 1123688999999986 44678999999999999999999999853221
Q ss_pred HHhhccch-hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 614 RAMKEDSL-FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 614 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..+.+ ..+....+........++.+.+++++||+.||.+||++.+++..++.+.
T Consensus 247 ---~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 247 ---QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred ---cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 11111 1112222222222235677999999999999999999999999998764
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=336.54 Aligned_cols=260 Identities=22% Similarity=0.265 Sum_probs=198.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||.||++... .++.||+|+.. .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 357999999999999999999965 58899999643 24578999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+. ++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 84 68888876543 5899999999999999999999998 99999999999999999999999999975432222
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc----ccHHHHHHHHhhcc--------
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED----KSLAAYFLRAMKED-------- 619 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~----~~~~~~~~~~~~~~-------- 619 (721)
.......||+.|+|||++.+..++.++||||||+++|||++|+.|+........ ..............
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 223345699999999999999999999999999999999999988653321110 00111111110000
Q ss_pred --chhhhh----hhhhc--c-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 --SLFEIL----DAHVL--K-----EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 --~~~~~~----~~~~~--~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+.+.. ..... . ......+.++.+|+.+||+.||++|||++|+++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000 00000 0 0011235578999999999999999999999753
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.59 Aligned_cols=264 Identities=25% Similarity=0.387 Sum_probs=196.7
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----cce
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----VPL 466 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~~~ 466 (721)
+|++.++||+|+||.||+|+.. +++.||||+++.. .......+.+|+.++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5788899999999999999965 5899999987642 2334567899999999999999999999886433 468
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+. ++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68888886543 5899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCce--eeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH--------HHH
Q 036483 547 AIDQTH--MTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--------FLR 614 (721)
Q Consensus 547 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~--------~~~ 614 (721)
...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||.............. ...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 322211 1233568999999999876 6789999999999999999999999865432110000000 000
Q ss_pred Hhhccchhhhhh---hhhcc---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 615 AMKEDSLFEILD---AHVLK---EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 615 ~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+......+.+. ..... +.....+..+.+++.+||+.+|++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000000000000 00000 0001123567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=325.17 Aligned_cols=263 Identities=22% Similarity=0.334 Sum_probs=197.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||.||+|+.. +++.||||.++... ......+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999976 58899999876533 2234567899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+. ++|.+++.... ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 67877776543 25889999999999999999999999 9999999999999999999999999987543221
Q ss_pred ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc---hhh---
Q 036483 551 THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS---LFE--- 623 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 623 (721)
.......+++.|+|||++.+ ..++.++||||||+++|||++|+.||....... .............. ...
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhh
Confidence 11233458899999999875 458889999999999999999999996532211 11111111110000 000
Q ss_pred --hhhhhhc---ccCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 --ILDAHVL---KEAS-------QEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 --~~~~~~~---~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+... .... ...+..+.+|+.+||+.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 0000000 0000 011245789999999999999999999976
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=347.41 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=204.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-C-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-D-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..|.+.+.||+|+||.||+|... + ++.||+|.....+......+.+|+.+|+.++||||+++++++...+..+|||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34889999999999999999854 3 577888877655555667788999999999999999999999999999999999
Q ss_pred ccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++|+|.+++... ....++++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988642 23346899999999999999999999998 9999999999999999999999999998764322
Q ss_pred c-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 551 T-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 551 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... ....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~~~~~-~~~~-------- 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIMQQVL-YGKY-------- 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHH-hCCC--------
Confidence 1 1233456999999999999999999999999999999999999998543211 1111111 1110
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+...+.++.+++.+||+.+|++||++.+++.
T Consensus 289 -~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 -DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred -CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1112223456899999999999999999999864
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=315.92 Aligned_cols=247 Identities=27% Similarity=0.435 Sum_probs=199.6
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcc
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLF 478 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 478 (721)
++||+|+||.||+|...+++.+|+|...... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 4799999999999998889999999876543 333457899999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeee
Q 036483 479 QYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558 (721)
Q Consensus 479 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~ 558 (721)
+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99875432 5889999999999999999999998 999999999999999999999999998754322211112223
Q ss_pred cCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 559 gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
++..|+|||++.+..++.++||||||+++|||++ |..||....... ........ .....+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKG---------YRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHHcC---------CCCCCCCCC
Confidence 4677999999999999999999999999999998 888885432111 11111111 011112234
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=319.22 Aligned_cols=255 Identities=25% Similarity=0.442 Sum_probs=202.4
Q ss_pred CCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-----
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV----- 464 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~----- 464 (721)
|.+.+.||+|+||.||+|.... +..||+|+++.. .....+.+.+|+.+++.++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998653 367999987643 23456789999999999999999999999876554
Q ss_pred -ceEEEeeccCCCcchhccccC---CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 465 -PLLVYEFIINGTLFQYLHDQN---EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 465 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
.++++||+++++|..++.... ....+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999985432 2246899999999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhc
Q 036483 541 GASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 541 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
|+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... . ....+..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~-~~~~~~~ 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------E-IYDYLRH 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHHHc
Confidence 9998664332221 112235678999999998999999999999999999999 88887532211 1 1111111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.. ....+...+.++.+++.+||+.+|++|||+.||++.|+++
T Consensus 231 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN---------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC---------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11 1112233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=337.38 Aligned_cols=252 Identities=23% Similarity=0.333 Sum_probs=204.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||+||+++.. +++.||||+++.. .....+.+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999976 6899999987642 2345677899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999997652 6899999999999999999999998 999999999999999999999999999866433
Q ss_pred C----------------------------ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCC
Q 036483 550 Q----------------------------THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601 (721)
Q Consensus 550 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~ 601 (721)
. ........||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112233468999999999999999999999999999999999999986543
Q ss_pred ccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHH
Q 036483 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-MKEVAVV 665 (721)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~ 665 (721)
..+ ......... ...........+.++.+++.+||. +|++||+ +.++++.
T Consensus 235 ~~~------~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQE------TYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHH------HHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 211 111111100 000000111134568899999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=334.08 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=202.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
..++|.+.++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3567999999999999999999965 5889999987542 23344567899999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999998653 4788889999999999999999998 9999999999999999999999999998664
Q ss_pred cCCceeeeeeecCCCCCCccccccC----CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSS----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
...........||+.|+|||++.+. .++.++||||||+++|||++|+.||...... ..+...+.......
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~~ 267 (370)
T cd05596 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNSLT 267 (370)
T ss_pred CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCcCC
Confidence 3322222345699999999998754 4788999999999999999999998643321 11111111110000
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVV 665 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 665 (721)
.......+.++.+++.+||+.+|++ ||++.|++..
T Consensus 268 -------~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 268 -------FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -------CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0011123456889999999999988 9999999765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=318.49 Aligned_cols=256 Identities=25% Similarity=0.413 Sum_probs=208.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++|.+.++||+|+||.||+|..++++.+|||.+.... ...+++.+|+.++++++|+||+++++++......++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 357899999999999999999998888899999876432 3456899999999999999999999999988899999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 83 MSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred cCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999976432 35899999999999999999999998 99999999999999999999999999976643222
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......++..|+|||.+.+..++.++||||||++++||++ |+.||...... .. ...+... ..
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~----~~~~~~~---------~~ 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EV----LEQVERG---------YR 222 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HH----HHHHHcC---------CC
Confidence 21222335678999999999899999999999999999998 99988543211 11 1111110 01
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
...+...+.++.+++.+||+.+|++||+++++.+.|+.
T Consensus 223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11122235578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=321.64 Aligned_cols=260 Identities=24% Similarity=0.404 Sum_probs=209.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-CCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLE-TEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~~~~ 465 (721)
.++|.+.++||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 5678899999999999999999765 678999987643 34456778999999999999999999998876 4678
Q ss_pred eEEEeeccCCCcchhccccCCC-----CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 466 LLVYEFIINGTLFQYLHDQNEE-----FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
++++||+++++|.+++...... ..+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998764322 46899999999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhc
Q 036483 541 GASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 541 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...... .+. ..+..
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~----~~~~~ 234 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMA----AYLKD 234 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHH----HHHHc
Confidence 9998764333221 122345778999999999999999999999999999999 99998543211 111 11111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+. ........+.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 235 ~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 GY---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred CC---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 10 001112234568999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.29 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=205.2
Q ss_pred CCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
+|.+.++||+|+||.||+|... ....+++|.+.... ....+++.+|+.+++.++||||+++++.+.+.+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999853 23578888776432 3445789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccC---------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 468 VYEFIINGTLFQYLHDQN---------------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
++||+.+++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999886421 1235889999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEE 604 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~ 604 (721)
||+++++.+||+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997654322211 122345678999999998899999999999999999998 998885432111
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....... ......+...+.++.+++.+||+.+|++||++.|+++.|+++..
T Consensus 238 -------~~~~~~~---------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 -------LFNLLKT---------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -------HHHHHhC---------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1111111 11111122334568999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=316.60 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=203.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|.+.+.||+|++|.||++...++..+|+|...... ...+.+.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5688889999999999999998777789999875432 23467899999999999999999999875 456789999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.++++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 9999999976432 35899999999999999999999998 9999999999999999999999999997664332222
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+... ....
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 223 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VLEQVERG---------YRMP 223 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------CCCC
Confidence 222346678999999999999999999999999999999 888885432111 11111111 0111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
.+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 223345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.64 Aligned_cols=259 Identities=25% Similarity=0.419 Sum_probs=210.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+|... +++.+|+|.++. .+....+.+.+|++++++++|+||+++++.+.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999976 789999997753 23344678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986532 2346899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ..... ........
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~-~~~~~~~~-------- 224 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSL-CKKIEKCD-------- 224 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHH-HhhhhcCC--------
Confidence 221 12234588899999999998999999999999999999999999853321 11111 11111111
Q ss_pred hcccCCH-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 629 VLKEASQ-EDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 629 ~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
....+. ..+..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus 225 -~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 225 -YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred -CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111112 34457899999999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=328.09 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=197.3
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999965 5889999987642 234456788999999998 799999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
|+|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence 99998886543 6999999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccc--cccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE--DKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence 34568999999999999999999999999999999999999996433222 11111222222222111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCC------HHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPT------MKEVAV 664 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt------~~ev~~ 664 (721)
.+...+.++.+++.+||+.+|++||+ +.++++
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 12223456899999999999999998 566654
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.01 Aligned_cols=262 Identities=27% Similarity=0.399 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|++.++||+|+||.||++... ++..+|+|.+... .....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999976 5788999977653 33445679999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 999999999997643 5889999999999999999999853 2999999999999999999999999998765322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh-------------
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK------------- 617 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------------- 617 (721)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ...+.....
T Consensus 158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 232 (333)
T cd06650 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL---ELMFGCPVEGDPAESETSPRPR 232 (333)
T ss_pred --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH---HHHhcCcccCCccccccCcccC
Confidence 12234589999999999998999999999999999999999999864332110 000000000
Q ss_pred ---------------ccchhhhhhhhhc---ccC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 618 ---------------EDSLFEILDAHVL---KEA-SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 618 ---------------~~~~~~~~~~~~~---~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
......+.+.... ... ......++.+|+.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h 299 (333)
T cd06650 233 PPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH 299 (333)
T ss_pred CccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence 0000000110000 000 01123568999999999999999999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=326.81 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=194.2
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHH---hhcCCCceeeEEEEEEeCCcceEE
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAIL---SQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il---~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
|.+.+.||+|+||.||++... +++.||||.++.. .....+.+.+|+.++ ++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999865 5889999987642 233456677777665 466899999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|..+++.. .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999998888643 5899999999999999999999999 99999999999999999999999999875432
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .+ ..+.....
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~~-~~i~~~~~------- 218 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------VF-DSIVNDEV------- 218 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------HH-HHHHhCCC-------
Confidence 22 12234568999999999999999999999999999999999999986433211 11 11111110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 664 (721)
..+...+..+.+++.+||+.+|++||+ +.++++
T Consensus 219 ---~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 219 ---RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred ---CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 112223456889999999999999994 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=337.49 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=209.0
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcC-CCceeeEEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQIN-HRNVVKLLGCC 459 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~g~~ 459 (721)
+++...++|.+.++||+|+||.||+|++.+ ++.||+|+++... ....+.+.+|+++|.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 355556778899999999999999998642 4589999987532 333457899999999997 99999999999
Q ss_pred EeCCcceEEEeeccCCCcchhccccCC-----------------------------------------------------
Q 036483 460 LETEVPLLVYEFIINGTLFQYLHDQNE----------------------------------------------------- 486 (721)
Q Consensus 460 ~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------- 486 (721)
...+..++||||+++|+|.+++++...
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred ------------------------------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcC
Q 036483 487 ------------------------------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524 (721)
Q Consensus 487 ------------------------------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~ 524 (721)
...+++..+++++.|++.||+|||+.+ |+||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 124778889999999999999999988 99999999
Q ss_pred ccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCc
Q 036483 525 TNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNF 602 (721)
Q Consensus 525 ~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~ 602 (721)
+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 9999999999999999999865322211 1122346788999999999899999999999999999998 8888754321
Q ss_pred cccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 603 EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
.+ .....+..+ .....+...+.++.+|+.+||+.+|++||+++||++.|+.+.
T Consensus 348 ~~------~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NE------QFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hH------HHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 111111111 111112223457999999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=333.39 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=194.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|+..++||+|+||.||+++.. +++.||||.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 44566789999999999999965 5899999987543 233456789999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.... .+.+..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 9999986532 3567788899999999999999999 99999999999999999999999999987642211
Q ss_pred eeeeeeecCCCCCCccccccC-----CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
......||..|+|||++... ..+.++||||||+++|||++|+.||......+ ...........
T Consensus 224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~-------- 291 (353)
T PLN00034 224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLMCAICMS-------- 291 (353)
T ss_pred -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHHHHHhcc--------
Confidence 12334689999999987532 34468999999999999999999986322211 11111000000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...........++.+|+.+||+.+|++|||+.|+++.
T Consensus 292 --~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 292 --QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred --CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111222344568999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=335.47 Aligned_cols=255 Identities=23% Similarity=0.322 Sum_probs=200.9
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
...++|++.++||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34578999999999999999999976 478999998753 22334556889999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999998653 4788999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecCCCCCCccccccCC----CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
............||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... ...+...+......
T Consensus 193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~------~~~~~~i~~~~~~~ 266 (370)
T cd05621 193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL------VGTYSKIMDHKNSL 266 (370)
T ss_pred ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH------HHHHHHHHhCCccc
Confidence 433222233456999999999997643 78899999999999999999999964332 11122111111100
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVV 665 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 665 (721)
. ..........+.+++.+||..++.+ ||++.|++++
T Consensus 267 ~-------~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 267 N-------FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred C-------CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0 0111123456788999999855543 8899998776
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.22 Aligned_cols=253 Identities=21% Similarity=0.291 Sum_probs=203.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||+||++... +++.||+|.++.. .....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46889999999999999999965 5889999987652 2335567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.+... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999976532 5899999999999999999999999 999999999999999999999999999876544
Q ss_pred CceeeeeeecCCCCCCccccc------cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFR------SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..+...+.......
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 229 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQRFLK 229 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCCCccC
Confidence 333334456899999999987 456789999999999999999999998643321 11222111111110
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ......+..+.+|+.+||+ +|++|||+.+++..
T Consensus 230 ~-------~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 230 F-------PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred C-------CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0 0111234568899999998 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=315.89 Aligned_cols=246 Identities=28% Similarity=0.429 Sum_probs=197.1
Q ss_pred eEeeeCcEEEEEEEEc---CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 401 ILGQGGQGTVYKGMLA---DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
.||+|+||.||+|.++ +++.+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999753 47889999876432 334678999999999999999999999875 45678999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee-
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT- 554 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~- 554 (721)
+|.+++.... .+++..+++++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999987543 5899999999999999999999998 99999999999999999999999999987643332211
Q ss_pred -eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 555 -TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 555 -~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
....++..|+|||.+....++.++||||||+++|||++ |+.||......+ ....+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~~~i~~~~---------~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGE---------RME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCC---------CCC
Confidence 12234578999999988889999999999999999998 999986432111 111222111 111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.+...+.++.+++.+||+.+|++||++.+|.+.|++.
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2233456789999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=323.74 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=204.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-C--cEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-G--RIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
++|++.++||+|+||.||+|...+ + ..+++|.++.. .....+.+.+|++++.++ +||||+++++++.+....++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999998754 3 24788877643 334557899999999999 799999999999999999999
Q ss_pred EeeccCCCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 469 YEFIINGTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
|||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999996532 1125889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 614 (721)
||+|||++...... ........+..|+|||++.+..++.++||||||+++|||++ |..||......+ .+ .
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~-~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LY-E 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-H
Confidence 99999998643211 11111123457999999999999999999999999999997 999985432211 11 1
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
..... .....+...+..+.+|+.+||+.+|.+||++.+|++.|+.+....
T Consensus 230 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 KLPQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred HHhcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 111112234456899999999999999999999999998887544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=316.29 Aligned_cols=256 Identities=23% Similarity=0.398 Sum_probs=206.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++|.+.+.||+|+||.||++...++..+|+|..+.. ....+.+.+|++++++++|+||+++++.+.+ ...+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35678999999999999999999877888999987643 3345789999999999999999999999887 778999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 157 (260)
T cd05073 82 MAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY 157 (260)
T ss_pred CCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence 999999999976432 36889999999999999999999998 99999999999999999999999999976543222
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......++..|+|||++....++.++||||||+++++|++ |+.||....... ......... .
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~~---------~ 221 (260)
T cd05073 158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGY---------R 221 (260)
T ss_pred ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhCCC---------C
Confidence 22222345678999999998899999999999999999999 888885432111 111111111 1
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.+.....+.++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 222 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 222 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 111223445689999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=321.24 Aligned_cols=255 Identities=26% Similarity=0.403 Sum_probs=205.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.+|...++||+|+||.||++... ++..+|+|..+.......+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 56778899999999999999742 356899998877666667889999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 468 VYEFIINGTLFQYLHDQNE------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
+|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999875431 125899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 613 (721)
||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~ 234 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 234 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH-------HH
Confidence 999999997654322211 122335678999999999999999999999999999998 888875322111 01
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
...... .....+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 235 ~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 235 ECITQG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHHcC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111111 011112234456899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.07 Aligned_cols=242 Identities=26% Similarity=0.351 Sum_probs=195.7
Q ss_pred ceEeeeCcEEEEEEEEc----CCcEEEEeecccc----CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLA----DGRIVAIKKSKVI----DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++||+|+||.||+++.. .++.||+|.++.. +......+.+|+.+|++++||||+++++.+.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 4789999987642 223445678999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.... .+.+..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 99999999987643 5788899999999999999999999 99999999999999999999999999875432221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+.... .
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~-~~~~~~~----------~ 217 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTI-DKILKGK----------L 217 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCC----------C
Confidence 223356899999999999989999999999999999999999998643221 111 1111111 1
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+......+.+++.+||+.+|++|| ++.+++..
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 11222345689999999999999999 78887664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=315.13 Aligned_cols=247 Identities=26% Similarity=0.416 Sum_probs=197.0
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
+.||+|+||.||+|+.. +++.+|+|..... .......+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999965 6889999976542 334457799999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee-ee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-TQ 556 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~-~~ 556 (721)
.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.......... ..
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 99987543 25899999999999999999999998 99999999999999999999999999875432111110 11
Q ss_pred eecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCH
Q 036483 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635 (721)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (721)
...+..|+|||.+.+..++.++||||||+++|||++ |..|+....... ..... ........+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~-------~~~~~---------~~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAI---------EQGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH-------HHHHH---------HcCCCCCCcc
Confidence 123456999999999999999999999999999998 888874322111 11111 1111112223
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 636 EDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 636 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+..+.+++.+||+.+|++|||+.+|++.|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 34567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=317.46 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=205.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-C---cEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-G---RIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|+..+.||+|+||.||+|.... + ..+|+|..+.. .....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 3568888999999999999999753 3 37999987654 34456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999997643 25899999999999999999999998 9999999999999999999999999997664
Q ss_pred cCCceeee--eeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 548 IDQTHMTT--QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 548 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
........ ....+..|+|||++....++.++||||||+++|||++ |+.||...... . +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~-~~~~i~~~----- 226 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------E-VMKAINDG----- 226 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------H-HHHHHhcC-----
Confidence 32221111 1123457999999998899999999999999999998 99998543211 1 11111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.........+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223446789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=319.72 Aligned_cols=256 Identities=23% Similarity=0.383 Sum_probs=201.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|...+.||+|+||+||+|.+. +++ .+++|...... .....++..|+.++++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 45778899999999999999964 344 47778765432 2345678889999999999999999998754 45689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
++||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999976432 5899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+..+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEKGER---- 229 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHCCCc----
Confidence 33221 2233456788999999999999999999999999999998 998885432211 1111111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
...+......+.+++.+||..+|++|||+.|+++.|..+..
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 230 -----LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 01111123457889999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=314.68 Aligned_cols=251 Identities=29% Similarity=0.477 Sum_probs=206.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|.+.+.||+|+||.||++... ++.||+|..+.... ..+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 356888999999999999999875 78899998875443 5678999999999999999999999999888999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999976543 25899999999999999999999999 99999999999999999999999999986632211
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
....+..|+|||++....++.++||||||++++||++ |..||......+ ........ ...
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------VVPHVEKG---------YRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHhcC---------CCC
Confidence 2234668999999998899999999999999999997 998875332211 11111111 011
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
..+...+..+.+++.+||+.+|++|||+.|++++|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11223346789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=317.74 Aligned_cols=260 Identities=24% Similarity=0.383 Sum_probs=209.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||++.. .+++.+|||.+... +....+++.+|+.+++.++|+||+++++++.+.+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999995 47899999976542 3344568899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999887422 2346899999999999999999999999 99999999999999999999999999876643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......++..|+|||.+.+..++.++||||||+++|||++|..||...... .... ........
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~-~~~~~~~~-------- 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSL-CKKIEQCD-------- 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHH-hhhhhcCC--------
Confidence 222 122345889999999999989999999999999999999999998543211 1111 11111000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
.........+.++.+++.+||+.+|++||||.+|++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 001111234567999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=320.24 Aligned_cols=256 Identities=27% Similarity=0.399 Sum_probs=202.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
+++|.+.+.||+|++|.||+|.+.+ +..||+|...... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678899999999999999999754 5678999876433 33456799999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCC----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---cEEEe
Q 036483 466 LLVYEFIINGTLFQYLHDQNE----EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVS 538 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~ 538 (721)
++||||+++++|.++++.... ...+++..+++++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999876432 235899999999999999999999998 99999999999998654 59999
Q ss_pred eccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHh
Q 036483 539 DFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 539 DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
|||+++......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......+ . ...+
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~----~~~~ 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V----MEFV 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHH
Confidence 999998763222111 111223567999999999999999999999999999997 988886432211 1 1111
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
... .....+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 235 ~~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111 111122334567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=317.43 Aligned_cols=255 Identities=24% Similarity=0.444 Sum_probs=199.0
Q ss_pred CCCCceEeeeCcEEEEEEEEcCC-c--EEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC------Cc
Q 036483 396 YNTNRILGQGGQGTVYKGMLADG-R--IVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET------EV 464 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~-~--~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------~~ 464 (721)
|.+.++||+|+||.||+|.+.+. . .+|+|..+.. .....+.+.+|++++++++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999997653 2 5899977543 345567899999999999999999999987532 24
Q ss_pred ceEEEeeccCCCcchhcccc---CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 465 PLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+++|||+++|+|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999887432 12235899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhcc
Q 036483 542 ASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 542 ls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+++......... .....+++.|++||.+.+..++.++||||||+++|||++ |+.||...... . ....+...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~----~~~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---E----IYDYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---H----HHHHHHcC
Confidence 998764332211 122235678999999999999999999999999999999 78887542211 1 11112221
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
... ..+...+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 231 ~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 111 11122345689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=326.59 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=193.5
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999987642 334456788899998877 899999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-cc
Confidence 99998886543 5899999999999999999999999 99999999999999999999999999875432211 22
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccc--cccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE--DKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ......+....+..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence 34568999999999999999999999999999999999999996432211 11112222222221111 1
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
.+.....++.+++.+||+.+|++||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 222334568899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=335.78 Aligned_cols=252 Identities=24% Similarity=0.347 Sum_probs=200.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.++||+|+||+||+++.. +++.||||++... .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46889999999999999999975 5889999987642 2344567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 5899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cce-------------------------------------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh
Q 036483 550 QTH-------------------------------------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592 (721)
Q Consensus 550 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt 592 (721)
... ......||+.|+|||++.+..++.++||||||+++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0012358999999999999999999999999999999999
Q ss_pred CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 036483 593 GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT---MKEVAVV 665 (721)
Q Consensus 593 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~~ 665 (721)
|..||...... .............. .........++.+++.+|+. +|.+|++ +.|+++.
T Consensus 235 G~~Pf~~~~~~------~~~~~i~~~~~~~~-------~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 235 GYPPFCSDNPQ------ETYRKIINWKETLQ-------FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCCHH------HHHHHHHcCCCccC-------CCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 99999643321 11111111000000 00011123467889999996 9999998 8888664
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=314.86 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=196.3
Q ss_pred eEeeeCcEEEEEEEEc---CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCC
Q 036483 401 ILGQGGQGTVYKGMLA---DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGT 476 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 476 (721)
.||+|+||.||+|.+. .+..||+|...... ....+.|.+|+.++++++|+||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999864 35579999876543 334567999999999999999999999875 456799999999999
Q ss_pred cchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee--
Q 036483 477 LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-- 554 (721)
Q Consensus 477 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~-- 554 (721)
|.+++.... ..+++..+++++.|++.||+|||+++ ++||||||+|||++.++.+||+|||+++....+.....
T Consensus 81 L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 999987543 25899999999999999999999998 99999999999999999999999999986543322211
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
....++..|+|||.+....++.++||||||+++|||++ |..||......+ +...+... .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE-------VMSFIEQG---------KRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH-------HHHHHHCC---------CCCCC
Confidence 11223578999999998889999999999999999996 999985432211 11111111 11122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
+...+.++.+++.+||+.+|++||++.+|++.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 333456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=335.36 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=197.3
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.|...+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.++++++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999865 5789999987542 23456778999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987643 5889999999999999999999998 9999999999999999999999999976431100
Q ss_pred c----------------------------------------------eeeeeeecCCCCCCccccccCCCCccccchhHH
Q 036483 551 T----------------------------------------------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFG 584 (721)
Q Consensus 551 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlG 584 (721)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001234699999999999999999999999999
Q ss_pred HHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHh--hccCCCCCCCHHHH
Q 036483 585 VVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRC--LNLNGKKRPTMKEV 662 (721)
Q Consensus 585 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c--l~~~p~~RPt~~ev 662 (721)
+++|||++|+.||......+. .......... ...........++.+++.++ +..++..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTET------QLKVINWENT-------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHH------HHHHHccccc-------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 999999999999964332110 1111110000 00001112234577888884 45566669999999
Q ss_pred HHH
Q 036483 663 AVV 665 (721)
Q Consensus 663 ~~~ 665 (721)
+..
T Consensus 303 l~h 305 (381)
T cd05626 303 KAH 305 (381)
T ss_pred hcC
Confidence 875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=324.07 Aligned_cols=263 Identities=24% Similarity=0.394 Sum_probs=209.1
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc--------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA--------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCL 460 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~ 460 (721)
...++|.+.+.||+|+||.||+++.. ++..||+|..... .....+++.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 33567888999999999999999742 2457999987643 234567899999999999 8999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
.....++||||+++++|.+++..... ...+++..+++++.||++||+|||+++ |+||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999976421 235889999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEED 605 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~ 605 (721)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..|+......
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-- 246 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-- 246 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence 99999999999999998764322221 222335678999999999999999999999999999998 77777433211
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
. ....+..... ...+...+..+.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 247 ----~-~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 247 ----E-LFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred ----H-HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1 1112221111 111223446789999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=315.06 Aligned_cols=251 Identities=27% Similarity=0.409 Sum_probs=203.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-----chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-----ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|...+.||+|++|.||++... +++.+|+|...... ....+.+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57899999999999999999864 58899999865422 2234678999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|+||+++++|.+++.... .+++..+.+++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987643 5889999999999999999999999 9999999999999999999999999987654
Q ss_pred cCCceee--eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHMT--TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
....... ....++..|+|||++.+..++.++||||||+++|||++|+.||...... .. ......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~-~~~~~~-------- 221 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-----AA-IFKIAT-------- 221 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-----HH-HHHHhc--------
Confidence 3221111 2345788999999999999999999999999999999999998532211 11 111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......+......+.+++.+||..+|++|||+.++++.
T Consensus 222 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 -QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred -cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 111112233345568999999999999999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=327.97 Aligned_cols=251 Identities=27% Similarity=0.401 Sum_probs=214.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-ceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV-PLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~-~~lv~ 469 (721)
++|...+++|+|+||.++..+.+ +++.+++|++... .+...+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999865 5788999986553 34445578999999999999999999999999998 89999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
+|++||+|.+.+.+++ ...++++.+.+++.|++.|+.|||++. |+|||||+.||+++.+..+||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998876 347999999999999999999999888 999999999999999999999999999988765
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ....+.||+.||.||.+.+.+|..|+|||||||++|||++-+++|...+... ...+..+ ..
T Consensus 160 ~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~----------~~ 222 (426)
T KOG0589|consen 160 DS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINR----------GL 222 (426)
T ss_pred hh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhh----------cc
Confidence 42 3445679999999999999999999999999999999999999997544322 1111111 11
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+.....++..|+..||+.+|+.||++.+++..
T Consensus 223 ~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 233455566779999999999999999999999876
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=323.02 Aligned_cols=261 Identities=25% Similarity=0.422 Sum_probs=207.9
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCLE 461 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~ 461 (721)
....++|.+.+.||+|+||.||++... .+..+|+|+.+... ....+.+.+|+.+++++ +|+||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567999999999999999999742 24579999876543 34456799999999999 79999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+..++||||+++++|.++++.... ..+++.+++.++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999975432 24899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhcc
Q 036483 542 ASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 542 ls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+++......... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..+.......
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~------~~~~~~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD------SKFYKLIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch------HHHHHHHHcC
Confidence 998664332211 122345678999999999999999999999999999998 99887543221 1111111111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.....+...+.++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 261 ---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 ---------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 01111112345699999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=318.71 Aligned_cols=257 Identities=25% Similarity=0.450 Sum_probs=203.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|...++||+|+||+||+|.+. +++ .||+|.++.. .....+.+.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEE
Confidence 56888899999999999999854 444 4899987653 334467889999999999999999999999754 5689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
++||+++|+|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999976432 5899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+. ..+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~----~~~~~~~----- 228 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIP----DLLEKGE----- 228 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHHCCC-----
Confidence 332221 112234678999999999999999999999999999998 88887532211 111 1111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+...+..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 229 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 229 ----RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred ----cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 1111223345688999999999999999999999999887554
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=324.66 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=207.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc--------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA--------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLET 462 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~ 462 (721)
.++|.+.+.||+|+||.||++... +...+|+|..+.. ......++.+|+.+++++ +|+||+++++++.+.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467999999999999999999753 2347999988653 234456788999999999 799999999999999
Q ss_pred CcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
+..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 999999999999999999976431 135899999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccccc
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKS 607 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~ 607 (721)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~---- 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH----
Confidence 999999999999987653221111 111224568999999999999999999999999999998 88887533211
Q ss_pred HHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 608 LAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
. +...+.... ..+.+...+.++.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus 250 --~-~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 --E-LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --H-HHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1 111111111 1122233456789999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.00 Aligned_cols=259 Identities=26% Similarity=0.336 Sum_probs=206.5
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE- 463 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~- 463 (721)
+.....++|.+.++||+|+||+||+++.. +++.||||.+... .......+.+|+.++..++|+||++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 34445679999999999999999999854 6899999987542 3455677899999999999999999988775433
Q ss_pred -------cceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 464 -------VPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 464 -------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
..++||||+++|+|.++++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 2579999999999999987532 2346899999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH
Q 036483 536 KVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 536 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 614 (721)
||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+..
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~ 256 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHK 256 (496)
T ss_pred EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHH
Confidence 9999999987643221 222345699999999999999999999999999999999999999864321 111111
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ... ....+...+.++.+++.+||+.+|++||++.+++..
T Consensus 257 ~~-~~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL-AGR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh-cCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 11 111 111223345679999999999999999999999764
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=325.37 Aligned_cols=236 Identities=26% Similarity=0.376 Sum_probs=192.2
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||+||+++.+ +++.||+|.++.. .....+.+..|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 5889999987542 234556788899998877 799999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999887543 5899999999999999999999999 9999999999999999999999999987543222 122
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~-~~~~i~~~~~----------~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------D-LFEAILNDEV----------VYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------H-HHHHHhcCCC----------CCC
Confidence 3356899999999999999999999999999999999999999643321 1 1111111111 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
...+.++.+++.+||+.||++||++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCC
Confidence 2234568899999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=331.36 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=196.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|+..+.||+|+||+||++... +++.||+|.++.. .......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999865 5889999987542 2334567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999997643 6899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCc
Q 036483 550 QT----------------------------------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER 595 (721)
Q Consensus 550 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~ 595 (721)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred ccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhc--cCCCCCCCHHHHHHH
Q 036483 596 AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLN--LNGKKRPTMKEVAVV 665 (721)
Q Consensus 596 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~~p~~RPt~~ev~~~ 665 (721)
||...... ..+......... +..+ .. .....++.+++.+++. .++..||++.||++.
T Consensus 235 Pf~~~~~~------~~~~~i~~~~~~--~~~p---~~--~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 235 PFCSETPQ------ETYKKVMNWKET--LIFP---PE--VPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCHH------HHHHHHHcCcCc--ccCC---Cc--CCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 99643321 111111110000 0000 00 0122356777777554 233356899999775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=323.56 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=195.4
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.||+|+||+||++... +++.+|+|.++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 5789999987642 234556788999999988 699999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99998886543 5999999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+..... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI----------RIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC----------CCC
Confidence 3456999999999999999999999999999999999999999654332222222222222221111 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
...+..+.+++.+||+.||++||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 22345688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.22 Aligned_cols=252 Identities=26% Similarity=0.324 Sum_probs=201.2
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
+|+..++||+|+||+||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4778899999999999999965 58899999875422 2234567889999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 35899999999999999999999998 9999999999999999999999999997654222
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
. .....|+..|+|||++.+..++.++||||||+++|||++|+.||....... ....+...+... .
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~---~~~~~~~~~~~~----------~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV---KREEVERRVKED----------Q 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh---HHHHHHHHhhhc----------c
Confidence 1 123458999999999999999999999999999999999999996433211 111111111110 1
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
...+...+..+.+|+.+||+.||++|| ++++++..
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 112233456689999999999999999 67777543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=328.76 Aligned_cols=242 Identities=24% Similarity=0.309 Sum_probs=196.3
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+.||+|+||.||++... +++.||+|.++.. .......+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999864 6889999987642 2334567889999999999999999999999999999999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
+|..++.... .+++..+..++.||+.||+|||+ .+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence 9998886543 58999999999999999999997 67 99999999999999999999999999875432221 22
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~-------~~~~i~~~~----------~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK-------LFELILMEE----------IRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH-------HHHHHhcCC----------CCCC
Confidence 33569999999999999999999999999999999999999986433211 111111111 0112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
.....++.+++.+||+.||++|+ ++.++++.
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 22345689999999999999996 89998765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=320.87 Aligned_cols=261 Identities=27% Similarity=0.424 Sum_probs=205.4
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
...++|++.++||+|+||.||+|..++ +..||+|.+.... ......+.+|+.++++++|+||+++++++.+.+
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 346789999999999999999997542 4579999875433 233456889999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCC-------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNE-------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ |+||||||+||++++++.+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 235678889999999999999999998 99999999999999999999
Q ss_pred EeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHH
Q 036483 537 VSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 614 (721)
|+|||+++......... .....++..|+|||.+.+..++.++||||||++++||++ |..||......+ +..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~-------~~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ-------VLK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence 99999998654322111 112235678999999999999999999999999999998 777875432211 111
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
....... ...+...+..+.+++.+||+.+|++|||+.++++.|+...
T Consensus 233 ~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 233 FVMDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHHcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 1111111 1112223457999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=321.33 Aligned_cols=240 Identities=23% Similarity=0.343 Sum_probs=191.7
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+..|..++..+ +||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 4789999987642 233445667777777654 899999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
|+|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999887543 5899999999999999999999998 9999999999999999999999999997643222 223
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~-~~~~i~~~~----------~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------E-LFDSILNDR----------PHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCC----------CCCC
Confidence 3456899999999999999999999999999999999999998643321 1 111111110 1112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMK-EVA 663 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 663 (721)
.....++.+++.+||+.+|++||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 22345688999999999999999975 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=321.30 Aligned_cols=255 Identities=23% Similarity=0.351 Sum_probs=202.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccCc-hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVIDE-SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
+|.+.+.||+|+||.||+|...+ ++.||+|+++.... ...+.+.+|+.++++++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 46677899999999999998642 47899999875433 334678999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc
Q 036483 468 VYEFIINGTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR 534 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 534 (721)
++||+.+++|.+++.... ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235889999999999999999999998 999999999999999999
Q ss_pred EEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHH
Q 036483 535 AKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 535 ~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~ 612 (721)
+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...... . .
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~-~ 235 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------D-V 235 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------H-H
Confidence 99999999886543221 11223345778999999998899999999999999999998 77787542211 1 1
Q ss_pred HHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 613 LRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
...+..... ...+...+..+.+++.+||+.+|++||++.+|+..|+.
T Consensus 236 ~~~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 IEMIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 112211111 11223345668999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=315.38 Aligned_cols=255 Identities=26% Similarity=0.437 Sum_probs=205.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-C---CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-D---GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.+|++.+.||+|+||.||+|... + +..+|+|.++... ....+.|.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56888999999999999999864 2 3479999876532 34457899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++..... .+++.++++++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 999999999999976532 5899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCceeeee--eecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 549 DQTHMTTQ--VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 549 ~~~~~~~~--~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
........ ..++..|+|||.+.+..++.++||||||++++|+++ |..||......+ ....+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~-------~~~~~~~~~----- 226 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD-------VIKAIEEGY----- 226 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH-------HHHHHhCCC-----
Confidence 33222211 223567999999999899999999999999999887 999985432211 111111110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
....+...+..+.+++.+||+.+|++||+|.++++.|+.+
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ----RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0111223345689999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=318.23 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=205.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++|.+.+.||+|+||.||+|...+ +..||+|...... ......+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 4678889999999999999998643 3689999876432 34456789999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCC-------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEe
Q 036483 466 LLVYEFIINGTLFQYLHDQNE-------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999975321 224789999999999999999999998 9999999999999999999999
Q ss_pred eccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHh
Q 036483 539 DFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 539 DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~~~ 234 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFV 234 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH-------HHHHH
Confidence 99999765433221 1223346788999999998899999999999999999998 888875432211 11111
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..... ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 IDGGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred hcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 11111 1112223567999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=311.74 Aligned_cols=250 Identities=27% Similarity=0.437 Sum_probs=205.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|.+.+.||+|++|.||++... +++.|++|.+.. ......+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999975 588999998654 2345667899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.++++... ...+++..+++++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998642 236899999999999999999999998 99999999999999999999999999886643322
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
. .....+++.|+|||++.+..++.++||||||++++||++|+.||...... . ......... ..
T Consensus 157 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~---------~~ 219 (256)
T cd08529 157 F-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG------A-LILKIIRGV---------FP 219 (256)
T ss_pred h-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCC---------CC
Confidence 1 22345888999999999999999999999999999999999998643311 0 111111111 11
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1222345679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=325.82 Aligned_cols=250 Identities=24% Similarity=0.423 Sum_probs=210.4
Q ss_pred CCCceEeeeCcEEEEEEEEcC--Cc--EEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 397 NTNRILGQGGQGTVYKGMLAD--GR--IVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
...++||+|.||.|++|.|.. |+ .||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....+|+|+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 345789999999999999764 54 5899998876554 67899999999999999999999999987 677899999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
.+.|+|.+.|+.. .+..|-......++.|||.||.||.+++ +|||||..+|+||-....+||+||||.|.+.....
T Consensus 192 aplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999983 3447888889999999999999999999 99999999999999999999999999998864433
Q ss_pred e-eee-eeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 552 H-MTT-QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 552 ~-~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. .+. ...-...|+|||.+....++.+||||+|||++|||++ |+.||.+.... .+.+.+|.+
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD~~ 331 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNIDAG 331 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhcccc
Confidence 2 222 2234567999999999999999999999999999999 88898654322 233445555
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
-+...+..+++.+.+++++||..+|++|||+..|.+.+-
T Consensus 332 erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 332 ERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred ccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 555667778889999999999999999999999975543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-37 Score=325.12 Aligned_cols=242 Identities=24% Similarity=0.340 Sum_probs=195.2
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+|+.. +++.||+|.++.. .....+.+..|++++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 47999999999999976 4789999987542 234456788899999876 799999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc-cc
Confidence 99998887543 5899999999999999999999999 99999999999999999999999999875432221 22
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... ... ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~-~~~----------~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILH-DDV----------LYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHc-CCC----------CCC
Confidence 3456899999999999999999999999999999999999999643321 11111111 110 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCC-------CHHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRP-------TMKEVAVV 665 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RP-------t~~ev~~~ 665 (721)
.....++.+++.+||+.+|++|| ++.++++.
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 12335688999999999999999 77777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=322.03 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=203.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc--EEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR--IVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
++|++.+.||+|+||.||+|.+. ++. .+++|+.+.. .....+.+.+|++++.++ +|+||+++++++.+.+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57888999999999999999965 344 4677776543 334556889999999999 899999999999999999999
Q ss_pred EeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 469 YEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
|||+++++|.++++.... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999975421 235889999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 614 (721)
||+|||+++...... ......++..|+|||++.+..++.++||||||++++||++ |..||......+ . ..
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~-~~ 234 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L-YE 234 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------H-HH
Confidence 999999986432111 1111224567999999988889999999999999999998 999985432211 1 11
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
..... ...+.+...+..+.+|+.+||+.+|++||++.++++.|..+...
T Consensus 235 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 01111222345689999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=334.26 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=197.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.++||+|+||+||++... +++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46889999999999999999865 6889999987542 2344567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999987543 5889999999999999999999999 999999999999999999999999998643210
Q ss_pred Cce----------------------------------------------eeeeeecCCCCCCccccccCCCCccccchhH
Q 036483 550 QTH----------------------------------------------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSF 583 (721)
Q Consensus 550 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~Sl 583 (721)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012458999999999999999999999999
Q ss_pred HHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCC---CCHH
Q 036483 584 GVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKR---PTMK 660 (721)
Q Consensus 584 Gvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ 660 (721)
|+++|||++|+.||......+ .+............ ........++.+++.+||. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~-------p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHE------TYRKIINWRETLYF-------PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHH------HHHHHHccCCccCC-------CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 999999999999986433211 11111110000000 0001123468899999997 66665 5999
Q ss_pred HHHHH
Q 036483 661 EVAVV 665 (721)
Q Consensus 661 ev~~~ 665 (721)
|++.+
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88775
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=334.46 Aligned_cols=261 Identities=25% Similarity=0.319 Sum_probs=199.5
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----cce
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----VPL 466 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~~~ 466 (721)
+|+..++||+|+||.||++... +++.||||++... +....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4788999999999999999964 6899999987543 2334567899999999999999999999998776 679
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 57777775433 5899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh--
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE-- 623 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 623 (721)
............++..|+|||.+.+. .++.++||||||++++||++|+.||........ ...+..........+
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ---LDLITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcCCCCHHHHH
Confidence 43333333344578999999998874 578999999999999999999999965443211 111111111000000
Q ss_pred --------hhhhhh--------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 --------ILDAHV--------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 --------~~~~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+.... ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000 001111224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=323.76 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=194.7
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCC-CceeeEEEEEEeCCcceEEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINH-RNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h-~niv~l~g~~~~~~~~~lv~ 469 (721)
+|.+.+.||+|+||.||+|+.. +++.||+|.++.. .....+.+..|++++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788899999999999999966 4789999987542 33456678899999999976 56888999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999887543 5899999999999999999999998 999999999999999999999999998753222
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ....+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-------~~~~i~~~~--------- 217 (324)
T cd05587 155 GK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-------LFQSIMEHN--------- 217 (324)
T ss_pred CC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCC---------
Confidence 21 2334568999999999999999999999999999999999999986432211 111111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
...+.....++.+++.+||+.+|++|++.
T Consensus 218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 218 -VSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred -CCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 11122234568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=314.66 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=205.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|.+.+.||+|+||.||+|...+ ...|+||...... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 3568888999999999999998643 2468999876544 4556789999999999999999999998875 45689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976432 5899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
...........++..|+|||.+....++.++||||||++++||++ |..||......+ .. ..+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~-~~~~~~~------ 225 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VI-GRIENGE------ 225 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HH-HHHHcCC------
Confidence 433222223334568999999988889999999999999999986 999985433211 11 1111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+..+.+++.+||..+|++|||+.++++.|++++.
T Consensus 226 ---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 226 ---RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 001122345579999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=324.77 Aligned_cols=266 Identities=25% Similarity=0.394 Sum_probs=209.1
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcC--------CcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEE
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLAD--------GRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCC 459 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~ 459 (721)
+....+|.+.+.||+|+||.||+++... ...||+|..+.. .....+++.+|+++++++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3344578999999999999999997421 236899987643 334567899999999999 799999999999
Q ss_pred EeCCcceEEEeeccCCCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 460 LETEVPLLVYEFIINGTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 460 ~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
.+.+..+++|||+++++|.+++.... ....+++..+++++.|++.||+|||+++ |+||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccce
Confidence 99999999999999999999987532 1235889999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEE 604 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~ 604 (721)
||+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 999999999999999997654322111 112234567999999999999999999999999999998 888875432211
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
+...+..... ...+...+.++.+++.+||+.+|++|||+.|+++.|+.+.....
T Consensus 245 -------~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 245 -------LFKLLKEGHR---------MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -------HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111111111 11122334568999999999999999999999999998875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=322.50 Aligned_cols=261 Identities=24% Similarity=0.407 Sum_probs=206.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc--------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA--------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLE 461 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~ 461 (721)
..++|.+.+.||+|+||.||++... ....+|+|..+.. .....+.+.+|+.+++++ +||||+++++++.+
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 89 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ 89 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence 3467888999999999999999742 2457899987643 234567789999999999 69999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEE
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNIL 528 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIl 528 (721)
.+..++||||+++++|.+++..... ...+++..+++++.|++.||.|||+++ |+||||||+|||
T Consensus 90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nil 166 (314)
T cd05099 90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVL 166 (314)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEE
Confidence 8899999999999999999975321 235899999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccc
Q 036483 529 LDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDK 606 (721)
Q Consensus 529 l~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~ 606 (721)
+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~-- 244 (314)
T cd05099 167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE-- 244 (314)
T ss_pred EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 9999999999999998664322111 111224467999999999999999999999999999999 888875332211
Q ss_pred cHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 607 SLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+...+..... .+.+...+.++.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 245 -----~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 -----LFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred -----HHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111111111 11122334568899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=327.05 Aligned_cols=238 Identities=27% Similarity=0.305 Sum_probs=193.4
Q ss_pred ceEeeeCcEEEEEEEE----cCCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 400 RILGQGGQGTVYKGML----ADGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
+.||+|+||.||+++. .+|+.+|+|.++... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 6799999999999874 357899999876432 2234567889999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999986543 5899999999999999999999999 9999999999999999999999999987654322 12
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ..+.... ...
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~-~~i~~~~----------~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETM-TMILKAK----------LGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHH-HHHHcCC----------CCC
Confidence 23456899999999999988999999999999999999999998643211 111 1111111 112
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKE 661 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~~e 661 (721)
+...+..+.+++.+||+.||++||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 2233456889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=314.74 Aligned_cols=255 Identities=23% Similarity=0.335 Sum_probs=202.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|++.+.||+|+||.||+|+.. +++.+|+|+.........+.+.+|+.++++++||||+++++.+...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357899999999999999999964 6889999988765555567788999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.++++... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999887543 5899999999999999999999998 99999999999999999999999999986532211
Q ss_pred eeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
......++..|+|||.+. ...++.++||||||++++||++|+.|+......+. .. .+...... .+.
T Consensus 162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~------~~-~~~~~~~~---~~~ 230 (267)
T cd06646 162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA------LF-LMSKSNFQ---PPK 230 (267)
T ss_pred -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh------he-eeecCCCC---CCC
Confidence 122345888999999884 34578899999999999999999999753221110 00 00000000 000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
. ......+..+.+++.+||+.+|++|||+++|++.|
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 231 L--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 00112345789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=334.30 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=195.2
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
+|...++||+|+||+||+|+.. +++.+|+|.+... .....+.+.+|+.++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999965 5889999987542 23445678999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999987643 5889999999999999999999999 9999999999999999999999999975331000
Q ss_pred ----------------------------------------------ceeeeeeecCCCCCCccccccCCCCccccchhHH
Q 036483 551 ----------------------------------------------THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFG 584 (721)
Q Consensus 551 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlG 584 (721)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001224689999999999999999999999999
Q ss_pred HHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC---HHH
Q 036483 585 VVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT---MKE 661 (721)
Q Consensus 585 vll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e 661 (721)
|+||||++|+.||......+ ......... .............++.+++.+++ .+|++|++ +.|
T Consensus 236 vil~elltG~~Pf~~~~~~~------~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLE------TQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHH------HHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 99999999999996433211 111111100 00000111122345777888876 59999997 777
Q ss_pred HHH
Q 036483 662 VAV 664 (721)
Q Consensus 662 v~~ 664 (721)
++.
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=311.78 Aligned_cols=249 Identities=27% Similarity=0.455 Sum_probs=200.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-CCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE-TEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~~~~~lv~e~~ 472 (721)
++|.+.+.||+|+||.||++... +..+|+|..+.. ...+.+.+|+.++++++|+|++++++++.+ ....+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999875 778999987543 335679999999999999999999998654 45679999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.++++.... ..+++..+++++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999876432 25899999999999999999999998 9999999999999999999999999987543221
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
....++..|+|||++.+..++.++||||||+++|||++ |+.|+...... .. ...+..+ ...
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~------~~-~~~~~~~---------~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DV-VPRVEKG---------YKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HH-HHHHhcC---------CCC
Confidence 12234568999999999999999999999999999998 88887533211 11 1111111 011
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
......+..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 12223456789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=323.25 Aligned_cols=237 Identities=25% Similarity=0.361 Sum_probs=189.5
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHH-HHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||+||+|+.. +++.||+|.+... .....+.+.+|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999975 5899999987542 2223345555655 46789999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence 99999887643 5899999999999999999999999 9999999999999999999999999987542221 223
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... .... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~-~~~~----------~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNIL-NKPL----------RLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHH-cCCC----------CCC
Confidence 3456899999999999999999999999999999999999998643221 1111111 1110 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
...+..+.+++.+||+.+|++||+++
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 22345689999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=310.50 Aligned_cols=252 Identities=26% Similarity=0.313 Sum_probs=207.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||.|.-|+||++.+++ +..+|+|.+.. ...+...+...|-+||+.++||.++.||+.+..++..+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456677899999999999999876 58999998754 33456678889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc-
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI- 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~- 548 (721)
||++||+|+.+++++..+ .+++..++.++.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999887655 7999999999999999999999999 99999999999999999999999998753310
Q ss_pred --------------------------------CCc----------------------eeeeeeecCCCCCCccccccCCC
Q 036483 549 --------------------------------DQT----------------------HMTTQVQGTFGYLDPEYFRSSRF 574 (721)
Q Consensus 549 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~ 574 (721)
... .....++||..|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 01123569999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCC
Q 036483 575 TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGK 654 (721)
Q Consensus 575 t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~ 654 (721)
+.++|+|+||++|||||.|..||.+.+..+ .+..++...+......+....+.+||++.|..||.
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~---------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKE---------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchh---------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChh
Confidence 999999999999999999999998765432 12222222222222235556799999999999999
Q ss_pred CCCC----HHHHHH
Q 036483 655 KRPT----MKEVAV 664 (721)
Q Consensus 655 ~RPt----~~ev~~ 664 (721)
+|.. +.||-+
T Consensus 378 kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKR 391 (459)
T ss_pred hhhccccchHHhhc
Confidence 9988 555533
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.06 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=202.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
.+|++.+.||+|+||.||++.+.+++.+|+|..+... ...++|.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4677889999999999999998778899999876432 234678999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999875432 5889999999999999999999998 9999999999999999999999999987654322211
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||...... .....+.... .. .
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~-------~~~~~~~~~~--~~-------~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS-------EVVETINAGF--RL-------Y 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH-------HHHHHHhCCC--CC-------C
Confidence 122235678999999998899999999999999999998 88887532211 1111111110 00 0
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
.+...+..+.+|+.+||+.+|++|||+.|+++.|.
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 11112456999999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=314.87 Aligned_cols=255 Identities=26% Similarity=0.438 Sum_probs=203.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-C---cEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-G---RIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
..|++.+.||+|+||.||+|.... + ..||||.++.. .....++|..|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 347788999999999999999653 3 36999987653 344567899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999876432 5899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcee--eeeee--cCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 549 DQTHM--TTQVQ--GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 549 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
..... ..... .+..|+|||.+.+..++.++||||||+++|||++ |..||...... . +...+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~------~-~~~~i~~~---- 227 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ------D-VINAIEQD---- 227 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH------H-HHHHHHcC----
Confidence 22111 11111 2357999999999999999999999999999886 99988533211 1 11111111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.....+.+.+..+.+++.+||+.+|++||++.+|+..|+++
T Consensus 228 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 228 -----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred -----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00111223455689999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.68 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=194.5
Q ss_pred EeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.++++++|+||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999865 68899999875422 22346778999999999999999999999999999999999999999
Q ss_pred chhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeee
Q 036483 478 FQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556 (721)
Q Consensus 478 ~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~ 556 (721)
..++.... ....+++..++.++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++..+..... ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 88875422 2346899999999999999999999998 99999999999999999999999999976543322 2233
Q ss_pred eecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHH
Q 036483 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQE 636 (721)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (721)
..||+.|+|||++.+..++.++||||||+++|||++|+.||........ . .......... . ...+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~-~~~~~~~~~~--------~--~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--N-KELKQRILND--------S--VTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--H-HHHHHhhccc--------C--CCCccc
Confidence 5689999999999999999999999999999999999999864332110 0 0001111000 0 112223
Q ss_pred HHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 036483 637 DIVTVAKLTNRCLNLNGKKRP-----TMKEVAV 664 (721)
Q Consensus 637 ~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 664 (721)
.+..+.+++.+||+.+|++|| +++++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 455689999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.49 Aligned_cols=260 Identities=23% Similarity=0.335 Sum_probs=203.5
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLET 462 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~ 462 (721)
.++....++|.+.+.||+|+||.||+++.. +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++.+.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344455689999999999999999999976 478999998753 2233455688999999999999999999999999
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
+..++||||+++|+|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998653 4788889999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCC----CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
++..............||+.|+|||++.... ++.++||||||+++|||++|+.||..... ...+...+..
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL------VGTYSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH------HHHHHHHHcC
Confidence 9876433332334456999999999987543 78899999999999999999999964332 1122222211
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVVL 666 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~L 666 (721)
.....+ .........+.+++.+||...+.+ ||++.|+++..
T Consensus 263 ~~~~~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KNSLTF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CCcccC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 111111 011123456889999999844433 77888887754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=317.61 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-----------------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-----------------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVK 454 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~ 454 (721)
.++|.+.+.||+|+||.||++...+ +..||+|.+.... ....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999988543 2458999876532 345678999999999999999999
Q ss_pred EEEEEEeCCcceEEEeeccCCCcchhccccCC--------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNE--------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 455 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
+++++...+..+++|||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976431 225899999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh--CCcccccCCcc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT--GERAIRVTNFE 603 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt--G~~p~~~~~~~ 603 (721)
|+++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ +..|+.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 99999999999999999765432211 1223346778999999998899999999999999999998 5566543221
Q ss_pred ccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 604 EDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
............... .......+...+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 111111111111100 01111112233457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=316.14 Aligned_cols=248 Identities=23% Similarity=0.270 Sum_probs=194.6
Q ss_pred EeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||+|+||.||++..+ +|+.+|+|.+.... ....+.+..|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999865 58999999875421 22334566799999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 557 (721)
.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 988865432 35899999999999999999999998 9999999999999999999999999987654322 22334
Q ss_pred ecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 558 ~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
.|+..|+|||++.+..++.++||||||+++|||++|+.||....... ...... ....... .. ......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~-~~~~~~~--------~~-~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELK-RRTLEDE--------VK-FEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHH-HHhhccc--------cc-cccccC
Confidence 58999999999999999999999999999999999999986432111 111111 1111110 00 001123
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
+.++.+|+.+||+.+|++||+++|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 456899999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=317.90 Aligned_cols=262 Identities=26% Similarity=0.410 Sum_probs=203.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-----cCCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccc
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~ 465 (721)
..|.+.+.||+|+||.||++.. .+++.||+|.++... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467889999999999999974 247889999876543 44457899999999999999999999998875 467
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++.+... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999865432 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcc--------ccccHHHHHHHH
Q 036483 546 MAIDQTH--MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFE--------EDKSLAAYFLRA 615 (721)
Q Consensus 546 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~--------~~~~~~~~~~~~ 615 (721)
+...... ......++..|+|||++.+..++.++||||||++++||++++.|....... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6433221 112344677899999999889999999999999999999987654221100 000000111111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
+... .........+..+.+|+.+||+.+|++|||+.++++.|+.+
T Consensus 239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111 11111223456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=308.59 Aligned_cols=265 Identities=25% Similarity=0.354 Sum_probs=203.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc--hhhHHHHHHHHHHhhcCCCc-eeeEEEEEEeCC-----
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRN-VVKLLGCCLETE----- 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~n-iv~l~g~~~~~~----- 463 (721)
...|...++||+|.||+||+|+.. +|+.||+|++....+ ..-....+|+.+|++++|+| |+.|++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 345666778999999999999954 689999998766433 23456789999999999999 999999998877
Q ss_pred -cceEEEeeccCCCcchhccccCCC-CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 464 -VPLLVYEFIINGTLFQYLHDQNEE-FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 464 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..++|+||+ ..+|..++...... ..++...+..++.||++||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 778999999 66899999875432 35777889999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc--
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE-- 618 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 618 (721)
+|+.+..+... .+..++|..|+|||++.+. .|+...||||+|+++.||+++++.|.+....+ .+.. +.+.+..
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~-If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFR-IFRLLGTPN 241 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHH-HHHHcCCCC
Confidence 99977644332 3445689999999999887 79999999999999999999998887655422 1221 2222211
Q ss_pred -cchhhhh---hhh--hc-----ccCCH---HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 619 -DSLFEIL---DAH--VL-----KEASQ---EDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 619 -~~~~~~~---~~~--~~-----~~~~~---~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.... +.. .. ..... .......+++.+||+.+|.+|.|++.++.+
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 1111100 100 00 00011 111367899999999999999999999876
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=310.10 Aligned_cols=248 Identities=27% Similarity=0.429 Sum_probs=197.9
Q ss_pred ceEeeeCcEEEEEEEEcC----CcEEEEeeccccCc-hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD----GRIVAIKKSKVIDE-SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+|.... +..+|+|....... ...+++.+|++++++++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 479999999999997532 26899998765433 35568999999999999999999999875 4567999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|.+++.... .+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999997654 5899999999999999999999998 99999999999999999999999999987643332221
Q ss_pred --eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 555 --TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 555 --~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... . +...+..... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~----~~~~~~~~~~---------~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---E----VIAMLESGER---------L 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---H----HHHHHHcCCc---------C
Confidence 11224567999999999999999999999999999998 99998543211 1 1111111110 1
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 112233456899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.30 Aligned_cols=242 Identities=22% Similarity=0.344 Sum_probs=196.1
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.||+|+||+||++... +++.||||.++.. .....+.+.+|+.++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999976 4789999987642 234556778899999888 799999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence 99998887653 5899999999999999999999998 99999999999999999999999999875322221 22
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....|++.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+..... ..+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~-~~~~i~~~~~----------~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------E-LFQSILEDEV----------RYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCC----------CCC
Confidence 3356899999999999999999999999999999999999998643311 1 1111111110 112
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTM-----KEVAVV 665 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~~ 665 (721)
...+..+.+++.+||+.+|++||++ .+++..
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 2234568999999999999999999 776543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=313.22 Aligned_cols=249 Identities=26% Similarity=0.428 Sum_probs=196.2
Q ss_pred ceEeeeCcEEEEEEEEcC-Cc--EEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD-GR--IVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+|++.+ +. .+++|..+.. .....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 468999999999999754 43 4688877643 344567899999999999 899999999999999999999999999
Q ss_pred CCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 475 GTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 475 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
++|.++++... ....+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999987532 1125889999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccc
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+++...... .......+..|+|||++....++.++||||||++++||++ |..||...... .. ...+...
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~-~~~~~~~- 227 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------EL-YEKLPQG- 227 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HH-HHHHhCC-
Confidence 986332110 1111223567999999998899999999999999999997 99998543211 11 1111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
...+.+...+.++.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 228 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 228 --------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred --------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 01111222345689999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=322.55 Aligned_cols=241 Identities=22% Similarity=0.324 Sum_probs=194.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+|.+.+.||+|+||.||+|+.. +++.||+|.++.. .....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999966 4789999987542 233445677888888877 5899999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999998887543 5899999999999999999999998 999999999999999999999999999754322
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~-~~i~~~~--------- 217 (323)
T cd05616 155 GV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELF-QSIMEHN--------- 217 (323)
T ss_pred CC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCC---------
Confidence 21 223456899999999999999999999999999999999999998643321 111 1111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
...+.....++.+++.+||+.+|++|++.
T Consensus 218 -~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 218 -VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 01122334568999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=320.04 Aligned_cols=255 Identities=21% Similarity=0.336 Sum_probs=199.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+++.. +++.||+|.+.. ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999965 588999998754 22334567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999997533 25899999999999999999999999 999999999999999999999999998765443
Q ss_pred CceeeeeeecCCCCCCcccccc-----CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.........||+.|+|||++.. ..++.++||||||+++|||++|+.||..... ...+...+.......+
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~~~~ 229 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEHFQF 229 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCcccC
Confidence 3323333469999999999873 4578899999999999999999999854321 1112222111111110
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGK--KRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~ev~~~ 665 (721)
.......+..+.+++.+||...++ .||+++++++.
T Consensus 230 ------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 230 ------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 001112345678889888865443 37899988776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=318.83 Aligned_cols=263 Identities=24% Similarity=0.391 Sum_probs=201.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC---------------CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD---------------GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLL 456 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~ 456 (721)
.++|++.+.||+|+||.||++...+ ...||+|..+.. .....+.|.+|++++++++|+||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999987532 235899987653 334456799999999999999999999
Q ss_pred EEEEeCCcceEEEeeccCCCcchhccccCC---------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNE---------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 457 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
+++...+..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ ++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999865321 124789999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh--CCcccccCCccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT--GERAIRVTNFEE 604 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt--G~~p~~~~~~~~ 604 (721)
++++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||++++||++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999997654322211 122335678999999999999999999999999999998 455654322111
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
............. .......+...+..+.+|+.+||+.+|++||++.+|++.|+
T Consensus 241 ---~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111000 00001112223457999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=317.60 Aligned_cols=250 Identities=26% Similarity=0.405 Sum_probs=204.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.+|...+.||+|+||.||+|+.. +++.+|+|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888999999999999999954 58899999887655556678999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.........
T Consensus 100 ~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~ 172 (296)
T cd06654 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (296)
T ss_pred CCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccc
Confidence 999999998643 4889999999999999999999998 999999999999999999999999998765432211
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....+++.|+|||.+.+..++.++||||||+++|||++|+.||....... .......... ....
T Consensus 173 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~~--------~~~~ 237 (296)
T cd06654 173 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT--------PELQ 237 (296)
T ss_pred -cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCCC--------CCCC
Confidence 122358889999999999889999999999999999999999985432211 1111111100 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+......+.+++.+||..+|++||++.+|+..
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 122344568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.26 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=204.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ....++|.+|+.++++++||||+++++++.+.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999864 46789999876532 33456799999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccC-------------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 466 LLVYEFIINGTLFQYLHDQN-------------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999997432 1135789999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEE 604 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~ 604 (721)
|++++++.+||+|||+++........ .......+..|+|||.+.+..++.++||||||+++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765332211 1122234667999999999999999999999999999998 877875332211
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
....+...... ..+...+.++.+++.+||+.+|++|||+.|+++.|++
T Consensus 241 -------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11112222111 1122334579999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=333.69 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=197.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.+|.+.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.+|++++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999965 5889999987542 2234567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997643 5889999999999999999999999 999999999999999999999999997532100
Q ss_pred C------------------------------------------ceeeeeeecCCCCCCccccccCCCCccccchhHHHHH
Q 036483 550 Q------------------------------------------THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVL 587 (721)
Q Consensus 550 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll 587 (721)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001134699999999999999999999999999999
Q ss_pred HHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC---CHHHHHH
Q 036483 588 AELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP---TMKEVAV 664 (721)
Q Consensus 588 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~ev~~ 664 (721)
|||++|+.||......+. .......... ...........++.+++.+|+ .+|++|+ ++.|++.
T Consensus 235 yell~G~~Pf~~~~~~~~------~~~i~~~~~~-------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAET------QLKVINWETT-------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHH------HHHHhccCcc-------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999965432211 1111100000 000011122345778888876 5999999 8888876
Q ss_pred H
Q 036483 665 V 665 (721)
Q Consensus 665 ~ 665 (721)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 5
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=317.25 Aligned_cols=264 Identities=24% Similarity=0.391 Sum_probs=202.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-----------------CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-----------------DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVK 454 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~ 454 (721)
.++|++.+.||+|+||.||++... +...+|+|..+.. .....++|.+|+.++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998632 2346899988653 3344578999999999999999999
Q ss_pred EEEEEEeCCcceEEEeeccCCCcchhccccCC--------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNE--------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 455 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
+++++...+..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999875321 124788999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh--CCcccccCCcc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT--GERAIRVTNFE 603 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt--G~~p~~~~~~~ 603 (721)
||+++++.+||+|||+++.+....... .....++..|++||...+..++.++||||||+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654332211 122234678999999988899999999999999999998 66676432211
Q ss_pred ccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 604 EDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
+ .............. ......+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 241 ~---~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 Q---VIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred H---HHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1 11111111110000 00011122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=321.88 Aligned_cols=262 Identities=23% Similarity=0.358 Sum_probs=199.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|.+.+.||+|+||.||+|+.. +++.||+|.++... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888999999999999999965 57889999876533 23345678999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++ +|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 78887765432 4889999999999999999999998 99999999999999999999999999976533221
Q ss_pred eeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---cchhhh---
Q 036483 552 HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---DSLFEI--- 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 624 (721)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ....+.. .....+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPTEETWPGISSN 235 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCCHHHHhhhcch
Confidence 1223357899999999865 4688999999999999999999999975443221111 1111100 000000
Q ss_pred ---hhhhhcc-------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 ---LDAHVLK-------EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ---~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+..... ......+.++.+++.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000 0011234567899999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.04 Aligned_cols=240 Identities=24% Similarity=0.352 Sum_probs=192.3
Q ss_pred ceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.||+|+||+||+|+..+ ++.||||.++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999764 789999987642 233445677788888765 899999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence 99999987543 5899999999999999999999998 99999999999999999999999999875432221 22
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||..|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.... + ..+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~-~~~~i~~~~------~----~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------E-LFQSIRMDN------P----CYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCC------C----CCC
Confidence 3456899999999999999999999999999999999999998643321 1 111111110 0 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMK-EVA 663 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 663 (721)
.....++.+++.+||+.+|++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 12334688999999999999999997 553
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=310.62 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=200.3
Q ss_pred ceEeeeCcEEEEEEEEcC--C--cEEEEeeccccCc-hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD--G--RIVAIKKSKVIDE-SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|++|.||+|.+.+ + ..||||.+..... ...+.+.+|+.++++++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998643 3 3689998876555 567889999999999999999999999988 888999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM- 553 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~- 553 (721)
++|.+++..... ..+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||+++.+.......
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999976543 36899999999999999999999998 9999999999999999999999999998765422211
Q ss_pred -eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 554 -TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 554 -~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.....++..|+|||++.+..++.++||||||++++||++ |+.||......+ .......... ..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~---------~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGE---------RL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHhcCC---------cC
Confidence 122346788999999999999999999999999999999 999985332211 1111110000 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+...+..+.+++.+||+.+|++||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 112234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=321.26 Aligned_cols=255 Identities=21% Similarity=0.340 Sum_probs=199.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||+||+++.. +++.||+|.+.. ......+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999965 578899998754 22334556889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999976432 5899999999999999999999999 999999999999999999999999999876544
Q ss_pred CceeeeeeecCCCCCCcccccc-----CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.........||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ...+...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH------HHHHHHHHcCCCccc-
Confidence 3333334569999999999876 4678899999999999999999999864322 111111111111000
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 665 (721)
. .......+.++.+++.+||...+++ |++++++++.
T Consensus 229 ----~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 229 ----F-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ----C-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0011123456889999999866544 4678777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=316.11 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=206.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-----CCcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-----DGRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLE--TEVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~ 465 (721)
++|...+.||+|+||.||++.+. .++.+|||.++..... ..+.|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3678999988764443 56789999999999999999999999887 5578
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999976543 5999999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccc--------cHHHHHHHH
Q 036483 546 MAIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK--------SLAAYFLRA 615 (721)
Q Consensus 546 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~--------~~~~~~~~~ 615 (721)
........ .....++..|++||.+.+..++.++||||||++++||++|+.|+......... .....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE- 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH-
Confidence 65322211 11223556799999999889999999999999999999999887543221100 00111111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.+........+...+.++.+++.+||+.+|++|||+.||+++|+.+
T Consensus 238 --------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 --------LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred --------HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111111122233446799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=311.60 Aligned_cols=259 Identities=25% Similarity=0.361 Sum_probs=204.1
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++.+++++.....||+|+||.||+|... ++..|++|..........+.+.+|+.++++++|+||+++++++...+..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4556677777789999999999999955 578899998876666667789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCcccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSM 546 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~ 546 (721)
|+||+++++|.+++.........++..++.++.|++.||+|||+.+ |+||||||+||+++. ++.+||+|||++...
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999976432212388889999999999999999998 999999999999976 679999999998765
Q ss_pred ccCCceeeeeeecCCCCCCccccccCC--CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
..... ......++..|+|||++.... ++.++||||||+++|+|++|+.|+....... ...+.....
T Consensus 160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~----~~~~~~~~~------- 227 (268)
T cd06624 160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ----AAMFKVGMF------- 227 (268)
T ss_pred ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh----hhHhhhhhh-------
Confidence 43222 122234789999999987643 7889999999999999999999985322111 000000000
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
......+.....++.+++.+||+.+|++|||+.|++..
T Consensus 228 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 ---KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ---ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 00111233344568999999999999999999999763
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=321.01 Aligned_cols=240 Identities=23% Similarity=0.348 Sum_probs=192.2
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+++.. +++.||+|.++.. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999976 5889999987642 133455677888888765 899999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999887543 5899999999999999999999999 9999999999999999999999999987532221 123
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~-~~~~~~~~~----------~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------E-LFESIRVDT----------PHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCC----------CCCC
Confidence 3456899999999999999999999999999999999999998643221 1 111111110 0111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMK-EVA 663 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 663 (721)
.....++.+++.+||+.||++||++. ++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 12334688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=307.34 Aligned_cols=247 Identities=27% Similarity=0.444 Sum_probs=199.3
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcc
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLF 478 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 478 (721)
++||+|+||.||++...+++.||+|..+..... ..+.+.+|++++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999987654333 5678999999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee-eee
Q 036483 479 QYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-TQV 557 (721)
Q Consensus 479 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~-~~~ 557 (721)
+++..... .+++..++.++.+++.||+|||+++ ++||||||+||+++.++.+||+|||++........... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99875432 5889999999999999999999998 99999999999999999999999999876532211111 112
Q ss_pred ecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHH
Q 036483 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQE 636 (721)
Q Consensus 558 ~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (721)
..+..|+|||.+.+..++.++||||||++++||++ |..||....... ....+.. ......+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~-------~~~~~~~---------~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIES---------GYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH-------HHHHHhc---------CCCCCCCcc
Confidence 23567999999998899999999999999999999 788875432211 1111111 001112233
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 637 DIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 637 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
.+.++.+++.+||+.+|++|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 4567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=325.82 Aligned_cols=261 Identities=28% Similarity=0.423 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE------cCCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC-
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE- 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~- 463 (721)
.++|.+.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 46799999999999999999973 346789999886532 33456788999999999 6899999999886544
Q ss_pred cceEEEeeccCCCcchhccccCC---------------------------------------------------------
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNE--------------------------------------------------------- 486 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 486 (721)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 56899999999999999864321
Q ss_pred -------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-eeeee
Q 036483 487 -------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQ 558 (721)
Q Consensus 487 -------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~ 558 (721)
...+++..+++++.|+++||+|||+.+ |+||||||+|||+++++++||+|||+++......... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 124788899999999999999999998 9999999999999999999999999997653222111 12233
Q ss_pred cCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 559 gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
++..|+|||.+.+..++.++||||||+++|||++ |..||....... .+...+...... ..+...
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~~---------~~~~~~ 307 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLKEGTRM---------RAPDYT 307 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHhccCCC---------CCCCCC
Confidence 5678999999999999999999999999999997 888875432111 111111111110 111112
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
..++.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 3468999999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=309.74 Aligned_cols=266 Identities=23% Similarity=0.311 Sum_probs=200.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----cceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----VPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~~~l 467 (721)
-.|...+++|.|+||.||+|.+.. ++.||||+.-...+ --.+|+++|++++|||||+|+-+|.... ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 356778999999999999999664 78999998643222 2247999999999999999999886533 2248
Q ss_pred EEeeccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeeccCccc
Q 036483 468 VYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRS 545 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGls~~ 545 (721)
|||||+. +|.++++.. ..+..++...+.-+..||++||+|||+.+ |+||||||.|+|+|.+ +.+||+|||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999965 787777641 12235778888889999999999999988 9999999999999966 9999999999998
Q ss_pred cccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
+..+... ..+.-|..|+|||.+.+. .|+.+.||||.||++.||+.|++.|.+....+. ...+.+.+......++
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ---L~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ---LVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH---HHHHHHHhCCCCHHHH
Confidence 8766554 445678999999999875 699999999999999999999999987543322 1222222222111111
Q ss_pred h----------hhhh-----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhhcccc
Q 036483 625 L----------DAHV-----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV--LAGIKAC 672 (721)
Q Consensus 625 ~----------~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~~~ 672 (721)
- .+.+ ..-.....+.+..+|+.++|+.+|.+|.++.|++.+ .+.++..
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 0 1111 111334455779999999999999999999998764 4455443
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=308.37 Aligned_cols=250 Identities=23% Similarity=0.357 Sum_probs=203.2
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+|++.++||+|+||.||++... +++.+|+|..+. ......+.+.+|+.++++++|+||+++++.+.+.+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4778899999999999999965 588999998754 23445678899999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... ..+++..+++++.|++.||.|||+++ |+|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999998865432 25889999999999999999999998 99999999999999999999999999976643222
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......++..|+|||++.+..++.++||||||+++|+|++|+.||...... . .......+.. ..
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~-~~~~~~~~~~---------~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWK------N-LILKVCQGSY---------KP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHH------H-HHHHHhcCCC---------CC
Confidence 223355889999999999989999999999999999999999998543211 1 1111111111 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+...+..+.+++.+||+.+|++||++.+|+..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 122334568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=313.43 Aligned_cols=256 Identities=26% Similarity=0.407 Sum_probs=204.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
++|...+.||+|+||.||+|+.+ +.+.+++|.+...... ..+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999964 2467999987654433 5678999999999999999999999999989999
Q ss_pred EEEeeccCCCcchhccccCCC------CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 467 LVYEFIINGTLFQYLHDQNEE------FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
+||||+++++|.++++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 25899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhcc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
|+++..............++..|+|||.+.+...+.++||||||+++++|++ |..||...... . +.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~------~-~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE------E-VLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH------H-HHHHHHcC
Confidence 9987543322222233346778999999988888999999999999999998 77787432211 1 11111111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
... .......+..+.+++.+||+.+|++|||+.|++..|.
T Consensus 235 ~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111 1112233457999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=310.21 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=199.2
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhh--HHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKV--DEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~--~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
|++.+.||+|+||+||+++... ++.+|+|.......... ....+|+.++++++||||+++++++.+....++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5677899999999999999765 66899998876544332 23466999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++.... .+++..++.++.|+++||.+||+.+ |+|+||||+||++++++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 9999999998333 5899999999999999999999998 9999999999999999999999999997642 1222
Q ss_pred eeeeeecCCCCCCccccc-cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFR-SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||++. +..++.++||||||+++++|++|..|+....... ....+....... .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~---~~~~~~~~~~~~-----~~~~~~~ 225 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD---QLEIIEKILKRP-----LPSSSQQ 225 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH---HHHHHHHHHHTH-----HHHHTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchh---hhhhhhhccccc-----ccccccc
Confidence 333456889999999998 8889999999999999999999999986542111 111111111100 0000000
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.......+.+++.+||+.+|++||++.++++
T Consensus 226 --~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 --SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp --HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred --cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011267999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=313.71 Aligned_cols=251 Identities=27% Similarity=0.337 Sum_probs=199.3
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
|+..++||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 677789999999999999965 58899999875422 22345678899999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++........
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT 157 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence 999999998865432 25899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.....|+..|+|||++.+..++.++||||||+++|||++|+.||........... ....... ...
T Consensus 158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~----------~~~ 222 (285)
T cd05630 158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKE----------VQE 222 (285)
T ss_pred --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhh----------hhh
Confidence 1234589999999999999999999999999999999999999964322110000 0000000 001
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
..+......+.+|+.+||+.+|++||| +.|+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 112223456889999999999999999 7777653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.76 Aligned_cols=249 Identities=32% Similarity=0.491 Sum_probs=203.9
Q ss_pred ceEeeeCcEEEEEEEEcC----CcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD----GRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||++.... +..+++|..+..... ..+.+.+|++++.+++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 788999988764433 368899999999999999999999999998999999999999
Q ss_pred CCcchhccccCC------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 475 GTLFQYLHDQNE------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 475 gsL~~~l~~~~~------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
++|.+++..... ...+++..+++++.|++.||+|||+++ |+||||||+||++++++.+||+|||.++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 246999999999999999999999998 99999999999999999999999999987654
Q ss_pred CCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 549 DQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 549 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
... .......++..|+|||.+....++.++||||||++++||++ |..||......+ +...+....
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~------ 224 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGY------ 224 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC------
Confidence 321 11233457889999999998899999999999999999999 688886542111 111111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
....+...+.++.+++.+||+.+|++|||+.++++.|+
T Consensus 225 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 225 ---RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11222334567999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=310.64 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=198.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.++||+|+||.||+|.. .+++.+|+|..... .....+++.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999985 46889999987543 334456799999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999986542 3788889999999999999999998 999999999999999999999999999765322
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....................... ...
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED--------PPV 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC--------CCC
Confidence 12234689999999999999999999999999999999999999854322111111101111111000 000
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
......+.++.+++.+||+.+|++||+++|+++.-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~ 254 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHP 254 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCc
Confidence 01112335689999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=313.72 Aligned_cols=253 Identities=25% Similarity=0.386 Sum_probs=198.9
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC------
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLET------ 462 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~------ 462 (721)
.+++.|+..+.||+|+||.||+|... +++.+|+|...... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45678899999999999999999965 47899999876543 3446788999999998 799999999998753
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
...++||||+++++|.+++..... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 356899999999999999876432 36899999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
++....... ......|+..|+|||++. ...++.++||||||+++|||++|+.||...... .... ...
T Consensus 158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~--~~~ 229 (272)
T cd06637 158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALF--LIP 229 (272)
T ss_pred ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHH--HHh
Confidence 976533221 223356889999999986 345888999999999999999999998532211 1111 001
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..... .......+.++.+|+.+||+.+|.+|||+.++++
T Consensus 230 ~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 230 RNPAP--------RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cCCCC--------CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 11000 0011123346899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.90 Aligned_cols=253 Identities=24% Similarity=0.350 Sum_probs=192.3
Q ss_pred ceEeeeCcEEEEEEEEcC---CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLAD---GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+.||+|+||.||+|...+ +..+|+|+++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 468999999999998654 4579999876543 233457899999999999999999999999999999999999999
Q ss_pred CcchhccccCC--CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 476 TLFQYLHDQNE--EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 476 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|.++++.... ...+++..+++++.|++.||+|||+.+ ++||||||+||+++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 235678888999999999999999998 9999999999999999999999999987543322211
Q ss_pred -eeeeecCCCCCCccccccC-------CCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 554 -TTQVQGTFGYLDPEYFRSS-------RFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 554 -~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.....++..|+|||++... .++.++||||||+++|||++ |+.||......+ . ....... .....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~---~~~~~~~-~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---V---LTYTVRE-QQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---H---HHHHhhc-ccCCC
Confidence 1223467889999998642 35789999999999999996 999985432211 1 1111111 11111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
.++... ......+.+++.+|| .+|++|||++||...|+
T Consensus 231 ~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLK----LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccC----CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 112345788999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=321.87 Aligned_cols=255 Identities=20% Similarity=0.329 Sum_probs=199.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.++||+|+||+||+++.+. ++.+|+|.+... .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468899999999999999999764 778999987532 2334456889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999976432 5899999999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.........||+.|+|||++. ...++.++||||||+++|||++|+.||..... ...+...........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~~- 228 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERFQ- 228 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCcccc-
Confidence 333333456999999999986 34688999999999999999999999864321 111222211111000
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 665 (721)
........+.++.+|+.+||..++++ |+++.|+++.
T Consensus 229 -----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 -----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 00111223456888999988665444 6889888766
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=319.75 Aligned_cols=243 Identities=23% Similarity=0.324 Sum_probs=190.8
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHH-HHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~-il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.||+|+||+||+++.. +++.+|+|.+.... ......+..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999966 47889999875421 222334444544 56788999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|.+++.... .+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 99999987643 5788889999999999999999999 9999999999999999999999999997543222 123
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... .... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~-~~~~----------~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNIL-NKPL----------QLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHH-hCCc----------CCC
Confidence 3456999999999999999999999999999999999999998643221 1111111 1110 111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+..+.+++.+||+.+|.+||++.+.+..+
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 22345689999999999999999987554443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=321.41 Aligned_cols=243 Identities=26% Similarity=0.361 Sum_probs=191.6
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHH-HHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||+||++... +|+.+|+|.+... .......+..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999865 5899999987542 2333455666655 46778999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 99998886543 6899999999999999999999999 9999999999999999999999999987542221 123
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... ..+ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~-~~~----------~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH-KPL----------VLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc-CCc----------cCC
Confidence 3456899999999999999999999999999999999999998643211 11111111 110 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
......+.+++.+||+.+|++||++++.++.+
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i 248 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLEI 248 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence 12344588999999999999999986444333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.67 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=193.7
Q ss_pred ceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-CCcceEEEeecc
Q 036483 400 RILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLE-TEVPLLVYEFII 473 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~~~~~lv~e~~~ 473 (721)
+.||+|+||.||+|.+.+ ...+|+|+.... .....+.+.+|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998542 357999987543 34456789999999999999999999998764 556789999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976432 4678888999999999999999998 9999999999999999999999999997653221111
Q ss_pred ---eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhC-CcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 554 ---TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG-ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 554 ---~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....++..|+|||.+.+..++.++||||||+++|||++| ..|+...... .+. ..+....
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~----~~~~~~~--------- 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DIT----VYLLQGR--------- 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHH----HHHhcCC---------
Confidence 1123456789999999989999999999999999999995 4555322111 111 1111110
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 00111122456899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=318.09 Aligned_cols=261 Identities=29% Similarity=0.426 Sum_probs=202.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.+.||+|+||.||++... ++..+|+|..+.. .....+++.+|++++.+++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 5788999987643 233456789999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.++++... .+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 99999999997653 589999999999999999999984 6 9999999999999999999999999987553221
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc-----------
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED----------- 619 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 619 (721)
.....++..|+|||.+.+..++.++||||||++++||++|+.||....... ....+.......
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccC
Confidence 223458899999999988889999999999999999999999985433111 111110000000
Q ss_pred ---------chhhhhhhhhc---ccC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 620 ---------SLFEILDAHVL---KEA-SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 620 ---------~~~~~~~~~~~---~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+..+.... ... ......++.+++.+||+.+|++|||+++|++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 00000000000 000 011345689999999999999999999998764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=314.49 Aligned_cols=260 Identities=25% Similarity=0.348 Sum_probs=193.8
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhc---CCCceeeEEEEEEeC-----C
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQI---NHRNVVKLLGCCLET-----E 463 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~~-----~ 463 (721)
+|++.+.||+|+||+||+|... +++.||+|.++... ......+.+|+.+++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999966 58899999876432 22234566788877766 699999999998643 3
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 488888865432 35899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---cc
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---DS 620 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~ 620 (721)
+...... ......+|..|+|||++.+..++.++||||||++++||++|++||......+ .+.. ....... ..
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~-~~~~~~~~~~~~ 230 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGK-IFDLIGLPPEDD 230 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHH-HHHHhCCCChhh
Confidence 8664221 1233457899999999999999999999999999999999999985432211 1111 1111100 00
Q ss_pred hhhh-------hh---hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 621 LFEI-------LD---AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 621 ~~~~-------~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
+... .. .............++.+++.+||+.||++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000 00 00000111223456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.69 Aligned_cols=239 Identities=23% Similarity=0.397 Sum_probs=189.0
Q ss_pred ceEeeeCcEEEEEEEEcC-------------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 400 RILGQGGQGTVYKGMLAD-------------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
+.||+|+||.||+|++.+ ...|++|.+..........|.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2258888876655556678899999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc-------EEEee
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR-------AKVSD 539 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-------~kl~D 539 (721)
+||||+++++|..++..... .+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999988875432 5899999999999999999999998 999999999999986654 89999
Q ss_pred ccCccccccCCceeeeeeecCCCCCCccccc-cCCCCccccchhHHHHHHHHH-hCCcccccCCccccccHHHHHHHHhh
Q 036483 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFR-SSRFTEKSDVYSFGVVLAELL-TGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 540 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~SlGvll~ell-tG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ +|..|+......+ ......
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-------~~~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-------KERFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-------HHHHHh
Confidence 9998655322 1234788899999987 467899999999999999998 4777764322111 000000
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
... . .......++.+|+.+||+.+|++||++.+|++.|
T Consensus 224 -~~~-~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -GQC-M---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -cCc-c---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000 0 0111234688999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=336.27 Aligned_cols=261 Identities=22% Similarity=0.324 Sum_probs=192.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLET-------- 462 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-------- 462 (721)
..++|.+.++||+|+||.||+|... .++.||||++.... ....+|+.+|++++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 58899999874321 2345799999999999999999886432
Q ss_pred CcceEEEeeccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeec
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDF 540 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DF 540 (721)
...++||||+++ +|.+++... .....+++..++.++.||+.||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999975 676666432 22346899999999999999999999999 99999999999999664 7999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
|+++.+..... .....||+.|+|||++.+. .++.++||||||++||||++|.+||......+ .+.. ....+...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~-i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVR-IIQVLGTP 290 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHHHhCCC
Confidence 99987643222 2234689999999998764 68999999999999999999999986543221 1111 11111100
Q ss_pred chhh--hhh-------------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 SLFE--ILD-------------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~~~~--~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... ... ..+...++...+.++.+|+.+||+.+|.+|||+.|+++.
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0000 000 001111122234578999999999999999999999865
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=345.00 Aligned_cols=261 Identities=23% Similarity=0.339 Sum_probs=204.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.++||+|+||.||+|+.. .++.||+|++... .....++|.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57899999999999999999965 4889999987642 2234567999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccC--------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 470 EFIINGTLFQYLHDQN--------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
||+++++|.+++.... ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999986421 1124677888999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCc-----------------eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccc
Q 036483 542 ASRSMAIDQT-----------------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604 (721)
Q Consensus 542 ls~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~ 604 (721)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986621110 01112458999999999999999999999999999999999999986422110
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhhccc
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-TMKEVAVVLAGIKA 671 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~ 671 (721)
.. .. ..+ .++... ......+..+.+++.+||+.+|++|| +++++.+.|+....
T Consensus 239 ---i~--~~-----~~i---~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 ---IS--YR-----DVI---LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred ---hh--hh-----hhc---cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00 00 000 000000 00123345688999999999999995 67778887876643
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=299.21 Aligned_cols=263 Identities=22% Similarity=0.283 Sum_probs=200.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchh--hHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESK--VDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~lv 468 (721)
++|+..+.|++|.||.||+|+.+ +++.||+|+++...+.. --.-.+||.+|.+.+|||||.+-.+..- -+..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 55777889999999999999965 58899999987644322 2245899999999999999999888664 3467999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||++ -+|..+++.-++ ++...++.-+..|+++||+|||++. |+|||||++|+|++..|.+||+|||+||.+..
T Consensus 156 Me~~E-hDLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVE-HDLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHH-hhHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99995 478888876553 5888999999999999999999999 99999999999999999999999999998865
Q ss_pred CCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh-hccch-hhh-
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM-KEDSL-FEI- 624 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~- 624 (721)
... ..+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++.|.+....+ .+...|...= ..+.+ ..+
T Consensus 230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~d--Ql~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEID--QLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHH--HHHHHHHHhCCCccccCCCcc
Confidence 432 34556679999999999876 69999999999999999999999887654332 2222221110 00110 000
Q ss_pred -hh------------hhhcccCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 -LD------------AHVLKEASQE-DIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 -~~------------~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+. ..+...+... ....-.+|+...|.+||++|.|+.|.++.
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 00 0011111111 22456789999999999999999998664
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=312.74 Aligned_cols=263 Identities=27% Similarity=0.377 Sum_probs=198.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|.+.+.||+|++|.||+|+.. +++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4778899999999999999975 5889999987543 233456788999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
++ ++|.+++........+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888876544457999999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh--cc------chh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK--ED------SLF 622 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~------~~~ 622 (721)
......+++.|+|||.+.+. .++.++||||||++++||++|+.||....... .....+..... +. .+.
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchhhH
Confidence 11223468899999988754 57889999999999999999999986432211 11110000000 00 000
Q ss_pred ---hhhhh---hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 623 ---EILDA---HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 623 ---~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..... ............++.+++.+||..||++|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000 0000001113456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=312.16 Aligned_cols=246 Identities=24% Similarity=0.299 Sum_probs=195.7
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
|...+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++.+.+.+.+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667789999999999999865 58899999875422 22345678899999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865432 26999999999999999999999998 9999999999999999999999999987653221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ............ .
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~---~~~~~~~~~~~~----------~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK---REEVDRRVLETE----------E 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhhhccc----------c
Confidence 12234689999999999999999999999999999999999999864322110 011111111100 0
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
........++.+|+.+||+.+|++||++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQ 251 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCc
Confidence 11222345688999999999999999943
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=318.43 Aligned_cols=242 Identities=22% Similarity=0.333 Sum_probs=194.5
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~ 469 (721)
+|+..+.||+|+||+||++... +++.||+|.++.. .....+.+..|+.++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999965 5889999987642 2344567888999998885 577888999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999887543 5899999999999999999999998 999999999999999999999999998754322
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ... ..+.....
T Consensus 155 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~-~~i~~~~~-------- 218 (323)
T cd05615 155 GV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELF-QSIMEHNV-------- 218 (323)
T ss_pred Cc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHH-HHHHhCCC--------
Confidence 21 223345899999999999999999999999999999999999998643221 111 11111110
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
..+.....++.+++.+||+.+|.+|++..
T Consensus 219 --~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 219 --SYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --CCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 11222345688999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=308.12 Aligned_cols=250 Identities=26% Similarity=0.482 Sum_probs=201.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC------chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID------ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
+|...+.||+|+||+||+|...+++.+|+|.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999998889999999865421 22346789999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.+.. ++++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 5889999999999999999999998 99999999999999999999999999876532
Q ss_pred CC-----ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 549 DQ-----THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 549 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.. ........++..|+|||++.+..++.++||||||++++||++|+.||....... . ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~-----~-~~~~~~~~~~-- 226 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA-----A-MFYIGAHRGL-- 226 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH-----H-HHHhhhccCC--
Confidence 11 111223458899999999999999999999999999999999999985332111 1 1111000000
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
....+.....++.+++.+||+.+|++||++.+++.
T Consensus 227 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 ------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11122234456899999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=317.42 Aligned_cols=237 Identities=25% Similarity=0.359 Sum_probs=188.2
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHH-HHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~-il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||.||+++.. +++.||+|.+... .......+..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999975 5889999987542 2223445555654 57889999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT 153 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence 99988886543 5888999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~-~~i~~~~----------~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMY-DNILHKP----------LQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHH-HHHhcCC----------CCCC
Confidence 3456899999999999999999999999999999999999998643211 111 1111111 1122
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 23345688999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=316.71 Aligned_cols=262 Identities=25% Similarity=0.386 Sum_probs=199.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|.+.+.||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999865 57899999876432 33345678999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
++ ++|.+++..... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 96 588888865432 5889999999999999999999998 99999999999999999999999999976533221
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh---ccchhhhhh-
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK---EDSLFEILD- 626 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 626 (721)
. .....+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+. ...+...+. ...+..++.
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 235 (301)
T cd07873 160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGILSN 235 (301)
T ss_pred c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhhhcc
Confidence 1 1223468899999998754 578899999999999999999999875433211 111111110 000000100
Q ss_pred --------hhhcc----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 627 --------AHVLK----EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 627 --------~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+.... ......+..+.+|+.+||+.||.+|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 236 EEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred ccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 0111234468899999999999999999999763
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=323.36 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=197.5
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE---- 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~---- 463 (721)
...++|.+.+.||+|+||.||++... .++.||+|++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34588999999999999999999865 588999998754 23445677889999999999999999999986543
Q ss_pred --cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 464 --VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 464 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..++||||+++ +|.+.++. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999965 55555532 3788899999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc-
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS- 620 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 620 (721)
+++..... .......||..|+|||.+.+..++.++||||||+++|||++|+.||......+. ............
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~ 243 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ---WNKVIEQLGTPSA 243 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCcH
Confidence 99754322 122334689999999999999999999999999999999999999975432110 000000000000
Q ss_pred ---------hhhhhhhh--------------h----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 ---------LFEILDAH--------------V----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ---------~~~~~~~~--------------~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........ . ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0 000111123568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=314.10 Aligned_cols=251 Identities=26% Similarity=0.406 Sum_probs=205.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 367899999999999999999964 6899999988765555667889999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.+. .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999998653 4889999999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
. .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||........ + . ..... .....
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~--~---~-~~~~~--------~~~~~ 235 (297)
T cd06656 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L---Y-LIATN--------GTPEL 235 (297)
T ss_pred C-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchh--e---e-eeccC--------CCCCC
Confidence 1 2234578899999999999999999999999999999999999854322110 0 0 00000 00001
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.+|++||++++|++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334568899999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=311.58 Aligned_cols=251 Identities=25% Similarity=0.333 Sum_probs=200.3
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
|++.+.||+|+||.||+|.... +..+++|..........+.+.+|+++++.++||||+++++.+...+..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5667889999999999999764 778899988766666678899999999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|..++.+.. .++++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 99998876533 26899999999999999999999998 9999999999999999999999999987653221 122
Q ss_pred eeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 555 TQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
....++..|+|||++. +..++.++||||||+++|||++|+.||...... ........... ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~~-~~------ 227 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSEP-PT------ 227 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcCC-CC------
Confidence 3345889999999984 445788999999999999999999998532211 11111111100 00
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+...+.++.+++.+||+.+|++||++.++++.-
T Consensus 228 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 228 -LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 011222345689999999999999999999986543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=326.59 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=196.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|+..+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.++.+++|+||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999965 5889999987542 2345667889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999987543 5899999999999999999999999 999999999999999999999999998754311
Q ss_pred Cc----------------------------------eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCc
Q 036483 550 QT----------------------------------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER 595 (721)
Q Consensus 550 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~ 595 (721)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00113468999999999999999999999999999999999999
Q ss_pred ccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 036483 596 AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT---MKEVAVV 665 (721)
Q Consensus 596 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~~ 665 (721)
||......+ .+...........+ .. ......++.+++.+++ .+|++|++ +.|++++
T Consensus 235 Pf~~~~~~~------~~~~i~~~~~~~~~-----p~--~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 235 PFCSETPQE------TYRKVMNWKETLVF-----PP--EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCHHH------HHHHHHcCCCceec-----CC--CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 986433211 11111110000000 00 0112345788888876 49999986 5555443
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=305.78 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=203.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
++|+..+.||+|+||.||+|...+ ++.+++|.++.... .+++.+|++++++++|+||+++++.+.+....++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678999999999999999999775 78999998765422 678999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999986543 36899999999999999999999998 99999999999999999999999999987643321
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......++..|+|||++.+..++.++||||||+++|||++|+.|+........ .. ....... ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~------~~-~~~~~~~-------~~~~ 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA------IF-MIPNKPP-------PTLS 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh------hh-hhccCCC-------CCCC
Confidence 22234478899999999999999999999999999999999999864322110 00 0000000 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.+......+.+++.+||+.+|++|||+.||++
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 12233456899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=327.99 Aligned_cols=262 Identities=23% Similarity=0.346 Sum_probs=197.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
....|.+.++||+|+||.||++.... ++.||||... ...+.+|+++|++++|+||+++++++...+..++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34579999999999999999999764 7889999532 2356789999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
++ .++|.+++..... .++|..++.|+.|++.||.|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 241 ~~-~~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KY-RSDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 99 4788888765332 5999999999999999999999999 9999999999999999999999999998654322
Q ss_pred ce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcc-ccccHHHHHHHHhhccch-------
Q 036483 551 TH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFE-EDKSLAAYFLRAMKEDSL------- 621 (721)
Q Consensus 551 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~~~------- 621 (721)
.. ......||..|+|||++.+..++.++||||||++||||++|..++...... ........+.+.+.....
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 11 122356999999999999999999999999999999999988765332211 111111111111111100
Q ss_pred ------hhhhhhh----hcccCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 622 ------FEILDAH----VLKEAS-------QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 622 ------~~~~~~~----~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....... ...... ......+.+|+.+||+.||++|||+.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000 000000 0122358899999999999999999999874
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=311.75 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=205.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.+.||+|+||+||++... +++.+|+|...... ....+.+.+|+++++.++||||+++++.+......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56788899999999999999965 58899999865432 34467899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++.... .+++..+..++.+++.||.|||+. + |+||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 99999999887543 589999999999999999999974 6 9999999999999999999999999986543211
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc-----ccHHHHHHHHhhccchhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED-----KSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 625 (721)
.....|+..|+|||++.+..++.++||||||++++||++|+.||......++ ......+......
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 228 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------- 228 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc-------
Confidence 1234689999999999888999999999999999999999999875433211 0111111111110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..........+.++.+++.+||+.+|++|||+.||+++..-++
T Consensus 229 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 229 --PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred --cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 0000011124557899999999999999999999998755444
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=306.77 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=190.2
Q ss_pred ceEeeeCcEEEEEEEEcC---CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLAD---GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+.||+|+||.||+|...+ ...+++|.+.... ......|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997543 3468888765432 334567899999999999999999999999999999999999999
Q ss_pred CcchhccccCC--CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 476 TLFQYLHDQNE--EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 476 sL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|.+++..... ....++...++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 223568888999999999999999998 9999999999999999999999999987543322111
Q ss_pred -eeeeecCCCCCCcccccc-------CCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 554 -TTQVQGTFGYLDPEYFRS-------SRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 554 -~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+ ......... ...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-~~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-DIKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-CccC
Confidence 122335678999998743 356789999999999999999 777775332111 111111111 1111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+. .+...+..+.+++..|| .+|++|||+++|++.|.
T Consensus 231 ~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 PKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1111 12233455778888998 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.04 Aligned_cols=251 Identities=29% Similarity=0.428 Sum_probs=205.3
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|+..+.||+|+||.||.++.. +++.+++|++... +....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 5888999999999999999854 5889999986543 345567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999997653 236899999999999999999999998 99999999999999999999999999987643332
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......+++.|+|||.+.+..++.++||||||++++||++|..||..... ........ .... .
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~-~~~~---------~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP------LNLVVKIV-QGNY---------T 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHH-cCCC---------C
Confidence 22334589999999999988899999999999999999999999854221 11111111 1111 1
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
......+.++.+++.+||+.+|++||++.++++.+
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11223345688999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.91 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=204.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-Cc----EEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GR----IVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.+|.+.+.||+|+||.||+|...+ ++ .+|+|..+... .....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 567888999999999999998653 33 58999876543 3455789999999999999999999999987 77899
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 9999999999999976543 4899999999999999999999988 9999999999999999999999999998765
Q ss_pred cCCceee-eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHMT-TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
....... ....++..|+|||.+....++.++||||||++++||++ |+.||......+ +...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDLLEKGER---- 229 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHHHhCCCC----
Confidence 3322211 11223568999999988899999999999999999998 999985432211 1112211110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
...+......+.+++.+||..+|++||++.++++.|+.+..
T Consensus 230 -----~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 230 -----LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11112233468899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=321.34 Aligned_cols=247 Identities=27% Similarity=0.395 Sum_probs=206.3
Q ss_pred eEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcch
Q 036483 401 ILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQ 479 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 479 (721)
+||+|.||+||.|+..+ ...+|||.+...+....+-+.+|+.+.++|+|+|||+++|.+.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 79999999999999765 55799999888777888899999999999999999999999999998899999999999999
Q ss_pred hccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCCcEEEeeccCccccccCCceeeeeee
Q 036483 480 YLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFGASRSMAIDQTHMTTQVQ 558 (721)
Q Consensus 480 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGls~~~~~~~~~~~~~~~ 558 (721)
+|+..=....=++.++-.+.+||++||.|||++. |||||||-.|+||+ -.|.+||+|||-++.+..-+ ..+.++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC-ccccccc
Confidence 9986433222278888899999999999999999 99999999999996 67899999999998775322 2345567
Q ss_pred cCCCCCCccccccC--CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHH
Q 036483 559 GTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQE 636 (721)
Q Consensus 559 gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (721)
||.-|||||++..+ .|..++|||||||.+.||.||++||...+... +. ++++---....+++.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq----AA----------MFkVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ----AA----------MFKVGMYKVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh----Hh----------hhhhcceecCCCCcHH
Confidence 99999999999876 48899999999999999999999996443221 11 1111111223456777
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 637 DIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 637 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+...+|.+|+..+|.+||+++++++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 88889999999999999999999999764
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=305.75 Aligned_cols=248 Identities=27% Similarity=0.502 Sum_probs=200.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc---------hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE---------SKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
+|.+.+.||+|++|.||+|... +++.+|+|.+..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999864 578999997654221 123578899999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997643 5889999999999999999999998 9999999999999999999999999988
Q ss_pred ccccCCce-----eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 545 SMAIDQTH-----MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 545 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
........ ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||..... ... .... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~-~~~~-~~- 226 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-----LQA-IFKI-GE- 226 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH-----HHH-HHHH-hc-
Confidence 76422111 11123578899999999998999999999999999999999999864221 111 1100 00
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
......+...+..+.+++.+||+.+|++||++.||++
T Consensus 227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 --------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred --------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0111222334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=310.37 Aligned_cols=239 Identities=23% Similarity=0.380 Sum_probs=187.6
Q ss_pred eEeeeCcEEEEEEEEcC-------------------------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeE
Q 036483 401 ILGQGGQGTVYKGMLAD-------------------------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKL 455 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l 455 (721)
.||+|+||.||+|.+.. ...|++|.+..........|.+|+.++++++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998521 13588888765544556788999999999999999999
Q ss_pred EEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC--
Q 036483 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-- 533 (721)
Q Consensus 456 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-- 533 (721)
++++.+....++||||+++++|..++..... .+++..+++++.|+++||+|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999998865432 5889999999999999999999998 99999999999997643
Q ss_pred -----cEEEeeccCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHH-hCCcccccCCccccc
Q 036483 534 -----RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELL-TGERAIRVTNFEEDK 606 (721)
Q Consensus 534 -----~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~ell-tG~~p~~~~~~~~~~ 606 (721)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......+
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-- 229 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE-- 229 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH--
Confidence 3899999988644221 12246788999998876 56899999999999999995 6888875432211
Q ss_pred cHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 607 SLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
....+ .. .. ..+......+.+++.+||+.+|++|||+.+|++.|.
T Consensus 230 -~~~~~----~~---------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 230 -KERFY----EK---------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred -HHHHH----Hh---------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11110 00 00 001112245889999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.32 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=204.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.+|+..+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|+||+++++.+.+.+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688899999999999999985 468999999887655556678899999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 999999988643 4899999999999999999999999 999999999999999999999999998765433221
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... .... ...
T Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~------~~~~~~~-~~~~-------~~~ 236 (296)
T cd06655 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR------ALYLIAT-NGTP-------ELQ 236 (296)
T ss_pred -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHh-cCCc-------ccC
Confidence 223458889999999999899999999999999999999999985433211 0111100 0000 001
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+...+..+.+++.+||..+|++||++.+|+..
T Consensus 237 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 237 NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 122234568899999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=308.19 Aligned_cols=250 Identities=29% Similarity=0.477 Sum_probs=197.8
Q ss_pred ceEeeeCcEEEEEEEEcC-------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLAD-------GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+.||+|+||.||+|+..+ ++.+|||...... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 469999999999998653 2578999765432 34567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccC----CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-----cEEEeeccC
Q 036483 472 IINGTLFQYLHDQN----EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-----RAKVSDFGA 542 (721)
Q Consensus 472 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-----~~kl~DFGl 542 (721)
+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 1235889999999999999999999998 99999999999999877 899999999
Q ss_pred ccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccc
Q 036483 543 SRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 543 s~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
++......... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~-~~~~~~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EV-LQHVTAGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HH-HHHHhcCC
Confidence 87654322111 112235678999999999999999999999999999998 99988533211 11 11111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
....+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 231 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ---------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 111223345678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=304.53 Aligned_cols=250 Identities=26% Similarity=0.388 Sum_probs=201.2
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-cceEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE-VPLLVYE 470 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-~~~lv~e 470 (721)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999965 4788999987543 2345567899999999999999999999876444 5789999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++..... ..+++.+++.++.|++.||++||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999876432 35899999999999999999999999 9999999999999999999999999997664322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||..... ...... ..... .
T Consensus 157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~-~~~~~---------~ 219 (257)
T cd08223 157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYR-IIEGK---------L 219 (257)
T ss_pred C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHH-HHhcC---------C
Confidence 2 22334588999999999999999999999999999999999999853221 111111 11111 1
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12223445679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.90 Aligned_cols=261 Identities=23% Similarity=0.329 Sum_probs=198.0
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE---- 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~---- 463 (721)
...++|...+.||+|+||.||++... .++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 45678999999999999999999865 5889999987642 3344567889999999999999999999886433
Q ss_pred --cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 464 --VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 464 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..++||||+++ +|.+.+.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 46899999965 56665542 4888999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE--- 618 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 618 (721)
+++..... .......||..|+|||++.+..++.++||||||+++|||++|+.||......+. ... ....+..
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~-~~~~~~~~~~ 239 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ--WNK-VIEQLGTPCP 239 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-HHHHhCCCCH
Confidence 99765322 222345689999999999999999999999999999999999999965432211 000 0000000
Q ss_pred -------cchhhhhhh----------hh--------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 619 -------DSLFEILDA----------HV--------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 619 -------~~~~~~~~~----------~~--------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...++. .. ..........++.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 000000000 00 001111223568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=307.60 Aligned_cols=248 Identities=26% Similarity=0.387 Sum_probs=203.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.+.||.|++|.||+|... +++.+|+|...... ......+.+|+++++.++|+||+++++++.+....++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999966 58899999876532 44567789999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998754 5899999999999999999999998 99999999999999999999999999987653321
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+..... .
T Consensus 154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~------~-~~~~~~~~~~---------~ 216 (274)
T cd06609 154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM------R-VLFLIPKNNP---------P 216 (274)
T ss_pred -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH------H-HHHHhhhcCC---------C
Confidence 222345788999999999988999999999999999999999998543211 0 1111111100 1
Q ss_pred cCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 EASQE-DIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... .+..+.+++.+||..+|++|||++++++.
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11111 34568999999999999999999999774
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=324.19 Aligned_cols=261 Identities=23% Similarity=0.313 Sum_probs=199.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc---CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA---DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..+|.+.+.||+|+||.||++... .++.||+|.+... +.+.+|+++|++++||||+++++.+......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999754 3568999976532 34568999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
|++. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9985 6788888433 26999999999999999999999999 999999999999999999999999999765432
Q ss_pred Cce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh------
Q 036483 550 QTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF------ 622 (721)
Q Consensus 550 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 622 (721)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||................+.+......
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~ 318 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS 318 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence 221 2234569999999999999999999999999999999999999986554332111111111111111000
Q ss_pred ----hh---hhhhhcccCC-------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 623 ----EI---LDAHVLKEAS-------QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 623 ----~~---~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+. .......... .....++.+++.+||..+|++|||+.|++..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000000 0123467889999999999999999999776
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=320.05 Aligned_cols=191 Identities=24% Similarity=0.424 Sum_probs=164.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..+|.+.+.||+|+||.||+|... .++.||+|.... .....|+.++++++|+||+++++++.+....++|||+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 457999999999999999999976 467899996432 2345799999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+ .++|.+++.... ..+++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 139 ~-~~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-- 210 (357)
T PHA03209 139 Y-SSDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-- 210 (357)
T ss_pred c-CCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence 9 468888886543 25899999999999999999999998 999999999999999999999999999753221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCccc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~ 597 (721)
.......||..|+|||++.+..++.++||||||+++|||+++..++
T Consensus 211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223356899999999999999999999999999999999966554
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=307.86 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=202.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.|++.++||+|+||.||+|.... ++.+++|.....+....+.+.+|+.++++++|+||+++++.+......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568889999999999999999764 8899999987766667788999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|..++.+... .+++..++.++.|++.+|+|||+.+ |+||||||+||+++.++.+||+|||++...... ..
T Consensus 92 ~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 92 PGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999888765432 5899999999999999999999998 999999999999999999999999998754322 11
Q ss_pred eeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 553 MTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
......++..|+|||++. ...++.++||||||+++|||++|+.||..... ...+....... ...
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~~-~~~---- 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE-PPT---- 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH------HHHHHHHhcCC-Ccc----
Confidence 223345889999999985 34578899999999999999999999853221 11111111110 000
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+.....++.+++.+||+.+|++||++.++++.
T Consensus 235 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 235 ---LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred ---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 01122234568899999999999999999999763
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=304.31 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=205.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||.||++... +++.+++|..........+.+.+|++++++++||||+++++.+.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367889999999999999999965 5788999988766556678899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA 156 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence 99999999987642 25899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeeeecCCCCCCccccccC---CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS---RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... .. .. ...... ...
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~--~~----~~-~~~~~~----~~~ 224 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR--AL----FL-ISKSNF----PPP 224 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HH----HH-HHhccC----CCc
Confidence 12234578899999999877 88999999999999999999999985432111 00 00 001100 000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
........+.++.+++.+||+.+|.+|||+.+|+.
T Consensus 225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 225 -KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred -cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00112334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=289.74 Aligned_cols=259 Identities=27% Similarity=0.415 Sum_probs=208.0
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc--------hhhHHHHHHHHHHhhc-CCCceeeEE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE--------SKVDEFINEVAILSQI-NHRNVVKLL 456 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~h~niv~l~ 456 (721)
.+-+...+.|...++||.|..++|-+...+ .|+.+|+|++..... .-.+.-..|+.||+++ .||+|+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 344566778999999999999999888755 578899997644211 1234567899999998 699999999
Q ss_pred EEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 457 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
+++..+...++|+|.|+.|.|.++|.... .++++...+|+.|+.+|+.|||..+ |+||||||+|||+|++.++|
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 99999999999999999999999998765 6999999999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCceeeeeeecCCCCCCccccccC------CCCccccchhHHHHHHHHHhCCcccccCCccccccHHH
Q 036483 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS------RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA 610 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~ 610 (721)
|+|||++..+.+.. ......||++|+|||.+... .|+...|+|+.||+||.|+.|.+||-... ..
T Consensus 164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-------Qm 234 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-------QM 234 (411)
T ss_pred EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-------HH
Confidence 99999999886543 34567899999999988543 47788999999999999999999983211 11
Q ss_pred HHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 611 YFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+.+.++... . ..+.=.+....+.+||.+||+.||.+|.|.+|++.+-
T Consensus 235 lMLR~ImeGkyq-F-----~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 235 LMLRMIMEGKYQ-F-----RSPEWADISATVKDLISRLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHHHHhcccc-c-----CCcchhhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence 123333333221 1 1111123445689999999999999999999998764
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=307.73 Aligned_cols=252 Identities=25% Similarity=0.354 Sum_probs=200.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
++|.+.+.||+|+||.||+|+.. +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46778889999999999999865 58899999887655555677899999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++.... .+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....... .
T Consensus 89 ~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06645 89 GGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A 161 (267)
T ss_pred CCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence 9999999987543 5899999999999999999999998 9999999999999999999999999987653221 1
Q ss_pred eeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 553 MTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
......|+..|+|||++. ...++.++||||||+++|||++|+.|+....... ..+ . ....... +..
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~-----~~~-~-~~~~~~~----~~~ 230 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALF-L-MTKSNFQ----PPK 230 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh-----hHH-h-hhccCCC----CCc
Confidence 223346899999999974 4568899999999999999999999975332111 000 0 0000000 000
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... ....+..+.+++.+||+.+|++||++.+|++
T Consensus 231 ~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000 0112345889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.28 Aligned_cols=253 Identities=26% Similarity=0.407 Sum_probs=202.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999976 6899999987643 344567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|..++........+++..+..++.|++.||.|||+. + |+||||||+||+++.++.+||+|||++..+...
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987643334689999999999999999999974 6 999999999999999999999999998765322
Q ss_pred ceeeeeeecCCCCCCccccccC------CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFRSS------RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... .....+. .+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~---------~~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLS---------AI 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHH---------HH
Confidence 12223478899999998654 3578999999999999999999998532211 1111110 01
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ......+.....++.+++.+||+.+|++||++.+++..
T Consensus 223 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 223 VD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred hh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11 01112233455678999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=303.65 Aligned_cols=238 Identities=25% Similarity=0.427 Sum_probs=189.4
Q ss_pred ceEeeeCcEEEEEEEEcCCc-----------EEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 400 RILGQGGQGTVYKGMLADGR-----------IVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
+.||+|+||.||+|.+.+.. .+++|........ ...|.+|+.++++++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999976533 5777876544333 6789999999999999999999999988 778999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-------cEEEeecc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-------RAKVSDFG 541 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-------~~kl~DFG 541 (721)
|||+++++|.+++..... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999986543 5899999999999999999999998 99999999999999887 79999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccC--CCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhc
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
++..... .....++..|+|||++... .++.++||||||+++|||++ |..|+......+ ... ....
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~---~~~----~~~~ 221 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE---KER----FYQD 221 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh---HHH----HHhc
Confidence 9976533 1223467789999999877 78999999999999999999 566664432111 000 0100
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
... .+......+.+++.+||..+|.+|||+.+|++.|+
T Consensus 222 ~~~-----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 222 QHR-----------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred CCC-----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00011156899999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=303.57 Aligned_cols=251 Identities=31% Similarity=0.514 Sum_probs=202.3
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-----CcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-----GRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+.+.+.||+|+||.||++...+ +..||+|..+..... ..+.+.+|+.++.+++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999764 378999998664433 5678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++...... .+++..++.++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999764421 2899999999999999999999998 999999999999999999999999999876544
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.........++..|+|||.+.+..++.++||||||++++||++ |..|+..... .. ..........
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~------~~-~~~~~~~~~~------- 222 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN------EE-VLEYLKKGYR------- 222 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH------HH-HHHHHhcCCC-------
Confidence 2222222336789999999988889999999999999999998 7777653211 11 1111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+...+.++.+++.+||..+|++|||+.|+++.|
T Consensus 223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 --LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 111222456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=311.11 Aligned_cols=197 Identities=26% Similarity=0.414 Sum_probs=160.3
Q ss_pred CceEeeeCcEEEEEEEEc---CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceEEEeecc
Q 036483 399 NRILGQGGQGTVYKGMLA---DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFII 473 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 473 (721)
.++||+|+||+||+|+.. +++.+|+|.++... ....+.+|+.++++++||||+++++.+.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999865 46789999876432 23467899999999999999999999865 345689999985
Q ss_pred CCCcchhccccC------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE----CCCCcEEEeeccCc
Q 036483 474 NGTLFQYLHDQN------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGAS 543 (721)
Q Consensus 474 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGls 543 (721)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57777765321 1235899999999999999999999999 9999999999999 45678999999999
Q ss_pred cccccCCce--eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCC
Q 036483 544 RSMAIDQTH--MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTN 601 (721)
Q Consensus 544 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~ 601 (721)
+........ ......||+.|+|||++.+. .++.++||||||++++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 876432211 12345689999999999774 58899999999999999999999986433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.91 Aligned_cols=247 Identities=28% Similarity=0.479 Sum_probs=199.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|.+.+.||+|+||.||++.. .++.+|+|..+.. ...+.+.+|+.++++++||||+++++++... ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 5778999987643 2346889999999999999999999998765 4699999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 9999999976432 35899999999999999999999998 9999999999999999999999999987543211
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ........ ....
T Consensus 155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~---------~~~~ 217 (254)
T cd05083 155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKG---------YRME 217 (254)
T ss_pred -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH-------HHHHHhCC---------CCCC
Confidence 11234567999999998899999999999999999998 898886433211 11111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
.....+..+.+++.+||+.+|++||++++|++.|+.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 122345678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=303.47 Aligned_cols=247 Identities=24% Similarity=0.408 Sum_probs=201.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-----chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-----ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
+|...+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.++++++|+||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999875533 23567899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997643 5889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. ......++..|++||.+.... ++.++|+||||+++|+|++|+.||..... ............
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~~~~------- 219 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKE------- 219 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH------HHHHHHHHhccc-------
Confidence 32 223445889999999998776 89999999999999999999999853321 011111111000
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
....+......+.+++.+||+.+|++||++.+++.
T Consensus 220 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 --LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred --CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11122234466889999999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=304.01 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=195.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-----chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-----ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~ 465 (721)
.+|...+.||+|+||.||+|... .++.+++|++.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999865 58899999865421 23456789999999999999999999998753 466
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++++||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 5889999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCc--eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 546 MAIDQT--HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 546 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||...... .. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~-~~~~~~~----- 224 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AA-IFKIATQ----- 224 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HH-HHHHhcC-----
Confidence 532111 1112345788999999999999999999999999999999999998532111 10 1111100
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
......+......+.+++ +||..+|++||+++||+.
T Consensus 225 ----~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 225 ----PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred ----CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 001122233344567777 788899999999999965
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=308.17 Aligned_cols=240 Identities=22% Similarity=0.395 Sum_probs=190.1
Q ss_pred ceEeeeCcEEEEEEEEcC--------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLAD--------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+.||+|+||.||+|.... ...+++|..........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 234888877655555567899999999999999999999999998999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc--------EEEeeccCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR--------AKVSDFGAS 543 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~kl~DFGls 543 (721)
+++|+|.++++.... .+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999976543 5899999999999999999999998 999999999999987765 699999998
Q ss_pred cccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCC-cccccCCccccccHHHHHHHHhhccch
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGE-RAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
...... ....++..|+|||++.+. .++.++||||||+++|||++|. .|+....... .......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~-------~~~~~~~--- 220 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK-------KLQFYED--- 220 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH-------HHHHHHc---
Confidence 654321 224578899999999874 5889999999999999999985 4443221110 0000000
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus 221 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 --------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01112222356899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=306.12 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=201.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC--CcEEEEeecccc----------CchhhHHHHHHHHHHhh-cCCCceeeEEEEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD--GRIVAIKKSKVI----------DESKVDEFINEVAILSQ-INHRNVVKLLGCCLE 461 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~E~~il~~-l~h~niv~l~g~~~~ 461 (721)
+|++.+.||+|+||.||+|.... ++.+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999765 688999976432 22345567889988875 799999999999999
Q ss_pred CCcceEEEeeccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCCcEEEee
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSD 539 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~D 539 (721)
.+..+++|||+++++|.+++... .....+++..+++++.|++.||.|||+ .+ |+|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 223368999999999999999999996 55 99999999999999999999999
Q ss_pred ccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 540 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
||++....... ......++..|++||.+.+..++.++||||||+++|||++|+.||...... . ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~------~-~~~~~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNML------S-LATKIVEA 228 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHH------H-HHHHHhhc
Confidence 99998654332 233455889999999999988999999999999999999999998533211 1 11111111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
... ..........+.+++.+||+.||++||++.||..+|+
T Consensus 229 ~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 VYE--------PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred cCC--------cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 110 0001123456899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.68 Aligned_cols=256 Identities=26% Similarity=0.483 Sum_probs=200.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|...+.||+|+||.||+|.+. ++. .+|+|...... .....++.+|+.++++++||||+++++++... ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45778899999999999999864 343 57888776533 23345789999999999999999999998754 4679
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
++||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 9999999999999876432 5889999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-------~~~~~~~~~~---- 229 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLLEKGER---- 229 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHCCCC----
Confidence 332211 122335678999999999999999999999999999997 888885432111 1111111110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
...+...+..+.+++.+||..+|++||+++++++.|+.+..
T Consensus 230 -----~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 -----LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 01111233468899999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=313.87 Aligned_cols=254 Identities=28% Similarity=0.383 Sum_probs=212.1
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCc---hhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCc
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDE---SKVDEFINEVAILSQIN-HRNVVKLLGCCLETEV 464 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~ 464 (721)
......|.+.+.||+|.||.||+++.+. |+.+|+|.+..... ...+.+.+|+.+|+++. |||||.+.+.+.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3455778999999999999999999775 99999998755332 24568999999999998 9999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC----CcEEEeec
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK----YRAKVSDF 540 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DF 540 (721)
.++|||++.||.|.+.+... .+++..+..++.|++.+++|||+.+ |+||||||+|+|+... +.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999876 2999999999999999999999999 9999999999999643 47999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
|++..... ........||+.|+|||++....|+..+||||+|+++|.|++|..||........ +. .+....
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~------~~-~i~~~~ 254 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI------FL-AILRGD 254 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH------HH-HHHcCC
Confidence 99998765 4456677899999999999999999999999999999999999999965443221 11 111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ....+.-......+.+++.++|..||..|+|+.+++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1 11122223345678999999999999999999999986
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=305.43 Aligned_cols=249 Identities=26% Similarity=0.389 Sum_probs=204.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..|+..+.||+|+||.||+|... +++.||+|...... ....+.+.+|+.++++++|+||+++++++.+....++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999975 58899999876432 44567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++... ++++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999988643 4889999999999999999999998 99999999999999999999999999976643221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||++.+..++.++||||||+++|||++|+.|+....... ..... ......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~---------~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-------VLFLI---------PKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-------Hhhhh---------hcCCCC
Confidence 2223457889999999998899999999999999999999999985332111 00001 111112
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
......+..+.+++.+||+.+|++||++.+++..-
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHK 254 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhCh
Confidence 23345667799999999999999999999997764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=318.86 Aligned_cols=261 Identities=24% Similarity=0.341 Sum_probs=197.8
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-----
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET----- 462 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~----- 462 (721)
...++|.+.+.||+|+||.||+++.. .++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34678999999999999999999965 5889999987642 344556788999999999999999999987643
Q ss_pred -CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 463 -EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 463 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
...++||||+++ +|.+++.. .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 346899999965 66666642 4788999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc--
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED-- 619 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 619 (721)
+++..... .......+|..|+|||++.+..++.++||||||+++|||++|+.||......+. ...........
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 246 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ---WNKVIEQLGTPCP 246 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 99765322 122334689999999999999999999999999999999999999965432211 00000000000
Q ss_pred --------chhhhhh--------------hhhc----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 --------SLFEILD--------------AHVL----KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 --------~~~~~~~--------------~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+..... .... .+........+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000000 0000 00111123468899999999999999999999774
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=303.15 Aligned_cols=253 Identities=23% Similarity=0.320 Sum_probs=189.1
Q ss_pred ceEeeeCcEEEEEEEEcCC---cEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 400 RILGQGGQGTVYKGMLADG---RIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+.||+|+||.||+|...++ ..+++|.++... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999985443 356677655432 345678999999999999999999999999999999999999999
Q ss_pred CcchhccccCC-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC-cee
Q 036483 476 TLFQYLHDQNE-EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ-THM 553 (721)
Q Consensus 476 sL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~-~~~ 553 (721)
+|.+++++... ...+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999976432 234677788899999999999999998 9999999999999999999999999986432111 111
Q ss_pred eeeeecCCCCCCcccccc-------CCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 554 TTQVQGTFGYLDPEYFRS-------SRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||..... ...+...... ......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~------~~~~~~~~~~-~~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD------REVLNHVIKD-QQVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHhh-cccccC
Confidence 223457889999998753 245789999999999999997 4566643221 1111111211 112222
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
++..... ....+.+++..|| .+|++||++++|++.|.
T Consensus 231 ~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222 2345788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=308.67 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=199.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|+..+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999976 58899999875432 2334568899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|..++.... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988887765432 5899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc-----------
Q 036483 551 THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE----------- 618 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----------- 618 (721)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.||......+. +.. .......
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ--LYL-IRKTLGDLIPRHQQIFST 230 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH--HHH-HHHHhCCCChHHhhhccc
Confidence 1 1223347889999999876 4678999999999999999999999865432211 000 0000000
Q ss_pred cchhh---hhhhhhcc---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 DSLFE---ILDAHVLK---EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ~~~~~---~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..... ..++.... ......+..+.+++.+||+.+|++||++.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000 00000000 000122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=302.85 Aligned_cols=250 Identities=25% Similarity=0.380 Sum_probs=203.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|+..+.||+|+||.||++... +++.+|+|++... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 5788999999999999999864 5889999987542 344556899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..+++++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998875432 25789999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......|+..|+|||++.+..++.++||||||+++++|++|+.|+..... .......... . ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~-~---------~~ 219 (256)
T cd08218 157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRG-S---------YP 219 (256)
T ss_pred -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcC-C---------CC
Confidence 12234578899999999999999999999999999999999999853221 1111111111 1 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.....++.+++.+||+.+|++||++.+|++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1222345568999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=308.57 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=204.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||.||++... ++..+|+|..........+.|.+|++++++++|+||+++++.+.+....++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888999999999999999975 5889999998776666778899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... .+++..+++++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999876432 5899999999999999999999999 99999999999999999999999999876533222
Q ss_pred eeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...... ...... ......
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~------~~~~~~-~~~~~~---- 226 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM------RVLLKI-LKSEPP---- 226 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH------HHHHHH-hcCCCC----
Confidence 223345899999999975 345778999999999999999999998543211 111111 111000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+...+.++.+++.+||+.+|.+||++.+|++.
T Consensus 227 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 227 ---TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 001122234568899999999999999999999765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=321.05 Aligned_cols=261 Identities=22% Similarity=0.310 Sum_probs=196.4
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC----
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET---- 462 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~---- 462 (721)
....++|...+.||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 345688999999999999999999864 5789999987642 223456788999999999999999999987543
Q ss_pred --CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 463 --EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 463 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
...++++|++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+||
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCC
Confidence 3458999987 78888877543 4899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
|+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ............
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~~~~~~~~~ 235 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID---QLKRIMEVVGTP 235 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH---HHHHHHHHhCCC
Confidence 999865322 223458999999999877 578899999999999999999999986533211 011111100000
Q ss_pred c---hhhhhhh---hh---cccCC--------HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 S---LFEILDA---HV---LKEAS--------QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~---~~~~~~~---~~---~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. +..+... .. ....+ ......+.+|+.+||+.||++|||+.|+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0 0000000 00 00000 0112347899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=302.53 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=197.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-----chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-----ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~ 465 (721)
.+|.+.++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46888999999999999999965 48899999764321 23456789999999999999999999998764 456
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
+++|||+++++|.+++.... .+++..+++++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 79999999999999987543 4788999999999999999999999 99999999999999999999999999876
Q ss_pred cccCCc--eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 546 MAIDQT--HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 546 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
...... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ... .......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~~-~~~~~~~----- 224 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-----MAA-IFKIATQ----- 224 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-----HHH-HHHHhcC-----
Confidence 532111 112234588899999999988899999999999999999999999853211 111 1111100
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
......+......+.+++.+|+. +|++||+++||++
T Consensus 225 ----~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 225 ----PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ----CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 01112233445668889999994 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=309.92 Aligned_cols=262 Identities=26% Similarity=0.338 Sum_probs=202.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|++.+.||+|+||.||+|... +++.||+|.++.. .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999976 4789999987542 33445789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|++++.|..++... ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99987776655432 25899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh-----------hc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM-----------KE 618 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 618 (721)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+ .+.. ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID--QLYL-IQKCLGPLPPSHQELFSS 231 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHhhhccc
Confidence 3233345678899999999888 88999999999999999999999986432211 0000 00000 00
Q ss_pred cc------hhhhhhhhh-cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 DS------LFEILDAHV-LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ~~------~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. ..+..+... ....+...+.++.+++++||..+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00 000000000 00112223567999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=319.80 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=197.9
Q ss_pred CCceEeeeCcEEEEEEEEcC-CcEEEE---eeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc--ceEEEe
Q 036483 398 TNRILGQGGQGTVYKGMLAD-GRIVAI---KKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV--PLLVYE 470 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~-~~~vav---K~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~--~~lv~e 470 (721)
...+||+|+|-+||+|.... |-.||= |.-.. .++...++|..|+.+|+.|+||||++++..+.+... ..+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 45689999999999999653 555552 22111 345567899999999999999999999999988776 678999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeeccCccccccC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAID 549 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGls~~~~~~ 549 (721)
.+..|+|..|+.+.+ .++.+.+..|++||++||.|||++. |||||||||-.||+|+.+ |.+||+|+|||......
T Consensus 124 L~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 999999999998876 5889999999999999999999986 579999999999999865 78999999999876432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
....+.|||.|||||++. ..|++..||||||+.|+||+|+..|+. +..+.+..+ +++..+.....+.
T Consensus 200 ---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs-----EC~n~AQIY-KKV~SGiKP~sl~--- 266 (632)
T KOG0584|consen 200 ---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS-----ECTNPAQIY-KKVTSGIKPAALS--- 266 (632)
T ss_pred ---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh-----hhCCHHHHH-HHHHcCCCHHHhh---
Confidence 223478999999999998 889999999999999999999999985 445555433 3333332221111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.-..++++++|.+||.. .++|||+.|+++.
T Consensus 267 -----kV~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 267 -----KVKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----ccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 11234699999999999 9999999999764
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=309.48 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=200.3
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.|...+.||+|+||.||+|... +++.||+|..... .....+.+.+|++++++++||||+++++++......++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999865 5788999987643 2345678999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++... .+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999988643 5899999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......++..|+|||++.+..++.++||||||++++||++|+.|+....... ........ ....
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-------~~~~~~~~---------~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-------VLFLIPKN---------SPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-------HHhhhhcC---------CCCC
Confidence 1222457889999999999999999999999999999999999975322111 00011111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.....+..+.+++.+||+.+|++||++.+|+..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 222344568999999999999999999999885
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=314.85 Aligned_cols=244 Identities=29% Similarity=0.398 Sum_probs=197.8
Q ss_pred CCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 396 YNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
|...+.||.|+||.||.|+. .+..+||||++.... .+.++++..|+..|.+++|||++.+-||+..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 55678899999999999995 467899999986643 34577899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+ -|+-.+++.-.+ +++.+..+..|..+.+.||+|||+++ .||||||..||||++.+.+||+|||.+....+.+
T Consensus 108 C-lGSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn- 180 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN- 180 (948)
T ss_pred H-hccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCchh-
Confidence 9 556666665443 36889999999999999999999999 9999999999999999999999999997765433
Q ss_pred eeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.++|||.|||||++. .+.|+.|+||||||++..||.-+++|+...+.. ...+--.-.+.+..
T Consensus 181 ----sFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM-----SALYHIAQNesPtL------ 245 (948)
T KOG0577|consen 181 ----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHIAQNESPTL------ 245 (948)
T ss_pred ----cccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH-----HHHHHHHhcCCCCC------
Confidence 456999999999875 468999999999999999999999997533211 11111111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+-...+.+++..||+.-|.+|||.++++..
T Consensus 246 ----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 246 ----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred ----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 123445679999999999999999999887654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=332.55 Aligned_cols=267 Identities=17% Similarity=0.262 Sum_probs=193.8
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCC------CceeeEEEEE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINH------RNVVKLLGCC 459 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h------~niv~l~g~~ 459 (721)
+++...+++|.+.++||+|+||+||+|... .++.||||+++... ....++..|+++++.++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556788999999999999999999965 47889999886432 233456678888777654 4588999988
Q ss_pred EeC-CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCC----
Q 036483 460 LET-EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKY---- 533 (721)
Q Consensus 460 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~---- 533 (721)
... ...++|||++ +++|.+++.... .+++..+..|+.||+.||.|||++ + |+||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 764 4678999988 778888886543 589999999999999999999984 7 99999999999998765
Q ss_pred ------------cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCC
Q 036483 534 ------------RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601 (721)
Q Consensus 534 ------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~ 601 (721)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred cccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 49999999875432 12234569999999999999999999999999999999999999997544
Q ss_pred ccccccHHHHH--------HHHhhccchhhhh----------hhhh----ccc---CCHHHHHHHHHHHHHhhccCCCCC
Q 036483 602 FEEDKSLAAYF--------LRAMKEDSLFEIL----------DAHV----LKE---ASQEDIVTVAKLTNRCLNLNGKKR 656 (721)
Q Consensus 602 ~~~~~~~~~~~--------~~~~~~~~~~~~~----------~~~~----~~~---~~~~~~~~l~~li~~cl~~~p~~R 656 (721)
..+........ ..........++. ++.. ... ........+.+|+.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 22111111000 0000000000000 0000 000 000123457899999999999999
Q ss_pred CCHHHHHHH
Q 036483 657 PTMKEVAVV 665 (721)
Q Consensus 657 Pt~~ev~~~ 665 (721)
||++|++++
T Consensus 430 ~ta~e~L~H 438 (467)
T PTZ00284 430 LNARQMTTH 438 (467)
T ss_pred CCHHHHhcC
Confidence 999999863
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=306.69 Aligned_cols=259 Identities=24% Similarity=0.358 Sum_probs=201.8
Q ss_pred CHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe-
Q 036483 385 TSKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLE- 461 (721)
Q Consensus 385 ~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~- 461 (721)
+..++....+.|++.+.||+|+||.||+|... +++.+|+|..... .....++..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555667788999999999999999999965 5789999987543 23446788999999998 79999999999863
Q ss_pred -----CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 462 -----TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 462 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
.+..+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 3467899999999999999876432 25888899999999999999999998 99999999999999999999
Q ss_pred EeeccCccccccCCceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH
Q 036483 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~ 611 (721)
|+|||++........ ......|+..|+|||.+. ...++.++||||||+++|||++|+.||....... ..
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~-----~~ 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR-----AL 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-----hh
Confidence 999999876532211 122345889999999986 3468889999999999999999999985322110 00
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. +.............+.++.+++.+||+.+|.+|||+.|+++
T Consensus 236 -~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 -FL---------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hh---------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 00000001111223457999999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=312.10 Aligned_cols=254 Identities=26% Similarity=0.350 Sum_probs=201.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCc---hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDE---SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|+..+.||+|++|.||++...+ ++.+|+|....... ...+.+.+|++++++++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 468889999999999999999764 89999998765322 35567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+.+++|.+++.... ...+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999987543 236899999999999999999999998 999999999999999999999999998754321
Q ss_pred Cce----------------------------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCC
Q 036483 550 QTH----------------------------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601 (721)
Q Consensus 550 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~ 601 (721)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 0112357889999999999999999999999999999999999986433
Q ss_pred ccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.. ..+.... ............+..+.+++.+||+.+|++||+.+..++.|
T Consensus 237 ~~------~~~~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l 286 (316)
T cd05574 237 RD------ETFSNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286 (316)
T ss_pred hH------HHHHHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence 21 1111111 11111111112456799999999999999999944444444
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.08 Aligned_cols=256 Identities=29% Similarity=0.417 Sum_probs=205.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47889999999999999999965 57899999875432 33567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.++++.......+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986543346899999999999999999999998 99999999999999999999999999877654322
Q ss_pred e---eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 552 H---MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 552 ~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
. ......++..|+|||++... .++.++||||||++++||++|+.||...... ..+........ +
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~------~~~~~~~~~~~------~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM------KVLMLTLQNDP------P 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh------hhHHHHhcCCC------C
Confidence 2 22334588999999998877 7899999999999999999999998533221 11111111110 0
Q ss_pred hhcccC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEA-SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...... ....+..+.+++.+||+.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 1233466899999999999999999999976
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=312.29 Aligned_cols=257 Identities=19% Similarity=0.264 Sum_probs=194.3
Q ss_pred CCceEeee--CcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 398 TNRILGQG--GQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 398 ~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.++||+| +|++||++..+ +|+.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 78999999865 6899999987653 2334567788999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... ..+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 99999999865432 25899999999999999999999998 999999999999999999999999875443211110
Q ss_pred ------eeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 553 ------MTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 553 ------~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... . ...... ......
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~----~~~~~~-~~~~~~ 230 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--M----LLEKLN-GTVPCL 230 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--H----HHHHhc-CCcccc
Confidence 0112246778999999976 468999999999999999999999986432111 0 000000 000000
Q ss_pred hh------------------------------------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LD------------------------------------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~------------------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
++ ..............+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 000001122334578999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=303.92 Aligned_cols=255 Identities=25% Similarity=0.447 Sum_probs=198.7
Q ss_pred CCCCceEeeeCcEEEEEEEEc----CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 396 YNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
|.+.+.||+|+||.||+|.+. .++.+|||.++.. .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999854 3678999987542 3445678999999999999999999999886543
Q ss_pred cceEEEeeccCCCcchhccccC---CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 464 VPLLVYEFIINGTLFQYLHDQN---EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
..++++||+++|+|..++.... ....+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2468899999999998875322 2235889999999999999999999998 999999999999999999999999
Q ss_pred cCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhc
Q 036483 541 GASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 541 Gls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
|+++......... .....+++.|++||.+....++.++||||||+++|||++ |+.||...... .+ ......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~----~~~~~~ 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EI----YNYLIK 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HH----HHHHHc
Confidence 9998664322111 122235678999999999999999999999999999999 88887532211 11 111111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
... ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 231 ~~~---------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNR---------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 110 011122345799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=302.27 Aligned_cols=252 Identities=25% Similarity=0.457 Sum_probs=202.1
Q ss_pred CCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC------chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 395 HYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID------ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
+|+..+.||+|++|.||++.. .+++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999985 468899999875432 1235788999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCcccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSM 546 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~ 546 (721)
||||+++++|.+++.+.. ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999987543 5899999999999999999999998 99999999999998775 6999999998776
Q ss_pred ccCCce---eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 547 AIDQTH---MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 547 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||....... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~--------- 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN---HLALIFK--------- 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc---hHHHHHH---------
Confidence 432111 1123457889999999998899999999999999999999999985332211 1111100
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..........+.....++.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00011112334445567999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=301.43 Aligned_cols=251 Identities=26% Similarity=0.418 Sum_probs=202.5
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceEEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVY 469 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~lv~ 469 (721)
+|++.+.||.|+||.||++... +++.+|+|.+.. ......+.+.+|++++++++|+||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4788899999999999999854 578999998754 334456778999999999999999999998764 34568999
Q ss_pred eeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHH-----hcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 470 EFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLH-----SAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH-----~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
||+++++|.+++.... ....+++..++.++.|++.||.||| +.+ |+|+||+|+||++++++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997532 2346999999999999999999999 666 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
......... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...... .+...+....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~--- 226 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL-------QLASKIKEGK--- 226 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH-------HHHHHHhcCC---
Confidence 876543321 23345899999999999988999999999999999999999998643311 1111121111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+...+..+.+++.+||+.+|++||++++|++.
T Consensus 227 ------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 227 ------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 112233445678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=300.19 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=201.5
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc--hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|...+.||+|+||.||+|... +++.+++|.++.... ...+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 688999998765443 3678899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999987543 5889999999999999999999999 99999999999999999999999999887654332
Q ss_pred eeee---eeecCCCCCCccccccCC---CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 552 HMTT---QVQGTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 552 ~~~~---~~~gt~~y~aPE~~~~~~---~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.... ...++..|+|||++.+.. ++.++||||||++++||++|+.||...... . ....... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~----~-~~~~~~~-~~~~~--- 225 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE----F-QIMFHVG-AGHKP--- 225 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch----H-HHHHHHh-cCCCC---
Confidence 2211 345788999999998766 889999999999999999999998533211 0 1010000 00000
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. ..........+.+++.+||+.+|++|||+.+++.
T Consensus 226 --~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 226 --P--IPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --C--CCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0 0001112456889999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=307.51 Aligned_cols=262 Identities=23% Similarity=0.323 Sum_probs=202.0
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe--
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLE-- 461 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~-- 461 (721)
.+.+..+.++|++.+.||+|+||.||++... +++.+|+|...... .....+.+|+.+++++ +|+||+++++++..
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455667889999999999999999999865 57899999875432 2346788999999999 69999999998853
Q ss_pred ---CCcceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 462 ---TEVPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 462 ---~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
.+..++||||+++++|.++++... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 346799999999999999876422 2336889999999999999999999998 999999999999999999999
Q ss_pred eeccCccccccCCceeeeeeecCCCCCCcccccc-----CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHH
Q 036483 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 538 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~ 612 (721)
+|||+++....... ......|+..|+|||++.. ..++.++||||||+++|||++|+.|+....... . .
T Consensus 166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-----~-~ 238 (286)
T cd06638 166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-----A-L 238 (286)
T ss_pred ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-----H-H
Confidence 99999986643221 2223458999999999853 457889999999999999999999985432111 0 0
Q ss_pred HHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 613 LRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.. .......... .+......+.+++.+||+.+|++|||+.||++.+
T Consensus 239 ~~-~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FK-IPRNPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hh-ccccCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 00 0000000000 1111234688999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=310.74 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=199.9
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
|.....||+|+||.||++... +++.||||.+........+.+.+|+.++++++|+||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344467999999999999865 5889999988765556667899999999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|.+++... .+++..++.++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ..
T Consensus 104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 9999988543 4889999999999999999999998 99999999999999999999999999876543222 22
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....++..|+|||.+.+..++.++||||||++++||++|+.||...... ..+. .+.. .+..... ..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~-~~~~-----~~~~~~~--~~ 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL------QAMR-RIRD-----NLPPRVK--DS 241 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHh-----cCCCccc--cc
Confidence 3345889999999999889999999999999999999999998642211 1111 1110 0011100 11
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
......+.+++.+||..+|++|||++++++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1233468899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=309.48 Aligned_cols=196 Identities=26% Similarity=0.416 Sum_probs=159.3
Q ss_pred CceEeeeCcEEEEEEEEcC---CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceEEEeecc
Q 036483 399 NRILGQGGQGTVYKGMLAD---GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFII 473 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~lv~e~~~ 473 (721)
.++||+|+||+||+|+..+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3689999999999999653 5689999876432 23467899999999999999999999864 446689999986
Q ss_pred CCCcchhcccc------CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE----CCCCcEEEeeccCc
Q 036483 474 NGTLFQYLHDQ------NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGAS 543 (721)
Q Consensus 474 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGls 543 (721)
++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4677766421 12235889999999999999999999998 9999999999999 56679999999999
Q ss_pred cccccCCce--eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccC
Q 036483 544 RSMAIDQTH--MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVT 600 (721)
Q Consensus 544 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~ 600 (721)
+........ ......+|+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876432221 12335689999999998764 5889999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=309.44 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=199.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|+..++||+|+||.||++... +++.+|+|+..... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999976 48899999865422 2245678899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|..+..... .+++..++.++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999998888765432 4899999999999999999999998 9999999999999999999999999988664332
Q ss_pred ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc--cchhhhhh-
Q 036483 551 THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE--DSLFEILD- 626 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~- 626 (721)
.......++..|+|||++.+ ..++.++||||||++++||++|++||......+ .... ....... .......+
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID--QLYH-IIKCLGNLIPRHQEIFQK 230 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH--HHHH-HHHHhCCCchhhHHHhcc
Confidence 22233457889999999875 457889999999999999999998885432211 0000 0000000 00000000
Q ss_pred -----h----hh-----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 627 -----A----HV-----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 627 -----~----~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. .. ........+..+.+++.+||+.+|++||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 231 NPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred chHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0 00 00011123466899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=306.92 Aligned_cols=262 Identities=24% Similarity=0.336 Sum_probs=201.9
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|.+.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999965 68899999876543 34457899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+ +++|.+++.... ..+++..++.++.||++||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987544 36999999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch------hhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL------FEI 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 624 (721)
.......++..|+|||.+.+. .++.++||||||++++||++|.++|...... ............... .++
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI---EQLAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH---HHHHHHHHHcCCCChHHHhhccCc
Confidence 223334588999999998754 4688999999999999999997777533211 111111111100000 000
Q ss_pred hh------hh----hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LD------AH----VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~------~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+ .. ...+...+....+.+++.+||+.+|++|||+++++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00 0001111234678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=315.89 Aligned_cols=200 Identities=30% Similarity=0.406 Sum_probs=174.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-C-----CceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-H-----RNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-----~niv~l~g~~~~~~~~ 465 (721)
..+|.+.++||+|.||.|-++... .++.||||+++.. .....+-..|+.+|..|+ | -|+|+++++|...++.
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 348999999999999999999955 5899999998864 445667789999999996 4 3899999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC--CcEEEeeccCc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK--YRAKVSDFGAS 543 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGls 543 (721)
+||+|.+ .-+|.++|+.++-. .++...++.|+.||+.||.+||+.+ |||.||||+||||.+- ..+||+|||.|
T Consensus 264 ciVfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS 338 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS 338 (586)
T ss_pred eeeehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence 9999998 67899999876644 6999999999999999999999999 9999999999999643 47999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCc
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~ 602 (721)
..... ... .+..+..|+|||++.+.+|+.+.|+||||||+.||++|.+.|.+.+.
T Consensus 339 c~~~q---~vy-tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 339 CFESQ---RVY-TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccCC---cce-eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 86532 122 45578899999999999999999999999999999999888776553
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=305.93 Aligned_cols=264 Identities=23% Similarity=0.331 Sum_probs=204.7
Q ss_pred ccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 036483 383 LFTSKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCL 460 (721)
Q Consensus 383 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~ 460 (721)
+++..++..+.++|.+.+.||+|+||.||++... +++.+|+|...... ...+.+.+|+.++.++ +|||++++++++.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4555666777899999999999999999999965 58899999875432 2346778899999999 8999999999987
Q ss_pred eCC-----cceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc
Q 036483 461 ETE-----VPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR 534 (721)
Q Consensus 461 ~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 534 (721)
..+ ..++||||+++++|.++++... ....+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 543 4789999999999999886422 2236899999999999999999999998 999999999999999999
Q ss_pred EEEeeccCccccccCCceeeeeeecCCCCCCccccccC-----CCCccccchhHHHHHHHHHhCCcccccCCccccccHH
Q 036483 535 AKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609 (721)
Q Consensus 535 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~ 609 (721)
+||+|||+++........ .....++..|+|||.+... .++.++||||||+++|||++|+.||....... .
T Consensus 167 ~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~-- 241 (291)
T cd06639 167 VKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--T-- 241 (291)
T ss_pred EEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--H--
Confidence 999999998765432211 1224578899999998654 36889999999999999999999985432111 0
Q ss_pred HHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
... +.......+ ..+......+.+++.+||+.+|++||++.|+++.
T Consensus 242 --~~~-~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 242 --LFK-IPRNPPPTL-------LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHH-HhcCCCCCC-------CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 111111111 1112234568999999999999999999999763
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.62 Aligned_cols=248 Identities=28% Similarity=0.443 Sum_probs=200.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|+..+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 5788899999999999999865 5788999986543 344567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++.... ...+++..+++++.|++.||+|||+++ |+|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 235899999999999999999999998 9999999999999855 468999999998764322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||...... ........ ...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~------~~~~~~~~-~~~--------- 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP------ALVLKIMS-GTF--------- 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH------HHHHHHHh-cCC---------
Confidence 122345788999999999888999999999999999999999998543211 11111111 110
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+...+..+.+++.+||+.+|++|||+.|++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1112223456899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.12 Aligned_cols=240 Identities=25% Similarity=0.289 Sum_probs=186.8
Q ss_pred EeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc---CCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI---NHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
||+|+||+||+|+.. +++.||+|.+... .......+..|..++.+. +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999965 5889999987542 222344566677777665 699999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
|+|.+++.... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Cc
Confidence 99998887543 5899999999999999999999999 99999999999999999999999999875432221 22
Q ss_pred eeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 555 TQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
....||+.|+|||++.+. .++.++||||||+++|||++|+.||...... . ....+..... . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~-~~~~i~~~~~-~-----~~--- 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------Q-MYRNIAFGKV-R-----FP--- 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------H-HHHHHHcCCC-C-----CC---
Confidence 345689999999998765 4889999999999999999999998643221 1 1111111111 0 00
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPT----MKEVAV 664 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt----~~ev~~ 664 (721)
.......+.+++.+||+.+|++||+ +.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1112346789999999999999984 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=339.66 Aligned_cols=257 Identities=23% Similarity=0.386 Sum_probs=199.1
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Cc
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLET--EV 464 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~ 464 (721)
+...++|.+.+.||+|+||+||++... .+..+|+|.+.. ........|..|+.+|++++||||+++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999965 477899997654 2344567899999999999999999999988654 45
Q ss_pred ceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCC----CCeeeccCcCccEEECC--------
Q 036483 465 PLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAAS----IPIYHRDIKSTNILLDG-------- 531 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~----~~ivHrDlk~~NIll~~-------- 531 (721)
.+|||||+++++|.++|.... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999997532 22369999999999999999999998542 23999999999999964
Q ss_pred ---------CCcEEEeeccCccccccCCceeeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccC
Q 036483 532 ---------KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVT 600 (721)
Q Consensus 532 ---------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~ 600 (721)
...+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3358999999998654322 2234568999999999864 45889999999999999999999998532
Q ss_pred CccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 601 NFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. ... +...+..... + .....+.++.+||.+||+.+|.+||++.|++.
T Consensus 247 ~~-----~~q-li~~lk~~p~-------l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NN-----FSQ-LISELKRGPD-------L---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred Cc-----HHH-HHHHHhcCCC-------C---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 21 111 1111111110 0 00112456899999999999999999999984
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.94 Aligned_cols=252 Identities=26% Similarity=0.386 Sum_probs=207.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCc-hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDE-SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.+.||+|++|.||++.... ++.+++|+...... ...+.+.+|+.++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 468889999999999999999764 89999998766443 4567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++... ..+++..++.++.|+++||+|||+ .+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999765 268999999999999999999999 88 9999999999999999999999999998764333
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.. .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... .......... ....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~-~~~~--------- 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP---SFFELMQAIC-DGPP--------- 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc---CHHHHHHHHh-cCCC---------
Confidence 22 22345889999999999999999999999999999999999998644321 1111111111 1110
Q ss_pred ccCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQE-DIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111222 45679999999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=307.51 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=200.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||++... .++.|++|.+.... ....+.+.+|+.+++.++||||+++++.+...+..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999976 47899999875532 234567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997543 5899999999999999999999998 999999999999999999999999998642110
Q ss_pred C--------------ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 550 Q--------------THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 550 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
. ........++..|+|||.+....++.++||||||+++|||++|..||...... ..+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~~ 228 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQV 228 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 0 00111235788999999999889999999999999999999999998532211 111111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
... ... .+ ......+..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 229 ~~~-~~~---~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 229 ISD-DIE---WP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred Hhc-ccC---CC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111 000 00 0011234568999999999999999997766666654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=289.84 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=202.5
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
..++|++.+.||+|.|+.||+.... .|+.+|+|.+.. ......+++.+|+.|-..|+||||++|.+.+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4567888899999999999998754 588888886533 3445678899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGls~~ 545 (721)
+|+|.|++|..-+-.. ...++..+-..+.||+++|.|.|.++ |||||+||+|+||-. .-.+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999987655433 35788889999999999999999999 999999999999953 34599999999988
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
+. ....-....||++|||||++...+|+..+|||+-||+||-||.|.+||.... ..+.+.+.+. +.. + +
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~------~~rlye~I~~-g~y-d-~ 231 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED------QHRLYEQIKA-GAY-D-Y 231 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc------HHHHHHHHhc-ccc-C-C
Confidence 76 3334455679999999999999999999999999999999999999996422 1222222222 111 0 0
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
++. .-....++..+|+++||..||.+|.|+.|.+..
T Consensus 232 ~~~----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSP----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCc----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 111 112234568899999999999999999988654
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=298.71 Aligned_cols=248 Identities=24% Similarity=0.368 Sum_probs=207.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
-|++..+||+|+||.||++.++ .|+++|||+... +...+++..|+.||++.+.|++|++||.+......|+||||+.
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3667789999999999999976 599999998876 4567899999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
-|++.++++..+ ++|++.++..++...++||+|||... -+|||||..||||+-+|.+||+|||.+-.+.. ....
T Consensus 112 AGSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAK 185 (502)
T KOG0574|consen 112 AGSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAK 185 (502)
T ss_pred CCcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhh-hHHh
Confidence 999999998654 37999999999999999999999988 78999999999999999999999999976642 2222
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh-hhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL-DAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 632 (721)
...+.||+.|||||++..-.|+.++||||||+...||.-|++|+.....-. .++-+. .+.....
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPPTFK 250 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCCCCC
Confidence 345779999999999999999999999999999999999999986433211 000000 1111112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+.+-..++.++++.||-.+|++|.|+.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 344456679999999999999999999888765
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=306.92 Aligned_cols=261 Identities=24% Similarity=0.340 Sum_probs=196.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|+..+.||+|+||.||+|+.. +|+.+|+|+++.. .......+.+|+.++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4788899999999999999975 5889999987543 223345788899999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
++ ++|.+++.... ..+++..++.++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 57777776433 25899999999999999999999999 99999999999999999999999999986543221
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc------hhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS------LFEI 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~ 624 (721)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+......+ ..+ ........... +.+.
T Consensus 155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHH-HHHHHHhCCCChHHhHHhhhc
Confidence 1 1223478899999998765 47899999999999999999998864322111 111 11111100000 0000
Q ss_pred hhhhhc---------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 625 LDAHVL---------KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 625 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.+.... .+.......++.+++.+||+.||.+|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0111223457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.72 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=198.9
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC----------chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID----------ESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
+|...+.||+|+||.||+|... +++.+|+|.++... ....+.+.+|+.++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677899999999999999854 58899999764311 112356889999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+++++|.++++... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999997653 6899999999999999999999998 999999999999999999999999999
Q ss_pred cccccCCce-eeeeeecCCCCCCccccccCC--CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 544 RSMAIDQTH-MTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 544 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+........ ......++..|+|||.+.... ++.++||||||++++||++|..||..... ....+ .... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~-~~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-----IAAMF-KLGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-----HHHHH-Hhhc-cc
Confidence 765322111 123345889999999987754 88999999999999999999999842211 11111 1110 00
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+ ........+.++.+++.+||+.+|++||++.+|++.
T Consensus 229 ~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 229 SAPPI----PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCcC----CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00001 111122345679999999999999999999998763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=305.67 Aligned_cols=262 Identities=23% Similarity=0.364 Sum_probs=196.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|+..+.||+|++|.||+|..+ +++.||+|.+.... ......+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67889999999999999999976 58899999875432 22335678899999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+.+ +|.+++.+... .+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 89888875443 5899999999999999999999998 99999999999999999999999999875432211
Q ss_pred eeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---cchhhh---
Q 036483 552 HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---DSLFEI--- 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--- 624 (721)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... .........+.. ......
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhhhhhhhhc
Confidence 1122346788999999876 458899999999999999999999985433111 011111111100 000000
Q ss_pred ----------hhhh-hcccC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 625 ----------LDAH-VLKEA-SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 625 ----------~~~~-~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.... +.... .......+.+++.+||+.+|++|||+.|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000 00000 0011256789999999999999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=304.55 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=197.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|+..+.||.|++|.||+|+.. +++.||||+++... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999865 58899999876432 23346789999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+. ++|..++..... ..+++..++.++.|++.||+|||+.+ ++||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 688888865432 36899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc--h----hhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS--L----FEI 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--~----~~~ 624 (721)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||......+ .....+ ....... . ..+
T Consensus 156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIF-RTLGTPDEVVWPGVTSL 231 (284)
T ss_pred c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-HHhCCCChhhhhhhhHH
Confidence 1 12234678999999887654 6889999999999999999999986433211 111111 1000000 0 000
Q ss_pred hh-----hhh----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 625 LD-----AHV----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 625 ~~-----~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. +.. ..........++.+++.+||+.||++|||++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 000 00001122345789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=305.04 Aligned_cols=250 Identities=26% Similarity=0.407 Sum_probs=204.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
++|.+.+.||+|+||.||++... +++.+|+|..........+.+.+|+.++++++||||+++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67889999999999999999854 57899999886655556678999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~ 171 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 171 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccccc
Confidence 999999998753 4789999999999999999999999 999999999999999999999999998765433221
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....+++.|+|||.+....++.++||||||+++|||++|+.||........ ........ .....
T Consensus 172 -~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~------~~~~~~~~--------~~~~~ 236 (293)
T cd06647 172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATNG--------TPELQ 236 (293)
T ss_pred -cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh------eeehhcCC--------CCCCC
Confidence 2233588899999999988899999999999999999999999864322110 00000000 00011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.....+..+.+++.+||..+|++||++.+++.+
T Consensus 237 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 237 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 122234568899999999999999999999876
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=302.96 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=200.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+|+..+.||+|++|.||+|+.. +++.||||.++... ....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5788999999999999999976 58899999876543 234567789999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++ +|.+++........+++..+++++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 88888876554456999999999999999999999998 99999999999999999999999999976533211
Q ss_pred eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh---ccchhhhh---
Q 036483 553 MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK---EDSLFEIL--- 625 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~--- 625 (721)
......++..|++||++.+. .++.++||||||+++|||++|+.||......+. ... ...... ...+..+.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLK-IFRIMGTPTESTWPGISQLP 232 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHH-HHHHhCCCChhhHHHHhcCc
Confidence 11223468899999998664 578899999999999999999999865443221 111 111100 00000000
Q ss_pred --hhh-------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 626 --DAH-------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 626 --~~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... .........+..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000 000111223456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=302.22 Aligned_cols=253 Identities=26% Similarity=0.390 Sum_probs=203.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|+..+.||+|++|.||++... +++.+|+|.+.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999976 58899999876543 34567899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++.... ..+++..+.+++.|++.||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999997653 368999999999999999999999 77 9999999999999999999999999987653222
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.. ...++..|+|||.+.+..++.++||||||+++++|++|+.||....... ...............
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~---------- 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP---------- 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC----------
Confidence 11 1558889999999999999999999999999999999999985432111 111111111111110
Q ss_pred ccCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQE-DIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+.. ...++.+++.+||..+|++|||+.+++..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 011111 45568999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=307.13 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=199.5
Q ss_pred CCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCC
Q 036483 398 TNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGT 476 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gs 476 (721)
....||+|+||.||++... +++.||+|.+........+.+.+|+.++..++||||+++++++...+..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999865 688999998866555556788999999999999999999999999999999999999999
Q ss_pred cchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeee
Q 036483 477 LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556 (721)
Q Consensus 477 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~ 556 (721)
|..++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........ ....
T Consensus 105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~ 176 (297)
T cd06659 105 LTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KRKS 176 (297)
T ss_pred HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cccc
Confidence 99887542 4899999999999999999999998 99999999999999999999999999876543221 2233
Q ss_pred eecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHH
Q 036483 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQE 636 (721)
Q Consensus 557 ~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 636 (721)
..++..|+|||++.+..++.++||||||++++||++|+.||......+ .. ..+....... ......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~-~~~~~~~~~~-------~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AM-KRLRDSPPPK-------LKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HHHhccCCCC-------ccccCC
Confidence 568999999999999899999999999999999999999986432111 01 1111110000 001112
Q ss_pred HHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 637 DIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 637 ~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
....+.+++.+||+.+|++||++.++++.-
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 234588999999999999999999998853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=299.68 Aligned_cols=247 Identities=26% Similarity=0.409 Sum_probs=201.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
-|...+.||+|+||.||+|... +++.+|+|...... ....+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4677889999999999999864 68899999865432 344567899999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999998643 4899999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......++..|+|||.+.+..++.++||||||+++++|++|..|+...... . ....+.... ...
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~---------~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------K-VLFLIPKNN---------PPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------H-HHHHHhcCC---------CCC
Confidence 122345788999999999888999999999999999999999998532211 0 111111110 111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.....+.++.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 222345668999999999999999999999885
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=301.01 Aligned_cols=255 Identities=25% Similarity=0.385 Sum_probs=200.2
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC-----
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE----- 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~----- 463 (721)
..+++|++.+.||+|++|.||+|... +++.+++|....... ..+.+.+|+.+++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35689999999999999999999975 578899998765433 446899999999999 7999999999997655
Q ss_pred -cceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 464 -VPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 464 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3799999999999999987532 2336899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCcccccc-----CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
++........ ......++..|+|||++.. ..++.++||||||+++++|++|+.||...... ..... +
T Consensus 159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~ 230 (275)
T cd06608 159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM------RALFK-I 230 (275)
T ss_pred cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH------HHHHH-h
Confidence 9876532221 1223458899999998754 34678999999999999999999998532111 00111 1
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
....... ...+.....++.+++.+||..||++|||+.++++
T Consensus 231 ~~~~~~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 231 PRNPPPT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hccCCCC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111000 1112224457899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=302.77 Aligned_cols=244 Identities=26% Similarity=0.340 Sum_probs=200.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||++... +++.+|+|.++.. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888999999999999999965 5889999987542 2345677899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999987653 6899999999999999999999998 999999999999999999999999999876433
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....+++.|+|||.+.+...+.++||||||+++++|++|+.||...... . .......+.
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~~~~~~--------- 214 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------Q-IYEKILEGK--------- 214 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------H-HHHHHhcCC---------
Confidence 22345889999999999888999999999999999999999998543311 1 111111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAV 664 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 664 (721)
...+......+.+++.+||..+|.+|| +++|++.
T Consensus 215 -~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 215 -VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 111222345689999999999999998 5566543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.01 Aligned_cols=248 Identities=26% Similarity=0.364 Sum_probs=197.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+.|...+.||+|+||.||+|... +++.||+|..... .....+++.+|+++++.++||||+++++++.+.+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999965 5889999987542 2334567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+. |+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9996 56767665433 25899999999999999999999998 999999999999999999999999998765322
Q ss_pred CceeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
....++..|+|||++. ...++.++||||||+++|||++|+.||....... ...... ....
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~~~~~-~~~~----- 231 (307)
T cd06607 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIA-QNDS----- 231 (307)
T ss_pred -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HHHHHh-cCCC-----
Confidence 2245788999999874 4568899999999999999999999985332111 001110 0000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
........+..+.+++.+||+.+|++||++.+|+....
T Consensus 232 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 ---PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00111224456899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=300.96 Aligned_cols=252 Identities=24% Similarity=0.383 Sum_probs=193.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHH-HhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAI-LSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~i-l~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|++.+.||+|+||.||++... +|+.||+|+++... .....++..|+.+ ++.++||||+++++++...+..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999976 58999999876532 2333456666665 566799999999999999999999999
Q ss_pred eccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 471 FIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 471 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|++ ++|.+++... .....+++..++.++.|++.||+|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888777642 2234689999999999999999999997 6 99999999999999999999999999976532
Q ss_pred CCceeeeeeecCCCCCCcccccc----CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRS----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.. ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... .. ......... ..
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~-~~~~~~~~~-~~--- 225 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----PF-QQLKQVVEE-PS--- 225 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----CH-HHHHHHHhc-CC---
Confidence 21 1223457889999998865 4568899999999999999999999853211 00 111111111 00
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+.. .....+.++.+++.+||+.+|++||++.+|++.
T Consensus 226 --~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 226 --PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred --CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 011234568999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=305.77 Aligned_cols=261 Identities=27% Similarity=0.347 Sum_probs=198.7
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc-----hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE-----SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
+|+..+.||+|++|.||+|... +++.||||+++.... .....+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778899999999999999965 588999998765332 2345678899999999999999999999998899999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+ +++|.+++.... ..+++..++.++.||++||+|||+++ |+|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999997643 25999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc--------
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED-------- 619 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 619 (721)
.... .....++..|+|||.+.+ ..++.++||||||++++||++|..+|......+ .+.. ........
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGK-IFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHH-HHHHcCCCchhhhhhc
Confidence 3211 122346788999998865 467889999999999999999977775433211 1111 11110000
Q ss_pred -chhhhhhhhhc-----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 -SLFEILDAHVL-----KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 -~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+......... ..........+.+++.+||+.+|++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000 01112234678899999999999999999999773
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=305.98 Aligned_cols=266 Identities=25% Similarity=0.351 Sum_probs=196.9
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC---CcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccce
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD---GRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPL 466 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~ 466 (721)
+|.+.++||+|+||.||+|.... ++.||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999999654 7899999876632 44456788999999999999999999999988 7889
Q ss_pred EEEeeccCCCcchhccccC--CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC----CCcEEEeec
Q 036483 467 LVYEFIINGTLFQYLHDQN--EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG----KYRAKVSDF 540 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~DF 540 (721)
+||||+++ +|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 6666664322 1236899999999999999999999998 999999999999999 999999999
Q ss_pred cCccccccCCc--eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCcccccc------HHHH
Q 036483 541 GASRSMAIDQT--HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKS------LAAY 611 (721)
Q Consensus 541 Gls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~------~~~~ 611 (721)
|+++....... .......++..|+|||.+.+. .++.++||||||++++||++|+.||.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99987643222 112334578899999988764 57899999999999999999999987544322000 0000
Q ss_pred HHHHhhcc------------chhhhhhhhhcccCC---------H--HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 612 FLRAMKED------------SLFEILDAHVLKEAS---------Q--EDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 612 ~~~~~~~~------------~~~~~~~~~~~~~~~---------~--~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
+...+... ......+.......+ . ....++.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00000000 000000000000000 0 22346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.03 Aligned_cols=261 Identities=24% Similarity=0.322 Sum_probs=198.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~lv 468 (721)
++|...+.||+|+||.||+|... +++.+++|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 56888999999999999999976 58899999876533 22334678899999999999999999998877 788999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+. ++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99996 589888876442 5899999999999999999999998 99999999999999999999999999987653
Q ss_pred CCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---------
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE--------- 618 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 618 (721)
... ......++..|+|||.+.+. .++.++||||||++++||++|+.||......+. . .........
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ--L-NKIFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHH--H-HHHHHHhCCCchHHHHHh
Confidence 321 12234578899999998765 468899999999999999999999864432111 0 000000000
Q ss_pred --------cchhhhhhhhhcccCCHH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 --------DSLFEILDAHVLKEASQE-DIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 --------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..........+...++.. ....+.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 3556889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=291.70 Aligned_cols=249 Identities=29% Similarity=0.436 Sum_probs=204.5
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
.|...+.||+|++|.||++... +++.+++|+.........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4778899999999999999976 688999999876555567889999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++.... ..+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 36899999999999999999999988 99999999999999999999999999987654332
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
.....++..|++||.+.+..++.++||||||+++++|++|+.|+...... ..... ......... ..
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~~~-------~~ 219 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM------KALFK-IATNGPPGL-------RN 219 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH------HHHHH-HHhcCCCCc-------Cc
Confidence 23456889999999999888999999999999999999999998533211 00000 000000000 00
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
....+..+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112456899999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=299.05 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=202.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.+.|..-++||+||||.||-.+.+ .|+.+|.|++... .........+|-+||++++.+.||.|--.+...+..+||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356788899999999999999855 5999999976431 222334568999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
+..|+||+|.-+|..... ..+++..++.++.+|+-||.+||... ||.|||||+|||||+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 999999999999987654 47999999999999999999999999 99999999999999999999999999988765
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.... ...+||.+|||||++.++.|+...|.|||||+||||+.|+.||....... +. +-+|.+
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------k~----eEvdrr 401 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------KR----EEVDRR 401 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------hH----HHHHHH
Confidence 5443 33479999999999999999999999999999999999999996433211 11 112222
Q ss_pred h---cccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 629 V---LKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 629 ~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
. ..+++....++...|....|+.||++|..-
T Consensus 402 ~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 402 TLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred HhcchhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence 1 123455566678899999999999999744
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=298.16 Aligned_cols=262 Identities=24% Similarity=0.290 Sum_probs=201.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC--cceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE--VPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~--~~~lv~ 469 (721)
++|...+.||.|++|.||++... +++.+|+|...... ......+.+|++++++++||||+++++++.+.. ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999975 57889999876432 345677999999999999999999999986543 678999
Q ss_pred eeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999998876422 2346899999999999999999999998 99999999999999999999999999875532
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...... ...........+ ...
T Consensus 158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~-~~~ 231 (287)
T cd06621 158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIEL-LSYIVNMPNPEL-KDE 231 (287)
T ss_pred ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHH-HHHHhcCCchhh-ccC
Confidence 211 23347889999999999999999999999999999999999987543211 111111 111111111110 000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
. ......+..+.+++.+||+.+|++|||+.||++.-
T Consensus 232 ~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 232 P--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred C--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 0 00012345789999999999999999999998853
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=299.07 Aligned_cols=264 Identities=22% Similarity=0.315 Sum_probs=195.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++++|.+.+.||+|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578999999999999999999865 58899999876533 223346789999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++++||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 67766665433 24788889999999999999999998 999999999999999999999999998764322
Q ss_pred CceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh--cc-------
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK--ED------- 619 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--~~------- 619 (721)
.. ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....... +.+.. ...... ..
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF-EQLEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH-HHHHH-HHHHcCCCChhhhhhhh
Confidence 21 11223478899999998764 57889999999999999999999986433211 00100 000000 00
Q ss_pred ---ch-hhhhh---hhhccc--CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 620 ---SL-FEILD---AHVLKE--ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 620 ---~~-~~~~~---~~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. .+... +..... ........+.+++.+|+..+|++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 00 00000 000000 00012356889999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=300.98 Aligned_cols=257 Identities=18% Similarity=0.281 Sum_probs=184.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeeccccCchhh-----------HHHHHHHHHHhhcCCCceeeEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVIDESKV-----------DEFINEVAILSQINHRNVVKLLG 457 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-----------~~~~~E~~il~~l~h~niv~l~g 457 (721)
.++|.+.++||+|+||+||+|...+ +..+|+|.......... .....+...+..++|+|++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 3679999999999999999999764 34566665433222110 11223344556678999999999
Q ss_pred EEEeCC----cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 458 CCLETE----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 458 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
++.... ..++++|++. .++.+++.... ..++..+..++.|++.||+|||+.+ |+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN 163 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence 876544 2356777663 35555554332 3578889999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccccc
Q 036483 534 RAKVSDFGASRSMAIDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKS 607 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~ 607 (721)
.+||+|||+++.+...... ......||+.|+|||++.+..++.++||||||++++||++|+.||..........
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~ 243 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI 243 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence 9999999999876432211 1123459999999999999999999999999999999999999997543221100
Q ss_pred H--HHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 608 L--AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 608 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
. ...+...+... ... ....+.++.+++..|++.+|++||++.++.+.|+
T Consensus 244 ~~~~~~~~~~~~~~--------~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 244 HAAKCDFIKRLHEG--------KIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHhHHHHHHHhhhh--------hhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 0 00011111111 110 1123466899999999999999999999998763
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=300.04 Aligned_cols=247 Identities=24% Similarity=0.366 Sum_probs=200.4
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 445579999999999999964 6889999988765555667789999999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|.+++... .+++..+..++.|++.||+|||+++ |+||||+|+||+++.++.+||+|||++........ ..
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999998762 4899999999999999999999999 99999999999999999999999998876543222 12
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....|+..|+|||.+.+..++.++||||||++++||++|+.||...... .... ....... +.. ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~-~~~~~~~-----~~~--~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMK-RIRDNLP-----PKL--KNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHH-HHHhcCC-----CCC--ccc
Confidence 2345889999999999888999999999999999999999998532211 1111 1111100 000 011
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 123456999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.93 Aligned_cols=250 Identities=24% Similarity=0.379 Sum_probs=201.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|...+.||+|+||.||++..+ ++..+|+|..... .....+.+.+|++++++++|+||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999976 4788999987543 233456788999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++..... ..+++..++.++.|+++||.|||+.+ |+|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999876432 25899999999999999999999998 99999999999999885 46999999987664322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
. ......|++.|+|||++.+..++.++||||||++++||++|+.||..... ......... ...
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-~~~--------- 219 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-GYF--------- 219 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-ccC---------
Confidence 1 22234588999999999988899999999999999999999999853221 111111111 111
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......+..+.+++.+||..+|++|||+.|+++.
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122334568999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=298.50 Aligned_cols=248 Identities=25% Similarity=0.408 Sum_probs=199.4
Q ss_pred CCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc-CchhhHHHHHHHHHHhhcC---CCceeeEEEEEEeCCcceEEE
Q 036483 395 HYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI-DESKVDEFINEVAILSQIN---HRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~---h~niv~l~g~~~~~~~~~lv~ 469 (721)
.|+..+.||+|+||.||+|.. .+++.+|+|.+... .....+++.+|+.++++++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477888999999999999996 46889999987543 3445678899999999996 999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++... .+++..++.++.|++.||.|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998653 5899999999999999999999999 999999999999999999999999999876543
Q ss_pred CceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. ......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .. ........ +.
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~------~~-~~~~~~~~-----~~ 221 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFR------AM-MLIPKSKP-----PR 221 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhh------hh-hccccCCC-----CC
Confidence 32 12334588899999998754 56889999999999999999999985432111 00 00000000 00
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+.. ...+.++.+++.+||+.+|++||++.+++..
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 222 LED---NGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 100 1134568999999999999999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-34 Score=299.15 Aligned_cols=254 Identities=25% Similarity=0.387 Sum_probs=205.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++.|+..+.||+|++|.||+|... +++.+++|.+..... ..+.+.+|++++++++|+||+++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999998875444 56788999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 999999999998754 36999999999999999999999988 9999999999999999999999999986554322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
. ......++..|++||.+.+..++.++||||||+++|+|++|+.|+...... ........ .....
T Consensus 171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~------~~~~~~~~-~~~~~------- 235 (286)
T cd06614 171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL------RALFLITT-KGIPP------- 235 (286)
T ss_pred h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-cCCCC-------
Confidence 1 122334788999999999888999999999999999999999997532211 11111111 11000
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.......+..+.+++.+||+.+|.+||++.+|++..
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 236 LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 011112345689999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=304.54 Aligned_cols=254 Identities=25% Similarity=0.362 Sum_probs=204.4
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecc--ccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSK--VIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~l 467 (721)
.....|++.++||.||.+.||++...+.+.+|+|+.. ..+.+..+-|.+|+..|.+| .|.+|++|+++-..++..|+
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3446789999999999999999999888999999754 36677788999999999999 49999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|||+- .-+|.++|+..... ...| .++.+..|++.++.++|.++ |||-||||.|+|+-. |.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99986 66899999865533 2334 67789999999999999999 999999999999864 589999999999888
Q ss_pred cCCceee-eeeecCCCCCCccccccCC-----------CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 548 IDQTHMT-TQVQGTFGYLDPEYFRSSR-----------FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 548 ~~~~~~~-~~~~gt~~y~aPE~~~~~~-----------~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
.+..... ....||+.||+||.+.... .+.++|||||||+||+|+.|+.||.... +..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~------ 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQI------ 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHH------
Confidence 7766553 4457999999999985432 5579999999999999999999984211 111
Q ss_pred hhccchhhhhhhhhcccCCHHH-HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 616 MKEDSLFEILDAHVLKEASQED-IVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.++..+.++....+++.-- ..++.++++.||+.||++||+..|+++.
T Consensus 580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 1233445553322322211 1238999999999999999999999764
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=302.32 Aligned_cols=263 Identities=22% Similarity=0.328 Sum_probs=195.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCc-----
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEV----- 464 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~----- 464 (721)
++|+..+.||+|+||.||+|... +++.||+|+.+... ......+.+|+.++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46889999999999999999965 58899999865432 223467889999999995 6999999999987665
Q ss_pred ceEEEeeccCCCcchhccccCC--CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeecc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNE--EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFG 541 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFG 541 (721)
.++||||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 78888765332 246899999999999999999999998 999999999999998 8899999999
Q ss_pred CccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+++.+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..||......+ .+.. +........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHH-HHHHhCCCC
Confidence 9876533211 1122246788999998865 457899999999999999999999986433211 1111 111110000
Q ss_pred h---hhh---hh--------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 621 L---FEI---LD--------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 621 ~---~~~---~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. ... .+ +............++.+++.+||+.+|.+||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0 000 00 00000011123456899999999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.95 Aligned_cols=263 Identities=23% Similarity=0.360 Sum_probs=197.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----c
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----V 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~ 464 (721)
.+++|.+.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++.... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 3578999999999999999999864 58899999876432 334567889999999999999999999876543 4
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++|+||+. ++|.+++... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 83 VYIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred EEEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECccccee
Confidence 689999996 4777777543 5899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCce--eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc--
Q 036483 545 SMAIDQTH--MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED-- 619 (721)
Q Consensus 545 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 619 (721)
........ ......|+..|+|||.+.+ ..++.++||||||++++||++|+.||....... ....+...+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~ 231 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQ 231 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCH
Confidence 65432211 1123457899999998755 568899999999999999999999986433211 111111111110
Q ss_pred -chhhhhhhhh---------ccc-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 -SLFEILDAHV---------LKE-----ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 -~~~~~~~~~~---------~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+..+.+... ... .......++.+++.+||+.+|++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000000000 000 011224568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=298.15 Aligned_cols=247 Identities=27% Similarity=0.341 Sum_probs=202.7
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788899999999999999976 5889999987542 22456789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+.+++|.+++... .++++..+..++.|+++||.|||+.+ |+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998765 26899999999999999999999998 9999999999999999999999999987664332
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ...+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------cc
Confidence 2233458889999999998889999999999999999999999986543321 1111111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTM--KEVA 663 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~ev~ 663 (721)
...+...+..+.+++.+||+.+|.+||++ +|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 12223344678999999999999999999 5553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=299.39 Aligned_cols=260 Identities=25% Similarity=0.337 Sum_probs=198.2
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceEEEe
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLLVYE 470 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~lv~e 470 (721)
|++.+.||+|++|.||+|...+ ++.+|+|++... .....+.+.+|+.++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5678899999999999999764 889999988764 244456788999999999999999999999988 78999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++ +|.+++.... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8888876543 36899999999999999999999998 9999999999999999999999999998765433
Q ss_pred ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---cchhh---
Q 036483 551 THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---DSLFE--- 623 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~--- 623 (721)
........++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .. ......... .....
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QL-EKIFELCGSPTDENWPGVSK 231 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHHhCCCchhhcccccc
Confidence 222233346788999998765 467899999999999999999999986443211 11 111111000 00000
Q ss_pred -----------hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 -----------ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 -----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+........+..+.+++.+||+.+|++||+++++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000011112567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=323.73 Aligned_cols=268 Identities=19% Similarity=0.275 Sum_probs=189.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC--CcEEEEe------------------eccccCchhhHHHHHHHHHHhhcCCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD--GRIVAIK------------------KSKVIDESKVDEFINEVAILSQINHRN 451 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~E~~il~~l~h~n 451 (721)
..++|.+.+.||+|+||+||++..+. +...++| +.. ........+.+|+.+|++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987542 2222222 111 11223456889999999999999
Q ss_pred eeeEEEEEEeCCcceEEEeeccCCCcchhccccCC--CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNE--EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 452 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
|+++++++.+.+..++|+|++. ++|.+++..... ........++.|+.||+.||+|||+++ |+||||||+||||
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 567666654221 112345667889999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCccc-ccCCccccccH
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI-RVTNFEEDKSL 608 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~-~~~~~~~~~~~ 608 (721)
+.++.+||+|||+++.+............||..|+|||++.+..++.++||||||+++|||++|..++ ..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 99999999999999876543333334456999999999999999999999999999999999987543 22221111111
Q ss_pred HHHHHHHhh--cc-------chhhhhhhhhcccC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 609 AAYFLRAMK--ED-------SLFEILDAHVLKEA---------SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 609 ~~~~~~~~~--~~-------~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... ..+. .. .+.+.++....... ....+..+.+++.+||+.||++|||+.|++..
T Consensus 381 ~~~~-~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 381 LKII-DSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHH-HhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1111 0000 00 00111110000000 00122356788999999999999999999764
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=312.65 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=202.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCc-EEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGR-IVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.|+++..||.|+||.||+|..++.. ..|.|.+...+.+..++|+-||+||+..+||+||+|++.|...+..|++.||+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 34555667999999999999987644 45667777778888999999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
.||.++.++-.-.. .|++.++.-++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+...... ..
T Consensus 112 ~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q 185 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ 185 (1187)
T ss_pred CCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence 99999998876543 6999999999999999999999999 999999999999999999999999998643211 12
Q ss_pred eeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 553 MTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
....+.||+.|||||++. ..+|+.++||||||+.|.||..+.+|-... +....+.+..+.++. .++
T Consensus 186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel------npMRVllKiaKSePP-TLl-- 256 (1187)
T KOG0579|consen 186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL------NPMRVLLKIAKSEPP-TLL-- 256 (1187)
T ss_pred hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc------chHHHHHHHhhcCCC-ccc--
Confidence 234567999999999875 457999999999999999999999885321 222222222222111 111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+..-...+.+++.+||..||..||++.+++++
T Consensus 257 -----qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -----QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -----CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 122334568999999999999999999998764
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=291.51 Aligned_cols=250 Identities=26% Similarity=0.434 Sum_probs=205.7
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceEEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLLVY 469 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~lv~ 469 (721)
+|...+.||+|++|.||+|... +++.|++|...... ....+.+.+|+.++++++|+||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777899999999999999976 68899999876543 25678899999999999999999999999988 8899999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999997654 6999999999999999999999988 999999999999999999999999999876543
Q ss_pred Cce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......++..|++||.+.+...+.++||||||+++++|++|..||.... ......... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~---------~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG-----NPMAALYKI---------GSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-----chHHHHHhc---------cccC
Confidence 321 1233458889999999998889999999999999999999999986443 111111111 1111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+...+..+.+++.+||+.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 112223334567999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=300.98 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=199.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.|...+.||+|+||.||+++.. ++..+|+|.+... .....+.+.+|++++++++|+|++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3677889999999999999965 5889999987542 23345678999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+. |+|.+++.... .++++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 106 ~~~-g~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (317)
T cd06635 106 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA- 178 (317)
T ss_pred CCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-
Confidence 996 57777765433 25899999999999999999999998 999999999999999999999999998754322
Q ss_pred ceeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
....++..|+|||++. ...++.++||||||+++|||++|+.||...... .. ........
T Consensus 179 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~-~~~~~~~~-------- 240 (317)
T cd06635 179 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SA-LYHIAQNE-------- 240 (317)
T ss_pred ----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HH-HHHHHhcc--------
Confidence 2235788999999974 456889999999999999999999997532111 00 11111110
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.........+..+.+++.+||+.+|.+||++.+|++.+..+...
T Consensus 241 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 284 (317)
T cd06635 241 -SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER 284 (317)
T ss_pred -CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence 01111223345689999999999999999999999877655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=301.68 Aligned_cols=265 Identities=26% Similarity=0.363 Sum_probs=198.3
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETE---- 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~---- 463 (721)
...++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999976 48899999876532 233457788999999999999999999987655
Q ss_pred ------cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 464 ------VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 464 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
..++|+||+++ +|..++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 67899999976 6767666542 25899999999999999999999998 999999999999999999999
Q ss_pred eeccCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 538 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
+|||++...............++..|+|||.+.+ ..++.++||||||++++||++|+.||...... .....+....
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~---~~~~~~~~~~ 234 (302)
T cd07864 158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL---AQLELISRLC 234 (302)
T ss_pred CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH---HHHHHHHHHh
Confidence 9999998764433222222346788999998865 45788999999999999999999998643211 1111111111
Q ss_pred hccc---hhhhh--------hhhh-----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 617 KEDS---LFEIL--------DAHV-----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 617 ~~~~---~~~~~--------~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.... ..++. +... ........+..+.+++.+||+.+|.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 00000 0000 00001113467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=297.49 Aligned_cols=249 Identities=24% Similarity=0.379 Sum_probs=209.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..-|++.+-||+|.|..|-+|++- .|..||||.+... +......++.|++.|+.++|||||+||.+.......|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 355888899999999999999844 6999999987553 3344567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE-CCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-DGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DFGls~~~~~ 548 (721)
|.-++|+|++|+..... .+.+..+.+++.||+.|+.|.|+.+ +|||||||+||.+ ..-|-+||.|||++..+.+
T Consensus 97 ELGD~GDl~DyImKHe~--Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEE--GLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhc--cccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 99999999999987654 4999999999999999999999999 9999999999876 5568899999999988765
Q ss_pred CCceeeeeeecCCCCCCccccccCCCC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. ..+...|.+.|.|||++.+..|+ ++.|||||||+||-|++|+.||+..+..+ .+..|+|-
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE---------------TLTmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE---------------TLTMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh---------------hhhhhhcc
Confidence 54 34556799999999999999988 46899999999999999999997554332 22333443
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+ ..+.-...+.++||..||..||++|.+.+||...
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 32 2344566789999999999999999999998754
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=299.93 Aligned_cols=261 Identities=25% Similarity=0.349 Sum_probs=196.5
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
|+..+.||.|++|.||+|... +|+.||+|++.... ....+.+.+|++++++++|+|++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999965 68999999876432 233467889999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
+ ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++||||+|+||+++.++.+||+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 4 689988875442 35899999999999999999999998 999999999999999999999999999765432211
Q ss_pred eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc--------hhh
Q 036483 553 MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS--------LFE 623 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 623 (721)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....... .+...+........ +.+
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhchh
Confidence 1222468899999988764 57889999999999999999999986443211 11111100000000 000
Q ss_pred hhh---h---hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILD---A---HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~---~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... . ..........+..+.+++.+||+.+|++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000 0 0000111122356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.95 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=198.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-----CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-----DESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~ 465 (721)
.+|.+.+.||+|+||.||+|... +++.+|+|..... .......+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47889999999999999999965 5889999976431 233456889999999999999999999998764 357
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++++||+++++|.+++.... .+++..+++++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 4889999999999999999999999 99999999999999999999999999986
Q ss_pred cccCC--ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 546 MAIDQ--THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 546 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
..... ........++..|+|||.+.+..++.++||||||++++||++|+.||..... ... +...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~-~~~~-------- 221 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-----MAA-IFKI-------- 221 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-----HHH-HHHH--------
Confidence 53211 1112234588999999999998899999999999999999999999853211 111 1111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.........+.....++.+++.+||+ +|..||+..+++.
T Consensus 222 -~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 -ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred -HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111122344455679999999999 5799999998765
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=297.01 Aligned_cols=257 Identities=21% Similarity=0.286 Sum_probs=192.5
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CcceEEEe
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQIN-HRNVVKLLGCCLET--EVPLLVYE 470 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~--~~~~lv~e 470 (721)
|.+.+.||+|+||.||+|... +++.+|+|+.+.. .........+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567889999999999999965 5889999987653 2222334567899999885 99999999999987 78899999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|++ ++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 57777776543 25899999999999999999999998 999999999999999 999999999998664322
Q ss_pred ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh-----------hc
Q 036483 551 THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM-----------KE 618 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~-----------~~ 618 (721)
.. ....++..|+|||++.. ..++.++||||||+++|||++|..||......+ ......... ..
T Consensus 154 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 154 PY--TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred Cc--CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhcc
Confidence 21 22447889999997654 567889999999999999999999986543221 111111110 00
Q ss_pred cchhhhhhhhh----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 DSLFEILDAHV----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
........+.. ........+.++.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000000 00011234577999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=292.97 Aligned_cols=242 Identities=26% Similarity=0.328 Sum_probs=195.2
Q ss_pred EeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||.|++|.||+++... ++.+|+|..... .....+.+.+|++++++++||||+++++.+.+....++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999764 889999987542 234457899999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 557 (721)
.+++.+.. .+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997643 4899999999999999999999998 9999999999999999999999999998764332 22234
Q ss_pred ecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 558 ~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
.++..|++||.+.+..++.++|+||||+++|||++|..||...... .......... .......+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~---------~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED----PMEIYNDILK---------GNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC----HHHHHHHHhc---------cCCCCCCCccc
Confidence 5788999999998888999999999999999999999998644321 1111111110 00111122223
Q ss_pred HHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 036483 638 IVTVAKLTNRCLNLNGKKRPT-----MKEVAV 664 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 664 (721)
+.++.+++.+||+.+|++||+ ++|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567999999999999999999 566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=296.16 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=187.0
Q ss_pred eEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhh---cCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 401 ILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQ---INHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~---l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
+||+|+||.||++... +++.+|+|.+.... ......+.+|..++.. .+|+||+.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999965 58899999765421 1222334455544443 479999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999887543 5999999999999999999999999 9999999999999999999999999987553221
Q ss_pred eeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....|+..|+|||.+.+ ..++.++||||||++++||++|..||.......... ...... .....
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~~~----------~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTL----------TVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHHhh----------cCCcC
Confidence 122358999999999874 568899999999999999999999986443221110 110000 00112
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
.+...+.++.+++.+||+.||++|| +++|++++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 2333456789999999999999999 58888665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.16 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=193.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|...+.||+|+||.||++... +++.+|+|++.... ......+.+|+.++.++. |+||+++++++......+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999965 58899999876432 345567899999999996 99999999999998899999999
Q ss_pred ccCCCcchhcc---ccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 472 IINGTLFQYLH---DQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 472 ~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
+.. +|.++.. .. ....+++..+.+++.|++.||+|||+. + |+||||||+||+++.++.+||+|||+++...
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 853 5544332 22 123689999999999999999999985 6 9999999999999999999999999997654
Q ss_pred cCCceeeeeeecCCCCCCccccccC---CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSS---RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.... .....|+..|+|||++.+. .++.++||||||+++|||++|+.||.... .............
T Consensus 160 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~~----- 227 (288)
T cd06616 160 DSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKGD----- 227 (288)
T ss_pred cCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCCC-----
Confidence 3221 1223578899999999876 68999999999999999999999985322 1111111111110
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+..........+.++.+|+.+||+.+|++|||+++|+..
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111122345679999999999999999999999775
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.23 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=198.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC--cc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE--VP 465 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~--~~ 465 (721)
+.++|.+.+.||+|+||.||+|... +++.+|+|++.. ........+.+|+.+++++ +|+||+++++++...+ ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578899999999999999999976 588999998743 2334456788999999999 9999999999986543 57
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||++ ++|..++... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999996 5888887653 5889999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCc----eeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHH--------
Q 036483 546 MAIDQT----HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF-------- 612 (721)
Q Consensus 546 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~-------- 612 (721)
...... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 643322 12233468899999998865 46788999999999999999999998643322110000000
Q ss_pred HHHhhccchhhhhhh---h---hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 613 LRAMKEDSLFEILDA---H---VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 613 ~~~~~~~~~~~~~~~---~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+......++++. . .........+.++.+++.+||+.+|++|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000001110 0 0001111234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=306.85 Aligned_cols=261 Identities=23% Similarity=0.337 Sum_probs=198.7
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE---- 463 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~---- 463 (721)
...++|...+.||+|+||.||++... +++.||+|.+.. .+....+.+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 35688999999999999999999965 688999998753 23344567889999999999999999999986443
Q ss_pred --cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 464 --VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 464 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..++||||+. ++|.+.+.. .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCc
Confidence 4689999995 577777753 2788899999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE--- 618 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 618 (721)
+++...... ......++..|+|||.+.+..++.++||||||+++++|++|+.||...+.... ..........
T Consensus 164 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 238 (353)
T cd07850 164 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ---WNKIIEQLGTPSD 238 (353)
T ss_pred cceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCCCH
Confidence 998654322 12334578899999999999999999999999999999999999865432110 0000000000
Q ss_pred ----------------cc------hhhhhhhhhc----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 619 ----------------DS------LFEILDAHVL----KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 619 ----------------~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. +.++...... .......+..+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0000000000 00012345668899999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=290.02 Aligned_cols=250 Identities=29% Similarity=0.437 Sum_probs=205.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|.+.+.||+|+||.||++... +++.+++|++.... ....+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788899999999999999965 58899999876543 35667899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999997643 1246999999999999999999999998 9999999999999999999999999998764433
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......+++.|+|||.+.+..++.++||||||+++++|++|+.||..... ........ ... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~------~~~~~~~~-~~~---------~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL------LELALKIL-KGQ---------Y 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH------HHHHHHHh-cCC---------C
Confidence 223334688899999999999999999999999999999999999854321 11111111 111 1
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+...+..+.+++.+||+.+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1112233456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=292.30 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=204.3
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|++.++||+|+||.||++... +++.+++|..... ......++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4788899999999999999855 5789999987643 344566788999999999999999999999999999999999
Q ss_pred ccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 2246899999999999999999999999 999999999999999999999999999876543
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
......++..|++||.+.+..++.++|+||||++++||++|+.||......+ +....... ..
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~-------~~~~~~~~---------~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRG---------KY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHhcC---------CC
Confidence 2222347889999999999999999999999999999999999986433211 11111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+.....++.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 12233455679999999999999999999999753
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=300.45 Aligned_cols=266 Identities=23% Similarity=0.337 Sum_probs=193.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-----
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEV----- 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~----- 464 (721)
.++|...+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357899999999999999999965 58899999875432 2223456789999999999999999999876544
Q ss_pred ---ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 465 ---PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 465 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+++ |+|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 389999996 57877776543 25899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCce---eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 542 ASRSMAIDQTH---MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 542 ls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
++......... ......++..|+|||.+.+. .++.++||||||++++||++|+.||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99766432211 11233578889999988765 478899999999999999999999864432211111111100000
Q ss_pred ccch-----hhhhhhh-hcccC---------CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 618 EDSL-----FEILDAH-VLKEA---------SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 618 ~~~~-----~~~~~~~-~~~~~---------~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.+.. .+..+.. ..... .......+.+++.+||+.+|++|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 0000000 00000 0011245679999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=300.88 Aligned_cols=263 Identities=24% Similarity=0.334 Sum_probs=196.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~l 467 (721)
.++|++.+.||+|+||.||+|... +|+.||+|..+... ......+.+|+.++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 367999999999999999999975 58999999876432 22234567899999999999999999998765 45799
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+. ++|.+++.... ..+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 47888876543 36899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc--chhh-
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED--SLFE- 623 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~- 623 (721)
.... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ............ ....
T Consensus 160 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 160 LPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIE---QLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred CccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCChhhchh
Confidence 3321 1122335788999999875 467899999999999999999999986443221 111111111000 0000
Q ss_pred --------h--hhhhhcc---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 --------I--LDAHVLK---EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 --------~--~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. +...... ........++.+++.+||+.||++|||+.+++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0 0000000 0001124567899999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=325.73 Aligned_cols=264 Identities=26% Similarity=0.415 Sum_probs=215.5
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEcC--------CcEEEEeeccc-cCchhhHHHHHHHHHHhhc-CCCceeeEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLAD--------GRIVAIKKSKV-IDESKVDEFINEVAILSQI-NHRNVVKLLG 457 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~l~g 457 (721)
.++...++..+.+.||+|.||.|++|.... ...||||.++. ....+.+.+..|+++|+.+ +|+||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 455556666777799999999999998431 34799999875 3446778999999999999 6999999999
Q ss_pred EEEeCCcceEEEeeccCCCcchhccccC-----CC--------CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcC
Q 036483 458 CCLETEVPLLVYEFIINGTLFQYLHDQN-----EE--------FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524 (721)
Q Consensus 458 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~--------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~ 524 (721)
+|...+..++|+||+..|+|.++|+... .. ..|+....+.++.|||.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999899999999999999999998765 00 13889999999999999999999998 99999999
Q ss_pred ccEEECCCCcEEEeeccCccccccCCceeeeeee--cCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCC
Q 036483 525 TNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ--GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTN 601 (721)
Q Consensus 525 ~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~ 601 (721)
+||||..+..+||+|||+++............-. -...|||||.+....|+.|+||||||++||||++ |..|+....
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999976655444433222 2456999999999999999999999999999999 888875411
Q ss_pred ccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.. .. +. +.+....+.+.+..+..++.++++.||+.+|++||++.++.+.|+..
T Consensus 527 ~~-----~~-l~---------~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PT-----EE-LL---------EFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cH-----HH-HH---------HHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 11 11 11 22233333445556677899999999999999999999999999884
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=307.12 Aligned_cols=266 Identities=22% Similarity=0.332 Sum_probs=200.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----c
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----V 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~ 464 (721)
.++|.+.+.||+|+||+||+++.. +++.||||++... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 467999999999999999999965 5889999987542 2334567789999999999999999999876543 4
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999995 68888876543 5999999999999999999999998 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh------
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK------ 617 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~------ 617 (721)
...... .......++..|+|||.+.. ..++.++||||||+++++|++|+.||........ .........
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 232 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSEED 232 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCChHH
Confidence 664332 12233457889999998865 4688999999999999999999999865432111 111111000
Q ss_pred -----ccchhhhhhhh---h---cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhhc
Q 036483 618 -----EDSLFEILDAH---V---LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV--LAGI 669 (721)
Q Consensus 618 -----~~~~~~~~~~~---~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l 669 (721)
.......+... . ........+.++.+++.+||+.+|++|||++++++. +..+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 233 LGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000000 0 000112234668999999999999999999999887 5444
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=288.46 Aligned_cols=247 Identities=28% Similarity=0.443 Sum_probs=203.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc--hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|.+.+.||+|++|.||++... +++.+++|....... ...+.+.+|++++++++|+|++++++++.+.+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4788899999999999999865 578999998766543 4667899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999987653 6899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
. .....++..|+|||...+..++.++|||+||+++++|++|+.|+..... ....+ .. ... ...
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-----~~~~~-~~-~~~---------~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-----MAALF-RI-VQD---------DHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-----HHHHH-HH-hcc---------CCC
Confidence 2 2334588899999999888889999999999999999999999853221 11111 11 000 011
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...+..+.+++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 122233456899999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=296.81 Aligned_cols=259 Identities=25% Similarity=0.345 Sum_probs=200.2
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
|...+.||+|++|.||++... +++.+++|+..... ......+.+|++++++++|+||+++++++...+..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999965 68899999876532 234578889999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++ +|.+++.... ..+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 65 8888877643 36899999999999999999999999 9999999999999999999999999997765433 1
Q ss_pred eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc---chhhhhh--
Q 036483 553 MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED---SLFEILD-- 626 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~-- 626 (721)
......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+. ........... .......
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ---LFKIFRTLGTPDPEVWPKFTSLA 230 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCchHhcccchhhh
Confidence 12234578889999998876 789999999999999999999999865443211 00011110000 0000000
Q ss_pred ---------h--hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 627 ---------A--HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 627 ---------~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. ....+.....+.++.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 231 RNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 0001112234567999999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=293.86 Aligned_cols=243 Identities=28% Similarity=0.378 Sum_probs=196.9
Q ss_pred EeeeCcEEEEEEEEcC-CcEEEEeeccccCc---hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDE---SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||+|+||.||++...+ ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999774 89999998755332 4567899999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc------
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT------ 551 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~------ 551 (721)
.+++.+.. .+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.+||+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99997654 5899999999999999999999998 99999999999999999999999999876543211
Q ss_pred -eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 -HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......++..|++||.+.....+.++||||||++++||++|+.||...... ..+.. ......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~-~~~~~~--------- 218 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQN-ILNGKI--------- 218 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHH-HhcCCc---------
Confidence 1223345788999999999888999999999999999999999998543211 11111 111111
Q ss_pred ccCCHH--HHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 631 KEASQE--DIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 631 ~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+.. .+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus 219 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 -EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred -CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111 2466899999999999999999977666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=305.98 Aligned_cols=266 Identities=22% Similarity=0.343 Sum_probs=199.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~ 465 (721)
.++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999965 58999999876532 2345678899999999999999999998763 3456
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+. ++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 68888886543 5899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCce---eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH--------HH
Q 036483 546 MAIDQTH---MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--------FL 613 (721)
Q Consensus 546 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~--------~~ 613 (721)
....... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||.............. +.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1223468899999999866 4688999999999999999999999865432211000000 00
Q ss_pred HHhhccchhhhhhhhh-cc-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 614 RAMKEDSLFEILDAHV-LK-----EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~-~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.....+.+.+..+... .. ......+.++.+++.+||+.+|++||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000011111110000 00 0112235679999999999999999999998875
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=296.94 Aligned_cols=255 Identities=24% Similarity=0.301 Sum_probs=201.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEc----CCcEEEEeeccccC----chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVID----ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
+|.+.+.||+|++|.||+++.. +++.+|||.++... ....+.+.+|++++.++ +|+||+++++.+......
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999843 46789999875421 23446788999999999 699999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 5889999999999999999999998 99999999999999999999999999887
Q ss_pred cccCCceeeeeeecCCCCCCccccccCC--CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.............|+..|+|||.+.+.. .+.++||||||++++||++|..||....... .. ..+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~-~~~~~~~~~~---- 227 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQ-SEISRRILKS---- 227 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hH-HHHHHHHHcc----
Confidence 6543332333345889999999987765 7889999999999999999999985322111 11 1111111000
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 228 ------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 ------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 011122234568999999999999999999988887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.07 Aligned_cols=270 Identities=27% Similarity=0.397 Sum_probs=204.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC------Ccce
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLET------EVPL 466 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------~~~~ 466 (721)
.|...+.||+|+||.||+|+.+ .|+.||||..+. ......+.+.+|+++|++++|+|||+++++-.+. +.++
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3556689999999999999954 699999998765 3345678899999999999999999999986543 4678
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC----CCCcEEEeeccC
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD----GKYRAKVSDFGA 542 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~----~~~~~kl~DFGl 542 (721)
+||||+.+|+|..+|.+..+...|++.+.+.+..++..||.|||+++ |+||||||.||++- +..-.||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998877788999999999999999999999999 99999999999983 334589999999
Q ss_pred ccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc--
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED-- 619 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-- 619 (721)
|+.+..+. ..+.+.||..|++||.+.. ..|+...|.|||||++||..||..||...... ++.....+......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p--k~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP--KNNKEIMWHIITKKPS 246 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc--cccchhhhhhhccCCC
Confidence 99886544 5677889999999999995 78899999999999999999999999643322 11111111111111
Q ss_pred chhhh--------hhhhh----cccCCHHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHhhccc
Q 036483 620 SLFEI--------LDAHV----LKEASQEDIVTVAKLTNRCLNLNGKKRP--TMKEVAVVLAGIKA 671 (721)
Q Consensus 620 ~~~~~--------~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RP--t~~ev~~~L~~l~~ 671 (721)
.+.-. ++... ...........+-+.+..+|..+|++|- ...+....+..|..
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN 312 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence 10000 00000 1112233334566777788888998887 55555555554443
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=296.61 Aligned_cols=244 Identities=25% Similarity=0.394 Sum_probs=197.4
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcc
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLF 478 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 478 (721)
.+||+|+||.||++... +++.||||++........+.+.+|+.++++++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 67999999999999875 68899999876655556678999999999999999999999999999999999999999999
Q ss_pred hhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeee
Q 036483 479 QYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558 (721)
Q Consensus 479 ~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~ 558 (721)
+++... .+++..++.++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........ ......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~ 177 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV 177 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence 987543 4899999999999999999999998 99999999999999999999999999876543221 123345
Q ss_pred cCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHH
Q 036483 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDI 638 (721)
Q Consensus 559 gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 638 (721)
++..|++||.+.+..++.++||||||++++||++|..||....... . ....... +.... ......+
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~---~----~~~~~~~-----~~~~~--~~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---A----MKMIRDN-----LPPKL--KNLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHHhh-----CCccc--CCcccCC
Confidence 8899999999988889999999999999999999999986422111 0 0111100 00000 0111234
Q ss_pred HHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 639 VTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 639 ~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.+++.+||+.+|.+||++.+++..
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 468899999999999999999998773
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=293.71 Aligned_cols=241 Identities=23% Similarity=0.288 Sum_probs=190.8
Q ss_pred EeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||+|+||+||++... +|+.+|+|.+... .....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999855 5889999987542 223345678899999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 557 (721)
.+++..... ..+++..++.++.|++.||.|||+.+ ++||||+|+||++++++.+||+|||++....... .....
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence 999876543 36899999999999999999999999 9999999999999999999999999987654321 12233
Q ss_pred ecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 558 ~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
.++..|+|||.+.+..++.++||||||+++++|++|+.||......... ......... .....+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~----------~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK---EELKRRTLE----------MAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH---HHHHhcccc----------ccccCCccC
Confidence 5788999999999888999999999999999999999998644321110 001000000 011122233
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHH
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKE 661 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~e 661 (721)
...+.+++.+||+.+|++||+.++
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 556899999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.56 Aligned_cols=262 Identities=24% Similarity=0.347 Sum_probs=195.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|+..+.||+|++|+||+|... +++.||+|+..... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888999999999999999975 68899999875432 2344678899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCccccccC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAID 549 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~~~~ 549 (721)
|++ ++|.+++.... ...+++..+..++.||+.||+|||+++ |+||||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 57777775433 224688889999999999999999998 999999999999985 567999999999765432
Q ss_pred CceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh---
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL--- 625 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 625 (721)
.. ......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......+ .... ........ ..+..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~-~~~~~~~~-~~~~~~~~ 231 (294)
T PLN00009 157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFK-IFRILGTP-NEETWPGV 231 (294)
T ss_pred cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCC-Chhhcccc
Confidence 11 11223468899999998764 57899999999999999999999986433211 1111 00100000 00000
Q ss_pred ----h-----hh----hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 ----D-----AH----VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ----~-----~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+ +. ...........++.+++.+||+.+|++||++.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00 0000112234568899999999999999999999763
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=286.73 Aligned_cols=263 Identities=22% Similarity=0.346 Sum_probs=216.5
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
+..-..++....++-+|.||.||.|.+.+ .+.|.+|.++. .++-+...+..|.-.+..+.|||+.++.+++.+
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 34445778888899999999999997654 34567776654 456677889999999999999999999999876
Q ss_pred -CCcceEEEeeccCCCcchhcc-----ccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 462 -TEVPLLVYEFIINGTLFQYLH-----DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 462 -~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
.+.++++|.++.-|+|..+|. +.+....++-.+...++.|++.|++|||+++ |||.||..+|.+||+..++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeE
Confidence 457899999999999999998 3344456888889999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCceeee-eeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTHMTT-QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 613 (721)
||+|-.++|.+-+.+.+-.. .-.....||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--------- 506 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--------- 506 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---------
Confidence 99999999987655444322 2235678999999999999999999999999999999 888876444332
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+...+..+.+...+-+++.++..++.-||+..|++||+++++..-|.+..
T Consensus 507 -------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 507 -------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 22333444445556778889999999999999999999999999887653
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=326.71 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=190.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-------
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLET------- 462 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------- 462 (721)
-..+|+..++||+||||.|||++.+ ||+.+|||++... +......+.+|+.+|++|+|||||+++..+.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467888899999999999999966 8999999987553 455567889999999999999999998654310
Q ss_pred --------------------------------------------------------------------------------
Q 036483 463 -------------------------------------------------------------------------------- 462 (721)
Q Consensus 463 -------------------------------------------------------------------------------- 462 (721)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHH
Q 036483 463 --------------------------------EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510 (721)
Q Consensus 463 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH 510 (721)
-..||-||||+..+|.++++++.-. -.....++++.+|++||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence 0135778888888888888765421 135678999999999999999
Q ss_pred hcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc-----------------CCceeeeeeecCCCCCCccccccC-
Q 036483 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI-----------------DQTHMTTQVQGTFGYLDPEYFRSS- 572 (721)
Q Consensus 511 ~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~~- 572 (721)
+.+ ||||||||.||+||++..+||+|||++..... ......+...||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 99999999999999999999999999987210 011123456799999999999765
Q ss_pred --CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhc
Q 036483 573 --RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLN 650 (721)
Q Consensus 573 --~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 650 (721)
.|+.|+|+||||+||+||+. ||.. .++. ......++...+... ..+.....+.=+++|+++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~T-sMER-----a~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEMLY---PFGT-SMER-----ASILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHhc---cCCc-hHHH-----HHHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 49999999999999999994 4422 1111 111222222222111 11223333445789999999
Q ss_pred cCCCCCCCHHHHHH
Q 036483 651 LNGKKRPTMKEVAV 664 (721)
Q Consensus 651 ~~p~~RPt~~ev~~ 664 (721)
.||.+|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=304.95 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=204.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----cce
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----VPL 466 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~~~ 466 (721)
+|.+.+.||+|++|.||+++..+ ++.+|||++.... ....+.+.+|+.+++.++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 58889999999999999999764 8899999876533 445678999999999999999999999988775 779
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||++ ++|.+++.+.. .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 57888886543 6999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc--eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc-----
Q 036483 547 AIDQT--HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE----- 618 (721)
Q Consensus 547 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 618 (721)
..... .......++..|+|||.+.+. .++.++||||||+++++|++|+.||......+. ..........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ---LNLIVEVLGTPSEED 230 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHhcCCCChhH
Confidence 54321 112334578899999999888 889999999999999999999999865543221 0001110000
Q ss_pred ------cchhhhhhhh------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhhc
Q 036483 619 ------DSLFEILDAH------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV--LAGI 669 (721)
Q Consensus 619 ------~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l 669 (721)
....+.+... .........+..+.+++.+||+.+|++||++.+++.. ++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0000000000 0001112234668999999999999999999999875 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=332.31 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=206.1
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
+...+-++....+||.|.||.||.+... +|...|+|.++. ........+.+|+.++..++|||+|+++|+-.+.+..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 3445667888899999999999999954 588999997655 3344567889999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
+|.|||+.+|+|.+++.... .+++.....+..|++.|++|||++| ||||||||+||+|+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999997543 3566667778899999999999999 99999999999999999999999999998
Q ss_pred cccCCcee---eeeeecCCCCCCccccccCC---CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 546 MAIDQTHM---TTQVQGTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 546 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+....... .....||+.|||||++.+.. -..++||||+|||++||+||++||...+.+-
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~--------------- 1448 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW--------------- 1448 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---------------
Confidence 86543222 23456999999999998754 3468999999999999999999996433211
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.++-.+...-..+++.....+=.+++.+||..||++|-++.|+++.
T Consensus 1449 aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1449 AIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred HHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1111111111234455566778899999999999999888776654
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=289.76 Aligned_cols=243 Identities=27% Similarity=0.295 Sum_probs=189.3
Q ss_pred ceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHH-hhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAIL-SQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il-~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.||+|+||.||+|... +++.||+|...... ......+..|..++ ...+|+|++++++++.+.+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999865 58899999875432 22233445555544 455899999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
++|.+++.... .+++..+.+++.|++.||.|||+.+ |+||||+|+||++++++.+||+|||+++.... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997543 5899999999999999999999998 99999999999999999999999999875432 2
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
....++..|+|||.+.+..++.++||||||++++||++|..||...... ..+.. +...... ......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~-~~~~~~~------~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDN-ILSRRIN------WPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHH-HHhcccC------CCCccc
Confidence 2345788999999999888999999999999999999999998543221 11111 1111100 001111
Q ss_pred HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 635 QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 635 ~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...+..+.+++.+||+.+|++||++.++.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 23446689999999999999999887665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=293.11 Aligned_cols=251 Identities=26% Similarity=0.338 Sum_probs=196.5
Q ss_pred CCCCCceEeeeCcEEEEEEEE----cCCcEEEEeeccccC----chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 395 HYNTNRILGQGGQGTVYKGML----ADGRIVAIKKSKVID----ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
+|++.+.||+|+||.||++.. .+|+.||+|.++... ....+.+.+|+.++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999986 368899999876422 23346788999999999 699999999999998889
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++.... .+++..+..++.|+++||.|||+.+ ++||||+|+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999987543 5889999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCceeeeeeecCCCCCCccccccC--CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.............|+..|+|||.+... .++.++||||||+++|+|++|+.||....... .............
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~---- 228 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSE---- 228 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccC----
Confidence 643332223345588999999998753 46789999999999999999999986432211 1111111111100
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 664 (721)
...+......+.+++.+||+.+|++|| ++.+++.
T Consensus 229 -------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 229 -------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 111223445688999999999999997 5555544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=286.46 Aligned_cols=246 Identities=22% Similarity=0.290 Sum_probs=189.9
Q ss_pred HHHhcCCCCCceE--eeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 390 ETATDHYNTNRIL--GQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 390 ~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
....++|++.+.+ |+|+||.||++..+ +++.+|+|.......... |+.+...+ +|+||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3344667776666 99999999999965 578899998754321111 22222223 799999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCcc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASR 544 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~ 544 (721)
++||||+++++|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+||+++.++ .++|+|||+++
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 99999999999999997653 6999999999999999999999999 99999999999999988 99999999987
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... ...++..|+|||++.+..++.++||||||++++||++|+.||......+ -....+ .... ..
T Consensus 159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~-~~----- 225 (267)
T PHA03390 159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESL-LKRQ-QK----- 225 (267)
T ss_pred ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHH-HHhh-cc-----
Confidence 654221 2358899999999999999999999999999999999999987332211 111111 1111 00
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-MKEVAV 664 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 664 (721)
........+..+.+++.+||+.+|.+||+ ++|+++
T Consensus 226 -----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 -----KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred -----cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 00112234556899999999999999996 688864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=291.06 Aligned_cols=259 Identities=29% Similarity=0.381 Sum_probs=195.4
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC--chhhHHHHHHHHHHhhc---CCCceeeEEEEEEeCCc-----
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID--ESKVDEFINEVAILSQI---NHRNVVKLLGCCLETEV----- 464 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~~~~----- 464 (721)
|++.+.||+|+||.||+|..+. ++.+|+|+++... ......+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999774 8999999876432 22334667788887766 59999999999988776
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+++|||+. ++|.+++..... ..+++..++.++.|+++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 478888865432 25899999999999999999999998 9999999999999999999999999997
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch---
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL--- 621 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 621 (721)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.||......+ .... +.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDK-IFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHH-HHHHcCCCChHhc
Confidence 7643321 122347889999999999999999999999999999999998886433211 1111 1111100000
Q ss_pred -------hhhhhhhh---cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 622 -------FEILDAHV---LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 622 -------~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
........ ...........+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00000000 01112234567889999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=295.23 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=197.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+.|...+.||+|+||.||+|+.. +++.+|+|.... ......+++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34666788999999999999965 578899998753 22334567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 67877775433 25899999999999999999999998 999999999999999999999999998765322
Q ss_pred CceeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
....++..|+|||.+. ...++.++||||||+++|||++|+.|+......+ ... .......
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~-~~~~~~~----- 231 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALY-HIAQNES----- 231 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHH-HHhhcCC-----
Confidence 2235788999999975 3567889999999999999999999974321110 000 0111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
...........+.+++.+||+.+|++||++.+++.....+.
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 01112234456899999999999999999999988755444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=297.74 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=193.0
Q ss_pred ceEeee--CcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQG--GQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
..||+| +||+||+++.. .++.||+|..... .....+.+.+|+.+++.++||||+++++++...+..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 99999999965 6899999987542 234457889999999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM- 553 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~- 553 (721)
++|.+++.+.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999998764322 5899999999999999999999998 9999999999999999999999998654332111110
Q ss_pred -----eeeeecCCCCCCccccccC--CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc------
Q 036483 554 -----TTQVQGTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS------ 620 (721)
Q Consensus 554 -----~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 620 (721)
.....++..|+|||++.+. .++.++||||||++++||++|+.||....... . ....+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~----~~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--M----LLQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--H----HHHHhcCCCCCCccc
Confidence 0112245679999999764 47899999999999999999999986432111 0 000000000
Q ss_pred ------------------------------hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 ------------------------------LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ------------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.....+..............+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000001111112233456779999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=294.19 Aligned_cols=261 Identities=19% Similarity=0.253 Sum_probs=192.5
Q ss_pred CCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 398 TNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+.+.+|.|+++.||++.. +++.||||+.+.. .....+.+.+|++++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 334455555555555554 6899999987653 4556778999999999999999999999999999999999999999
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc----
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT---- 551 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~---- 551 (721)
+|.+++...... .+++..+..++.|++.||+|||+++ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999864322 5889999999999999999999998 99999999999999999999999998865532111
Q ss_pred --eeeeeeecCCCCCCccccccC--CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh----hcc----
Q 036483 552 --HMTTQVQGTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM----KED---- 619 (721)
Q Consensus 552 --~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~----~~~---- 619 (721)
.......++..|+|||++... .++.++||||||+++|||++|+.||....... .......... ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhh
Confidence 011223467889999998763 58899999999999999999999986432111 1111000000 000
Q ss_pred ---chhh----hhhhh----hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 ---SLFE----ILDAH----VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ---~~~~----~~~~~----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+.. ..+.. ...........++.+++.+||+.+|++|||++++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000 00000 0011122334578899999999999999999999875
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=299.62 Aligned_cols=248 Identities=29% Similarity=0.385 Sum_probs=206.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
...|.+.+.||+|.|++|..|+.. .+..||||.+... +....+.+.+|+++|+.|+|||||+++.+.......++||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 467889999999999999999965 5889999987553 3444566899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||..+|.+++|+.... .+....+..++.|+.+|++|+|++. |+|||||++||||+.+.++||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~g---r~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHG---RMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred EeccCchhHHHHHhcc---cchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec--
Confidence 9999999999998765 3666888999999999999999999 9999999999999999999999999998875
Q ss_pred CceeeeeeecCCCCCCccccccCCCC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.........|++.|.|||++.+..|+ +.+|+||+|++||-|+.|..||.+....+... ..+...
T Consensus 207 ~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~---------------rvl~gk 271 (596)
T KOG0586|consen 207 YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP---------------RVLRGK 271 (596)
T ss_pred ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc---------------hheeee
Confidence 33445667899999999999998765 68999999999999999999997554332111 011111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+. .+--...+..++++++|-++|.+|+++++|.+.
T Consensus 272 ~r--Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 272 YR--IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ec--ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 11 111223357889999999999999999998664
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=297.45 Aligned_cols=263 Identities=25% Similarity=0.336 Sum_probs=193.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
.++|.+.+.||+|+||.||+|... +++.+|+|++.... ......+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999965 58899999875432 223356789999999999999999999876544
Q ss_pred --cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 464 --VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 464 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..++|+||+.+ +|...+.... ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999864 6666665432 35999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCce----------eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHH
Q 036483 542 ASRSMAIDQTH----------MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA 610 (721)
Q Consensus 542 ls~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~ 610 (721)
+++........ ..+...+++.|+|||.+.+. .++.++||||||++++||++|+.||........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~---~~ 237 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ---LH 237 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 99765422211 11234578889999988654 588999999999999999999999864332211 11
Q ss_pred HHHHHhhcc---c------hhhhhh-------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 611 YFLRAMKED---S------LFEILD-------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 611 ~~~~~~~~~---~------~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
......... . +....+ +....+........+.+++.+||+.+|++|||+.|++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 238 LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 111110000 0 000000 00000000112256889999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=293.93 Aligned_cols=254 Identities=22% Similarity=0.389 Sum_probs=194.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
..++|.+.+.||+|+||.||+|...+ ++.||||.++... .....++..|+.++.+. .|+||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999875 8899999876532 23445677788877777 499999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|||+. ++|.+++..... .+++..+..++.|++.||+|||+. + |+||||+|+||++++++.+||+|||++..+.
T Consensus 93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99984 567776654332 689999999999999999999974 6 9999999999999999999999999987654
Q ss_pred cCCceeeeeeecCCCCCCccccccCC----CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.... .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...... ........... ...
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~-~~~ 238 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-----FEVLTKILQEE-PPS 238 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-----HHHHHHHhcCC-CCC
Confidence 3221 12234778999999987654 788999999999999999999998532111 11111111111 000
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.......+.++.+++.+||+.+|++||++.++++.-
T Consensus 239 -------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 239 -------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred -------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 001112345689999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=300.89 Aligned_cols=267 Identities=24% Similarity=0.309 Sum_probs=200.0
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEE
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCL 460 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~ 460 (721)
....++..++++|...+.||+|+||.||++.. .+++.||+|+++.. .....+.+.+|+.++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 34566778889999999999999999999985 46889999987642 2334567889999999999999999999886
Q ss_pred eC------CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc
Q 036483 461 ET------EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR 534 (721)
Q Consensus 461 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~ 534 (721)
.. ...+++++++ +++|.+++... .+++..+..++.|+++||+|||+.+ |+||||||+||++++++.
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCC
Confidence 43 2357788876 78888877543 4899999999999999999999999 999999999999999999
Q ss_pred EEEeeccCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 535 AKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 535 ~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
+||+|||+++..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+. ...
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~-~~~ 231 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLK-LIL 231 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH-HHH
Confidence 999999998764321 223457889999999876 568889999999999999999999985433211 110 010
Q ss_pred HHhh-----------ccchhhhh---hhhhc---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 614 RAMK-----------EDSLFEIL---DAHVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 614 ~~~~-----------~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... .......+ ..... .........++.+++.+||+.+|.+||++.+++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000 00000000 00000 00000124568899999999999999999998765
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=290.56 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=195.2
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCc-hhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDE-SKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
|.+.+.||+|++|+||+|+..+ ++.|+||++..... .......+|+..+++++ |+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5678899999999999999764 78899998754322 22334567999999998 999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
+++|.+++..... ..+++..++.++.|++.+|.|||+++ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 8899988876542 35899999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh-------------c
Q 036483 553 MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK-------------E 618 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-------------~ 618 (721)
.....++..|+|||++.. ..++.++||||||++++||++|+.||......+. ......... .
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ---LYKICSVLGTPTKQDWPEGYKLA 230 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHH---HHHHHHhcCCCChhhhhhHhhhh
Confidence 123457889999998854 4578999999999999999999999865432111 000000000 0
Q ss_pred cchhhhhhhhh---cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 DSLFEILDAHV---LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...+.... ...........+.+++.+||+.+|++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000000 00001112456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=291.59 Aligned_cols=244 Identities=26% Similarity=0.377 Sum_probs=192.4
Q ss_pred CCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
|...+.||+|+||+||+|+.. +++.|++|++... .....+.+.+|++++++++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 566778999999999999965 5889999987542 223456788999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+. ++|.+++.... .++++..++.++.|++.||.|||+.+ |+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 57777775433 25899999999999999999999998 99999999999999999999999999864322
Q ss_pred eeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.....|+..|+|||++. ...++.++||||||+++|||++|..|+...... ......... ...
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~-~~~------ 238 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQN-DSP------ 238 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhc-CCC------
Confidence 12345888999999984 456888999999999999999999997533211 111111111 000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......+..+.+++.+||+.+|++||++.+++..
T Consensus 239 --~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 --TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred --CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111223458899999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=290.14 Aligned_cols=248 Identities=27% Similarity=0.395 Sum_probs=202.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.+.||+|+||.||++... +++.+|+|..... .....+.+.+|++++.+++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888999999999999999975 6899999987542 2344577899999999998 99999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||++++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999997654 6999999999999999999999998 99999999999999999999999999876643
Q ss_pred CCc-------------------eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHH
Q 036483 549 DQT-------------------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609 (721)
Q Consensus 549 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~ 609 (721)
... .......++..|+|||.+....++.++||||||+++++|++|+.||......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------ 228 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY------ 228 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH------
Confidence 221 1122345788999999999888999999999999999999999998644311
Q ss_pred HHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 036483 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM----KEVAV 664 (721)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~ev~~ 664 (721)
..+..... .....+...+..+.+++.+||+.+|++||++ ++++.
T Consensus 229 ~~~~~~~~-----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 229 LTFQKILK-----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHHHHh-----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11111110 0111223335668999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=297.82 Aligned_cols=263 Identities=25% Similarity=0.329 Sum_probs=195.4
Q ss_pred hcCCC-CCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchh--------------hHHHHHHHHHHhhcCCCceeeEE
Q 036483 393 TDHYN-TNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESK--------------VDEFINEVAILSQINHRNVVKLL 456 (721)
Q Consensus 393 ~~~~~-~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~E~~il~~l~h~niv~l~ 456 (721)
.++|. +.+.||+|+||+||+|... +++.||||..+...... ...+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35565 4577999999999999965 58899999875432211 12578999999999999999999
Q ss_pred EEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 457 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
+++...+..++||||+. ++|.+++.... .+++.....++.|++.||+|||+.+ |+||||+|+||+++.++.+|
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999996 68888886533 5899999999999999999999998 99999999999999999999
Q ss_pred EeeccCccccccCC-------------ceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCc
Q 036483 537 VSDFGASRSMAIDQ-------------THMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNF 602 (721)
Q Consensus 537 l~DFGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~ 602 (721)
|+|||+++...... ........++..|+|||.+.+. .++.++||||||++++||++|+.||.....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654110 1111223467889999998764 468899999999999999999999865432
Q ss_pred cccccHHHHHHHHhhccc---hhhhhh-----------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 603 EEDKSLAAYFLRAMKEDS---LFEILD-----------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~---~~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+ ....+........ +.+... +..........+.++.+++.+||+.+|++|||+.|++..
T Consensus 240 ~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 ID---QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HH---HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 21 1111111111000 000000 000000111224568899999999999999999999763
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=287.23 Aligned_cols=241 Identities=22% Similarity=0.294 Sum_probs=186.0
Q ss_pred eEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHH---HhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 401 ILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAI---LSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~i---l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
+||+|+||.||++... +++.||+|.+.... ......+..|..+ ++..+||||+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999865 58899999765421 1122234444443 444579999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999886543 6999999999999999999999998 9999999999999999999999999987653221
Q ss_pred eeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....|+..|+|||.+.+. .++.++||||||++++||++|+.||.......... ....... ...+
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~----------~~~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT----------MAVE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhc----------cCCC
Confidence 1233589999999999754 68999999999999999999999986542221111 1111100 0011
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAV 664 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 664 (721)
.+...+.++.+++.+||..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2222345789999999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=298.16 Aligned_cols=265 Identities=22% Similarity=0.324 Sum_probs=198.2
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-CCc
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLE-TEV 464 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~~~ 464 (721)
+..++++|...+.||+|+||.||++... +++.||+|++.. ......+.+.+|++++++++||||+++++++.. ...
T Consensus 5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 3457789999999999999999999855 689999998643 223345678899999999999999999999876 457
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++++||+ +++|.++++.. .+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++
T Consensus 85 ~~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccc
Confidence 78999998 56888887643 4788889999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH--------HHHH
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--------FLRA 615 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~--------~~~~ 615 (721)
..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||.............. +...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 122357889999999866 5689999999999999999999999865432111000000 0000
Q ss_pred hhccchhhhhhhh-hcccCC-----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 616 MKEDSLFEILDAH-VLKEAS-----QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 616 ~~~~~~~~~~~~~-~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......+.+... .....+ .....++.+++.+||+.+|++|||+.+++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0000000110000 000001 1123578999999999999999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=299.36 Aligned_cols=263 Identities=23% Similarity=0.354 Sum_probs=194.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE----- 463 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~----- 463 (721)
..++|...+.||+|+||.||+|... +++.||+|++... .......+.+|+.++++++|+||+++++++....
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3578999999999999999999964 6899999987542 2333457889999999999999999999987543
Q ss_pred -cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 464 -VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 464 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
..++|+||+. .+|..++. ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 3589999985 36665542 14889999999999999999999998 99999999999999999999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH------
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA------ 615 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~------ 615 (721)
++..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ........
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~---~~~~~~~~~~~~~~ 236 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGP 236 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHhcCCCCH
Confidence 8764321 123457889999999876 468899999999999999999999996533211 00000000
Q ss_pred -----hhccchhhhhhh--hh-cccC---CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhhcc
Q 036483 616 -----MKEDSLFEILDA--HV-LKEA---SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV--LAGIK 670 (721)
Q Consensus 616 -----~~~~~~~~~~~~--~~-~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~ 670 (721)
............ .. .... .......+.+++.+||+.+|++||++.+++.. ++.++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 237 EFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000000000000 00 0000 01123468899999999999999999999855 55554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-33 Score=288.93 Aligned_cols=259 Identities=27% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
|+..+.||+|++|.||+|+... ++.+|+|..... .....+.+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 5667889999999999999764 899999987664 2444577889999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
+ ++|.+++.... ..+++..+++++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT 154 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccc
Confidence 7 58999998653 25999999999999999999999998 999999999999999999999999999876433221
Q ss_pred eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---cchhhh----
Q 036483 553 MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---DSLFEI---- 624 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~---- 624 (721)
.....++..|+|||.+.+. .++.++||||||++++||++|+.||......+. .......... .....+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 155 -YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred -cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcccc
Confidence 1223357789999998776 889999999999999999999998865332111 0111111000 000000
Q ss_pred --------hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 625 --------LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 625 --------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
................+.+++.+||..+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000111122457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=277.12 Aligned_cols=242 Identities=25% Similarity=0.334 Sum_probs=201.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.-++|+..++||+|.||.|.+.+.+ .++.+|+|+++. ........-..|-++|+..+||.+..|--.|...+..++
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 3478999999999999999999855 689999998865 345556677889999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||..||.|..+|.+.. .+++...+.+..+|..||.|||+++ ||.||||.+|.|||.+|++||+|||+++.-.
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999999998754 6888888999999999999999998 9999999999999999999999999997643
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.....+..+.||+.|+|||++....|..+.|.|.+||++|||++|+.||.....+. .|.-.+.+
T Consensus 320 -~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k------LFeLIl~e--------- 383 (516)
T KOG0690|consen 320 -KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK------LFELILME--------- 383 (516)
T ss_pred -cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH------HHHHHHhh---------
Confidence 23344567889999999999999999999999999999999999999996433221 11111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCC
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 657 (721)
. ..++....++...|+...|..+|++|.
T Consensus 384 d--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 D--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred h--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 0 123334445678899999999999995
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=298.34 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=197.6
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE- 463 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~- 463 (721)
.+....++|.+.+.||+|+||.||++... +++.||||+.... .....+.+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 34556788999999999999999999854 6899999987532 2233457889999999999999999999987654
Q ss_pred -----cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEe
Q 036483 464 -----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 464 -----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
..++||||+ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||+++.++.+||+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 348999998 77888887642 5899999999999999999999998 9999999999999999999999
Q ss_pred eccCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH------
Q 036483 539 DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY------ 611 (721)
Q Consensus 539 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~------ 611 (721)
|||+++..... .....+++.|+|||.+.+ ..++.++||||||+++++|++|+.||....... .....
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~--~~~~~~~~~~~ 234 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD--QLMEIMKVTGT 234 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCC
Confidence 99999765322 123457889999999876 468899999999999999999999986433211 00000
Q ss_pred ----HHHHhhccchhhhhhh--hh----cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 612 ----FLRAMKEDSLFEILDA--HV----LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 612 ----~~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
+...+........... .. ...........+.+++.+||+.+|++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000000000 00 00011123345889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=285.34 Aligned_cols=249 Identities=24% Similarity=0.329 Sum_probs=194.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccc-----cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKV-----IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
+|.+.+.||+|+||.||++.... +..+++|..+. .......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999998653 34455554432 1223345677899999999999999999999999999999
Q ss_pred EeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 469 YEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ ++|+||+|+||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 99999999999886522 2346999999999999999999999998 999999999999986 469999999987664
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... .......++..|+|||.+.+..++.++||||||+++|+|++|..||.... .......... .
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~-~-------- 220 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVE-G-------- 220 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHc-C--------
Confidence 322 12233457889999999988889999999999999999999999985321 1111111111 1
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+...+.++.+++.+||+.+|++||++.|+++
T Consensus 221 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 221 -PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred -CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 011123345567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=295.91 Aligned_cols=261 Identities=23% Similarity=0.332 Sum_probs=191.6
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-C--CcEEEEeecccc--CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC----Cc
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-D--GRIVAIKKSKVI--DESKVDEFINEVAILSQI-NHRNVVKLLGCCLET----EV 464 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~----~~ 464 (721)
+|.+.+.||+|+||.||++... . +..+|+|++... .....+.+.+|+.+++++ +||||+++++..... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999965 3 678999987542 223456788999999999 599999999875432 34
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++++||+. ++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678888885 68888886433 6899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce---eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh---
Q 036483 545 SMAIDQTH---MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK--- 617 (721)
Q Consensus 545 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--- 617 (721)
.+...... ......|+..|+|||++.+ ..++.++||||||+++++|++|+.||....... ........+.
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~ 230 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD---QLNQILQVLGTPD 230 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH---HHHHHHHHhCCCC
Confidence 65432211 1223468999999998766 468899999999999999999999986543211 1110000000
Q ss_pred --------ccchhhhhhh---h---hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 618 --------EDSLFEILDA---H---VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 618 --------~~~~~~~~~~---~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......... . ............+.+++.+||+.+|++|||+.+++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 231 EETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 0 0000011124568999999999999999999998643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=297.26 Aligned_cols=262 Identities=23% Similarity=0.343 Sum_probs=194.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC---------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLET--------- 462 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--------- 462 (721)
..+|...+.||+|+||.||+|... +++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 467999999999999999999965 5889999988766666677899999999999999999999776543
Q ss_pred -----CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCCcEE
Q 036483 463 -----EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAK 536 (721)
Q Consensus 463 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~k 536 (721)
...++||||++ ++|.+++... .+++..++.++.||++||.|||+.+ |+||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999996 5888877543 4889999999999999999999998 99999999999997 556789
Q ss_pred EeeccCccccccCCcee--eeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 537 VSDFGASRSMAIDQTHM--TTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
|+|||+++......... .....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+. .. ...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--~~-~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ--MQ-LIL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH-HHH
Confidence 99999997653221111 122347889999998754 5688899999999999999999999964432111 00 000
Q ss_pred HHhhcc------chhhhhhh-----hhcc-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 614 RAMKED------SLFEILDA-----HVLK-----EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 614 ~~~~~~------~~~~~~~~-----~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...... .....+.. .... ........++.+++.+||+.+|++|||+.|++..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 00000000 0000 0111233568899999999999999999999753
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.29 Aligned_cols=260 Identities=25% Similarity=0.341 Sum_probs=197.6
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc---
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV--- 464 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~--- 464 (721)
.+.++|...+.||+|++|.||+|+.. +++.||+|++... +....+.+.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999976 5789999987542 23345678899999999999999999998776554
Q ss_pred ---ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 465 ---PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 465 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.++|+||+ +++|.+++... .+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 78999998 67898888653 5899999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH-----
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA----- 615 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~----- 615 (721)
++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....... .+ ......
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~--~~-~~i~~~~~~~~ 236 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID--QL-KRIMNLVGTPD 236 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HH-HHHHHhcCCCC
Confidence 99765432 223457889999999865 367899999999999999999999986433211 00 000000
Q ss_pred ------hhccchhhhhhhhhcc------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 616 ------MKEDSLFEILDAHVLK------EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 616 ------~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+........+...... +.....+.++.+++.+||+.+|++|||+.||+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0000000000000000 0001124578999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=268.34 Aligned_cols=247 Identities=23% Similarity=0.410 Sum_probs=193.5
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccc-cCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKV-IDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
...||.|..|.|++.+.+ .|..+|||.+.. .+.++.++++..+.++.+-+ .|+||+.+|+|..+...++.||.| ..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 456999999999999966 489999998755 45667788888888877664 899999999999999999999998 44
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeee
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~ 555 (721)
-++.+|.+.+. ++++..+-++...+..||.||.+++ .|+|||+||+|||+|+.|++|++|||++-.+.....+ +
T Consensus 176 C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh--t 249 (391)
T KOG0983|consen 176 CAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH--T 249 (391)
T ss_pred HHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccccc--c
Confidence 56666665443 6999999999999999999999877 3999999999999999999999999999766433222 3
Q ss_pred eeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 556 QVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 556 ~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
...|-+.|||||.+.- ..|+-++||||||+.|+||.||+.|+.....+- +.......++. ..++..
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln~eP--P~L~~~---- 318 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLNEEP--PLLPGH---- 318 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHhcCC--CCCCcc----
Confidence 3458899999999864 468899999999999999999999997643321 11111111111 111111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
......+.+++..||+.|+.+||.+.+++++
T Consensus 319 --~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 319 --MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred --cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1144569999999999999999999998764
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=271.67 Aligned_cols=273 Identities=23% Similarity=0.307 Sum_probs=199.8
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcC-----CcEEEEeeccccCc--hhhHHHHHHHHHHhhcCCCceeeEEEEEEe-C
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLAD-----GRIVAIKKSKVIDE--SKVDEFINEVAILSQINHRNVVKLLGCCLE-T 462 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~ 462 (721)
.....|+....||+|.||.||+|..++ .+.+|||+++.... ..-....+|+.+++.++|||++.|..++.. +
T Consensus 21 e~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 21 EDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 334568999999999999999996432 23799998876432 223567899999999999999999999988 7
Q ss_pred CcceEEEeeccCCCcchhcccc--CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC----CcEE
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQ--NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK----YRAK 536 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~k 536 (721)
...+|++||.+. +|.++++-. .....++...+..|+.||+.|+.|||++= |+||||||.||||..+ |.+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeE
Confidence 788999999954 777777532 22347899999999999999999999998 9999999999999877 8999
Q ss_pred EeeccCccccccCCcee--eeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCcccccc------
Q 036483 537 VSDFGASRSMAIDQTHM--TTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKS------ 607 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~------ 607 (721)
|+|||++|.+...-... ...++-|..|+|||.+.+. .||.+.|||+.||++.||++-++.|......-...
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 99999999886433222 3456789999999999886 69999999999999999999988876543221111
Q ss_pred HHHHHHHHhhccchhh------------hh-hhhhcccCC----------HHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 608 LAAYFLRAMKEDSLFE------------IL-DAHVLKEAS----------QEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 608 ~~~~~~~~~~~~~~~~------------~~-~~~~~~~~~----------~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
....+...+......+ .+ +.+.....+ ...++.-.+|+.++|..||.+|.|+++.++
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 1111111111100000 00 000000000 001123678999999999999999999977
Q ss_pred HHh
Q 036483 665 VLA 667 (721)
Q Consensus 665 ~L~ 667 (721)
..-
T Consensus 337 h~y 339 (438)
T KOG0666|consen 337 HPY 339 (438)
T ss_pred ccc
Confidence 653
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.6e-33 Score=311.34 Aligned_cols=260 Identities=24% Similarity=0.337 Sum_probs=215.5
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
..++....++|.+.++||+|+||.|..++.+ .++++|+|+++. .......-|..|-.+|..-+.+-|+++.-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3456666789999999999999999999976 488999998876 344556789999999999999999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+..|+|||||+||+|..+|.... .+++..++.++.+|.-||.-||+.| +|||||||.|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 999999999999999999998765 5999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCcccccc-----CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
.+-.+..+..-.....+|||.|++||++.. +.|+...|.||+||++|||+.|..||.. +++...+.+.+
T Consensus 221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm 294 (1317)
T KOG0612|consen 221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIM 294 (1317)
T ss_pred hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHh
Confidence 998887776666677789999999999853 5688999999999999999999999963 34455455444
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC---HHHHHHH
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT---MKEVAVV 665 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~ev~~~ 665 (721)
.......+.+ ....+.+..+||.+.+ -+|+.|-. +.++-.+
T Consensus 295 ~hk~~l~FP~-------~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 295 NHKESLSFPD-------ETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNH 338 (1317)
T ss_pred chhhhcCCCc-------ccccCHHHHHHHHHHh-cChhhhcccccHHHHHhC
Confidence 4322222110 1235567888988876 57778876 7776544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-32 Score=275.76 Aligned_cols=236 Identities=30% Similarity=0.368 Sum_probs=192.7
Q ss_pred EeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 402 LGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++.+......++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 48899999865432 23566899999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~ 557 (721)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99997653 5899999999999999999999988 9999999999999999999999999997664322 122334
Q ss_pred ecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 558 ~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
.++..|++||.+.+...+.++|+||||++++||++|+.||..... .. ......... ...+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~------~~-~~~~~~~~~----------~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR------KE-IYEKILKDP----------LRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HH-HHHHHhcCC----------CCCCCCC
Confidence 578899999999988899999999999999999999999854321 11 111111111 1122223
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHH
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKE 661 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~e 661 (721)
+..+.+++.+||..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 456899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=276.63 Aligned_cols=241 Identities=24% Similarity=0.350 Sum_probs=198.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccc---cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKV---IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~l 467 (721)
..+|++..+||+|+||.|.+|..+. .+.+|||+++. ......+--+.|-++|+.. +-|.+++|..++..-+..++
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 3569999999999999999998664 56899998765 2334455567888888877 67899999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+.||+|-.++++-. .+.+..+..+|.+||.||-+||+++ ||.||||..|||||.+|++||+|||+++.-.
T Consensus 428 VMEyvnGGDLMyhiQQ~G---kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni 501 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG---KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI 501 (683)
T ss_pred EEEEecCchhhhHHHHhc---ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence 999999999998887654 4777888999999999999999999 9999999999999999999999999997543
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.+ ...+.++.||+.|+|||.+..++|+..+|.|||||+||||+.|++||.+.+..+ .|...+..+
T Consensus 502 ~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~aI~ehn-------- 566 (683)
T KOG0696|consen 502 FD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQAIMEHN-------- 566 (683)
T ss_pred cC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHcc--------
Confidence 32 233556789999999999999999999999999999999999999997543221 222222111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCC
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 657 (721)
..++...+.+...+....|...|.+|.
T Consensus 567 ---vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 567 ---VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred ---CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 123455566788899999999999995
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=268.42 Aligned_cols=258 Identities=20% Similarity=0.321 Sum_probs=202.4
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE 463 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~ 463 (721)
..++-+.++ ++||+|+|+.|-... +.+|..+|||++.........+..+|++++.+. .|+||++|+.+|.++.
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~ 149 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT 149 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc
Confidence 344444544 689999999999887 667999999998777667788999999999999 5999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---cEEEeec
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDF 540 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DF 540 (721)
..|||||.|.||+|..++++++ .+++.++.++.++|+.||.|||.++ |.||||||+|||..+-. -+||+||
T Consensus 150 ~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDf 223 (463)
T KOG0607|consen 150 RFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDF 223 (463)
T ss_pred eEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecc
Confidence 9999999999999999998765 6999999999999999999999999 99999999999996543 5899999
Q ss_pred cCccccccC------CceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccc---
Q 036483 541 GASRSMAID------QTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK--- 606 (721)
Q Consensus 541 Gls~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~--- 606 (721)
.|..-+... .........|+..|||||+.. ...|+.+.|.||||||||-||+|.+||.+...++..
T Consensus 224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr 303 (463)
T KOG0607|consen 224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR 303 (463)
T ss_pred ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence 887544321 112223456889999999863 235888999999999999999999999876653311
Q ss_pred -----cHHHHHHHHhhccchhhhhhhhhcccCCHH----HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 607 -----SLAAYFLRAMKEDSLFEILDAHVLKEASQE----DIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 607 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.-.......+.++.. +++.+ ...+..+++...|..++.+|.++.+++.
T Consensus 304 Ge~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 304 GEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111112222211 23333 2345678888999999999999988876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-33 Score=281.06 Aligned_cols=262 Identities=27% Similarity=0.421 Sum_probs=201.8
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccc---cC----chhhHHHHHHHHHHhhcCCCceeeEEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV---ID----ESKVDEFINEVAILSQINHRNVVKLLGCC 459 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~----~~~~~~~~~E~~il~~l~h~niv~l~g~~ 459 (721)
+.....++|-...+||+|||+.||+|. +...+.||+|+-.. .. +...+...+|..|.+.|.||.||++|+++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyf 536 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYF 536 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeee
Confidence 344556788899999999999999998 45688999997432 11 12245578999999999999999999998
Q ss_pred E-eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcE
Q 036483 460 L-ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRA 535 (721)
Q Consensus 460 ~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~ 535 (721)
. +.+..+-|+||++|.+|+-||...+ .+++++++.|+.||+.||.||.... +||||-||||.||||-+ -|.+
T Consensus 537 slDtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeI 612 (775)
T KOG1151|consen 537 SLDTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEI 612 (775)
T ss_pred eeccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCccccee
Confidence 6 4557789999999999999998765 6999999999999999999999875 67999999999999953 4789
Q ss_pred EEeeccCccccccCCc------eeeeeeecCCCCCCccccccC----CCCccccchhHHHHHHHHHhCCcccccCCcccc
Q 036483 536 KVSDFGASRSMAIDQT------HMTTQVQGTFGYLDPEYFRSS----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605 (721)
Q Consensus 536 kl~DFGls~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~ 605 (721)
||.||||++.+..+.. ..+....||.+|++||.+.-+ +.+.|+||||.||++|+.+.|++||.......
T Consensus 613 KITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ- 691 (775)
T KOG1151|consen 613 KITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ- 691 (775)
T ss_pred EeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH-
Confidence 9999999998764332 223456799999999988643 47789999999999999999999995432211
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+.++.+...-. +.....+....+...+|++||++.-++|.+..+++.
T Consensus 692 --------dILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 692 --------DILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------HHHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 1122222221111 111112234456889999999999999988877643
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=309.10 Aligned_cols=145 Identities=27% Similarity=0.405 Sum_probs=131.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.++||+|+||+||+|... +++.||||+++.. .......+.+|+.+++.++|+||+++++.+...+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67889999999999999999976 5889999987543 2334567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
||+.+++|.+++.... .+++..+++|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997543 5889999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-32 Score=245.76 Aligned_cols=261 Identities=24% Similarity=0.368 Sum_probs=198.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+|+..++||+|.||+||+|+..+ ++.||+|+.+.. ++..-....+|+-+|+.++|+|||++++....+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999999654 789999987653 334456789999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+ ..+|..|...-+. .++.+....++.|+++||.+.|+++ +.||||||.|.||+.+|++|++|||+++.+...-.
T Consensus 83 c-dqdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred h-hHHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 9 4578888776554 4889999999999999999999999 99999999999999999999999999998865543
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHH--hhccch---hhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRA--MKEDSL---FEI 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~ 624 (721)
.... ..-|..|.+|.++.+. .|+...|+||-|+++.||.. |++.|.+.+. ++.+...|... ..++.+ ..+
T Consensus 157 cysa-evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 157 CYSA-EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eeec-eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHHHHHHHHhCCCccccCCccccC
Confidence 3333 3468999999999876 58889999999999999988 5555544332 22333333222 122222 111
Q ss_pred hhhhhccc---------CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 625 LDAHVLKE---------ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 625 ~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.|-..... ..+.....=++|+++.|.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11111111 11112223468889999999999999988755
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=273.16 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=203.0
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcC-C-C----ceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQIN-H-R----NVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-~----niv~l~g~~~~~~~ 464 (721)
.+++|.+...+|+|.||.|-...... +..||||+++.... ..+..+-|+++|.++. + | -+|++.++|...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 37899999999999999999998554 68999999887533 3456678999999994 2 2 37888899999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-------------
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG------------- 531 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~------------- 531 (721)
.+||+|.+ |-++.++|..++.. +++...++.++.|++++++|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~-~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYI-PFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCcc-ccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 77999999876544 7899999999999999999999999 999999999999821
Q ss_pred -------CCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccc
Q 036483 532 -------KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604 (721)
Q Consensus 532 -------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~ 604 (721)
+..+||+|||.|+...... ..++.|..|.|||++.+-.++.++||||+||||+||.+|...|+.....+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3468999999998654333 34567999999999999999999999999999999999999998766333
Q ss_pred cccHHHHHHHHhhccchhhh----------hh---------------hh----hcccCCHHHHHHHHHHHHHhhccCCCC
Q 036483 605 DKSLAAYFLRAMKEDSLFEI----------LD---------------AH----VLKEASQEDIVTVAKLTNRCLNLNGKK 655 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~----------~~---------------~~----~~~~~~~~~~~~l~~li~~cl~~~p~~ 655 (721)
.-.+.+.+...+....+... +| .- ........+..+|.+|+++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 11111111111000000000 00 00 000123345567999999999999999
Q ss_pred CCCHHHHHHH
Q 036483 656 RPTMKEVAVV 665 (721)
Q Consensus 656 RPt~~ev~~~ 665 (721)
|+|+.|++.+
T Consensus 397 RiTl~EAL~H 406 (415)
T KOG0671|consen 397 RITLREALSH 406 (415)
T ss_pred cccHHHHhcC
Confidence 9999999764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=270.88 Aligned_cols=220 Identities=22% Similarity=0.186 Sum_probs=176.5
Q ss_pred eCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcchhccc
Q 036483 405 GGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD 483 (721)
Q Consensus 405 G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 483 (721)
|.+|.||+++.. +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999965 58899999876532 234555556666899999999999999999999999999999999875
Q ss_pred cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCC
Q 036483 484 QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563 (721)
Q Consensus 484 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 563 (721)
.. .+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 43 5899999999999999999999998 999999999999999999999999988655322 1223356789
Q ss_pred CCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHH
Q 036483 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643 (721)
Q Consensus 564 ~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (721)
+|||.+.+..++.++||||+|++++||++|+.|+....... ... .....+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~~~---------~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------NTH---------TTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------ccc---------cccCCcccCCHHHHH
Confidence 99999988889999999999999999999998764221100 000 000112223456899
Q ss_pred HHHHhhccCCCCCCCHH
Q 036483 644 LTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 644 li~~cl~~~p~~RPt~~ 660 (721)
++.+||+.||++||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.78 Aligned_cols=242 Identities=24% Similarity=0.281 Sum_probs=195.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+++.|.+...+|.|+|+.|-..... .++..++|++... ..+-.+|+.++.+. +||||+++.+.+.+....++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4678888889999999999988854 5788999987643 23445678777766 7999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE-CCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-DGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll-~~~~~~kl~DFGls~~~~~ 548 (721)
|.+.++-|.+.+.... .....+..|+.+|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877776544 222777889999999999999999 9999999999999 5889999999999987765
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
+ .....-|..|.|||++....|++++||||||++||+||+|+.||...... ......+..
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~---------- 528 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQM---------- 528 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcC----------
Confidence 4 22234588999999999999999999999999999999999998654432 111112221
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
..++...+...++|+.+||+.+|.+||+|.++...=
T Consensus 529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred --CccccccCHHHHHHHHHhccCChhhCcChhhhccCc
Confidence 122244556689999999999999999999997653
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-33 Score=267.38 Aligned_cols=250 Identities=25% Similarity=0.367 Sum_probs=189.5
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
...||.|.||+|+|-.++ .|+..|||+++... +.+.++++.|.+...+- +.||||+++|.+..++..|+.||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 457999999999999866 59999999986644 46678888888876555 7999999999999999999999999 44
Q ss_pred Ccchhccc--cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 476 TLFQYLHD--QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 476 sL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|..+... ...+..+++...-+|..-...||.||..... |||||+||+|||||..|.+||+|||++-.+.. +..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--SiA 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SIA 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH--HHH
Confidence 55554432 1122368999999999999999999998764 99999999999999999999999999876532 222
Q ss_pred eeeeecCCCCCCccccccC--CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 554 TTQVQGTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.+.-.|-..|||||.+... .|+-+|||||||++|+|+.||+.|++.-.. ..+........ |+....
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~g-------dpp~l~ 291 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIG-------DPPILL 291 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcC-------CCCeec
Confidence 2334577889999999653 488999999999999999999999753221 11111111111 111111
Q ss_pred --cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 --EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 --~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+....+.+++.-||..|-.+||.+.++.++
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1112345678999999999999999999987653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=296.12 Aligned_cols=259 Identities=20% Similarity=0.288 Sum_probs=170.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-----CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEE------EE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-----GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC------CL 460 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~------~~ 460 (721)
..++|.+.++||+|+||.||+|++.+ +..||+|++..... .+.+.+| .+.+..+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 68999998754221 1222222 1222223333322221 23
Q ss_pred eCCcceEEEeeccCCCcchhccccCCC-----------------CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCc
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNEE-----------------FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk 523 (721)
+....+|||||+.+++|.++++..... .......+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 456789999999999999998754311 01123345679999999999999998 9999999
Q ss_pred CccEEECC-CCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccC----------------------CCCccccc
Q 036483 524 STNILLDG-KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS----------------------RFTEKSDV 580 (721)
Q Consensus 524 ~~NIll~~-~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV 580 (721)
|+|||+++ ++.+||+|||+++.+............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 57999999999987654433344456789999999966432 23456799
Q ss_pred hhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc-----hhhhhhhhhccc------CCHHHHHHHHHHHHHhh
Q 036483 581 YSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS-----LFEILDAHVLKE------ASQEDIVTVAKLTNRCL 649 (721)
Q Consensus 581 ~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~------~~~~~~~~l~~li~~cl 649 (721)
|||||+||||+++..+... .+.. +...+.... +...+......+ ..........+|+.+||
T Consensus 363 wSlGviL~el~~~~~~~~~-------~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDS-------NLIQ-FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred HHHHHHHHHHHhCcCCCch-------HHHH-HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHc
Confidence 9999999999987655321 1111 111111100 000111110000 00011123458999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 036483 650 NLNGKKRPTMKEVAVV 665 (721)
Q Consensus 650 ~~~p~~RPt~~ev~~~ 665 (721)
+.||++|||++|++++
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999876
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=259.76 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=197.2
Q ss_pred HhcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCc
Q 036483 392 ATDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLE----TEV 464 (721)
Q Consensus 392 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~----~~~ 464 (721)
++++|.+. ++||-|-.|.|-....+ .|+.+|+|.+... ...++|+++.-+. .|||||.+++++.. ..-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 68999999999988865 5889999987643 3557888887666 69999999999864 335
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeecc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFG 541 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFG 541 (721)
.++|||.|+||.|...++++... .+++.++..|..||..|+.|||+.+ |.||||||+|+|... |-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 57999999999999999876543 7999999999999999999999999 999999999999964 4579999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
+++.... ........-|+.|.|||++..++|+...|+||+||++|-||.|.+||...... .+..-....+..+..
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~~gqy 284 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIRTGQY 284 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhhccCc
Confidence 9986532 22334456799999999999999999999999999999999999999643321 111112222222211
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
++-+ +.=...++...++|+.+|+.+|.+|.|+.++...-
T Consensus 285 -~FP~-----pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 285 -EFPE-----PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred -cCCC-----hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence 1101 11123445678899999999999999999997763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=264.76 Aligned_cols=238 Identities=29% Similarity=0.398 Sum_probs=192.9
Q ss_pred CcEEEEEEEEcC-CcEEEEeeccccCchh-hHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcchhccc
Q 036483 406 GQGTVYKGMLAD-GRIVAIKKSKVIDESK-VDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD 483 (721)
Q Consensus 406 ~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 483 (721)
+||.||+|...+ ++.+++|+........ .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999874 8999999987654444 68999999999999999999999999999999999999999999999876
Q ss_pred cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCC
Q 036483 484 QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563 (721)
Q Consensus 484 ~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y 563 (721)
.. .+++..++.++.+++++|.|||+.+ |+|+||+|+||++++++.++|+|||.+....... ......++..|
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 44 3899999999999999999999998 9999999999999999999999999998765432 22334578899
Q ss_pred CCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHH
Q 036483 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643 (721)
Q Consensus 564 ~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (721)
++||.+....++.++||||||+++++|++|..||...... .. ............ .......+.++.+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~----~~~~~~~~~~~~-------~~~~~~~~~~~~~ 219 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LE----LFKKIGKPKPPF-------PPPEWKISPEAKD 219 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HH----HHHHHhccCCCC-------ccccccCCHHHHH
Confidence 9999999888999999999999999999999998542111 11 111111111100 0000003456899
Q ss_pred HHHHhhccCCCCCCCHHHHHH
Q 036483 644 LTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 644 li~~cl~~~p~~RPt~~ev~~ 664 (721)
++.+||..+|++||++.++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHccCCchhccCHHHHhh
Confidence 999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=286.75 Aligned_cols=262 Identities=19% Similarity=0.229 Sum_probs=182.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEE-----------------cCCcEEEEeeccccCchhhHHH--------------HHH
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGML-----------------ADGRIVAIKKSKVIDESKVDEF--------------INE 440 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E 440 (721)
..++|.+.++||+|+||+||+|.+ .+++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999964 2356899999865443333333 346
Q ss_pred HHHHhhcCCCce-----eeEEEEEEe--------CCcceEEEeeccCCCcchhccccCC---------------------
Q 036483 441 VAILSQINHRNV-----VKLLGCCLE--------TEVPLLVYEFIINGTLFQYLHDQNE--------------------- 486 (721)
Q Consensus 441 ~~il~~l~h~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~--------------------- 486 (721)
+.++.+++|.++ +++++++.. .+..+|||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 677777653 3467999999999999999875321
Q ss_pred CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCc
Q 036483 487 EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566 (721)
Q Consensus 487 ~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aP 566 (721)
...++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 123567889999999999999999998 99999999999999999999999999976543222111222357899999
Q ss_pred cccccCCC----------------------CccccchhHHHHHHHHHhCCc-ccccCCcccc-----ccHHHHHHHHhhc
Q 036483 567 EYFRSSRF----------------------TEKSDVYSFGVVLAELLTGER-AIRVTNFEED-----KSLAAYFLRAMKE 618 (721)
Q Consensus 567 E~~~~~~~----------------------t~ksDV~SlGvll~elltG~~-p~~~~~~~~~-----~~~~~~~~~~~~~ 618 (721)
|.+..... ..+.||||+|++++||++|.. |+........ ...... .+....
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~-~r~~~~ 458 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNR-WRMYKG 458 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHH-HHhhcc
Confidence 98764321 234799999999999999875 5532211110 000000 000110
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCC---CCCCCHHHHHHH
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNG---KKRPTMKEVAVV 665 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~ev~~~ 665 (721)
.. ..............+|+.++|..+| .+|+|++|++++
T Consensus 459 ~~--------~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 459 QK--------YDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cC--------CCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 00 0011112234568899999999766 689999999764
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=259.31 Aligned_cols=247 Identities=23% Similarity=0.370 Sum_probs=203.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.++||+|+|.+|..++++ ..+.+|+|.++. .+.+..+-.+.|-.+..+. +||.+|.|..+|..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 67899999999999999999965 478899997655 3445566778888888877 799999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
.||+++|+|--+++++. .|+++.++.+..+|.-||.|||+.| ||.||||..|+|||..|.+||.|+|+++.-..
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999988887665 6999999999999999999999999 99999999999999999999999999976432
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc-ccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED-KSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
....+.++.||+.|+|||.+.+..|....|.|+|||+++||+.|+.||........ .+-.++..+.+.+..+
T Consensus 404 -~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi------ 476 (593)
T KOG0695|consen 404 -PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI------ 476 (593)
T ss_pred -CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc------
Confidence 23345668899999999999999999999999999999999999999987665432 3333443333332221
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCC
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 657 (721)
+ ++.........+++.-|+.||++|.
T Consensus 477 --r--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 477 --R--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --c--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 2223334466788899999999985
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=262.00 Aligned_cols=272 Identities=22% Similarity=0.324 Sum_probs=198.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLET-------- 462 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-------- 462 (721)
..|....+||+|.||+||+|+.+ .|+.||+|+.-. ..+..-....+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 34555678999999999999965 478899997533 2233345678999999999999999999887532
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
...++|+++++ -+|.-+|..... .++..++.+++.++..||.|+|... |+|||+|++|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ce-hDLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCE-HDLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhh-hhHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 24689999995 467777765443 4888999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCC---ceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc
Q 036483 543 SRSMAIDQ---THMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 543 s~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
++.+.... ....+..+-|..|++||.+.+. .|+++.|||.-||++.||++|.+.++.......-.++......+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98775322 2223445569999999998875 6899999999999999999999887654432222222222222221
Q ss_pred cc--------hhhhhhhhhccc----CCHHH------HHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 619 DS--------LFEILDAHVLKE----ASQED------IVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 619 ~~--------~~~~~~~~~~~~----~~~~~------~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+. +.+.+......+ .-.+. ..+..+|+.++|..||.+|+++.+++..----+.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 11 111111000000 00111 1357899999999999999999999877654433
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=276.55 Aligned_cols=242 Identities=23% Similarity=0.309 Sum_probs=202.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCc-EEEEeecc---ccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGR-IVAIKKSK---VIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~---~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.+++...-||-||||.|=++..++.+ .+|+|.++ ..+..+.+....|-.||...+.|.||+||..|.+....|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 44555677999999999999876544 37777554 466777888999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
|-+-||.|+..|+... .++..+...++..+.+|+.|||+++ ||.|||||+|.+||.+|-+||.|||+++.+...
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999998765 5888899999999999999999999 999999999999999999999999999988644
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. .+-++.||+.|.|||++.+...+.++|.||||++++|||+|.+||+..+...- + .. |+..--
T Consensus 574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt------Y-n~--------ILkGid 636 (732)
T KOG0614|consen 574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT------Y-NL--------ILKGID 636 (732)
T ss_pred C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH------H-HH--------HHhhhh
Confidence 3 34567899999999999999999999999999999999999999976543221 1 11 111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCC
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPT 658 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt 658 (721)
.-+++........+|+++..+.+|.+|..
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 22345555667889999999999999975
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=285.56 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=205.7
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe-----
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLE----- 461 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~----- 461 (721)
+...++-|++.+.||.|.+|.||+++. ++++..|+|+.... ....+++..|..+|+.+ .|||++.++|++.-
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 334567789999999999999999994 46888999977653 34456778899999888 69999999999864
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
++..|||||||.+|+..++++... ...+.|..+..|+.+++.||++||.+. ++|||||-.|||++.++.+||.|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence 567899999999999999998766 457999999999999999999999998 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccC-----CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
++..+..... ......||+.|||||++... .|+..+|+||||++..||--|.+|+...... .+.-.+
T Consensus 169 vSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm-------raLF~I 240 (953)
T KOG0587|consen 169 VSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM-------RALFLI 240 (953)
T ss_pred eeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh-------hhhccC
Confidence 9987753322 23345699999999999643 4777899999999999999999997533221 111111
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..++- .....+..-..++.++|..||..|.++||++.+++++
T Consensus 241 pRNPP-------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 241 PRNPP-------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred CCCCC-------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11111 1112234455779999999999999999999988764
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=273.17 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=191.5
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
.++||.|.||+||-|+.+ +|+.||||.+.. ...++..++++|+.||++++||.||.|.-.|...+..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 579999999999999965 699999997644 23445578999999999999999999999999999999999999655
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC---CcEEEeeccCccccccCCce
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGls~~~~~~~~~ 552 (721)
-|+-+|...+. .|++..-..+..||+.||.|||.++ |+|.||||+||||.+. -.+||+|||.+|.+... .
T Consensus 649 MLEMILSsEkg--RL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 649 MLEMILSSEKG--RLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred HHHHHHHhhcc--cchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 55555555444 5899988999999999999999999 9999999999999643 47999999999988543 3
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
....+.||+.|+|||+++...|...-|+||.||++|--|+|..||.... ++.+.+ .....+ .-+..-
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQI----QNAaFM--yPp~PW-- 788 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQI----QNAAFM--YPPNPW-- 788 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHh----hccccc--cCCCch--
Confidence 3456789999999999999999999999999999999999999985322 222211 111110 000111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA 663 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 663 (721)
.+...+..+||...|+..-.+|-+...-+
T Consensus 789 --~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 789 --SEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred --hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 12334567888888888888888776543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=283.92 Aligned_cols=279 Identities=25% Similarity=0.374 Sum_probs=205.8
Q ss_pred CCCCCceEeeeCcEE-EEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeec
Q 036483 395 HYNTNRILGQGGQGT-VYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
-|...+++|.|..|+ ||+|.. +|+.||||++-. +..+-..+|+..|+.- +|||||++++.-.+....||..|.+
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 355567899999986 799998 478999998753 3445668999999988 6999999999999999999999999
Q ss_pred cCCCcchhccccCCC-CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-----CCcEEEeeccCcccc
Q 036483 473 INGTLFQYLHDQNEE-FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-----KYRAKVSDFGASRSM 546 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGls~~~ 546 (721)
..+|.+++...... ....-...+.+..|++.||++||+.+ ||||||||.||||+. ..+++|+|||+++.+
T Consensus 586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 66899999764111 11121445778899999999999998 999999999999975 357999999999998
Q ss_pred ccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhC-CcccccCCccccccHHHHHHHHhhc-cchh
Q 036483 547 AIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG-ERAIRVTNFEEDKSLAAYFLRAMKE-DSLF 622 (721)
Q Consensus 547 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~ 622 (721)
..+.... .....||.+|+|||++....-+.++|||||||++|+.++| ..||...-..+ ...+.. ..+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------~NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------ANILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------hhhhcCcccee
Confidence 7655443 2346699999999999999888999999999999999995 88884221111 011111 1111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH---------HHHhhccccCCCCccccccccccccccccc
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA---------VVLAGIKACDGTSNIIQESVESDIAESYET 693 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~---------~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~ 693 (721)
. +.. ..+. +..+||.+|++.+|..||++.+|+ +.|+-++....-.+..+...++++-..+++
T Consensus 734 ~------L~~-~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL~Fl~dvSDRvE~e~r~~~s~lL~~le~ 804 (903)
T KOG1027|consen 734 H------LEP-LPDC--EAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRLSFLRDVSDRVEKENRDSPSELLRALEA 804 (903)
T ss_pred e------ecc-CchH--HHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHHHHHHhhhhhhhhhhccCchHHHHhhcc
Confidence 0 011 1111 678999999999999999999996 345555555444455555555555555666
Q ss_pred CCCcc
Q 036483 694 GESFT 698 (721)
Q Consensus 694 ~~~~~ 698 (721)
+.+..
T Consensus 805 ~~~~v 809 (903)
T KOG1027|consen 805 GARVV 809 (903)
T ss_pred CCceE
Confidence 55433
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-31 Score=253.25 Aligned_cols=263 Identities=24% Similarity=0.330 Sum_probs=199.7
Q ss_pred CCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----cceEE
Q 036483 397 NTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----VPLLV 468 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~~~lv 468 (721)
+..+-||-|+||.||.... ++|+.||+|++...- -...+.+.+|+++|.-++|.|++..+++..... +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 4567899999999999884 479999999876632 334678999999999999999999998876543 45788
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
+|.| ..+|++++-... .|+-..+.-+..||++||+|||+.+ |.||||||.|.|++.+..+||+|||++|....
T Consensus 136 TELm-QSDLHKIIVSPQ---~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVSPQ---ALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHH-HhhhhheeccCC---CCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 8988 668888876543 6888888899999999999999999 99999999999999999999999999998877
Q ss_pred CCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh--------cc
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK--------ED 619 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------~~ 619 (721)
++...++.-.-|..|.|||.+++. .|+.+.||||.|+++.||+.++-.|...+..+.-.++........ ++
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 766666666678999999999886 699999999999999999998888876655443333222211100 11
Q ss_pred chhhhhhhhhcc---------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 620 SLFEILDAHVLK---------EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 620 ~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
....++...... ..+.....+-..+..+++..+|+.|.+..+.+..+
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 111111111100 00111223456788889999999999988887654
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=264.32 Aligned_cols=206 Identities=24% Similarity=0.352 Sum_probs=176.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
...|..++-||-|+||+|.++...| ...+|+|.++.. ...+....+.|-.||+..+.+-||+|+-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3567788899999999999998555 567899977653 345667788999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc-
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA- 547 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~- 547 (721)
|||++||++-.+|.+.. .+.+..++.++.++.-|+++.|..| +|||||||.|||||.+|++||.||||+.-+.
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999998765 6888889999999999999999999 9999999999999999999999999975321
Q ss_pred --------cCC--------------------------------ceeeeeeecCCCCCCccccccCCCCccccchhHHHHH
Q 036483 548 --------IDQ--------------------------------THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVL 587 (721)
Q Consensus 548 --------~~~--------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll 587 (721)
... .......+||+.|+|||++....|+...|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 000 0001124599999999999999999999999999999
Q ss_pred HHHHhCCcccccCCccc
Q 036483 588 AELLTGERAIRVTNFEE 604 (721)
Q Consensus 588 ~elltG~~p~~~~~~~~ 604 (721)
+||+.|+.||-.....+
T Consensus 862 ~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGE 878 (1034)
T ss_pred HHHhhCCCCccCCCCCc
Confidence 99999999997665544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=233.58 Aligned_cols=206 Identities=24% Similarity=0.382 Sum_probs=167.4
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc-cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV-IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
++...+.......||+|++|.|-+-++. +|+..|+|++.. .+.+..++..+|+.+..+- ..|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4444455566678999999999888854 699999998766 3455667888899886655 799999999999999999
Q ss_pred eEEEeeccCCCcchhccc-cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 466 LLVYEFIINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
|+.||.| .-+|..+.++ -+....+++...-+||..+.+||.|||++-+ ++|||+||+||||+.+|++|++|||++-
T Consensus 121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999 4567666543 2233479999999999999999999999864 9999999999999999999999999997
Q ss_pred ccccCCceeeeeeecCCCCCCcccccc----CCCCccccchhHHHHHHHHHhCCccccc
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRS----SRFTEKSDVYSFGVVLAELLTGERAIRV 599 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~SlGvll~elltG~~p~~~ 599 (721)
.+... -..+...|-..|||||.+.. ..|+-||||||||+.+.||.+++.|+..
T Consensus 198 ~L~dS--iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 198 YLVDS--IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred eehhh--hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 66422 11222347778999999854 3688999999999999999999999753
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=233.85 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=196.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLET--EVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~--~~~~lv 468 (721)
.++|++.+++|+|.+++||.|. ..+.+.++||.++.. ..+.+.+|++||..|. ||||++|++...+. ..+.||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4789999999999999999998 456788999998754 4467899999999996 99999999998764 467899
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMA 547 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~~ 547 (721)
+||+++.+...+.. .|+...+...+.+++.||.|.|+.| |+|||+||.|++||. ...++|+|+|+|..+.
T Consensus 114 FE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 99999888776653 4778889999999999999999999 999999999999995 4679999999999887
Q ss_pred cCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc------
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS------ 620 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 620 (721)
+...... ...+..|--||.+-. ..|+..-|+|||||+|..|+..+.||.......+ .+.. +.+.+..+.
T Consensus 185 p~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVk-IakVLGt~el~~Yl~ 260 (338)
T KOG0668|consen 185 PGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVK-IAKVLGTDELYAYLN 260 (338)
T ss_pred CCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHH-HHHHhChHHHHHHHH
Confidence 6554332 335677889999865 4688889999999999999999999865543322 2221 111111111
Q ss_pred ---------hhhhhhhhhcc--------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 ---------LFEILDAHVLK--------EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ---------~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+++....+. +...-..++..+++.+.|..|-.+|||++|....
T Consensus 261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 11111111110 1111123678899999999999999999998653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=235.19 Aligned_cols=210 Identities=37% Similarity=0.598 Sum_probs=183.5
Q ss_pred EeeeCcEEEEEEEEcC-CcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcch
Q 036483 402 LGQGGQGTVYKGMLAD-GRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQ 479 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 479 (721)
||+|.+|.||++...+ ++.+++|+....... ..+.+.+|++.++.++|++|+++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999765 889999987764332 45789999999999999999999999999999999999999999999
Q ss_pred hccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCccccccCCceeeeeee
Q 036483 480 YLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAIDQTHMTTQVQ 558 (721)
Q Consensus 480 ~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~~~~~~~~~~~~~ 558 (721)
++.... ..+++..++.++.+++++|++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 987643 25899999999999999999999998 999999999999999 89999999999976643321 122345
Q ss_pred cCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHH
Q 036483 559 GTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637 (721)
Q Consensus 559 gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 637 (721)
+...|++||.+... ..+.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999887 888999999999999999
Q ss_pred HHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 638 ~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 348889999999999999999999764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=245.55 Aligned_cols=131 Identities=27% Similarity=0.417 Sum_probs=111.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-----C---CceeeEEEEEEeC--
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-----H---RNVVKLLGCCLET-- 462 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h---~niv~l~g~~~~~-- 462 (721)
.+|.+.++||+|.|++||++... +.+.||+|+.+.. +...+..+.||++|++++ | ..||+|++.|...
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 67889999999999999999965 4678999987653 344567889999999983 3 3699999999764
Q ss_pred --CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 463 --EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 463 --~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
.+.++|+|++ |.+|..++.....+ .++...+.+|+.||+.||.|||... +|||-||||+|||+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 4679999999 77888888765544 6999999999999999999999987 49999999999998
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=241.11 Aligned_cols=261 Identities=25% Similarity=0.363 Sum_probs=195.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
..+|.-.+.+|.|.. .|-.+.. -.++.||+|+... .+....++..+|..++..++|+||++++.++.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777788898888 5555553 2588999998643 34456678889999999999999999999997543
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++|||+| ..+|...++. .++-+++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m-~~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELM-DANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhh-hhHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 458999999 6678877763 3677888999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHH--------HHHHHH
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA--------AYFLRA 615 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~--------~~~~~~ 615 (721)
+....+ ...+.+..|..|.|||++.+..+.+.+||||.||++.||++|+-.|.+...-+..... ..|...
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 865433 4667788999999999999988999999999999999999999888643321111110 011111
Q ss_pred hhc-c--------c-----hhhhh-hhhh--cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 616 MKE-D--------S-----LFEIL-DAHV--LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 616 ~~~-~--------~-----~~~~~-~~~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+.. . + ..+.+ |... ..+.+........+++.+||..+|++|.+.++++.+
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 100 0 0 00000 0000 111222334557899999999999999999998664
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=255.59 Aligned_cols=196 Identities=25% Similarity=0.357 Sum_probs=167.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc--------CchhhHHHHHHHHHHhhcC---CCceeeEEEEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI--------DESKVDEFINEVAILSQIN---HRNVVKLLGCCLE 461 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~--------~~~~~~~~~~E~~il~~l~---h~niv~l~g~~~~ 461 (721)
..|...+.||+|+||.|+.+.++. ...|+||.+... .....-..-.|++||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 458889999999999999999764 567888865431 1122334567999999997 9999999999999
Q ss_pred CCcceEEEeec-cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 462 TEVPLLVYEFI-INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 462 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
++.++|+||-. ++-+|.+++..+. .+++.++.-|++||+.|+++||+.+ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999977 4668999998765 5999999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCc-cccchhHHHHHHHHHhCCcccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE-KSDVYSFGVVLAELLTGERAIR 598 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~SlGvll~elltG~~p~~ 598 (721)
|.+...... ....++||..|.|||++.+.+|-- .-|||++|++||.++....|+.
T Consensus 715 gsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999776433 234567999999999999998765 4799999999999998887763
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=232.14 Aligned_cols=198 Identities=35% Similarity=0.542 Sum_probs=173.3
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
|.+.+.||+|++|.||++...+ ++.+++|........ ..+.+.+|++.+.+++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999875 889999988765444 67889999999999999999999999999899999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... .+++..+..++.+++.+|.+||+.+ ++|+||+|+||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999876542 1889999999999999999999998 9999999999999999999999999998765432112
Q ss_pred eeeeecCCCCCCcccc-ccCCCCccccchhHHHHHHHHHhCCcccc
Q 036483 554 TTQVQGTFGYLDPEYF-RSSRFTEKSDVYSFGVVLAELLTGERAIR 598 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SlGvll~elltG~~p~~ 598 (721)
.....++..|++||.+ ....++.++|||+||++++||++|+.||.
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 2334578899999999 66778889999999999999999999984
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-28 Score=258.25 Aligned_cols=254 Identities=25% Similarity=0.358 Sum_probs=203.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..++|+..+.+|.|.+|.|||++.. .++..|+|.++.......+-.+.|+-+++..+|+||+.++|.+...+..|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 4578999999999999999999955 588999999888777778888999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+.+|+|++..+-.. ++++.++..+.++.++||+|||+.+ =+|||||-.|||+++.+.+|++|||.+-.+...
T Consensus 93 ycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat- 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT- 165 (829)
T ss_pred ecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh-
Confidence 999999999988654 7999999999999999999999999 789999999999999999999999998765421
Q ss_pred ceeeeeeecCCCCCCcccc---ccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYF---RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
-.....+.||+.|||||+. ..+.|..++|||++|+...||---++|..... .......+.... .++
T Consensus 166 i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-------pmr~l~LmTkS~----~qp 234 (829)
T KOG0576|consen 166 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-------PMRALFLMTKSG----FQP 234 (829)
T ss_pred hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-------hHHHHHHhhccC----CCC
Confidence 1123456799999999986 35678999999999999999977666643211 111111221111 111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+++ ...-.+.+.++++.+|..+|++||++..++.
T Consensus 235 p~lkD-k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKD-KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccC-CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11111 1223345889999999999999999876643
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=223.65 Aligned_cols=254 Identities=19% Similarity=0.270 Sum_probs=188.6
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEE-EEeCCcceE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGC-CLETEVPLL 467 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~-~~~~~~~~l 467 (721)
...+.|++.+.||+|.||.+.++.++. .+.+++|-... .....++|.+|..---.| .|.||+.-++. |...+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 345789999999999999999999775 66788886643 345678999998876666 59999998876 455667779
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC--CCCcEEEeeccCccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD--GKYRAKVSDFGASRS 545 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGls~~ 545 (721)
++||.+.|+|..-+... .+.+..-.+++.|++.||.|||+++ +||||||.+||||- +..++||+|||+.+.
T Consensus 100 ~qE~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eeccCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 99999999998877654 4888888999999999999999999 99999999999993 345899999999875
Q ss_pred cccCCceeeeeeecCCCCCCccccccC-----CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSS-----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
... ......-+..|.+||..... ...+.+|||.||++++..+||+.||+ .....++....|....-+.
T Consensus 173 ~g~----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ-ka~~~d~~Y~~~~~w~~rk-- 245 (378)
T KOG1345|consen 173 VGT----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ-KASIMDKPYWEWEQWLKRK-- 245 (378)
T ss_pred cCc----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch-hhhccCchHHHHHHHhccc--
Confidence 431 12223346679999987533 34568999999999999999999998 4444455555443222111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
... -+..... ..+.+.++.++-|..++++|=-..++.+.
T Consensus 246 ~~~--~P~~F~~----fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 246 NPA--LPKKFNP----FSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred Ccc--Cchhhcc----cCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 111 1111112 23457889999999999999544444443
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-27 Score=245.31 Aligned_cols=272 Identities=21% Similarity=0.229 Sum_probs=207.2
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC------CCceeeEEEE
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN------HRNVVKLLGC 458 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~------h~niv~l~g~ 458 (721)
..--+....+|.+....|+|-|++|..|... -|+.||||++... +.-.+.=+.|++||++|+ .-|.++|+..
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~ 502 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRH 502 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHH
Confidence 3344666788999999999999999999855 3789999998753 334456688999999995 3589999999
Q ss_pred EEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEE
Q 036483 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKV 537 (721)
Q Consensus 459 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl 537 (721)
|...++++||+|-+ ..+|.++|........|....+..++.|+.-||..|...+ |+|-||||.|||+++. ..+||
T Consensus 503 F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 503 FKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred hhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeee
Confidence 99999999999987 6689999988776677999999999999999999999999 9999999999999865 56899
Q ss_pred eeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH----
Q 036483 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL---- 613 (721)
Q Consensus 538 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~---- 613 (721)
+|||.|....... .+.+.-+..|.|||++.+-.|+...|+||.||.||||.||+-.|.+.....--.+.+...
T Consensus 579 CDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 579 CDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9999997654332 233445678999999999999999999999999999999999987654322111111110
Q ss_pred -HHhhccch---------------------------hhhhhh------hh-----cccCCHHHHHHHHHHHHHhhccCCC
Q 036483 614 -RAMKEDSL---------------------------FEILDA------HV-----LKEASQEDIVTVAKLTNRCLNLNGK 654 (721)
Q Consensus 614 -~~~~~~~~---------------------------~~~~~~------~~-----~~~~~~~~~~~l~~li~~cl~~~p~ 654 (721)
+.++.+.+ +..+.+ .+ ...........+.+|+.+||.+||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 00111100 000000 00 1112233456788999999999999
Q ss_pred CCCCHHHHHHH
Q 036483 655 KRPTMKEVAVV 665 (721)
Q Consensus 655 ~RPt~~ev~~~ 665 (721)
+|.|..+.+++
T Consensus 736 KRit~nqAL~H 746 (752)
T KOG0670|consen 736 KRITVNQALKH 746 (752)
T ss_pred hcCCHHHHhcC
Confidence 99999988764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.3e-26 Score=269.82 Aligned_cols=196 Identities=20% Similarity=0.229 Sum_probs=140.2
Q ss_pred hcCC-CceeeEEEEE-------EeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036483 446 QINH-RNVVKLLGCC-------LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517 (721)
Q Consensus 446 ~l~h-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 517 (721)
.++| +||+++++.+ .+.+..++++|++ +++|.++|.... ..+++..++.++.||++||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888877 3334567888987 669999997532 35999999999999999999999999 9
Q ss_pred eeccCcCccEEECC-------------------CCcEEEeeccCccccccCC---------------ceeeeeeecCCCC
Q 036483 518 YHRDIKSTNILLDG-------------------KYRAKVSDFGASRSMAIDQ---------------THMTTQVQGTFGY 563 (721)
Q Consensus 518 vHrDlk~~NIll~~-------------------~~~~kl~DFGls~~~~~~~---------------~~~~~~~~gt~~y 563 (721)
+||||||+||||+. ++.+||+|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456667777765421100 0001123478899
Q ss_pred CCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHH
Q 036483 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643 (721)
Q Consensus 564 ~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (721)
||||++.+..++.++|||||||+||||++|..|+.... .. +.. +.. ..+.+. ..........
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~---~~~-~~~----~~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS-----RT---MSS-LRH----RVLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH-----HH---HHH-HHH----hhcChh-----hhhcCHHHHH
Confidence 99999999999999999999999999999887753110 00 000 000 001111 0112234568
Q ss_pred HHHHhhccCCCCCCCHHHHHHH
Q 036483 644 LTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 644 li~~cl~~~p~~RPt~~ev~~~ 665 (721)
++.+||+.+|.+||+|.||++.
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.3e-25 Score=230.02 Aligned_cols=265 Identities=25% Similarity=0.353 Sum_probs=196.7
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE 463 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~ 463 (721)
+....+.|...++||+|.|++||++.+.. .+.||+|.+...+ ....+.+|++.|..+ -+.||+++.+++...+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34556778999999999999999998543 6789999876543 346789999999999 5999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccC
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGA 542 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGl 542 (721)
...+|+||++.....+++.. ++...+..++..++.||+++|++| ||||||||+|+|.+. -+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999988888763 778889999999999999999999 999999999999984 46789999999
Q ss_pred ccccccCC-------------------------------------------ceeeeeeecCCCCCCcccccc-CCCCccc
Q 036483 543 SRSMAIDQ-------------------------------------------THMTTQVQGTFGYLDPEYFRS-SRFTEKS 578 (721)
Q Consensus 543 s~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ks 578 (721)
+....... ........||++|.|||++.. ...+++.
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87211000 000112459999999999876 4678899
Q ss_pred cchhHHHHHHHHHhCCcccccCCccccccHHH---HHHH-Hh-----hccc--hhh------h---------hh-hhh--
Q 036483 579 DVYSFGVVLAELLTGERAIRVTNFEEDKSLAA---YFLR-AM-----KEDS--LFE------I---------LD-AHV-- 629 (721)
Q Consensus 579 DV~SlGvll~elltG~~p~~~~~~~~~~~~~~---~~~~-~~-----~~~~--~~~------~---------~~-~~~-- 629 (721)
||||-||+++-+++++.||......- ..+.. .|.. .+ ..+. +.+ + ++ ...
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~-~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~ 338 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDA-DALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK 338 (418)
T ss_pred ceeeccceeehhhccccccccCcccc-chHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence 99999999999999999985433221 11111 1100 00 0011 000 0 00 000
Q ss_pred -------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 -------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 -------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........+..+.+|+.+||..||.+|.|+++.+++
T Consensus 339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 001111223468899999999999999999999765
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.6e-24 Score=225.76 Aligned_cols=262 Identities=22% Similarity=0.249 Sum_probs=199.9
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCC--cEEEEeeccccCchhhHHHHHHHHHHhhcCC----CceeeEEEEE-EeCCcceE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADG--RIVAIKKSKVIDESKVDEFINEVAILSQINH----RNVVKLLGCC-LETEVPLL 467 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~il~~l~h----~niv~l~g~~-~~~~~~~l 467 (721)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997653 4788887655433333478889999999863 6899999999 47777899
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-----CcEEEeeccC
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-----YRAKVSDFGA 542 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-----~~~kl~DFGl 542 (721)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|.+||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999886655 347999999999999999999999999 9999999999999754 4699999999
Q ss_pred cc--ccccCCce------e-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 543 SR--SMAIDQTH------M-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 543 s~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
++ .+...... . .....||.+|.++..+.+...+.+.|+||++.++.|++.|..||........ ...+.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~---~~~~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL---KSKFE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch---HHHHH
Confidence 98 43222111 1 2345699999999999999999999999999999999999999965443221 11111
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
....... ... .....+.++.++...+-..+..++|....+...|+......
T Consensus 251 ~~~~~~~----~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 251 KDPRKLL----TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHhhhhc----ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 1111110 000 11223345666777777799999999999999988776554
|
|
| >PF13947 GUB_WAK_bind: Wall-associated receptor kinase galacturonan-binding | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-25 Score=193.62 Aligned_cols=101 Identities=43% Similarity=0.809 Sum_probs=87.7
Q ss_pred CCC-CCCCCccccccCCCCCCCCCCCCCCeeeccCCCCCCCCcccccccceEEeEeeccceEEEeeceeeecccCCCCCC
Q 036483 25 LMC-DQCGDFGSDDYPFGIGEGCYFDKSFEVFCDNSSGSPKPLLKSINLNMLLNFVFQKGLIAVEAPVISLNSSKSMGNA 103 (721)
Q Consensus 25 ~~C-~~CG~i~~ipyPFGi~~~C~~~~~F~l~C~~~~~~p~~~l~~~~~~~v~~is~~~~~~~v~~~~~~~~~~~~~~~~ 103 (721)
++| ++|||| +||||||||+||++++||+|+|++++++|++++.+++++ |++|++++++++|..++.+ .|.......
T Consensus 2 ~~C~~~CGnv-~IpYPFgi~~~C~~~~~F~L~C~~~~~~~~l~l~~~~~~-V~~I~~~~~~i~v~~~~~~-~~~~~~~~~ 78 (106)
T PF13947_consen 2 PGCPSSCGNV-SIPYPFGIGPGCGRDPGFELTCNNNTSPPKLLLSSGNYE-VLSISYENGTIRVSDPISS-NCYSSSSSN 78 (106)
T ss_pred CCCCCccCCE-eecCCCccCCCCCCCCCcEEECCCCCCCceeEecCCcEE-EEEEecCCCEEEEEecccc-ceecCCCCc
Confidence 689 999999 999999999999996799999999988899999999999 9999999999999999877 466544332
Q ss_pred ---cccccCCCCeEEeecCcEEEEEcccc
Q 036483 104 ---KGVNLTGTPFSFSQKNNKFTTAGCDS 129 (721)
Q Consensus 104 ---~~~~~~~~pf~~s~~~n~~~~~GC~~ 129 (721)
..+++.+ ||.+|+++|.|+++||++
T Consensus 79 ~~~~~~~~~~-~~~~s~~~N~~~~~GC~t 106 (106)
T PF13947_consen 79 SSNSNLSLNG-PFFFSSSSNKFTVVGCNT 106 (106)
T ss_pred ccccEEeecC-CceEccCCcEEEEECCCC
Confidence 3444555 899999999999999985
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.6e-24 Score=206.57 Aligned_cols=168 Identities=21% Similarity=0.224 Sum_probs=126.2
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
|+|.++++..+ ..+++..++.|+.|+++||+|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 68888887543 25999999999999999999999876 999999999999999 99987654322
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCC
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEAS 634 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 634 (721)
..||+.|||||++.+..++.++||||||+++|||++|+.||...... ..........+..... . .....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~------~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDP------R-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCc------c-ccccH
Confidence 25889999999999999999999999999999999999998532211 1111111111111000 0 00111
Q ss_pred HHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 635 QEDIV--TVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 635 ~~~~~--~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..... ++.+++.+||+.+|++||++.|+++.+..+.
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 12222 5899999999999999999999999987664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=221.04 Aligned_cols=177 Identities=19% Similarity=0.161 Sum_probs=135.5
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc--CCcEEEEeecccc-----CchhhHHHHHHHHHHhhcCCCceee-EEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA--DGRIVAIKKSKVI-----DESKVDEFINEVAILSQINHRNVVK-LLGCC 459 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~-l~g~~ 459 (721)
......++|.+.+.||+|+||+||+|+.. +++.+|||+.... .....+.|.+|+++|++++|+|+++ +++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~-- 89 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA-- 89 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE--
Confidence 34456688999999999999999999865 5778899975422 1223567999999999999999985 443
Q ss_pred EeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-cCccEEECCCCcEEEe
Q 036483 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDI-KSTNILLDGKYRAKVS 538 (721)
Q Consensus 460 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~ 538 (721)
.+..+|||||+++++|.. +.. .. ...++.|++++|.|||+.+ |+|||| ||+|||++.++.+||+
T Consensus 90 --~~~~~LVmE~~~G~~L~~-~~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 90 --TGKDGLVRGWTEGVPLHL-ARP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred --cCCcEEEEEccCCCCHHH-hCc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence 245799999999999963 211 11 1467889999999999999 999999 9999999999999999
Q ss_pred eccCccccccCCce-------eeeeeecCCCCCCccccccCC------CCccccch
Q 036483 539 DFGASRSMAIDQTH-------MTTQVQGTFGYLDPEYFRSSR------FTEKSDVY 581 (721)
Q Consensus 539 DFGls~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~ 581 (721)
|||+++.+...... ..+...+++.|+|||++...+ .+..+|-|
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 99999876532211 113456888999999986442 23346766
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=201.56 Aligned_cols=265 Identities=16% Similarity=0.204 Sum_probs=206.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..-+|.+.++||+|.||+++.|. +-+++.||||.-... ...-++..|....+.| ..++|...+-+..+...-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34579999999999999999998 557999999965432 2345677888888888 4799999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-----CCcEEEeeccCcc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-----KYRAKVSDFGASR 544 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGls~ 544 (721)
|.+ |-+|+++..=... .++.+++..+|.|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+++
T Consensus 104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 8888887764333 5999999999999999999999999 999999999999953 3468999999999
Q ss_pred ccccCCcee------eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc
Q 036483 545 SMAIDQTHM------TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 545 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
.+....+.. .....||.+||+-..+.+.+.+...|+-|||-|+++.|-|..||.+......+...+.+...-+.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 875433221 23355999999999999999999999999999999999999999876654433322222111111
Q ss_pred cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
-.+. +.....+.++...+.-.-+++-++-|+.+-+...+..+....
T Consensus 258 T~i~---------~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 258 TPIE---------VLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred CCHH---------HHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 1121 122334556788888888899999999988877777665443
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.7e-24 Score=204.31 Aligned_cols=248 Identities=21% Similarity=0.318 Sum_probs=194.2
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++..+|.+...|+.|+|++..+ -+++|+++.. ....-.+|..|.-.|+-+.||||+.++|.|.....+.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4445788999999999999744 4556766543 233456899999999999999999999999999999999999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEe--eccCccccccCCce
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS--DFGASRSMAIDQTH 552 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~--DFGls~~~~~~~~~ 552 (721)
|+|+..|+++.. ..++-.++.+++.++|+|++|||+..++ |----|.+..++||++.+++|+ |--++.
T Consensus 272 gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf-------- 341 (448)
T KOG0195|consen 272 GSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF-------- 341 (448)
T ss_pred hHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee--------
Confidence 999999998653 3677788999999999999999998843 4445789999999999998875 222211
Q ss_pred eeeeeecCCCCCCccccccCCCC---ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFT---EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t---~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
......-.+.||+||.++..+.+ .++|+|||+++||||.|+.-||......+.. +++.-..+
T Consensus 342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialegl 406 (448)
T KOG0195|consen 342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEGL 406 (448)
T ss_pred eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhccc
Confidence 11112235789999999887644 4789999999999999999999754433321 22223344
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+..+++.....+.+|+.-|++.||.+||.+..|+-.|+.++
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 45566777778999999999999999999999999998764
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=194.54 Aligned_cols=267 Identities=19% Similarity=0.218 Sum_probs=206.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEE-EcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCC-CceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINH-RNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~g~~~~~~~~~lv~ 469 (721)
....|.+.++||.|+||.+|.|. ..+|..||||.-+. .....++..|.++...|+| ..|..+..+..+...-.+||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~--~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESS--KAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecc--cCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 34679999999999999999998 56799999997543 2233567889999999975 67888888888999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC---CcEEEeeccCcccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSM 546 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGls~~~ 546 (721)
|.+ |-+|++++.--.. .++..+++-++-|++.-++|+|.++ ++||||||+|+|..-+ ..+.++|||+|+.+
T Consensus 91 dLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence 998 8899998875443 4888999999999999999999999 9999999999998643 46899999999877
Q ss_pred ccCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 547 AIDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 547 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
....+. ......||.+|.+-..+.+...+...|+-|+|.+|.++.-|..||++..........+.+...-..-
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~- 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST- 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC-
Confidence 532221 1234569999999999888888999999999999999999999998766544333322222111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
.-..+.. ..|.++.-.+..|-..--++-|+..-+.+.++-+......
T Consensus 244 ----~ie~LC~----G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~ 290 (341)
T KOG1163|consen 244 ----PIEVLCK----GFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNH 290 (341)
T ss_pred ----CHHHHhC----CCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccc
Confidence 1111222 3345688889999999999999998887777766554443
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-20 Score=197.96 Aligned_cols=261 Identities=30% Similarity=0.387 Sum_probs=196.5
Q ss_pred CCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCch---hhHHHHHHHHHHhhcCCC-ceeeEEEEEEeCCcceEEEee
Q 036483 396 YNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES---KVDEFINEVAILSQINHR-NVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~il~~l~h~-niv~l~g~~~~~~~~~lv~e~ 471 (721)
|...+.||.|+|+.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999987 77899987553322 477899999999999988 799999999777778999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~~~~~ 550 (721)
+.+++|.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966654321125888999999999999999999999 99999999999999988 79999999998654333
Q ss_pred ce-----eeeeeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 551 TH-----MTTQVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 551 ~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
.. ......|+..|++||.+.+ ..++...|+|++|++++++++|..|+...... .........+......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELPTP 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcCCc
Confidence 22 2355679999999999988 57888999999999999999999996543321 0011111111111100
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.................+.+++.+++..+|..|.++.+....
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 -SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred -ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001223468899999999999999999887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-22 Score=227.47 Aligned_cols=254 Identities=22% Similarity=0.264 Sum_probs=191.0
Q ss_pred CCCceEeeeCcEEEEEEEEc-CCcEEEEeecc-----ccCchh-hHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 397 NTNRILGQGGQGTVYKGMLA-DGRIVAIKKSK-----VIDESK-VDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~-----~~~~~~-~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
...+++|.|.+|.|+..... ..+..+.|... ...... ...+..|+.+-..++|+|++..+....+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45689999999988777633 34434444321 111111 222677888888999999988888777766666669
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||++. +|..++.... .++...+..++.|++.|++|||+.| |.|||||++|++++.++.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999997652 4888899999999999999999999 999999999999999999999999999876533
Q ss_pred Cc---eeeeeeecCCCCCCccccccCCCCcc-ccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 550 QT---HMTTQVQGTFGYLDPEYFRSSRFTEK-SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 550 ~~---~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.. .......|+..|+|||.+.+..|++. .||||.|+++..|++|+.||......++.... ....... -
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~-----~~~~~~~---~ 545 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT-----NNYSDQR---N 545 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh-----hcccccc---c
Confidence 32 45567789999999999999999874 79999999999999999999876655433200 0000000 0
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...-........+.+.+.++.+||+.+|.+|.|+++|++.
T Consensus 546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 0001112223445667899999999999999999999764
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=9.9e-21 Score=186.96 Aligned_cols=172 Identities=12% Similarity=0.109 Sum_probs=134.0
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCch---hhHH------HHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES---KVDE------FINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~------~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
...++|...++||.|+||.||.... +++.+|||.+...... ..+. +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999655 5778999987643222 2222 6799999999999999999988664
Q ss_pred C--------CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 462 T--------EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 462 ~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
. ...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||++|+||+++.++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 24689999999999977632 222 24569999999999999 99999999999999888
Q ss_pred cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHH
Q 036483 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ell 591 (721)
++|+|||.......+... ..+.....+..++|+|+||+.+..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999988655322111 01334455677999999999988764
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.9e-20 Score=181.57 Aligned_cols=139 Identities=20% Similarity=0.193 Sum_probs=107.9
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCch--h-------hHHH-----------------HHHHHHHhhcCCCce
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES--K-------VDEF-----------------INEVAILSQINHRNV 452 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~~-----------------~~E~~il~~l~h~ni 452 (721)
...||+|+||.||+|...+|+.||||..+..... . ...| ..|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999987653211 1 1122 349999999988776
Q ss_pred eeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHH-HhcCCCCeeeccCcCccEEECC
Q 036483 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL-HSAASIPIYHRDIKSTNILLDG 531 (721)
Q Consensus 453 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivHrDlk~~NIll~~ 531 (721)
.....+.. ...+|||||+++++|...+... ..+++....+++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44333222 2348999999988776543222 2588999999999999999999 6888 99999999999998
Q ss_pred CCcEEEeeccCcccc
Q 036483 532 KYRAKVSDFGASRSM 546 (721)
Q Consensus 532 ~~~~kl~DFGls~~~ 546 (721)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2e-20 Score=201.85 Aligned_cols=256 Identities=25% Similarity=0.453 Sum_probs=186.5
Q ss_pred HhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe-eeccC
Q 036483 444 LSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI-YHRDI 522 (721)
Q Consensus 444 l~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i-vHrDl 522 (721)
|+.+.|.|+.+++|.+.+....++|.+|+..|+|.+.+.... ..++|.-...+.++|+.||+|||+.. | +|+.|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~---i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP---IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc---ceeeeee
Confidence 457899999999999999999999999999999999998733 46999999999999999999999865 4 99999
Q ss_pred cCccEEECCCCcEEEeeccCccccccC-CceeeeeeecCCCCCCccccccCC-------CCccccchhHHHHHHHHHhCC
Q 036483 523 KSTNILLDGKYRAKVSDFGASRSMAID-QTHMTTQVQGTFGYLDPEYFRSSR-------FTEKSDVYSFGVVLAELLTGE 594 (721)
Q Consensus 523 k~~NIll~~~~~~kl~DFGls~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~t~ksDV~SlGvll~elltG~ 594 (721)
+++|.++|..+.+||+|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766421 011111122456799999987641 466799999999999999999
Q ss_pred cccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 595 RAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 595 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
.||......... .+.+.+ ++. .....+.+.+... .+..+++..++.+||..+|++||++++|...++.+.....
T Consensus 156 ~~~~~~~~~~~~--~eii~~-~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~ 229 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILR-VKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGS 229 (484)
T ss_pred CccccccccCCh--HHHHHH-HHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccccc
Confidence 999765443332 122222 111 0011111111111 1334468999999999999999999999999887765431
Q ss_pred C-------------------------------------CcccccccccccccccccCCCcccccccCcccccc
Q 036483 675 T-------------------------------------SNIIQESVESDIAESYETGESFTESYTDSVTIPVD 710 (721)
Q Consensus 675 ~-------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 710 (721)
. +.+.....+..+++++..+...++..++++++-++
T Consensus 230 ~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL~~mLP~~VA~~lk~G~~v~pe~~~~vti~fs 302 (484)
T KOG1023|consen 230 SKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLLGQMLPKSVAESLKLGKTVDPESFDSVTIYFS 302 (484)
T ss_pred ccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHHHHhcCHHHhhHhhcCCcCCccccCceeeeeH
Confidence 1 11122222234677778888888888888776544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.7e-19 Score=174.34 Aligned_cols=140 Identities=21% Similarity=0.195 Sum_probs=110.4
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCch--------------------------hhHHHHHHHHHHhhcCCCce
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES--------------------------KVDEFINEVAILSQINHRNV 452 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E~~il~~l~h~ni 452 (721)
...||+|++|.||+|...+|+.||||..+..... ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999986543211 01224678999999999987
Q ss_pred eeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECC
Q 036483 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDG 531 (721)
Q Consensus 453 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~ 531 (721)
.....+... ..+|||||++++++....... ..++.....+++.|++.+|.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 554444332 348999999888654332221 247888999999999999999999 88 99999999999999
Q ss_pred CCcEEEeeccCccccc
Q 036483 532 KYRAKVSDFGASRSMA 547 (721)
Q Consensus 532 ~~~~kl~DFGls~~~~ 547 (721)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.8e-20 Score=208.10 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=182.9
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC-chhhHHHHHHHHH--HhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID-ESKVDEFINEVAI--LSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~i--l~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++...+.||.+.|=+|.+++.++|. |+||..-..+ .-..+.|.++++- ...++|||.+++...-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778899999999999999998887 8888754433 3344455444433 4556999999998887777777888888
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc--ccC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM--AID 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~--~~~ 549 (721)
. ..+|++.|.... -|...+...|+.|++.||...|..+ |+|||||.+||||+.-.=+.|+||..-+.. +.+
T Consensus 103 v-khnLyDRlSTRP---FL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTRP---FLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred H-hhhhhhhhccch---HHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 8 557888776543 5788889999999999999999999 999999999999999888999999876533 344
Q ss_pred Cceeeeeeec----CCCCCCccccccC-----------CCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHH
Q 036483 550 QTHMTTQVQG----TFGYLDPEYFRSS-----------RFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 550 ~~~~~~~~~g----t~~y~aPE~~~~~-----------~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 613 (721)
++...+.+.- -..|+|||.+... ..+++-||||+||++.||++ |+++|... ..+.
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL~a 246 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QLLA 246 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HHHh
Confidence 4433333333 3469999987542 16678999999999999998 77777422 1111
Q ss_pred HHhh-ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 614 RAMK-EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 614 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
-.-. ..... ..++++. ...+++|+..|++.||++|.++++.++.-+++.
T Consensus 247 Yr~~~~~~~e-----~~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~ 296 (1431)
T KOG1240|consen 247 YRSGNADDPE-----QLLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLV 296 (1431)
T ss_pred HhccCccCHH-----HHHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhhhccc
Confidence 1111 11111 1111111 125899999999999999999999988855443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.9e-20 Score=197.29 Aligned_cols=225 Identities=27% Similarity=0.285 Sum_probs=179.2
Q ss_pred eEeeeCcEEEEEEE----EcCCcEEEEeeccccCch--hhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEeecc
Q 036483 401 ILGQGGQGTVYKGM----LADGRIVAIKKSKVIDES--KVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
.+|+|.||.|+... ...+..+|+|.++..... .......|..++...+ ||.++++.-.+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999765 334677888865442211 1125567888899886 9999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|.|...+.... ...+.........++-++.++|+.+ |+|||+|++||+++.+|.+|+.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988876544 4677777888889999999999999 999999999999999999999999999876433222
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
.||..|||||++. .....+|.||||++++||++|..||.. +.....++. ....
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~-----------~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKA-----------ELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhh-----------ccCC
Confidence 6899999999998 556789999999999999999999864 111111111 1234
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
+.+.......++.+++..+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 56677778899999999999999655
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=167.74 Aligned_cols=184 Identities=15% Similarity=0.054 Sum_probs=137.6
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCc----hhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEee
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDE----SKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.+...|++|+||+||.+.. .+.+++.+.+..... .....|.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997665 577788776655332 11235889999999995 5889999886 346899999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccC-cCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDI-KSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDl-k~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
+.|.+|...+.. ....++.|++++|.++|+++ |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999888654321 12357789999999999999 999999 7999999999999999999998554322
Q ss_pred ce----e--------eeeeecCCCCCCccccccC-CCC-ccccchhHHHHHHHHHhCCcccc
Q 036483 551 TH----M--------TTQVQGTFGYLDPEYFRSS-RFT-EKSDVYSFGVVLAELLTGERAIR 598 (721)
Q Consensus 551 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~SlGvll~elltG~~p~~ 598 (721)
.. . ......++.|++|+...-- ..+ ...+.++-|..+|.++|++.+.-
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 10 0 0112257788888865432 333 45688899999999999987753
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.5e-18 Score=174.96 Aligned_cols=232 Identities=20% Similarity=0.260 Sum_probs=150.3
Q ss_pred CCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCC----------CceeeEEEEEEe
Q 036483 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINH----------RNVVKLLGCCLE 461 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h----------~niv~l~g~~~~ 461 (721)
+...+.||.|+++.||.++..+ ++.+|+|..... .....+++.+|......+.+ -.++.-++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456799999999999999875 899999975332 23356777777766655432 223332332221
Q ss_pred ---------C---C-----cceEEEeeccCCCcchhccc----cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 036483 462 ---------T---E-----VPLLVYEFIINGTLFQYLHD----QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHR 520 (721)
Q Consensus 462 ---------~---~-----~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHr 520 (721)
. . ..+++|+-+ .++|.+++.. ......+....++.+..|+++.+++||+.| ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1 1 125667766 6677777542 222234666777888899999999999999 9999
Q ss_pred cCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCcccccc--------CCCCccccchhHHHHHHHHHh
Q 036483 521 DIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS--------SRFTEKSDVYSFGVVLAELLT 592 (721)
Q Consensus 521 Dlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~SlGvll~ellt 592 (721)
||+|+|++++.+|.++|+||+....... .. .....+..|.+||.... ..++.+.|.|+||+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~--~~--~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGT--RY--RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTE--EE--EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCc--ee--eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 9999999999999999999987654321 11 11234578999997644 247889999999999999999
Q ss_pred CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCC
Q 036483 593 GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKR 656 (721)
Q Consensus 593 G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 656 (721)
+..||.....+..... ...... +.++.+..||..+|+.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999865443321111 112223 667789999999999999988
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=168.49 Aligned_cols=137 Identities=15% Similarity=0.154 Sum_probs=106.6
Q ss_pred CCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-----CCCceeeEEEEEEeCC---c-ce
Q 036483 396 YNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-----NHRNVVKLLGCCLETE---V-PL 466 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~l~g~~~~~~---~-~~ 466 (721)
+...+.||+|+||.||. ..+....+||+.........+.+.+|+.+++++ +||||++++|++.++. . ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 34567999999999996 333233468887654444567899999999999 5799999999998874 2 33
Q ss_pred EEEee--ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHH-HHHHhcCCCCeeeccCcCccEEECC----CCcEEEee
Q 036483 467 LVYEF--IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV-SYLHSAASIPIYHRDIKSTNILLDG----KYRAKVSD 539 (721)
Q Consensus 467 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L-~yLH~~~~~~ivHrDlk~~NIll~~----~~~~kl~D 539 (721)
+|+|| ..+++|.+++.+. .+++. ..++.|++.++ +|||+++ |+||||||+|||++. +..++|+|
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 78999 5579999999653 25544 35677888777 9999999 999999999999973 34899999
Q ss_pred ccCc
Q 036483 540 FGAS 543 (721)
Q Consensus 540 FGls 543 (721)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5444
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.7e-18 Score=197.61 Aligned_cols=202 Identities=21% Similarity=0.304 Sum_probs=163.0
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC---CCceeeEEEEEEeC
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN---HRNVVKLLGCCLET 462 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~g~~~~~ 462 (721)
..+.+.-.+.|.+.+.||+|+||+||+|...+|+.||+|.-+.... -+|.--.+++.+|+ -+-|+.+.....-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4455666788999999999999999999988899999997654221 12222334455555 34555566666667
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-------CCCcE
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-------GKYRA 535 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-------~~~~~ 535 (721)
+.-+||+||.+.|+|.+++... ..++|...+.++.|++.-+.+||..+ |||+||||+|+||. +...+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~---~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTN---KVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhccC---CCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 7789999999999999999843 36999999999999999999999999 99999999999993 34469
Q ss_pred EEeeccCcccccc-CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcc
Q 036483 536 KVSDFGASRSMAI-DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERA 596 (721)
Q Consensus 536 kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p 596 (721)
+|+|||-+..+.. .........++|-.+-.+|+..+..++...|.|.|+.+++-||.|+..
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999876542 222345667799999999999999999999999999999999999754
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-18 Score=184.86 Aligned_cols=243 Identities=23% Similarity=0.330 Sum_probs=160.0
Q ss_pred CCCCceEeeeCcEEEEEEEEcCC----cEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEE-------EEEe---
Q 036483 396 YNTNRILGQGGQGTVYKGMLADG----RIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLG-------CCLE--- 461 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g-------~~~~--- 461 (721)
....+..+..+++.+......++ ..+.-+.....+........+++..+....|.+..-+.+ ....
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v 325 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKV 325 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhcccccc
Confidence 34445566666666665543222 223333333332233334455555555554444333333 1111
Q ss_pred --CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEee
Q 036483 462 --TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSD 539 (721)
Q Consensus 462 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 539 (721)
...+++.|+++...+|.++|.+.......++...+.++.|++.|+.| ++ .+|||+||.||+...+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhh
Confidence 22468999999999999999876655578899999999999999999 66 89999999999999999999999
Q ss_pred ccCccccccCC-----ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhC-CcccccCCccccccHHHHHH
Q 036483 540 FGASRSMAIDQ-----THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG-ERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 540 FGls~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG-~~p~~~~~~~~~~~~~~~~~ 613 (721)
||+........ ....+...||..||+||.+.+..|+.|+||||||++|+||+.- ..++.. ....
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----------~~t~ 469 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----------IATL 469 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----------HHhh
Confidence 99987765433 2233456799999999999999999999999999999999961 111110 0011
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA 663 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 663 (721)
.-++.+.+ .+....+. ++=..|+.+++.+.|.+||++.++.
T Consensus 470 ~d~r~g~i----p~~~~~d~-----p~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 470 TDIRDGII----PPEFLQDY-----PEEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhhhcCCC----ChHHhhcC-----cHHHHHHHHhcCCCcccCchHHHHh
Confidence 11111111 11111112 2235799999999999999655543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=161.70 Aligned_cols=143 Identities=17% Similarity=0.137 Sum_probs=111.5
Q ss_pred cCCCCCceEeeeCcEEEEEEE--EcCCcEEEEeeccccCch------------------------hhHHHHHHHHHHhhc
Q 036483 394 DHYNTNRILGQGGQGTVYKGM--LADGRIVAIKKSKVIDES------------------------KVDEFINEVAILSQI 447 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~il~~l 447 (721)
..|.+.+.||+|++|.||+|. ..+|+.||+|..+..... ....+.+|+.++.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357888999999999999998 567999999986543210 112357899999999
Q ss_pred CCC--ceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCc
Q 036483 448 NHR--NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKST 525 (721)
Q Consensus 448 ~h~--niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~ 525 (721)
.+. .+.++++. ...++||||+++.+|...+... ..+.......++.|++.+|++||+.+ .|+||||||+
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~ 178 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEY 178 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChh
Confidence 753 34455543 2358999999998887655322 13566677899999999999999987 3999999999
Q ss_pred cEEECCCCcEEEeeccCcccc
Q 036483 526 NILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 526 NIll~~~~~~kl~DFGls~~~ 546 (721)
||+++ +++++|+|||.+...
T Consensus 179 NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 179 NILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred hEEEE-CCCEEEEEChhhhcc
Confidence 99999 789999999998654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-16 Score=159.81 Aligned_cols=134 Identities=22% Similarity=0.309 Sum_probs=113.0
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCc--------hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDE--------SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
+.||+|++|.||+|.. ++..+++|+...... .....+.+|+.++..++|++++....++...+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 567788886543211 1234678999999999999998877777777888999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
+++++|.+++.... + .+..++.+++.+|.+||+.+ ++|||++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999886432 2 78899999999999999999 99999999999999 78999999999864
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.7e-17 Score=163.27 Aligned_cols=197 Identities=23% Similarity=0.279 Sum_probs=139.5
Q ss_pred CCCceeeEEEEEEe---------------------------CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHH
Q 036483 448 NHRNVVKLLGCCLE---------------------------TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI 500 (721)
Q Consensus 448 ~h~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 500 (721)
+|||||+++++|.+ ....|+||.-. .-+|.+|+..+. .+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC----CchHHHHHHHH
Confidence 69999999988753 23457888766 457888887654 66777888999
Q ss_pred HHHHHHHHHHhcCCCCeeeccCcCccEEEC--CC--CcEEEeeccCcccccc-----CCceeeeeeecCCCCCCcccccc
Q 036483 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLD--GK--YRAKVSDFGASRSMAI-----DQTHMTTQVQGTFGYLDPEYFRS 571 (721)
Q Consensus 501 qia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~--~~~kl~DFGls~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~ 571 (721)
|+++|+.|||+++ |.|||+|++||||. +| -.+.|+|||.+--... +........-|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 99999999999993 33 3578999998743221 11111122337778999999865
Q ss_pred CC------CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHH
Q 036483 572 SR------FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLT 645 (721)
Q Consensus 572 ~~------~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 645 (721)
.+ .-.|+|.|+.|.+.||+++...||....... +. .+...+.. ....+...+..+++++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~---L~---~r~Yqe~q---------LPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML---LD---TRTYQESQ---------LPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe---ec---hhhhhhhh---------CCCCcccCChHHHHHH
Confidence 43 1258999999999999999999986422111 00 00111111 1223445666789999
Q ss_pred HHhhccCCCCCCCHHHHHHHHh
Q 036483 646 NRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 646 ~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
...|+.||++|++..-....|.
T Consensus 491 ~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHhcCCccccCCccHHHhHHH
Confidence 9999999999999876666553
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.6e-16 Score=155.48 Aligned_cols=138 Identities=21% Similarity=0.185 Sum_probs=109.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCc----------------------hhhHHHHHHHHHHhhcCCC-
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDE----------------------SKVDEFINEVAILSQINHR- 450 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~E~~il~~l~h~- 450 (721)
..|.+.+.||+|+||.||++...+|+.||||+...... .....+..|+.++..+.|+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred chhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 34777899999999999999988899999997543210 0112367889999999877
Q ss_pred -ceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 451 -NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 451 -niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
.+++.++ ....++||||+++++|..+... .....++.+++.++.++|+.+ |+||||||+||++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill 158 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILV 158 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEE
Confidence 4455554 2456899999999998765431 234678899999999999988 9999999999999
Q ss_pred CCCCcEEEeeccCccccc
Q 036483 530 DGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~ 547 (721)
++++.++|+|||++....
T Consensus 159 ~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 159 DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cCCCcEEEEECCccccCC
Confidence 999999999999996553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.7e-16 Score=178.70 Aligned_cols=138 Identities=20% Similarity=0.284 Sum_probs=112.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccc-cC------chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKV-ID------ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~-~~------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
...|...++||+|+||+||+|.+.+...++.++... .. ....+.+.+|++++++++|++++....+.......
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 345567899999999999999876544333222211 11 11235688999999999999999888888777788
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++. ....++.+++++|.+||+.+ |+||||||+|||+ +++.++|+|||+++.
T Consensus 412 ~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred EEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 99999999999988775 35678999999999999999 9999999999999 577999999999965
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.1e-16 Score=155.00 Aligned_cols=130 Identities=22% Similarity=0.338 Sum_probs=106.0
Q ss_pred eEeeeCcEEEEEEEEcCCcEEEEeeccccC--c------hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 401 ILGQGGQGTVYKGMLADGRIVAIKKSKVID--E------SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.||+|+||.||+|.+ ++..+++|...... . ...+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 56788998743311 1 12356789999999999887665555556667779999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++++|.+++.... . .++.+++.+|.+||+.+ ++|||++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998875421 1 78999999999999999 99999999999999 78999999999864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.9e-16 Score=178.69 Aligned_cols=208 Identities=27% Similarity=0.375 Sum_probs=145.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..+|+.++.|..|++|.||..+++. .+.+|+|+-+. ..+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq------~lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc------chhhhc--cccccCCccee------------------
Confidence 3689999999999999999998774 56778753221 111111 22223333333
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC--
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID-- 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~-- 549 (721)
|+=...+.... +++. +++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++.....
T Consensus 136 ---gDc~tllk~~g---~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhcccCC---CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 33333333222 2332 2378999999999 999999999999999999999999998653211
Q ss_pred ------------CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 550 ------------QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 550 ------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
.......+.||+.|+|||++..+.|...+|+|++|+++||.+-|+.||.....++ .|...+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee------lfg~vis 272 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVIS 272 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH------HHhhhhh
Confidence 1112345679999999999999999999999999999999999999997655443 2222222
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 657 (721)
..-. ..+.....+.+.++++.+.|+.+|..|-
T Consensus 273 d~i~--------wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 273 DDIE--------WPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred hhcc--------ccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 2111 1122334556799999999999999994
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.8e-15 Score=143.42 Aligned_cols=136 Identities=24% Similarity=0.259 Sum_probs=99.1
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCch--hhHH----------------------HHHHHHHHhhcCCC--ce
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES--KVDE----------------------FINEVAILSQINHR--NV 452 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~il~~l~h~--ni 452 (721)
.+.||+|+||+||+|...+++.||||........ .... ...|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999976542111 1111 13566666666443 34
Q ss_pred eeEEEEEEeCCcceEEEeeccCCCcchh-ccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEEC
Q 036483 453 VKLLGCCLETEVPLLVYEFIINGTLFQY-LHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLD 530 (721)
Q Consensus 453 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~ 530 (721)
.+.+++ ...++||||++++.+... +.... .. .....++.+++.++.++|. .+ |+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 555543 246899999998654322 21111 11 5678899999999999999 87 99999999999999
Q ss_pred CCCcEEEeeccCccccc
Q 036483 531 GKYRAKVSDFGASRSMA 547 (721)
Q Consensus 531 ~~~~~kl~DFGls~~~~ 547 (721)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.4e-14 Score=135.52 Aligned_cols=135 Identities=23% Similarity=0.221 Sum_probs=114.3
Q ss_pred CCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCC--CceeeEEEEEEeCCcceEEEeeccCC
Q 036483 398 TNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINH--RNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| .+++++++.....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35789999999999999855 7799998755333 4678999999999976 58999999888878899999999888
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
.+..+ +......++.+++++|++||.....+++|+|++|+||+++..+.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77654 4566778899999999999986544599999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=3.6e-14 Score=143.73 Aligned_cols=136 Identities=20% Similarity=0.289 Sum_probs=105.4
Q ss_pred CceEe-eeCcEEEEEEEEcCCcEEEEeecccc-------------CchhhHHHHHHHHHHhhcCCCce--eeEEEEEEeC
Q 036483 399 NRILG-QGGQGTVYKGMLADGRIVAIKKSKVI-------------DESKVDEFINEVAILSQINHRNV--VKLLGCCLET 462 (721)
Q Consensus 399 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~E~~il~~l~h~ni--v~l~g~~~~~ 462 (721)
..+|| .||.|+||++... +..++||+.... +......+.+|+.++.+|+|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45788 8999999999875 667888865321 11233568899999999998875 6777765443
Q ss_pred C----cceEEEeeccC-CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 463 E----VPLLVYEFIIN-GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 463 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
. ..++|||++++ .+|.+++... .++.. .+.+++.+|.+||+.+ |+||||||+|||++.++.++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 23599999997 6888887543 34443 3568999999999999 999999999999998889999
Q ss_pred eeccCcccc
Q 036483 538 SDFGASRSM 546 (721)
Q Consensus 538 ~DFGls~~~ 546 (721)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.9e-16 Score=174.36 Aligned_cols=255 Identities=22% Similarity=0.304 Sum_probs=190.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC--CcEEEEeeccccC--chhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD--GRIVAIKKSKVID--ESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~l 467 (721)
...|.+.+.||+|.|+.|-...... ...+|+|...... ....+....|..+-..+. |+|++.+++...+.+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 3567788889999999998887543 4467777655432 334455566888888886 9999999999999999999
Q ss_pred EEeeccCCCcchhc-cccCCCCCccHHHHHHHHHHHHHHHHHHH-hcCCCCeeeccCcCccEEECCCC-cEEEeeccCcc
Q 036483 468 VYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAIEVSDAVSYLH-SAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASR 544 (721)
Q Consensus 468 v~e~~~~gsL~~~l-~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~ 544 (721)
++++..++++.+.+ +... ...+....-..+.|+..++.|+| ..+ +.||||||+|.+++..+ ..|++|||+|.
T Consensus 99 ~~~~s~g~~~f~~i~~~~~--~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDS--TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred ccCcccccccccccccCCc--cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhc
Confidence 99999999999888 3322 13556667789999999999999 777 99999999999999999 99999999998
Q ss_pred cccc--CCceeeeeeec-CCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 545 SMAI--DQTHMTTQVQG-TFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 545 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
.+.. ..........| ++.|+|||...+. ......|+||.|+++.-+++|..|+......... ...+ +....
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~----~~~~~ 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSW----KSNKG 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceee----ccccc
Confidence 8765 33333445568 9999999999885 4456789999999999999999998765543311 1111 10000
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...............+++.+++..+|..|.+.+++-.
T Consensus 249 -------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 -------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred -------ccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0000011112234677888999999999999888744
|
|
| >PF08488 WAK: Wall-associated kinase; InterPro: IPR013695 This domain is found together with the eukaryotic protein kinase domain IPR000719 from INTERPRO in plant wall-associated kinases (WAKs) and related proteins | Back alignment and domain information |
|---|
Probab=99.47 E-value=8.6e-14 Score=119.53 Aligned_cols=86 Identities=22% Similarity=0.501 Sum_probs=63.9
Q ss_pred CccccccccccCCCC-cceeeccccc-cccccCCcceeEEEEEeccceecccccccccccCCCcccEEEEEeeeeccccc
Q 036483 155 QYADCCDLLCTVPPN-TKVFDTNSSY-KYYQSIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQVPAVLEWGKYKGTCTE 232 (721)
Q Consensus 155 ~g~gCc~~~~~i~~~-l~~~~~~~~~-~~~~~~~~~c~~a~~~e~~~~~~~~~~~~~~~~~~~~vp~vldW~i~~~~C~~ 232 (721)
+|.+|||+ .||.+ +++|.+++.. ..+....++|.||||+|+.| |.+..++.....+.+.|||+|||+|.....
T Consensus 5 sG~~CCQt--~iP~~~~qv~~~~i~~~~~~~~~~~~Ck~AFL~d~~~-~~~n~t~p~~~~~~~y~pv~L~W~i~t~~~-- 79 (103)
T PF08488_consen 5 SGIGCCQT--SIPSGLLQVFNVTIESTDGNNQTSNGCKVAFLVDEDW-FSSNITDPEDFHAMGYVPVVLDWFIDTSDS-- 79 (103)
T ss_pred CCcceecc--CCCCCCceEEEEEeEecCCCcccCCCceEEEEecccc-ccccCCChHHhccCCeeEEEEEEEEecCCc--
Confidence 69999999 99997 5678776442 22223358999999999999 666666666677889999999999965532
Q ss_pred ccCCCCcccCCCCc
Q 036483 233 EYNSHTKMCNKDNH 246 (721)
Q Consensus 233 ~~~~~~~~C~s~s~ 246 (721)
....+++|.....
T Consensus 80 -~~~~s~~C~~~~~ 92 (103)
T PF08488_consen 80 -SFSNSLACKNNTE 92 (103)
T ss_pred -CcCcCccCCCcee
Confidence 1223588987754
|
WAKs are serine-threonine kinases which might be involved in signalling to the cytoplasm and are required for cell expansion []. ; GO: 0004674 protein serine/threonine kinase activity, 0016021 integral to membrane |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.4e-12 Score=143.58 Aligned_cols=145 Identities=19% Similarity=0.209 Sum_probs=102.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhh---------------------------------------
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKV--------------------------------------- 434 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------- 434 (721)
..|+ .+.||.|++|.||+|++++|+.||||..+.......
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3344 367999999999999999999999997543211100
Q ss_pred -HHHHHHHHHHhhcC----CCceeeEEEEEE-eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHH-HHH
Q 036483 435 -DEFINEVAILSQIN----HRNVVKLLGCCL-ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD-AVS 507 (721)
Q Consensus 435 -~~~~~E~~il~~l~----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~-~L~ 507 (721)
-+|.+|+..+.+++ |.+-+.+-..+. .....+|||||++|++|.++....... . .+.+++..++. .+.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLN 271 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHH
Confidence 13556666666652 333333333332 244579999999999998876532211 2 23456666666 478
Q ss_pred HHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 508 yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
.+|..+ ++|+|++|.||+++.+++++++|||++..+.
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 899988 9999999999999999999999999997664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.3e-13 Score=132.16 Aligned_cols=202 Identities=21% Similarity=0.278 Sum_probs=139.2
Q ss_pred HHHhhcCCCceeeEEEEEEeCC-----cceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCC
Q 036483 442 AILSQINHRNVVKLLGCCLETE-----VPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASI 515 (721)
Q Consensus 442 ~il~~l~h~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~ 515 (721)
.-|-++-|.|||++..++.+.. ...++.|||..|+|..+|++.+ .+..+......+|+.||+.||.|||+.. |
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 3455667999999999986543 3578999999999999998633 3456888888999999999999999986 6
Q ss_pred CeeeccCcCccEEECCCCcEEEeeccCccccccC----CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHH
Q 036483 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID----QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591 (721)
Q Consensus 516 ~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ell 591 (721)
+|+|+++.-+-|++..++-+|+.- +........ .........+.++|.+||.-.....+.++|||+||+..+||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 699999999999999888888752 111111100 001111223678999999988888888999999999999998
Q ss_pred hCCcccccCCc-cccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 592 TGERAIRVTNF-EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 592 tG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
-+.---..... .+. +..+...+ ...+. ..=+.++.+|++..|..||+|++++.+
T Consensus 277 ilEiq~tnseS~~~~------------ee~ia~~i---~~len-----~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEV------------EENIANVI---IGLEN-----GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCCcceeeh------------hhhhhhhe---eeccC-----ccccCcCcccccCCCCCCcchhhhhcC
Confidence 76532111110 000 00000000 00000 012457889999999999999987544
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.1e-12 Score=137.81 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=177.9
Q ss_pred cCCCCCceEee--eCcEEEEEEEE---cCCcEEEEeeccc--cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 394 DHYNTNRILGQ--GGQGTVYKGML---ADGRIVAIKKSKV--IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
..|...+.+|. |.+|.||.+.. .++..+|+|+-+. .....-..=.+|+.-...+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677889999 99999999986 3578899997544 2223333445666666666 499999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHH----HHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeec
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD----AVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDF 540 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~----~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DF 540 (721)
++-+|++ +.+|..+.+.... .++....+.+..+..+ ||.++|+.. |+|-|+||.||++..+ ...+++||
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df 267 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF 267 (524)
T ss_pred eeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence 9999988 5788888876543 2566667777777777 999999998 9999999999999999 88999999
Q ss_pred cCccccccCCcee----eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 541 GASRSMAIDQTHM----TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 541 Gls~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
|+...+....-.. .....|...|++||... ..++.++|||++|.+..+..++........... | .
T Consensus 268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W----~ 336 (524)
T KOG0601|consen 268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS------W----S 336 (524)
T ss_pred ceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC------c----c
Confidence 9998876443211 22235788899999876 456889999999999999988876544321100 0 0
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...... +..++...-..++...+..++..+|..|++.+++..
T Consensus 337 ~~r~~~------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 QLRQGY------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccccc------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000000 001111112234555888999999999998876644
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.3e-11 Score=116.66 Aligned_cols=130 Identities=20% Similarity=0.144 Sum_probs=97.1
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCcee-eEEEEEEeCCcceEEEeeccCCCc
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV-KLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv-~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
.+.|+.|.++.||++... ++.+++|....... ....+.+|+.+++.+.+.+++ +++.+. ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357889999999999875 77899998654322 234568899999998655544 455443 3345899999999887
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA--SIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+.. . ....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+.
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 6530 0 11245679999999999987 22359999999999999 6689999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=2.2e-10 Score=125.44 Aligned_cols=166 Identities=19% Similarity=0.200 Sum_probs=125.6
Q ss_pred EcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHH
Q 036483 415 LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEI 494 (721)
Q Consensus 415 ~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~ 494 (721)
..++.+|.|...+.......+...+-++-|+.++||||++++..+.+.+..|||+|-+ ..|..++.+ ++...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH------hHHHH
Confidence 4467788888776665655667788899999999999999999999999999999976 345555553 33455
Q ss_pred HHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCC
Q 036483 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574 (721)
Q Consensus 495 ~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 574 (721)
....+.||+.||.|||+.+. ++|++|.-..|+++..|..||++|.++.....-.. ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66678999999999997663 99999999999999999999999988754421111 111111223466676554332
Q ss_pred CccccchhHHHHHHHHHhC
Q 036483 575 TEKSDVYSFGVVLAELLTG 593 (721)
Q Consensus 575 t~ksDV~SlGvll~elltG 593 (721)
-..|.|-||++++|++.|
T Consensus 182 -~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred -cchhhhhHHHHHHHHhCc
Confidence 346999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.3e-11 Score=131.02 Aligned_cols=146 Identities=16% Similarity=0.144 Sum_probs=96.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCch------------------------------h----h--
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDES------------------------------K----V-- 434 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~------------------------------~----~-- 434 (721)
....|+. +.||.|++|.||+|++++ |+.||||..+..-.. . .
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999987 999999976532100 0 1
Q ss_pred ----HHHHHHHHHHhhcC----CCceeeEEEEEEe-CCcceEEEeeccCCCcchhc--cccC-CCCCccHHHHHHHHHHH
Q 036483 435 ----DEFINEVAILSQIN----HRNVVKLLGCCLE-TEVPLLVYEFIINGTLFQYL--HDQN-EEFPITWEIRLRIAIEV 502 (721)
Q Consensus 435 ----~~~~~E~~il~~l~----h~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~-~~~~l~~~~~~~i~~qi 502 (721)
-+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++- .... ....+....+..++.|
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q- 275 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ- 275 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-
Confidence 12455555555552 4444444444433 45678999999999997742 2211 0112333333333333
Q ss_pred HHHHHHHHhcCCCCeeeccCcCccEEECCCC----cEEEeeccCcccccc
Q 036483 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKY----RAKVSDFGASRSMAI 548 (721)
Q Consensus 503 a~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFGls~~~~~ 548 (721)
++..| ++|+|+||.||+++.++ ++++.|||+...+..
T Consensus 276 ------if~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 276 ------VFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 34567 99999999999999888 999999999877653
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=5e-10 Score=108.63 Aligned_cols=136 Identities=18% Similarity=0.131 Sum_probs=98.5
Q ss_pred ceEeeeCcEEEEEEEEcC-------CcEEEEeecccc-------------C---------chhhHHHH----HHHHHHhh
Q 036483 400 RILGQGGQGTVYKGMLAD-------GRIVAIKKSKVI-------------D---------ESKVDEFI----NEVAILSQ 446 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~il~~ 446 (721)
..||.|--+.||.|...+ +..+|||..+.. + ....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998543 478999943221 0 01122333 89999999
Q ss_pred cCC--CceeeEEEEEEeCCcceEEEeeccCCCcch-hccccCCCCCccHHHHHHHHHHHHHHHHHH-HhcCCCCeeeccC
Q 036483 447 INH--RNVVKLLGCCLETEVPLLVYEFIINGTLFQ-YLHDQNEEFPITWEIRLRIAIEVSDAVSYL-HSAASIPIYHRDI 522 (721)
Q Consensus 447 l~h--~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~qia~~L~yL-H~~~~~~ivHrDl 522 (721)
+.. -++++++++ ...+|||||+.+..+.. .+.+ ..++......+..+++.+|..| |+.+ |+|+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd----~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD----AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc----cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 853 567777765 45689999997654322 2222 1345556677889999999999 7888 999999
Q ss_pred cCccEEECCCCcEEEeeccCccccc
Q 036483 523 KSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 523 k~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
++.|||+++ +.+.|+|||.+....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCC
Confidence 999999974 689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.4e-10 Score=110.35 Aligned_cols=142 Identities=21% Similarity=0.251 Sum_probs=111.6
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCc-hhhHHHHHHHHHHhhcCC--CceeeEEEEEEeCC---cceEEEeecc
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDE-SKVDEFINEVAILSQINH--RNVVKLLGCCLETE---VPLLVYEFII 473 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h--~niv~l~g~~~~~~---~~~lv~e~~~ 473 (721)
+.|+.|.++.||++...+|+.+++|....... .....+..|+++++.+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778899998654322 235678999999999975 44677887776543 5689999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC----------------------------------------
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA---------------------------------------- 513 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------------- 513 (721)
+.+|.+.+.. ..++...+..++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988876642 14777888888999999999998531
Q ss_pred -------------CCCeeeccCcCccEEECC--CCcEEEeeccCccc
Q 036483 514 -------------SIPIYHRDIKSTNILLDG--KYRAKVSDFGASRS 545 (721)
Q Consensus 514 -------------~~~ivHrDlk~~NIll~~--~~~~kl~DFGls~~ 545 (721)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.08 E-value=6.4e-11 Score=128.63 Aligned_cols=262 Identities=18% Similarity=0.213 Sum_probs=182.6
Q ss_pred CCccccCHHH-HHHHhcCCCCCceEeeeCcEEEEEEEEc--CCcEEEEeeccccCchhhHH--HHHHHHHHhhc-CCCce
Q 036483 379 DKSKLFTSKE-LETATDHYNTNRILGQGGQGTVYKGMLA--DGRIVAIKKSKVIDESKVDE--FINEVAILSQI-NHRNV 452 (721)
Q Consensus 379 ~~~~~~~~~e-l~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~--~~~E~~il~~l-~h~ni 452 (721)
...++|..++ .-....+|..+..||.|.|+.|++...+ ++..+++|.+...-....++ -..|+.+...+ .|.++
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccccc
Confidence 3445565555 3445678999999999999999987744 57789999776543333222 24566666666 59999
Q ss_pred eeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC
Q 036483 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532 (721)
Q Consensus 453 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~ 532 (721)
+..+..+...+..++=-||++++++...+... ..+....++++..|++.++.++|+.. ++|+|+||+||++..+
T Consensus 329 ~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~ 402 (524)
T KOG0601|consen 329 VGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISND 402 (524)
T ss_pred CCCCCCccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccc
Confidence 99988888888888999999998876655221 24677788999999999999999988 9999999999999876
Q ss_pred -CcEEEeeccCccccccCCceeeeeeecCCCC-CCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHH
Q 036483 533 -YRAKVSDFGASRSMAIDQTHMTTQVQGTFGY-LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA 610 (721)
Q Consensus 533 -~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~ 610 (721)
+..++.|||.+..+... .......+..| .+|+......+-.+.|++|||.-+.|.+++..--.. ..
T Consensus 403 ~~~~~~~~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~-~~-------- 470 (524)
T KOG0601|consen 403 GFFSKLGDFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES-GV-------- 470 (524)
T ss_pred hhhhhcccccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcc-cc--------
Confidence 88899999998643211 11111123334 356666677888999999999999999988643210 00
Q ss_pred HHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 611 YFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
....+...... -.+. ....+..+.+.++..++..||.+.++....+..
T Consensus 471 ---------~~~~i~~~~~p-~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 471 ---------QSLTIRSGDTP-NLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ---------cceeeeccccc-CCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 00011111111 1111 124577888899999999999988876655443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.7e-09 Score=113.39 Aligned_cols=169 Identities=22% Similarity=0.333 Sum_probs=129.3
Q ss_pred cEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcceEEEeeccC-CCcchh
Q 036483 407 QGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVYEFIIN-GTLFQY 480 (721)
Q Consensus 407 ~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~~ 480 (721)
-.+.||+.. .||..+++|++.............-++.++++.|.|+|++..++.. +...+|||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 357889884 4899999999954433333344566888999999999999998862 3456899999986 577766
Q ss_pred ccccC------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 481 LHDQN------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 481 l~~~~------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
..... ....+++...+.++.|++.||.++|+.| +.-+-|.+++||++++.+++|+..|....+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1235788999999999999999999999 88899999999999999999999998776654
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcc
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERA 596 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p 596 (721)
+.. |-+.. -.+-|.-.||.+++.|.+|...
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 431 11111 1257888999999999999643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.2e-09 Score=102.13 Aligned_cols=131 Identities=24% Similarity=0.317 Sum_probs=100.3
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEee-ccc-cCch------hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKK-SKV-IDES------KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~-~~~~------~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..+.+|+-..+|.+.+.+ ..+++|. .+. .... ..+.-.+|+.++.+++--.|.-.+=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g-~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG-LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccC-cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 357899999999997754 3466663 221 1111 234568899999998766665555566677788899999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++|..|.+++... ...++..+-+-+.-||..+ |+|+||.++||++.++. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999998888754 2456777888888999999 99999999999998774 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.9e-09 Score=98.98 Aligned_cols=143 Identities=22% Similarity=0.266 Sum_probs=107.0
Q ss_pred CCceEeeeCcEEEEEEEEcCCcEEEEee-ccc-c-----C-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 398 TNRILGQGGQGTVYKGMLADGRIVAIKK-SKV-I-----D-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~-~~~-~-----~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
...+|-+|+-+.|+++.+. |+...||. ... . + .-...+..+|+++|.++.--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4578999999999999985 67777773 221 1 1 112456788999999987656655555666777778999
Q ss_pred eeccC-CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---cEEEeeccCccc
Q 036483 470 EFIIN-GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDFGASRS 545 (721)
Q Consensus 470 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGls~~ 545 (721)
||+++ .++.+++...... .........++..|-+.+.-||..+ |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~-~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMED-ESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccC-cccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 4788888765443 2222333778899999999999999 99999999999996543 468999999853
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=2.8e-10 Score=129.68 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=171.8
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
...+.+.+.+-+-.|.++.++.+.-. .|...++|.... ......+....+-.++-..+||-++...--+.-.....
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34566777778889999999887643 243334443222 11222333444444444455677766655556677789
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
|+++|..+++|...|+... ..+.......+..+..+++|||... +.|||++|.|+|+..++..+++|||.....
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999999998654 4555566667778889999999987 899999999999999999999999843221
Q ss_pred cc------------------------------CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcc
Q 036483 547 AI------------------------------DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERA 596 (721)
Q Consensus 547 ~~------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p 596 (721)
.. +.........||+.|.+||...+......+|+|++|+.++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 000112235689999999999999999999999999999999999999
Q ss_pred cccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 597 IRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 597 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
|....... .|...... .+ - ....+.+...+..+++.+.+..+|.+|-.+.
T Consensus 1035 ~na~tpq~------~f~ni~~~-~~---~----~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQ------IFENILNR-DI---P----WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhh------hhhccccC-CC---C----CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 86433221 11111110 00 0 0112333445688899999999999997765
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.84 E-value=5.2e-08 Score=99.96 Aligned_cols=141 Identities=16% Similarity=0.124 Sum_probs=100.6
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCch-hh----------HHHHHHHHHHhhcCCC--ceeeEEEEEEe-----
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDES-KV----------DEFINEVAILSQINHR--NVVKLLGCCLE----- 461 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~E~~il~~l~h~--niv~l~g~~~~----- 461 (721)
+.+-+.....|.+..+ +|+.+.||+....... .. ..+.+|...+.++... ..++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4455444455667655 5778999965332211 11 1478999999888433 33455556543
Q ss_pred CCcceEEEeeccCC-CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-------CC
Q 036483 462 TEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-------KY 533 (721)
Q Consensus 462 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-------~~ 533 (721)
....+||+|++++. +|.+++..... .+.+...+..++.+++..+.-||..| |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 22468999999886 89888754221 24566778899999999999999999 999999999999975 56
Q ss_pred cEEEeeccCccc
Q 036483 534 RAKVSDFGASRS 545 (721)
Q Consensus 534 ~~kl~DFGls~~ 545 (721)
.+.|+||+.++.
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 899999998853
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.84 E-value=2e-08 Score=97.15 Aligned_cols=125 Identities=24% Similarity=0.243 Sum_probs=82.9
Q ss_pred EEEEEEEcCCcEEEEeecccc---------------C---------c--hhhHHHHHHHHHHhhcCCC--ceeeEEEEEE
Q 036483 409 TVYKGMLADGRIVAIKKSKVI---------------D---------E--SKVDEFINEVAILSQINHR--NVVKLLGCCL 460 (721)
Q Consensus 409 ~Vy~~~~~~~~~vavK~~~~~---------------~---------~--~~~~~~~~E~~il~~l~h~--niv~l~g~~~ 460 (721)
.||.|...+|..+|||.-+.. . . .......+|.+.|.++..- ++++++++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999989999999943221 0 0 0123467899999999765 567776553
Q ss_pred eCCcceEEEeecc--CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHH-HHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 461 ETEVPLLVYEFII--NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY-LHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 461 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y-LH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
...|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4589999998 54554433221 2234456677888886666 56888 9999999999999988 9999
Q ss_pred eeccCcccc
Q 036483 538 SDFGASRSM 546 (721)
Q Consensus 538 ~DFGls~~~ 546 (721)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.5e-07 Score=95.22 Aligned_cols=262 Identities=16% Similarity=0.166 Sum_probs=156.1
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEE-------EEeCCcceEE
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGC-------CLETEVPLLV 468 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~-------~~~~~~~~lv 468 (721)
...+-||+|+.+.+|-.-.-.+ .|| |+...-......+ .+..|... .||-+-.-+.+ -......-++
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-~VA-KIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-QVA-KIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchhhc-hhh-eeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 3567899999999996432111 122 3322211111111 12223332 45533221111 0112224567
Q ss_pred EeeccCC-Ccchhcc---ccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 469 YEFIING-TLFQYLH---DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 469 ~e~~~~g-sL~~~l~---~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
|..+++. ....++. +...-....|.-.++.+..+|.+.+.||..| .+-+|+.++|+|+.++..+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 7777654 2333332 1222235789999999999999999999999 8899999999999999999999855433
Q ss_pred ccccCCceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhC-CcccccCCcccccc--HHHHHHHHh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTG-ERAIRVTNFEEDKS--LAAYFLRAM 616 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG-~~p~~~~~~~~~~~--~~~~~~~~~ 616 (721)
.- .+.....-..|...|.+||.-. +..-+...|-|.||+++++||.| +.||.+.....+.. .... +
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~----I 239 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD----I 239 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh----h
Confidence 22 2222233345889999999754 34456789999999999999886 89987644322110 1000 0
Q ss_pred hccchhhhhhhhh-----cccCCH-HHHHHHHHHHHHhhccC--CCCCCCHHHHHHHHhhcccc
Q 036483 617 KEDSLFEILDAHV-----LKEASQ-EDIVTVAKLTNRCLNLN--GKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 617 ~~~~~~~~~~~~~-----~~~~~~-~~~~~l~~li~~cl~~~--p~~RPt~~ev~~~L~~l~~~ 672 (721)
..+.....-+.+. ..+.+- ..+..+..|..+|+... +.-|||.+.++..|..+...
T Consensus 240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 0111100001000 112222 23467888999999764 56899999999999877654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=3.1e-07 Score=91.30 Aligned_cols=135 Identities=21% Similarity=0.209 Sum_probs=99.2
Q ss_pred CCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc---------------Cc-------hhhHHHHHHHHHHhhcCCC--c
Q 036483 396 YNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI---------------DE-------SKVDEFINEVAILSQINHR--N 451 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~---------------~~-------~~~~~~~~E~~il~~l~h~--n 451 (721)
..+..+||-|--+.||.|...+|.++|||.-+.. +. .......+|.++|.+|... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3466899999999999999999999999932110 00 1123457899999999655 7
Q ss_pred eeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC
Q 036483 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG 531 (721)
Q Consensus 452 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~ 531 (721)
+++.+++ +...+|||++++-.|...-- +.+..-.++..|++-+..+-..| |||+|+.+-||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7777765 34579999998876655431 22333445556666666666777 999999999999999
Q ss_pred CCcEEEeeccCccc
Q 036483 532 KYRAKVSDFGASRS 545 (721)
Q Consensus 532 ~~~~kl~DFGls~~ 545 (721)
++.+.++||--+..
T Consensus 238 dg~~~vIDwPQ~v~ 251 (304)
T COG0478 238 DGDIVVIDWPQAVP 251 (304)
T ss_pred CCCEEEEeCccccc
Confidence 99999999976543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.60 E-value=6.3e-07 Score=87.20 Aligned_cols=139 Identities=19% Similarity=0.136 Sum_probs=102.9
Q ss_pred EeeeCcEEEEEEEEcCCcEEEEeeccc-cC-----chhhHHHHHHHHHHhhcCC--CceeeEEEEEEeC----CcceEEE
Q 036483 402 LGQGGQGTVYKGMLADGRIVAIKKSKV-ID-----ESKVDEFINEVAILSQINH--RNVVKLLGCCLET----EVPLLVY 469 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~~~~~vavK~~~~-~~-----~~~~~~~~~E~~il~~l~h--~niv~l~g~~~~~----~~~~lv~ 469 (721)
-|+||.+-|+.-... |+.+-+|+-.. .. +-....|.+|+..|.+|.. -.+++.+.+.... ...+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999997764 44799997542 11 3345789999999999853 2355555222221 1347999
Q ss_pred eeccC-CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc--EEEeeccCccc
Q 036483 470 EFIIN-GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR--AKVSDFGASRS 545 (721)
Q Consensus 470 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGls~~ 545 (721)
|-+++ -+|.+++.+... .+.+...+..++.++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~-~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAV-SPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCc-CCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98764 588888765432 24677788899999999999999999 999999999999986666 99999987754
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-08 Score=110.93 Aligned_cols=150 Identities=22% Similarity=0.267 Sum_probs=104.3
Q ss_pred HHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee--------eeeeecCCCCCCcccccc
Q 036483 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM--------TTQVQGTFGYLDPEYFRS 571 (721)
Q Consensus 500 ~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~ 571 (721)
.+++.||.|+|...+ +||++|.|++|.++.++..||+.|+.+.......... ..-.+....|.|||++..
T Consensus 106 ~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345699999998764 9999999999999999999999999876543311111 111234567999999999
Q ss_pred CCCCccccchhHHHHHHHHHhCCcc-cccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhc
Q 036483 572 SRFTEKSDVYSFGVVLAELLTGERA-IRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLN 650 (721)
Q Consensus 572 ~~~t~ksDV~SlGvll~elltG~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 650 (721)
...+.++|+||+|++++-+..|.++ +...+...... + ....+..-....+.+.+.++.+=+.+++.
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~----~---------~~~~~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS----F---------SRNLLNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhh----h---------hhcccccccccccccCcHHHHHHHHHHhc
Confidence 9999999999999999999955444 33222111000 0 00111111122345566778899999999
Q ss_pred cCCCCCCCHHHHHH
Q 036483 651 LNGKKRPTMKEVAV 664 (721)
Q Consensus 651 ~~p~~RPt~~ev~~ 664 (721)
.++.-||++.++..
T Consensus 251 ~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 251 GDSAVRPTLDLLLS 264 (700)
T ss_pred CCcccCcchhhhhc
Confidence 99999998877643
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=6.5e-07 Score=88.77 Aligned_cols=107 Identities=20% Similarity=0.212 Sum_probs=85.0
Q ss_pred hHHHHHHHHHHhhcC--CCceeeEEEEEEeCC----cceEEEeeccCC-CcchhccccCCCCCccHHHHHHHHHHHHHHH
Q 036483 434 VDEFINEVAILSQIN--HRNVVKLLGCCLETE----VPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506 (721)
Q Consensus 434 ~~~~~~E~~il~~l~--h~niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L 506 (721)
.....+|...+.+|. .=..++.+++..... ..+||+|++++. +|.+++..... ++......++.++++.+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 446788888888874 334566677766533 347999999874 79998876432 55667788999999999
Q ss_pred HHHHhcCCCCeeeccCcCccEEECCCC---cEEEeeccCcccc
Q 036483 507 SYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDFGASRSM 546 (721)
Q Consensus 507 ~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGls~~~ 546 (721)
+-||..+ |+|+|+++.|||++.+. .+.++||+-++..
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 99999999999999887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.26 E-value=1e-05 Score=81.24 Aligned_cols=132 Identities=16% Similarity=0.167 Sum_probs=84.6
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc--eeeEEEEEEeCCcceEEEeeccCCC-
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN--VVKLLGCCLETEVPLLVYEFIINGT- 476 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~g~~~~~~~~~lv~e~~~~gs- 476 (721)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..-. +.+.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57899999999983 24457788765422 3345789999999986443 4677888777777789999998863
Q ss_pred cchhccccCCCCCccHHHHHHHHHHHHHHH---------------------------------------HHHHhc-CCCC
Q 036483 477 LFQYLHDQNEEFPITWEIRLRIAIEVSDAV---------------------------------------SYLHSA-ASIP 516 (721)
Q Consensus 477 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L---------------------------------------~yLH~~-~~~~ 516 (721)
+...+.. +......++.++++.+ .+|... ..+.
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 0111111112222222 222211 1234
Q ss_pred eeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 517 IYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 517 ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
++|+|+.|.||++++++ +.|+||+.+.
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 78999999999999887 9999999874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.3e-05 Score=78.43 Aligned_cols=138 Identities=17% Similarity=0.221 Sum_probs=91.5
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHH---------HHHHHHHhhcCC---CceeeEEEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEF---------INEVAILSQINH---RNVVKLLGC 458 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~il~~l~h---~niv~l~g~ 458 (721)
...++|...+++-......|.+-.. +|+.+.+|..+.......+.| .+++..+.+++. ..+..++.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3456788888888777666666555 578899997655433222222 234444444432 223332322
Q ss_pred EE-----eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 459 CL-----ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 459 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
.. .....+|+|||++|..|.++.. ++. .++..+.+++.-||+.| ++|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22 2234568999999988876542 222 35567788899999999 9999999999999965
Q ss_pred cEEEeeccCcc
Q 036483 534 RAKVSDFGASR 544 (721)
Q Consensus 534 ~~kl~DFGls~ 544 (721)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 59999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.21 E-value=8e-06 Score=90.85 Aligned_cols=146 Identities=19% Similarity=0.203 Sum_probs=94.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCc------------------------------hhhH-------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDE------------------------------SKVD------- 435 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------------------~~~~------- 435 (721)
...|+. +-|+.++-|.||+|++++|+.||||..+..-. ...+
T Consensus 125 F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 344443 67999999999999999999999995433100 0011
Q ss_pred ---HHHHHHHHHhhcC-----CCceeeEEEEEE-eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHH-
Q 036483 436 ---EFINEVAILSQIN-----HRNVVKLLGCCL-ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA- 505 (721)
Q Consensus 436 ---~~~~E~~il~~l~-----h~niv~l~g~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~- 505 (721)
++.+|+.-+.+++ .+++ ++=.++. -....+|+|||++|-.+.+...-... .++.+. ++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~--g~d~k~---ia~~~~~~f 277 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA--GIDRKE---LAELLVRAF 277 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhc--CCCHHH---HHHHHHHHH
Confidence 2445666555552 2332 2223333 35667999999999988888432221 244322 33322222
Q ss_pred HHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 506 L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
+..+-..| ++|.|..|.||+++.++++.+.|||+...+..
T Consensus 278 ~~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 22333355 99999999999999999999999999876653
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.5e-05 Score=77.43 Aligned_cols=105 Identities=23% Similarity=0.328 Sum_probs=83.2
Q ss_pred HHHHHHHhhcCC-CceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 036483 438 INEVAILSQINH-RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516 (721)
Q Consensus 438 ~~E~~il~~l~h-~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 516 (721)
.+|.-+|+.+++ +++++++|.|- .++|.||...+++......-..-...+|..|.+||.++++.+.+|++...-.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888888865 69999999993 4789999987766532111111124789999999999999999999865445
Q ss_pred eeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 517 ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+...|++++|+-+++++++|++|.......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.09 E-value=3.8e-05 Score=78.35 Aligned_cols=139 Identities=16% Similarity=0.112 Sum_probs=85.3
Q ss_pred EeeeCc-EEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEeeccCCCcch
Q 036483 402 LGQGGQ-GTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIINGTLFQ 479 (721)
Q Consensus 402 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 479 (721)
|-.|.. ..||+.... +..+.+|+..... .....+|++++..+. +--+.+++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 444554 788998764 4678888765432 346778999988883 4456678888777667899999999887764
Q ss_pred hcc-------------------ccCC-CCCcc--HHHHHHHHH--------------------HHHHHHHHHHh----cC
Q 036483 480 YLH-------------------DQNE-EFPIT--WEIRLRIAI--------------------EVSDAVSYLHS----AA 513 (721)
Q Consensus 480 ~l~-------------------~~~~-~~~l~--~~~~~~i~~--------------------qia~~L~yLH~----~~ 513 (721)
... .... ..++. ....+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 421 1100 00111 000000000 01111222211 12
Q ss_pred CCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 514 ~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+.++|+|+.|.|||++++....|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2448999999999999998778999998774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.06 E-value=5e-07 Score=98.75 Aligned_cols=188 Identities=17% Similarity=0.101 Sum_probs=132.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN-VVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~g~~~~~~~~~lv~e~ 471 (721)
+.-+...+-++++++++++|.+-.-.+....+.+.. .....-++++|.+++||| .+..++-+..++..++++++
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 333444556788999999998744333333443221 145567889999999999 66667767777788999999
Q ss_pred ccCC-CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 472 IING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 472 ~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
...+ +-...... ....+...+...+...-+++|++||+.- =+|+| ||+..+ ...|..||+....+....
T Consensus 316 ~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 316 CSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred hcCCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 9776 22221111 1112444455566777789999999865 58999 777766 588999999987765433
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCccc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~ 597 (721)
......+++.|+|||+.....+..+.|+|++|+--.++--|-+|-
T Consensus 386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234456899999999999999999999999998777776666553
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.05 E-value=4.4e-05 Score=76.86 Aligned_cols=143 Identities=22% Similarity=0.212 Sum_probs=85.1
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCC--ceeeEEEEEEeC---CcceEEEeecc
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHR--NVVKLLGCCLET---EVPLLVYEFII 473 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l~g~~~~~---~~~~lv~e~~~ 473 (721)
.+.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+... .+.+++...... ...+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3679999999999999877 68999976543 4556788999999888533 356777654333 24579999999
Q ss_pred CCCcch----------------hcc---cc-CCCCCccHHH---------HHHH------------HHHHHH-HHHHHHh
Q 036483 474 NGTLFQ----------------YLH---DQ-NEEFPITWEI---------RLRI------------AIEVSD-AVSYLHS 511 (721)
Q Consensus 474 ~gsL~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~qia~-~L~yLH~ 511 (721)
+..+.. .+. .. .....+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988777 111 11 0111111110 0000 112222 3344443
Q ss_pred c----CCCCeeeccCcCccEEEC-CCCcEEEeeccCcc
Q 036483 512 A----ASIPIYHRDIKSTNILLD-GKYRAKVSDFGASR 544 (721)
Q Consensus 512 ~----~~~~ivHrDlk~~NIll~-~~~~~kl~DFGls~ 544 (721)
. ....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 334499999999999999 66666899998774
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.05 E-value=9.7e-05 Score=73.12 Aligned_cols=151 Identities=22% Similarity=0.233 Sum_probs=102.3
Q ss_pred CHHHHHHHhcCCCCCceEe---eeCcEEEEEEEEcCCcEEEEeeccccCch-----------------------h-hHHH
Q 036483 385 TSKELETATDHYNTNRILG---QGGQGTVYKGMLADGRIVAIKKSKVIDES-----------------------K-VDEF 437 (721)
Q Consensus 385 ~~~el~~~~~~~~~~~~lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------------~-~~~~ 437 (721)
+.+.+..+..+..+....| .|--..||+|...++..+|+|+.+..... . ..-.
T Consensus 36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~ 115 (268)
T COG1718 36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWA 115 (268)
T ss_pred HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHH
Confidence 3455666666666666555 56667899999888999999965432110 0 1112
Q ss_pred HHHHHHHhhcC--CCceeeEEEEEEeCCcceEEEeeccCC-CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cC
Q 036483 438 INEVAILSQIN--HRNVVKLLGCCLETEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AA 513 (721)
Q Consensus 438 ~~E~~il~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~ 513 (721)
.+|+.-|.++. +-.+.+-+++. .-.|||||+... .-.-.|.+ .++.......+..++++.+.-|-. .+
T Consensus 116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 46777777773 44555555554 347999999543 11111221 134444677788899999998888 56
Q ss_pred CCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 514 ~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
+||+||+.=|||+. ++.+.|+||+-+....
T Consensus 188 ---LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 188 ---LVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred ---cccccchhhheEEE-CCeEEEEECccccccC
Confidence 99999999999999 7799999999886543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00028 Score=68.98 Aligned_cols=130 Identities=22% Similarity=0.297 Sum_probs=90.2
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC----------------chhhHHHHHHHHHHhhcC------CCceee
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID----------------ESKVDEFINEVAILSQIN------HRNVVK 454 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~il~~l~------h~niv~ 454 (721)
+....||+|+.-.||.- .+.....||...... ....+++.+|+.....+. +.+|.+
T Consensus 4 ~~~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r 81 (199)
T PF10707_consen 4 SESDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR 81 (199)
T ss_pred CCCcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence 34568999999999963 344456667654433 223566777777766665 889999
Q ss_pred EEEEEEeCCcceEEEeeccC------CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEE
Q 036483 455 LLGCCLETEVPLLVYEFIIN------GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNIL 528 (721)
Q Consensus 455 l~g~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIl 528 (721)
++|+...+...-+|+|.+.+ -+|.+++.+. .++. . +...+-+-..||-+++ |+.+||+|.||+
T Consensus 82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv 150 (199)
T PF10707_consen 82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIV 150 (199)
T ss_pred EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEE
Confidence 99999999999999998743 2577777433 2444 3 3333444556777777 999999999999
Q ss_pred ECCC---C-cEEEee
Q 036483 529 LDGK---Y-RAKVSD 539 (721)
Q Consensus 529 l~~~---~-~~kl~D 539 (721)
+..+ . .+.|+|
T Consensus 151 ~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 151 VQRRDSGEFRLVLID 165 (199)
T ss_pred EEecCCCceEEEEEe
Confidence 9532 2 566776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00026 Score=84.95 Aligned_cols=80 Identities=14% Similarity=0.284 Sum_probs=58.0
Q ss_pred CceEeeeCcEEEEEEEEcCC---cEEEEeeccccC-chhhHHHHHHHHHHhhcC-CCce--eeEEEEEEeC---CcceEE
Q 036483 399 NRILGQGGQGTVYKGMLADG---RIVAIKKSKVID-ESKVDEFINEVAILSQIN-HRNV--VKLLGCCLET---EVPLLV 468 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~-h~ni--v~l~g~~~~~---~~~~lv 468 (721)
.+.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.+. |.++ .+++.++.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46788999999999876654 357777654322 123357889999999995 6665 7788887664 467899
Q ss_pred EeeccCCCcc
Q 036483 469 YEFIINGTLF 478 (721)
Q Consensus 469 ~e~~~~gsL~ 478 (721)
|||+++..+.
T Consensus 123 ME~v~G~~~~ 132 (822)
T PLN02876 123 MEYLEGRIFV 132 (822)
T ss_pred EEecCCcccC
Confidence 9999876543
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00019 Score=79.81 Aligned_cols=142 Identities=16% Similarity=0.150 Sum_probs=89.8
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCch-------------------------------------hhHHHHHHHH
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDES-------------------------------------KVDEFINEVA 442 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------------------------~~~~~~~E~~ 442 (721)
+-|+.-+.|.||+|++++|+.||||.-+..-+. +.-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 679999999999999999999999953321000 0113555665
Q ss_pred HHhhc----CCCce---eeEEEEEEe-CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCC
Q 036483 443 ILSQI----NHRNV---VKLLGCCLE-TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514 (721)
Q Consensus 443 il~~l----~h~ni---v~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~ 514 (721)
-..+. +|-++ |.+=.++.+ ....+|+|||++|..+.+.-.-.+. .++...+..-+.+...-+ |=..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~~~q--If~~G- 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAYLEQ--IFKTG- 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHHHHH--HHhcC-
Confidence 54443 45551 112222222 3466899999999887776432221 355554443333322211 12234
Q ss_pred CCeeeccCcCccEEEC----CCCcEEEeeccCcccccc
Q 036483 515 IPIYHRDIKSTNILLD----GKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 515 ~~ivHrDlk~~NIll~----~~~~~kl~DFGls~~~~~ 548 (721)
++|.|=.|.||+++ .++.+.+-|||+...+..
T Consensus 322 --ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 --FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred --CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999998 367899999999876643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0003 Score=71.34 Aligned_cols=75 Identities=17% Similarity=0.230 Sum_probs=47.2
Q ss_pred ceEeeeCcE-EEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCC---ceeeEEEEEEeCC---cceEEEeec
Q 036483 400 RILGQGGQG-TVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHR---NVVKLLGCCLETE---VPLLVYEFI 472 (721)
Q Consensus 400 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~g~~~~~~---~~~lv~e~~ 472 (721)
+.|+.|+.. .||+. +..+++|..+. ......+.+|++++..+... -+.++++.....+ ..+++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777766 58874 23466776443 22345788999999888532 3445555443322 358999999
Q ss_pred cCCCcchh
Q 036483 473 INGTLFQY 480 (721)
Q Consensus 473 ~~gsL~~~ 480 (721)
+|.++.+.
T Consensus 77 ~G~~l~~~ 84 (235)
T cd05155 77 EGETATAA 84 (235)
T ss_pred cCCCCCcc
Confidence 99877543
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00044 Score=69.97 Aligned_cols=74 Identities=20% Similarity=0.138 Sum_probs=49.0
Q ss_pred ceEeeeCcEEEEEEEEcC--CcEEEEeeccccCchhhHHHHHHHHHHhhcCCC-ceeeEEEEEEeCCcceEEEeeccCCC
Q 036483 400 RILGQGGQGTVYKGMLAD--GRIVAIKKSKVIDESKVDEFINEVAILSQINHR-NVVKLLGCCLETEVPLLVYEFIINGT 476 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~-niv~l~g~~~~~~~~~lv~e~~~~gs 476 (721)
+.|..|-...+|+....+ ++.+++|........ .-+-.+|+.+++.+... -.+++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567788889999988764 678888876543221 12334788888888533 3444544332 248999999877
Q ss_pred cc
Q 036483 477 LF 478 (721)
Q Consensus 477 L~ 478 (721)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 64
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00029 Score=65.98 Aligned_cols=128 Identities=19% Similarity=0.208 Sum_probs=87.5
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceee-EEEEEEeCCcceEEEeeccCC
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK-LLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~-l~g~~~~~~~~~lv~e~~~~g 475 (721)
...+.|++|.+|.||++.+.++ .+|+|.-+. +.....+..|+++|..++-.++-+ ++.+-. .++.|||+.|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~~~-~~a~Kvrr~--ds~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWRGG-EVALKVRRR--DSPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeeccCc-eEEEEEecC--CcchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 4567899999999999999754 788886543 334568899999999998766644 444432 24559999887
Q ss_pred CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCc-CccEEECCCCcEEEeeccCcc
Q 036483 476 TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK-STNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 476 sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk-~~NIll~~~~~~kl~DFGls~ 544 (721)
.|.+.-... +- +-...+++.---|...| |-|+.|. |..++|-.+..+.|+||..|+
T Consensus 98 ~L~~~~~~~------~r----k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG------DR----KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc------cH----HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 776654321 11 22334555544556667 9999987 444444444499999999886
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00037 Score=71.65 Aligned_cols=137 Identities=16% Similarity=0.165 Sum_probs=78.6
Q ss_pred EeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEeeccCCCcchh
Q 036483 402 LGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIINGTLFQY 480 (721)
Q Consensus 402 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gsL~~~ 480 (721)
+..|-.+.+|+... +++.+++|..........-...+|..+++.+....+ .+++.... .++||||++|..+...
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 45677788998873 566788887543322211245789999998854333 44454432 4799999998776432
Q ss_pred -----------------ccccCC-CCCccHHHH-HHHHH---------HHHHHHHHHHhc-----CCCCeeeccCcCccE
Q 036483 481 -----------------LHDQNE-EFPITWEIR-LRIAI---------EVSDAVSYLHSA-----ASIPIYHRDIKSTNI 527 (721)
Q Consensus 481 -----------------l~~~~~-~~~l~~~~~-~~i~~---------qia~~L~yLH~~-----~~~~ivHrDlk~~NI 527 (721)
+|.... ..+++.... .+... .+...+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 111110 112222211 11111 111112222221 123489999999999
Q ss_pred EECCCCcEEEeeccCcc
Q 036483 528 LLDGKYRAKVSDFGASR 544 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~ 544 (721)
++++++ +.|+||..+.
T Consensus 159 l~~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYAS 174 (256)
T ss_pred EEeCCC-CEEEeccccC
Confidence 999876 7899998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00088 Score=70.35 Aligned_cols=77 Identities=10% Similarity=0.030 Sum_probs=56.9
Q ss_pred CCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCC---CceeeEEEEEEeC---CcceEEEee
Q 036483 398 TNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINH---RNVVKLLGCCLET---EVPLLVYEF 471 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h---~niv~l~g~~~~~---~~~~lv~e~ 471 (721)
..+.||.|..+.||.....+++ +.+|..+. ......|..|...|+.|.. -.++++++.+... +..+||||+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~ 94 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLER 94 (297)
T ss_pred eeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEec
Confidence 3467999999999998876664 55565332 1123588999999998843 3688889887543 568999999
Q ss_pred ccCCCc
Q 036483 472 IINGTL 477 (721)
Q Consensus 472 ~~~gsL 477 (721)
+++.++
T Consensus 95 i~G~~~ 100 (297)
T PRK10593 95 LRGVSV 100 (297)
T ss_pred cCCEec
Confidence 998765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00069 Score=65.67 Aligned_cols=125 Identities=30% Similarity=0.460 Sum_probs=90.1
Q ss_pred cCCCCCceEeeeCc-EEEEEEEEcCCcEEEEeeccc---cC-----------c-------hhhHHHHHHHHHHhhcC---
Q 036483 394 DHYNTNRILGQGGQ-GTVYKGMLADGRIVAIKKSKV---ID-----------E-------SKVDEFINEVAILSQIN--- 448 (721)
Q Consensus 394 ~~~~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~-----------~-------~~~~~~~~E~~il~~l~--- 448 (721)
..++..+.||.|.. |.||++++. |+.+|+|..+. .. + ...+.|..|-+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78889999999999 999999984 77999997221 00 0 22356888998888874
Q ss_pred CCce--eeEEEEEEeCC------------------cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHH
Q 036483 449 HRNV--VKLLGCCLETE------------------VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508 (721)
Q Consensus 449 h~ni--v~l~g~~~~~~------------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~y 508 (721)
+.++ |+.+|+..-.. ...||.||.+... .+ ..+=+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~----~~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL----QIRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----chhHHHHHHHHHHH
Confidence 4566 89999874331 1136777664432 12 22345577788889
Q ss_pred HHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 509 LH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999976 4589999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.00063 Score=80.05 Aligned_cols=196 Identities=19% Similarity=0.227 Sum_probs=135.3
Q ss_pred HHHHHHHHhhcCCCceeeEEEEEEeCCcc----eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc
Q 036483 437 FINEVAILSQINHRNVVKLLGCCLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512 (721)
Q Consensus 437 ~~~E~~il~~l~h~niv~l~g~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~ 512 (721)
...|+..+.++.|+|++.++.+-.+.... .+..|++..-++...+.... .++..+.+.+..++.+||+|+|+.
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHh
Confidence 34566667788999999999998765433 24456777777777776544 588889999999999999999998
Q ss_pred CCCCeeeccCcCc---cEEECCCCcEEEe--eccCccccccCCceeeeeeecCCCCCCccccccCCCCc--cccchhHHH
Q 036483 513 ASIPIYHRDIKST---NILLDGKYRAKVS--DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTE--KSDVYSFGV 585 (721)
Q Consensus 513 ~~~~ivHrDlk~~---NIll~~~~~~kl~--DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~--ksDV~SlGv 585 (721)
. ..|.-|..+ +--.+..+...++ ||+.++.+....... ...-+..+.+||.......+. ..|+|.+|.
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~--~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF--SDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch--hhcCccccccccccccccchhhhhhHHHHHHH
Confidence 6 666655555 5555667777777 998887664332211 122355677888777665554 479999999
Q ss_pred HHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 586 VLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 586 ll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
++..+..|..+-.... ....+++. .. .........+|+..++++|++..+++..
T Consensus 381 l~~~~~~~~~i~~~~~------------------~~~~~l~~-----~~---~~~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSA------------------VPVSLLDV-----LS---TSELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCccccccc------------------chhhhhcc-----cc---chhhhhhhhhhcchhhhhccchhhhhhc
Confidence 9999998865521100 00111111 01 1146778889999999999999998775
Q ss_pred H
Q 036483 666 L 666 (721)
Q Consensus 666 L 666 (721)
.
T Consensus 435 ~ 435 (1351)
T KOG1035|consen 435 P 435 (1351)
T ss_pred h
Confidence 4
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0033 Score=66.07 Aligned_cols=142 Identities=18% Similarity=0.165 Sum_probs=85.0
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc--eeeEEEE------EEeCCcceEEEe
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN--VVKLLGC------CLETEVPLLVYE 470 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~g~------~~~~~~~~lv~e 470 (721)
.+.|..|....+|+....+ ..+++|+... ...+....|++++..+.+.+ +++++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778778999987654 4688887654 22345677888888874332 4454432 123445689999
Q ss_pred eccCCCcchh----c----------cccCCC--------CCccHHHHH----------HHHHHHHHHHHHHHhc----CC
Q 036483 471 FIINGTLFQY----L----------HDQNEE--------FPITWEIRL----------RIAIEVSDAVSYLHSA----AS 514 (721)
Q Consensus 471 ~~~~gsL~~~----l----------~~~~~~--------~~l~~~~~~----------~i~~qia~~L~yLH~~----~~ 514 (721)
|++|..+... + |..... ....|.... .....+..++.++... .+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998776430 0 110000 011222211 0112233445555431 12
Q ss_pred CCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 515 ~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
..++|+|+.|.||+++++..+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 348999999999999998777899998874
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0017 Score=68.56 Aligned_cols=140 Identities=23% Similarity=0.288 Sum_probs=84.0
Q ss_pred ceEeeeCcEEEEEEEEcC-------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLAD-------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRN-VVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~g~~~~~~~~~lv~e~ 471 (721)
+.|..|-...+|+....+ ++.+++|...... .......+|.+++..+.... ..++++.+. ..+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhhe
Confidence 456677778999988655 4788889865432 23345678888888885333 345555553 2468999
Q ss_pred ccCCCcchh-----------------ccccCCCC--------CccHHHHHH--------------------------HHH
Q 036483 472 IINGTLFQY-----------------LHDQNEEF--------PITWEIRLR--------------------------IAI 500 (721)
Q Consensus 472 ~~~gsL~~~-----------------l~~~~~~~--------~l~~~~~~~--------------------------i~~ 500 (721)
++|..+... +|...... +.-|....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988776532 11111110 011111111 111
Q ss_pred HHHHHHHHHHh------cCCCCeeeccCcCccEEECCC----CcEEEeeccCcc
Q 036483 501 EVSDAVSYLHS------AASIPIYHRDIKSTNILLDGK----YRAKVSDFGASR 544 (721)
Q Consensus 501 qia~~L~yLH~------~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGls~ 544 (721)
++...+.+|.. .....++|+|+.+.|||++++ +.++|+||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22233334432 133458999999999999985 789999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.15 E-value=0.0067 Score=65.80 Aligned_cols=75 Identities=20% Similarity=0.236 Sum_probs=55.3
Q ss_pred ceEeeeCcEEEEEEEEcCC-cEEEEeecccc-----C--chhhHHHHHHHHHHhhcC---CCceeeEEEEEEeCCcceEE
Q 036483 400 RILGQGGQGTVYKGMLADG-RIVAIKKSKVI-----D--ESKVDEFINEVAILSQIN---HRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~il~~l~---h~niv~l~g~~~~~~~~~lv 468 (721)
+.||.|.+..||++...+| +.++||..... . ....+++..|.+.|..+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998877 58999974321 1 224567788888888762 3467778777 34567899
Q ss_pred EeeccCCC
Q 036483 469 YEFIINGT 476 (721)
Q Consensus 469 ~e~~~~gs 476 (721)
||++++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99997643
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0081 Score=63.84 Aligned_cols=156 Identities=14% Similarity=0.191 Sum_probs=84.1
Q ss_pred CHHHHHHHhcCCCC-----CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc--eeeEEE
Q 036483 385 TSKELETATDHYNT-----NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN--VVKLLG 457 (721)
Q Consensus 385 ~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~g 457 (721)
+..++...-..|.+ .+.|..|....+|+....+| .+++|+..... .+....|+.++..|...+ +.+.+.
T Consensus 8 s~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 8 SDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCccee
Confidence 44555544455654 34566777789999887655 57888765222 233444556665553211 333332
Q ss_pred ------EEEeCCcceEEEeeccCCCcchh--------------ccccCCC--------CCccH-HHHHH-----------
Q 036483 458 ------CCLETEVPLLVYEFIINGTLFQY--------------LHDQNEE--------FPITW-EIRLR----------- 497 (721)
Q Consensus 458 ------~~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~--------~~l~~-~~~~~----------- 497 (721)
+....+..++++||++|..+... +|..... ..+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 11234567899999988754321 1111110 01112 11111
Q ss_pred -HH-HHHHHHHHHHHhc----CCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 498 -IA-IEVSDAVSYLHSA----ASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 498 -i~-~qia~~L~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.. ..+...++.+.+. -+..++|+|+.+.||+++++...-|+||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 11 1111222333211 23359999999999999977656899999874
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0064 Score=65.27 Aligned_cols=140 Identities=21% Similarity=0.239 Sum_probs=81.8
Q ss_pred ceEeeeCcEEEEEEEEcC-----CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEeecc
Q 036483 400 RILGQGGQGTVYKGMLAD-----GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~ 473 (721)
+.|-.|-...+|+....+ ++.+++|..........++ .+|..+++.+...++ .++++.+... .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778899887532 3678888765543333333 679999988854443 4566665332 5899998
Q ss_pred CCCcchh-----------------ccccCC---CCCccHHHHHHHHHH-----------------HHHHHHHHH----h-
Q 036483 474 NGTLFQY-----------------LHDQNE---EFPITWEIRLRIAIE-----------------VSDAVSYLH----S- 511 (721)
Q Consensus 474 ~gsL~~~-----------------l~~~~~---~~~l~~~~~~~i~~q-----------------ia~~L~yLH----~- 511 (721)
+.+|... +|.... .....|....++..+ +...+..|. .
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 111110 001223333333221 111222222 1
Q ss_pred cCCCCeeeccCcCccEEECC-CCcEEEeeccCcc
Q 036483 512 AASIPIYHRDIKSTNILLDG-KYRAKVSDFGASR 544 (721)
Q Consensus 512 ~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~ 544 (721)
.....++|+|+++.|||+++ ++.+.|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 12334899999999999986 4689999998874
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.012 Score=62.28 Aligned_cols=156 Identities=20% Similarity=0.255 Sum_probs=88.2
Q ss_pred HHHHHHHhcCCCC-----CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc--eeeEEEE
Q 036483 386 SKELETATDHYNT-----NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN--VVKLLGC 458 (721)
Q Consensus 386 ~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~g~ 458 (721)
.+++...-++|.+ .+.++.|-...+|+....++ .+++|+..... ..+....|++++..|.... +.+++..
T Consensus 9 ~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t 85 (307)
T TIGR00938 9 DEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKS 85 (307)
T ss_pred HHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccC
Confidence 4555555455544 34566777789999876555 46678654321 1344556777777774222 3444432
Q ss_pred ------EEeCCcceEEEeeccCCCcchh--------------ccccCCCC---------CccHHHHH------------H
Q 036483 459 ------CLETEVPLLVYEFIINGTLFQY--------------LHDQNEEF---------PITWEIRL------------R 497 (721)
Q Consensus 459 ------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~~---------~l~~~~~~------------~ 497 (721)
....+..++++||++|..+... +|...... .-.|.... .
T Consensus 86 ~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~ 165 (307)
T TIGR00938 86 RDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH 165 (307)
T ss_pred CCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH
Confidence 1123456899999988654311 11111110 01121110 0
Q ss_pred HHHHHHHHHHHHHh----cCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 498 IAIEVSDAVSYLHS----AASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 498 i~~qia~~L~yLH~----~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
....+...++++.. .-+..++|+|+.+.||++++++...|+||+.+.
T Consensus 166 ~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 166 MGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 11223345555543 223459999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0016 Score=66.66 Aligned_cols=135 Identities=17% Similarity=0.169 Sum_probs=94.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccc--c---------------Cc---hh--hHHHHHHHHHHhhcC-CC-
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKV--I---------------DE---SK--VDEFINEVAILSQIN-HR- 450 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~---------------~~---~~--~~~~~~E~~il~~l~-h~- 450 (721)
-+.+.+.||-|--+.||.+-..+|++.++|.-.. . .. .. .-...+|...|+.|. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567899999999999999999999999983111 0 00 00 113467888888884 33
Q ss_pred ceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC
Q 036483 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD 530 (721)
Q Consensus 451 niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~ 530 (721)
-+++.+++ +..++|||++.+-.|...-+-.. . ..+...+..-+.-|..+| +||+|..-=||+++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~d------~---~~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHVED------P---PTLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeecCC------h---HHHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 24445554 34689999999888876554322 1 123334444455666778 99999999999999
Q ss_pred CCCcEEEeeccCccc
Q 036483 531 GKYRAKVSDFGASRS 545 (721)
Q Consensus 531 ~~~~~kl~DFGls~~ 545 (721)
++..++++||--...
T Consensus 237 dd~~i~vIDFPQmvS 251 (465)
T KOG2268|consen 237 DDDKIVVIDFPQMVS 251 (465)
T ss_pred cCCCEEEeechHhhc
Confidence 999999999975443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.86 E-value=0.0082 Score=62.28 Aligned_cols=30 Identities=23% Similarity=0.453 Sum_probs=25.1
Q ss_pred CeeeccCcCccEEECCCCc-EEEeeccCccc
Q 036483 516 PIYHRDIKSTNILLDGKYR-AKVSDFGASRS 545 (721)
Q Consensus 516 ~ivHrDlk~~NIll~~~~~-~kl~DFGls~~ 545 (721)
.++|+|+.+.|||++++++ .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.013 Score=60.88 Aligned_cols=73 Identities=25% Similarity=0.261 Sum_probs=48.7
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc---CCCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI---NHRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
.+.|+.|....+|+.. .+++.+.||... ......|..|++-|+.| .--.+++++++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4578889999999977 567889999765 33346788888888877 3556889999988888889999999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.021 Score=59.86 Aligned_cols=133 Identities=17% Similarity=0.231 Sum_probs=82.8
Q ss_pred eCcEEEEEEEEcCCcEEEEeecc-ccCchhhHHHHHHHHHHhhcCC--CceeeEEEEEEeCC--cceEEEeeccCCCcch
Q 036483 405 GGQGTVYKGMLADGRIVAIKKSK-VIDESKVDEFINEVAILSQINH--RNVVKLLGCCLETE--VPLLVYEFIINGTLFQ 479 (721)
Q Consensus 405 G~~g~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~E~~il~~l~h--~niv~l~g~~~~~~--~~~lv~e~~~~gsL~~ 479 (721)
|-.-.+|..... ++.+++++.. ...........+|+.+|+.+.- --+...++.|.++. .++.||+|.+|..+..
T Consensus 36 G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~ 114 (321)
T COG3173 36 GWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWS 114 (321)
T ss_pred CcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccC
Confidence 333344444433 6677777332 2333455667788888888743 33455677777666 7799999998865444
Q ss_pred hccccCCCCCccHHHHHHHH-HHHHHHHHHHH------------------------------------------------
Q 036483 480 YLHDQNEEFPITWEIRLRIA-IEVSDAVSYLH------------------------------------------------ 510 (721)
Q Consensus 480 ~l~~~~~~~~l~~~~~~~i~-~qia~~L~yLH------------------------------------------------ 510 (721)
.+.... .. .+++ ..+++.|+-||
T Consensus 115 ~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W 186 (321)
T COG3173 115 ALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW 186 (321)
T ss_pred cCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence 333211 01 1111 24444444444
Q ss_pred --hcC-----CCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 511 --SAA-----SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 511 --~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
.+. .+.++|+|+.+.||+++.+..+=|.||+++..-
T Consensus 187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 222 234999999999999999888999999998654
|
|
| >KOG1219 consensus Uncharacterized conserved protein, contains laminin, cadherin and EGF domains [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.0032 Score=77.23 Aligned_cols=61 Identities=20% Similarity=0.401 Sum_probs=43.3
Q ss_pred ccCCCCceeeccCCCccccccc--cCCccC--------cCCCCCccccCCCcccCCCCCCCCcCCCCCCCC
Q 036483 240 MCNKDNHCLLQLGTGHFCLCDY--TRSVAS--------RHCAGDLICSTTSGHNCSECPQGYYLSSYNSDQ 300 (721)
Q Consensus 240 ~C~s~s~C~~~~~~G~~c~~~~--~~~~~~--------~~C~~~~~C~~~~g~~c~~C~~g~~gn~~~~~g 300 (721)
-|...-.|....+.||-|.|.. ...+|. .+|...+.|....+++-|+|+.||.|..+--.|
T Consensus 3871 pCqhgG~C~~~~~ggy~CkCpsqysG~~CEi~~epC~snPC~~GgtCip~~n~f~CnC~~gyTG~~Ce~~G 3941 (4289)
T KOG1219|consen 3871 PCQHGGTCISQPKGGYKCKCPSQYSGNHCEIDLEPCASNPCLTGGTCIPFYNGFLCNCPNGYTGKRCEARG 3941 (4289)
T ss_pred cccCCCEecCCCCCceEEeCcccccCcccccccccccCCCCCCCCEEEecCCCeeEeCCCCccCceeeccc
Confidence 3555556776777899999973 333332 578888999998777744999999987764443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.0002 Score=85.79 Aligned_cols=162 Identities=13% Similarity=-0.003 Sum_probs=115.9
Q ss_pred HHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceEEEeeccCCCcchhccccCCC-CCccHHHHHHHHHHHHHHHHHHHh
Q 036483 435 DEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLVYEFIINGTLFQYLHDQNEE-FPITWEIRLRIAIEVSDAVSYLHS 511 (721)
Q Consensus 435 ~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~qia~~L~yLH~ 511 (721)
+....|...++...|+++.....-... ....+.+++++..|.+.+.+.....+ ..+...-....-.+...+..-.|+
T Consensus 1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence 334445555566789998877665543 34568999999999999988754332 234444444444444566666555
Q ss_pred cC--CCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHH
Q 036483 512 AA--SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAE 589 (721)
Q Consensus 512 ~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~e 589 (721)
.. ...-+|++||+.|.+|..+.++|++++|+.+...+.. .......+++-|+.|+....-.++.++|+|..+..+|+
T Consensus 1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred cccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence 43 2337899999999999999999999999998433222 22233457778999999998899999999999999999
Q ss_pred HHhCCccc
Q 036483 590 LLTGERAI 597 (721)
Q Consensus 590 lltG~~p~ 597 (721)
+-.|..++
T Consensus 1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred HhcccHHH
Confidence 98887765
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.022 Score=56.53 Aligned_cols=28 Identities=29% Similarity=0.466 Sum_probs=20.3
Q ss_pred eeeccCcCccEEE-CCCCcEEEeeccCcc
Q 036483 517 IYHRDIKSTNILL-DGKYRAKVSDFGASR 544 (721)
Q Consensus 517 ivHrDlk~~NIll-~~~~~~kl~DFGls~ 544 (721)
+.|+||.+.|||+ +.++.++++||..+.
T Consensus 145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 145 FCHNDLNPGNILINNKDGEVKLIDFEYAG 173 (211)
T ss_dssp EE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred EeeccCccccEEeccCCCeEEEecHHHHh
Confidence 7899999999999 888999999999875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.088 Score=57.06 Aligned_cols=80 Identities=18% Similarity=0.139 Sum_probs=54.1
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccc----cCc---hhhHHHHHHHHHHhhcC---CCceeeEEEEEEeCCcceEE
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKV----IDE---SKVDEFINEVAILSQIN---HRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~il~~l~---h~niv~l~g~~~~~~~~~lv 468 (721)
.+.||.|....||+.... ++.++||+-.. ... ...++-..|+..|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998864 55688997441 111 23445556677776653 357888888886 456889
Q ss_pred EeeccC--CCcchhc
Q 036483 469 YEFIIN--GTLFQYL 481 (721)
Q Consensus 469 ~e~~~~--gsL~~~l 481 (721)
||++++ ..+.+-+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999976 2344444
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.063 Score=57.29 Aligned_cols=140 Identities=18% Similarity=0.207 Sum_probs=79.1
Q ss_pred ceEeeeCcEEEEEEEEcC----CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD----GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.|..|-...+|+....+ +..+++|....... ..-.-.+|..+++.+..-++ +++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 455557778889887543 23788887654332 22233678889988865444 45666652 22 58999977
Q ss_pred CCcchh-------c----------cccCC---CCCccHHHHHHHHHHH----------------------HHHHHHHHh-
Q 036483 475 GTLFQY-------L----------HDQNE---EFPITWEIRLRIAIEV----------------------SDAVSYLHS- 511 (721)
Q Consensus 475 gsL~~~-------l----------~~~~~---~~~l~~~~~~~i~~qi----------------------a~~L~yLH~- 511 (721)
..|..- + |.... ..+--|..+.++..++ .+-+..+..
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 665321 1 11110 0011233332222221 111222211
Q ss_pred ---cC-CCCeeeccCcCccEEECC-CCcEEEeeccCcc
Q 036483 512 ---AA-SIPIYHRDIKSTNILLDG-KYRAKVSDFGASR 544 (721)
Q Consensus 512 ---~~-~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~ 544 (721)
.+ +.-+.|+|+.+.|||+++ ++.++++||..+-
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11 223699999999999974 5789999998874
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.073 Score=56.67 Aligned_cols=79 Identities=19% Similarity=0.157 Sum_probs=51.5
Q ss_pred eEeeeCcEEEEEEEEcCC-cEEEEeeccc-------cCchhhHHHHHHHHHHhhcC--CC-ceeeEEEEEEeCCcceEEE
Q 036483 401 ILGQGGQGTVYKGMLADG-RIVAIKKSKV-------IDESKVDEFINEVAILSQIN--HR-NVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~il~~l~--h~-niv~l~g~~~~~~~~~lv~ 469 (721)
.||.|-...||++...+| +.|+||.... ..+-..++..-|...|+... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 478899999999997654 6899996321 11334566677888887663 23 45555544 345567999
Q ss_pred eeccCC-Ccchhc
Q 036483 470 EFIING-TLFQYL 481 (721)
Q Consensus 470 e~~~~g-sL~~~l 481 (721)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998653 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.19 Score=53.08 Aligned_cols=29 Identities=31% Similarity=0.345 Sum_probs=25.0
Q ss_pred CCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 515 ~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 35899999999999987 578999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.015 Score=63.38 Aligned_cols=50 Identities=18% Similarity=0.243 Sum_probs=38.5
Q ss_pred HHHHHHHHHHhhcCCCceeeEEEEEEeCC-cceEEEeeccCCCcchhccccC
Q 036483 435 DEFINEVAILSQINHRNVVKLLGCCLETE-VPLLVYEFIINGTLFQYLHDQN 485 (721)
Q Consensus 435 ~~~~~E~~il~~l~h~niv~l~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~ 485 (721)
.++.-..++++.+.|+|+...+++....- ...+|+|++ +.+|++++....
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 45666778899999999999998875433 357899988 778888886543
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.18 Score=53.00 Aligned_cols=139 Identities=20% Similarity=0.207 Sum_probs=93.6
Q ss_pred CCceEeeeCcEEEEEEEEcCCcEEEEeecccc-----Cc--------------------hhhHH-HHHHHHHHhhcCCCc
Q 036483 398 TNRILGQGGQGTVYKGMLADGRIVAIKKSKVI-----DE--------------------SKVDE-FINEVAILSQINHRN 451 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-----~~--------------------~~~~~-~~~E~~il~~l~h~n 451 (721)
+.-.|..|--..||.+...+|..+|||+.+.. +. .-++. ...|++-|.+|+...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 44578889999999999999999999954321 00 01111 235777788876544
Q ss_pred eeeEEEEEEeCCcceEEEeeccCCC-cchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC
Q 036483 452 VVKLLGCCLETEVPLLVYEFIINGT-LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD 530 (721)
Q Consensus 452 iv~l~g~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~ 530 (721)
|.-.--+.. ...+|||+|+.... -.-.|. ...++...+..+-.|++.-+.-|.+... +||.||.-=|+|+-
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence 432211111 23479999995321 111122 2257777888888899999999988763 99999999999986
Q ss_pred CCCcEEEeeccCccc
Q 036483 531 GKYRAKVSDFGASRS 545 (721)
Q Consensus 531 ~~~~~kl~DFGls~~ 545 (721)
+ |.+.|+|-+-+..
T Consensus 300 d-G~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVE 313 (520)
T ss_pred C-CEEEEEEcccccc
Confidence 4 5899999876643
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.05 E-value=0.2 Score=52.87 Aligned_cols=31 Identities=13% Similarity=0.188 Sum_probs=27.6
Q ss_pred CCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 515 ~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
..++|+|+.+.|||+++++.+.|+||..+..
T Consensus 196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 3599999999999999998999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.77 E-value=0.096 Score=54.96 Aligned_cols=72 Identities=21% Similarity=0.210 Sum_probs=56.5
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..+++|++. +++|.. +. ...|.+.+.|+.+.+.-+.-|...- ++-|||+.-.||||+ +|++-|+||-++
T Consensus 300 y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkls 368 (488)
T COG5072 300 YLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLS 368 (488)
T ss_pred EEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeee
Confidence 345666665 444432 21 3568899999999999888888766 489999999999999 999999999999
Q ss_pred ccc
Q 036483 544 RSM 546 (721)
Q Consensus 544 ~~~ 546 (721)
|.-
T Consensus 369 Rl~ 371 (488)
T COG5072 369 RLS 371 (488)
T ss_pred ecc
Confidence 853
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.53 E-value=0.29 Score=53.15 Aligned_cols=74 Identities=26% Similarity=0.306 Sum_probs=45.4
Q ss_pred ceEeeeCcEEEEEEEEcCC--c-----EEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLADG--R-----IVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~--~-----~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e~ 471 (721)
+.|..|-...+|+....++ . .|.++..... ....-+-.+|+++++.+...++ .++++.+. -++++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4565688889999875443 1 2444432221 1111223578999999965544 55666663 2699999
Q ss_pred ccCCCcc
Q 036483 472 IINGTLF 478 (721)
Q Consensus 472 ~~~gsL~ 478 (721)
++|.+|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9988765
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.14 Score=55.23 Aligned_cols=74 Identities=15% Similarity=0.086 Sum_probs=50.5
Q ss_pred CceEeeeCcEEEEEEEEcC-CcEEEEeeccc------cCchhhHHHHHHHHHHhhcC--CC-ceeeEEEEEEeCCcceEE
Q 036483 399 NRILGQGGQGTVYKGMLAD-GRIVAIKKSKV------IDESKVDEFINEVAILSQIN--HR-NVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~il~~l~--h~-niv~l~g~~~~~~~~~lv 468 (721)
.+.||-|--.-||++...+ ++.|+||.-.. ..+-..++..-|.+.|+.+. -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999999753 57899996321 12334667778888888763 23 45556654 34556788
Q ss_pred EeeccC
Q 036483 469 YEFIIN 474 (721)
Q Consensus 469 ~e~~~~ 474 (721)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 888854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.21 Score=48.84 Aligned_cols=136 Identities=14% Similarity=0.136 Sum_probs=79.7
Q ss_pred EEEeeccccCch-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHH
Q 036483 421 VAIKKSKVIDES-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIA 499 (721)
Q Consensus 421 vavK~~~~~~~~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~ 499 (721)
..+|++....-. ...-|.++..++++++ .|++|..= ..-..-++.|++-.-. .. . ..++
T Consensus 88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~-------------i~--~-~N~i 147 (308)
T PF07387_consen 88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIK-------------IN--F-SNFI 147 (308)
T ss_pred hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcc-------------cc--h-hHHH
Confidence 445555444333 4456788888888874 35555511 2223457888772210 00 0 1111
Q ss_pred HHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCcccc
Q 036483 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSD 579 (721)
Q Consensus 500 ~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksD 579 (721)
.-=+..|.-.|+... ..+|+|-.|+||+-|..|.+||.|=+.--. . .. -|.- ......|.++.
T Consensus 148 ~agi~~L~~fH~~~~-~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~---~---~V-------~~vN---~~Y~~lT~~aE 210 (308)
T PF07387_consen 148 TAGIKDLMDFHSENQ-HCLHGDCNPDNIMCDKFGYLKLVDPVCLLE---N---QV-------NMVN---IEYESLTQEAE 210 (308)
T ss_pred HHhHHHHHHhhccCC-CeecCCCChhheeecCCCCEEecChhhhhh---h---ee-------eEEe---eeccccChHHH
Confidence 111466777885542 389999999999999999999999764311 0 00 1111 11233566777
Q ss_pred chhHHHHHHHHHhC
Q 036483 580 VYSFGVVLAELLTG 593 (721)
Q Consensus 580 V~SlGvll~elltG 593 (721)
+-+|=.-++++...
T Consensus 211 ~~~fv~s~l~~v~~ 224 (308)
T PF07387_consen 211 VKVFVKSCLKLVEK 224 (308)
T ss_pred HHHHHHHHHHHHHH
Confidence 87887777777654
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.07 E-value=1.9 Score=45.86 Aligned_cols=95 Identities=17% Similarity=0.097 Sum_probs=55.2
Q ss_pred cccCHHHHHHHhcCCCCC---c-eEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCC--ceeeE
Q 036483 382 KLFTSKELETATDHYNTN---R-ILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHR--NVVKL 455 (721)
Q Consensus 382 ~~~~~~el~~~~~~~~~~---~-~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l 455 (721)
..++.+.+..+...+.+. + ..=.+.-..||+....+++.+++|..+.. .....+...|++.+..|... .++..
T Consensus 9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p 87 (325)
T PRK11768 9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAP 87 (325)
T ss_pred CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 345566666555555332 1 22345667899998888888999976432 12345667788877766321 12221
Q ss_pred E---E--EEEeCCcceEEEeeccCCCc
Q 036483 456 L---G--CCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 456 ~---g--~~~~~~~~~lv~e~~~~gsL 477 (721)
. | ....++..+.++++++|..+
T Consensus 88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 88 LAFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred ccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 1 1 12224556789999987654
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.02 E-value=0.6 Score=46.17 Aligned_cols=74 Identities=18% Similarity=0.206 Sum_probs=51.6
Q ss_pred eEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc---CCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 401 ILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI---NHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 401 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
.+.-|.--..|.... +...+-||.-. ......|..|+.-|..| +.-++.+++....+.+..+||+||++-+.+
T Consensus 23 ~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~ 98 (286)
T COG3001 23 EVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPL 98 (286)
T ss_pred ccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCC
Confidence 344444444444332 35678888543 34556788888877766 456788899999999999999999998776
Q ss_pred c
Q 036483 478 F 478 (721)
Q Consensus 478 ~ 478 (721)
.
T Consensus 99 d 99 (286)
T COG3001 99 D 99 (286)
T ss_pred C
Confidence 6
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 721 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-44 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-43 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-34 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-34 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-33 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-27 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-27 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-27 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-26 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-24 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-24 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-24 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-24 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 8e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-24 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-24 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-23 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-23 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-23 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-23 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-23 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-23 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-23 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-23 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-23 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-23 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-23 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-23 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-23 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-23 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-23 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-23 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-23 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-23 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-23 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-23 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-23 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-23 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-23 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-23 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-23 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-23 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 6e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-22 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-22 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-22 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-22 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-22 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-22 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 7e-22 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-20 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-20 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-20 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 5e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-20 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-20 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-20 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 9e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-19 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-19 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-19 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-19 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-19 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-19 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-19 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-19 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 6e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-19 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-19 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-19 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-19 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-19 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 7e-19 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-19 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-19 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 8e-19 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-19 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-19 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 9e-19 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 9e-19 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-19 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-18 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-18 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-18 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-18 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 3e-18 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 3e-18 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 4e-18 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-18 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-18 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-18 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-18 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-18 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-18 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-18 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-18 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-17 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-17 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-17 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-17 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 9e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 9e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-16 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-16 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-16 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-16 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-16 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-16 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-16 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-16 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-16 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 6e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-16 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-16 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-16 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 9e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-15 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-15 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-15 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-15 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-15 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-15 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-15 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 4e-15 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 7e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-15 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-15 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 8e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-15 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-14 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-14 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-14 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-14 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-14 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 2e-14 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 3e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 7e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-13 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 1e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-13 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-13 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-13 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-13 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-13 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-13 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-13 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-13 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-13 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 4e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-13 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 6e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-13 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 7e-13 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 8e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-13 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 8e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-13 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 8e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 8e-13 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-13 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-13 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 9e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 9e-13 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-13 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-13 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 9e-13 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-13 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-13 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-12 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 4e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 5e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 7e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 8e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-11 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-11 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-11 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-11 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-11 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-11 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-11 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 5e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 5e-11 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 5e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 6e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 7e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 3e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-10 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-10 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-10 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-10 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 6e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-10 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 9e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 9e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 9e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-10 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 9e-10 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-10 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-09 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-09 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-09 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-09 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-09 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-09 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 8e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-09 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 9e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 2e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-08 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-08 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-08 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-08 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-08 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-08 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 4e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 4e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 6e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 6e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 6e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 7e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 9e-08 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-07 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-07 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 3e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-07 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 6e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 7e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 7e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 8e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 3e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 4e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 5e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 6e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 6e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 9e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 9e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 9e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 9e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 9e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-05 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-05 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-110
Identities = 110/301 (36%), Positives = 169/301 (56%), Gaps = 5/301 (1%)
Query: 371 LASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID 430
L+S+ +S +LE AT++++ ++G G G VYKG+L DG VA+K+
Sbjct: 16 LSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES 75
Query: 431 ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEE-FP 489
++EF E+ LS H ++V L+G C E +L+Y+++ NG L ++L+ +
Sbjct: 76 SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS 135
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI- 548
++WE RL I I + + YLH+ I HRD+KS NILLD + K++DFG S+
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192
Query: 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608
DQTH++T V+GT GY+DPEYF R TEKSDVYSFGVVL E+L AI + E +L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252
Query: 609 AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668
A + + + L +I+D ++ + E + +CL L+ + RP+M +V L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312
Query: 669 I 669
Sbjct: 313 A 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 319 bits (821), Expect = e-104
Identities = 107/298 (35%), Positives = 176/298 (59%), Gaps = 4/298 (1%)
Query: 375 EGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKV 434
E ++ + K F+ +EL+ A+D+++ ILG+GG G VYKG LADG +VA+K+ K
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 435 D-EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNE-EFPITW 492
+ +F EV ++S HRN+++L G C+ LLVY ++ NG++ L ++ E + P+ W
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552
R RIA+ + ++YLH I HRD+K+ NILLD ++ A V DFG ++ M TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF--EEDKSLAA 610
+TT V+GT G++ PEY + + +EK+DV+ +GV+L EL+TG+RA + ++D L
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 611 YFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668
+ +KE L ++D + E++ + ++ C + +RP M EV +L G
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-101
Identities = 97/316 (30%), Positives = 163/316 (51%), Gaps = 23/316 (7%)
Query: 368 QQELASTEGNIDKSKLFTSKELETATD------HYNTNRILGQGGQGTVYKGMLADGRIV 421
+ L ++ F+ EL+ T+ +G+GG G VYKG + + V
Sbjct: 2 NKSLEVSDTRF---HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTV 57
Query: 422 AIKKSKVIDESKV----DEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477
A+KK + + +F E+ ++++ H N+V+LLG + + LVY ++ NG+L
Sbjct: 58 AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117
Query: 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537
L + P++W +R +IA ++ +++LH I HRDIKS NILLD + AK+
Sbjct: 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI---HRDIKSANILLDEAFTAKI 174
Query: 538 SDFGASRSMAI-DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERA 596
SDFG +R+ QT MT+++ GT Y+ PE R T KSD+YSFGVVL E++TG A
Sbjct: 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPA 233
Query: 597 IRVTNFEEDKSLAAYFLRAMKED-SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKK 655
+ E + L E+ ++ + +D + +A + + + ++CL+ K
Sbjct: 234 VDEH--REPQLLLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNK 290
Query: 656 RPTMKEVAVVLAGIKA 671
RP +K+V +L + A
Sbjct: 291 RPDIKKVQQLLQEMTA 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 4e-73
Identities = 88/319 (27%), Positives = 148/319 (46%), Gaps = 35/319 (10%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
++G+G G V K + VAIK+ + ES+ FI E+ LS++NH N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 460 LETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
L P+ LV E+ G+L+ LH T + ++ S V+YLHS +
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 519 HRDIKSTNILLDGKYR-AKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HRD+K N+LL K+ DFG + + QTHMT G+ ++ PE F S ++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637
DV+S+G++L E++T + F+E A + A+ + ++ ++ K
Sbjct: 184 CDVFSWGIILWEVITRRKP-----FDEIGGPAFRIMWAVHNGTRPPLIK-NLPKP----- 232
Query: 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQESVESDIAESYETGESF 697
+ L RC + + +RP+M+E+ ++ +++++ +D Y S
Sbjct: 233 ---IESLMTRCWSKDPSQRPSMEEIVKIM---------THLMRYFPGADEPLQYPCQHSL 280
Query: 698 TESYTDSVTIPVDADPLIS 716
V VD
Sbjct: 281 PPGEDGRVEPYVDFAEFYR 299
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 237 bits (608), Expect = 6e-73
Identities = 81/272 (29%), Positives = 125/272 (45%), Gaps = 20/272 (7%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLG 457
+G G GTV++ G VA+K +V+EF+ EVAI+ ++ H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
+ +V E++ G+L++ LH + RL +A +V+ ++YLH+ + PI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPI 160
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEK 577
HR++KS N+L+D KY KV DFG SR A + GT ++ PE R EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEK 219
Query: 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQED 637
SDVYSFGV+L EL T ++ + K L E +
Sbjct: 220 SDVYSFGVILWELATLQQP-----WGNLNPAQVVAAVGFKCKRL----------EIPRNL 264
Query: 638 IVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
VA + C KRP+ + +L +
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-69
Identities = 62/313 (19%), Positives = 113/313 (36%), Gaps = 37/313 (11%)
Query: 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAI 443
++ L + + +G G V+K L VA+K + D+ + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQSW-QNEYEVYS 71
Query: 444 LSQINHRNVVKLLGCCLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIA 499
L + H N+++ +G L+ F G+L +L ++W IA
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNELCHIA 127
Query: 500 IEVSDAVSYLHSAASI-------PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552
++ ++YLH I HRDIKS N+LL A ++DFG + ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 553 -MTTQVQGTFGYLDPEYFRSS-----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK 606
T GT Y+ PE + + D+Y+ G+VL EL + A E
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--- 244
Query: 607 SLAAYFLRAMKEDSLFEILDAHVLKE----------ASQEDIVTVAKLTNRCLNLNGKKR 656
F + + E + V+ + + + + C + + + R
Sbjct: 245 -YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
Query: 657 PTMKEVAVVLAGI 669
+ V + +
Sbjct: 304 LSAGCVGERITQM 316
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-68
Identities = 89/309 (28%), Positives = 144/309 (46%), Gaps = 37/309 (11%)
Query: 376 GNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDES-- 432
G + S+ S+ A + + +G+GG G V+KG + D +VAIK + D
Sbjct: 1 GAMGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60
Query: 433 -----KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEE 487
K EF EV I+S +NH N+VKL G P +V EF+ G L+ L D+
Sbjct: 61 TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH- 117
Query: 488 FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-----GKYRAKVSDFGA 542
PI W ++LR+ ++++ + Y+ + + PI HRD++S NI L AKV+DFG
Sbjct: 118 -PIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL 175
Query: 543 SRSMAIDQTHMTTQVQGTFGYLDPEYF--RSSRFTEKSDVYSFGVVLAELLTGERAIRVT 600
S+ H + + G F ++ PE +TEK+D YSF ++L +LTGE
Sbjct: 176 SQ----QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP---- 227
Query: 601 NFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK 660
F+E F+ ++E+ L + + + C + + KKRP
Sbjct: 228 -FDEYSYGKIKFINMIREEGLRPTIPEDCPPR--------LRNVIELCWSGDPKKRPHFS 278
Query: 661 EVAVVLAGI 669
+ L+ +
Sbjct: 279 YIVKELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-67
Identities = 83/282 (29%), Positives = 131/282 (46%), Gaps = 35/282 (12%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDES----KVDEFINEVAILSQINHRNVVKL 455
I+G GG G VY+ G VA+K ++ + ++ E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
G CL+ LV EF G L + L + I +I + A++++ ++YLH A +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 516 PIYHRDIKSTNILLDGKYR--------AKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
PI HRD+KS+NIL+ K K++DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPE 184
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627
R+S F++ SDV+S+GV+L ELLTGE F LA + AM + +L
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVP-----FRGIDGLAVAYGVAMNKLALPIPSTC 239
Query: 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
AKL C N + RP+ + L I
Sbjct: 240 P----------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-64
Identities = 56/278 (20%), Positives = 112/278 (40%), Gaps = 31/278 (11%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLG 457
L + G ++KG G + +K KV K +F E L +H NV+ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 458 CCLETEVPLL--VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
C P + ++ G+L+ LH+ F + ++ A++++ +++LH+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE-GTNFVVDQSQAVKFALDMARGMAFLHTL-EP 132
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR---SS 572
I + S ++++D A++S S ++ ++ PE +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF-----QSPGRM-YAPAWVAPEALQKKPED 186
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632
+D++SF V+L EL+T E F + ++ A++ +
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVP-----FADLSNMEIGMKVALEGLRP------TIPPG 235
Query: 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670
S V+KL C+N + KRP + +L ++
Sbjct: 236 ISPH----VSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-60
Identities = 74/314 (23%), Positives = 133/314 (42%), Gaps = 36/314 (11%)
Query: 400 RILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
+LG+G G K G ++ +K+ DE F+ EV ++ + H NV+K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+ + + E+I GTL + + ++P W R+ A +++ ++YLH S+ I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLH---SMNII 130
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-------------TQVQGTFGYLD 565
HRD+ S N L+ V+DFG +R M ++T V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 566 PEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625
PE + EK DV+SFG+VL E++ A + F ++
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA-----DPDYLPRTMDFGLNVRG------- 238
Query: 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQ---ES 682
+ + + +T RC +L+ +KRP+ ++ L ++ + E
Sbjct: 239 --FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLEQ 296
Query: 683 VESDIAESYETGES 696
++ E+Y GES
Sbjct: 297 LDRGFWETYRRGES 310
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-60
Identities = 63/286 (22%), Positives = 109/286 (38%), Gaps = 38/286 (13%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLG 457
++G+G G VY G G VAI+ + +E ++ F EV Q H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
C+ ++ TL+ + D +IA E+ + YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD--VNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAI----DQTHMTTQVQGTFGYLDPEYFRSSR 573
H+D+KS N+ D + ++DFG + + G +L PE R
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 574 ---------FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
F++ SDV++ G + EL E F+ + A + M +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWP-----FKTQPAEAIIW--QMGTGMKPNL 263
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670
+ KE ++ + C ++RPT ++ +L +
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-58
Identities = 64/323 (19%), Positives = 120/323 (37%), Gaps = 46/323 (14%)
Query: 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAI 443
+ E D+ ++G+G G VYKG L D R VA+K + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 444 --LSQINHRNVVKLLGCCLETEVP-----LLVYEFIINGTLFQYLHDQNEEFPITWEIRL 496
+ + H N+ + + LLV E+ NG+L +YL W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVSSC 114
Query: 497 RIAIEVSDAVSYLHSAASI------PIYHRDIKSTNILLDGKYRAKVSDFGASRSMA--- 547
R+A V+ ++YLH+ I HRD+ S N+L+ +SDFG S +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 548 ----IDQTHMTTQVQGTFGYLDPEYFRSS-------RFTEKSDVYSFGVVLAELLTGERA 596
++ + GT Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 597 IRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK----------EASQEDIVTVAKLTN 646
+ + A+ + ++ + + + + ++ +
Sbjct: 235 LFPGESVPE-YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 647 RCLNLNGKKRPTMKEVAVVLAGI 669
C + + + R T + +A +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAEL 316
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 3e-58
Identities = 71/275 (25%), Positives = 123/275 (44%), Gaps = 29/275 (10%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLG 457
+ +G G GTVYKG G VA+K V ++ F NEV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 458 CCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
T L +V ++ +L+ +LH +F + + IA + + + YLH+
Sbjct: 88 YS--TAPQLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQTARGMDYLHA---KS 140
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMA-IDQTHMTTQVQGTFGYLDPEYFR---SS 572
I HRD+KS NI L K+ DFG + + +H Q+ G+ ++ PE R S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIR-VTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631
++ +SDVY+FG+VL EL+TG+ + N ++ + + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR--- 257
Query: 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ +L CL +RP+ + +
Sbjct: 258 ---------MKRLMAECLKKKRDERPSFPRILAEI 283
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 6e-54
Identities = 65/302 (21%), Positives = 115/302 (38%), Gaps = 45/302 (14%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAI--LSQINHRNVVKLLG 457
+ +G+G G V+ G G VA+K V ++ + E I + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIA 98
Query: 458 CCLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
++ L+ ++ NG+L+ YL + + L++A + +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 514 SI-----PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH----MTTQVQGTFGYL 564
I HRD+KS NIL+ ++D G + D T+V GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 565 DPE------YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
PE + +D+YSFG++L E+ R + + + +
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-----RCVSGGIVEEYQLPYHDLVPS 268
Query: 619 DSLFEILDAHVLKE----------ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668
D +E + V + +S E + + KL C N R T V LA
Sbjct: 269 DPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 669 IK 670
+
Sbjct: 329 MS 330
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 7e-54
Identities = 62/301 (20%), Positives = 112/301 (37%), Gaps = 45/301 (14%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAI--LSQINHRNVVKLLG 457
+G+G G V++G G VA+K + + E + + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 458 CCLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+ + L+ + G+L+ YL + LRI + ++ +++LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 514 SI-----PIYHRDIKSTNILLDGKYRAKVSDFGASR----SMAIDQTHMTTQVQGTFGYL 564
I HRD+KS NIL+ + ++D G + S +V GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 565 DPE------YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
PE ++ D+++FG+VL E+ R+ + + F +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-----RMVSNGIVEDYKPPFYDVVPN 239
Query: 619 DSLFEILDAHVLKE----------ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668
D FE + V + S + ++AKL C N R T + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 669 I 669
I
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 7e-52
Identities = 63/305 (20%), Positives = 119/305 (39%), Gaps = 45/305 (14%)
Query: 401 ILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAI--LSQINHRNVVKLLGC 458
+G+G G V++G G VA+K + + + E I + H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 459 CLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
+ LV ++ +G+LF YL+ +T E +++A+ + +++LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIV 160
Query: 515 -----IPIYHRDIKSTNILLDGKYRAKVSDFGASR----SMAIDQTHMTTQVQGTFGYLD 565
I HRD+KS NIL+ ++D G + + +V GT Y+
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKRYMA 219
Query: 566 PEYFRSS------RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619
PE S +++D+Y+ G+V E+ R + + + + D
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-----RCSIGGIHEDYQLPYYDLVPSD 274
Query: 620 SLFEILDAHVLKE----------ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
E + V ++ S E + +AK+ C NG R T + L+ +
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334
Query: 670 KACDG 674
+G
Sbjct: 335 SQQEG 339
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-44
Identities = 70/282 (24%), Positives = 122/282 (43%), Gaps = 25/282 (8%)
Query: 389 LETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILS 445
+ + + Y +G G G K +DG+I+ K+ + E++ ++EV +L
Sbjct: 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLR 60
Query: 446 QINHRNVVKLLGCCLETEVPLL--VYEFIINGTLFQYLHDQNEE-FPITWEIRLRIAIEV 502
++ H N+V+ ++ L V E+ G L + +E + E LR+ ++
Sbjct: 61 ELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQL 120
Query: 503 SDAVSYLHS--AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
+ A+ H + HRD+K N+ LDGK K+ DFG +R + D + T V GT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GT 179
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620
Y+ PE + EKSD++S G +L EL + +E L +
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE--------LAGKIREG 231
Query: 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
F + S E + ++ R LNL RP+++E+
Sbjct: 232 KFRRIPYRY----SDE----LNEIITRMLNLKDYHRPSVEEI 265
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 5e-43
Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 24/275 (8%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK---SKVIDESKVDEFINEVAILSQINH 449
++ + +G+G VY+ L DG VA+KK ++D + I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSDAVSY 508
NV+K +E +V E G L + + ++ I + +++ A+ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
+HS + HRDIK N+ + K+ D G R + T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFE-EDKSLAAYFLRAMKEDSLFEILDA 627
+ + KSD++S G +L E+ + F + +L + + + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP-----FYGDKMNLYSLCKKIEQ-CDYPPLPSD 261
Query: 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
H S+E + +L N C+N + +KRP + V
Sbjct: 262 HY----SEE----LRQLVNMCINPDPEKRPDVTYV 288
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHR 450
+ Y + +G+G G DGR IK+ + + + +E EVA+L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+V+ E +V ++ G LF+ ++ Q + L +++ A+ ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVH 142
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I HRDIKS NI L ++ DFG +R + + GT YL PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
+ + KSD+++ G VL EL T + A F E S+ L+ + F + H
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA-----F-EAGSMKNLVLKIISGS--FPPVSLHY- 249
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
S + + L ++ N + RP++ +
Sbjct: 250 ---SYD----LRSLVSQLFKRNPRDRPSVNSI 274
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-42
Identities = 70/300 (23%), Positives = 120/300 (40%), Gaps = 53/300 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
+ +LGQG G V K D R AIKK + E K+ ++EV +L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQY 63
Query: 452 VVKLLGCCLETEVPL-------------LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI 498
VV+ LE + + E+ NGTL+ +H +N E R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD-EYW-RL 121
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM------------ 546
++ +A+SY+HS I HRD+K NI +D K+ DFG ++++
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 547 --AIDQTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFE 603
++T+ + GT Y+ E + EK D+YS G++ E++ F
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--------FS 229
Query: 604 EDKSLAAYFLRAMKEDSLF-EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ F D + +K K+ ++ + KRP + +
Sbjct: 230 TGMERVNILKKLRSVSIEFPPDFDDNKMKVEK--------KIIRLLIDHDPNKRPGARTL 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 4e-42
Identities = 63/298 (21%), Positives = 114/298 (38%), Gaps = 38/298 (12%)
Query: 384 FTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVA 442
F + HY + LG+GG V L DG A+K+ ++ +E E
Sbjct: 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREAD 78
Query: 443 ILSQINHRNVVKLLGCCLETEVP----LLVYEFIINGTLFQYL---HDQNEEFPITWEIR 495
+ NH N+++L+ CL L+ F GTL+ + D+ +I
Sbjct: 79 MHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQI- 136
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR--SMAIDQTHM 553
L + + + + +H+ HRD+K TNILL + + + D G+ + ++ +
Sbjct: 137 LWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQ 193
Query: 554 TTQVQ------GTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604
+Q T Y PE F E++DV+S G VL ++ GE ++
Sbjct: 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP-----YDM 248
Query: 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
A++ H S + +L N + ++ +RP + +
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPRH-----SSA----LWQLLNSMMTVDPHQRPHIPLL 297
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-41
Identities = 62/294 (21%), Positives = 109/294 (37%), Gaps = 46/294 (15%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRN 451
+ + LG+GG G V++ D AIK+ ++ + E ++ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 452 VVKLLGCCLE-------TEVPLLVYEFII-----NGTLFQYLHDQNEEFPITWEIRLRIA 499
+V+ LE VY +I L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ- 558
+++++AV +LHS + HRD+K +NI KV DFG +M D+ T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 559 ----------GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608
GT Y+ PE + ++ K D++S G++L ELL F
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--------YPFSTQMER 233
Query: 609 AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
F L + L+ + +RP +
Sbjct: 234 VRTLTDVRNLK--FPPLFTQKYPCEYV--------MVQDMLSPSPMERPEAINI 277
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 63/274 (22%), Positives = 114/274 (41%), Gaps = 36/274 (13%)
Query: 399 NRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESK--VDEFINEVAILSQINHRNVVKL 455
+ +G+G TVYKG+ VA + + +K F E +L + H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 456 LGCCLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
T +LV E + +GTL YL + ++ ++ + +LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 147
Query: 512 AASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
+ PI HRD+K NI + G K+ D G + + + V GT ++ PE +
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE 203
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED---SLFEILDA 627
+ E DVY+FG+ + E+ T E + E ++ A + R S ++
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
V ++I+ C+ N +R ++K+
Sbjct: 258 EV------KEII------EGCIRQNKDERYSIKD 279
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 66/206 (32%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRN 451
Y LG GG TVY VAIK E + F EV SQ++H+N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+V ++ E + LV E+I TL +Y+ P++ + + ++ D + + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT--QVQGTFGYLDPEYF 569
I HRDIK NIL+D K+ DFG ++ A+ +T +T V GT Y PE
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAK--ALSETSLTQTNHVLGTVQYFSPEQA 184
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGER 595
+ E +D+YS G+VL E+L GE
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 2e-40
Identities = 64/285 (22%), Positives = 117/285 (41%), Gaps = 50/285 (17%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
+ ++G GG G V+K DG+ IK+ + + ++ EV L++++H N+V
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKR---VKYNN-EKAEREVKALAKLDHVNIVH 68
Query: 455 LLGCCLETEVPLLVYE-----------FII-----NGTLFQYLHDQNEEFPITWEIRLRI 498
GC + FI GTL Q++ + E + + L +
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLALEL 127
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
+++ V Y+HS + +RD+K +NI L + K+ DFG S+ D + +
Sbjct: 128 FEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--K 182
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
GT Y+ PE S + ++ D+Y+ G++LAELL A +
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD------------------TAFET 224
Query: 619 DSLFEILDAHVLKEA-SQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
F L ++ + ++ L + L+ + RP E+
Sbjct: 225 SKFFTDLRDGIISDIFDKK----EKTLLQKLLSKKPEDRPNTSEI 265
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 8e-40
Identities = 52/247 (21%), Positives = 91/247 (36%), Gaps = 39/247 (15%)
Query: 394 DHYNTNRILGQGGQGTVYKG--MLADGRIVAIKKSKVI----DESKVDEFINEVAILSQI 447
Y + GG G +Y +GR V +K + D + E L+++
Sbjct: 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK---GLVHSGDAEAQAMAMAERQFLAEV 136
Query: 448 NHRNVVKLL-----GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
H ++V++ V +V E++ +L + + + +E+
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEI 191
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
A+SYLHS + + D+K NI+L + + K+ D GA I+ + GT G
Sbjct: 192 LPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--RINSFGY---LYGTPG 242
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER----------AIRVTNFEEDKSLAAYF 612
+ PE R+ T +D+Y+ G LA L + S
Sbjct: 243 FQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGRLL 301
Query: 613 LRAMKED 619
RA+ D
Sbjct: 302 RRAIDPD 308
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 9e-40
Identities = 55/197 (27%), Positives = 93/197 (47%), Gaps = 10/197 (5%)
Query: 400 RILGQGGQGTVYKGMLADGRI-VAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLG 457
+G+G G V+ G L VA+K + + +F+ E IL Q +H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
C + + +V E + G +L + + + L++ + + + YL S I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI-- 235
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFT 575
HRD+ + N L+ K K+SDFG SR A D + + PE R++
Sbjct: 236 -HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 576 EKSDVYSFGVVLAELLT 592
+SDV+SFG++L E +
Sbjct: 294 SESDVWSFGILLWETFS 310
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 68/240 (28%), Positives = 108/240 (45%), Gaps = 9/240 (3%)
Query: 357 KFFKRNGGLL---LQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKG 413
L L + E LG G G VY+G
Sbjct: 180 HHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEG 239
Query: 414 MLADGRI-VAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472
+ + VA+K K D +V+EF+ E A++ +I H N+V+LLG C ++ EF+
Sbjct: 240 VWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298
Query: 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532
G L YL + N + ++ + L +A ++S A+ YL I HR++ + N L+
Sbjct: 299 TYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI---HRNLAARNCLVGEN 354
Query: 533 YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ KV+DFG SR M D + + PE ++F+ KSDV++FGV+L E+ T
Sbjct: 355 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 414
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-39
Identities = 62/279 (22%), Positives = 113/279 (40%), Gaps = 35/279 (12%)
Query: 396 YNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVK 454
+ +LG G +GT+ + D R VA+ K I EV +L + + H NV++
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAV---KRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
+ + + E TL +Y+ + ++F + + + + +++LHS
Sbjct: 83 YFCTEKDRQFQYIAIEL-CAATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN- 138
Query: 515 IPIYHRDIKSTNILL-----DGKYRAKVSDFGASRSMAIDQ--THMTTQVQGTFGYLDPE 567
I HRD+K NIL+ GK +A +SDFG + +A+ + + V GT G++ PE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 568 YFRSS---RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
T D++S G V +++ F + A L
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHP----FGKSLQRQANILLGACSLDCLHP 252
Query: 625 LDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+A+ L + + ++ +KRP+ K V
Sbjct: 253 EK----------HEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-39
Identities = 65/286 (22%), Positives = 118/286 (41%), Gaps = 42/286 (14%)
Query: 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRN 451
Y+ + +G GG V++ + +I AIK + D +D + NE+A L+++ +
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHS 87
Query: 452 --VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
+++L + + +V E N L +L + + WE + + +AV +
Sbjct: 88 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP-WERK-SYWKNMLEAVHTI 143
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT--HMTTQVQGTFGYLDPE 567
H I H D+K N L+ K+ DFG + M D T +QV GT Y+ PE
Sbjct: 144 HQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPE 198
Query: 568 -----------YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616
S+ + KSDV+S G +L + G+ T F++ + + +
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-----TPFQQIINQISKLHAII 253
Query: 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ E D K+ + CL + K+R ++ E+
Sbjct: 254 DPNHEIEFPD-IPEKDLQD--------VLKCCLKRDPKQRISIPEL 290
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-38
Identities = 55/212 (25%), Positives = 84/212 (39%), Gaps = 24/212 (11%)
Query: 395 HYNTNRILGQGGQGTVYKGMLAD---GRIVAIKKSKVI------DESKVDEFINEVAILS 445
Y R++G+GG G VY+ D RIVA+K ++ D E
Sbjct: 35 PYRLRRLVGRGGMGDVYEAE--DTVRERIVALK---LMSETLSSDPVFRTRMQREARTAG 89
Query: 446 QINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
++ +VV + + I L L + P+ + I ++ A
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSA 146
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT--QVQGTFGY 563
+ H+A HRD+K NIL+ A + DFG + A +T GT Y
Sbjct: 147 LDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIAS--ATTDEKLTQLGNTVGTLYY 201
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGER 595
+ PE F S T ++D+Y+ VL E LTG
Sbjct: 202 MAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 68/196 (34%), Positives = 104/196 (53%), Gaps = 10/196 (5%)
Query: 400 RILGQGGQGTVYKGMLADGRI-VAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
LG G G VY+G+ + VA+K K D +V+EF+ E A++ +I H N+V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
C ++ EF+ G L YL + N + ++ + L +A ++S A+ YL I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI--- 133
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFTE 576
HRD+ + N L+ + KV+DFG SR M D T F PE ++F+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 577 KSDVYSFGVVLAELLT 592
KSDV++FGV+L E+ T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 2e-38
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVK 454
++G+G G VY G L D A+K I D +V +F+ E I+ +H NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 455 LLGCCLETEVPLL-VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
LLG CL +E L V ++ +G L ++ +NE T + + ++V+ + YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL-----DPEY 568
+ HRD+ + N +LD K+ KV+DFG +R + + T L E
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARD--MYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 569 FRSSRFTEKSDVYSFGVVLAELLT 592
++ +FT KSDV+SFGV+L EL+T
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-38
Identities = 72/276 (26%), Positives = 118/276 (42%), Gaps = 33/276 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ + +LG+G VY+ + G VAIK K + V NEV I Q+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVS 507
++++L E + LV E NG + +YL ++ + F E R + ++ +
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFMHQIITGML 126
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG-ASRSMAIDQTHMTTQVQGTFGYLDP 566
YLHS I HRD+ +N+LL K++DFG A++ + H T GT Y+ P
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISP 181
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
E S +SDV+S G + LL G F + ++ + + D +E+
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP-----F-DTDTVKNTLNKVVLAD--YEMPS 233
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ EA L ++ L N R ++ V
Sbjct: 234 -FLSIEA--------KDLIHQLLRRNPADRLSLSSV 260
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 67/212 (31%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 396 YNTNRILGQGGQGTVYKGMLAD---GRIVAIKKSK---VIDESKVDEFINEVAILSQINH 449
Y ILG GG V+ D R VA+K + D S F E + +NH
Sbjct: 14 YELGEILGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 450 RNVVKLL--GC--CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
+V + G +P +V E++ TL +H E P+T + + + + A
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQA 128
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT--QVQGTFGY 563
+++ H I HRD+K NI++ KV DFG +R++A +T V GT Y
Sbjct: 129 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 185
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGER 595
L PE R +SDVYS G VL E+LTGE
Sbjct: 186 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-38
Identities = 59/195 (30%), Positives = 94/195 (48%), Gaps = 10/195 (5%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+ LG G G V G VA+K K DEF E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ +V E+I NG L YL ++ + L + +V + +++L S I H
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI---H 127
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFTEK 577
RD+ + N L+D KVSDFG +R + DQ + V F PE F +++ K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 578 SDVYSFGVVLAELLT 592
SDV++FG+++ E+ +
Sbjct: 186 SDVWAFGILMWEVFS 200
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 5e-38
Identities = 65/285 (22%), Positives = 117/285 (41%), Gaps = 40/285 (14%)
Query: 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIK--KSKVIDESKVDEFINEVAILSQINH--R 450
Y+ + +G GG V++ + +I AIK + D +D + NE+A L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+++L + + +V E N L +L + + WE + + +AV +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK-KKKSIDP-WERK-SYWKNMLEAVHTIH 125
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT--HMTTQVQGTFGYLDPE- 567
I H D+K N L+ K+ DFG + M D T +QV GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 180
Query: 568 ----------YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617
S+ + KSDV+S G +L + G+ T F++ + + +
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK-----TPFQQIINQISKLHAIID 235
Query: 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ E D K+ + CL + K+R ++ E+
Sbjct: 236 PNHEIEFPD-IPEKDLQD--------VLKCCLKRDPKQRISIPEL 271
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 6e-38
Identities = 51/206 (24%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR-----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVV 453
++LG G GTVYKG+ VAIK+ + E ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG CL + V L+ + + G L Y+ + + + L ++++ ++YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT---FGYLDPEYFR 570
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 571 SSRFTEKSDVYSFGVVLAELLT-GER 595
+T +SDV+S+GV + EL+T G +
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 7e-38
Identities = 64/304 (21%), Positives = 115/304 (37%), Gaps = 41/304 (13%)
Query: 391 TATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQIN 448
T+ + + ILGQG V++G G + AIK + + VD + E +L ++N
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 449 HRNVVKLLGC--CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
H+N+VKL T +L+ EF G+L+ L + + + + L + +V +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 507 SYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
++L I HR+IK NI+ DG+ K++DFGA+R + D + GT
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEE 180
Query: 563 YLDPEYFRSS--------RFTEKSDVYSFGVVLAELLTGE----------------RAIR 598
YL P+ + + ++ D++S GV TG I
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 599 VTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT 658
S + S + + + + + L + +K
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL----LTPVLANILEADQEKCWG 296
Query: 659 MKEV 662
+
Sbjct: 297 FDQF 300
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 9e-38
Identities = 67/199 (33%), Positives = 103/199 (51%), Gaps = 11/199 (5%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+ +G G G V+ G + VAIK + ++FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
LE LV EF+ +G L YL Q F E L + ++V + ++YL A I H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---H 127
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFTEK 577
RD+ + N L+ KVSDFG +R + DQ T+ F PE F SR++ K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQ--YTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 578 SDVYSFGVVLAELLT-GER 595
SDV+SFGV++ E+ + G+
Sbjct: 186 SDVWSFGVLMWEVFSEGKI 204
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-38
Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVK 454
++G+G G VY G L D A+K I D +V +F+ E I+ +H NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 455 LLGCCLETEVPLL-VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
LLG CL +E L V ++ +G L ++ +NE T + + ++V+ + +L A
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFL---A 209
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL-----DPEY 568
S HRD+ + N +LD K+ KV+DFG +R + + T L E
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 569 FRSSRFTEKSDVYSFGVVLAELLT 592
++ +FT KSDV+SFGV+L EL+T
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 12/196 (6%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LG G G V+ G VA+K K D F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 460 LETEVPLL-VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
T+ P+ + E++ NG+L +L +T L +A ++++ ++++ I
Sbjct: 78 --TQEPIYIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYI--- 131
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFTE 576
HRD+++ NIL+ K++DFG +R I+ T + F PE FT
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 577 KSDVYSFGVVLAELLT 592
KSDV+SFG++L E++T
Sbjct: 190 KSDVWSFGILLTEIVT 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 62/199 (31%), Positives = 99/199 (49%), Gaps = 11/199 (5%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+ LG G G V G VAIK K DEFI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519
+ ++ E++ NG L YL + + L + +V +A+ YL S + H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQFL---H 143
Query: 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFTEK 577
RD+ + N L++ + KVSDFG SR + D+ T+ V F PE S+F+ K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 578 SDVYSFGVVLAELLT-GER 595
SD+++FGV++ E+ + G+
Sbjct: 202 SDIWAFGVLMWEIYSLGKM 220
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 1e-37
Identities = 69/238 (28%), Positives = 121/238 (50%), Gaps = 27/238 (11%)
Query: 366 LLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRI---VA 422
+ +E+ E +D+ L LE ++ LG G GTV KG ++ VA
Sbjct: 1 MALEEIRPKEVYLDRKLL----TLE--------DKELGSGNFGTVKKGYYQMKKVVKTVA 48
Query: 423 IK--KSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQY 480
+K K++ D + DE + E ++ Q+++ +V+++G C E +LV E G L +Y
Sbjct: 49 VKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKY 107
Query: 481 LHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540
L QN + + +VS + YL + + HRD+ + N+LL ++ AK+SDF
Sbjct: 108 LQ-QNRHVKDKN--IIELVHQVSMGMKYLEESNFV---HRDLAARNVLLVTQHYAKISDF 161
Query: 541 GASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GER 595
G S+++ D+ + Q G + + PE +F+ KSDV+SFGV++ E + G++
Sbjct: 162 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 386 SKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEV 441
SK+ + A + + R LG+G G VY I+A+K K+++ + EV
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 442 AILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLR-IA 499
I S + H N+++L G + L+ E+ GT+++ L + +F E R
Sbjct: 61 EIQSHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYREL-QKLSKFD---EQRTATYI 115
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG 559
E+++A+SY HS + HRDIK N+LL K++DFG S A G
Sbjct: 116 TELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL--CG 169
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619
T YL PE EK D++S GV+ E L G+ F E + + R + +
Sbjct: 170 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK-----PPF-EANTYQETYKRISRVE 223
Query: 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
F V + A L +R L N +RP ++EV
Sbjct: 224 FTFP---DFVTEGA--------RDLISRLLKHNPSQRPMLREV 255
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-37
Identities = 74/362 (20%), Positives = 131/362 (36%), Gaps = 43/362 (11%)
Query: 391 TATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQIN 448
T+ + + ILGQG V++G G + AIK + + VD + E +L ++N
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 449 HRNVVKLLGC--CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
H+N+VKL T +L+ EF G+L+ L + + + + L + +V +
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 507 SYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
++L I HR+IK NI+ DG+ K++DFGA+R + D + GT
Sbjct: 126 NHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEE 180
Query: 563 YLDPEYFRSS--------RFTEKSDVYSFGVVLAELLTGE----------------RAIR 598
YL P+ + + ++ D++S GV TG I
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240
Query: 599 VTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT 658
S + S + + + + + L + +K
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVL----LTPVLANILEADQEKCWG 296
Query: 659 MKEVAVVLAGI--KACDGTSNIIQESVESDIAESYETGESFTESYTDSVTIPVDADPLIS 716
+ + I + ++ Q + SY T F E I LI
Sbjct: 297 FDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQELIY 356
Query: 717 KN 718
+
Sbjct: 357 EG 358
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-37
Identities = 56/242 (23%), Positives = 110/242 (45%), Gaps = 8/242 (3%)
Query: 352 IMLKQKFFKRNGGLLLQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVY 411
+ ++ ++ L + + +++ E + LGQG G V+
Sbjct: 142 LQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVW 201
Query: 412 KGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYE 470
G VAIK K + F+ E ++ ++ H +V+L +E P+ +V E
Sbjct: 202 MGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV--SEEPIYIVTE 258
Query: 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD 530
++ G+L +L + ++ + + +A +++ ++Y+ + HRD+++ NIL+
Sbjct: 259 YMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HRDLRAANILVG 314
Query: 531 GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAEL 590
KV+DFG +R + ++ + + PE RFT KSDV+SFG++L EL
Sbjct: 315 ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 374
Query: 591 LT 592
T
Sbjct: 375 TT 376
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 2e-37
Identities = 57/214 (26%), Positives = 102/214 (47%), Gaps = 27/214 (12%)
Query: 399 NRILGQGGQGTVYKGMLADG----RIVAIK--KSKVIDESKVDEFINEVAILSQINHRNV 452
R+LG+G G+V + L VA+K K+ +I S ++EF+ E A + + +H +V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 453 VKLLGCCLETE------VPLLVYEFIINGTLFQYL---HDQNEEFPITWEIRLRIAIEVS 503
KL+G L + +P+++ F+ +G L +L F + + +R ++++
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
+ YL +S HRD+ + N +L V+DFG SR + + QG
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 564 L-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
L E + +T SDV++FGV + E++T
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-37
Identities = 62/221 (28%), Positives = 110/221 (49%), Gaps = 16/221 (7%)
Query: 375 EGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKV 434
G++ F + +G+G G V G G VA+K K +++
Sbjct: 2 GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATA 58
Query: 435 DEFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWE 493
F+ E ++++Q+ H N+V+LLG +E + L +V E++ G+L YL + + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGD 117
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
L+ +++V +A+ YL + HRD+ + N+L+ AKVSDFG ++ +
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 168
Query: 554 TTQVQGTFGY--LDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+TQ G PE R +F+ KSDV+SFG++L E+ +
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 209
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 57/213 (26%), Positives = 100/213 (46%), Gaps = 26/213 (12%)
Query: 399 NRILGQGGQGTVYKGMLADGR----IVAIK--KSKVIDESKVDEFINEVAILSQINHRNV 452
+ILG+G G+V +G L VA+K K + +++EF++E A + +H NV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 453 VKLLGCCLETE-----VPLLVYEFIINGTLFQYL---HDQNEEFPITWEIRLRIAIEVSD 504
++LLG C+E P+++ F+ G L YL + I + L+ ++++
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ YL ++ HRD+ + N +L V+DFG S+ + + QG +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 565 -----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
E +T KSDV++FGV + E+ T
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 58/274 (21%), Positives = 99/274 (36%), Gaps = 33/274 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQI-NH 449
+ LG G G V+K DGR+ A+K+S D + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR-IAIEVSDAVSY 508
V+L E + L E +L Q+ P E ++ + A+++
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHS + H D+K NI L + R K+ DFG + Q G Y+ PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-GEVQE-GDPRYMAPEL 227
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628
+ S + +DV+S G+ + E+ + + +++ L A
Sbjct: 228 LQGS-YGTAADVFSLGLTILEVACNMEL-----PHGGEG-----WQQLRQGYLPPEFTAG 276
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ E + L + K R T + +
Sbjct: 277 LSSELRS--------VLVMMLEPDPKLRATAEAL 302
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 63/204 (30%), Positives = 104/204 (50%), Gaps = 18/204 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVK 454
R++G+G G VY G D AIK I + +V+ F+ E ++ +NH NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 455 LLGCCLETE-VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
L+G L E +P ++ ++ +G L Q++ ++ + T + + ++V+ + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL-----DPEY 568
+ HRD+ + N +LD + KV+DFG +R I + Q L E
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSVQQHRHARLPVKWTALES 199
Query: 569 FRSSRFTEKSDVYSFGVVLAELLT 592
++ RFT KSDV+SFGV+L ELLT
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLT 223
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 400 RILGQGGQGTVYKGMLADGR----IVAIK--KSKVIDESKVDEFINEVAILSQINHRNVV 453
+I+G G G V G L VAIK K+ + + D F++E +I+ Q +H N++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+L G + ++V E++ NG+L +L + +F T + + V + YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQF--TIMQLVGMLRGVGAGMRYLSDLG 171
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL--DPEYFRS 571
+ HRD+ + N+L+D KVSDFG SR + D T G PE
Sbjct: 172 YV---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 572 SRFTEKSDVYSFGVVLAELLT-GER 595
F+ SDV+SFGVV+ E+L GER
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-37
Identities = 63/223 (28%), Positives = 110/223 (49%), Gaps = 16/223 (7%)
Query: 373 STEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES 432
EG + F + +G+G G V G G VA+K K +++
Sbjct: 172 VMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDA 228
Query: 433 KVDEFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPIT 491
F+ E ++++Q+ H N+V+LLG +E + L +V E++ G+L YL + +
Sbjct: 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLG 287
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551
+ L+ +++V +A+ YL + HRD+ + N+L+ AKVSDFG ++ +
Sbjct: 288 GDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS---- 340
Query: 552 HMTTQVQGTFGY--LDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+TQ G PE R +F+ KSDV+SFG++L E+ +
Sbjct: 341 --STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 381
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 68/315 (21%), Positives = 127/315 (40%), Gaps = 43/315 (13%)
Query: 368 QQELASTEGNIDKSKLFTSKELETAT---DHYNTNRILGQGGQGTVYKGMLADGRIVAIK 424
+Q + S + D +S E + Y+ + +G GG V++ + +I AIK
Sbjct: 27 RQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIK 86
Query: 425 --KSKVIDESKVDEFINEVAILSQINH--RNVVKLLGCCLETEVPLLVYEFIINGTLFQY 480
+ D +D + NE+A L+++ +++L + + +V E N L +
Sbjct: 87 YVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSW 145
Query: 481 LHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540
L + + WE + + +AV +H I H D+K N L+ K+ DF
Sbjct: 146 LK-KKKSIDP-WERK-SYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDF 198
Query: 541 GASRSMAIDQT--HMTTQVQGTFGYLDPE-----------YFRSSRFTEKSDVYSFGVVL 587
G + M D T +QV G Y+ PE S+ + KSDV+S G +L
Sbjct: 199 GIANQMQPDTTSVVKDSQV-GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 257
Query: 588 AELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNR 647
+ G+ T F++ + + + + E D ++ + +
Sbjct: 258 YYMTYGK-----TPFQQIINQISKLHAIIDPNHEIEFPD-----IPEKD----LQDVLKC 303
Query: 648 CLNLNGKKRPTMKEV 662
CL + K+R ++ E+
Sbjct: 304 CLKRDPKQRISIPEL 318
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 63/202 (31%), Positives = 99/202 (49%), Gaps = 14/202 (6%)
Query: 400 RILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
+ LG+G G+V G +VA+KK + E + +F E+ IL + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 455 LLGCCLET-EVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
G C L L+ E++ G+L YL Q + I L+ ++ + YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGTK 133
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFR 570
I HRD+ + NIL++ + R K+ DFG ++ + D+ + G + PE
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 571 SSRFTEKSDVYSFGVVLAELLT 592
S+F+ SDV+SFGVVL EL T
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-37
Identities = 62/202 (30%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 400 RILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
+ LG+G G+V G +VA+KK + E + +F E+ IL + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 455 LLGCCLET-EVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
G C L L+ E++ G+L YL E L+ ++ + YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIK--LLQYTSQICKGMEYLGTK 164
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFR 570
I HRD+ + NIL++ + R K+ DFG ++ + D+ + + G + PE
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 571 SSRFTEKSDVYSFGVVLAELLT 592
S+F+ SDV+SFGVVL EL T
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 74/285 (25%), Positives = 118/285 (41%), Gaps = 28/285 (9%)
Query: 400 RILGQGGQGTVYKGML-----ADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVV 453
R LG+G G V G +VA+K K + E+ IL + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 454 KLLGCCLETEVP--LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
K GCC + LV E++ G+L YL + I L A ++ + ++YLH+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA 152
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYF 569
I HRD+ + N+LLD K+ DFG ++++ + + G + PE
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 570 RSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA- 627
+ +F SDV+SFGV L ELLT + + + A M L E+L+
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLERG 267
Query: 628 HVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
L + E V L C RPT + + +L +
Sbjct: 268 ERLPRPDKCPAE----VYHLMKNCWETEASFRPTFENLIPILKTV 308
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 64/206 (31%), Positives = 108/206 (52%), Gaps = 16/206 (7%)
Query: 400 RILGQGGQGTVYKGMLADGRI-----VAIK--KSKVIDESKVDEFINEVAILSQINHRNV 452
+++G G G VYKGML VAIK K+ ++ +VD F+ E I+ Q +H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
++L G + + +++ E++ NG L ++L + ++ + + + ++ + YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFR 570
+ HRD+ + NIL++ KVSDFG SR + D T G PE
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 571 SSRFTEKSDVYSFGVVLAELLT-GER 595
+FT SDV+SFG+V+ E++T GER
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-36
Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 13/204 (6%)
Query: 400 RILGQGGQGTVYKGML----ADGRIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVK 454
+++G G G V G L VAIK KV E + +F+ E +I+ Q +H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L G +++ ++V E++ NG+L +L + +F T + + ++ + YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMGY 168
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL--DPEYFRSS 572
+ HRD+ + NIL++ KVSDFG R + D T G PE
Sbjct: 169 V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 573 RFTEKSDVYSFGVVLAELLT-GER 595
+FT SDV+S+G+VL E+++ GER
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGER 249
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-36
Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 50/299 (16%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNV 452
+ + +ILG G GTV GR VA+ K + D + E+ +L++ +H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAV---KRMLIDFCDIALMEIKLLTESDDHPNV 71
Query: 453 VKLLGCCLETEVPL-LVYEFIINGTLFQYL---HDQNEEFPITWEIRLRIAI-EVSDAVS 507
++ C T+ L + E N L + + +E + E + +++ V+
Sbjct: 72 IRYY-CSETTDRFLYIALEL-CNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 508 YLHSAASIPIYHRDIKSTNILLDGK-------------YRAKVSDFGASRSMAIDQTHMT 554
+LH S+ I HRD+K NIL+ R +SDFG + + Q+
Sbjct: 130 HLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186
Query: 555 TQVQ---GTFGYLDPEYFRSS-------RFTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604
T + GT G+ PE S R T D++S G V +L+ + F +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK----HPFGD 242
Query: 605 DKSLAAYFLRA-MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
S + +R D + + D ++ EA D++ ++ ++ + KRPT +V
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEA--TDLI------SQMIDHDPLKRPTAMKV 293
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 54/194 (27%), Positives = 97/194 (50%), Gaps = 8/194 (4%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
LGQG G V+ G VAIK K + F+ E ++ ++ H +V+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 460 LETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
+E P+ +V E++ G+L +L + ++ + + +A +++ ++Y+ +
Sbjct: 332 --SEEPIYIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV--- 385
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKS 578
HRD+++ NIL+ KV+DFG +R + ++ + + PE RFT KS
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 579 DVYSFGVVLAELLT 592
DV+SFG++L EL T
Sbjct: 446 DVWSFGILLTELTT 459
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 60/217 (27%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
LG+G G V+ + +VA+K K ES +F E +L+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYL------------HDQNEEFPITWEIRLRIAIE 501
+ G C E L+V+E++ +G L ++L + P+ L +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGT 560
V+ + YL A + HRD+ + N L+ K+ DFG SR + + D + +
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGR---- 219
Query: 561 FGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
L PE +FT +SDV+SFGVVL E+ T
Sbjct: 220 -TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 4e-36
Identities = 68/293 (23%), Positives = 113/293 (38%), Gaps = 22/293 (7%)
Query: 373 STEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDE 431
S + E + D +LG+G G VY G L++ +AIK+ D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 432 SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPIT 491
E+A+ + H+N+V+ LG E + E + G+L L +
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQ 550
+ ++ + + YLH I HRDIK N+L++ K+SDFG S+ +A
Sbjct: 121 EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN 177
Query: 551 THMTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608
T GT Y+ PE + + +D++S G + E+ TG+ +E +
Sbjct: 178 PCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP----FYELGEPQ 232
Query: 609 AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
AA F + EI + S E +C + KR +
Sbjct: 233 AAMF-KVGMFKVHPEIPE-----SMSAE----AKAFILKCFEPDPDKRACAND 275
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 60/202 (29%), Positives = 105/202 (51%), Gaps = 15/202 (7%)
Query: 402 LGQGGQGTVYKGML--ADGRI-VAIK--KSKVIDESKVDEFINEVAILSQINHRNVVKLL 456
LG G G+V +G+ +I VAIK K +E + E I+ Q+++ +V+L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMREAQIMHQLDNPYIVRLI 76
Query: 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516
G C + +LV E G L ++L + EE + +VS + YL +
Sbjct: 77 GVCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV- 132
Query: 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFRSSRF 574
HRD+ + N+LL ++ AK+SDFG S+++ D ++ T + G + + PE +F
Sbjct: 133 --HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 575 TEKSDVYSFGVVLAELLT-GER 595
+ +SDV+S+GV + E L+ G++
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQK 212
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 400 RILGQGGQGTVYKGML--ADGRI--VAIK--KSKVIDESKV-DEFINEVAILSQINHRNV 452
LG G G V +G G+ VA+K K V+ + + D+FI EV + ++HRN+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 453 VKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
++L G L P+ +V E G+L L F + R A++V++ + YL S
Sbjct: 84 IRLYGVVLTP--PMKMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES 139
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYF 569
I HRD+ + N+LL + K+ DFG R++ + H Q + PE
Sbjct: 140 KRFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 570 RSSRFTEKSDVYSFGVVLAELLT-GER 595
++ F+ SD + FGV L E+ T G+
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 55/202 (27%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 400 RILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
LG+G G+V G +VA+K+ + + +F E+ IL ++ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 455 LLGCCLET-EVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
G L LV E++ +G L +L Q + L + ++ + YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGSR 146
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYFR 570
+ HRD+ + NIL++ + K++DFG ++ + +D+ + + G + PE
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 571 SSRFTEKSDVYSFGVVLAELLT 592
+ F+ +SDV+SFGVVL EL T
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-36
Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 38/278 (13%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
Y R LG+GG ++ + A K KS ++ + ++ E++I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDA 505
++VV G E + +V E +L + + E E R ++
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 153
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG-ASRSMAIDQTHMTTQVQGTFGYL 564
YLH + HRD+K N+ L+ K+ DFG A++ + GT Y+
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYI 208
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE + + DV+S G ++ LL G+ F E L +LR K + + I
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-----F-ETSCLKETYLRIKKNE--YSI 260
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
H+ A A L + L + RPT+ E+
Sbjct: 261 -PKHINPVA--------ASLIQKMLQTDPTARPTINEL 289
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-36
Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 26/285 (9%)
Query: 400 RILGQGGQGTVYKGMLA-----DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVV 453
R LG+G G V G VA+K K + + + E+ IL + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 454 KLLGCCLETEV-PL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
K G C E + L+ EF+ +G+L +YL + I + +L+ A+++ + YL S
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF--GYLDPEYF 569
+ HRD+ + N+L++ +++ K+ DFG ++++ D+ + T + + PE
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 570 RSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA- 627
S+F SDV+SFGV L ELLT + + M L L
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH--GQMTVTRLVNTLKEG 259
Query: 628 HVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
L E V +L +C R + + + +
Sbjct: 260 KRLPCPPNCPDE----VYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-36
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 399 NRILGQGGQGTVYKGMLADGR------IVAIKKSKVI-DESKVDEFINEVAILSQINHRN 451
+R LGQG G VY+G+ VAIK + EF+NE +++ + N +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL-------HDQNEEFPITWEIRLRIAIEVSD 504
VV+LLG + + L++ E + G L YL + P + +++A E++D
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
++YL + HRD+ + N ++ + K+ DFG +R + + +G G L
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 565 -----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
PE + FT SDV+SFGVVL E+ T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 9e-36
Identities = 65/278 (23%), Positives = 109/278 (39%), Gaps = 38/278 (13%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
Y R LG+GG ++ + A K KS ++ + ++ E++I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDA 505
++VV G E + +V E +L + + E E R ++
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG-ASRSMAIDQTHMTTQVQGTFGYL 564
YLH + HRD+K N+ L+ K+ DFG A++ + GT Y+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYI 182
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE + + DV+S G ++ LL G+ F E L +LR K + + I
Sbjct: 183 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP-----F-ETSCLKETYLRIKKNE--YSI 234
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
H+ A A L + L + RPT+ E+
Sbjct: 235 -PKHINPVA--------ASLIQKMLQTDPTARPTINEL 263
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-36
Identities = 74/356 (20%), Positives = 131/356 (36%), Gaps = 38/356 (10%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQINHR 450
+ LG GG G V + + G VAIK+ + + + + E+ I+ ++NH
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 451 NVVKLLGCCLETE-------VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVS 503
NVV + +PLL E+ G L +YL+ + + ++S
Sbjct: 73 NVVSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLD---GKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
A+ YLH I HRD+K NI+L + K+ D G ++ + DQ + T+ GT
Sbjct: 132 SALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGT 186
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFE-------EDKSLAAYFL 613
YL PE ++T D +SFG + E +TG R +KS +
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246
Query: 614 RAMKEDSL---FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV-------A 663
++ + + L + + L + ++R T + A
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLE---RWLQCMLMWHQRQRGTDPQNPNVGCFQA 303
Query: 664 VVLAGIKACDGTSNIIQESVESDIAESYETGESFTESYTDSVTIPVDADPLISKNG 719
+ N++ V + E ++ IP + L+ +G
Sbjct: 304 LDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELLQASG 359
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-35
Identities = 34/311 (10%), Positives = 72/311 (23%), Gaps = 52/311 (16%)
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAI 443
L L G + V+ + A+K S+++
Sbjct: 56 LLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFA 115
Query: 444 LSQINHRNVVKLLGCCLETEVP--------------------------LLVYEFIINGTL 477
+++ + + LL+ + L
Sbjct: 116 AARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDL 174
Query: 478 FQYLHD----QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533
+ ++ + L S + H N+ +
Sbjct: 175 ELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDG 231
Query: 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELL 591
R + D A + Y E+ +S FT + + G+ + +
Sbjct: 232 RLMLGDVSALWKV----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287
Query: 592 TGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNL 651
+ S LR DSL + + ++ R LN
Sbjct: 288 CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFV--KTLIG------RFLNF 339
Query: 652 NGKKRPTMKEV 662
+ ++R E
Sbjct: 340 DRRRRLLPLEA 350
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 50/204 (24%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 400 RILGQGGQGTVYKGMLADGR-----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVV 453
++LG G GTVYKG+ VAIK+ + E ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG CL L+ + + G L Y+ + + + L ++++ ++YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFGYLDPEYFRSS 572
+ HRD+ + N+L+ K++DFG ++ + A ++ + + ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR 194
Query: 573 RFTEKSDVYSFGVVLAELLT-GER 595
+T +SDV+S+GV + EL+T G +
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+ LG G G V+ VA+K K V+ F+ E ++ + H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 460 LETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIY 518
T+ P+ ++ EF+ G+L +L +E + + ++++ ++++ I
Sbjct: 253 --TKEPIYIITEFMAKGSLLDFLKS-DEGSKQPLPKLIDFSAQIAEGMAFIEQRNYI--- 306
Query: 519 HRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFTE 576
HRD+++ NIL+ K++DFG +R I+ T + F PE FT
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 577 KSDVYSFGVVLAELLT 592
KSDV+SFG++L E++T
Sbjct: 365 KSDVWSFGILLMEIVT 380
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 59/203 (29%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 400 RILGQGGQGTVYKGMLADGRI----VAIK--KSKVIDESKVDEFINEVAILSQINHRNVV 453
RILG+G G VY+G+ + + VA+K K ++K ++F++E I+ ++H ++V
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFMSEAVIMKNLDHPHIV 76
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
KL+G E E ++ E G L YL + + ++++ A++YL S
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESIN 133
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
+ HRDI NIL+ K+ DFG SR + + + + + ++ PE R
Sbjct: 134 CV---HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 574 FTEKSDVYSFGVVLAELLT-GER 595
FT SDV+ F V + E+L+ G++
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQ 213
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 72/340 (21%), Positives = 127/340 (37%), Gaps = 49/340 (14%)
Query: 384 FTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVA 442
F + +E R+L +GG VY+ + GR A+K+ +E K I EV
Sbjct: 18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 443 ILSQI-NHRNVVKLLGCCLET--EVPLLVYEFII-----NGTLFQYLHDQNEEFPITWEI 494
+ ++ H N+V+ E EF++ G L ++L P++ +
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554
L+I + AV ++H PI HRD+K N+LL + K+ DFG++ +++ +
Sbjct: 138 VLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196
Query: 555 TQVQ-----------GTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVT 600
+ + T Y PE EK D+++ G +L L +
Sbjct: 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ-----H 251
Query: 601 NFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK 660
FE+ L I++ L L +N ++R ++
Sbjct: 252 PFEDGAKLR--------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIA 297
Query: 661 EVAVVLAGIKACDGTSNIIQESVESDIAESYETGESFTES 700
EV L I N+ + +S I E E + +
Sbjct: 298 EVVHQLQEIA---AARNV---NPKSPITELLEQNGGYGSA 331
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-35
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 400 RILGQGGQGTVYKGMLADGR----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVK 454
R +G+G G V++G+ VAIK K +S ++F+ E + Q +H ++VK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L+G E ++ E G L +L Q ++ + + A ++S A++YL S
Sbjct: 81 LIGVITE-NPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
+ HRDI + N+L+ K+ DFG SR M + ++ + ++ PE RF
Sbjct: 138 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 575 TEKSDVYSFGVVLAELLT-GER 595
T SDV+ FGV + E+L G +
Sbjct: 195 TSASDVWMFGVCMWEILMHGVK 216
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 46/206 (22%), Positives = 92/206 (44%), Gaps = 18/206 (8%)
Query: 400 RILGQGGQGTVYKGMLADGR-----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVV 453
++LG G GTV+KG+ V IK + + + + ++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+LLG C LV +++ G+L ++ ++ L ++++ + YL
Sbjct: 79 RLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG 135
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT---FGYLDPEYFR 570
+ HR++ + N+LL + +V+DFG + + D + ++ E
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKWMALESIH 190
Query: 571 SSRFTEKSDVYSFGVVLAELLT-GER 595
++T +SDV+S+GV + EL+T G
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-35
Identities = 57/218 (26%), Positives = 98/218 (44%), Gaps = 33/218 (15%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
R LG+G G V+ + +VA+K K + +F E +L+ + H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYL-------------HDQNEEFPITWEIRLRIAI 500
K G C + + ++V+E++ +G L ++L + + + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQG 559
+++ + YL AS HRD+ + N L+ K+ DFG SR + + D +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH--- 194
Query: 560 TFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
L PE +FT +SDV+SFGV+L E+ T
Sbjct: 195 --TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIK--KSKVIDESKVDEFINEVAILSQINHRN 451
R LG G G VY+G ++ VA+K ++ ++D F+ E I+S+ NH+N
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL----HDQNEEFPITWEIRLRIAIEVSDAVS 507
+V+ +G L++ ++ E + G L +L ++ + L +A +++
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 508 YLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
YL HRDI + N LL AK+ DFG +R I + +G L
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRASYYR--KGGCAML 207
Query: 565 -----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
PE F FT K+D +SFGV+L E+ +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-35
Identities = 57/303 (18%), Positives = 103/303 (33%), Gaps = 34/303 (11%)
Query: 367 LQQELASTEGNIDKSKLF-TSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK 424
L E EG + KL E +G+G G V++ G A+K
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 425 KSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ 484
K ++ E+ + ++ +V L G E + E + G+L Q +
Sbjct: 90 KVRLEVFRV-----EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI--- 141
Query: 485 NEEFPITWEIRLR-IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGA 542
++ E R + + + YLH+ + H D+K+ N+LL RA + DFG
Sbjct: 142 -KQMGCLPEDRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFGH 197
Query: 543 SRSMAIDQTHMTTQ----VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIR 598
+ + D + + GT ++ PE K D++S ++ +L G
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP-- 255
Query: 599 VTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT 658
+ + A + + EI + A+ L R +
Sbjct: 256 ---WTQYFRGPLCLKIASEPPPIREIPP-----SCAPL----TAQAIQEGLRKEPVHRAS 303
Query: 659 MKE 661
E
Sbjct: 304 AME 306
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 140 bits (353), Expect = 6e-35
Identities = 60/201 (29%), Positives = 108/201 (53%), Gaps = 13/201 (6%)
Query: 402 LGQGGQGTVYKGML--ADGRI-VAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLG 457
LG G G+V +G+ +I VAIK K +++ +E + E I+ Q+++ +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 458 CCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517
C + +LV E G L ++L + EE P + +VS + YL +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY--LDPEYFRSSRFT 575
HR++ + N+LL ++ AK+SDFG S+++ D ++ T + G + PE +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 576 EKSDVYSFGVVLAELLT-GER 595
+SDV+S+GV + E L+ G++
Sbjct: 518 SRSDVWSYGVTMWEALSYGQK 538
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-35
Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 44/222 (19%)
Query: 400 RILGQGGQGTVYKGMLADGRI--------VAIKKSKVIDESKVDEFINEVAILSQINHRN 451
LGQG ++KG+ + V +K + + F +++S+++H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+V G C+ + +LV EF+ G+L YL I W+ L +A +++ A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLEE 131
Query: 512 AASIPIYHRDIKSTNILLDGKYR--------AKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
I H ++ + NILL + K+SD G S ++
Sbjct: 132 NTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------IL 177
Query: 564 LDP---------EYFRSSRFTEKSDVYSFGVVLAELLT-GER 595
+ E + +D +SFG L E+ + G++
Sbjct: 178 QERIPWVPPECIENPK--NLNLATDKWSFGTTLWEICSGGDK 217
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-34
Identities = 74/278 (26%), Positives = 115/278 (41%), Gaps = 40/278 (14%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
D ++ R LG+G G VY LA + I+A+K KS++ E + E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLR-IAIEVSD 504
+ H N++++ + L+ EF G L++ L ++ F E R E++D
Sbjct: 71 LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQ-KHGRFD---EQRSATFMEELAD 125
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
A+ Y H + HRDIK N+L+ K K++DFG S A T GT YL
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM--CGTLDYL 179
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE EK D++ GV+ E L G F + S R + D F
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGM-----PPF-DSPSHTETHRRIVNVDLKF-- 231
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ + L ++ L + +R +K V
Sbjct: 232 -PPFLSDGS--------KDLISKLLRYHPPQRLPLKGV 260
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIK--KSKVIDESKVDEFINEVAILSQINHRN 451
R LG G G VY+G ++ VA+K ++ ++D F+ E I+S+ NH+N
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL----HDQNEEFPITWEIRLRIAIEVSDAVS 507
+V+ +G L++ ++ E + G L +L ++ + L +A +++
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 508 YLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
YL HRDI + N LL AK+ DFG +R + + +G L
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----RKGGCAML 248
Query: 565 -----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
PE F FT K+D +SFGV+L E+ +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 62/226 (27%), Positives = 106/226 (46%), Gaps = 40/226 (17%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIKKSKVI-DESKVDEFINEVAILSQINHRNV 452
+ LG+G G V K + VA+K K S++ + ++E +L Q+NH +V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYL---------------------HDQNEEFPIT 491
+KL G C + LL+ E+ G+L +L D +E +T
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551
+ A ++S + YL A + + HRD+ + NIL+ + K+SDFG SR + + +
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 552 HMTTQVQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ V+ + G + E +T +SDV+SFGV+L E++T
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-33
Identities = 73/331 (22%), Positives = 134/331 (40%), Gaps = 51/331 (15%)
Query: 367 LQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLA--DGRIVAIK 424
++ L++ I +K KE + + Y R L QG + L D + A+K
Sbjct: 6 MKDILSNYSNLIYLNK--YVKEKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALK 60
Query: 425 -----------------KSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL- 466
K+ +SK D+F NE+ I++ I + + G + +
Sbjct: 61 KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVY 119
Query: 467 LVYEFIINGTLFQYLH-----DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521
++YE++ N ++ ++ D+N I ++ I V ++ SY+H+ +I HRD
Sbjct: 120 IIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRD 177
Query: 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT--EKSD 579
+K +NIL+D R K+SDFG S +D+ + +GT+ ++ PE+F + K D
Sbjct: 178 VKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGS--RGTYEFMPPEFFSNESSYNGAKVD 234
Query: 580 VYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED-------SLFEILDAHVLKE 632
++S G+ L + V F SL F ++ + F +
Sbjct: 235 IWSLGICLYVMFYN-----VVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKST 289
Query: 633 ASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
S + L N +R T ++
Sbjct: 290 CSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-33
Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 37/294 (12%)
Query: 380 KSKLFTSKELETATDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVIDESKVD 435
+F +D Y R+LG+G G V G+ A+K K +V ++ +
Sbjct: 12 TPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKE 71
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITW 492
+ EV +L Q++H N++KL + LV E G LF + + +E
Sbjct: 72 SLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV----- 126
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAID 549
+ RI +V ++Y+H I HRD+K N+LL+ K ++ DFG S
Sbjct: 127 DAA-RIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182
Query: 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609
+ M ++ GT Y+ PE + + EK DV+S GV+L LL+G F +
Sbjct: 183 KK-MKDKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPP-----F-NGANEY 233
Query: 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ K F + K+ S+ AK L + L R + ++
Sbjct: 234 DILKKVEKGKYTF---ELPQWKKVSES-----AKDLIRKMLTYVPSMRISARDA 279
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 46/269 (17%), Positives = 84/269 (31%), Gaps = 30/269 (11%)
Query: 381 SKLFTSKELETATDHYNTNRILGQGGQGTVYKGM------LADGRIVAIKKSKVIDESKV 434
+ E + + + +LG+G VY+ + + +K V +
Sbjct: 52 PAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLK---VQKPANP 108
Query: 435 DEF---INEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD--QNEEFP 489
EF + L +K L +LV E GTL ++ E
Sbjct: 109 WEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV 168
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA-----------KVS 538
+ + + A+ + + +H I H DIK N +L + +
Sbjct: 169 MPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI 225
Query: 539 DFGASRSM-AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597
D G S M + + T T G+ E + + + D + + +L G +
Sbjct: 226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT-YM 284
Query: 598 RVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
+V N + F R D E
Sbjct: 285 KVKNEGGECKPEGLFRRLPHLDMWNEFFH 313
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 3e-33
Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 12/202 (5%)
Query: 400 RILGQGGQGTVYKGMLADGR----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVK 454
R +G+G G V++G+ VAIK K +S ++F+ E + Q +H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS 514
L+G E V ++ E G L +L + + + A ++S A++YL S
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLESKRF 512
Query: 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF 574
+ HRDI + N+L+ K+ DFG SR M + ++ + ++ PE RF
Sbjct: 513 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 575 TEKSDVYSFGVVLAELLT-GER 595
T SDV+ FGV + E+L G +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVK 591
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-33
Identities = 55/227 (24%), Positives = 103/227 (45%), Gaps = 42/227 (18%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIK--KSKVIDESKVDEFINEVAILSQINHRN 451
R +G+G G V++ +VA+K K + + + D F E A++++ ++ N
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL---------------------HDQNEEFPI 490
+VKLLG C + L++E++ G L ++L P+
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 491 TWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550
+ +L IA +V+ ++YL + HRD+ + N L+ K++DFG SR++
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD 228
Query: 551 THMTTQVQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ + PE +R+T +SDV+++GVVL E+ +
Sbjct: 229 YY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 6e-33
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 400 RILGQGGQGTVYKGMLADGR--------IVAIKKSKVI-DESKVDEFINEVAILSQI-NH 449
+ LG+G G V VA+K K E + + ++E+ ++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYL-------------HDQNEEFPITWEIRL 496
+N++ LLG C + ++ E+ G L +YL ++ E +T++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
+++ + YL AS HRD+ + N+L+ K++DFG +R + +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 557 VQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ T G L PE +T +SDV+SFGV++ E+ T
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 51/216 (23%), Positives = 96/216 (44%), Gaps = 28/216 (12%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIK--KSKVIDESKVDEFINEVAILSQINHRN 451
LG+ G VYKG L VAIK K K + + F +E + +++ H N
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREE-FRHEAMLRARLQHPN 73
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLH-------------DQNEEFPITWEIRLRI 498
VV LLG + + +++ + +G L ++L D+ + + + +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
+++ + YL +S + H+D+ + N+L+ K K+SD G R + +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-YAADYYKLLGN 189
Query: 559 GTF--GYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592
++ PE +F+ SD++S+GVVL E+ +
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-33
Identities = 66/220 (30%), Positives = 99/220 (45%), Gaps = 34/220 (15%)
Query: 400 RILGQGGQGTVYKGMLAD------GRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRN 451
+ LG+G G V + R VA+K K S+ ++E+ IL I +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 452 VVKLLGCCLETEVPLLV-YEFIINGTLFQYL-------------HDQNEEFPITWEIRLR 497
VV LLG C + PL+V EF G L YL + + +T E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557
+ +V+ + +L AS HRD+ + NILL K K+ DFG +R + D + V
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205
Query: 558 QGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ L PE +T +SDV+SFGV+L E+ +
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-32
Identities = 32/303 (10%), Positives = 79/303 (26%), Gaps = 65/303 (21%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQ--------- 446
+LGQ + G + ++ + + + EV L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 447 -------------INHRNVVKLLGCCLETEVPLLVYEFII-------NGTLFQYLHDQNE 486
+ K++ L+ ++ F + T + L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 487 EF-PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545
+ RL++ ++V ++ LH + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSR-----FTEKSDVYSFGVVLAELLTGERAIRVT 600
+ + T D ++ G+ + + +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP---- 316
Query: 601 NFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDI-VTVAKLTNRCLNLNGKKRPTM 659
+D+ + S ++I V L L + R
Sbjct: 317 -NT--------------DDAALGGSEWIF---RSCKNIPQPVRALLEGFLRYPKEDRLLP 358
Query: 660 KEV 662
+
Sbjct: 359 LQA 361
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 35/221 (15%)
Query: 400 RILGQGGQGTVYKGMLADGR--------IVAIKKSKVI-DESKVDEFINEVAILSQI-NH 449
+ LG+G G V VA+K K E + + ++E+ ++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYL-------------HDQNEEFPITWEIRL 496
+N++ LLG C + ++ E+ G L +YL ++ E +T++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
+++ + YL AS HRD+ + N+L+ K++DFG +R + +
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259
Query: 557 VQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ T G L PE +T +SDV+SFGV++ E+ T
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-32
Identities = 76/294 (25%), Positives = 119/294 (40%), Gaps = 38/294 (12%)
Query: 380 KSKLFTSKELETATDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVIDESKVD 435
+F + + ++ Y + LG G G V AIK K+ V
Sbjct: 23 TPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTS-SNS 81
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITW 492
+ + EVA+L ++H N++KL + LV E G LF + + NE
Sbjct: 82 KLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV----- 136
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAID 549
+ I +V V+YLH I HRD+K N+LL+ K K+ DFG S
Sbjct: 137 DAA-VIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609
+ M ++ GT Y+ PE R + EK DV+S GV+L LL G ++
Sbjct: 193 KK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFG------GQTDQ 243
Query: 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ K F D+ K S+ AK L + L + ++R + ++
Sbjct: 244 EILRKVEKGKYTF---DSPEWKNVSEG-----AKDLIKQMLQFDSQRRISAQQA 289
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 400 RILGQGGQGTVYKGMLADG---RIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVK 454
++G+G G V K + AIK+ K + +F E+ +L ++ +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 455 LLGCCLETEVPLLVYEFIINGTLFQYL-------------HDQNEEFPITWEIRLRIAIE 501
LLG C L E+ +G L +L + ++ + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
V+ + YL + HRD+ + NIL+ Y AK++DFG SR + V+ T
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QE-----VYVKKTM 200
Query: 562 GYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
G L E S +T SDV+S+GV+L E+++
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 4e-32
Identities = 58/222 (26%), Positives = 97/222 (43%), Gaps = 35/222 (15%)
Query: 399 NRILGQGGQGTVYKGMLAD--------GRIVAIKKSKVI-DESKVDEFINEVAILSQI-N 448
+ LG+G G V VA+K K E + + I+E+ ++ I
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL-------------HDQNEEFPITWEIR 495
H+N++ LLG C + ++ E+ G L +YL N E ++ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
+ A +V+ + YL AS HRD+ + N+L+ K++DFG +R + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 556 QVQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ T G L PE +T +SDV+SFGV+L E+ T
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 58/222 (26%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIK--KSKVIDESKVDEFINEVAILSQI-NHR 450
+ LG G G V + VA+K K + ++E+ +LS + NH
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHM 87
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYL---------------HDQNEEFPITWEIR 495
N+V LLG C L++ E+ G L +L +++E + E
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
L + +V+ +++L AS HRD+ + NILL K+ DFG +R + D +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY--- 201
Query: 556 QVQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
V L PE + +T +SDV+S+G+ L EL +
Sbjct: 202 -VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 33/218 (15%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIK--KSKVIDESKVDEFINEVAILSQI-NHR 450
+ LG G G V + VA+K KS + K ++E+ I+S + H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEA-LMSELKIMSHLGQHE 110
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-----------PITWEIRLRIA 499
N+V LLG C L++ E+ G L +L ++ + L +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 500 IEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQG 559
+V+ +++L AS HRD+ + N+LL + AK+ DFG +R + D + +
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVK 223
Query: 560 TFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
L PE +T +SDV+S+G++L E+ +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 82/297 (27%), Positives = 130/297 (43%), Gaps = 58/297 (19%)
Query: 386 SKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFIN-- 439
K+ E Y +LG+GG GTV+ G L D VAIK +++V+ S + + +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 440 -EVAILSQIN----HRNVVKLLGCCLETEVPL-LVYEFIINGT-LFQYLHDQ---NEEFP 489
EVA+L ++ H V++LL ET+ LV E + LF Y+ ++ E
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-- 139
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAI 548
R +V A+ + HS + HRDIK NIL+D + AK+ DFG+ +
Sbjct: 140 ---PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALL-- 190
Query: 549 DQTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKS 607
T GT Y PE+ ++ + V+S G++L +++ G+ FE D+
Sbjct: 191 HDEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD-----IPFERDQ- 243
Query: 608 LAAYFLRAMKEDSLFEILDA--HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
EIL+A H S + L RCL RP+++E+
Sbjct: 244 ---------------EILEAELHFPAHVSPD----CCALIRRCLAPKPSSRPSLEEI 281
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 35/308 (11%), Positives = 84/308 (27%), Gaps = 74/308 (24%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQI-------- 447
+LGQ + G + ++ + + + EV L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 448 -----------------NHRNVVKLLGCCLETEVPLLVYEFII----NGTLFQYLHDQNE 486
+ ++++ + V + + T + L +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 487 E-FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545
+ RL++ ++V ++ LH + H ++ +I+LD + ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYF-----------RSSRFTEKSDVYSFGVVLAELLTGE 594
+ G+ PE R + T D ++ G+V+ + +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 595 RAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGK 654
+D +L ++ Q V L L +
Sbjct: 311 LP-----ITKDAALGGSEWIFRSCKNI------------PQP----VRALLEGFLRYPKE 349
Query: 655 KRPTMKEV 662
R +
Sbjct: 350 DRLLPLQA 357
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 56/226 (24%), Positives = 98/226 (43%), Gaps = 40/226 (17%)
Query: 400 RILGQGGQGTVYKGMLADGR------IVAIKKSK-VIDESKVDEFINEVAILSQI-NHRN 451
++LG G G V VA+K K D S+ + ++E+ +++Q+ +H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYL--------------------HDQNEEFPIT 491
+V LLG C + L++E+ G L YL ++ + +T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 492 WEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551
+E L A +V+ + +L HRD+ + N+L+ K+ DFG +R + D
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 552 HMTTQVQGTFGYL-----DPEYFRSSRFTEKSDVYSFGVVLAELLT 592
+ V L PE +T KSDV+S+G++L E+ +
Sbjct: 228 Y----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 81/309 (26%), Positives = 130/309 (42%), Gaps = 56/309 (18%)
Query: 372 ASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSK 427
+ ++ +KL KE E Y +LG GG G+VY G+ ++D VAIK K +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 428 VIDESKVDEFIN---EVAILSQINHR--NVVKLLGCCLETEVPL-LVYEFIIN-GTLFQY 480
+ D ++ EV +L +++ V++LL E L+ E LF +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139
Query: 481 LHDQ---NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAK 536
+ ++ EE R +V +AV + H+ + HRDIK NIL+D + K
Sbjct: 140 ITERGALQEE-----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190
Query: 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGER 595
+ DFG+ + T T GT Y PE+ R R+ + V+S G++L +++ G+
Sbjct: 191 LIDFGSGALL--KDTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD- 246
Query: 596 AIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA--HVLKEASQEDIVTVAKLTNRCLNLNG 653
FE D+ EI+ + S E L CL L
Sbjct: 247 ----IPFEHDE----------------EIIRGQVFFRQRVSSE----CQHLIRWCLALRP 282
Query: 654 KKRPTMKEV 662
RPT +E+
Sbjct: 283 SDRPTFEEI 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-30
Identities = 75/282 (26%), Positives = 117/282 (41%), Gaps = 40/282 (14%)
Query: 393 TDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
+ YN +LG+G G V K + A+K K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD-TSTILREVELLKKLD 79
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSD 504
H N++KL E +V E G LF + + +E + RI +V
Sbjct: 80 HPNIMKLFEIL-EDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFS 132
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
++Y+H I HRD+K NILL+ K K+ DFG S + M ++ GT
Sbjct: 133 GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTA 187
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
Y+ PE R + + EK DV+S GV+L LL+G F K+ R
Sbjct: 188 YYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP-----F-YGKNEYDILKRVETGKYA 240
Query: 622 FEILDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
F D + S + AK L + L + R T +
Sbjct: 241 F---DLPQWRTISDD-----AKDLIRKMLTFHPSLRITATQC 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 81/304 (26%), Positives = 123/304 (40%), Gaps = 47/304 (15%)
Query: 380 KSKLFTSKELETATDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVID----- 430
++ K+ + Y R LG G G V AIK KS+
Sbjct: 22 NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81
Query: 431 -----ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ- 484
E +E NE+++L ++H N++KL + + LV EF G LF+ + ++
Sbjct: 82 DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141
Query: 485 --NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSD 539
+E + I ++ + YLH I HRDIK NILL+ K K+ D
Sbjct: 142 KFDEC-----DAA-NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD 192
Query: 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRV 599
FG S + D + ++ GT Y+ PE + + EK DV+S GV++ LL G
Sbjct: 193 FGLSSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP--- 246
Query: 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPT 658
F ++ + K F D + K S E AK L L + KR T
Sbjct: 247 --F-GGQNDQDIIKKVEKGKYYF---DFNDWKNISDE-----AKELIKLMLTYDYNKRCT 295
Query: 659 MKEV 662
+E
Sbjct: 296 AEEA 299
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 58/295 (19%), Positives = 112/295 (37%), Gaps = 52/295 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDE--FINEVAILSQI-N 448
T ++ +G G G+V+K + DG I AIK+SK VDE + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLR-IAIEVSDAVS 507
H +VV+ E + L+ E+ G+L + + E L+ + ++V +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 508 YLHSAASIPIYHRDIKSTNILLD-------------------GKYRAKVSDFGASRSMAI 548
Y+HS + + H DIK +NI + K K+ D G ++
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 549 DQTHMTTQVQGTFGYLDPEYFR-SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKS 607
Q +G +L E + + K+D+++ + + E
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNGDQ 236
Query: 608 LAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+R + + ++L SQE +L ++ + ++RP+ +
Sbjct: 237 WHE--IRQGRLPRIPQVL--------SQE----FTELLKVMIHPDPERRPSAMAL 277
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 7e-30
Identities = 72/291 (24%), Positives = 111/291 (38%), Gaps = 48/291 (16%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVI-----DESKVDEFINEVAI 443
D Y ++ LG G G V + VAI+ K K + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 444 LSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAI 500
L ++NH ++K+ + E +V E + G LF + E +
Sbjct: 194 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTHMTTQV 557
++ AV YLH I HRD+K N+LL + K++DFG S+ + + + M T
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC 302
Query: 558 QGTFGYLDPEYFRSSRF---TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614
GT YL PE S D +S GV+L L+G F E ++
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-----YPPFSEHRT------- 349
Query: 615 AMKEDSLFE-ILDAHVLKEASQEDIVTV-AK-LTNRCLNLNGKKRPTMKEV 662
+ SL + I V+ A L + L ++ K R T +E
Sbjct: 350 ---QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 7e-30
Identities = 62/204 (30%), Positives = 102/204 (50%), Gaps = 11/204 (5%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
Y +GQG GTVY M +A G+ VAI++ + + K + INE+ ++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLH 510
+V L L + +V E++ G+L + + +E I + E A+ +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA-----AVCRECLQALEFLH 133
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
S I HRDIKS NILL K++DFG + +Q+ +T V GT ++ PE
Sbjct: 134 SNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 571 SSRFTEKSDVYSFGVVLAELLTGE 594
+ K D++S G++ E++ GE
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 9/203 (4%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
++ +G+G G V GR VA+K + + + + NEV I+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
VV++ L E ++ EF+ G L D + + E + V A++YLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
I HRDIKS +ILL R K+SDFG ++ D + V GT ++ PE
Sbjct: 160 QGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 572 SRFTEKSDVYSFGVVLAELLTGE 594
S + + D++S G+++ E++ GE
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGE 238
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 63/284 (22%), Positives = 114/284 (40%), Gaps = 36/284 (12%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDE--FINEVAILSQ 446
D Y ++G+G V + + G+ A+K +K + E +I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSD 504
+ H ++V+LL ++ L +V+EF+ L + + + + E + ++ +
Sbjct: 83 LKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTF 561
A+ Y H I HRD+K +LL K + K+ FG + + +V GT
Sbjct: 142 ALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTP 197
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
++ PE + + + DV+ GV+L LL+G F ++ L
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG-----CLPFYGT------------KERL 240
Query: 622 FE-ILDAHVLKEASQEDIVTV-AK-LTNRCLNLNGKKRPTMKEV 662
FE I+ Q ++ AK L R L L+ +R T+ E
Sbjct: 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEA 284
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 61/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVID----ESKVDEFINEVAILSQI 447
+ + +G+G G V+KG+ ++VAIK +ID E ++++ E+ +LSQ
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIK---IIDLEEAEDEIEDIQQEITVLSQC 77
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAV 506
+ V K G L+ ++ E++ G+ L +E I +R E+ +
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGL 132
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
YLHS I HRDIK+ N+LL K++DFG + + Q T V GT ++ P
Sbjct: 133 DYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAP 188
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGE 594
E + S + K+D++S G+ EL GE
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 51/211 (24%), Positives = 97/211 (45%), Gaps = 18/211 (8%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
+ + LG G G VYK G + A K + E +++++I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI---EVSDAVSY 508
+VKLLG ++ EF G + + + + I + ++ +A+++
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ-----IQVVCRQMLEALNF 132
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE- 567
LHS I HRD+K+ N+L+ + +++DFG S + + GT ++ PE
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 568 ----YFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ + + K+D++S G+ L E+ E
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHR 450
+ ++ LG+G G+VYK + G+IVAIK + ES + E I E++I+ Q +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK---QVPVESDLQEIIKEISIMQQCDSP 84
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI---EVSDAVS 507
+VVK G + +V E+ G++ + +N+ IA +
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE-----IATILQSTLKGLE 139
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
YLH I HRDIK+ NILL+ + AK++DFG + + T + GT ++ PE
Sbjct: 140 YLHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPE 195
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ + +D++S G+ E+ G+
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGK 222
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 77/287 (26%), Positives = 128/287 (44%), Gaps = 39/287 (13%)
Query: 385 TSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINE 440
+ + + +Y + +G+G V + GR VAIK K++ ++ + + + E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFRE 64
Query: 441 VAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRL 496
V I+ +NH N+VKL +ETE L L+ E+ G +F YL E+ E R
Sbjct: 65 VRIMKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK-----EAR- 117
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
++ AV Y H I HRD+K+ N+LLD K++DFG S + +
Sbjct: 118 SKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAF 173
Query: 557 VQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615
G Y PE F+ ++ + DV+S GV+L L++G F + ++L LR
Sbjct: 174 C-GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG-----SLPF-DGQNLKE--LRE 224
Query: 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ I ++ + L R L LN KR T++++
Sbjct: 225 RVLRGKYRIPF-YMSTDC--------ENLLKRFLVLNPIKRGTLEQI 262
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 57/282 (20%), Positives = 111/282 (39%), Gaps = 41/282 (14%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESKVDEFINEVAILSQIN 448
D+Y+ LG G G V++ + A GR+ I +D NE++I++Q++
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLH 106
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAV 506
H ++ L E + + L+ EF+ G LF + ++ + E + + + + +
Sbjct: 107 HPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVINYMRQACEGL 162
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRA--KVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
++H + I H DIK NI+ + K + K+ DFG + ++ + T +
Sbjct: 163 KHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFA 217
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--FLRAMKEDSLF 622
PE +D+++ GV+ LL+G F ++L
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSG-----------------LSPFAGEDDLETLQ 260
Query: 623 EILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ E + + AK L +KR T+ +
Sbjct: 261 NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 72/291 (24%), Positives = 121/291 (41%), Gaps = 46/291 (15%)
Query: 386 SKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEV 441
S + + +LG G V+ G++ A+K KS +S ++ NE+
Sbjct: 1 SMQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEI 57
Query: 442 AILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLR 497
A+L +I H N+V L E+ LV + + G LF + ++ E+ +
Sbjct: 58 AVLKKIKHENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DAS-L 110
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDFGASRSMAIDQTHMT 554
+ +V AV YLH I HRD+K N+L + ++DFG S+ ++Q +
Sbjct: 111 VIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIM 164
Query: 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614
+ GT GY+ PE +++ D +S GV+ LL G F E+
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG-----YPPFYEE--------- 210
Query: 615 AMKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
E LFE I + + + +DI AK L + +R T ++
Sbjct: 211 --TESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 73/294 (24%), Positives = 112/294 (38%), Gaps = 54/294 (18%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVI-----DESKVDEFINEVAI 443
D Y ++ LG G G V + VAIK K K + E+ I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 444 LSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRL------R 497
L ++NH ++K+ + E +V E + G LF + RL
Sbjct: 69 LKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDK---------VVGNKRLKEATCKL 118
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTHMT 554
++ AV YLH I HRD+K N+LL + K++DFG S+ + + + M
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMR 174
Query: 555 TQVQGTFGYLDPEYFRSS---RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611
T GT YL PE S + D +S GV+L L+G F E ++
Sbjct: 175 TLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG-----YPPFSEHRT---- 224
Query: 612 FLRAMKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ SL + I ++ A L + L ++ K R T +E
Sbjct: 225 ------QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 71/283 (25%), Positives = 116/283 (40%), Gaps = 42/283 (14%)
Query: 393 TDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
+ YN +LG+G G V K + A+K K+ ++ + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDA 505
H N++KL ++ +V E G LF + + +E + RI +V
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH-----DAA-RIIKQVFSG 133
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTFG 562
++Y+H I HRD+K NILL+ K + K+ DFG S + M ++ GT
Sbjct: 134 ITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAY 188
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
Y+ PE R + + EK DV+S GV+L LL+G F E +
Sbjct: 189 YIAPEVLRGT-YDEKCDVWSAGVILYILLSG-----TPPFYGK-----------NEYDIL 231
Query: 623 E-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ + I AK L + L + R T +
Sbjct: 232 KRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 64/284 (22%), Positives = 104/284 (36%), Gaps = 46/284 (16%)
Query: 393 TDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
+Y +G+G G V A K K V D + E+ I+ ++
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLD 64
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSD 504
H N+++L E + LV E G LF+ + + E + RI +V
Sbjct: 65 HPNIIRLYETF-EDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAA-RIMKDVLS 117
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
AV+Y H + HRD+K N L K+ DFG + + M T+V GT
Sbjct: 118 AVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTP 172
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
Y+ P+ + + D +S GV++ LL G F + +
Sbjct: 173 YYVSPQVLEGL-YGPECDEWSAGVMMYVLLCG-----YPPFSAP-----------TDSEV 215
Query: 622 FE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
I + E ++ A+ L R L + K+R T +
Sbjct: 216 MLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 75/293 (25%), Positives = 121/293 (41%), Gaps = 48/293 (16%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVID----ESKVDEFINEVAILSQIN 448
D Y ++G G V VAIK I+ ++ +DE + E+ +SQ +
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIK---RINLEKCQTSMDELLKEIQAMSQCH 71
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIING---TLFQYLHDQNEEFPITWEIRLRIAI---EV 502
H N+V + + LV + + G + +++ + E + IA EV
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREV 130
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF- 561
+ + YLH I HRD+K+ NILL +++DFG S +A +V+ TF
Sbjct: 131 LEGLEYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 562 G---YLDPEYF-RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF-LRAM 616
G ++ PE + + K+D++SFG+ EL TG A Y M
Sbjct: 188 GTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA--------------APYHKYPPM 233
Query: 617 KEDSLFEIL--DAHVLKEASQEDIVTVA------KLTNRCLNLNGKKRPTMKE 661
K L L D L+ Q+ + K+ + CL + +KRPT E
Sbjct: 234 K--VLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 62/281 (22%), Positives = 108/281 (38%), Gaps = 36/281 (12%)
Query: 393 TDHYNTNRILGQGGQGTVYKG-MLADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
D + R LG G G V+ + G IK K + + +++ E+ +L ++
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLD 78
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIR-LRIAIEVSDAV 506
H N++K+ E + +V E G L + + E + ++ +A+
Sbjct: 79 HPNIIKIFEVF-EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTFGY 563
+Y HS + H+D+K NIL K+ DFG + D+ T GT Y
Sbjct: 138 AYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH-STNAA-GTALY 192
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
+ PE F+ T K D++S GVV+ LLTG F + + +
Sbjct: 193 MAPEVFKRD-VTFKCDIWSAGVVMYFLLTG-----CLPFTGT-----------SLEEVQQ 235
Query: 624 -ILDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ A L + L + ++RP+ +V
Sbjct: 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQV 276
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 4e-28
Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 52/284 (18%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFIN-----EVAILS 445
Y+T LG G G V+ + + V +K K KV+++ +++ E+AILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 446 QINHRNVVKLLGCCLETEVPL-LVYEFIINGT-LFQYL--HDQNEEFPITWEIRLRIAIE 501
++ H N++K+L E + LV E +G LF ++ H + +E I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
+ AV YL I HRDIK NI++ + K+ DFG++ + + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTI 193
Query: 562 GYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620
Y PE + + + +++S GV L L+ E F E +
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP-----FCELE-------------- 234
Query: 621 LFEILDA--HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E ++A H S+E + L + L ++R T++++
Sbjct: 235 --ETVEAAIHPPYLVSKE----LMSLVSGLLQPVPERRTTLEKL 272
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 4e-28
Identities = 65/284 (22%), Positives = 117/284 (41%), Gaps = 43/284 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
+D+Y+ LG+G V + + G A K K+ + E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARD-FQKLEREARICRKLQ 63
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSD 504
H N+V+L + E LV++ + G LF+ + + +E + ++ +
Sbjct: 64 HPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILE 116
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTF 561
+++Y HS I HR++K N+LL K + K++DFG + + D GT
Sbjct: 117 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTP 171
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
GYL PE + +++ D+++ GV+L LL G F ++ + L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG-----YPPFWDE-----------DQHRL 215
Query: 622 FE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ I + + AK L + L +N KKR T +
Sbjct: 216 YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 7e-28
Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 36/284 (12%)
Query: 393 TDHYN---TNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI- 447
HY+ ++ LG+G K + + A+K +I + E+ L
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCE 63
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSD 504
H N+VKL + LV E + G LF+ + + +E E I ++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-----EAS-YIMRKLVS 117
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTF 561
AVS++H + HRD+K N+L + K+ DFG +R D + T T
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF-EEDKSLAAYFLRAMKEDS 620
Y PE + + E D++S GV+L +L+G F D+SL + +
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSG-----QVPFQSHDRSLTCTSAVEIMK-- 226
Query: 621 LFEILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+I + + +++ AK L L ++ KR M +
Sbjct: 227 --KIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGL 268
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 21/204 (10%)
Query: 400 RILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNV 452
+ILG+G TV +LA R AIK K +I E+KV E ++S+++H
Sbjct: 36 KILGEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 453 VKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLH 510
VKL + + L + NG L +Y+ + F E R E+ A+ YLH
Sbjct: 93 VKLYFTF-QDDEKLYFGLSYAKNGELLKYIR-KIGSFD---ETCTRFYTAEIVSALEYLH 147
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFG-ASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
I HRD+K NILL+ +++DFG A + GT Y+ PE
Sbjct: 148 GKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELL 204
Query: 570 RSSRFTEKSDVYSFGVVLAELLTG 593
+ SD+++ G ++ +L+ G
Sbjct: 205 TEKSACKSSDLWALGCIIYQLVAG 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 61/283 (21%), Positives = 112/283 (39%), Gaps = 44/283 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDE--FINEVAILSQINH 449
+ Y LG+G G V++ + + + K + D+ E++IL+ H
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK---FVKVKGTDQVLVKKEISILNIARH 60
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIE----VSD 504
RN++ L E+ L +++EFI +F+ ++ E E R + V +
Sbjct: 61 RNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELN---E---REIVSYVHQVCE 113
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRA--KVSDFGASRSMAIDQTHMTTQVQGTFG 562
A+ +LHS I H DI+ NI+ + + K+ +FG +R +
Sbjct: 114 ALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPE 168
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
Y PE + + +D++S G ++ LL+G + F + +
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSG-----INPFLAE-----------TNQQII 212
Query: 623 E-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
E I++A E + ++I A +R L K R T E
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 73/288 (25%), Positives = 113/288 (39%), Gaps = 46/288 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESK---VDEFINEVAILS 445
D Y+ LG G V K + G A IKK + + +E EV+IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 446 QINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNE--EFPITWEIRLRIAIEV 502
Q+ H NV+ L E + L+ E + G LF +L + E T I+ ++
Sbjct: 71 QVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI 124
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
D V+YLH+ I H D+K NI+L K+ DFG + I+ +
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--FLRAM 616
GT ++ PE ++D++S GV+ LL+G FL
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----------------ASPFLGDT 222
Query: 617 KEDSLFEILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
K+++L I E +AK + L +KR T++E
Sbjct: 223 KQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 53/301 (17%), Positives = 100/301 (33%), Gaps = 37/301 (12%)
Query: 377 NIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDE 436
+ + K+ + +H R + K I +S S
Sbjct: 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP 104
Query: 437 ---FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWE 493
++ + + +N V L + + L +++ +
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ--- 550
+ L I I++++AV +LHS + HRD+K +NI KV DFG +M D+
Sbjct: 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 221
Query: 551 ---------THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601
T QV GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 222 TVLTPMPAYATHTGQV-GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS-------- 272
Query: 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
F M+ + + + + L+ + +RP +
Sbjct: 273 ----------FSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322
Query: 662 V 662
+
Sbjct: 323 I 323
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 22/124 (17%), Positives = 47/124 (37%), Gaps = 6/124 (4%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFI-NEVAILSQINHRN 451
+ + +G+GG G V++ D AIK+ ++ + E + EV L+++ H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 452 VVKLLGCCLE----TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
+V+ LE + ++ + + L + + +IR + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 508 YLHS 511
L
Sbjct: 126 QLQP 129
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-27
Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 39/282 (13%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQ-INHR 450
TD Y +G G + + A A+K +ID+SK D E+ IL + H
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVK---IIDKSKRDPT-EEIEILLRYGQHP 76
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDAVS 507
N++ L + + +V E + G L + Q +E E + ++ V
Sbjct: 77 NIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITKTVE 130
Query: 508 YLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
YLH+ + HRD+K +NIL ++ DFG ++ + + + T T +
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YTANF 186
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
+ PE + D++S GV+L +LTG T F + +
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTG-----YTPF--------ANGPDDTPEEILA 233
Query: 624 -ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
I L + AK L ++ L+++ +R T V
Sbjct: 234 RIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 52/294 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVD------EFINEVA 442
++Y ILG+G V + + + A+K + S + + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 443 ILSQIN-HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLR 497
IL +++ H N+++L ET LV++ + G LF YL ++ +E+ E R +
Sbjct: 76 ILRKVSGHPNIIQLKDTY-ETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-K 128
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557
I + + + LH I HRD+K NILLD K++DFG S + + +
Sbjct: 129 IMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC 184
Query: 558 QGTFGYLDPEYFRSSRF------TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611
GT YL PE S ++ D++S GV++ LL G F
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG-----SPPFWHR------ 232
Query: 612 FLRAMKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
K+ + I+ + +D K L +R L + +KR T +E
Sbjct: 233 -----KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 281
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 42/219 (19%), Positives = 77/219 (35%), Gaps = 25/219 (11%)
Query: 393 TDHYNTNRILGQGGQ--GTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQI 447
Y ++G+G + TV G V +++ + V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYL-HDQNEEFPITWEIRLRIAI---EVS 503
NH N+V + +V F+ G+ + + IA V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA-----IAYILQGVL 138
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ----- 558
A+ Y+H + HR +K+++IL+ + +S ++ SM
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 559 -GTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGE 594
+L PE + + + KSD+YS G+ EL G
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 7e-27
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 43/305 (14%)
Query: 372 ASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSK 427
+ + + F +D+Y+ LG+G V + + G A K K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 428 VIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ-- 484
+ + E I ++ H N+V+L + E LV++ + G LF+ + +
Sbjct: 67 LSARD-FQKLEREARICRKLQHPNIVRLHDSI-QEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 485 -NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDF 540
+E + ++ ++++Y HS I HR++K N+LL K + K++DF
Sbjct: 125 YSEA-----DAS-HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADF 175
Query: 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVT 600
G + + D GT GYL PE + +++ D+++ GV+L LL G
Sbjct: 176 GLAIEVN-DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG-----YP 228
Query: 601 NFEEDKSLAAYFLRAMKEDSLFE-ILDAHVLKEASQEDIVTV-AK-LTNRCLNLNGKKRP 657
F ++ + L+ I + + D VT AK L + L +N KKR
Sbjct: 229 PFWDE-----------DQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 277
Query: 658 TMKEV 662
T +
Sbjct: 278 TADQA 282
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 63/235 (26%), Positives = 104/235 (44%), Gaps = 21/235 (8%)
Query: 369 QELASTEGNIDKSKLFT---SKELETATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIK 424
+EL E + + F K E D + LG G G V+K G ++A K
Sbjct: 5 EELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARK 64
Query: 425 KSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD 483
+ I + ++ I E+ +L + N +V G + E + G+L Q L
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124
Query: 484 QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543
I +I +++I V ++YL I HRD+K +NIL++ + K+ DFG S
Sbjct: 125 AG---RIPEQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 544 ----RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
SMA + V GT Y+ PE + + ++ +SD++S G+ L E+ G
Sbjct: 180 GQLIDSMA------NSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 65/279 (23%), Positives = 111/279 (39%), Gaps = 36/279 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN----EVAILSQIN 448
+ ++ + LG+G G V + VA+K ++D + + E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAIEVSDA 505
H NVVK G L E+ G LF + E + + R ++
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAG 117
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA-IDQTHMTTQVQGTFGYL 564
V YLH I HRDIK N+LLD + K+SDFG + ++ + ++ GT Y+
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 565 DPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
PE + F E DV+S G+VL +L GE +++ + ++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAGELP-----WDQPSDSCQEYSDWKEKK--TY 227
Query: 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ + L ++ L N R T+ ++
Sbjct: 228 LNPWKKI---DSA----PLALLHKILVENPSARITIPDI 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-27
Identities = 59/277 (21%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
DHY+ + LG G G V++ A G A K ES + E+ +S + H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 452 VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI-EVSDAVSYL 509
+V L E + + ++YEF+ G LF+ + D++ + E + +V + ++
Sbjct: 216 LVNLHDAF-EDDNEMVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMRQVCKGLCHM 271
Query: 510 HSAASIPIYHRDIKSTNILLDGK--YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
H H D+K NI+ K K+ DFG + +D GT + PE
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAH--LDPKQSVKVTTGTAEFAAPE 326
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627
+D++S GV+ LL+G F +++L +
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSP---------------FGGENDDETLRNVKSC 371
Query: 628 HV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ +++ I K + L + R T+ +
Sbjct: 372 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 9e-27
Identities = 67/284 (23%), Positives = 114/284 (40%), Gaps = 42/284 (14%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
T+ Y LG+G V + + + G+ A K+ + E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSD 504
H N+V+L E L+++ + G LF+ + + +E + ++ +
Sbjct: 69 HPNIVRLHDSI-SEEGHHYLIFDLVTGGELFEDIVAREYYSEA-----DAS-HCIQQILE 121
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTF 561
AV + H + HR++K N+LL K + K++DFG + + +Q GT
Sbjct: 122 AVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTP 177
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
GYL PE R + + D+++ GV+L LL G F + L
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVILYILLVG-----YPPF-----------WDEDQHRL 221
Query: 622 FE-ILDAHVLKEASQEDIVTV-AK-LTNRCLNLNGKKRPTMKEV 662
++ I + + D VT AK L N+ L +N KR T E
Sbjct: 222 YQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 46/288 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESK---VDEFINEVAILS 445
D+Y+T LG G V K + G A IKK + + ++ EV+IL
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 446 QINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNE--EFPITWEIRLRIAIEV 502
+I H NV+ L E + + L+ E + G LF +L ++ E T ++ ++
Sbjct: 70 EIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK-----QI 123
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA----KVSDFGASRSMAIDQTHMTTQVQ 558
+ V YLHS I H D+K NI+L + K+ DFG + ID + +
Sbjct: 124 LNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 178
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--FLRAM 616
GT ++ PE ++D++S GV+ LL+G FL
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----------------ASPFLGDT 221
Query: 617 KEDSLFEILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
K+++L + + ++ + +AK R L + KKR T+++
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 68/293 (23%), Positives = 120/293 (40%), Gaps = 43/293 (14%)
Query: 384 FTSKELETATDHYNTNR--ILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESKVDEF 437
+ + Y ++ ILG G G V+K A G +A IK + D +E
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEV 133
Query: 438 INEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPIT-WEIR 495
NE+++++Q++H N+++L E++ + LV E++ G LF + D++ T +
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTI 190
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA--KVSDFGASRSMAIDQTHM 553
++ + + ++H I H D+K NIL + K+ DFG +R
Sbjct: 191 -LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARR--YKPREK 244
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY-- 611
GT +L PE + +D++S GV+ LL+G
Sbjct: 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-----------------LSP 287
Query: 612 FLRAMKEDSLFEILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
FL ++L IL L++ +DI AK ++ L R + E
Sbjct: 288 FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEA 340
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 70/287 (24%), Positives = 112/287 (39%), Gaps = 44/287 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESK---VDEFINEVAILS 445
DHY LG G V K G+ A IKK ++ + +E EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 446 QINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNE--EFPITWEIRLRIAIEV 502
+I H N++ L E + + L+ E + G LF +L ++ E T ++ ++
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-----QI 117
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA----KVSDFGASRSMAIDQTHMTTQVQ 558
D V YLHS I H D+K NI+L K K+ DFG + +
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIF- 172
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
GT ++ PE ++D++S GV+ LL+G + F + +
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----ASPFLGE-----------TK 216
Query: 619 DSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
I + E + +AK R L + K+R T+ +
Sbjct: 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 46/290 (15%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESKVDEFINEVA 442
+ +D + LG+G VY+ + A +KK+ E+
Sbjct: 46 SNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIG 100
Query: 443 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRI 498
+L +++H N++KL ET + LV E + G LF + ++ +E +
Sbjct: 101 VLLRLSHPNIIKLKEIF-ETPTEISLVLELVTGGELFDRIVEKGYYSER-----DAA-DA 153
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTT 555
++ +AV+YLH I HRD+K N+L K++DFG S+ + Q M T
Sbjct: 154 VKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKT 209
Query: 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615
GT GY PE R + + D++S G++ LL G F +++
Sbjct: 210 VC-GTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG-----FEPFYDERG-------- 255
Query: 616 MKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ +F IL+ +++ AK L + + L+ KKR T +
Sbjct: 256 --DQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 69/339 (20%), Positives = 119/339 (35%), Gaps = 74/339 (21%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESK 433
++ F L Y+ +GQG G V + I AIK K+K+ +
Sbjct: 10 GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69
Query: 434 VDE--FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPIT 491
D EV ++ +++H N+ +L + + LV E G L L+ ++
Sbjct: 70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129
Query: 492 WEIRL-------------------------------------RIAIEVSDAVSYLHSAAS 514
+ + I ++ A+ YLH+
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG- 188
Query: 515 IPIYHRDIKSTNILL--DGKYRAKVSDFGASRSMAI----DQTHMTTQVQGTFGYLDPEY 568
I HRDIK N L + + K+ DFG S+ + MTT+ GT ++ PE
Sbjct: 189 --ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEV 245
Query: 569 FRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE-IL 625
++ + K D +S GV+L LL G F + +L
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMG-----AVPFPGV-----------NDADTISQVL 289
Query: 626 DAHVLKEASQEDIVTV-AK-LTNRCLNLNGKKRPTMKEV 662
+ + E ++++ A+ L + LN N +R
Sbjct: 290 NKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 56/211 (26%), Positives = 89/211 (42%), Gaps = 22/211 (10%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF---INEVAILSQIN 448
++ R +G G G VY + + +VAIKK + +++ I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIING--TLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
H N ++ GC L LV E+ + L + +E I +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH-----GALQGL 167
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
+YLHS I HRD+K+ NILL K+ DFG++ M + V GT ++ P
Sbjct: 168 AYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAP 219
Query: 567 E---YFRSSRFTEKSDVYSFGVVLAELLTGE 594
E ++ K DV+S G+ EL +
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 73/288 (25%), Positives = 114/288 (39%), Gaps = 46/288 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESK---VDEFINEVAILS 445
D Y+ LG G V K + G A IKK + + +E EV+IL
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 446 QINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNE--EFPITWEIRLRIAIEV 502
Q+ H N++ L E + L+ E + G LF +L + E T I+ ++
Sbjct: 71 QVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-----QI 124
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGK----YRAKVSDFGASRSMAIDQTHMTTQVQ 558
D V+YLH+ I H D+K NI+L K K+ DFG + I+ +
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDGVEFKNIF 179
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY--FLRAM 616
GT ++ PE ++D++S GV+ LL+G FL
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-----------------ASPFLGDT 222
Query: 617 KEDSLFEILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
K+++L I E +AK + L +KR T++E
Sbjct: 223 KQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 76/276 (27%), Positives = 120/276 (43%), Gaps = 36/276 (13%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHR 450
HY LG G G V G G VA+K + K+ V + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 451 NVVKLLGCCLETEVPL-LVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAIEVSDAVS 507
+++KL + T +V E++ G LF Y+ H + EE E R R+ ++ AV
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILSAVD 125
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
Y H + HRD+K N+LLD AK++DFG S M+ + T+ G+ Y PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 180
Query: 568 YFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
+ + D++S GV+L LL G F +D+ + F + F I +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP-----F-DDEHVPTLFKKIRGGV--FYIPE 232
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
++ + A L L ++ KR T+K++
Sbjct: 233 -YLNRSV--------ATLLMHMLQVDPLKRATIKDI 259
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 29/202 (14%), Positives = 58/202 (28%), Gaps = 48/202 (23%)
Query: 402 LGQGGQGTVYKGMLAD---GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
G ++ + D R VA+ V+ + + E ++ LS+I+ V ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
L L+V E+I G+L + + +R ++ A H A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 516 PIYHRDIKSTNILL--DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
+ + + + DG + +
Sbjct: 149 GVALSIDHPSRVRVSIDG--DVVL---------------------AYPATMPDA------ 179
Query: 574 FTEKSDVYSFGVVLAELLTGER 595
+ D+ G L LL
Sbjct: 180 -NPQDDIRGIGASLYALLVNRW 200
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 38/280 (13%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN----EVAILSQIN 448
+ ++ + LG+G G V + VA+K ++D + + E+ I +N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVK---IVDMKRAVDCPENIKKEICINKMLN 63
Query: 449 HRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAIEVSDA 505
H NVVK G L E+ G LF + E + + R ++
Sbjct: 64 HENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFFHQLMAG 117
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT--HMTTQVQGTFGY 563
V YLH I HRDIK N+LLD + K+SDFG + + + GT Y
Sbjct: 118 VVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173
Query: 564 LDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
+ PE + F E DV+S G+VL +L GE +++ + ++ +
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP-----WDQPSDSCQEYSDWKEKK-TY 227
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ L ++ L N R T+ ++
Sbjct: 228 LNPWKKIDSAP--------LALLHKILVENPSARITIPDI 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-26
Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 51/293 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKV-----IDESKVDEFINEVAI 443
Y+ ++G+G V + + A G A+K + E + E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 444 LSQI-NHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRI 498
L Q+ H +++ L+ E+ + LV++ + G LF YL ++ +E+ E R I
Sbjct: 153 LRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SI 205
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
+ +AVS+LH+ I HRD+K NILLD + ++SDFG S + + +
Sbjct: 206 MRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC- 260
Query: 559 GTFGYLDPEYFRSSRF------TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612
GT GYL PE + S ++ D+++ GV+L LL G F
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG-----SPPFWHR------- 308
Query: 613 LRAMKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
++ + I++ +D + K L +R L ++ + R T ++
Sbjct: 309 ----RQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 11/205 (5%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN--EVAILSQINHR 450
+ Y +G+G G V+K G+IVAIKK ++ V + I E+ +L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+V LL LV+E+ + T+ L P ++ I + AV++ H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEH-LVK-SITWQTLQAVNFCH 119
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY-F 569
HRD+K NIL+ K+ DFG +R + + +V T Y PE
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLV 175
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGE 594
+++ DV++ G V AELL+G
Sbjct: 176 GDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 50/211 (23%), Positives = 90/211 (42%), Gaps = 19/211 (9%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFIN-EVAILSQINH 449
Y +LG+G G V + + A+K K K+ + + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 450 RNVVKLLG-CCLETEVPL-LVYEFIINGT--LFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
+NV++L+ E + + +V E+ + G + + + FP+ + ++ D
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--PEKRFPV-CQAH-GYFCQLIDG 121
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM-AIDQTHMTTQVQGTFGYL 564
+ YLHS I H+DIK N+LL K+S G + ++ QG+ +
Sbjct: 122 LEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178
Query: 565 DPEYFRSSRFTE--KSDVYSFGVVLAELLTG 593
PE K D++S GV L + TG
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTG 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN--EVAILSQINHR 450
+ Y ++G+G G V K GRIVAIKK D+ K+ + I E+ +L Q+ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+V LL C + + LV+EF+ + T+ L ++ + ++ + + + H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQ-VVQ-KYLFQIINGIGFCH 141
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY-F 569
S I HRDIK NIL+ K+ DFG +R++A +V T Y PE
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLV 197
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGE 594
++ + DV++ G ++ E+ GE
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 67/297 (22%), Positives = 119/297 (40%), Gaps = 39/297 (13%)
Query: 380 KSKLFTSKELETATDHYN-TNRILGQGGQGTVYKGM-LADGRIVA---IKKSKVIDESKV 434
++ + +E + Y T++ LG+G V + + + G+ A +KK + + +
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCR- 72
Query: 435 DEFINEVAILSQINHR-NVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITW 492
E ++E+A+L V+ L E + L+ E+ G +F + E
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSEN 131
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDFGASRSMAID 549
++ R+ ++ + V YLH I H D+K NILL Y K+ DFG SR I
Sbjct: 132 DVI-RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IG 185
Query: 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609
++ GT YL PE T +D+++ G++ LLT
Sbjct: 186 HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH---------------- 229
Query: 610 AY--FLRAMKEDSLFEILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
F+ +++ I +V E + + +A L N +KRPT +
Sbjct: 230 -TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEIC 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (263), Expect = 6e-25
Identities = 58/207 (28%), Positives = 105/207 (50%), Gaps = 16/207 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQIN 448
+ Y +G+G G VYK + GRIVA+K+ ++ E DE I E+++L +++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTAIREISLLKELH 77
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
H N+V L+ LV+EF+ L + L + + +I++ ++ V++
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFM-EKDLKKVLDENKTGLQDS-QIKI-YLYQLLRGVAH 134
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
H I HRD+K N+L++ K++DFG +R+ I T +V T Y P+
Sbjct: 135 CHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDV 190
Query: 569 -FRSSRFTEKSDVYSFGVVLAELLTGE 594
S +++ D++S G + AE++TG+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 65/240 (27%), Positives = 107/240 (44%), Gaps = 37/240 (15%)
Query: 373 STEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES 432
+ K K E Y +++G G G V++ L + VAIK KV+ +
Sbjct: 19 DDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDK 76
Query: 433 KVDEFIN-EVAILSQINHRNVVKLLGCCLET-----EVPL-LVYEFIINGTLFQYLHD-- 483
F N E+ I+ + H NVV L EV L LV E+ + T+++
Sbjct: 77 ---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY-VPETVYRASRHYA 132
Query: 484 -QNEEFPITWEIR------LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRA 535
+ P+ I+ LR +++Y+HS I HRDIK N+LLD
Sbjct: 133 KLKQTMPML-LIKLYMYQLLR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVL 181
Query: 536 KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
K+ DFG+++ + + + + + Y PE F ++ +T D++S G V+AEL+ G+
Sbjct: 182 KLIDFGSAKILIAGEP-NVSYI-CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-24
Identities = 71/276 (25%), Positives = 115/276 (41%), Gaps = 36/276 (13%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHR 450
HY LG G G V G G VA+K + K+ V + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 451 NVVKLLGCCLETEVPL-LVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAIEVSDAVS 507
+++KL + T + +V E++ G LF Y+ + + +E E R R+ ++ V
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILSGVD 130
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
Y H + HRD+K N+LLD AK++DFG S M+ + T+ G+ Y PE
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE 185
Query: 568 YFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
+ + D++S GV+L LL G F +D + F + F
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP-----F-DDDHVPTLFKKICDGI--FYTPQ 237
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
++ L L ++ KR T+K++
Sbjct: 238 -YLNPSV--------ISLLKHMLQVDPMKRATIKDI 264
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 56/224 (25%), Positives = 92/224 (41%), Gaps = 26/224 (11%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFIN 439
KE+ D + +++G+G V + G++ A+K K ++ +V F
Sbjct: 54 KEVRLQRDDFEILKVIGRGAFSEV---AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI 498
E +L + R + +L + E L LV E+ + G L L E P R
Sbjct: 111 ERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARF 166
Query: 499 -AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557
E+ A+ +H + HRDIK NILLD +++DFG+ + D T +
Sbjct: 167 YLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA 223
Query: 558 QGTFGYLDPEYFRSSRFTEKSDVY-------SFGVVLAELLTGE 594
GT YL PE ++ + Y + GV E+ G+
Sbjct: 224 VGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 52/218 (23%), Positives = 96/218 (44%), Gaps = 21/218 (9%)
Query: 389 LETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEFINEVAI-LS 445
+E D LG+G G V K + G+I+A+K+ + ++ + + ++ I +
Sbjct: 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 446 QINHRNVVKLLGCCL-ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
++ V G E +V + E + Y ++ I +I +IA+ +
Sbjct: 62 TVDCPFTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS----RSMAIDQTHMTTQVQGT 560
A+ +LHS S+ I HRD+K +N+L++ + K+ DFG S +A G
Sbjct: 121 ALEHLHSKLSV-I-HRDVKPSNVLINALGQVKMCDFGISGYLVDDVA-----KDIDA-GC 172
Query: 561 FGYLDPE----YFRSSRFTEKSDVYSFGVVLAELLTGE 594
Y+ PE ++ KSD++S G+ + EL
Sbjct: 173 KPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQIN 448
+ Y+ +G+G G VYK G A+KK ++ E DE I E++IL ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELK 58
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
H N+VKL + +LV+E + + L + L + +++ + ++Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESV-TAKS-FLLQLLNGIAY 115
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
H + HRD+K N+L++ + K++DFG +R+ I T ++ T Y P+
Sbjct: 116 CHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDV 171
Query: 569 -FRSSRFTEKSDVYSFGVVLAELLTGE 594
S +++ D++S G + AE++ G
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 61/303 (20%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVI--------------------- 429
Y +G+G G V D A+K K K+I
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 430 --DESKVDEFINEVAILSQINHRNVVKL---LGCCLETEVPLLVYEFIINGTLFQYLHDQ 484
+++ E+AIL +++H NVVKL L E + +V+E + G + + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132
Query: 485 --NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
+E+ + R ++ + YLH I HRDIK +N+L+ K++DFG
Sbjct: 133 PLSED-----QAR-FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT---EKSDVYSFGVVLAELLTGERAIRV 599
S ++ V GT ++ PE +R + DV++ GV L + G +
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG----QC 238
Query: 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659
F D+ + + + E D + +++ + L R L+ N + R +
Sbjct: 239 P-F-MDERIMCLHSKIKSQA--LEFPDQPDI---AED----LKDLITRMLDKNPESRIVV 287
Query: 660 KEV 662
E+
Sbjct: 288 PEI 290
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 73/301 (24%), Positives = 120/301 (39%), Gaps = 49/301 (16%)
Query: 393 TDHYNTNR-ILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQI 447
D Y +LG+G V + L + A+K K S+V EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRV---FREVEMLYQC 67
Query: 448 -NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVS 503
HRNV++L+ E + LV+E + G++ ++H + NE E + +V+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVA 121
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSM-------AIDQTHM 553
A+ +LH+ I HRD+K NIL + + K+ DF + I +
Sbjct: 122 SALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKS-----DVYSFGVVLAELLTGERAIRVTNF----EE 604
T G+ Y+ PE + D++S GV+L LL+G F
Sbjct: 179 LTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG-----YPPFVGRCGS 232
Query: 605 DKSLAAYFLRAMKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKE 661
D ++ LFE I + + I AK L ++ L + K+R + +
Sbjct: 233 DCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQ 292
Query: 662 V 662
V
Sbjct: 293 V 293
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 49/217 (22%), Positives = 94/217 (43%), Gaps = 17/217 (7%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEFINEVAIL 444
+ + + +G G G V+K G ++A+K+ + ++ + + ++ ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV 77
Query: 445 -SQINHRNVVKLLGCCL-ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
+ +V+ G + T+V + E + Q PI I ++ + +
Sbjct: 78 LKSHDCPYIVQCFGTFITNTDV-FIAMELMGTCAEKLKKRMQG---PIPERILGKMTVAI 133
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
A+ YL + I HRD+K +NILLD + + K+ DFG S + +D G
Sbjct: 134 VKALYYLKEKHGV-I-HRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSA-GCAA 189
Query: 563 YLDPE-----YFRSSRFTEKSDVYSFGVVLAELLTGE 594
Y+ PE + ++DV+S G+ L EL TG+
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 66/276 (23%), Positives = 110/276 (39%), Gaps = 37/276 (13%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINHR 450
Y LG+G G V + VA+K + + E++ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 451 NVVKLLGCCLETEVPL-LVYEFIINGTLFQYL--HDQNEEFPITWEIRLRIAIEVSDAVS 507
+++KL + T + +V E+ G LF Y+ + E E R R ++ A+
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED----EGR-RFFQQIICAIE 122
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
Y H I HRD+K N+LLD K++DFG S M T+ G+ Y PE
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE 177
Query: 568 YFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
+ + DV+S G+VL +L G F +D+ + F + + + D
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLP-----F-DDEFIPNLFKKVNSCV--YVMPD 229
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ A L R + + +R T++E+
Sbjct: 230 -FLSPGA--------QSLIRRMIVADPMQRITIQEI 256
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 74/300 (24%), Positives = 115/300 (38%), Gaps = 70/300 (23%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHR 450
+ ++G G G VYKG + G++ AIK V + +E E+ +L + +HR
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGDEEEEIKQEINMLKKYSHHR 81
Query: 451 NVVKLLGCCLETEVPL------LVYEF--------IINGTLFQYLHDQNEEFPITWEIRL 496
N+ G ++ P LV EF +I T L EE+
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEW-------- 130
Query: 497 RIAI---EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
IA E+ +S+LH I HRDIK N+LL K+ DFG S +
Sbjct: 131 -IAYICREILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 554 TTQVQGTFGYLDPE-----YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608
T + GT ++ PE + + KSD++S G+ E+ G
Sbjct: 187 NTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA-------------- 231
Query: 609 AAYF-LRAMKEDSLFEIL--DAHVLKEA--SQE--DIVTVAKLTNRCLNLNGKKRPTMKE 661
+ M+ +LF I A LK S++ + CL N +RP ++
Sbjct: 232 PPLCDMHPMR--ALFLIPRNPAPRLKSKKWSKKFQSFI------ESCLVKNHSQRPATEQ 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-24
Identities = 52/211 (24%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQI 447
Y +G+G GTV+K IVA+K+ ++ D+ DE + E+ +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKEL 58
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
H+N+V+L + LV+EF + L +Y N + ++ ++ +
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPE-IVKS-FLFQLLKGLG 115
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
+ HS + HRD+K N+L++ K+++FG +R+ I + +V T Y P+
Sbjct: 116 FCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPD 171
Query: 568 Y-FRSSRFTEKSDVYSFGVVLAELLTGERAI 597
F + ++ D++S G + AEL R +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-24
Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 19/225 (8%)
Query: 380 KSKLFTSKELETATDHYNTNRILGQGGQGTVYK-GMLADGRIVAIK---KSKVIDESKVD 435
K + ++L + Y +++G+G G V + ++ A+K K ++I S
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEI 494
F E I++ N VV+L + + L +V E++ G L + N + P E
Sbjct: 115 FFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVP---EK 168
Query: 495 RLRI-AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
R EV A+ +HS + HRD+K N+LLD K++DFG M +
Sbjct: 169 WARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225
Query: 554 TTQVQGTFGYLDPEYFRS----SRFTEKSDVYSFGVVLAELLTGE 594
GT Y+ PE +S + + D +S GV L E+L G+
Sbjct: 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 55/222 (24%), Positives = 98/222 (44%), Gaps = 24/222 (10%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV-IDESKVDEFINEVAI- 443
+ + + +G+G G+V K + G+I+A+K+ + +DE + + + ++ +
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV 74
Query: 444 LSQINHRNVVKLLGCCL-ETEVPLLVYEFIINGTLFQYLHDQNEEF--PITWEIRLRIAI 500
+ + +V+ G E + + E + + + ++ I EI +I +
Sbjct: 75 MRSSDCPYIVQFYGALFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITL 132
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS----RSMAIDQTHMTTQ 556
A+++L I HRDIK +NILLD K+ DFG S S+A T
Sbjct: 133 ATVKALNHLKENLKI--IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA-----KTRD 185
Query: 557 VQGTFGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGE 594
G Y+ PE S + +SDV+S G+ L EL TG
Sbjct: 186 A-GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-24
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
R+LG+GG G V + G++ A K K ++ +NE IL ++N R VV L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 456 LGCCLETEVPL-LVYEFIINGTLFQYLHDQNEE-FPITWEIRLRI-AIEVSDAVSYLHSA 512
ET+ L LV + G L +++ + FP E R A E+ + LH
Sbjct: 250 -AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCGLEDLHRE 305
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
I +RD+K NILLD ++SD G + + QT GT GY+ PE ++
Sbjct: 306 R---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMAPEVVKNE 360
Query: 573 RFTEKSDVYSFGVVLAELLTG 593
R+T D ++ G +L E++ G
Sbjct: 361 RYTFSPDWWALGCLLYEMIAG 381
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 38/221 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFIN-EVAILSQINHR 450
Y +++G G G VY+ L D G +VAIKK V+ + + F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK--VLQDKR---FKNRELQIMRKLDHC 107
Query: 451 NVVKLLGCCLET-----EVPL-LVYEFIINGTLFQYLHD---QNEEFPITWEIR------ 495
N+V+L + EV L LV +++ T+++ + P+ ++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVI-YVKLYMYQL 165
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQTHMT 554
R +++Y+HS I HRDIK N+LLD K+ DFG+++ + +
Sbjct: 166 FR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NV 214
Query: 555 TQVQGTFGYLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
+ + + Y PE F ++ +T DV+S G VLAELL G+
Sbjct: 215 SYI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 52/201 (25%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKL 455
R+LG+GG G V+ + G++ A K K ++ + E IL++++ R +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 456 LGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAA 513
ET+ L LV + G + ++++ +E+ P E R ++ + +LH
Sbjct: 251 A-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN 309
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I +RD+K N+LLD ++SD G + + QT GT G++ PE
Sbjct: 310 ---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGEE 365
Query: 574 FTEKSDVYSFGVVLAELLTGE 594
+ D ++ GV L E++
Sbjct: 366 YDFSVDYFALGVTLYEMIAAR 386
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 54/204 (26%), Positives = 98/204 (48%), Gaps = 10/204 (4%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDE-FINEVAILSQINHRN 451
+ Y LG+G TVYKG +VA+K+ ++ E I EV++L + H N
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+V L + LV+E++ + L QYL D + ++L ++ ++Y H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMH-NVKL-FLFQLLRGLAYCHR 118
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY-FR 570
+ HRD+K N+L++ + K++DFG +R+ +I +V T Y P+
Sbjct: 119 QK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLG 174
Query: 571 SSRFTEKSDVYSFGVVLAELLTGE 594
S+ ++ + D++ G + E+ TG
Sbjct: 175 STDYSTQIDMWGVGCIFYEMATGR 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 60/211 (28%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
D Y+ + +G G G +VA+K + IDE V E+ + H
Sbjct: 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQ---REIINHRSLRH 75
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDA 505
N+V+ + T L ++ E+ G L++ + + +E+ E R ++
Sbjct: 76 PNIVRFKEV-ILTPTHLAIIMEYASGGELYERICNAGRFSED-----EAR-FFFQQLLSG 128
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKY--RAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
VSY HS I HRD+K N LLDG R K+ DFG S+S + +T GT Y
Sbjct: 129 VSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAY 183
Query: 564 LDPEYFRSSRFT-EKSDVYSFGVVLAELLTG 593
+ PE + + +DV+S GV L +L G
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 61/200 (30%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQINHRNVVKL 455
LG+G TVYK +IVAIKK K+ S+ + IN E+ +L +++H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 456 LGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASI 515
L LV++F+ L + D + + I+ + + YLH
Sbjct: 78 LDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPS-HIKA-YMLMTLQGLEYLHQHW-- 132
Query: 516 PIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY-FRSSRF 574
I HRD+K N+LLD K++DFG ++S T QV T Y PE F + +
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMY 190
Query: 575 TEKSDVYSFGVVLAELLTGE 594
D+++ G +LAELL
Sbjct: 191 GVGVDMWAVGCILAELLLRV 210
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 55/236 (23%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 375 EGNIDKSKLFTS--KELETATDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---K 425
++ +K FTS K++ + + +++G+G G V + ++ A+K K
Sbjct: 53 LEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNK 109
Query: 426 SKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQ 484
+++ ++ F E +L + + + L + + L LV ++ + G L L
Sbjct: 110 WEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKF 168
Query: 485 NEEFPITWEIRLRI-AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543
+ P E R E+ A+ +H + HRDIK NIL+D +++DFG+
Sbjct: 169 EDRLP---EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSC 222
Query: 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKS-----DVYSFGVVLAELLTGE 594
+ D T ++ GT Y+ PE ++ + D +S GV + E+L GE
Sbjct: 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-23
Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 19/211 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
DH+ R +G+G G V D ++ A+K K K ++ ++V E+ I+ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 450 RNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVS 507
+V L + E + +V + ++ G L +L QN F E +++ E+ A+
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALD 129
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
YL + I HRD+K NILLD ++DF + + + T + GT Y+ PE
Sbjct: 130 YLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPE 184
Query: 568 YFRSSRFTEKS---DVYSFGVVLAELLTGER 595
F S + S D +S GV ELL G R
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 53/213 (24%), Positives = 104/213 (48%), Gaps = 17/213 (7%)
Query: 391 TATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILS 445
+++ + LG G TVYKG+ G VA+K+ K+ E + I E++++
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMK 58
Query: 446 QINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF---PITWEIRLRIAIEV 502
++ H N+V+L LV+EF+ + L +Y+ + + + ++
Sbjct: 59 ELKHENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
+++ H I HRD+K N+L++ + + K+ DFG +R+ I +++V T
Sbjct: 118 LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLW 173
Query: 563 YLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
Y P+ S ++ D++S G +LAE++TG+
Sbjct: 174 YRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 98.0 bits (245), Expect = 2e-22
Identities = 59/217 (27%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 392 ATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN-----EVAILS 445
AT Y +G G GTVYK G VA+K +V + + EVA+L
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 446 QIN---HRNVVKLLGCCLETEVPL-----LVYEFIINGTLFQYLHDQNEEFPITWEIRLR 497
++ H NVV+L+ C + LV+E + + L YL I+
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIK-D 124
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557
+ + + +LH+ I HRD+K NIL+ K++DFG +R + +T V
Sbjct: 125 LMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPVV 180
Query: 558 QGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
T Y PE S + D++S G + AE+ +
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQI 447
D Y LG+G G VYK + VAIK+ ++ E +E + EV++L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKEL 90
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
HRN+++L L++E+ L +Y+ D+N + + I+ ++ + V+
Sbjct: 91 QHRNIIELKSVIHHNHRLHLIFEY-AENDLKKYM-DKNPDVSMR-VIK-SFLYQLINGVN 146
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRA-----KVSDFGASRSMAIDQTHMTTQVQGTFG 562
+ HS HRD+K N+LL + K+ DFG +R+ I T ++ T
Sbjct: 147 FCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLW 202
Query: 563 YLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
Y PE S ++ D++S + AE+L
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 62/236 (26%), Positives = 103/236 (43%), Gaps = 25/236 (10%)
Query: 367 LQQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLA----DGRIVA 422
+++ LA + + K S+ ++ + LG G G V ML G A
Sbjct: 15 VKEFLAKAKEDFLKKWETPSQNTAQLDQ-FDRIKTLGTGSFGRV---MLVKHKESGNHYA 70
Query: 423 IK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLF 478
+K K KV+ +++ +NE IL +N +VKL + L +V E++ G +F
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMF 129
Query: 479 QYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537
+L F E R A ++ YLHS + +RD+K N+L+D + +V
Sbjct: 130 SHLRRIGR-FS---EPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQV 182
Query: 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
+DFG A T + GT L PE S + + D ++ GV++ E+ G
Sbjct: 183 TDFG----FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 5e-22
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+ + ++LG+G G V +L GR A+K K ++ + +V + E +L
Sbjct: 148 NEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSD 504
H + L +T L V E+ G LF +L + F E R R E+
Sbjct: 205 SRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS-RERVFS---EDRARFYGAEIVS 259
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
A+ YLHS ++ +Y RD+K N++LD K++DFG + I GT YL
Sbjct: 260 ALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYL 316
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + + D + GVV+ E++ G
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 63/282 (22%), Positives = 110/282 (39%), Gaps = 37/282 (13%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRN 451
D+ T+++LG G G V + A+K ++ + EV + + +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVELHWRASQCPH 116
Query: 452 VVKLLGCCLETEVP-----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
+V+++ E L+V E + G LF + D+ ++ E I + +A+
Sbjct: 117 IVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS-EIMKSIGEAI 174
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTFGY 563
YLHS I I HRD+K N+L K K++DFG ++ + +TT T Y
Sbjct: 175 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-YTPYY 229
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
+ PE ++ + D++S GV++ LL G F + LA +
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCG-----YPPFYSNHGLAI-------SPGMKT 277
Query: 624 -ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
I ++ K L L +R T+ E
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 37/283 (13%)
Query: 393 TDHYNTNR-ILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NH 449
TD Y ++ +LG G G V + G+ A+K ++ + EV Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALK---LLY--DSPKARQEVDHHWQASGG 81
Query: 450 RNVVKLLGCCLETEVP----LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
++V +L L++ E + G LF + ++ ++ E I ++ A
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA-EIMRDIGTA 140
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHMTTQVQGTFG 562
+ +LHS I HRD+K N+L K + K++DFG ++ Q + T T
Sbjct: 141 IQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE--TTQNALQTPC-YTPY 194
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
Y+ PE ++ + D++S GV++ LL G F + A +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCG-----FPPFYSNTGQAI-------SPGMK 242
Query: 623 E-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
I ++ AK L L + +R T+ +
Sbjct: 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 2e-21
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 400 RILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEVAILSQIN---HRNV 452
RI+G+GG G VY AD G++ A+K K ++ + +NE +LS ++ +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 453 VKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYLH 510
V + T L + + + G L +L Q+ F E +R A E+ + ++H
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS---EADMRFYAAEIILGLEHMH 309
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YF 569
+ + +RD+K NILLD ++SD G + + + H V GT GY+ PE
Sbjct: 310 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQ 363
Query: 570 RSSRFTEKSDVYSFGVVLAELLTG 593
+ + +D +S G +L +LL G
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRG 387
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 6e-21
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 25/216 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKG--MLADGRIVAIKKSKVIDESKVDEFIN-----EVAILSQ 446
Y +G+G G V+K + GR VA+K+ +V +E + EVA+L
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMPLSTIREVAVLRH 67
Query: 447 IN---HRNVVKLLGCCLETEVPL-----LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI 498
+ H NVV+L C + LV+E + + L YL E T I+ +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIK-DM 125
Query: 499 AIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
++ + +LHS + HRD+K NIL+ + K++DFG +R + +T+ V
Sbjct: 126 MFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSVVV 181
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
T Y PE S + D++S G + AE+ +
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 6e-21
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 27/219 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEF----INEVAILSQIN 448
Y +GQG G V+K G+ VA+KK + E++ + F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM--ENEKEGFPITALREIKILQLLK 74
Query: 449 HRNVVKLLGCCLETEVPL--------LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAI 500
H NVV L+ C P LV++F + L L + +F ++ EI+ R+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQ 131
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI----DQTHMTTQ 556
+ + + Y+H I HRD+K+ N+L+ K++DFG +R+ ++ T +
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 557 VQGTFGYLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
V T Y PE + D++ G ++AE+ T
Sbjct: 189 VV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 52/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHR 450
D Y R LG+G V++ + + + V +K K + + K+ E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKI---KREIKILENLRGGP 91
Query: 451 NVVKLLGCCL--ETEVPLLVYEFIING---TLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
N++ L + P LV+E + N L+Q L D + F +EI L+ A
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRF-YMYEI-LK-------A 142
Query: 506 VSYLHSAASIPIYHRDIKSTNILLDGKYRA-KVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ Y HS I HRD+K N+++D ++R ++ D+G + +V + +
Sbjct: 143 LDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-YHPGQEYNVRV-ASRYFK 197
Query: 565 DPEYFRSSRFTEKS-DVYSFGVVLAELLTGERAI 597
PE + + S D++S G +LA ++ +
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 26/212 (12%)
Query: 402 LGQGGQGTVYKGM---LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGC 458
+G+G G VYK D + A+K+ + E+A+L ++ H NV+ L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIALLRELKHPNVISLQKV 86
Query: 459 CLE-TEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVS------DAVSYLH 510
L + + L++++ L+ + ++L + S D + YLH
Sbjct: 87 FLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 511 SAASIPIYHRDIKSTNILLDGKYRA----KVSDFGASRSMAI---DQTHMTTQVQGTFGY 563
+ + HRD+K NIL+ G+ K++D G +R + V TF Y
Sbjct: 146 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWY 201
Query: 564 LDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + +T+ D+++ G + AELLT E
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 59/226 (26%), Positives = 90/226 (39%), Gaps = 39/226 (17%)
Query: 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKK--SKVIDESKVDEFIN---------EV 441
Y R + G G V G+ ++G VAIK+ + V D V+ + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 442 AILSQINHRNVVKLLGCCLETEVPL-----LVYEFIINGT-LFQYLHDQNEEFP------ 489
+L+ +H N++ L + E P LV E + T L Q +HDQ
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVIHDQRIVISPQHIQY 138
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549
+ I L + LH A + HRD+ NILL + DF +R D
Sbjct: 139 FMYHI-LL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTAD 187
Query: 550 QTHMTTQVQGTFGYLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
+ T V Y PE + FT+ D++S G V+AE+ +
Sbjct: 188 A-NKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 21/210 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+ ++ ++LG+G G V +L GR A+K K +I + +V + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSD 504
H + L +T L V E+ G LF +L + F E R R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVS 116
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
A+ YLHS + +RDIK N++LD K++DFG + I GT YL
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 172
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + + D + GVV+ E++ G
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 4e-20
Identities = 59/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
++ R++G+G V +L RI A+K K V D+ +D E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 447 I-NHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVS 503
NH +V L C +TE L V E++ G L ++ + + P E R + E+S
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 120
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
A++YLH I +RD+K N+LLD + K++D+G + + T+ GT Y
Sbjct: 121 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNY 176
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ PE R + D ++ GV++ E++ G
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 5e-20
Identities = 54/222 (24%), Positives = 98/222 (44%), Gaps = 34/222 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEF--INEVAILSQINH 449
D + R+ GQG GTV G G VAIKK + + + + L+ ++H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKK---VIQDPRFRNRELQIMQDLAVLHH 78
Query: 450 RNVVKLL------GCCLETEVPL-LVYEFIINGTLFQYL-HDQNEEFPITWE-IR----- 495
N+V+L G ++ L +V E++ TL + + + I+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 496 -LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQTHM 553
+R ++ LH S+ + HRDIK N+L++ K+ DFG+++ ++ +
Sbjct: 138 LIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP-N 188
Query: 554 TTQVQGTFGYLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
+ + Y PE F + +T D++S G + AE++ GE
Sbjct: 189 VAYICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 5e-20
Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 26/210 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+ R LG G G V L +GR A+K K V+ +V+ +E +LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEE-FPITWEIRLRI-AIEVS 503
+ H ++++ G + + ++ ++I G LF L + + FP + A EV
Sbjct: 63 VTHPFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLL--RKSQRFP---NPVAKFYAAEVC 116
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
A+ YLHS I +RD+K NILLD K++DFG A +T + GT Y
Sbjct: 117 LALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG----FAKYVPDVTYTLCGTPDY 169
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
+ PE + + + D +SFG+++ E+L G
Sbjct: 170 IAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 9e-20
Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 19/209 (9%)
Query: 394 DHYNTNRILGQGGQGTVY----KGMLADGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+ ++LGQG G V+ ++ A+K K+ + +V E IL +
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDILVE 82
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSD 504
+NH +VKL +TE L L+ +F+ G LF L + F E ++ E++
Sbjct: 83 VNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS-KEVMFT---EEDVKFYLAELAL 137
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
A+ +LHS I +RD+K NILLD + K++DFG S+ +ID GT Y+
Sbjct: 138 ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYM 193
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
PE T+ +D +SFGV++ E+LTG
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTG 222
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 1e-19
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
++ R++G+G V +L RI A++ K V D+ +D E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 447 I-NHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVS 503
NH +V L C +TE L V E++ G L ++ + + P E R + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 163
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
A++YLH I +RD+K N+LLD + K++D+G + + T+ GT Y
Sbjct: 164 LALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNY 219
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ PE R + D ++ GV++ E++ G
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 34/218 (15%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINH 449
Y + +G G QG V R VAIKK +++ E+ ++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 450 RNVVKLLGCCLETEVPL------LVYEF-------IINGTLFQYLHDQNEEFPITWEIRL 496
+N++ LL + +V E +I L + + + +++ L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ----MELDHERMSY-LLYQM-L 137
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
+ +LHSA I HRD+K +NI++ K+ DFG +R+ MT
Sbjct: 138 C-------GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPY 186
Query: 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
V T Y PE + E D++S G ++ E++ G
Sbjct: 187 V-VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-19
Identities = 53/214 (24%), Positives = 92/214 (42%), Gaps = 26/214 (12%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINH 449
Y + +G G QG V R VAIKK +++ E+ ++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 450 RNVVKLL-----GCCLETEVPL-LVYEFI---INGTLFQYLHDQNEEFPITWEIRLRIAI 500
+N++ LL LE + LV E + + + L + + + +++ L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQM-LC--- 175
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
+ +LHSA I HRD+K +NI++ K+ DFG +R+ MT V T
Sbjct: 176 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPYV-VT 226
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
Y PE + E D++S G ++ E++ +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 25/214 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA-------DGRIVAIK---KSKVIDESK-VDEFINEVA 442
+ + R+LG+GG G V G+I A+K K+ ++ +K E
Sbjct: 17 ECFELLRVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 443 ILSQINHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AI 500
IL ++ H +V L+ +T L L+ E++ G LF L + F E
Sbjct: 74 ILEEVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM---EDTACFYLA 128
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
E+S A+ +LH I +RD+K NI+L+ + K++DFG + +I +T GT
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGT 184
Query: 561 FGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
Y+ PE S D +S G ++ ++LTG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 57/257 (22%), Positives = 102/257 (39%), Gaps = 70/257 (27%)
Query: 389 LETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFIN-EVAILSQ 446
LET++ Y+ + LG G G V + + G+ A+KK V+ + + + N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKK--VLQDPR---YKNRELDIMKV 56
Query: 447 INHRNVVKLLGC-------------------------------------CLETEVPL-LV 468
++H N++KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 469 YEFIINGTLFQYLH---DQNEEFPITWEIR------LRIAIEVSDAVSYLHSAASIPIYH 519
E++ TL + L P+ I R AV ++HS I H
Sbjct: 117 MEYV-PDTLHKVLKSFIRSGRSIPMN-LISIYIYQLFR-------AVGFIHSLG---ICH 164
Query: 520 RDIKSTNILLDGK-YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE-YFRSSRFTEK 577
RDIK N+L++ K K+ DFG+++ + + + + Y PE ++ +T
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-SVAYI-CSRFYRAPELMLGATEYTPS 222
Query: 578 SDVYSFGVVLAELLTGE 594
D++S G V EL+ G+
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINH 449
Y + +G G G+V + G VAIKK +S++ E+ +L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 450 RNVVKLLGCCLETEVPL------LVYEFI---INGTLFQYLHDQNEEFPITWEIRLRIAI 500
NV+ LL LV F+ + + ++ ++ + +++ L+
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-LVYQM-LK--- 137
Query: 501 EVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGT 560
+ Y+HSA + HRD+K N+ ++ K+ DFG +R MT V T
Sbjct: 138 ----GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA---DAEMTGYVV-T 186
Query: 561 FGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
Y PE + + D++S G ++AE+LTG+
Sbjct: 187 RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 55/228 (24%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN---------EVA 442
Y +G+G G V + VAIKK + F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK--------ISPFEHQTYCQRTLREIK 77
Query: 443 ILSQINHRNVVKLLGCCLETEVPL-----LVYEF-------IINGTLFQYLHDQNEEFPI 490
IL + H N++ + + +V + ++ Q+L + + +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT---QHLSNDHICY-F 133
Query: 491 TWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550
++I LR + Y+HSA + HRD+K +N+LL+ K+ DFG +R D
Sbjct: 134 LYQI-LR-------GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
Query: 551 TH---MTTQVQGTFGYLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
H +T V T Y PE S +T+ D++S G +LAE+L+
Sbjct: 183 DHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 56/219 (25%), Positives = 95/219 (43%), Gaps = 36/219 (16%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINH 449
Y + +G G G V + G VAIKK +S++ E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 450 RNVVKLLGCCLETEVPL------LVYEF-------IINGTLFQYLHDQNEEFPITWEIRL 496
NV+ LL E LV F ++ + L + +F + +++ L
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQF-LVYQM-L 138
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
+ + Y+H+A I HRD+K N+ ++ K+ DFG +R + MT
Sbjct: 139 K-------GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTGY 185
Query: 557 VQGTFGYLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
V T Y PE R+T+ D++S G ++AE++TG+
Sbjct: 186 VV-TRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 2e-18
Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 22/205 (10%)
Query: 400 RILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ-INHRN 451
+++G+G G V +LA + A+K K ++ + + ++E +L + + H
Sbjct: 44 KVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 452 VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSDAVSYL 509
+V L +T L V ++I G LF +L + F E R R A E++ A+ YL
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFL---EPRARFYAAEIASALGYL 155
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS I +RD+K NILLD + ++DFG + I+ T+ GT YL PE
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGE 594
+ D + G VL E+L G
Sbjct: 212 HKQPYDRTVDWWCLGAVLYEMLYGL 236
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 3e-18
Identities = 66/211 (31%), Positives = 102/211 (48%), Gaps = 22/211 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
D++ R+LG+G G V MLA G + A+K K ++ + V+ + E ILS
Sbjct: 23 DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 447 I-NHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVS 503
NH + +L CC +T L V EF+ G L ++ ++ F E R R A E+
Sbjct: 80 ARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEII 134
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
A+ +LH I +RD+K N+LLD + K++DFG + I T GT Y
Sbjct: 135 SALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDY 190
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ PE + + D ++ GV+L E+L G
Sbjct: 191 IAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-18
Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 394 DHYNTNRILGQGGQGTVY---KGMLAD-GRIVAIK---KSKVIDESK-VDEFINEVAILS 445
+++ ++LG G G V+ K D G++ A+K K+ ++ ++K + E +L
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 446 QINHRN-VVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEE-FPITWEIRLRI-AIE 501
I +V L +TE L L+ ++I G LF +L E F E ++I E
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHL--SQRERFT---EHEVQIYVGE 167
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
+ A+ +LH I +RDIK NILLD ++DFG S+ D+T GT
Sbjct: 168 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 562 GYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTG 593
Y+ P+ R + D +S GV++ ELLTG
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+N +LG+G G V ML+ + A+K K VI + V+ + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 447 I-NHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVS 503
+ +L C +T L V E++ G L ++ Q F E A E++
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIA 131
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
+ +L S I +RD+K N++LD + K++DFG + I T GT Y
Sbjct: 132 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDY 187
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ PE + + D ++FGV+L E+L G+
Sbjct: 188 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 60/219 (27%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINH 449
+ Y +G G G+V G VA+KK +S + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 450 RNVVKLLGCCLETEVPL------LVYEF-------IINGTLFQYLHDQNEEFPITWEIRL 496
NV+ LL LV I+ Q L D + +F + ++I L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQF-LIYQI-L 142
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ 556
R + Y+HSA I HRD+K +N+ ++ K+ DFG +R A MT
Sbjct: 143 R-------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGY 189
Query: 557 VQGTFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTGE 594
V T Y PE + + D++S G ++AELLTG
Sbjct: 190 VA-TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 1e-17
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+ + +++LG+G G V LA + AIK K V+ + V+ + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 447 -INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVS 503
H + + C +T+ L V E++ G L ++ +F R A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEII 128
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
+ +LHS I +RD+K NILLD K++DFG + + T GT Y
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDY 184
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
+ PE ++ D +SFGV+L E+L G+
Sbjct: 185 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 53/231 (22%), Positives = 99/231 (42%), Gaps = 49/231 (21%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK---SKVIDESKVDEFINEVAILSQIN 448
Y + LG GG G V+ + + VAIKK + + E+ I+ +++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRRLD 66
Query: 449 HRNVVKLL------GCCLETEVPL--------LVYEF-------IINGTLFQYLHDQNEE 487
H N+VK+ G L +V +V E+ ++ L +++
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ---GPLLEEHAR 123
Query: 488 FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSM 546
+++ LR + Y+HSA + HRD+K N+ ++ + K+ DFG +R M
Sbjct: 124 L-FMYQL-LR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 547 AIDQTH---MTTQVQGTFGYLDPE-YFRSSRFTEKSDVYSFGVVLAELLTG 593
+H ++ + T Y P + +T+ D+++ G + AE+LTG
Sbjct: 172 DPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 1e-17
Identities = 54/234 (23%), Positives = 89/234 (38%), Gaps = 55/234 (23%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFIN---------EVA 442
+ + +LG+G G V G IVAIKK ++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 443 ILSQINHRNVVKLLGCCLETEVPL-----LVYEF-------IINGTLFQYLHDQNEEFPI 490
IL H N++ + ++ E +I+ Q L D + ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST---QMLSDDHIQY-F 117
Query: 491 TWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550
++ LR AV LH + + HRD+K +N+L++ KV DFG +R +
Sbjct: 118 IYQT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166
Query: 551 THMTTQVQGTFG---------YLDPEY-FRSSRFTEKSDVYSFGVVLAELLTGE 594
+ G Y PE S++++ DV+S G +LAEL
Sbjct: 167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-17
Identities = 47/241 (19%), Positives = 93/241 (38%), Gaps = 51/241 (21%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQINH 449
D+Y ++G+G G VY + VAIKK + E +D + E+ IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 450 RNVVKLLGCCLETEVPL-----LVYEF-------IINGTLFQYLHDQNEEFPITWEIRLR 497
+++L + ++ +V E + +L +++ + I + + L
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP--IFLTEEHIKT-ILYNL-LL 140
Query: 498 IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQV 557
+++H + I HRD+K N LL+ KV DFG +R++ ++
Sbjct: 141 -------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 558 QGTFGYLDP----------EY------------FRSSRFTEKSDVYSFGVVLAELLTGER 595
P + +T+ D++S G + AELL +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQ 250
Query: 596 A 596
+
Sbjct: 251 S 251
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 4e-17
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 20/210 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
+N +LG+G G V ML+ + A+K K VI + V+ + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 447 INHRNVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRI-AIEVSD 504
+ L C +T L V E++ G L ++ Q F E A E++
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIAI 453
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
+ +L S I +RD+K N++LD + K++DFG + I T GT Y+
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 509
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
PE + + D ++FGV+L E+L G+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 66/343 (19%), Positives = 115/343 (33%), Gaps = 94/343 (27%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK----KSKVIDESKVDEFINEVAIL 444
E D Y + ++G+G G V K + VAIK K ++++++ EV +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLL 104
Query: 445 SQINHR------NVVKLLGC-------CLETEVPLL---VYEFI-INGTLFQYLHDQNEE 487
+N +V L CL E +L +Y+ + F+ +
Sbjct: 105 ELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLLRNTN--FRGVSLNL-- 158
Query: 488 FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL--DGKYRAKVSDFGASRS 545
R + A ++ A+ +L + + I H D+K NILL + K+ DFG S
Sbjct: 159 ------TR-KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG---S 207
Query: 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG------------ 593
+ +Q F Y PE + D++S G +L E+ TG
Sbjct: 208 SCQLGQRIYQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 594 ----------------ERAIRVTNFEEDKSLAAYFLRAMKED----------SLFEILDA 627
++A + F E + L+ K+ L IL
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 628 HVLKEASQEDIVTVAKLTN---------RCLNLNGKKRPTMKE 661
+ + + + R L+ + K R
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 58/292 (19%), Positives = 101/292 (34%), Gaps = 58/292 (19%)
Query: 384 FTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVA 442
K+ D+ T+++LG G G V + A+K ++ + EV
Sbjct: 8 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---MLQ--DCPKARREVE 62
Query: 443 ILSQI-NHRNVVKLLGCCLETEVP-----LLVYEFIINGTLFQYLHDQNEEFPITWEIRL 496
+ + ++V+++ E L+V E + G LF + D+ ++ E
Sbjct: 63 LHWRASQCPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS- 120
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA---KVSDFGASRSMAIDQTHM 553
I + +A+ YLHS I HRD+K N+L K K++DFG
Sbjct: 121 EIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG------------ 165
Query: 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613
E ++ + D++S GV++ LL G F + LA
Sbjct: 166 ----------FAKE-TTGEKYDKSCDMWSLGVIMYILLCG-----YPPFYSNHGLAI--- 206
Query: 614 RAMKEDSLFE-ILDAHV-LKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ I ++ K L L +R T+ E
Sbjct: 207 ----SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 5e-16
Identities = 59/271 (21%), Positives = 106/271 (39%), Gaps = 59/271 (21%)
Query: 368 QQELASTEGNIDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKS 426
+++ S++ + + ++ D Y ++G G G V + + R+VAIKK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 427 KVIDESKVD--EFINEVAILSQINHRNVVKLLGCCLETEVPL-----LVYEF-------I 472
+ E +D + E+AIL+++NH +VVK+L + +V +V E +
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKL 146
Query: 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK 532
YL + + + + + + L V Y+HSA I HRD+K N L++
Sbjct: 147 FRTP--VYLTELHIKT-LLYNL-LV-------GVKYVHSAG---ILHRDLKPANCLVNQD 192
Query: 533 YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP---------------EY--------- 568
KV DFG +R++ + + +
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252
Query: 569 ---FRSSRFTEKSDVYSFGVVLAELLTGERA 596
+TE DV+S G + AELL +
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKE 283
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-16
Identities = 48/230 (20%), Positives = 89/230 (38%), Gaps = 49/230 (21%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIK--KSK------VIDESKVDEFINEVAILSQ 446
Y R LG G TV+ + + VA+K + DE K+ + +N+ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 447 --INHRNVVKLLGC-----------CLETEVPLL---VYEFIINGTLFQYLHDQNEEFPI 490
+ +++KLL + E +L + I + E I
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALIK----------KYEHRGI 128
Query: 491 TWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD------GKYRAKVSDFGASR 544
+I+ ++ + Y+H I I H DIK N+L++ + K++D G +
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186
Query: 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE 594
H T +Q Y PE + + +D++S ++ EL+TG+
Sbjct: 187 W---YDEHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 61/241 (25%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVD--EFINEVAILSQIN- 448
Y + LG+G G V+K + G +VA+KK ++ D E+ IL++++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSG 67
Query: 449 HRNVVKLLGCCLETEVPL--------LVYEF-------IINGTLFQYLHDQNEEFPITWE 493
H N+V LL V LV+++ +I L ++++ + ++
Sbjct: 68 HENIVNLL------NVLRADNDRDVYLVFDYMETDLHAVIRA---NILEPVHKQY-VVYQ 117
Query: 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553
+ ++ + YLHS + HRD+K +NILL+ + KV+DFG SRS +
Sbjct: 118 L-IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 554 TTQVQGTFGYLDP---------EY------------FRSSRFTEKSDVYSFGVVLAELLT 592
+ +Y S+++T+ D++S G +L E+L
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226
Query: 593 G 593
G
Sbjct: 227 G 227
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 3e-15
Identities = 71/331 (21%), Positives = 111/331 (33%), Gaps = 89/331 (26%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIK----KSKVIDESKVDEFINEVAILSQINHR 450
Y +++G+G G V K + VA+K + + ++ E+ IL + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEHLRKQ 153
Query: 451 ------NVVKLLGC-------CLETEVPLL---VYEFIINGTLFQYLHDQNEEFPITWEI 494
NV+ +L C+ E LL +YE I FQ +
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNK-FQGFSLP--------LV 202
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL--DGKYRAKVSDFGASRSMAIDQTH 552
R + A + + LH I H D+K NILL G+ KV DFG S +
Sbjct: 203 R-KFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQR 255
Query: 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG------------------- 593
+ T +Q F Y PE +R+ D++S G +LAELLTG
Sbjct: 256 VYTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
Query: 594 ---------ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI-----LDAHVLKEASQEDIV 639
+ + R NF K Y D + + +
Sbjct: 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374
Query: 640 TVAKLTN---------RCLNLNGKKRPTMKE 661
K + +CL + R T +
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQ 405
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 3e-14
Identities = 34/115 (29%), Positives = 56/115 (48%), Gaps = 12/115 (10%)
Query: 483 DQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542
+ + +T E + + +V+ + +L AS HRD+ + NILL K K+ DFG
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGL 239
Query: 543 SRSMAIDQTHMTTQVQGTFGYLD-----PEYFRSSRFTEKSDVYSFGVVLAELLT 592
+R + D + V+ L PE +T +SDV+SFGV+L E+ +
Sbjct: 240 ARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 77/346 (22%), Positives = 122/346 (35%), Gaps = 110/346 (31%)
Query: 393 TDHYNTNRILGQGGQGTVYKG--MLADGRIVAIK----KSKVIDESKVDEFINEVAILSQ 446
+ Y LG+G G V + A GR VA+K + + ++ E+ +L
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----EIQVLEH 67
Query: 447 INHR------NVVKLLGC-------CLETEVPLL---VYEFI-INGTLFQYLHDQNEEFP 489
+N V++L C+ E LL Y+FI NG F F
Sbjct: 68 LNTTDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFIKENG--FLP-------FR 116
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-DGKYRA------------- 535
+ IR ++A ++ +V++LHS H D+K NIL Y
Sbjct: 117 LD-HIR-KMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 536 -----KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAEL 590
KV DFG S D H +T V Y PE + +++ DV+S G +L E
Sbjct: 172 INPDIKVVDFG---SATYDDEHHSTLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEY 227
Query: 591 LTG----------------------------ERAIRVTNF-------EEDKSLAAYFLRA 615
G ++ + F +E S Y RA
Sbjct: 228 YLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA 287
Query: 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
K L E + + ++ D++ + L + KR T++E
Sbjct: 288 CK--PLKEFMLSQDVEHERLFDLIQ------KMLEYDPAKRITLRE 325
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 64/345 (18%), Positives = 112/345 (32%), Gaps = 108/345 (31%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM--LADGRIVAIK----KSKVIDESKVDEFINEVAILSQ 446
+ Y LG+G G V + + VA+K K + +++ E+ +L +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVLKK 72
Query: 447 INHR------NVVKLLGC-------CLETEVPLL---VYEFIINGTLFQYLHDQNEEFPI 490
I + V + C+ E LL +EF+ + +P+
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFLKEN--------NFQPYPL 122
Query: 491 TWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-DGKYRA-------------- 535
+R +A ++ A+ +LH H D+K NIL + ++
Sbjct: 123 P-HVR-HMAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 536 ----KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELL 591
+V+DFG S D H TT V Y PE + + DV+S G +L E
Sbjct: 178 NTSIRVADFG---SATFDHEHHTTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 592 TGE-------------RAIRV----------------------TNFEEDKSLAAYFLRAM 616
G ++ ++E+ S Y
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
K L + L+ D++ R L + +R T+ E
Sbjct: 294 K--PLKSYMLQDSLEHVQLFDLMR------RMLEFDPAQRITLAE 330
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 59/247 (23%), Positives = 89/247 (36%), Gaps = 69/247 (27%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK----KSKVIDESKVDEFINEVAILSQI 447
+ + R +G G G V + + + A+K K +K+ E IL +I
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILKKI 88
Query: 448 NHR-----NVVKLLGC-------CLETEVPLL---VYEFIINGTLFQYLHDQNEEFPITW 492
+ N+VK G CL E L +YE I + F I
Sbjct: 89 QNDDINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEIITR-NNYNG-------FHIE- 137
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-DGKYRA---------------- 535
+I+ IE+ A++YL + H D+K NILL D +
Sbjct: 138 DIK-LYCIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 536 --------KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVL 587
K+ DFG + + + Y PE + + SD++SFG VL
Sbjct: 194 YRTKSTGIKLIDFG---CATFKSDYHGSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 588 AELLTGE 594
AEL TG
Sbjct: 250 AELYTGS 256
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 73/379 (19%), Positives = 116/379 (30%), Gaps = 128/379 (33%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK--KSKVIDESKVDEFINEVAILSQ 446
+ Y+ R LG G TV+ + + VA+K KS E + ++E+ +L
Sbjct: 33 DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKS 89
Query: 447 I--------NHRNVVKLLGC-----------CLETEVPLL--VYEFIINGTLFQYLHDQN 485
+ N VV+LL C+ E L + ++I ++
Sbjct: 90 VRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWI----------IKS 138
Query: 486 EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---------------- 529
+ +I +V + YLH+ I H DIK NILL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 530 ---------------------------------DGKYRAKVSDFGASRSMAIDQTHMTTQ 556
K + K++D G + H T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHFTED 253
Query: 557 VQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER---AIRVTNFEEDKSLAA--- 610
+Q T Y E S + +D++S + EL TG+ + D+ A
Sbjct: 254 IQ-TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 611 -------------------YF--------LRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643
+F + +K LFE+L E SQE+
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTD 370
Query: 644 LTNRCLNLNGKKRPTMKEV 662
L L +KR T E
Sbjct: 371 FLLPMLELIPEKRATAAEC 389
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 34/159 (21%), Positives = 63/159 (39%), Gaps = 17/159 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRN 451
HY R +G+G G +++G L + + VAIK S + +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 452 VVKLLGCCLETEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+ + E +LV + + G +L L +F + + A ++ V +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 511 SAASIPIYHRDIKSTNILL---DGKYRAKVS--DFGASR 544
+ + +RDIK N L+ + K + DFG +
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 15/157 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINH-RN 451
+ Y R +G G G +Y G +A G VAIK V ++K + E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 452 VVKLLGCCLETEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+ + C E + ++V E + G +L + + +F + + L +A ++ + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAK---VSDFGASR 544
S I HRD+K N L+ + + DFG ++
Sbjct: 123 SKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 41/178 (23%), Positives = 66/178 (37%), Gaps = 26/178 (14%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--------IDESKV------DEFIN 439
+ + +G GG G +Y A KV E K + I
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN---GTLFQYLHDQNEEFPITWEIRL 496
+ Q+++ + G L TE Y F++ G Q + QN F L
Sbjct: 98 KWIERKQLDYLGIPLFYGSGL-TEFKGRSYRFMVMERLGIDLQKISGQNGTFKK--STVL 154
Query: 497 RIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV--SDFGASRSMAIDQTH 552
++ I + D + Y+H + H DIK+ N+LL K +V +D+G S + H
Sbjct: 155 QLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 36/157 (22%), Positives = 71/157 (45%), Gaps = 15/157 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRN 451
+ + R +G G G +Y G + VAIK V ++K + + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 452 VVKLLGCCLETEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
+ + +E + +LV + + G +L + + + + + L +A ++ + V ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAK---VSDFGASR 544
S + + HRDIK N L+ RA + DFG ++
Sbjct: 121 SKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 34/159 (21%), Positives = 65/159 (40%), Gaps = 19/159 (11%)
Query: 395 HYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNV 452
++ + +G G G + G L VAIK + +S+ + E Q+ + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 453 VKLLGCCLETEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
++ + +V E + G +L + F + + L IAI++ + Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVS------DFGASR 544
I +RD+K N L+ G+ K DF ++
Sbjct: 124 KNLI---YRDVKPENFLI-GRPGNKTQQVIHIIDFALAK 158
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 54.9 bits (131), Expect = 3e-08
Identities = 41/265 (15%), Positives = 79/265 (29%), Gaps = 66/265 (24%)
Query: 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVD--------EFINEVAI 443
T+ +G+G G V++ + AD VAIK + V+ E + E+ I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 444 LSQI---------NHRNVVKLLGCCL----------------------ETEVPL------ 466
++ + L + P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 467 --LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524
+V EF G + + + + I +++ +++ + S+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190
Query: 525 TNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL-DPEYFRSSRFTEKSDVYSF 583
N+LL K+ +S I + G + SR V
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTI----------PSCGLQVSIIDYTLSRLERDGIVVFC 240
Query: 584 GVVLA-ELLTGERAIRVTNFEEDKS 607
V + +L TG+ + + K
Sbjct: 241 DVSMDEDLFTGDGDYQFDIYRLMKK 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 6e-08
Identities = 34/180 (18%), Positives = 65/180 (36%), Gaps = 27/180 (15%)
Query: 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI-----------DESKVDEFINEVAI 443
+ +GQGG G +Y + V V+ E K + +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 444 LSQINHRNVVKLLG-----CCLETEVPLLVYEFII----NGTLFQYLHDQNEEFPITWEI 494
+ + +K LG + Y F+I L + + F +
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSR--KT 153
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV--SDFGASRSMAIDQTH 552
L++++ + D + Y+H + H DIK++N+LL+ K +V D+G + + H
Sbjct: 154 VLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 26/183 (14%), Positives = 66/183 (36%), Gaps = 31/183 (16%)
Query: 395 HYNTNRILGQGGQGTVYKGM---------LADGRIVAIK----KSKVIDESKV------D 435
+ + QG +Y+ + ++K ++ +E
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 436 EFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN---GTLFQYLHDQNEEFPITW 492
+N+ L + +G + + Y F++ G Q D + + ++
Sbjct: 103 LQVNKWKKLYSTPLLAIPTCMGFGVHQDK----YRFLVLPSLGRSLQSALDVSPKHVLSE 158
Query: 493 EIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV--SDFGASRSMAIDQ 550
L++A + DA+ +LH + H ++ + NI +D + +++V + +G +
Sbjct: 159 RSVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215
Query: 551 THM 553
H+
Sbjct: 216 KHV 218
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.2 bits (124), Expect = 5e-07
Identities = 79/547 (14%), Positives = 155/547 (28%), Gaps = 160/547 (29%)
Query: 158 DCCDLLCTVPPNTKVFDTNSSYKYYQSIPQECSVVFVVEQEWLFNNYQTNSVVLKDQEQV 217
DC D V K + + S + W + Q V Q+ V
Sbjct: 34 DCKD----VQDMPKSILSKEEIDHIIMSKDAVSGTLRLF--WTLLSKQEEMV----QKFV 83
Query: 218 PAVLE------WGKYKGTC------TEEYNS-HTKMCNKDNHCLLQLGTGHFCLCDYTRS 264
VL K T Y ++ N DN + +
Sbjct: 84 EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN-DNQVFAK------------YN 130
Query: 265 VASRHCAGDLICSTTSGHNCSECPQGYYLSSYNSDQEPLCSRSTQLTFGKKSRNKYIVIG 324
V SR +P L + K ++I
Sbjct: 131 V-SRL-------------------------------QPYLKLRQALL--ELRPAKNVLI- 155
Query: 325 CTSGGFGML-CLLTGAWWMYKFLKRKMEIMLKQKF--F------KRNGGLLLQQELASTE 375
G+L G W+ + ++ K F F + +L+ L
Sbjct: 156 -----DGVLGS---GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEM-LQKLL 206
Query: 376 GNIDKSKLFTSKELETATDHYNTN-------RILGQGGQGTVYKGMLADGRIVAIKKSKV 428
ID + +TS+ ++ + R+L + Y+ L +V V
Sbjct: 207 YQIDPN--WTSRSDHSSNIKLRIHSIQAELRRLL----KSKPYENCL----LVL---LNV 253
Query: 429 IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF 488
+ + F IL + V L T + L + D+ +
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISL---DHHSMT----LTPDEVKSL 306
Query: 489 PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS----R 544
+ + + D +P R++ +TN + D A+ +
Sbjct: 307 LLKY-----LDCRPQD----------LP---REVLTTNPRRLSIIAESIRDGLATWDNWK 348
Query: 545 SMAIDQTHMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAEL---LTGERA 596
+ D+ +TT ++ + L+P +R S F + + + ++L+ + +
Sbjct: 349 HVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT--ILLSLIWFDVIKSDV 404
Query: 597 IRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTV-AKLTN-----RCLN 650
+ V N SL + KE S I ++ + E+ + + + + +
Sbjct: 405 MVVVNKLHKYSLVE---KQPKE-STISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFD 460
Query: 651 LNGKKRP 657
+ P
Sbjct: 461 SDDLIPP 467
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 721 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.88 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.76 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.63 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.92 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.6 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.5 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.36 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.24 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.23 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.9 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.82 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.79 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.71 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.38 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.29 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.19 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.16 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.15 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.1 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.01 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.81 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.8 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.71 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.49 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.31 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.78 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.51 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 84.3 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 83.8 | |
| 1gl4_A | 285 | Nidogen-1, entactin; immunoglobulin-like domain, e | 83.12 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 82.79 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 82.7 | |
| 2bou_A | 143 | EGF-like module containing mucin-like hormone rece | 81.51 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=448.93 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=217.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|.+.+.||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|++.+.+..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999864 367899999987777778899999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccC----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 468 VYEFIINGTLFQYLHDQN----------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
||||+++|+|.++|+... ....++|..+++|+.|||+||+|||+++ |+||||||+||||++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997632 2346999999999999999999999998 999999999999999999999
Q ss_pred eeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHH
Q 036483 538 SDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 538 ~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
+|||+|+......... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||...... . ....
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~-~~~~ 242 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E-VIEC 242 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H-HHHH
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H-HHHH
Confidence 9999998765433322 234569999999999999999999999999999999999 89998653321 1 1122
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
+..+. ..+.+...+.++.+|+.+||+.||++|||++||.+.|+++...
T Consensus 243 i~~~~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 243 ITQGR---------VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp HHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22211 1223344556799999999999999999999999999988643
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=450.70 Aligned_cols=259 Identities=26% Similarity=0.416 Sum_probs=210.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|.+.++||+|+||+||+|++. +++.||||+++..+....++|.+|+++|++++|||||+++|++.+.+..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 46777889999999999999864 478899999987777778899999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCC------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 468 VYEFIINGTLFQYLHDQNE------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
||||+++|+|.++++.... ..+++|.++++|+.|||+||+|||+.+ |+||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 9999999999999976432 246999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHH
Q 036483 536 KVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 536 kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 613 (721)
||+|||+++....... .......||+.|||||++.+..++.++|||||||+||||+| |+.||......+ ..
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~ 270 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AI 270 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HH
Confidence 9999999987654332 22345679999999999999999999999999999999999 899986433211 11
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
..+..+ ...+.+...+.++.+|+.+||+.||++||||.||++.|+.+..
T Consensus 271 ~~i~~g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 271 DCITQG---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp HHHHHT---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcC---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 111111 1122334455679999999999999999999999999998865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-53 Score=445.21 Aligned_cols=258 Identities=23% Similarity=0.355 Sum_probs=213.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
.++++.++||+|+||+||+|.+. +++.||||+++.. +....++|.+|+.+|++++|||||+++|++.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 34567789999999999999863 4678999998653 3344678999999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 467 LVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
|||||+++|+|.++|+.... ...++|..+++|+.|||+||+|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999965321 236999999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHH
Q 036483 534 RAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~ 611 (721)
++||+|||+++....... .......||+.|||||++.+..|+.++|||||||+||||+| |+.||......+
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~------- 255 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------- 255 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------
Confidence 999999999987654332 23345679999999999999999999999999999999998 899986443211
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
+...+..+ ...+.+...+.++.+|+.+||+.||++||||.||++.|+...
T Consensus 256 ~~~~i~~~---------~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 VVEMIRNR---------QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHHHcC---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 12222222 122334455677999999999999999999999999998753
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-52 Score=436.81 Aligned_cols=261 Identities=27% Similarity=0.416 Sum_probs=206.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.+++.+.++||+|+||+||+|++++ .||||.++.. +....+.|.+|+.+|++++|||||+++|++.+ +..+||||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 4677888999999999999999753 5899987653 34556889999999999999999999998865 56799999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.++|+.... .++|..+++|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 186 (307)
T 3omv_A 112 WCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS 186 (307)
T ss_dssp CCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred cCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence 9999999999976543 5999999999999999999999998 9999999999999999999999999998765322
Q ss_pred -ceeeeeeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 551 -THMTTQVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 551 -~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
........||+.|||||++.+ ..|+.++|||||||+||||+||+.||....... .....+..+.. .
T Consensus 187 ~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~~~~~~~~~----~ 256 (307)
T 3omv_A 187 GSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QIIFMVGRGYA----S 256 (307)
T ss_dssp -------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHTTCC----C
T ss_pred cceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCC----C
Confidence 223445679999999999964 468999999999999999999999996433211 11111111110 0
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
+. ....+...+.++.+|+.+||+.+|++||||.||++.|+.|+..
T Consensus 257 p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 257 PD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 00 1122334556799999999999999999999999999988643
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-51 Score=439.16 Aligned_cols=270 Identities=28% Similarity=0.405 Sum_probs=221.2
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhcCC-CceeeE
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQINH-RNVVKL 455 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h-~niv~l 455 (721)
++..+++...++|++.+.||+|+||+||+|.+.. ++.||||+++... ....+.|.+|+++|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3455666777899999999999999999998643 3689999986533 3456789999999999965 899999
Q ss_pred EEEEEeC-CcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 036483 456 LGCCLET-EVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521 (721)
Q Consensus 456 ~g~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 521 (721)
+|+|.+. +..+|||||+++|+|.++|+.... ...++|..++.++.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999775 467999999999999999975321 235899999999999999999999999 99999
Q ss_pred CcCccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCccccc
Q 036483 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRV 599 (721)
Q Consensus 522 lk~~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~ 599 (721)
|||+||||++++.+||+|||+|+.+..+... ......||+.|||||++.+..|+.++|||||||+||||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999977544433 3445679999999999999999999999999999999998 8999865
Q ss_pred CCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+ .+...+..+ .....+...+.++.+++.+||+.||++|||+.||+++|+.+..
T Consensus 291 ~~~~~------~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 291 VKIDE------EFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp CCCSH------HHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCHHH------HHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 43221 122222222 1122333445679999999999999999999999999998754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=433.20 Aligned_cols=251 Identities=25% Similarity=0.379 Sum_probs=204.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|.+.+.||+|+||+||+|+.. +|+.||||++... .....+.|.+|+++|++++|||||++++++.+.+..+||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 68999999999999999999965 5899999987543 34556789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.++|...+. ..+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999976542 35799999999999999999999999 9999999999999999999999999998764321
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ...+...... ..
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~-~~--------- 242 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISG-SF--------- 242 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHT-CC---------
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcC-CC---------
Confidence 123345699999999999999999999999999999999999999964332 2222222211 11
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11122334568999999999999999999999874
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=429.23 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=209.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56889999999999999999976 58999999987666666778999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~- 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP- 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence 999999999753 4999999999999999999999999 99999999999999999999999999987754332
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+ ..+....... ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~-~~i~~~~~~~-------~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAM-KMIRDNLPPR-------LK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSSCCC-------CS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH-HHHHcCCCCC-------CC
Confidence 334567999999999999999999999999999999999999999643221 111 1111111000 01
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+.++.+|+.+||+.||++|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11223456899999999999999999999865
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-50 Score=422.69 Aligned_cols=253 Identities=20% Similarity=0.225 Sum_probs=206.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.|...++||+|+||+||+|+.. +|+.||||+++... ...+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 56778889999999999999975 58999999886422 2247999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCccccccCCc
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~~~~~~ 551 (721)
++|+|.++|++.. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+|+.+..+..
T Consensus 133 ~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 133 EGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp TTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred CCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999998654 6999999999999999999999999 99999999999999887 699999999987754322
Q ss_pred e----eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 552 H----MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 552 ~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
. ....+.||+.|||||++.+..|+.++|||||||+||||++|+.||......+ +.. .......
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~---~i~~~~~------- 273 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP---LCL---KIASEPP------- 273 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC---CHH---HHHHSCC-------
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH---HHH---HHHcCCC-------
Confidence 1 1233569999999999999999999999999999999999999996543322 111 1111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
...+.+...+.++.+++.+||+.||++|||+.|+++.|.....
T Consensus 274 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~ 316 (336)
T 4g3f_A 274 -PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ 316 (336)
T ss_dssp -GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 0112333445678999999999999999999999998876543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-50 Score=414.46 Aligned_cols=246 Identities=24% Similarity=0.405 Sum_probs=197.9
Q ss_pred CCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcceEEE
Q 036483 397 NTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVY 469 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~~lv~ 469 (721)
.+.++||+|+||+||+|... +++.||+|++.. ......+.|.+|+++|++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999976 488999998754 334456789999999999999999999999875 24578999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~~~ 548 (721)
||+++|+|.+++++.. .+++..++.++.||+.||+|||+++. +|+||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998654 69999999999999999999999863 4999999999999984 78999999999986432
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.......||+.|||||++.+ .|+.++|||||||+||||+||+.||..... ... ....+..+....
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~-~~~~i~~~~~~~----- 249 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQ-IYRRVTSGVKPA----- 249 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHH-HHHHHTTTCCCG-----
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHH-HHHHHHcCCCCC-----
Confidence 23345679999999999865 699999999999999999999999964321 111 122222211110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 250 ---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 250 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 111112345899999999999999999999865
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-50 Score=419.81 Aligned_cols=248 Identities=24% Similarity=0.375 Sum_probs=209.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.. +++.||||.+... +....+.+.+|+++|++++|||||++++++.+.+..+|||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 56999999999999999999965 5899999987542 3445678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998654 6999999999999999999999999 999999999999999999999999999987543
Q ss_pred Cc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. .......||+.|||||++.+..|+.++|||||||+||||++|+.||..... ...+.... ....
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~-~~~~------- 251 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKII-KLEY------- 251 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HTCC-------
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHH-cCCC-------
Confidence 32 234556799999999999999999999999999999999999999964332 11122221 1111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.++...+.++.+|+.+||+.||++|||++|++.
T Consensus 252 ---~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 252 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp ---CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred ---CCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 112233456899999999999999999998743
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=420.62 Aligned_cols=269 Identities=22% Similarity=0.310 Sum_probs=202.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----cceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE----VPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~----~~~lv~ 469 (721)
++|.+.++||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||++++++.+.+ ..+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4577889999999999999998 588999999864322 1122334555667889999999999998764 468999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-----CCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-----ASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-----~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
||+++|+|.++|+.. .++|..+++++.|+++||+|||++ ..++|+||||||+||||+.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999864 499999999999999999999987 12349999999999999999999999999998
Q ss_pred ccccCCcee---eeeeecCCCCCCccccccC------CCCccccchhHHHHHHHHHhCCcccccCCccc--------ccc
Q 036483 545 SMAIDQTHM---TTQVQGTFGYLDPEYFRSS------RFTEKSDVYSFGVVLAELLTGERAIRVTNFEE--------DKS 607 (721)
Q Consensus 545 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SlGvll~elltG~~p~~~~~~~~--------~~~ 607 (721)
......... .....||+.|||||++.+. .++.++|||||||+||||+||+.|+....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765433222 2345799999999999764 36789999999999999999988764332211 001
Q ss_pred HHHHHHHHhhccchhhhhhhhhcc-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 608 LAAYFLRAMKEDSLFEILDAHVLK-EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
........+....+ ++.+.. ..+.+.+..+.+|+.+||+.||++||||.||++.|+++...
T Consensus 237 ~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 11111222211111 111111 12335667899999999999999999999999999988653
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=430.44 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=210.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.+.|+..+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999976 5899999998776666778899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+|+.+.....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 302 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCc
Confidence 9999999999754 4999999999999999999999999 99999999999999999999999999987754332
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+ ..+...... . .
T Consensus 303 -~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~-~~i~~~~~~-----~--~ 367 (423)
T 4fie_A 303 -RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAM-KMIRDNLPP-----R--L 367 (423)
T ss_dssp -CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH-HHHHHSCCC-----C--C
T ss_pred -cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH-HHHHcCCCC-----C--C
Confidence 334567999999999999999999999999999999999999999643221 111 111111100 0 0
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
......+.++.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111223456899999999999999999999865
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=405.84 Aligned_cols=246 Identities=24% Similarity=0.361 Sum_probs=192.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.. +|+.||||.+... +....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999965 6899999987542 2334568999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+ +|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999987654 6999999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.......||+.|||||++.+..+ +.++|||||||+||||++|+.||..... ...+. .+.....
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~-~i~~~~~------- 229 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFK-NISNGVY------- 229 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHH-HHHHTCC-------
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHH-HHHcCCC-------
Confidence 22345679999999999998876 5799999999999999999999964321 12121 1111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 230 ---~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 ---TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1122234568999999999999999999999774
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=412.50 Aligned_cols=242 Identities=26% Similarity=0.300 Sum_probs=194.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|++.+.||+|+||+||+|+.. .++.||||.++.. .......+.+|+++|++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999853 3679999987542 23344578999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998754 6999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... .......||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+.... ....
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~-~~~~------ 243 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMIL-KAKL------ 243 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC------
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHH-cCCC------
Confidence 322 2234467999999999999999999999999999999999999999643321 1111111 1111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
..+...+.++.+|+.+||+.||++|||+
T Consensus 244 ----~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 244 ----GMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred ----CCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 1222344568999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=405.21 Aligned_cols=250 Identities=23% Similarity=0.367 Sum_probs=189.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-------
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEV------- 464 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~------- 464 (721)
++|++.+.||+|+||+||+|+.+ +|+.||||+++... +...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999965 68999999886543 3345789999999999999999999999876543
Q ss_pred -----ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEee
Q 036483 465 -----PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSD 539 (721)
Q Consensus 465 -----~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 539 (721)
.++||||+++|+|.+++..........+..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999987654445677889999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCce-----------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccH
Q 036483 540 FGASRSMAIDQTH-----------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608 (721)
Q Consensus 540 FGls~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~ 608 (721)
||+|+.+..+... ..+...||+.|||||++.+..|+.++|||||||+||||++ ||... ...
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-----~~~ 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-----MER 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-----HHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-----cHH
Confidence 9999876543221 1233569999999999999999999999999999999996 55311 001
Q ss_pred HHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 609 AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 609 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... .......... .......+.+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~~~-~~~~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VRT-LTDVRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HHH-HHHHHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHH-HHHHhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 111 1111111110 011223345678999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=390.64 Aligned_cols=286 Identities=37% Similarity=0.608 Sum_probs=247.5
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
++..++..++++|+..+.||+|+||.||+|...+++.||||+.........+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44455666789999999999999999999998889999999987766677789999999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCC-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNE-EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
..++||||+++++|.+++..... ...+++..+++++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999976432 236999999999999999999999998 99999999999999999999999999
Q ss_pred ccccccC-CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 543 SRSMAID-QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 543 s~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
++..... .........||+.|+|||++.+..++.++||||||+++|||++|+.||......+......+.........+
T Consensus 186 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQL 265 (321)
T ss_dssp CEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCC
T ss_pred ccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccH
Confidence 9865422 222234456899999999999999999999999999999999999999876665555566665555556666
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
..++++........+.+..+.+++.+||+.||++|||+.||++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 266 EQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 666777766677888899999999999999999999999999999988654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=400.88 Aligned_cols=263 Identities=22% Similarity=0.332 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC------C
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET------E 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------~ 463 (721)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. .....+.+.+|+++|++++|||||++++++... +
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 367999999999999999999975 6999999998653 234457789999999999999999999997643 5
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..+|||||++ |+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999995 67999987643 6999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCC---ceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 544 RSMAIDQ---THMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 544 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+.+.... ........||+.|||||++.+. .++.++||||+||++|||++|+.||......+. ...+.......
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~---l~~I~~~~g~p 282 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ---LQLIMMVLGTP 282 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH---HHHHHHHHCCC
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH---HHHHHHhcCCC
Confidence 8764321 2223456799999999998875 568999999999999999999999975443221 11111111110
Q ss_pred ch-----------hhhhhhhh-cccC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 SL-----------FEILDAHV-LKEA-----SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~~-----------~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ...+.... .... ......++.+|+.+||+.||++|||+.|++++
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 00000000 0000 01123568899999999999999999998764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-45 Score=388.31 Aligned_cols=293 Identities=36% Similarity=0.638 Sum_probs=247.7
Q ss_pred CCccccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEE
Q 036483 379 DKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLG 457 (721)
Q Consensus 379 ~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g 457 (721)
...+.|+..++..+.++|...++||+|+||.||+|...+++.||||++.... ......+.+|+.++++++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 4456789999999999999999999999999999998889999999886543 223447999999999999999999999
Q ss_pred EEEeCCcceEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 458 CCLETEVPLLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 458 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
++.+.+..++||||+++++|.+++.... ....+++..++.++.|++.||+|||+...++|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 9999999999999999999999998654 234699999999999999999999999222299999999999999999999
Q ss_pred EeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCc--cccccHHHHHHH
Q 036483 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF--EEDKSLAAYFLR 614 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~--~~~~~~~~~~~~ 614 (721)
|+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||..... ........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999987765555555556699999999999999999999999999999999999999963322 223334455545
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
......+..+.+...........+..+.+++.+||+.+|++|||+.||+++|+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 555556666667776777788889999999999999999999999999999987543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=388.79 Aligned_cols=200 Identities=19% Similarity=0.334 Sum_probs=171.4
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcc
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~ 465 (721)
...++|++.++||+|+||+||+|+.+ .++.||||++... ....++.+|+++|+++ +||||+++++++.+.+..
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 45688999999999999999999853 3678999987543 2345788999999998 699999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeeccCcc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASR 544 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGls~ 544 (721)
+|||||+++|+|.+++. .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 96 ~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 99999999999999984 4899999999999999999999999 9999999999999876 799999999998
Q ss_pred ccccCCc---------------------------eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcc
Q 036483 545 SMAIDQT---------------------------HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERA 596 (721)
Q Consensus 545 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p 596 (721)
....... .......||+.|||||++.+. .++.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6532211 112335699999999999876 589999999999999999999999
Q ss_pred cccCC
Q 036483 597 IRVTN 601 (721)
Q Consensus 597 ~~~~~ 601 (721)
|....
T Consensus 247 f~~~~ 251 (361)
T 4f9c_A 247 FYKAS 251 (361)
T ss_dssp SSCCS
T ss_pred CCCCC
Confidence 96433
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=407.56 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=210.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|++.+.||+|+||+||+++.+ +|+.||||.+........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 368999999999999999999976 5899999998776666678899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC--CcEEEeeccCccccccC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK--YRAKVSDFGASRSMAID 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~--~~~kl~DFGls~~~~~~ 549 (721)
+++|+|.++|..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999875432 5999999999999999999999999 9999999999999854 89999999999987543
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. ......||+.|||||++.+..|+.++|||||||+||||++|+.||...... ..+.. +...... +....
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~-i~~~~~~--~~~~~ 379 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRN-VKSCDWN--MDDSA 379 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHH-HHTTCCC--CCSGG
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHH-HHhCCCC--CCccc
Confidence 3 334567999999999999999999999999999999999999999654322 11111 1111110 00011
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+.++.+|+.+||+.||++|||+.|++++
T Consensus 380 ----~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 380 ----FSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11223458899999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=400.93 Aligned_cols=249 Identities=20% Similarity=0.260 Sum_probs=200.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHH---HHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEF---INEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~---~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
++|++.++||+|+||+||+|+.+ +|+.||||.+... .......+ ..++.+++.++|||||++++++.+.+..+
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 67999999999999999999976 5899999987532 11222233 34466777889999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
|||||++||+|.++|.+.. .+++..+..++.||+.||.|||+++ ||||||||+||||+.++.+||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999998754 6999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.... .....||+.|||||++.. ..|+.++|||||||+||||++|+.||......+ ....+. ......
T Consensus 343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~---~~~i~~-~i~~~~----- 410 (689)
T 3v5w_A 343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD---KHEIDR-MTLTMA----- 410 (689)
T ss_dssp SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC---HHHHHH-HHHHCC-----
T ss_pred CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHH-hhcCCC-----
Confidence 5332 234579999999999975 579999999999999999999999996543222 111111 111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
...+...+.++.+|+.+||+.||++|++ +.||.++
T Consensus 411 -----~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred -----CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1122233456899999999999999998 5676543
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-42 Score=361.91 Aligned_cols=284 Identities=33% Similarity=0.569 Sum_probs=231.0
Q ss_pred CccccCHHHHHHHhcCCCCC------ceEeeeCcEEEEEEEEcCCcEEEEeecccc----CchhhHHHHHHHHHHhhcCC
Q 036483 380 KSKLFTSKELETATDHYNTN------RILGQGGQGTVYKGMLADGRIVAIKKSKVI----DESKVDEFINEVAILSQINH 449 (721)
Q Consensus 380 ~~~~~~~~el~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~h 449 (721)
....|+..++..++++|... +.||+|+||.||+|.. +++.||||++... .....+.+.+|+.++++++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999999987 8999999999999987 5789999987542 23456789999999999999
Q ss_pred CceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 450 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
|||+++++++.+.+..++||||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999976544457999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccH
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~ 608 (721)
+.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||....... ..
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~ 243 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LL 243 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--BT
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--HH
Confidence 99999999999999876433222 2334568999999998875 57899999999999999999999997544322 11
Q ss_pred HHHHHHHhh-ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 609 AAYFLRAMK-EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 609 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
......... ...+.+.++.. ....+...+..+.+++.+||+.+|++|||+.+|++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred HHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 111111111 11222333322 234566778889999999999999999999999999998864
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=369.22 Aligned_cols=260 Identities=26% Similarity=0.405 Sum_probs=214.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
++|.+.++||+|+||+||++... +++.||+|++...+....+.|.+|++++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 57888999999999999999975 58999999887777777889999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 90 ~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 90 KGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp TTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred CCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999986433 5999999999999999999999999 999999999999999999999999999876433221
Q ss_pred e-------------eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 553 M-------------TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 553 ~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+........... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~----------~ 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----------L 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------B
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------h
Confidence 1 1135699999999999999999999999999999999999998864332221100 0
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
......+. ..+...+..+.+++.+||+.||++|||+.++++.|+.++..
T Consensus 235 ~~~~~~~~----~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~ 283 (310)
T 3s95_A 235 NVRGFLDR----YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283 (310)
T ss_dssp CHHHHHHH----TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhhccccc----cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 00011111 11222334589999999999999999999999999988754
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=370.63 Aligned_cols=270 Identities=30% Similarity=0.424 Sum_probs=208.6
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
.++....++|++.+.||+|+||+||+|.. +++.||||++... .....+.+.+|++++++++||||+++++++.+.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 33444567899999999999999999987 5788999987553 34456789999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+++++|.+++........+++..++.++.|++.||+|||+.+. +|+||||||+|||++.++.+||+|||+++
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 99999999999999999865433359999999999999999999999863 49999999999999999999999999997
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~----- 255 (309)
T 3p86_A 188 LKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKC----- 255 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSC-----
T ss_pred cccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcC-----
Confidence 653322 22334569999999999999999999999999999999999999986433211 111110000
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
.....+...+.++.+|+.+||+.+|++|||+.+|++.|+.+.....
T Consensus 256 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 256 ----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 1112233344568999999999999999999999999998876543
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=356.70 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=214.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|.+.+.||+|+||.||+|...++..||+|+++.... ..+++.+|++++.+++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 467899999999999999999998888999998865432 3467999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 86 SNGCLLNYLRSHG--KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp TTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred CCCcHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 9999999997653 25899999999999999999999999 999999999999999999999999999876554433
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......+|+.|+|||.+.+..++.++||||||++++||++ |+.||......+ .... +.... ..
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~-~~~~~---------~~ 224 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VVLK-VSQGH---------RL 224 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HHHH-HHTTC---------CC
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HHHH-HHcCC---------CC
Confidence 3344456778999999999999999999999999999999 999986433211 1111 11111 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
..+...+..+.+++.+||+.+|++|||+.|+++.|+.++...
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~ 266 (268)
T 3sxs_A 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD 266 (268)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence 112223456899999999999999999999999999997654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=359.99 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=209.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||+||+|.. .+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 98 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence 46899999999999999999995 46899999998766666677899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 171 (297)
T 3fxz_A 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (297)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence 9999999999764 4899999999999999999999999 99999999999999999999999999987654332
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....... .......... . ..
T Consensus 172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~-~-------~~ 236 (297)
T 3fxz_A 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT-P-------EL 236 (297)
T ss_dssp -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS-C-------CC
T ss_pred -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC-C-------CC
Confidence 2334569999999999999999999999999999999999999986432211 1111111110 0 01
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1122234568999999999999999999999763
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=366.57 Aligned_cols=259 Identities=28% Similarity=0.431 Sum_probs=210.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|.+.+.||+|+||.||+|... .+..||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 467888999999999999999975 3456999998653 34456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.++++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 128 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 202 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE 202 (325)
T ss_dssp EEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence 9999999999999975432 5999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCce--eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 548 IDQTH--MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 548 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~-------~~~~~~~~----- 270 (325)
T 3kul_A 203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEG----- 270 (325)
T ss_dssp ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTT-----
T ss_pred cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHHcC-----
Confidence 43222 2223346778999999999999999999999999999999 999985433211 11111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.....+...+..+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 271 ----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 271 ----YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ----CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11122333456799999999999999999999999999998654
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=368.92 Aligned_cols=267 Identities=28% Similarity=0.465 Sum_probs=210.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-----cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~ 465 (721)
.++|++.+.||+|+||+||++++ .+++.||||++........+.+.+|+.++++++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999984 25889999998877777778999999999999999999999998654 457
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~ 163 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 163 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred EEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence 899999999999999976542 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc----
Q 036483 546 MAIDQTH--MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED---- 619 (721)
Q Consensus 546 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 619 (721)
....... ......++..|+|||.+.+..++.++||||||+++|||++|..|+...... +.......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~ 235 (295)
T 3ugc_A 164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQGQ 235 (295)
T ss_dssp ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH--------HHHHHCTTCCTH
T ss_pred ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH--------HHhhhcCccccc
Confidence 6533221 122234677799999999999999999999999999999999887532111 11111111
Q ss_pred ----chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 620 ----SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 620 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.+.+.+........+...+.++.+++.+||+.+|++|||+.|+++.|+.++..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 11111111222233444556799999999999999999999999999988653
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.19 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=213.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc--------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA--------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLET 462 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~ 462 (721)
.++|.+.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 477899999999999999999853 3457999998654 334567899999999999 899999999999999
Q ss_pred CcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
+..++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 999999999999999999986432 235899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccccc
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKS 607 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~ 607 (721)
+.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 99999999999999866432221 1223346788999999999999999999999999999999 999986543221
Q ss_pred HHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 608 LAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+. ..+.. ......+...+.++.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 314 ~~----~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~ 364 (370)
T 2psq_A 314 LF----KLLKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364 (370)
T ss_dssp HH----HHHHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HH----HHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11 11111 11122233445679999999999999999999999999998864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=357.89 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=212.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|.+.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 67889999999999999999998899999999875432 34679999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.........
T Consensus 89 ~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 89 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999976443 5899999999999999999999999 9999999999999999999999999998664433222
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....+|+.|+|||.+.+..++.++||||||++++||++ |+.||...... .. ...+... ....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~-~~~~~~~---------~~~~ 227 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EV-VEDISTG---------FRLY 227 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH-HHHHHTT---------CCCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HH-HHHHhcC---------ccCC
Confidence 333446778999999999999999999999999999999 99998643321 11 1111111 1111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 228 KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 122234568999999999999999999999999998865
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.46 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=202.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|.+.+.||+|+||.||+|+.. ++..||||+++.. .....+.|.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 367999999999999999999865 4678999998754 34456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.++++... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~sL~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHD--AQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp EEECCTTCBHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEeCCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 999999999999997643 35999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 548 IDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 548 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~-------~~~~i-------- 263 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAV-------- 263 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH-------HHHHH--------
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHH--------
Confidence 432221 122335778999999999999999999999999999998 999985432211 11111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
........+...+..+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 264 -~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 264 -DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp -HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred -HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 11111222334456799999999999999999999999999988653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=376.80 Aligned_cols=259 Identities=24% Similarity=0.402 Sum_probs=212.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..++|.+.+.||+|+||.||+|... +++.||||.++.. .....+.|.+|+++|++++||||+++++++.+.+..++||
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 3567889999999999999999986 6899999987653 2344568999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.++++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 192 e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp ECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 99999999999976432 5899999999999999999999999 999999999999999999999999999865432
Q ss_pred Cceee-eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 550 QTHMT-TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 550 ~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
..... ....++..|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+..
T Consensus 267 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~-------~~~~~~~--------- 330 (377)
T 3cbl_A 267 VYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-------TREFVEK--------- 330 (377)
T ss_dssp EEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH-------HHHHHHT---------
T ss_pred ceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc---------
Confidence 21111 12235778999999999999999999999999999998 999986433211 1111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
......+...+.++.+|+.+||+.+|++|||+.+|++.|+.++.
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 11112233345678999999999999999999999999998865
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-42 Score=357.68 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=209.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 467999999999999999999965 5889999987442 334467899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... ++++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998654 6999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
..........||+.|+|||.+.+..++.++||||||+++|||++|+.||...... ......+.. ....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~-~~~~----- 231 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAV------SIAIKHIQD-SVPN----- 231 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHH------HHHHHHHSS-CCCC-----
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhhc-cCCC-----
Confidence 4333344566999999999999999999999999999999999999999643321 111111111 1110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhhcccc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRP-TMKEVAVVLAGIKAC 672 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~~ 672 (721)
.........+..+.+++.+||+.+|++|| +++++.+.|+.+...
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 01111223345689999999999999998 999999999887654
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=369.03 Aligned_cols=268 Identities=22% Similarity=0.304 Sum_probs=209.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc----ceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV----PLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~----~~lv 468 (721)
.++|.+.++||+|+||+||+|+.. ++.||||++.... .....+.+|+.++++++||||+++++++.+... .++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 468999999999999999999876 7899999986543 334556679999999999999999999987553 5899
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc----------CCCCeeeccCcCccEEECCCCcEEEe
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA----------ASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~----------~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
|||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.++.+||+
T Consensus 101 ~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~ 173 (322)
T 3soc_A 101 TAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA 173 (322)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred EecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence 9999999999999764 499999999999999999999998 7 9999999999999999999999
Q ss_pred eccCccccccCCce-eeeeeecCCCCCCccccccC-----CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH-
Q 036483 539 DFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSS-----RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY- 611 (721)
Q Consensus 539 DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~- 611 (721)
|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||++|+.||..............
T Consensus 174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~ 253 (322)
T 3soc_A 174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253 (322)
T ss_dssp CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence 99999876543322 22335689999999999873 456688999999999999999999875443221111110
Q ss_pred --------HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 612 --------FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 612 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.............+... ......+.++.+|+.+||+.||++|||+.||++.|+.+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 254 GQHPSLEDMQEVVVHKKKRPVLRDY---WQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccCCchhhhhhhhhcccCCCCcccc---ccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11111111100000000 01224566799999999999999999999999999998754
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=357.62 Aligned_cols=263 Identities=25% Similarity=0.366 Sum_probs=215.2
Q ss_pred ccccCHHHHHHHhcC----------CCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCC
Q 036483 381 SKLFTSKELETATDH----------YNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINH 449 (721)
Q Consensus 381 ~~~~~~~el~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h 449 (721)
...++.++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 345778888877764 666789999999999999976 699999999877666667889999999999999
Q ss_pred CceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 450 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
|||+++++++...+..++||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 99999999999999999999999999999998643 5999999999999999999999998 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHH
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~ 609 (721)
+.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------ 247 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------ 247 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------
T ss_pred CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------
Confidence 9999999999999987654322 223456999999999999999999999999999999999999998643221
Q ss_pred HHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
... ..+........ ......+..+.+++.+||+.||++|||+.|+++.
T Consensus 248 ~~~-~~~~~~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 248 QAM-KRLRDSPPPKL-------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHH-HHHHHSSCCCC-------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHH-HHHhcCCCCCc-------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 11111110000 0111233468999999999999999999999774
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=386.22 Aligned_cols=265 Identities=22% Similarity=0.385 Sum_probs=216.6
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
..+++...++|.+.+.||+|+||+||+|.++++..||||+++... ...+.|.+|+.+|++++||||+++++++. .+..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 344455668899999999999999999999888999999987543 35678999999999999999999999986 5678
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++|+|.++++.... ..+++..+++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~ 333 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV 333 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence 999999999999999975421 24889999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.............++..|+|||++....++.++||||||++||||++ |+.||......+ ....+..
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~------ 400 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALER------ 400 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-------HHHHHHH------
T ss_pred cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc------
Confidence 64332222233346788999999999999999999999999999999 999986433211 1111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
......+...+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 401 ---~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 401 ---GYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp ---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 111122334456799999999999999999999999999988653
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=371.89 Aligned_cols=271 Identities=28% Similarity=0.406 Sum_probs=218.8
Q ss_pred ccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceee
Q 036483 383 LFTSKELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVK 454 (721)
Q Consensus 383 ~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~ 454 (721)
.+...+++...++|.+.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|++++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3556677778899999999999999999999842 3578999998653 334557899999999999 7999999
Q ss_pred EEEEEEeCCc-ceEEEeeccCCCcchhccccCC-----------------------------------------------
Q 036483 455 LLGCCLETEV-PLLVYEFIINGTLFQYLHDQNE----------------------------------------------- 486 (721)
Q Consensus 455 l~g~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------- 486 (721)
+++++.+.+. .++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999988654 8899999999999999976532
Q ss_pred ----------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 487 ----------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 487 ----------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
...+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 112899999999999999999999999 9999999999999999999999999998764332
Q ss_pred c-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 551 T-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 551 ~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||......+ . +...+....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~----~~~~~~~~~-------- 313 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--E----FCRRLKEGT-------- 313 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--H----HHHHHHHTC--------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--H----HHHHHHcCC--------
Confidence 2 23344568999999999999999999999999999999998 999986543221 1 111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+.++.+++.+||+.+|++|||+.||+++|+.+..
T Consensus 314 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 314 -RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 111222334568999999999999999999999999998864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=361.15 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=207.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.++|.+.+.||+|+||.||+|.. .+|+.||||++... +....+.+.+|+++|++++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 46899999999999999999997 46899999987543 3455678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 94 e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 9999999999997654 5899999999999999999999999 999999999999999999999999999876433
Q ss_pred CceeeeeeecCCCCCCccccccCCCC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. ......||+.|+|||++.+..++ .++||||||+++|||++|+.||...... . ....+.....
T Consensus 168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~-~~~~i~~~~~------- 231 (328)
T 3fe3_A 168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------E-LRERVLRGKY------- 231 (328)
T ss_dssp C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC-------
T ss_pred C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------H-HHHHHHhCCC-------
Confidence 2 22345699999999999988875 7899999999999999999999654321 1 1111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 232 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 232 ---RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1122234568899999999999999999999764
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=359.02 Aligned_cols=265 Identities=15% Similarity=0.187 Sum_probs=212.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||+||+|+. .+++.||||.+.... ..+.+.+|+.+++++ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999996 468999999876432 345789999999999 99999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc-----EEEeeccCccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR-----AKVSDFGASRS 545 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFGls~~ 545 (721)
|+ +++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCD--RTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 999999998643 26999999999999999999999999 999999999999998887 99999999987
Q ss_pred cccCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 546 MAIDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 546 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6433221 1234569999999999999999999999999999999999999997654322111111111110000
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
.. ... ....+ ++.+++.+||+.+|.+||++.+|.+.|+.+....+.
T Consensus 240 ~~-----~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~ 285 (330)
T 2izr_A 240 PI-----EVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY 285 (330)
T ss_dssp CH-----HHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred CH-----HHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence 00 000 01122 799999999999999999999999999988765543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-42 Score=355.50 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=210.0
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++|.+.+.||+|+||+||++...++..||+|+++.... ..+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 3467899999999999999999999888999999875432 346799999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 101 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 175 (283)
T 3gen_A 101 MANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 175 (283)
T ss_dssp CTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH
T ss_pred cCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccccc
Confidence 999999999976432 5999999999999999999999999 99999999999999999999999999986643332
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+... ..
T Consensus 176 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~~~~~---------~~ 239 (283)
T 3gen_A 176 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQG---------LR 239 (283)
T ss_dssp HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHHHHTT---------CC
T ss_pred ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH-------HHHHHhcc---------cC
Confidence 22233346778999999999999999999999999999998 999986433211 11111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
...+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 11122234568999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=361.19 Aligned_cols=265 Identities=27% Similarity=0.400 Sum_probs=216.4
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCL 460 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~ 460 (721)
++....++|.+.+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 33444678999999999999999999852 3578999998653 3455678999999999999999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCC---------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNE---------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH 519 (721)
+.+..++||||+++++|.+++..... ...+++..+++++.||++||+|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 99999999999999999999986432 234899999999999999999999999 999
Q ss_pred ccCcCccEEECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCccc
Q 036483 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAI 597 (721)
Q Consensus 520 rDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~ 597 (721)
|||||+|||++.++.+||+|||+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999999998765433222 223457788999999999999999999999999999999 99998
Q ss_pred ccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 598 RVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....... . ...+... .....+...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 254 ~~~~~~~---~----~~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 254 PGIPPER---L----FNLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TTCCGGG---H----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHH---H----HHHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 6543321 1 1111111 1112223345569999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=378.60 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=209.1
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+...++|.+.+.||+|+||.||+|.+.++..||||+++... ...+.|.+|+.+|++++||||+++++++.+ +..++||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 34457788999999999999999999888889999987543 335789999999999999999999999876 6789999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 258 e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 333 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 333 (452)
T ss_dssp CCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred hhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence 99999999999975321 25899999999999999999999999 999999999999999999999999999876543
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.........++..|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+
T Consensus 334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~-------~~~~i~~~--------- 397 (452)
T 1fmk_A 334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG--------- 397 (452)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT---------
T ss_pred ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC---------
Confidence 3222333457789999999999999999999999999999999 999986433211 11111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
.....+...+..+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus 398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 111223345567999999999999999999999999999886543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=383.20 Aligned_cols=259 Identities=29% Similarity=0.455 Sum_probs=216.0
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..++|.+.++||+|+||.||+|.+.. +..||||.++... ...++|.+|+.+|++++||||+++++++.+.+..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 45678889999999999999999875 8899999987543 346789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.++++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 297 ~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 372 (495)
T 1opk_A 297 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372 (495)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred ccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence 9999999999986432 36899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
........++..|+|||++.+..++.++||||||++||||++ |+.||......+ .. +.+....
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~-------------~~~~~~~ 436 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY-------------ELLEKDY 436 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH-------------HHHHTTC
T ss_pred eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHHHcCC
Confidence 222333446788999999999999999999999999999999 999986543221 11 1111122
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~ 478 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence 222333455679999999999999999999999999998753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=349.67 Aligned_cols=266 Identities=18% Similarity=0.179 Sum_probs=214.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||.||+|.. .+++.||||.+... ...+.+.+|+.+++++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 46799999999999999999996 46899999987543 3345788999999999 79999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc-----EEEeeccCccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR-----AKVSDFGASRS 545 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~DFGls~~ 545 (721)
|+ +++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.
T Consensus 87 ~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 9999999986532 5999999999999999999999998 999999999999987766 99999999987
Q ss_pred cccCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 546 MAIDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 546 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 240 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence 6543221 2334569999999999999999999999999999999999999997644332222222111111111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
...+ .....+.++.+++.+||+.+|++|||+.+|++.|+++......
T Consensus 241 ~~~~---------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 241 PLRE---------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp CHHH---------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cHHH---------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 1111 1112345689999999999999999999999999998765443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=367.36 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=216.4
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc--------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEE
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA--------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCC 459 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~ 459 (721)
+...++|.+.+.||+|+||+||+|... .+..||||+++.. .....+.+.+|+++++++ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 445578999999999999999999853 2357999988653 344567899999999999 999999999999
Q ss_pred EeCCcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCcc
Q 036483 460 LETEVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 460 ~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~N 526 (721)
.+.+..++||||+++|+|.+++..... ...+++..+++++.||+.||+|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999986532 235999999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccc
Q 036483 527 ILLDGKYRAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEE 604 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~ 604 (721)
|||+.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987643222 22233457889999999999999999999999999999999 999986433211
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
....+.... ....+...+.++.+|+.+||+.+|++|||++||++.|+.+....
T Consensus 302 -------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 354 (382)
T 3tt0_A 302 -------LFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALT 354 (382)
T ss_dssp -------HHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred -------HHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 111221111 11222234456999999999999999999999999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=351.97 Aligned_cols=271 Identities=25% Similarity=0.364 Sum_probs=216.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC--cceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE--VPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~--~~~lv 468 (721)
.++|.+.++||+|+||+||+|.... ++.||||+++... ....+.+.+|++++++++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 3678999999999999999999764 8999999876533 334677889999999999999999999998766 66899
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE----CCCCcEEEeeccCcc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGASR 544 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGls~ 544 (721)
|||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655556999999999999999999999999 9999999999999 888899999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccc--------cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFR--------SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
....... .....||+.|+|||++. +..++.++||||||+++|||++|+.||........ .........
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 240 (319)
T 4euu_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKII 240 (319)
T ss_dssp ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHHH
T ss_pred ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHHh
Confidence 7654332 23346899999999986 57889999999999999999999999965433221 111122222
Q ss_pred hccc---hhhhh-----------hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 617 KEDS---LFEIL-----------DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 617 ~~~~---~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
.... +..+. +..............+.+++.+||+.||++|||++|+++...+..
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~ 308 (319)
T 4euu_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL 308 (319)
T ss_dssp HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence 1111 00000 001112345677888999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-41 Score=372.91 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=210.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-cceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE-VPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-~~~lv~e 470 (721)
..++|.+.+.||+|+||.||+|.+. ++.||||.++.. ...+.|.+|+.+|++++||||+++++++.+.+ ..++|||
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e 267 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 267 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSC--TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCc--hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence 3467888999999999999999985 779999998753 35678999999999999999999999988765 6899999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 268 ~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 342 (450)
T 1k9a_A 268 YMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 342 (450)
T ss_dssp CCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc-
Confidence 9999999999986542 24799999999999999999999999 999999999999999999999999999854322
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....++..|+|||.+.+..++.++||||||++||||++ |+.||......+ .. ..+.. ..
T Consensus 343 ---~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~----~~i~~---------~~ 403 (450)
T 1k9a_A 343 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEK---------GY 403 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT---HH----HHHHT---------TC
T ss_pred ---ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHc---------CC
Confidence 122357889999999999999999999999999999998 999986543221 11 11111 11
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+...+.++.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 1223334556799999999999999999999999999988653
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=348.70 Aligned_cols=254 Identities=30% Similarity=0.481 Sum_probs=198.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC----chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID----ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.++||+|+||.||+|... ++.||||..+... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 367889999999999999999975 8899999876532 23357899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC--------CCcEEEeec
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG--------KYRAKVSDF 540 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~--------~~~~kl~DF 540 (721)
|||+++++|.+++... .+++..++.++.|++.||+|||+++..+|+||||||+|||++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998643 5899999999999999999999998666899999999999986 678999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
|+++...... .....||+.|+|||.+.+..++.++||||||++++||++|+.||....... .......
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~--- 228 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVAM--- 228 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHT---
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhhc---
Confidence 9998654322 223468999999999999999999999999999999999999986433211 1111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.......+...+..+.+++.+||+.+|++|||+.|+++.|+.|
T Consensus 229 ------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 229 ------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp ------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred ------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 1111122333445699999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-41 Score=360.50 Aligned_cols=256 Identities=23% Similarity=0.460 Sum_probs=203.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|+..++||+|+||+||+|++. +++ .||+|.+... .....+.|.+|+.++++++||||+++++++.+.. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56899999999999999999964 344 3688877543 3345678999999999999999999999998755 689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|+||+++|+|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 94 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 9999999999999987543 5999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+ + ...+
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~-------------~~~~ 232 (327)
T 3poz_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SSIL 232 (327)
T ss_dssp TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H-------------HHHH
T ss_pred CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---H-------------HHHH
Confidence 43322 2233456889999999999999999999999999999999 999986543322 1 1111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
........+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 233 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1111122233345568999999999999999999999999988754
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=351.62 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=199.4
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
..++|.+.+.||+|+||.||+|.... +..||+|..+.. .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 34678999999999999999998653 457999987653 3445678999999999999999999999984 56779
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 92 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp EEEECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence 9999999999999997653 25899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
............+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .. ..+....
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~----~~i~~~~----- 234 (281)
T 1mp8_A 167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI----GRIENGE----- 234 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----HHHHTTC-----
T ss_pred CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH----HHHHcCC-----
Confidence 5433333333456788999999999999999999999999999997 999986543221 11 1111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 111223345678999999999999999999999999998754
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=357.42 Aligned_cols=268 Identities=25% Similarity=0.417 Sum_probs=217.3
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEE------cCCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGC 458 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~ 458 (721)
.+++...++|.+.+.||+|+||.||+|.. .+++.||||.++... ....+.+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 33444567899999999999999999985 246789999886543 34567899999999999 99999999999
Q ss_pred EEeCCcceEEEeeccCCCcchhccccCC---------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCc
Q 036483 459 CLETEVPLLVYEFIINGTLFQYLHDQNE---------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523 (721)
Q Consensus 459 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk 523 (721)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ |+|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999986542 125899999999999999999999999 9999999
Q ss_pred CccEEECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCC
Q 036483 524 STNILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTN 601 (721)
Q Consensus 524 ~~NIll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~ 601 (721)
|+|||++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 999999999999999999998775443322 233457889999999999999999999999999999999 999986543
Q ss_pred ccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
... . +...+.. ......+...+..+.+++.+||+.||++|||+.|+++.|+++...
T Consensus 253 ~~~--~----~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 253 VDS--K----FYKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp SSH--H----HHHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred chh--H----HHHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 221 1 1111111 111111223345689999999999999999999999999987643
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=375.49 Aligned_cols=263 Identities=20% Similarity=0.326 Sum_probs=211.8
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
.+++....++|++.++||+|+||+||+|+..+ ++.||+|+++.. .....+.+.+|+.++.+++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 34555567899999999999999999999775 789999987542 22334568999999999999999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+..+|||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999986432 5999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..+...+
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~------~~~~~i~ 294 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIM 294 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh------HHHHhhh
Confidence 99877655544445567999999999997 567899999999999999999999999643322 1111111
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVV 665 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~ 665 (721)
....... ........+.++.+|+.+||..+|++ ||+++|+++.
T Consensus 295 ~~~~~~~------~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKERFQ------FPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHHHCC------CCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hcccccc------CCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 1100000 00111123456889999999888888 9999999775
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=361.66 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=214.7
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLET 462 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~ 462 (721)
....++|.+.+.||+|+||.||+|+..+ ++.||||.++.. .....+.+.+|+.++++++||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 122 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG 122 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence 3456889999999999999999999753 478999998754 334567899999999999999999999999999
Q ss_pred CcceEEEeeccCCCcchhccccCC---------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNE---------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 521 (721)
+..++||||+++++|.+++..... ...+++..++.++.||++||.|||+++ |+|||
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D 199 (343)
T 1luf_A 123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD 199 (343)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 999999999999999999976421 146999999999999999999999999 99999
Q ss_pred CcCccEEECCCCcEEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCccccc
Q 036483 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRV 599 (721)
Q Consensus 522 lk~~NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~ 599 (721)
|||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 999999999999999999999986643222 22234457899999999999999999999999999999999 9999864
Q ss_pred CCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+ ....+..... ...+...+..+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus 280 ~~~~~-------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 280 MAHEE-------VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp SCHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred CChHH-------HHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 33211 1112222211 112233445699999999999999999999999999988653
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=348.59 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=212.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|.+.+.||+|+||.||++...+++.||+|++..... ..+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 357888999999999999999998889999999875433 3468999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999976532 5899999999999999999999999 999999999999999999999999999866432222
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... .. ...+... ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~-~~~i~~~---------~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EV-VEDISTG---------FRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HH-HHHHHTT---------CCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HH-HHHHhcC---------CcC
Confidence 2223346778999999999999999999999999999999 89998643221 11 1111111 011
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
..+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 1122234568999999999999999999999999998865
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=355.74 Aligned_cols=248 Identities=25% Similarity=0.317 Sum_probs=206.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+++.. +++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 67899999999999999999976 5899999987542 3345678899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 9999999999997654 5899999999999999999999999 999999999999999999999999999864322
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... ....
T Consensus 159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~-~~~~-------- 222 (337)
T 1o6l_A 159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELIL-MEEI-------- 222 (337)
T ss_dssp T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC--------
T ss_pred C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHH-cCCC--------
Confidence 2 2234457999999999999999999999999999999999999998643221 1111111 1111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+...+.++.+|+.+||+.||++|| +++||+++
T Consensus 223 --~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 11223345689999999999999999 89988765
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-41 Score=351.35 Aligned_cols=261 Identities=22% Similarity=0.343 Sum_probs=203.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhh--cCCCceeeEEEEEEeC----Ccce
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQ--INHRNVVKLLGCCLET----EVPL 466 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~g~~~~~----~~~~ 466 (721)
.++|.+.+.||+|+||+||+|+. +++.||||++.. ...+.+.+|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 56899999999999999999998 688999998754 334566777777776 7999999999997653 3578
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeccCcCccEEECCCCcEEEe
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH--------SAASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
+||||+++|+|.++++.. .+++..+++++.|++.||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 999999999999999643 5999999999999999999999 777 9999999999999999999999
Q ss_pred eccCccccccCCcee---eeeeecCCCCCCccccccC------CCCccccchhHHHHHHHHHhC----------Cccccc
Q 036483 539 DFGASRSMAIDQTHM---TTQVQGTFGYLDPEYFRSS------RFTEKSDVYSFGVVLAELLTG----------ERAIRV 599 (721)
Q Consensus 539 DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~t~ksDV~SlGvll~elltG----------~~p~~~ 599 (721)
|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999998765433322 2234699999999999877 445799999999999999999 777754
Q ss_pred CCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
...... .. ...............+. ........+.++.+|+.+||+.||++|||+.||++.|+++
T Consensus 236 ~~~~~~-~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 236 VVPNDP-SF-EDMRKVVCVDQQRPNIP---NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TSCSSC-CH-HHHHHHHTTSCCCCCCC---GGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCCc-ch-hhhhHHHhccCCCCCCC---hhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 332221 11 11111111111100000 0112334667899999999999999999999999999876
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=356.41 Aligned_cols=253 Identities=25% Similarity=0.373 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|++.+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999976 68999999875432 2334678999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997543 5999999999999999999999999 9999999999999999999999999998764332
Q ss_pred c-eeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 551 T-HMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 551 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ . +..........
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~----~~~~~~~~~~~------ 228 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-E----YSDWKEKKTYL------ 228 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-H----HHHHHTTCTTS------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-H----HHHHhcccccC------
Confidence 2 22334569999999999988775 7789999999999999999999965432211 0 11111111000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 229 ---~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 229 ---NPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp ---TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ---CccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 0011233457899999999999999999999765
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=359.53 Aligned_cols=266 Identities=24% Similarity=0.420 Sum_probs=213.6
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCL 460 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~ 460 (721)
++...++|.+.+.||+|+||.||+|... +++.||||.++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4445688999999999999999999962 3568999988653 344567899999999999 8999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCCC--------------------CCccHHHHHHHHHHHHHHHHHHHhcCCCCeeec
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNEE--------------------FPITWEIRLRIAIEVSDAVSYLHSAASIPIYHR 520 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHr 520 (721)
+.+..++||||+++|+|.+++...... ..+++..++.++.||+.||+|||+++ |+||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~ 196 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR 196 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence 999999999999999999999765421 24899999999999999999999999 9999
Q ss_pred cCcCccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccc
Q 036483 521 DIKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIR 598 (721)
Q Consensus 521 Dlk~~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~ 598 (721)
||||+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 99999999999999999999999876543332 2334567889999999999999999999999999999998 999986
Q ss_pred cCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 599 VTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 599 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
...... .+...+... .....+...+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus 277 ~~~~~~------~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 277 GIPVDA------NFYKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TCCCSH------HHHHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred cCCcHH------HHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 543221 111111111 11122223355699999999999999999999999999988654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-41 Score=356.52 Aligned_cols=252 Identities=23% Similarity=0.361 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEV------ 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~------ 464 (721)
.++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.+|++++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467899999999999999999976 68999999886533 3456789999999999999999999999876542
Q ss_pred ---------------------------------------------------ceEEEeeccCCCcchhccccCCCCCccHH
Q 036483 465 ---------------------------------------------------PLLVYEFIINGTLFQYLHDQNEEFPITWE 493 (721)
Q Consensus 465 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~ 493 (721)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 68999999999999999876655567888
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc-----------eeeeeeecCCC
Q 036483 494 IRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT-----------HMTTQVQGTFG 562 (721)
Q Consensus 494 ~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~-----------~~~~~~~gt~~ 562 (721)
.+++++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987654321 11233469999
Q ss_pred CCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHH
Q 036483 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVA 642 (721)
Q Consensus 563 y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 642 (721)
|+|||++.+..++.++||||||+++|||++|..|+.. ... .......... ..........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--------~~~-~~~~~~~~~~---------~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--------RVR-IITDVRNLKF---------PLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--------HHH-HHHHHHTTCC---------CHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--------HHH-HHHHhhccCC---------CcccccCChhHH
Confidence 9999999999999999999999999999998776421 000 1111111111 111123345678
Q ss_pred HHHHHhhccCCCCCCCHHHHHHH
Q 036483 643 KLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 643 ~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+++.+||+.||++|||+.|+++.
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHccCCCCcCCCHHHHhhc
Confidence 99999999999999999999763
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=351.20 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=213.2
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++...++|.+.+.||+|+||.||+|...+++.||+|.++... ...+.+.+|++++++++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 334457899999999999999999999888899999886543 34578999999999999999999999986 4568999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||++++++.+||+|||+++....
T Consensus 86 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp EECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999999975321 25899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
..........++..|+|||.+.+..++.++||||||++++||++ |+.||...... . ....+...
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~-~~~~~~~~-------- 226 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------E-VIQNLERG-------- 226 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------H-HHHHHHTT--------
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------H-HHHHHhcc--------
Confidence 43333333457789999999998999999999999999999999 89998643221 1 11111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus 227 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 270 (279)
T 1qpc_A 227 -YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (279)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -cCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence 11112223345799999999999999999999999999987643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-41 Score=353.36 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=203.5
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..++|.+.+.||+|+||+||+|+..+++.||+|++... .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999987643 2334578899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++ +|.+++.... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFMEK-DLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCSE-EHHHHHHTCT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCCC-CHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 99974 7888776543 25899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch---hhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL---FEIL 625 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 625 (721)
.. ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .............. ....
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD---QLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT---HHHHHHHHHCCCCTTTSGGGT
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHHCCCChHHhhhhh
Confidence 22 2233468999999999876 568999999999999999999999997544332 11112221111100 0000
Q ss_pred -------------hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 626 -------------DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 626 -------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..............++.+|+.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000000011122356889999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=356.20 Aligned_cols=263 Identities=24% Similarity=0.407 Sum_probs=198.7
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcCC----cEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLADG----RIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
...++|.+.+.||+|+||.||+|..... ..||||.++.. .....+.+.+|++++++++||||+++++++.....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 3456899999999999999999996543 27999987653 45567889999999999999999999999988765
Q ss_pred c------eEEEeeccCCCcchhccccC---CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 465 P------LLVYEFIINGTLFQYLHDQN---EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 465 ~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
. ++||||+++++|.+++.... ....+++..+++++.|++.||+|||+.+ |+||||||+|||++.++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 89999999999999996532 2235999999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~ 613 (721)
||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ..
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~---- 249 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---IY---- 249 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH----
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---HH----
Confidence 99999999876433221 2223456788999999999999999999999999999999 899986543221 11
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
..+... .....+...+.++.+++.+||+.||++|||+.++++.|+++...
T Consensus 250 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 250 NYLIGG---------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HHHHTT---------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHhcC---------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111 11122233445699999999999999999999999999988654
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=350.70 Aligned_cols=260 Identities=29% Similarity=0.456 Sum_probs=218.3
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
...++|.+.+.||+|+||.||+|.... ++.||+|.+... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 346789999999999999999999765 889999988653 445678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 89 e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 99999999999976443 36999999999999999999999999 999999999999999999999999999877655
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||....... .. +.+...
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~-------------~~~~~~ 228 (288)
T 3kfa_A 165 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VY-------------ELLEKD 228 (288)
T ss_dssp SSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HH-------------HHHHTT
T ss_pred ccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH-------------HHHhcc
Confidence 4444455567889999999999999999999999999999999 999986543221 11 111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 229 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 229 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 1122233345679999999999999999999999999988754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=367.01 Aligned_cols=260 Identities=24% Similarity=0.368 Sum_probs=210.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++|.+.+.||+|+||+||+|.+. +++.||||+++.. .......+.+|+.++++++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999953 3668999998653 344556799999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCC----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---cEEEe
Q 036483 466 LLVYEFIINGTLFQYLHDQNE----EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVS 538 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~ 538 (721)
++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence 999999999999999986432 235999999999999999999999999 99999999999999554 59999
Q ss_pred eccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHh
Q 036483 539 DFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 539 DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |..||...... . ....+
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~-~~~~i 299 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------E-VLEFV 299 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------H-HHHHH
Confidence 9999986532221 12233457889999999999999999999999999999998 99998643321 1 11111
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.... ....+...+..+.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus 300 ~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 300 TSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 1111 112223344568999999999999999999999999998754
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=360.18 Aligned_cols=271 Identities=28% Similarity=0.429 Sum_probs=219.2
Q ss_pred cccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceee
Q 036483 382 KLFTSKELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVK 454 (721)
Q Consensus 382 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~ 454 (721)
..+..++++...++|.+.+.||+|+||.||+|... .++.||||.+.... ......+.+|+.++++++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 34556667777889999999999999999999864 36789999886533 344567999999999999999999
Q ss_pred EEEEEEeCCcceEEEeeccCCCcchhccccC-------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 455 LLGCCLETEVPLLVYEFIINGTLFQYLHDQN-------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 455 l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.|++.||+|||+++ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 9999999999999999999999999997532 1135799999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEED 605 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~ 605 (721)
|++.++.+||+|||+++......... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~- 248 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ- 248 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-
Confidence 99999999999999998664332211 223457889999999999999999999999999999999 888885432211
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+..... ...+...+..+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 249 ------~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 249 ------VLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp ------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 1111111111 11223344568999999999999999999999999988754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=353.66 Aligned_cols=253 Identities=25% Similarity=0.318 Sum_probs=206.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCch------hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDES------KVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
..++|.+.+.||+|+||.||++... +|+.||+|.++..... ..+.+.+|+.+|++++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999976 5899999987653221 34689999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC----cEEEeec
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY----RAKVSDF 540 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DF 540 (721)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997543 6999999999999999999999999 99999999999998776 7999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... ..+. .+....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~-~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLA-NITAVS 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHTTC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHH-HHHhcC
Confidence 9998765332 223456999999999999999999999999999999999999999643321 1111 111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. .+..... ..+..+.+|+.+||..||++|||+.|+++.
T Consensus 235 ~~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 YD--FDEEFFS----QTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp CC--CCHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CC--CCchhcc----CCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00 0011111 123458899999999999999999999753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-41 Score=362.01 Aligned_cols=273 Identities=16% Similarity=0.217 Sum_probs=209.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccCch-----------hhHHHHHHHHHHhhcCCCceee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVIDES-----------KVDEFINEVAILSQINHRNVVK 454 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~niv~ 454 (721)
..++|.+.+.||+|+||.||+|.+.+ ++.||||.+...... ....+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999765 478999987553321 1123455666778889999999
Q ss_pred EEEEEEeC----CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC
Q 036483 455 LLGCCLET----EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD 530 (721)
Q Consensus 455 l~g~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~ 530 (721)
+++++.+. ...+|||||+ +++|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 3479999999 999999997643 25999999999999999999999998 99999999999999
Q ss_pred --CCCcEEEeeccCccccccCCcee------eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCc
Q 036483 531 --GKYRAKVSDFGASRSMAIDQTHM------TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602 (721)
Q Consensus 531 --~~~~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~ 602 (721)
.++.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332211 1234599999999999999999999999999999999999999974322
Q ss_pred cccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCCC
Q 036483 603 EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTS 676 (721)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~~ 676 (721)
.. ......... ....+.++++..+.. ...+.++.+++.+||+.+|++||++.+|++.|+.+.......
T Consensus 267 ~~--~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~ 334 (364)
T 3op5_A 267 DP--KYVRDSKIR-YRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSK 334 (364)
T ss_dssp CH--HHHHHHHHH-HHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred CH--HHHHHHHHH-hhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 21 111111111 112233333332211 122456899999999999999999999999999887654443
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=359.03 Aligned_cols=256 Identities=22% Similarity=0.399 Sum_probs=204.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|.+.+.||+|+||+||+|... +++ .||+|.+... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888999999999999999965 344 3788876442 2344567889999999999999999999886 456889
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 92 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 999999999999997643 25899999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-------~~~~~~~~------ 233 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKG------ 233 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH-------HHHHHHTT------
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH-------HHHHHHcC------
Confidence 44322 2344568889999999999999999999999999999999 999986543221 11111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.....+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 234 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 234 ---ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp ---CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred ---CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111122233458899999999999999999999999998854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=347.55 Aligned_cols=261 Identities=23% Similarity=0.352 Sum_probs=200.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|.+.+.||+|+||+||+|...+++.||+|++.... ....+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 5788999999999999999999889999999875532 23357889999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++ +|.+++..... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence 975 88888875432 5899999999999999999999999 99999999999999999999999999986543221
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc---hhhh---
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS---LFEI--- 624 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--- 624 (721)
......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ............. ....
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD---QLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHHCCCChhhchhhhcc
Confidence 22334689999999999764 58999999999999999999999986543221 1111111111100 0000
Q ss_pred --hhhhh-------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 625 --LDAHV-------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 625 --~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.++.. ........+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000 00111223456889999999999999999999875
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=343.73 Aligned_cols=254 Identities=22% Similarity=0.348 Sum_probs=207.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+|+.. ++.||||.++.. .....+.|.+|+.++++++||||+++++++.+. ...++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 67889999999999999999985 888999987653 344567899999999999999999999999887 6789999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++..... ..+++..++.++.|++.||+|||+.+. +|+||||||+|||++.++.+||.|||+.......
T Consensus 89 e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp ECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred cccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 99999999999986542 368999999999999999999999763 4999999999999999999999999887543222
Q ss_pred CceeeeeeecCCCCCCccccccCCCCc---cccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTE---KSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
...||+.|+|||.+.+..++. ++||||||+++|||++|+.||...... .........
T Consensus 167 ------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~-------- 226 (271)
T 3kmu_A 167 ------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALE-------- 226 (271)
T ss_dssp ------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHS--------
T ss_pred ------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhc--------
Confidence 235799999999998765544 799999999999999999998643221 111111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
......+...+..+.+++.+||+.||++|||+.|+++.|+.++.
T Consensus 227 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 -GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp -CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11112233345569999999999999999999999999998864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-41 Score=368.48 Aligned_cols=259 Identities=22% Similarity=0.319 Sum_probs=209.7
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
+++...++|.+.++||+|+||+||+++.. +++.||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 44455688999999999999999999976 4889999987542 2234456889999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+++|+|.++++.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a 215 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 215 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEecccee
Confidence 999999999999999999754 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCC----CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSR----FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+..............||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... ..+...+...
T Consensus 216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~ 289 (410)
T 3v8s_A 216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMNHK 289 (410)
T ss_dssp EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTHH
T ss_pred EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHHhcc
Confidence 877554433444567999999999998765 788999999999999999999999643321 1111111110
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCC--CCCHHHHHHHH
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKK--RPTMKEVAVVL 666 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~ev~~~L 666 (721)
.. .........+.++.+|+.+||+.+|++ ||+++||+++-
T Consensus 290 ~~-------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp 331 (410)
T 3v8s_A 290 NS-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 331 (410)
T ss_dssp HH-------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred cc-------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence 00 000001123356899999999999988 99999998763
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=382.16 Aligned_cols=263 Identities=25% Similarity=0.373 Sum_probs=214.2
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++...++|.+.++||+|+||.||+|.+.++..||||+++... ...++|.+|+++|++++|+||+++++++.+ +..+||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 344567789999999999999999999888889999987543 335789999999999999999999999876 678999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.++++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 340 ~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp ECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred eehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999999975321 25899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
..........++..|+|||++....++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~-------~~~~i~~~-------- 480 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERG-------- 480 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH-------HHHHHHTT--------
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC--------
Confidence 22222223346788999999999999999999999999999999 899986432211 11111111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
.....+...+..+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus 481 -~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 481 -YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 111223344567899999999999999999999999999886543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=349.61 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=201.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|++.+.||+|+||+||++... ++.||||++.. ....+.|.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 56888999999999999999985 78899998864 345678999999999999999999999886 45799999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc-EEEeeccCccccccCCce
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR-AKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-~kl~DFGls~~~~~~~~~ 552 (721)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--- 159 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--- 159 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence 9999999987654445789999999999999999999932223999999999999988876 799999999755322
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..... ...... ...
T Consensus 160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~-~~~~~~---------~~~ 224 (307)
T 2eva_A 160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMW-AVHNGT---------RPP 224 (307)
T ss_dssp ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHH-HHHTTC---------CCC
T ss_pred -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHH-HHhcCC---------CCC
Confidence 223458999999999999999999999999999999999999986432211 11111 111111 111
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
.....+..+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus 225 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 265 (307)
T 2eva_A 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265 (307)
T ss_dssp CBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred cccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence 12223456899999999999999999999999999987543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=359.16 Aligned_cols=250 Identities=24% Similarity=0.378 Sum_probs=201.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~l 467 (721)
.++|++.++||+|+||+||+++.+ +++.||+|+++.. .....+.+.+|..++.++ +||||+++++++.+.+..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 467999999999999999999976 4789999987643 334456788999999887 89999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|..++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 131 V~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~ 204 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 204 (396)
T ss_dssp EEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence 999999999999998654 5999999999999999999999999 9999999999999999999999999998633
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc--ccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED--KSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 625 (721)
.. ........||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........+....
T Consensus 205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----- 278 (396)
T 4dc2_A 205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----- 278 (396)
T ss_dssp CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence 22 2233456799999999999999999999999999999999999999965432221 111111112211111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
...+...+.++.+|+.+||+.||++||++
T Consensus 279 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 279 -----IRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred -----cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11223344568999999999999999996
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=347.50 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=196.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--------------------------chhhHHHHHHHHHHh
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--------------------------ESKVDEFINEVAILS 445 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------------------------~~~~~~~~~E~~il~ 445 (721)
.++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 367999999999999999999965 58899999875432 112467899999999
Q ss_pred hcCCCceeeEEEEEEe--CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCc
Q 036483 446 QINHRNVVKLLGCCLE--TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523 (721)
Q Consensus 446 ~l~h~niv~l~g~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk 523 (721)
+++||||+++++++.+ .+..++||||+++++|.+++... .+++..++.++.|++.||+|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999987 55789999999999999876532 5999999999999999999999999 9999999
Q ss_pred CccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCC---CCccccchhHHHHHHHHHhCCcccccC
Q 036483 524 STNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVT 600 (721)
Q Consensus 524 ~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SlGvll~elltG~~p~~~~ 600 (721)
|+|||++.++.+||+|||+++....... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987654322 233456999999999998765 377899999999999999999998643
Q ss_pred CccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 601 NFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 601 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... . ....+...... .......+..+.+++.+||+.||++|||+.|+++
T Consensus 244 ~~~------~-~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIM------C-LHSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHH------H-HHHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHH------H-HHHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 211 1 11111111110 0111123356899999999999999999999865
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=348.55 Aligned_cols=254 Identities=22% Similarity=0.300 Sum_probs=207.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..++|.+.+.||+|+||.||++... +++.+|+|.++.. ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3578999999999999999999976 5889999987643 3445678999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC--CCcEEEeeccCcccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG--KYRAKVSDFGASRSMAI 548 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGls~~~~~ 548 (721)
|+++++|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+++....
T Consensus 82 ~~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~ 156 (321)
T 1tki_A 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred eCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCC
Confidence 999999999997543 25899999999999999999999999 999999999999987 78999999999987654
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. ......||+.|+|||++.+..++.++||||||+++|||++|..||...... ..+..... .... ....
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~-~~~~--~~~~ 225 (321)
T 1tki_A 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMN-AEYT--FDEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH-TCCC--CCHH
T ss_pred CC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHc-CCCC--CChh
Confidence 32 234456999999999999988999999999999999999999999643321 11111111 1110 0000
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
... ..+.++.+++.+||+.||++|||+.|+++.-
T Consensus 226 ~~~----~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 226 AFK----EISIEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp HHT----TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred hhc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 011 1235689999999999999999999998854
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=345.87 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=206.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|.+.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678999999999999999998643 336999987654 34456789999999999999999999999764 45689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999976542 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
...........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ... .+....
T Consensus 165 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~----~~~~~~------ 231 (281)
T 3cc6_A 165 DEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIG----VLEKGD------ 231 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHH----HHHHTC------
T ss_pred cccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHH----HHhcCC------
Confidence 443333334457889999999999999999999999999999998 999986433221 111 111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+..+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 232 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 232 ---RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 111122234568999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=352.77 Aligned_cols=253 Identities=26% Similarity=0.353 Sum_probs=205.4
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc------hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE------SKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
..++|.+.+.||+|+||.||++... +++.||+|.++.... ...+.+.+|+.+|++++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3466899999999999999999976 589999998755322 135789999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC----cEEEeec
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY----RAKVSDF 540 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DF 540 (721)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Df 162 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 162 (326)
T ss_dssp EEEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence 999999999999999997543 6999999999999999999999999 99999999999999887 8999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
|+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .... +....
T Consensus 163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~-~~~~~ 233 (326)
T 2y0a_A 163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLAN-VSAVN 233 (326)
T ss_dssp TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHH-HHHTC
T ss_pred CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------HHHH-HHhcC
Confidence 9998764332 2234569999999999999999999999999999999999999986433211 1111 11100
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. . ....... ..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~-~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 234 Y-E-FEDEYFS----NTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp C-C-CCHHHHT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred C-C-cCccccc----cCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0 0 0000011 123468899999999999999999999874
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.70 Aligned_cols=249 Identities=24% Similarity=0.342 Sum_probs=201.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcce
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~ 466 (721)
..++|++.++||+|+||+||+++.+ +++.||||+++.. .....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3478999999999999999999976 5899999987642 334556788999999998 7999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 101 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 9999999999999997654 5999999999999999999999999 999999999999999999999999999854
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... ....
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~-~~~~----- 241 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAIL-NDEV----- 241 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC-----
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHH-cCCC-----
Confidence 3222 2234457999999999999999999999999999999999999999654321 1111111 1111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM------KEVAV 664 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~ev~~ 664 (721)
..+......+.+|+.+||+.||++||++ .||++
T Consensus 242 -----~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 242 -----VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred -----CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1122234568899999999999999998 66654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=353.58 Aligned_cols=263 Identities=25% Similarity=0.405 Sum_probs=213.6
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc--------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA--------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCL 460 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~ 460 (721)
...++|.+.+.||+|+||.||+|... ++..||||+++.. .....+.+.+|+.+++++ +||||+++++++.
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 111 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 111 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence 34578999999999999999999863 4678999988653 334567899999999999 8999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||+|||+.+ |+||||||+||
T Consensus 112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI 188 (334)
T 2pvf_A 112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV 188 (334)
T ss_dssp SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence 99999999999999999999986432 124899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEED 605 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~ 605 (721)
|++.++.+||+|||+++......... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~- 267 (334)
T 2pvf_A 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE- 267 (334)
T ss_dssp EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence 99999999999999998765433222 233457788999999999999999999999999999999 999986433211
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+.... ....+...+..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 268 ------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~ 319 (334)
T 2pvf_A 268 ------LFKLLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319 (334)
T ss_dssp ------HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHhcCC---------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111 1112233445689999999999999999999999999988654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=352.21 Aligned_cols=271 Identities=28% Similarity=0.416 Sum_probs=217.8
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEE------cCCcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeE
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKL 455 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l 455 (721)
+...++....++|.+.+.||+|+||+||+|.. .+++.||||.++... ....+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 44555666678999999999999999999984 246789999886533 34557899999999999 79999999
Q ss_pred EEEEEeCC-cceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeecc
Q 036483 456 LGCCLETE-VPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRD 521 (721)
Q Consensus 456 ~g~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrD 521 (721)
++++.+.+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998765 48999999999999999986542 123899999999999999999999999 99999
Q ss_pred CcCccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCccccc
Q 036483 522 IKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRV 599 (721)
Q Consensus 522 lk~~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~ 599 (721)
|||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~ 253 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 253 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999999999999999876543322 2334568899999999999999999999999999999998 9999865
Q ss_pred CCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+ . +...+.... ....+...+..+.+++.+||+.+|++|||+.||++.|+.+...
T Consensus 254 ~~~~~--~----~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 311 (316)
T 2xir_A 254 VKIDE--E----FCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 311 (316)
T ss_dssp CCCSH--H----HHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchhH--H----HHHHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 43221 1 111111111 1111222345689999999999999999999999999988643
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=353.18 Aligned_cols=269 Identities=26% Similarity=0.379 Sum_probs=210.7
Q ss_pred CCCCceEeeeCcEEEEEEEEc-----CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--CcceE
Q 036483 396 YNTNRILGQGGQGTVYKGMLA-----DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVPLL 467 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~~l 467 (721)
|.+.+.||+|+||+||++.+. +++.||||+++... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999998643 57899999986543 34567899999999999999999999999884 56789
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 113 v~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 99999999999999765 3899999999999999999999999 9999999999999999999999999998775
Q ss_pred cCCce--eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTH--MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ..............+.+.+
T Consensus 186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 264 (318)
T 3lxp_A 186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTELL 264 (318)
T ss_dssp TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHHHH
T ss_pred ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHHHH
Confidence 43322 22334578889999999999999999999999999999999999853221100 0000000000011122222
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
........+...+.++.+|+.+||+.+|++|||+.|+++.|+.+...
T Consensus 265 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 311 (318)
T 3lxp_A 265 ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK 311 (318)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence 22222333444556799999999999999999999999999988643
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=341.17 Aligned_cols=266 Identities=20% Similarity=0.258 Sum_probs=211.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEE-EeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC-LETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~-~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||.||+|+. .+++.||||.+.... ..+.+.+|+.++++++|++++..+..+ .+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 57899999999999999999996 568999999875432 335789999999999988866666555 56667799999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~~~~ 547 (721)
|+ +++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999975432 5999999999999999999999999 9999999999999 488899999999998765
Q ss_pred cCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 548 IDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 548 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 239 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence 43321 123456999999999999999999999999999999999999999765443333322222211111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
. .. ....+.++.+++.+||+.+|++|||+.+|++.|+.+......
T Consensus 240 ~-----~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 240 E-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp H-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred H-----HH----HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 0 01 112235689999999999999999999999999998765543
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=343.44 Aligned_cols=268 Identities=20% Similarity=0.257 Sum_probs=208.0
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEE-EeCCcceEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC-LETEVPLLV 468 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~-~~~~~~~lv 468 (721)
...++|.+.+.||+|+||.||+|+. .+++.||||..... ...+.+.+|+.++++++|++++..++.+ .+.+..++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccc--ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999996 46889999975442 2335688999999999988877766655 566778999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~~ 545 (721)
|||+ +++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||+++.
T Consensus 84 ~e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred EEcc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 9999 9999999975432 5999999999999999999999999 9999999999999 7889999999999987
Q ss_pred cccCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 546 MAIDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 546 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......................
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence 6543221 1234568999999999999999999999999999999999999997654443333322221111111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
... .. ....+.++.+++.+||+.+|++|||+.+|++.|+++....+.
T Consensus 238 ~~~-----~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 238 PIE-----VL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp CHH-----HH----TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred hhh-----hh----hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 110 00 111235699999999999999999999999999998765443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=353.80 Aligned_cols=257 Identities=23% Similarity=0.462 Sum_probs=202.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
.++|.+.++||+|+||+||+|... +++ .||+|.+.. ......+.+.+|+.++++++||||+++++++.... .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367999999999999999999965 344 357777644 33445678999999999999999999999998765 78
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+|+|++.+|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999987543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 547 AIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 547 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ + .. .
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~----~~---------~ 231 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I----SS---------I 231 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HH---------H
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H----HH---------H
Confidence 433222 2233446788999999999999999999999999999999 999986543322 1 11 1
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+........+...+.++.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11111112233344568999999999999999999999999998864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=352.87 Aligned_cols=264 Identities=26% Similarity=0.414 Sum_probs=208.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-----cCCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--Ccc
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLET--EVP 465 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~--~~~ 465 (721)
++|++.+.||+|+||.||++++ .+++.||+|+++.. .....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 5588899999999999999984 35889999987643 334567899999999999999999999999877 567
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 899999999999999966443 5999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc-----
Q 036483 546 MAIDQTH--MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE----- 618 (721)
Q Consensus 546 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 618 (721)
....... ......+|..|+|||.+.+..++.++||||||+++|||++|..|+.... ..+......
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~~ 247 (302)
T 4e5w_A 176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM--------ALFLKMIGPTHGQM 247 (302)
T ss_dssp CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH--------HHHHHHHCSCCGGG
T ss_pred ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchh--------hHHhhccCCccccc
Confidence 7544322 2233457888999999999999999999999999999999998864221 001111000
Q ss_pred --cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 619 --DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 619 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..+...+........+...+..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 248 TVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 0011111111122233345567999999999999999999999999998764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=343.70 Aligned_cols=255 Identities=32% Similarity=0.561 Sum_probs=203.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCch-------hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDES-------KVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-------~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
.++|.+.+.||+|+||+||+|+.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 367999999999999999999975 6899999987543221 1268999999999999999999999986543
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc-----EEEee
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR-----AKVSD 539 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~-----~kl~D 539 (721)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++. +||+|
T Consensus 97 -~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDKA--HPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred -eEEEEecCCCCHHHHHhccc--CCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 79999999999999887644 36999999999999999999999986 34999999999999988776 99999
Q ss_pred ccCccccccCCceeeeeeecCCCCCCccccc--cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFR--SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 540 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
||+++.... ......||+.|+|||.+. ...++.++||||||+++|||++|+.||........ . ......
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~-~~~~~~ 243 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----K-FINMIR 243 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----H-HHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----H-HHHHHh
Confidence 999975432 233456899999999984 45678999999999999999999999964432211 1 111111
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.. ......+...+..+.+++.+||+.||++|||+.|+++.|+++
T Consensus 244 ~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 244 EE--------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HS--------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred cc--------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 11 111122333456799999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.31 Aligned_cols=255 Identities=23% Similarity=0.362 Sum_probs=205.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-C-------cEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-G-------RIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
.++|.+.+.||+|+||+||+|.... + ..||+|.+........+.+.+|+.++++++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 3678899999999999999998653 3 4799999877666777889999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc--------EE
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR--------AK 536 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--------~k 536 (721)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK--NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 999999999999999998653 24899999999999999999999999 999999999999998877 99
Q ss_pred EeeccCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
|+|||++...... ....+|+.|+|||.+.+ ..++.++||||||+++|||++|..|+...... .. ....
T Consensus 162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-----~~-~~~~ 230 (289)
T 4fvq_A 162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-----QR-KLQF 230 (289)
T ss_dssp ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-----HH-HHHH
T ss_pred eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-----HH-HHHH
Confidence 9999999755322 22358999999999987 67999999999999999999965544322111 00 0011
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
.... ...+...+.++.+++.+||+.||++|||+.|+++.|+.+.....
T Consensus 231 ~~~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~ 278 (289)
T 4fvq_A 231 YEDR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDL 278 (289)
T ss_dssp HHTT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred hhcc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence 1110 01111123458899999999999999999999999999876443
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=356.70 Aligned_cols=266 Identities=26% Similarity=0.363 Sum_probs=213.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-----cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~ 466 (721)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|++++++++||||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 6789999999999999999984 3588999999887767777889999999999999999999999874 45678
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 103 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999976432 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc------
Q 036483 547 AIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE------ 618 (721)
Q Consensus 547 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------ 618 (721)
....... .....+|..|+|||++.+..++.++||||||+++|||++|+.||....... ......
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~--------~~~~~~~~~~~~ 249 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF--------LRMMGCERDVPA 249 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH--------HHHCC----CCH
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh--------hhhccccccccc
Confidence 5433222 223457888999999999999999999999999999999999985322110 000000
Q ss_pred -cchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 619 -DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 619 -~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
..+.+.+........+...+..+.+|+.+||+.||++|||+.|+++.|+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred HHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 011112222222233444556799999999999999999999999999988653
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=354.99 Aligned_cols=254 Identities=23% Similarity=0.347 Sum_probs=206.4
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
...++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 44678999999999999999999975 5899999987543 34456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---cEEEeeccCcc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDFGASR 544 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGls~ 544 (721)
||||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++
T Consensus 106 v~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~ 179 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAI 179 (362)
T ss_dssp EECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred EEecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence 999999999999887543 6899999999999999999999999 99999999999998654 59999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... . ....+...... .
T Consensus 180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~-~~~~i~~~~~~-~ 249 (362)
T 2bdw_A 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------R-LYAQIKAGAYD-Y 249 (362)
T ss_dssp CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHTCCC-C
T ss_pred EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHhCCCC-C
Confidence 765322 223456999999999999999999999999999999999999998643221 1 11111111110 0
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS-----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT-----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc-----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0001223568999999999999999999999765
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=356.72 Aligned_cols=267 Identities=23% Similarity=0.386 Sum_probs=214.9
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEcC------CcEEEEeeccccC-chhhHHHHHHHHHHhhc-CCCceeeEEEE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLAD------GRIVAIKKSKVID-ESKVDEFINEVAILSQI-NHRNVVKLLGC 458 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~l~g~ 458 (721)
++++...++|.+.+.||+|+||.||+|.... .+.||+|.++... ....+.+.+|+.+++++ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3455566889999999999999999999643 2479999886543 34567899999999999 89999999999
Q ss_pred EEeCCcceEEEeeccCCCcchhccccC-----------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 459 CLETEVPLLVYEFIINGTLFQYLHDQN-----------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 459 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
+.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 999999999999999999999997532 1235899999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEED 605 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~ 605 (721)
|++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.......
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~- 274 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS- 274 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH-
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH-
Confidence 9999999999999999876443322 2234457889999999999999999999999999999998 888986433211
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.+...... ......+...+..+.+++.+||+.+|++|||+.||++.|+.+..
T Consensus 275 -----~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 275 -----KFYKLVKD---------GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp -----HHHHHHHH---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----HHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 11111111 11111122234568999999999999999999999999987753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=357.23 Aligned_cols=253 Identities=20% Similarity=0.269 Sum_probs=208.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+|++++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 478999999999999999999976 5889999988765555667899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC--CCcEEEeeccCccccccC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG--KYRAKVSDFGASRSMAID 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGls~~~~~~ 549 (721)
+++++|.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 130 ~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 99999999997543 25999999999999999999999999 999999999999974 578999999999876543
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .... .+...... .
T Consensus 205 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~-~i~~~~~~------~ 269 (387)
T 1kob_A 205 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQ-NVKRCDWE------F 269 (387)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHHCCCC------C
T ss_pred c--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHH-HHHhCCCC------C
Confidence 2 233446999999999999999999999999999999999999999643321 1111 11111100 0
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 270 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 270 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 011112234568999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=357.18 Aligned_cols=266 Identities=28% Similarity=0.454 Sum_probs=213.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-----cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC--cc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-----ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE--VP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~--~~ 465 (721)
.++|.+.+.||+|+||.||+++. .+++.||||++........+.+.+|+.++++++||||+++++++...+ ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 46788999999999999999984 358899999988776777789999999999999999999999987654 67
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~ 194 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV 194 (326)
T ss_dssp EEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence 899999999999999986542 5899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc----
Q 036483 546 MAIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED---- 619 (721)
Q Consensus 546 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~---- 619 (721)
........ .....++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+.......
T Consensus 195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~--------~~~~~~~~~~~~~ 266 (326)
T 2w1i_A 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA--------EFMRMIGNDKQGQ 266 (326)
T ss_dssp CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH--------HHHHHHCTTCCTH
T ss_pred ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH--------HHHHhhccccchh
Confidence 75443221 1223467789999999998999999999999999999999988753210 011111110
Q ss_pred ----chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 620 ----SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 620 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.+.+.+........+...+.++.+++.+||+.+|++|||+.||++.|+.++.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 267 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 0111111111122233455679999999999999999999999999998864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=357.62 Aligned_cols=267 Identities=18% Similarity=0.260 Sum_probs=204.7
Q ss_pred hcCCCCCceEeee--CcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQG--GQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|++.++||+| +||+||+++.. +++.||||+++.. .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4679999999999 99999999976 6899999987653 34456788899999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++...... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 99999999999999865322 5999999999999999999999999 9999999999999999999999999986543
Q ss_pred cCCce------eeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh--
Q 036483 548 IDQTH------MTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK-- 617 (721)
Q Consensus 548 ~~~~~------~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~-- 617 (721)
..... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ...........
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~ 257 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCL 257 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT--HHHHC--------
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhcCCCCcc
Confidence 22111 1122358889999999987 579999999999999999999999996543221 11100000000
Q ss_pred -------cc-------------chhhhhhh---------hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 618 -------ED-------------SLFEILDA---------HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 618 -------~~-------------~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. .+.+.+.. ..........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp ------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 00 00000000 00001122334568999999999999999999999865
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=344.88 Aligned_cols=260 Identities=27% Similarity=0.450 Sum_probs=197.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.++||+|+||+||+|+..+ .+|+|.++.. .....+.|.+|+.++++++||||++++++. .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 5679999999999999999998643 5999987653 344567899999999999999999999965 4566899999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 174 (289)
T 3og7_A 100 WCEGSSLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174 (289)
T ss_dssp CCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred ecCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccc
Confidence 999999999997543 35999999999999999999999999 9999999999999999999999999997654321
Q ss_pred -ceeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 551 -THMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 551 -~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
........||+.|+|||.+. +..++.++||||||+++|||++|+.||......+ ..............
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~~~~~~-- 246 (289)
T 3og7_A 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVGRGSLSPD-- 246 (289)
T ss_dssp ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHHHTSCCCC--
T ss_pred ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhcccccCcc--
Confidence 22233456899999999987 5678889999999999999999999986433211 11122222111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
........+..+.+|+.+||+.+|++|||+.++++.|+.+..
T Consensus 247 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 247 ---LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp ---TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ---hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 011122344679999999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=350.81 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=201.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.+.||+|+||.||+++.+ +++.||+|+++.. .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 57899999999999999999976 4889999987643 334566789999999988 899999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 89 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~ 162 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162 (345)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence 99999999999997654 5999999999999999999999999 99999999999999999999999999986432
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccc--cHHHHHHHHhhccchhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK--SLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 626 (721)
.. .......||+.|+|||++.+..++.++||||||+++|||++|+.||......... .........+....
T Consensus 163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 235 (345)
T 3a8x_A 163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 235 (345)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence 22 2234457999999999999999999999999999999999999999653322110 11111111111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
...+...+.++.+|+.+||+.||++||++
T Consensus 236 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 236 ----IRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11222344568999999999999999996
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=345.09 Aligned_cols=262 Identities=23% Similarity=0.335 Sum_probs=200.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|++.+.||+|+||+||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999976 5889999987643 33445788999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++ +|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 5555554433 25999999999999999999999999 9999999999999999999999999998764322
Q ss_pred ceeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh---hhhh
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF---EILD 626 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 626 (721)
. ......||+.|+|||++.+.. ++.++||||||++++||++|..|+....... ................ ....
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH--HHHHHHHHHhCCCChhhhhhhcc
Confidence 2 223346899999999998765 8999999999999999999888864322211 1111111111111000 0000
Q ss_pred ------------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 627 ------------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 627 ------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.............++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 00001111234456889999999999999999999976
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=343.64 Aligned_cols=257 Identities=26% Similarity=0.394 Sum_probs=209.5
Q ss_pred cCCCCCc-eEeeeCcEEEEEEEEc---CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNR-ILGQGGQGTVYKGMLA---DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.+ .||+|+||.||+|... ++..||||.++.. .....+.+.+|++++++++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 9999999999999854 5778999998764 344567899999999999999999999999 55678999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 88 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHhCC--ccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 99999999999997543 35999999999999999999999999 99999999999999999999999999987754
Q ss_pred CCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 549 DQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 549 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+...
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-------~~~~i~~~------ 229 (287)
T 1u59_A 163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG------ 229 (287)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTT------
T ss_pred CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH-------HHHHHhcC------
Confidence 33322 122346789999999998899999999999999999998 999986433211 11111111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.....+...+..+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 230 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 273 (287)
T 1u59_A 230 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273 (287)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122334456799999999999999999999999999988654
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=348.51 Aligned_cols=264 Identities=23% Similarity=0.344 Sum_probs=208.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~~l 467 (721)
.++|.+.+.||+|+||.||++.. .+++.||||++........+.+.+|+.++++++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 47899999999999999999997 4689999998876666777889999999999999999999999873 346789
Q ss_pred EEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 468 VYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 999999999999997631 2346999999999999999999999998 999999999999999999999999998765
Q ss_pred ccCCce--------eeeeeecCCCCCCccccccCC---CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 547 AIDQTH--------MTTQVQGTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 547 ~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
...... ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||........ ...
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~------ 257 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVA------ 257 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHH------
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhh------
Confidence 321110 011234699999999987654 68899999999999999999999853211110 111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
..+............+..+.+++.+||+.||++|||+.++++.|+.+....
T Consensus 258 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 258 -------LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp -------HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred -------HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 111111111112233456999999999999999999999999999987543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-40 Score=347.82 Aligned_cols=246 Identities=21% Similarity=0.251 Sum_probs=194.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~l 467 (721)
..++|+..++||+|+||+||+|+.. +++.||||++... .......+..|+..+.++ +||||+++++++.+.+..++
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3467999999999999999999976 6899999986542 233444566666666665 89999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+ +++|.+++..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 135 v~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~ 208 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG 208 (311)
T ss_dssp EEECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred EEecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence 99999 7789988876543 5999999999999999999999998 9999999999999999999999999997664
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... ......||+.|+|||++.+ .++.++||||||+++|||++|..++.... ....+..... .+
T Consensus 209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~----------~~~~~~~~~~----~~ 271 (311)
T 3p1a_A 209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE----------GWQQLRQGYL----PP 271 (311)
T ss_dssp --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH----------HHHHHTTTCC----CH
T ss_pred cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc----------HHHHHhccCC----Cc
Confidence 322 2334458999999999876 78999999999999999999977653211 0111111111 11
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... ...+.++.+++.+||+.||++|||+.|+++
T Consensus 272 ~~~----~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 EFT----AGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HHH----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccc----cCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 122356899999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=344.74 Aligned_cols=272 Identities=23% Similarity=0.322 Sum_probs=207.1
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc--CCCceeeEEEEEEeC-
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI--NHRNVVKLLGCCLET- 462 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l--~h~niv~l~g~~~~~- 462 (721)
........++|.+.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 104 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGT 104 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence 3344556688999999999999999999986 889999987532 234556666666655 899999999999887
Q ss_pred ---CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc--------CCCCeeeccCcCccEEECC
Q 036483 463 ---EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA--------ASIPIYHRDIKSTNILLDG 531 (721)
Q Consensus 463 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~--------~~~~ivHrDlk~~NIll~~ 531 (721)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+. + |+||||||+|||++.
T Consensus 105 ~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~ 177 (337)
T 3mdy_A 105 GSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKK 177 (337)
T ss_dssp GGGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECT
T ss_pred CCCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECC
Confidence 6789999999999999999754 499999999999999999999998 6 999999999999999
Q ss_pred CCcEEEeeccCccccccCCcee---eeeeecCCCCCCccccccCCCCcc------ccchhHHHHHHHHHhC---------
Q 036483 532 KYRAKVSDFGASRSMAIDQTHM---TTQVQGTFGYLDPEYFRSSRFTEK------SDVYSFGVVLAELLTG--------- 593 (721)
Q Consensus 532 ~~~~kl~DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDV~SlGvll~elltG--------- 593 (721)
++.+||+|||+++......... .....||+.|+|||++.+...+.+ +||||||+++|||++|
T Consensus 178 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~ 257 (337)
T 3mdy_A 178 NGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE 257 (337)
T ss_dssp TSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred CCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccc
Confidence 9999999999997764332221 123469999999999988777665 9999999999999999
Q ss_pred -CcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 594 -ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 594 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
+.||........ .................... .......+.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 258 ~~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~ 332 (337)
T 3mdy_A 258 YQLPYHDLVPSDP--SYEDMREIVCIKKLRPSFPN---RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332 (337)
T ss_dssp CCCTTTTTSCSSC--CHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ccccHhhhcCCCC--chhhhHHHHhhhccCccccc---cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhh
Confidence 555543222111 11111111111111000000 011235677899999999999999999999999999998765
Q ss_pred C
Q 036483 673 D 673 (721)
Q Consensus 673 ~ 673 (721)
.
T Consensus 333 ~ 333 (337)
T 3mdy_A 333 Q 333 (337)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=351.10 Aligned_cols=258 Identities=26% Similarity=0.447 Sum_probs=203.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|...+.||+|+||.||+|.... +..||||.++.. .......+.+|+.++++++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 567778999999999999998653 236999988653 33456689999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++..... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 124 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999976432 5999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 548 IDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 548 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....+...
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~-~~~~~~~~----- 266 (333)
T 1mqb_A 199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------E-VMKAINDG----- 266 (333)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHTT-----
T ss_pred cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------H-HHHHHHCC-----
Confidence 332211 122346778999999999999999999999999999999 99998543221 1 11111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.....+...+..+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus 267 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 267 ----FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp ----CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ----CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11112223455689999999999999999999999999988653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=364.01 Aligned_cols=262 Identities=22% Similarity=0.300 Sum_probs=209.7
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
.+++....++|++.++||+|+||+||+++.+ +++.||||+++.. .....+.+.+|+.++.+++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455556789999999999999999999975 6899999987642 23345678999999999999999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+..+|||||+++|+|.+++.+... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999986432 5899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccc-------cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFR-------SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 614 (721)
+++..............||+.|+|||++. ...++.++||||||+++|||++|+.||...... ..+..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~ 281 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETYGK 281 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 99877554443344567999999999997 356899999999999999999999999653321 11111
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCC---CCHHHHHHH
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKR---PTMKEVAVV 665 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ev~~~ 665 (721)
.+....... ........+.++.+|+.+||. +|++| |+++||+++
T Consensus 282 i~~~~~~~~------~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEHLS------LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHHCC------CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccCcC------CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 111000000 000112234568999999999 99998 588888664
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.34 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=199.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCC--CceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINH--RNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h--~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+|.+++| +||+++++++.+.+..++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999987543 34456789999999999976 9999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|| +.+++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 88 ~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 56889999998654 6899999999999999999999999 99999999999997 57899999999987654
Q ss_pred CCce-eeeeeecCCCCCCcccccc-----------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 549 DQTH-MTTQVQGTFGYLDPEYFRS-----------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 549 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... ....+.
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~--- 231 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH--- 231 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-----HHHHHH---
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-----HHHHHH---
Confidence 3322 2334569999999999865 6788999999999999999999999853221 111111
Q ss_pred hccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.+++.......+...+..+.+|+.+||+.||++|||+.|+++..
T Consensus 232 ------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 232 ------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp ------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 12222222222223345689999999999999999999998764
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.01 Aligned_cols=267 Identities=16% Similarity=0.224 Sum_probs=201.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeeccccCch-----------hhHHHHHHHHHHhhcCCCceeeEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVIDES-----------KVDEFINEVAILSQINHRNVVKLLG 457 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~E~~il~~l~h~niv~l~g 457 (721)
.++|.+.+.||+|+||.||+|... .+..+|||+....... ....+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 367999999999999999999975 4678999987653321 1234678899999999999999999
Q ss_pred EEEe----CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 458 CCLE----TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 458 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9988 67889999999 999999998654 6999999999999999999999998 99999999999998877
Q ss_pred --cEEEeeccCccccccCCcee------eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc
Q 036483 534 --RAKVSDFGASRSMAIDQTHM------TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605 (721)
Q Consensus 534 --~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~ 605 (721)
.+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~- 267 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP- 267 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH-
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc-
Confidence 99999999998764332111 133469999999999999999999999999999999999999996422111
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
............. +...+.... .....+.++.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus 268 -~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~ 329 (345)
T 2v62_A 268 -VAVQTAKTNLLDE-LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGIP 329 (345)
T ss_dssp -HHHHHHHHHHHHT-TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCC
T ss_pred -HHHHHHHHhhccc-ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCCc
Confidence 1111111111110 111110000 0012344699999999999999999999999999987653
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=352.68 Aligned_cols=256 Identities=21% Similarity=0.307 Sum_probs=204.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-----CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-----DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
..++|.+.+.||+|+||+||++... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999975 5899999987532 122457899999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc---EEEeecc
Q 036483 466 LLVYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR---AKVSDFG 541 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFG 541 (721)
++||||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999988876432 2335899999999999999999999999 999999999999986654 9999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..+. .+.....
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~-~i~~~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFE-GIIKGKY 249 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHH-HHHHTCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHH-HHHcCCC
Confidence 9987654322 23345699999999999999999999999999999999999999964211 1111 1111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ..+.... ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 250 ~--~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQWS----HISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCccccc----cCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 0000011 123468999999999999999999999864
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=342.41 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=206.3
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC-C---cEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc-eEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD-G---RIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP-LLV 468 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~-~lv 468 (721)
.|...++||+|+||+||+|...+ + ..+|+|.++... ....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45667899999999999998543 2 379999876533 34567899999999999999999999999876655 999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ--RNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 99999999999997643 35899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCc---eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 549 DQT---HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 549 ~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
... .......+++.|+|||.+.+..++.++||||||+++|||++|..|+...... ..... .+...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~--~~~~~----~~~~~------ 244 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDP--FDLTH----FLAQG------ 244 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCG--GGHHH----HHHTT------
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCH--HHHHH----HhhcC------
Confidence 221 1122345788999999999999999999999999999999966554322111 11111 11111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
.....+...+..+.+++.+||+.+|++|||+.++++.|+.+......
T Consensus 245 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 245 ---RRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred ---CCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 11112223345689999999999999999999999999998765443
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-40 Score=346.16 Aligned_cols=245 Identities=26% Similarity=0.356 Sum_probs=204.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+++.. +|+.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 67899999999999999999976 5899999987542 2234567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~ 159 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 159 (318)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence 9999999999998653 5899999999999999999999999 999999999999999999999999999865422
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+...... ..
T Consensus 160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-~~-------- 220 (318)
T 1fot_A 160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-EL-------- 220 (318)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-CC--------
T ss_pred ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC-CC--------
Confidence 23456999999999999999999999999999999999999999643221 111111111 11
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+...+.++.+++.+||+.+|++|| +++||+++
T Consensus 221 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 221 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 11222345689999999999999999 88888654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=362.13 Aligned_cols=255 Identities=22% Similarity=0.295 Sum_probs=205.9
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
...++|.+.+.||+|+||+||++... +|+.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 45678999999999999999999865 68899999875432 3456779999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC---CCCcEEEeeccCcc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD---GKYRAKVSDFGASR 544 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGls~ 544 (721)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999987654 5999999999999999999999999 99999999999998 46789999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... . ....+..+... .
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~-~~~~i~~~~~~-~ 232 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------R-LYQQIKAGAYD-F 232 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCCC-C
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------H-HHHHHHhCCCC-C
Confidence 7654322 223456999999999999999999999999999999999999998543211 1 11112111110 0
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 233 -----~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 233 -----PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp -----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 000011234568999999999999999999999874
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=356.56 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=204.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 67999999999999999999976 4889999987542 2345678899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999997643 5999999999999999999999999 999999999999999999999999999876433
Q ss_pred CceeeeeeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.......||+.|+|||++.. ..++.++||||||+++|||++|+.||............ ..+....
T Consensus 169 --~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~----~~~~~~~------ 236 (384)
T 4fr4_A 169 --TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV----HTFETTV------ 236 (384)
T ss_dssp --CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH----HHHHHCC------
T ss_pred --CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH----HHHhhcc------
Confidence 22345679999999999974 45899999999999999999999999654332211111 1111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-MKEVAV 664 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~ 664 (721)
...+...+..+.+|+.+||+.||++||+ +.+|.+
T Consensus 237 ----~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 237 ----VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1122233456899999999999999998 666654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=357.07 Aligned_cols=258 Identities=28% Similarity=0.456 Sum_probs=197.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEcC--C--cEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-CCcceEE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLAD--G--RIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLE-TEVPLLV 468 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~~~~~lv 468 (721)
.|.+.++||+|+||+||+|.+.+ + ..||+|.++.. +....++|.+|+.++++++||||+++++++.+ .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999998642 2 36899987653 34567889999999999999999999999765 4577999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.+++..... .+++..++.++.||++||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 170 ~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999976433 5899999999999999999999999 99999999999999999999999999986643
Q ss_pred CCce---eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 549 DQTH---MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 549 ~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
.... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+ ... .+....
T Consensus 245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~---~~~----~~~~~~---- 313 (373)
T 3c1x_A 245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGR---- 313 (373)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC---HHH----HHHTTC----
T ss_pred cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH---HHH----HHHcCC----
Confidence 2211 1233457788999999999999999999999999999999 667765433221 111 111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
....+...+..+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus 314 -----~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~ 357 (373)
T 3c1x_A 314 -----RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 357 (373)
T ss_dssp -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 11112233456899999999999999999999999999886543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.91 Aligned_cols=262 Identities=24% Similarity=0.297 Sum_probs=204.8
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-----CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-----DESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
++..+.++|.+.+.||+|+||+||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 45677889999999999999999999975 5889999986542 34566789999999999999999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccC-------------------------------------CCCCccHHHHHHHHHHHHH
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQN-------------------------------------EEFPITWEIRLRIAIEVSD 504 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~qia~ 504 (721)
.+..++||||+++|+|.+++.... ....+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999986210 1223567888999999999
Q ss_pred HHHHHHhcCCCCeeeccCcCccEEECCCC--cEEEeeccCccccccCCc---eeeeeeecCCCCCCcccccc--CCCCcc
Q 036483 505 AVSYLHSAASIPIYHRDIKSTNILLDGKY--RAKVSDFGASRSMAIDQT---HMTTQVQGTFGYLDPEYFRS--SRFTEK 577 (721)
Q Consensus 505 ~L~yLH~~~~~~ivHrDlk~~NIll~~~~--~~kl~DFGls~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~k 577 (721)
||+|||+.+ |+||||||+|||++.++ .+||+|||+++.+..... .......||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 999999999 99999999999998766 899999999986643221 12344569999999999975 678999
Q ss_pred ccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC
Q 036483 578 SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657 (721)
Q Consensus 578 sDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 657 (721)
+||||||+++|||++|+.||......+ ............. . ......+..+.+|+.+||+.+|++||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~--~-----~~~~~~~~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDAD------TISQVLNKKLCFE--N-----PNYNVLSPLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCTT--S-----GGGGGSCHHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChHH------HHHHHHhcccccC--C-----cccccCCHHHHHHHHHHcCCChhHCC
Confidence 999999999999999999986443221 1111111111100 0 00111235689999999999999999
Q ss_pred CHHHHHHH
Q 036483 658 TMKEVAVV 665 (721)
Q Consensus 658 t~~ev~~~ 665 (721)
|+.|+++.
T Consensus 324 s~~~~l~h 331 (345)
T 3hko_A 324 DAMRALQH 331 (345)
T ss_dssp CHHHHHHS
T ss_pred CHHHHhcC
Confidence 99999874
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=351.96 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=203.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36799999999999999999996 46899999987542 123346789999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+ +|+|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 788988887654 5999999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ...+..
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~----------------~~~i~~ 222 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL----------------FKKVNS 222 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC----------------BCCCCS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH----------------HHHHHc
Confidence 32 2234469999999999998876 6899999999999999999999965332211 000000
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
. ....+...+..+.+|+.+||+.||++|||+.|+++.-
T Consensus 223 ~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 C-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp S-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred C-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 0 0112223345689999999999999999999997753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-40 Score=377.75 Aligned_cols=255 Identities=25% Similarity=0.386 Sum_probs=203.9
Q ss_pred CCCCCc-eEeeeCcEEEEEEEEc---CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 395 HYNTNR-ILGQGGQGTVYKGMLA---DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 395 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++.+.+ .||+|+||.||+|.+. ++..||||.++.. .....++|.+|+++|++++||||+++++++.. +..++||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999864 4567999998764 34467889999999999999999999999976 5689999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 415 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 9999999999997543 35999999999999999999999999 999999999999999999999999999876543
Q ss_pred Cceee--eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 550 QTHMT--TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 550 ~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
..... ....+++.|+|||++.+..++.++||||||++||||++ |+.||......+ ....+..+
T Consensus 490 ~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~------- 555 (613)
T 2ozo_A 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG------- 555 (613)
T ss_dssp ------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH-------HHHHHHTT-------
T ss_pred CceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH-------HHHHHHcC-------
Confidence 32221 22335689999999999999999999999999999998 999986543221 11111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.....+...+.++.+|+.+||+.+|++||++.+|++.|+.+..
T Consensus 556 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 598 (613)
T 2ozo_A 556 --KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 598 (613)
T ss_dssp --CCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1122334455679999999999999999999999999988754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=349.51 Aligned_cols=251 Identities=23% Similarity=0.304 Sum_probs=181.3
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEeeccCCC
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIINGT 476 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gs 476 (721)
.+.||+|+||+||++... +++.||||++.. .....+.+|+.+++++. ||||+++++++.+....++||||+++++
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 478999999999999976 589999998753 34467889999999996 9999999999999999999999999999
Q ss_pred cchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---cEEEeeccCccccccCCcee
Q 036483 477 LFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY---RAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 477 L~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~---~~kl~DFGls~~~~~~~~~~ 553 (721)
|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++....... .
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~ 165 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P 165 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence 999998653 6999999999999999999999999 99999999999997665 899999999986643322 2
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..................+....... ..+.
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 3345689999999999999999999999999999999999999975443221111112222222221100 0000
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+.++.+|+.+||+.||++|||+.|+++.
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 01234568999999999999999999998643
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=345.49 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=206.9
Q ss_pred hcCCCCCc-eEeeeCcEEEEEEEEc---CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 393 TDHYNTNR-ILGQGGQGTVYKGMLA---DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 393 ~~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
.++|.+.+ .||+|+||+||+|... .++.||||.++.. +....+++.+|+.++++++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46778777 9999999999999643 3678999987653 233467899999999999999999999999 667789
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 94 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 9999999999999998643 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceee--eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 547 AIDQTHMT--TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 547 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
........ ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ....+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~~~~~~~~~--- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGE--- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTC---
T ss_pred ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HHHHHHcCC---
Confidence 54433222 22346788999999999889999999999999999999 999986433211 111111111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+..+.+++.+||+.||++||++.+|++.|+++-.
T Consensus 238 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 238 ------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 112233345679999999999999999999999999998753
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=342.73 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=203.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe-CCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLE-TEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-~~~~~l 467 (721)
.+|.+.++||+|+||+||+|...+ ...+|+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 568888999999999999998643 236899987653 34456789999999999999999999998654 457799
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHCTT--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 999999999999997643 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCc---eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhC-CcccccCCccccccHHHHHHHHhhccchhh
Q 036483 548 IDQT---HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG-ERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 548 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.... .......+|+.|+|||.+.+..++.++||||||++++||++| .+||......+ ... ......
T Consensus 180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~----~~~~~~--- 249 (298)
T 3f66_A 180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITV----YLLQGR--- 249 (298)
T ss_dssp CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHH----HHHTTC---
T ss_pred ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhcCC---
Confidence 3322 122334578899999999999999999999999999999994 55554322211 111 111110
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+...+..+.+++.+||+.+|++|||+.|+++.|+.+...
T Consensus 250 ------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 250 ------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp ------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred ------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111222345689999999999999999999999999988654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=350.85 Aligned_cols=245 Identities=22% Similarity=0.281 Sum_probs=205.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+++.. +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 67999999999999999999976 5899999987542 2345678899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~ 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC
Confidence 9999999999998654 5899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+.....
T Consensus 195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~~-------- 255 (350)
T 1rdq_E 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIY-EKIVSGKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCC--------
T ss_pred ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHH-HHHHcCCC--------
Confidence 23456999999999999999999999999999999999999999643221 111 11111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
..+...+.++.+++.+||+.||++||+ ++||++.
T Consensus 256 --~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 112233456899999999999999998 7777653
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=356.50 Aligned_cols=273 Identities=24% Similarity=0.284 Sum_probs=211.8
Q ss_pred CCccccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-----CCce
Q 036483 379 DKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-----HRNV 452 (721)
Q Consensus 379 ~~~~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----h~ni 452 (721)
+....++.++.....++|.+.++||+|+||+||+|+.. +++.||||.++.. ....+.+..|+.++++++ ||||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34455666666677899999999999999999999974 5889999988642 344567888999999986 9999
Q ss_pred eeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-
Q 036483 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG- 531 (721)
Q Consensus 453 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~- 531 (721)
+++++++...+..++||||+ +++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 99999999999999999999 99999999865432 5899999999999999999999999 999999999999975
Q ss_pred ------------------------CCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHH
Q 036483 532 ------------------------KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVL 587 (721)
Q Consensus 532 ------------------------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll 587 (721)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il 249 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence 789999999999865322 2335689999999999999999999999999999
Q ss_pred HHHHhCCcccccCCccccccHHHHHHHHhhccc---h--------hhhhhhh-hc-----------------ccCC---H
Q 036483 588 AELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS---L--------FEILDAH-VL-----------------KEAS---Q 635 (721)
Q Consensus 588 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~--------~~~~~~~-~~-----------------~~~~---~ 635 (721)
|||++|+.||......+ ............. + ...++.. .. ...+ .
T Consensus 250 ~ell~g~~pf~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 326 (360)
T 3llt_A 250 AELYTGSLLFRTHEHME---HLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKI 326 (360)
T ss_dssp HHHHHSSCSCCCSSHHH---HHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHH
T ss_pred HHHHHCCCCCCCCcHHH---HHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccccccc
Confidence 99999999997544222 1111111111000 0 0000000 00 0000 0
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 636 EDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 636 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+.+|+.+||+.||++|||+.|+++
T Consensus 327 ~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 327 IKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred chHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 01156789999999999999999999865
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-40 Score=353.32 Aligned_cols=250 Identities=23% Similarity=0.343 Sum_probs=204.5
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCc
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEV 464 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~ 464 (721)
....++|.+.+.||+|+||.||+|+.+ +++.||||.++.. .....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 345578999999999999999999976 5889999987652 234456788999999987 99999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999998654 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+ ..+....
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~-~~i~~~~---- 234 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELF-HSIRMDN---- 234 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCC----
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHH-HHHHhCC----
Confidence 643222 2234457999999999999999999999999999999999999999643321 111 1111111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK-EVA 663 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~ 663 (721)
...+...+.++.+|+.+||+.||++||++. +|+
T Consensus 235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 011222345689999999999999999997 554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-40 Score=346.49 Aligned_cols=260 Identities=25% Similarity=0.403 Sum_probs=190.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|++.+.||+|+||.||+|... +++.||+|+++... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999965 58999999876533 3345788999999999999999999999999999999999
Q ss_pred eccCCCcchhccccC---CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 471 FIINGTLFQYLHDQN---EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|++ ++|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 69999886532 2235899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc--c----
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED--S---- 620 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~---- 620 (721)
.... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ ............ .
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~ 235 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE---QLKLIFDIMGTPNESLWPS 235 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCTTTCGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHhCCCChhHhhh
Confidence 3222 22334689999999999864 68999999999999999999999997544322 111111111110 0
Q ss_pred ------------------hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 621 ------------------LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 621 ------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
+.+.+.+. .....+.++.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 236 VTKLPKYNPNIQQRPPRDLRQVLQPH----TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGCTTCCTTCCCCCCCCSHHHHGGG----CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhcccccccccchhHHHhhccc----ccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 00000111 11122346899999999999999999999865
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=347.50 Aligned_cols=259 Identities=27% Similarity=0.366 Sum_probs=199.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc---
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP--- 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~--- 465 (721)
.++|.+.+.||+|+||.||+++. .+++.||||+++.. +....+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999996 46889999987653 234456889999999999999999999998876654
Q ss_pred -eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 466 -LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 466 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
++||||+++++|.++++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 99999999999999998654 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce--eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 545 SMAIDQTH--MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 545 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .............
T Consensus 165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~------~~~~~~~~~~~~~ 238 (311)
T 3ork_A 165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDPIP 238 (311)
T ss_dssp -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCCCC
T ss_pred cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHhcCCCCC
Confidence 76433221 223456899999999999999999999999999999999999998643321 1112222221111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHhhcc
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA-VVLAGIK 670 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~-~~L~~l~ 670 (721)
. .. .....+.++.+++.+||+.||++||+..+++ ..|..+.
T Consensus 239 ~---~~----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 239 P---SA----RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp H---HH----HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred c---cc----ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 0 00 0111335689999999999999999666554 4455543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=345.03 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=199.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.++|.+.+.||+|+||+||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 3679999999999999999999764 8999999875432 234567889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999998886543 5899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc----------
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---------- 618 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---------- 618 (721)
.. ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... .......
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL---IRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCCHHHHHHHH
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhcccccccccccc
Confidence 22 2234468999999999976 5789999999999999999999999975443221111 1111100
Q ss_pred -cchhh---hhhhhhc---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 619 -DSLFE---ILDAHVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 619 -~~~~~---~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... +.++... .......+..+.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 00000 0000000 00001234568899999999999999999999764
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=356.61 Aligned_cols=273 Identities=25% Similarity=0.348 Sum_probs=216.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC--cceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE--VPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~--~~~lv 468 (721)
.++|.+.++||+|+||+||+|+... ++.||||+++... ....+.+.+|++++++++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 3678999999999999999999764 8999999886533 334577889999999999999999999998765 66999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE----CCCCcEEEeeccCcc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL----DGKYRAKVSDFGASR 544 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~kl~DFGls~ 544 (721)
|||+++++|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987655445999999999999999999999999 9999999999999 788889999999998
Q ss_pred ccccCCceeeeeeecCCCCCCcccccc--------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRS--------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
....... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ........+
T Consensus 165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~~ 240 (396)
T 4eut_A 165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKII 240 (396)
T ss_dssp ECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHHH
T ss_pred EccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHHh
Confidence 7643322 233458999999999875 4677899999999999999999999965332221 112222222
Q ss_pred hccchhh---h---h--------hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 617 KEDSLFE---I---L--------DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 617 ~~~~~~~---~---~--------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....... . . +..............+.+++.+||+.||++||++.|+++.++.+...
T Consensus 241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2211000 0 0 00111234567788899999999999999999999999999887653
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=347.22 Aligned_cols=249 Identities=25% Similarity=0.342 Sum_probs=194.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE----cCCcEEEEeecccc----CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML----ADGRIVAIKKSKVI----DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
.++|.+.++||+|+||.||+++. .+++.||+|.++.. .......+.+|+.+|++++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 46899999987653 22345678899999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999997654 5899999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+..... ..
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~-~~---- 237 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILK-CK---- 237 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHH-TC----
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHh-CC----
Confidence 643222 1223456899999999999999999999999999999999999999643321 11111111 11
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
...+...+.++.+++.+||+.||++|| ++.|++++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 111223345689999999999999999 66777654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=350.09 Aligned_cols=250 Identities=21% Similarity=0.306 Sum_probs=204.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcce
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~ 466 (721)
..++|.+.+.||+|+||.||+++... ++.||||.++.. .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34789999999999999999999765 789999987642 234567789999999988 8999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999998654 5999999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+.... ....
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~-~~~~----- 238 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM-EHNV----- 238 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-HCCC-----
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hCCC-----
Confidence 3222 2234456999999999999999999999999999999999999999643221 1111111 1111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH-----HHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM-----KEVAVV 665 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~-----~ev~~~ 665 (721)
..+...+.++.+|+.+||+.+|++||+. ++|+++
T Consensus 239 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 239 -----AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1222334568999999999999999964 666543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.35 Aligned_cols=252 Identities=23% Similarity=0.298 Sum_probs=206.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..++|.+.+.||+|+||.||+|.... +..+|+|++........+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999999764 77899999876656667889999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~~~~ 547 (721)
|+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||+ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999987654 5899999999999999999999999 9999999999999 788999999999998765
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... ......||+.|+|||.+.+. ++.++||||||++++||++|+.||......+ ....+....... ..
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~~-~~- 228 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VMLKIREGTFTF-PE- 228 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-CH-
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhCCCCC-Cc-
Confidence 332 22334699999999998764 8999999999999999999999986433211 111111111100 00
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... ..+..+.+++.+||+.+|++|||+.++++.
T Consensus 229 ~~~~----~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 229 KDWL----NVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hhhh----cCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0000 123568999999999999999999999763
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=340.04 Aligned_cols=260 Identities=23% Similarity=0.276 Sum_probs=201.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||++... +++.||+|.+... +....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 478999999999999999999976 6889999987653 233457899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 113 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 99999999999998654 5899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
..........|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .....+..... .
T Consensus 187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~-~----- 253 (309)
T 2h34_A 187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP-R----- 253 (309)
T ss_dssp ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC-C-----
T ss_pred cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC-C-----
Confidence 4333334456899999999999999999999999999999999999998643211 11111111110 0
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhhcccc
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRP-TMKEVAVVLAGIKAC 672 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~~~ 672 (721)
........+.++.+++.+||+.||++|| +++++++.|+.+...
T Consensus 254 -~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 254 -PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp -GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred -ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0111223345689999999999999999 999999999877544
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.09 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=202.5
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
..++|.+.+.||+|+||.||+|... +++.||||+++. .+....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 3467999999999999999999964 689999998764 234456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 468 VYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999987521 2336899999999999999999999999 999999999999999999999999999765
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... ... ....+......
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~~~---- 256 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-LCKKIEQCDYP---- 256 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHH-HHHHHHTTCSC----
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHH-HHHHhhcccCC----
Confidence 43221 223346899999999999999999999999999999999999998643221 111 11111111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
.......+.++.+++.+||+.||++|||+.+|++.|+++++..
T Consensus 257 ----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~ 299 (310)
T 2wqm_A 257 ----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT 299 (310)
T ss_dssp ----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence 0011223456899999999999999999999999999997653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=341.16 Aligned_cols=253 Identities=26% Similarity=0.454 Sum_probs=201.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-cceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE-VPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-~~~lv~e~ 471 (721)
.++|.+.+.||+|+||.||++... ++.||||.++.. ...+.+.+|+.++++++||||+++++++.+.+ ..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 467999999999999999999875 889999988643 35578999999999999999999999976554 68999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 999999999976431 13789999999999999999999999 999999999999999999999999998755322
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ . ...+... ..
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~----~~~~~~~---------~~ 232 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V----VPRVEKG---------YK 232 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---H----HHHHTTT---------CC
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---H----HHHHhcC---------CC
Confidence 122357889999999999999999999999999999998 999986543221 1 1111111 11
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
...+...+..+.+++.+||+.+|++|||+.|+++.|+.++..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 233 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 122333456799999999999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=357.28 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=199.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcC--CCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQIN--HRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||++...+++.||||++... +....+.+.+|+.+|++++ ||||+++++++...+..++||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 569999999999999999999888999999987543 3455678999999999996 599999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
| +.+++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++.+...
T Consensus 136 E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 56889999998654 6899999999999999999999998 99999999999996 579999999999876543
Q ss_pred Cce-eeeeeecCCCCCCcccccc-----------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 550 QTH-MTTQVQGTFGYLDPEYFRS-----------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 550 ~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||..... ....+.
T Consensus 208 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~---- 278 (390)
T 2zmd_A 208 TTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-----QISKLH---- 278 (390)
T ss_dssp ------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHH----
T ss_pred CccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-----HHHHHH----
Confidence 322 2334569999999999875 4688999999999999999999999853221 111111
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.+++.......+...+.++.+|+.+||+.||++|||+.|+++.-
T Consensus 279 -----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 279 -----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp -----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred -----HHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 12222211122222245689999999999999999999998763
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=351.03 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=191.6
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
..+.++|.+.+.||+|+||.||+|+.. +++.||||.++... ..+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999976 47899999886532 346788999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGls~~ 545 (721)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999987543 5899999999999999999999999 999999999999975 88999999999986
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... . ....+......
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~-~~~~i~~~~~~--- 269 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----F-MFRRILNCEYY--- 269 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----H-HHHHHHTTCCC---
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----H-HHHHHHhCCCc---
Confidence 5432 22334568999999999999999999999999999999999999985432211 1 11111111110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 270 ---~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 ---FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ---cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001112234568999999999999999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-40 Score=352.84 Aligned_cols=254 Identities=22% Similarity=0.291 Sum_probs=196.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|.+.+.||+|+||+||+++.. +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 468999999999999999999976 68999999886532 3346788999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc--EEEeeccCccccccC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR--AKVSDFGASRSMAID 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGls~~~~~~ 549 (721)
+++|+|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++. +||+|||+++.....
T Consensus 98 ~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 98 ASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp CCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999997654 5999999999999999999999999 999999999999987765 999999999754322
Q ss_pred CceeeeeeecCCCCCCccccccCCCCcc-ccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEK-SDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. ......||+.|+|||++.+..++.+ +||||||+++|||++|+.||....... ............ .
T Consensus 172 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~~~~~~~~~~~~---------~ 238 (361)
T 3uc3_A 172 S--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR--DYRKTIQRILSV---------K 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CC--CHHHHHHHHHTT---------C
T ss_pred C--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhcC---------C
Confidence 1 2234569999999999998888766 899999999999999999996543221 111111111111 1
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.........+.++.+|+.+||+.+|++|||+.|++++-
T Consensus 239 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 10011112235688999999999999999999998863
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-40 Score=339.86 Aligned_cols=251 Identities=27% Similarity=0.435 Sum_probs=206.1
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--------
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE-------- 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~-------- 461 (721)
...++|.+.+.||+|+||.||+|... +++.||+|+++... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 34567999999999999999999976 68999999886532 467899999999999999999999864
Q ss_pred --------CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 462 --------TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 462 --------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCC
Confidence 3457899999999999999975432 26899999999999999999999999 99999999999999999
Q ss_pred cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
.+||+|||++........ .....||+.|+|||.+.+..++.++||||||+++|||++|..|+... .. ..
T Consensus 160 ~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~-~~ 228 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SK-FF 228 (284)
T ss_dssp EEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HH-HH
T ss_pred CEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HH-HH
Confidence 999999999987654322 23345899999999999999999999999999999999999886311 00 11
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....... .+...+..+.+++.+||+.||++|||+.|+++.|+.++..
T Consensus 229 ~~~~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 TDLRDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHhhccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111111 1112234588999999999999999999999999988643
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=343.80 Aligned_cols=274 Identities=23% Similarity=0.332 Sum_probs=213.7
Q ss_pred cCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhh--cCCCceeeEEEEEEe
Q 036483 384 FTSKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQ--INHRNVVKLLGCCLE 461 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~--l~h~niv~l~g~~~~ 461 (721)
.+......+.++|.+.+.||+|+||.||+|.. +++.||||.+.. ...+.+.+|++++.. ++||||+++++++..
T Consensus 32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~ 107 (342)
T 1b6c_B 32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNK 107 (342)
T ss_dssp SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred CceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence 33444566778999999999999999999998 488999998753 334678889999887 789999999999988
Q ss_pred CC----cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHH--------hcCCCCeeeccCcCccEEE
Q 036483 462 TE----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH--------SAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 462 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH--------~~~~~~ivHrDlk~~NIll 529 (721)
.. ..++||||+++|+|.+++... .+++..++.++.|++.||+||| +.+ |+||||||+|||+
T Consensus 108 ~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll 180 (342)
T 1b6c_B 108 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILV 180 (342)
T ss_dssp CCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEE
T ss_pred cCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEE
Confidence 76 789999999999999999764 4999999999999999999999 777 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCcee---eeeeecCCCCCCccccccCC------CCccccchhHHHHHHHHHhC-------
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTHM---TTQVQGTFGYLDPEYFRSSR------FTEKSDVYSFGVVLAELLTG------- 593 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~t~ksDV~SlGvll~elltG------- 593 (721)
+.++.+||+|||+++......... .....||+.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 260 (342)
T 1b6c_B 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH 260 (342)
T ss_dssp CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence 999999999999998765433221 23346899999999998763 33689999999999999999
Q ss_pred ---CcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 594 ---ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 594 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..||........ .. ..+...+........+... ....+.+..+.+|+.+||+.+|++|||+.||++.|+.+.
T Consensus 261 ~~~~~p~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~ 335 (342)
T 1b6c_B 261 EDYQLPYYDLVPSDP-SV-EEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335 (342)
T ss_dssp CCCCCTTTTTSCSSC-CH-HHHHHHHTTSCCCCCCCGG---GGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHH
T ss_pred cccccCccccCcCcc-cH-HHHHHHHHHHHhCCCCccc---ccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHH
Confidence 667654332211 11 1122222111111100000 112356678999999999999999999999999999987
Q ss_pred ccC
Q 036483 671 ACD 673 (721)
Q Consensus 671 ~~~ 673 (721)
...
T Consensus 336 ~~~ 338 (342)
T 1b6c_B 336 QQE 338 (342)
T ss_dssp HTT
T ss_pred HHh
Confidence 543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=345.09 Aligned_cols=262 Identities=24% Similarity=0.407 Sum_probs=200.2
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
...++|.+.+.||+|+||.||+|.... ++.||+|.++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 110 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSS 110 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC---
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccc
Confidence 345778899999999999999998642 458999987653 34456789999999999999999999999987653
Q ss_pred -----ceEEEeeccCCCcchhcccc---CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 465 -----PLLVYEFIINGTLFQYLHDQ---NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 465 -----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
.++||||+++++|.+++... .....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+|
T Consensus 111 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~k 187 (313)
T 3brb_A 111 QGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVC 187 (313)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEE
T ss_pred cCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence 48999999999999998532 22346999999999999999999999998 99999999999999999999
Q ss_pred EeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHH
Q 036483 537 VSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 537 l~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 614 (721)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ ...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~---- 260 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---MYD---- 260 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH----
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---HHH----
Confidence 9999999876433221 1233457889999999999999999999999999999999 888886543221 111
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.+.... ....+...+..+.+++.+||+.+|++|||+.++++.|+.+..
T Consensus 261 ~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 261 YLLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp HHHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111110 111222334569999999999999999999999999998864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=345.58 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=206.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcE--EEEeeccc-cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRI--VAIKKSKV-IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~--vavK~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.+.||+|+||.||+|+.. ++.. +|+|.++. ......+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67899999999999999999965 4554 48998764 2344567899999999999 899999999999999999999
Q ss_pred EeeccCCCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 469 YEFIINGTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
|||+++++|.+++.... ....+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 2236999999999999999999999999 9999999999999999999
Q ss_pred EEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~ 614 (721)
||+|||+++..... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ ...
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~-------~~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH-------HHH
Confidence 99999998744321 11223347889999999999999999999999999999998 999986433211 111
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
.+... .....+...+..+.+|+.+||+.+|++|||+.|+++.|+.+....
T Consensus 253 ~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HhhcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111 111222234456999999999999999999999999999887643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=350.72 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=202.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.+.|...+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|++++++++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35588899999999999999996 468999999876432 33456799999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+. |+|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99996 67888876543 25999999999999999999999999 99999999999999999999999999986643
Q ss_pred CCceeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
. ....||+.|+|||++. ...++.++||||||+++|||++|+.||...... ........... .
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~-~--- 271 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-P--- 271 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-C---
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCC-C---
Confidence 2 2346899999999985 567899999999999999999999998643221 11111111110 0
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhh
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAG 668 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~ 668 (721)
.......+..+.+++.+||+.+|++|||+.++++...-
T Consensus 272 -----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 272 -----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred -----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 00111234568899999999999999999999876543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=353.69 Aligned_cols=247 Identities=23% Similarity=0.287 Sum_probs=197.7
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
.++||+|+||.||+|... +|+.||+|+++.......+.+.+|+.+|++++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999965 5899999998776656678899999999999999999999999999999999999999999
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE--CCCCcEEEeeccCccccccCCceeee
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL--DGKYRAKVSDFGASRSMAIDQTHMTT 555 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll--~~~~~~kl~DFGls~~~~~~~~~~~~ 555 (721)
.+++.... ..+++..++.++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 99887543 25899999999999999999999999 9999999999999 6778999999999987654322 23
Q ss_pred eeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCH
Q 036483 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQ 635 (721)
Q Consensus 556 ~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 635 (721)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+...... .. .. .... ..
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~-~~-~~-~~~~----~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILAC-RW-DL-EDEE----FQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT-CC-CS-CSGG----GT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc-cC-CC-Chhh----hc
Confidence 345999999999999999999999999999999999999999654321 111111111 10 00 0000 11
Q ss_pred HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 636 EDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 636 ~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.++.+|+.+||+.+|++|||+.|+++.
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 233568999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=375.84 Aligned_cols=248 Identities=28% Similarity=0.412 Sum_probs=200.1
Q ss_pred ceEeeeCcEEEEEEEEc---CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLA---DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
+.||+|+||+||+|.+. .++.||||+++.. +....++|.+|+++|++++||||+++++++. .+..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999753 3678999988653 3344678999999999999999999999986 4557899999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce--
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH-- 552 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~-- 552 (721)
|+|.+++.... .+++..++.|+.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+..+...
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997643 5899999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
......+|+.|+|||++.+..++.++||||||++||||++ |+.||......+ ....+.. ....
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~---------~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEK---------GERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHT---------TCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHc---------CCCC
Confidence 1233446788999999999999999999999999999998 999986543221 1111111 1112
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
..+...+.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 630 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 630 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 233345567999999999999999999999999998764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-40 Score=345.81 Aligned_cols=261 Identities=22% Similarity=0.309 Sum_probs=200.1
Q ss_pred hcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.+.|.+. ++||+|+||+||++... +++.||||++........+.+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 3567774 78999999999999954 6899999998766566678899999999985 7999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc---EEEeeccCcccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR---AKVSDFGASRSM 546 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGls~~~ 546 (721)
||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998654 5899999999999999999999999 999999999999998766 999999999765
Q ss_pred ccCCc------eeeeeeecCCCCCCcccccc-----CCCCccccchhHHHHHHHHHhCCcccccCCccccccH-------
Q 036483 547 AIDQT------HMTTQVQGTFGYLDPEYFRS-----SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL------- 608 (721)
Q Consensus 547 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~------- 608 (721)
..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223458999999999975 5588999999999999999999999975443221000
Q ss_pred -HHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 609 -AAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 609 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......+...... ... .... ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~i~~~~~~-~~~-~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 245 CQNMLFESIQEGKYE-FPD-KDWA----HISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHHCCCC-CCH-HHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHHhccCcc-cCc-hhcc----cCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 01111111111110 000 0000 123568999999999999999999999774
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-40 Score=363.02 Aligned_cols=249 Identities=23% Similarity=0.305 Sum_probs=195.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.++||+|+||.||++... +++.||||.++.. .......+.+|+.++++++||||+++++++.+.+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 467999999999999999999965 5899999987642 344556788999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
|||+++++|.+++.... .+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++.+||+|||+++...
T Consensus 227 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 99999999999997654 58999999999999999999998 77 9999999999999999999999999998643
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+..... ...
T Consensus 301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~-~~~------ 366 (446)
T 4ejn_A 301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-EEI------ 366 (446)
T ss_dssp C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCC------
T ss_pred CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHh-CCC------
Confidence 322 2234466999999999999999999999999999999999999999643321 11111111 110
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+...+.++.+|+.+||+.||++|| +++|++++
T Consensus 367 ----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 367 ----RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 11223345689999999999999999 99998763
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=348.61 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=196.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc-hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE-SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|.+.+.||+|+||+||+|... +++.||+|+++.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999976 688999998765332 2233566899999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
++ ++|.+++..... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 155 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence 97 588888876542 5899999999999999999999999 99999999999999999999999999976543222
Q ss_pred eeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---cchhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE---DSLFEILDA 627 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 627 (721)
......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ ........... ..+......
T Consensus 156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---QLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCCCTTTSTTGGGC
T ss_pred -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCChHhchhhhcc
Confidence 2233468999999999876 568999999999999999999999997544322 11111111111 111111100
Q ss_pred hh-------------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HV-------------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ..........++.+|+.+||+.||++|||++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00 000111233568899999999999999999999874
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=345.21 Aligned_cols=264 Identities=25% Similarity=0.327 Sum_probs=199.7
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccC-----chhhHHHHHHHHHHhhcC---CCceeeEEEEEEe
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVID-----ESKVDEFINEVAILSQIN---HRNVVKLLGCCLE 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~il~~l~---h~niv~l~g~~~~ 461 (721)
...++|.+.+.||+|+||+||+|+. .+++.||||++.... ......+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467899999999999999999996 468999999876422 222356778888887774 9999999999987
Q ss_pred CC-----cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 462 TE-----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 462 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
.. ..++||||+. ++|.+++...... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEE
Confidence 65 4689999996 6999999765432 4999999999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHh
Q 036483 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~ 616 (721)
|+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .........
T Consensus 161 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~ 235 (308)
T 3g33_A 161 LADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD---QLGKIFDLI 235 (308)
T ss_dssp ECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH---HHHHHHHHH
T ss_pred EeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHh
Confidence 99999998664322 2234568999999999999999999999999999999999999986543221 111111111
Q ss_pred hccchhhh------hhhhh-------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 617 KEDSLFEI------LDAHV-------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 617 ~~~~~~~~------~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
........ ..... ......+.+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 11000000 00000 00011123456899999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=350.08 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=194.7
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEe-------
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLE------- 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~------- 461 (721)
....+|.+.++||+|+||.||+++.. +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34468999999999999999999965 68999999887666667788999999999995 9999999999953
Q ss_pred -CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 462 -TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 462 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
....++||||+. |+|.+++........+++..++.++.||+.||+|||+.+. +|+||||||+|||++.++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCCCCEEEecC
Confidence 334689999995 7899988764444479999999999999999999999863 4999999999999999999999999
Q ss_pred cCccccccCCcee-----------eeeeecCCCCCCcccc---ccCCCCccccchhHHHHHHHHHhCCcccccCCccccc
Q 036483 541 GASRSMAIDQTHM-----------TTQVQGTFGYLDPEYF---RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK 606 (721)
Q Consensus 541 Gls~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~ 606 (721)
|+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.......
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-- 260 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-- 260 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH--
Confidence 9998765322211 1134589999999998 56678999999999999999999999985322110
Q ss_pred cHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 607 SLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
++............+..+.+|+.+||+.+|++|||+.|+++.|+.+.....
T Consensus 261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~ 311 (337)
T 3ll6_A 261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311 (337)
T ss_dssp ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence 001011111111122347899999999999999999999999999876543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-39 Score=336.54 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=205.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
..++|.+.+.||+|+||.||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999976 5889999987543 344567889999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc---EEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR---AKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFGls~~ 545 (721)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999998887654 5899999999999999999999999 999999999999986655 99999999976
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||....... ....+.......
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-------~~~~~~~~~~~~-- 226 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------LYAQIKAGAYDY-- 226 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCC--
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH-------HHHHHHhccccC--
Confidence 64322 2234568999999999999999999999999999999999999986433211 111111111100
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........+.++.+++.+||+.+|++|||+.|+++.
T Consensus 227 ----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 227 ----PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ----CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ----CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 000111234568999999999999999999999774
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.87 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=202.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||+||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467999999999999999999866 4779999987542 122356789999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence 99999999999997654 5899999999999999999999998 99999999999999999999999999865432
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+...
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~--------- 222 (279)
T 3fdn_A 162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TY-KRISRV--------- 222 (279)
T ss_dssp ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHHT---------
T ss_pred c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------HH-HHHHhC---------
Confidence 2 2234568999999999999999999999999999999999999986433211 11 111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
....+...+..+.+|+.+||+.+|++|||+.|+++.-
T Consensus 223 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 223 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp -CCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred -CCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 0112222345688999999999999999999998864
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=349.70 Aligned_cols=266 Identities=14% Similarity=0.185 Sum_probs=207.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC---------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceee---------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD---------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK--------- 454 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~--------- 454 (721)
.++|.+.+.||+|+||.||+|+... ++.||||..... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999999764 789999987643 57889999999999999988
Q ss_pred ------EEEEEEe-CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 455 ------LLGCCLE-TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 455 ------l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 6777776 67789999999 999999998652 236999999999999999999999998 99999999999
Q ss_pred EECCCC--cEEEeeccCccccccCCcee------eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCccccc
Q 036483 528 LLDGKY--RAKVSDFGASRSMAIDQTHM------TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRV 599 (721)
Q Consensus 528 ll~~~~--~~kl~DFGls~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~ 599 (721)
|++.++ .+||+|||+++.+....... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 99999999998765332211 1234699999999999999999999999999999999999999975
Q ss_pred CCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 600 TNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 600 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
...... ..... ....... ...+.+.... ....+.++.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus 271 ~~~~~~-~~~~~-~~~~~~~-~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~ 339 (352)
T 2jii_A 271 CLPNTE-DIMKQ-KQKFVDK-PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR 339 (352)
T ss_dssp GTTCHH-HHHHH-HHHHHHS-CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred CCcCHH-HHHHH-HHhccCC-hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence 432211 11111 1111110 0011110000 00123568999999999999999999999999998876544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=354.12 Aligned_cols=264 Identities=23% Similarity=0.376 Sum_probs=194.2
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCC--c
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETE--V 464 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~--~ 464 (721)
...++|.+.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.++.++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 45678999999999999999999965 589999998754 23455677889999999997 999999999998654 6
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||++ ++|.+++... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 6899888763 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccC--------------------CceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCcc
Q 036483 545 SMAID--------------------QTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFE 603 (721)
Q Consensus 545 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~ 603 (721)
.+... .....+...||+.|+|||++.+ ..++.++||||||++++||++|+.||......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112334579999999999987 67899999999999999999999999754432
Q ss_pred ccccHHHHHHHHhhccchhh-----------hhh---------------------hhh-cccCCHHHHHHHHHHHHHhhc
Q 036483 604 EDKSLAAYFLRAMKEDSLFE-----------ILD---------------------AHV-LKEASQEDIVTVAKLTNRCLN 650 (721)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~-----------~~~---------------------~~~-~~~~~~~~~~~l~~li~~cl~ 650 (721)
+. .......+....... .+. ... ..........++.+|+.+||+
T Consensus 238 ~~---~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~ 314 (388)
T 3oz6_A 238 NQ---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ 314 (388)
T ss_dssp HH---HHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred HH---HHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence 21 111111111000000 000 000 000000223568999999999
Q ss_pred cCCCCCCCHHHHHHH
Q 036483 651 LNGKKRPTMKEVAVV 665 (721)
Q Consensus 651 ~~p~~RPt~~ev~~~ 665 (721)
.||++|||+.|++++
T Consensus 315 ~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 315 FNPNKRISANDALKH 329 (388)
T ss_dssp SSGGGSCCHHHHTTS
T ss_pred cCcccCCCHHHHhCC
Confidence 999999999999765
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=333.72 Aligned_cols=253 Identities=25% Similarity=0.370 Sum_probs=204.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999976 6899999987543 2345578999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999997543 6899999999999999999999999 999999999999999999999999999866433
Q ss_pred Cc-eeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 550 QT-HMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 550 ~~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. .......||+.|+|||.+.+..+ +.++||||||++++||++|+.||........ . +..........
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~---~~~~~~~~~~~----- 228 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E---YSDWKEKKTYL----- 228 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH--H---HHHHHTTCTTS-----
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH--H---HHHhhhccccc-----
Confidence 22 12334568999999999988765 7789999999999999999999965432211 0 11111111000
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
......+..+.+++.+||+.||++|||+.|+++
T Consensus 229 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 229 ----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 001123346889999999999999999999865
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=337.26 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=202.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
++|....+||+|+||.||+|... +++.||||.+........+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 34555669999999999999964 58899999987766666788999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeeccCccccccCCc
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFGls~~~~~~~~ 551 (721)
++++|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999987655556789999999999999999999998 999999999999987 89999999999987643221
Q ss_pred eeeeeeecCCCCCCccccccCC--CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
......|++.|+|||.+.+.. ++.++||||||+++|||++|+.||....... ......... ..
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~----------~~ 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQ----AAMFKVGMF----------KV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHH----HHHHHHHHH----------CC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchh----HHHHhhccc----------cc
Confidence 123346899999999997653 8899999999999999999999986432111 010100000 01
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+...+.++.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112223344568999999999999999999999753
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=343.38 Aligned_cols=253 Identities=25% Similarity=0.323 Sum_probs=205.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCch------hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDES------KVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
..++|.+.+.||+|+||.||++... +++.||+|.++..... ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999976 5899999987553221 35789999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC----cEEEeec
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY----RAKVSDF 540 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DF 540 (721)
.++||||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999997543 6999999999999999999999999 99999999999999887 7999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
|+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .+....
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~-~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLA-NITSVS 234 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHH-HHHTTC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHH-HHHhcc
Confidence 9998765332 223446899999999999999999999999999999999999998643221 1111 111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ........ ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 235 ~--~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 Y--DFDEEFFS----HTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp C--CCCHHHHT----TCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred c--ccChhhhc----ccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 00111111 123458899999999999999999999874
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.63 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=195.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHH-HhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAI-LSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~i-l~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|++.+.||+|+||.||+++.+ +++.||||.++... ....+.+.+|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 467999999999999999999976 48899999875432 3344567778777 567899999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++.+.. .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 117 v~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 999999999999998654 5899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+...+. ..+
T Consensus 191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~-~~~------ 256 (373)
T 2r5t_A 191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN-KPL------ 256 (373)
T ss_dssp CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH------HHHHHHHH-SCC------
T ss_pred cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHh-ccc------
Confidence 222 2234457999999999999999999999999999999999999999643221 11111111 111
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
..+...+..+.+|+.+||+.||++||++.+.++.+.
T Consensus 257 ----~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 257 ----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp ----CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred ----CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 112223456899999999999999999865444443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=335.22 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=184.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 367899999999999999999974 68999999875422 23357899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999997643 35899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. ...... ..
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~--------~~ 228 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVL--------AD 228 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCS--------SC
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHhh--------cc
Confidence 222 12235689999999999999999999999999999999999999865432210 000000 00
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+...+.++.+++.+||+.||++|||+.++++
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 229 --YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 0112223456899999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.20 Aligned_cols=271 Identities=23% Similarity=0.352 Sum_probs=199.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHH--HhhcCCCceeeEEEEEEe-----CCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAI--LSQINHRNVVKLLGCCLE-----TEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~i--l~~l~h~niv~l~g~~~~-----~~~~ 465 (721)
.++|.+.+.||+|+||.||+|+. +++.||||++... ..+.+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36799999999999999999987 6889999988643 23445555555 445899999999986543 2245
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc---------CCCCeeeccCcCccEEECCCCcEE
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA---------ASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~---------~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
++||||+++|+|.+++.... +++..+++++.||+.||+|||+. + |+||||||+|||++.++.+|
T Consensus 88 ~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp EEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred EEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence 89999999999999997653 68999999999999999999998 7 99999999999999999999
Q ss_pred EeeccCccccccCCc-------eeeeeeecCCCCCCcccccc-------CCCCccccchhHHHHHHHHHhCCcccccCCc
Q 036483 537 VSDFGASRSMAIDQT-------HMTTQVQGTFGYLDPEYFRS-------SRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602 (721)
Q Consensus 537 l~DFGls~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SlGvll~elltG~~p~~~~~~ 602 (721)
|+|||+++.+..... .......||+.|+|||++.+ ..++.++||||||+++|||++|..|+.....
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~ 240 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES 240 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence 999999987643221 11223458999999999987 3566789999999999999999877644332
Q ss_pred cccc-cHH----------HHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 603 EEDK-SLA----------AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 603 ~~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
.... ... ...............+.. ........+.++.+|+.+||+.||++|||+.|+++.|+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE--AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT--TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc--ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 2111 000 000000100000000000 001123356679999999999999999999999999999876
Q ss_pred cCCCC
Q 036483 672 CDGTS 676 (721)
Q Consensus 672 ~~~~~ 676 (721)
.....
T Consensus 319 ~~~~~ 323 (336)
T 3g2f_A 319 IWERN 323 (336)
T ss_dssp CCCC-
T ss_pred HHHhc
Confidence 54433
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=349.72 Aligned_cols=255 Identities=28% Similarity=0.342 Sum_probs=205.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE----cCCcEEEEeeccccC----chhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML----ADGRIVAIKKSKVID----ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~ 463 (721)
.++|.+.++||+|+||.||+++. .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 36799999999999999999997 368999999876422 23456788999999999 6999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999998654 5899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
+.+............||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... ............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS--- 281 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC--CHHHHHHHHHHC---
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc--hHHHHHHHHhcc---
Confidence 8765444333445569999999999986 357899999999999999999999996543222 111111111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHHH
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVVL 666 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~L 666 (721)
....+...+..+.+|+.+||+.||++|| ++.|+++..
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 0112233345688999999999999999 888887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=342.65 Aligned_cols=259 Identities=24% Similarity=0.303 Sum_probs=204.6
Q ss_pred HHHHHhcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 036483 388 ELETATDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQI-NHRNVVKLLGCCLET 462 (721)
Q Consensus 388 el~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~ 462 (721)
..+...++|.+. +.||+|+||.||+|... +++.||+|.++.. .......+.+|+.++.++ +||||+++++++.+.
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~ 101 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT 101 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC
Confidence 345566778877 89999999999999976 5899999987653 233467899999999999 579999999999999
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEee
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSD 539 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~D 539 (721)
+..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+++ |+||||||+|||++. ++.+||+|
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~D 177 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVD 177 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECC
T ss_pred CeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEee
Confidence 999999999999999999865432 36999999999999999999999999 999999999999997 78999999
Q ss_pred ccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 540 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ........
T Consensus 178 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~- 248 (327)
T 3lm5_A 178 FGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNISQV- 248 (327)
T ss_dssp GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHT-
T ss_pred CccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHHhc-
Confidence 99998764322 2234569999999999999999999999999999999999999986533211 11111110
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ...........+..+.+++.+||+.||++|||++|+++.
T Consensus 249 ~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 249 N------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp C------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred c------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 0 000111112234568999999999999999999999754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=358.56 Aligned_cols=247 Identities=26% Similarity=0.389 Sum_probs=205.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+|+.. +|+.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 67899999999999999999976 6899999987543 2234568899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 9999999999997543 6999999999999999999999999 999999999999999999999999999876433
Q ss_pred CceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ..+ ..+.....
T Consensus 170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~~-~~i~~~~~------- 233 (476)
T 2y94_A 170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TLF-KKICDGIF------- 233 (476)
T ss_dssp C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HHH-HHHHTTCC-------
T ss_pred c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HHH-HHHhcCCc-------
Confidence 2 2334569999999999998775 68999999999999999999999643321 111 11111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+.++.+|+.+||+.||++|||+.|+++.
T Consensus 234 ---~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 234 ---YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 1112233468999999999999999999999874
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-39 Score=334.88 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=200.4
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~l 467 (721)
..++|.+.+.||+|+||+||+|... +++.||||.++. ........+.+|+.++.++ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3577999999999999999999976 689999998765 2344567889999999999 99999999999999999999
Q ss_pred EEeeccCCCcchhccccCC-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---------------
Q 036483 468 VYEFIINGTLFQYLHDQNE-EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG--------------- 531 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~--------------- 531 (721)
||||+++++|.+++..... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999976421 135899999999999999999999999 999999999999984
Q ss_pred ----CCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccc
Q 036483 532 ----KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK 606 (721)
Q Consensus 532 ----~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~ 606 (721)
...+||+|||++....... ...||+.|+|||.+.+. .++.++||||||++++||++|.+++....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 4479999999998764332 23489999999999876 56689999999999999999987753211
Q ss_pred cHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 607 SLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ...+..... ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 236 -~----~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 236 -Q----WHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp -H----HHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred -H----HHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0 111111111 11222334568999999999999999999999764
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=357.17 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=196.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
.++|.+.+.||+|+||+||+|+.. +++.||||++... .....+.+.+|+.+|++++||||+++++++...+
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 578999999999999999999865 5889999987643 4455678999999999999999999999997654
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..+|||||++++ |.+.+.. .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||++
T Consensus 141 ~~~lv~E~~~~~-l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 459999999764 5555532 3899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc---
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS--- 620 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 620 (721)
+..... .......||+.|+|||++.+..++.++||||||++++||++|+.||......+. .......+....
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~---~~~i~~~lg~p~~~~ 286 (464)
T 3ttj_A 212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ---WNKVIEQLGTPCPEF 286 (464)
T ss_dssp -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCSCCHHH
T ss_pred eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHHH
Confidence 866432 233456799999999999999999999999999999999999999975443221 111111110000
Q ss_pred -------hh---------------hhhhhhhcc---cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 -------LF---------------EILDAHVLK---EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 -------~~---------------~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ......... +.......++.+|+.+||+.||++|||++|++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000000000 0111225678999999999999999999999875
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=354.56 Aligned_cols=266 Identities=20% Similarity=0.267 Sum_probs=210.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcCC-CceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQINH-RNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.++||+|+||.||+|.. .+++.||||...... ..+++.+|+++++.++| +++..+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 47899999999999999999996 468999999765432 23568899999999976 566667777778888899999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~~~~ 547 (721)
|+ +++|.+++..... .+++..++.|+.||+.||+|||+++ |+||||||+|||| +.++.+||+|||+++.+.
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999975433 5999999999999999999999999 9999999999999 688999999999998765
Q ss_pred cCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 548 IDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 548 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
..... ......||+.|+|||++.+..++.++||||||++||||++|+.||..............+........+
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 237 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI 237 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence 43321 122456999999999999999999999999999999999999999765443322222211111111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCCC
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~~ 675 (721)
.. +... .+.++.+|+.+||+.+|++||++.+|++.|+.+......
T Consensus 238 ~~-----l~~~----~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~ 282 (483)
T 3sv0_A 238 EA-----LCRG----YPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGF 282 (483)
T ss_dssp HH-----HHTT----SCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred HH-----HhcC----CcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCC
Confidence 11 1111 235689999999999999999999999999988665443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=346.19 Aligned_cols=261 Identities=24% Similarity=0.367 Sum_probs=206.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
..++|.+.+.||+|+||.||+|+.. +++.||||.+... ......++.+|+.++++++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 3478999999999999999999842 4678999998643 34456789999999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCC----CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEE
Q 036483 465 PLLVYEFIINGTLFQYLHDQNE----EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKV 537 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl 537 (721)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999986532 135899999999999999999999999 999999999999984 456999
Q ss_pred eeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHH
Q 036483 538 SDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 538 ~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||...... . ....
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~-~~~~ 257 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------E-VLEF 257 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------H-HHHH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------H-HHHH
Confidence 999999765332221 1223457889999999999999999999999999999998 88998643221 1 1111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+.... ....+...+..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 258 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 258 VTSGG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCC---------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 11111 111222344568999999999999999999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=363.82 Aligned_cols=254 Identities=25% Similarity=0.323 Sum_probs=207.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.++||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.+|++++||||+++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999976 5899999987542 233456789999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 263 mEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 999999999999976442 25999999999999999999999999 99999999999999999999999999987653
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ... ....+....
T Consensus 339 ~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~-i~~~i~~~~-------- 405 (576)
T 2acx_A 339 GQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REE-VERLVKEVP-------- 405 (576)
T ss_dssp TC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHH-HHHHHHHCC--------
T ss_pred Cc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHH-HHHHhhccc--------
Confidence 32 22345799999999999999999999999999999999999999975432211 111 111111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
...+...+.++.+|+.+||+.||++|| ++.||+++
T Consensus 406 --~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 406 --EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 112223345689999999999999999 67887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-39 Score=335.65 Aligned_cols=249 Identities=22% Similarity=0.351 Sum_probs=206.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999976 4789999986542 334567889999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 99999999999887654 5899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......||+.|+|||.+.+..++.++||||||++++||++|+.||...... ..+... .....
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~-~~~~~------- 232 (294)
T 2rku_A 168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI-KKNEY------- 232 (294)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HTTCC-------
T ss_pred Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHH-hhccC-------
Confidence 322 223356899999999999999999999999999999999999998643321 111111 11110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 233 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 1122233568899999999999999999999775
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=345.89 Aligned_cols=244 Identities=24% Similarity=0.348 Sum_probs=203.4
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--------chhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--------ESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
...++|.+.+.||+|+||+||+|... +++.||||.++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 34678999999999999999999964 58899999876532 1244578899999999999999999999999
Q ss_pred CCcceEEEeeccCC-CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 462 TEVPLLVYEFIING-TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 462 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
.+..++||||+..| +|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+||
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeec
Confidence 99999999999776 9999987654 5999999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
|+++...... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------------- 235 (335)
T 3dls_A 175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------------- 235 (335)
T ss_dssp TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG-----------------
T ss_pred ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH-----------------
Confidence 9998765432 2334569999999999998876 7899999999999999999999853111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...... ..+...+.++.+|+.+||+.+|++|||+.|+++.
T Consensus 236 ----~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ----TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ----GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ----HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 1111133468999999999999999999999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=351.83 Aligned_cols=254 Identities=25% Similarity=0.317 Sum_probs=192.9
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--------chhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--------ESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
...++|.+.+.||+|+||+||+|... +++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 45688999999999999999999965 47899999875421 223346889999999999999999999975
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC---CcEEEe
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVS 538 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~ 538 (721)
.+..++||||+++++|.+++.... .+++..++.++.|++.||+|||+++ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 455799999999999999887543 6999999999999999999999999 9999999999999754 459999
Q ss_pred eccCccccccCCceeeeeeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 539 DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 539 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
|||+++..... .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....... .+.. .
T Consensus 285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~----~ 356 (419)
T 3i6u_A 285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKD----Q 356 (419)
T ss_dssp CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSC--CHHH----H
T ss_pred ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchH--HHHH----H
Confidence 99999876432 23344669999999999864 578889999999999999999999996433221 1111 1
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+....... .+.... ..+..+.+|+.+||+.||++|||+.|+++.
T Consensus 357 i~~~~~~~--~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 357 ITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHTTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HhcCCCCC--Cchhhc----ccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 11111100 000011 123568999999999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=345.41 Aligned_cols=264 Identities=23% Similarity=0.319 Sum_probs=193.4
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
....++|.+.++||+|+||+||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 344578999999999999999999965 68899999886533 233567889999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE-----CCCCcEEEeecc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL-----DGKYRAKVSDFG 541 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll-----~~~~~~kl~DFG 541 (721)
+||||++ ++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+ ++++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 59999987654 5899999999999999999999999 9999999999999 455669999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+++....... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+ .+.. .........
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~-~~~~~~~~~ 258 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFK-IFEVLGLPD 258 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCC
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHH-HHHHhCCCc
Confidence 9987643222 22334589999999999875 48999999999999999999999986543221 1111 111110000
Q ss_pred ---hhhhh-------------hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 621 ---LFEIL-------------DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 621 ---~~~~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..... ..............++.+|+.+||+.||++|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 00000 000000000112356889999999999999999999975
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=348.48 Aligned_cols=264 Identities=26% Similarity=0.403 Sum_probs=205.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 367899999999999999999976 5889999987653 34456789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
|+++++|.+++.... .+++..+..++.|++.||+|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998654 589999999999999999999996 7 999999999999999999999999999765322
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHH-------------------
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA------------------- 610 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~------------------- 610 (721)
......||+.|+|||++.+..++.++||||||+++|||++|+.||......+......
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 2233568999999999999999999999999999999999999997543322100000
Q ss_pred ----HHHHHhhccchhhhhhhhhc----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 611 ----YFLRAMKEDSLFEILDAHVL----KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 611 ----~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+...........+.++.... .......+.++.+|+.+||+.||++|||++|+++.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000001111111110 01111234568999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.12 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=199.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc--CCc--EEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA--DGR--IVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++|.+.+.||+|+||+||+|.+. +++ .||||.++.. .....+.+.+|+.++++++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 367899999999999999999853 233 6899987653 3455678999999999999999999999998765 7
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++||||+++++|.+++.... ..+++..+++++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhcc--CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 89999999999999997643 25899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchh
Q 036483 546 MAIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 546 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
........ .....+|..|+|||.+.+..++.++||||||+++|||++ |+.||...... ...........
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~-- 242 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE-- 242 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC--
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC--
Confidence 65433222 223457788999999999889999999999999999999 99998643321 11111111110
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+...+..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus 243 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 243 -------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred -------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 1111223445699999999999999999999999999988653
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=336.11 Aligned_cols=252 Identities=25% Similarity=0.348 Sum_probs=197.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||.||++... +++.+|+|++... .....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467899999999999999999975 5889999987653 23456789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCcccc
Q 036483 471 FIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASRSM 546 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~~~ 546 (721)
|+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986531 1236999999999999999999999999 9999999999999 45678999999999865
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.... ......||+.|+|||.+. ..++.++||||||++++||++|+.||......+ .............
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~~--- 245 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQKATYKEPNYA--- 245 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCC---
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHhhhccCCcccc---
Confidence 4322 233456899999999986 568999999999999999999999996543221 1111111110000
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 246 ----~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 246 ----VE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----C---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----cc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0012346889999999999999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=334.95 Aligned_cols=257 Identities=26% Similarity=0.352 Sum_probs=204.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc------hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE------SKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++|.+.+.||+|+||.||++... +++.||+|.++.... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357899999999999999999976 589999998754321 2357899999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC----cEEEeecc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY----RAKVSDFG 541 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFG 541 (721)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 5899999999999999999999999 99999999999998877 89999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+.....
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------TL-TNISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------HH-HHhHhccc
Confidence 998764322 2233458999999999999999999999999999999999999986433211 11 11111100
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhhcc
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV--LAGIK 670 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~ 670 (721)
. ....... ..+..+.+++.+||+.+|++|||+.|+++. ++.++
T Consensus 229 ~--~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 D--FDEEYFS----NTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp C--CCHHHHT----TCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred C--Ccchhcc----cCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0 0001111 123468999999999999999999999874 45543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.21 Aligned_cols=249 Identities=22% Similarity=0.357 Sum_probs=206.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||++...+ ++.+|+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 4679999999999999999999764 789999987542 334567899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 99999999999987653 5899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..+... .....
T Consensus 194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~-~~~~~------- 258 (335)
T 2owb_A 194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRI-KKNEY------- 258 (335)
T ss_dssp TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHH-HHTCC-------
T ss_pred Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHH-hcCCC-------
Confidence 322 223456899999999999999999999999999999999999998643321 111111 11110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+......+.+|+.+||+.||++|||+.|+++.
T Consensus 259 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 259 ---SIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112233468899999999999999999999874
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-39 Score=336.50 Aligned_cols=252 Identities=23% Similarity=0.317 Sum_probs=203.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..++|.+.+.||+|+||.||+++.. +++.||+|.++.......+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4567999999999999999999976 689999999876555555778999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~~~~ 547 (721)
|+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||++ ++++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999987654 5899999999999999999999999 9999999999999 788999999999997543
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+......
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~-~~~~i~~~~~~----- 225 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------K-LFEKIKEGYYE----- 225 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------H-HHHHHHHCCCC-----
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------H-HHHHHHcCCCC-----
Confidence 22 122345899999999999999999999999999999999999998643221 1 11111111110
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.........+..+.+++.+||+.||++|||+.|+++.
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 226 -FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011112234568999999999999999999999874
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=337.94 Aligned_cols=260 Identities=24% Similarity=0.390 Sum_probs=205.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~l 467 (721)
.++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999976 5899999987643 34456789999999999999999999998864 557799
Q ss_pred EEeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcC--CCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 468 VYEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAA--SIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~--~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ..+|+||||||+|||++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997532 2335999999999999999999999987 2349999999999999999999999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~----~~~~i~~~~~--- 233 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E----LAGKIREGKF--- 233 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H----HHHHHHHTCC---
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---H----HHHHHhhccc---
Confidence 7643221 122345899999999999999999999999999999999999998643321 1 1111222111
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
...+...+.++.+++.+||+.+|++|||+.||++.+...
T Consensus 234 ------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 ------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred ------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 112223445689999999999999999999998866543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=349.65 Aligned_cols=254 Identities=22% Similarity=0.280 Sum_probs=193.8
Q ss_pred hcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhh-cCCCceeeEEEEEEe----CCcc
Q 036483 393 TDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQ-INHRNVVKLLGCCLE----TEVP 465 (721)
Q Consensus 393 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~-l~h~niv~l~g~~~~----~~~~ 465 (721)
.++|.+. ++||+|+||+||++... +++.||||+++. ...+.+|+.++.+ .+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3566665 78999999999999976 588999998853 2467789998755 489999999999875 5567
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeeccC
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFGA 542 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGl 542 (721)
+|||||+++|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999986432 36999999999999999999999999 999999999999997 78999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccc-cHHHHHHHHhhccch
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDK-SLAAYFLRAMKEDSL 621 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 621 (721)
++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..... +.....
T Consensus 211 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~ 284 (400)
T 1nxk_A 211 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCC
T ss_pred ccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCcc
Confidence 98654322 233456899999999999999999999999999999999999999654432211 11111 111110
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
. . ........+.++.+|+.+||+.||++|||+.|+++.-.
T Consensus 285 ~-~-----~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~ 324 (400)
T 1nxk_A 285 E-F-----PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 324 (400)
T ss_dssp C-C-----CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred c-C-----CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence 0 0 00001123456899999999999999999999998643
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=336.33 Aligned_cols=253 Identities=25% Similarity=0.396 Sum_probs=208.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.+.|...+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 356899999999999999999865 58899999876533 3456889999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999998653 5899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhc
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 630 (721)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... ....+.... .
T Consensus 174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~---------~ 236 (303)
T 3a7i_A 174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK-------VLFLIPKNN---------P 236 (303)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHHHHSC---------C
T ss_pred c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH-------HHHHhhcCC---------C
Confidence 1 2234568999999999999999999999999999999999999986432211 111111111 1
Q ss_pred ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 631 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.......+..+.+|+.+||+.+|++|||+.|+++...-.
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~ 275 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence 111222345689999999999999999999998865433
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=345.00 Aligned_cols=258 Identities=17% Similarity=0.204 Sum_probs=208.0
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEE------EcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC---CCceeeEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGM------LADGRIVAIKKSKVIDESKVDEFINEVAILSQIN---HRNVVKLLGC 458 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~g~ 458 (721)
+++...++|.+.++||+|+||+||+|. ...++.||||+++.. ...++..|++++.+++ |+||++++++
T Consensus 59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 344456789999999999999999994 446889999988643 3457788888888886 9999999999
Q ss_pred EEeCCcceEEEeeccCCCcchhccccC--CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-----
Q 036483 459 CLETEVPLLVYEFIINGTLFQYLHDQN--EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG----- 531 (721)
Q Consensus 459 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~----- 531 (721)
+...+..+|||||+++|+|.+++.... ....+++..++.|+.||+.||+|||+++ |+||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~ 212 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQ 212 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCc
Confidence 999999999999999999999997522 2346999999999999999999999998 999999999999998
Q ss_pred ------CCcEEEeeccCcccccc-CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccc
Q 036483 532 ------KYRAKVSDFGASRSMAI-DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE 604 (721)
Q Consensus 532 ------~~~~kl~DFGls~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~ 604 (721)
++.+||+|||+++.+.. ..........||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 89999999999976542 22333445679999999999999999999999999999999999999985332211
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHhhcccc
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKR-PTMKEVAVVLAGIKAC 672 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~ev~~~L~~l~~~ 672 (721)
. .+... .... .....+.+++.+||+.+|.+| |+++++.+.|+.+...
T Consensus 293 ~--------------~~~~~----~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 293 C--------------KPEGL----FRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp E--------------EECSC----CTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred e--------------eechh----cccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 0 00000 0011 123457889999999999999 7889998888877543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=344.65 Aligned_cols=254 Identities=20% Similarity=0.277 Sum_probs=202.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~ 469 (721)
..++|.+.+.||+|+||.||++..+ +++.||||.++... ..+.+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4577999999999999999999976 58899999886432 2345788898888 7999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC----CcEEEeeccCccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK----YRAKVSDFGASRS 545 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGls~~ 545 (721)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997653 5999999999999999999999999 9999999999998543 3599999999987
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... ....+......
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~-~~~~i~~~~~~--- 241 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDT---PEE-ILARIGSGKFS--- 241 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC---HHH-HHHHHHHCCCC---
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC---HHH-HHHHHccCCcc---
Confidence 654332 2234568999999999998889999999999999999999999996432211 111 11122221110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.........+.++.+|+.+||+.||++|||+.|+++.-
T Consensus 242 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 242 ---LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp ---CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ---cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 00111122345689999999999999999999998753
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.28 Aligned_cols=194 Identities=30% Similarity=0.437 Sum_probs=155.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Cc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLET-----EV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-----~~ 464 (721)
.++|.+.++||+|+||+||+|+.. +++.||||++.. .+....+.+.+|+.+|++++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999965 689999998754 2344567899999999999999999999999543 46
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+ +++|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 578998887543 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc--------------------------eeeeeeecCCCCCCcccc-ccCCCCccccchhHHHHHHHHHhC
Q 036483 545 SMAIDQT--------------------------HMTTQVQGTFGYLDPEYF-RSSRFTEKSDVYSFGVVLAELLTG 593 (721)
Q Consensus 545 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SlGvll~elltG 593 (721)
....... ...+...||+.|+|||++ ....++.++||||||++||||++|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 7642211 123445689999999986 456799999999999999999993
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=343.11 Aligned_cols=267 Identities=23% Similarity=0.278 Sum_probs=198.2
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc-----hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE-----SKVDEFINEVAILSQINHRNVVKLLGCCLETE 463 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~ 463 (721)
....++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 344578999999999999999999975 589999998764321 22357889999999999999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+++ +|.+++.... ..+++..++.++.|+++||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred ceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccc
Confidence 99999999975 8888886543 35889999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
+....... ......||+.|+|||++.+. .++.++||||||+++|||++|..||......+ .+.. ...........
T Consensus 160 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~-i~~~~~~~~~~ 235 (346)
T 1ua2_A 160 KSFGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTR-IFETLGTPTEE 235 (346)
T ss_dssp STTTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCTT
T ss_pred eeccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHH-HHHHcCCCChh
Confidence 87643322 22345689999999999764 58899999999999999999999986543211 1111 11111110000
Q ss_pred hhh------hh---hhcccC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 623 EIL------DA---HVLKEA-----SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 623 ~~~------~~---~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
... +. ...... ....+.++.+|+.+||+.||++|||+.|+++.-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~ 293 (346)
T 1ua2_A 236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK 293 (346)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence 000 00 000000 122335699999999999999999999998753
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=328.66 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=197.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 367999999999999999999976 6899999987543 233456889999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred EeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999997654 5899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.. ......+++.|+|||.+.+..+ +.++||||||++++||++|+.||...... . ....+.....
T Consensus 164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~------ 228 (276)
T 2h6d_A 164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------T-LFKKIRGGVF------ 228 (276)
T ss_dssp ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCC------
T ss_pred Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------H-HHHHhhcCcc------
Confidence 22 2233468999999999988765 58999999999999999999998643211 1 1111111110
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 229 ----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 229 ----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 1122234568999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=330.67 Aligned_cols=249 Identities=24% Similarity=0.380 Sum_probs=198.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~~ 466 (721)
..|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 34778889999999999999975 5788999987543 34556789999999999999999999999875 34578
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCCcEEEeeccCccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFGASRS 545 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGls~~ 545 (721)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||||+|||++ .++.+||+|||++..
T Consensus 106 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 9999999999999997653 5899999999999999999999986 3499999999999998 789999999999975
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.... ......||+.|+|||.+.+ .++.++||||||+++++|++|+.||...... .. ....+.......
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~-~~~~~~~~~~~~-- 249 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPA-- 249 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCG--
T ss_pred cccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HH-HHHHHhccCCcc--
Confidence 4332 2234568999999998874 5899999999999999999999998643221 11 111111111110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...+.++.+++.+||+.+|++|||+.|+++
T Consensus 250 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 250 ------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp ------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111112245899999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=345.11 Aligned_cols=264 Identities=26% Similarity=0.406 Sum_probs=199.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.++|.+.++||+|+||.||+++... ++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 3679999999999999999999764 8999999875432 334566889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988766443 5999999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH----------HHhhc
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL----------RAMKE 618 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~----------~~~~~ 618 (721)
.. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||......+. +..... .....
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHHH
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhhh
Confidence 22 22334689999999999875 789999999999999999999999865433211 111000 00000
Q ss_pred cchhh-hhhhhhcc-----cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 619 DSLFE-ILDAHVLK-----EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 619 ~~~~~-~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... ...+.... ......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 255 NPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000 00000000 0111234679999999999999999999998764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.43 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=204.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 67899999999999999999976 4788999987542 1233467899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 9999999999997654 5899999999999999999999998 999999999999999999999999998765432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. .....|++.|+|||.+.+..++.++||||||+++|||++|+.||......+ .. ..+....
T Consensus 168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~-~~~~~~~--------- 228 (284)
T 2vgo_A 168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------TH-RRIVNVD--------- 228 (284)
T ss_dssp C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HH-HHHHTTC---------
T ss_pred c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------HH-HHHhccc---------
Confidence 1 233468999999999999999999999999999999999999986433211 11 1111110
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 229 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 -LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 11122234568999999999999999999999874
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=353.43 Aligned_cols=242 Identities=14% Similarity=0.153 Sum_probs=191.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccc---cCchhhHHHHHHHH---HHhhcCCCceeeEE-------EE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKV---IDESKVDEFINEVA---ILSQINHRNVVKLL-------GC 458 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~---il~~l~h~niv~l~-------g~ 458 (721)
.++|.+.+.||+|+||+||+|+. .+|+.||||++.. ......+.+.+|+. ++++++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999996 4689999998763 33455688999994 55556899999998 66
Q ss_pred EEeCC-----------------cceEEEeeccCCCcchhccccC----CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCe
Q 036483 459 CLETE-----------------VPLLVYEFIINGTLFQYLHDQN----EEFPITWEIRLRIAIEVSDAVSYLHSAASIPI 517 (721)
Q Consensus 459 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~i 517 (721)
+.+.+ ..++||||+ +|+|.+++.... ....+++..++.|+.||+.||+|||+++ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 65543 278999999 689999997532 1224567899999999999999999999 9
Q ss_pred eeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccC-----------CCCccccchhHHHH
Q 036483 518 YHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-----------RFTEKSDVYSFGVV 586 (721)
Q Consensus 518 vHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~SlGvl 586 (721)
+||||||+||||+.++.+||+|||+++.... ......| +.|+|||++.+. .++.++||||||++
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999985322 2334557 999999999887 89999999999999
Q ss_pred HHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 587 LAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 587 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
+|||++|+.||....... ....+... ....+.++.+|+.+||+.||++|||+.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~---------------~~~~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG---------------GSEWIFRS------CKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C---------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc---------------chhhhhhh------ccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999985432211 11111110 0122356899999999999999999999986
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-39 Score=343.82 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=200.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLET------- 462 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------- 462 (721)
.++|.+.+.||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++||||+++++++.+.
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 367999999999999999999974 68999999875432 33456788999999999999999999999874
Q ss_pred -CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 463 -EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 463 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
+..++||||+++ +|.+.+..... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 77777765432 5999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCC---ceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 542 ASRSMAIDQ---THMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 542 ls~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
+++.+.... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ .........
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~ 246 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQ---LALISQLCG 246 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhC
Confidence 998764221 122234568999999999876 4589999999999999999999999875433221 111111111
Q ss_pred c---cchhhhhhhhhc--------ccCC-HH------HHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 618 E---DSLFEILDAHVL--------KEAS-QE------DIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 618 ~---~~~~~~~~~~~~--------~~~~-~~------~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ............ .... .. ....+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 1 000000000000 0000 00 13458899999999999999999999774
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-39 Score=346.32 Aligned_cols=258 Identities=22% Similarity=0.319 Sum_probs=196.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
.++|...+.||+|+||.||+|... +|+.||||++.. ......+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 578999999999999999999975 589999998754 23344678899999999999999999999998764
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+ +++|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 359999999 88999998763 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc--
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS-- 620 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 620 (721)
+..... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||......+. ............
T Consensus 176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ---LKEIMKVTGTPPAE 248 (367)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCHH
T ss_pred cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCCHH
Confidence 875432 234568999999999987 6899999999999999999999999975443211 111111110000
Q ss_pred ---------hhhhhh------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 ---------LFEILD------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ---------~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+. ..............+.+|+.+||+.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 000000 000011112234568999999999999999999999874
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=346.80 Aligned_cols=269 Identities=23% Similarity=0.301 Sum_probs=200.6
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCc-----------hhhHHHHHHHHHHhhcCCCceee
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDE-----------SKVDEFINEVAILSQINHRNVVK 454 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~il~~l~h~niv~ 454 (721)
..++..+.++|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 4577888999999999999999999999988899999998754221 22478999999999999999999
Q ss_pred EEEEEEeCC-----cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 455 LLGCCLETE-----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 455 l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
+++++...+ ..++||||++ |+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999986533 4689999997 68888887543 36999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccH
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSL 608 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~ 608 (721)
+.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+ .
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~ 242 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN---Q 242 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H
T ss_pred cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH---H
Confidence 999999999999997543322 2334568999999999887 678999999999999999999999997544221 1
Q ss_pred HHHHHHHhhccchhh-----------hhhhhh-------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 609 AAYFLRAMKEDSLFE-----------ILDAHV-------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 609 ~~~~~~~~~~~~~~~-----------~~~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..............+ .+.... ...........+.+|+.+||+.||++|||+.|+++.
T Consensus 243 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 243 LNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111111111100 000000 001111224568999999999999999999999764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.10 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=187.7
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
....++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 344578999999999999999999854 68899999876532 3446788999999999999999999999999999999
Q ss_pred EEeeccCCCcchhcccc-----CCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 468 VYEFIINGTLFQYLHDQ-----NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence 99999999999998741 12336999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCc----eeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhh
Q 036483 543 SRSMAIDQT----HMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMK 617 (721)
Q Consensus 543 s~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 617 (721)
+........ .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... . ......
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK---V---LMLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhh---H---HHHHhc
Confidence 876643221 11234568999999999876 568999999999999999999999986543221 1 111111
Q ss_pred ccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
... ..........+.....+.++.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDP-PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSC-CCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCC-CccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 111 00000000011111223468999999999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=357.66 Aligned_cols=250 Identities=21% Similarity=0.293 Sum_probs=204.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|...++||+|+||.||+++.. +|+.||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 67888899999999999999976 5899999987542 2234567899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCC-CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNE-EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999876432 346999999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ...... ..+....
T Consensus 342 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~--~~~~~~-~~i~~~~-------- 409 (543)
T 3c4z_A 342 GQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV--ENKELK-QRVLEQA-------- 409 (543)
T ss_dssp TCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC--CHHHHH-HHHHHCC--------
T ss_pred CCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch--hHHHHH-HHHhhcc--------
Confidence 322 2234579999999999999999999999999999999999999997543211 111111 1111111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK 660 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 660 (721)
...+...+..+.+|+.+||+.||++||++.
T Consensus 410 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 410 --VTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --cCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 112233445689999999999999999763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=369.14 Aligned_cols=263 Identities=25% Similarity=0.417 Sum_probs=209.1
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
.+.+...++|.+.+.||+|+||.||+|.+.. +..||||+.+.. .....+.|.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 3444456788999999999999999998643 457999987653 3344578999999999999999999999985
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 456899999999999999997643 35899999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccc
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+++..............+|+.|+|||.+.+..++.++||||||+++|||++ |..||......+ ....+....
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-------~~~~i~~~~ 609 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGE 609 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHHHHHHTC
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH-------HHHHHHcCC
Confidence 998765443333334457789999999999999999999999999999997 999986433211 111111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+...+..+.+++.+||+.||++|||+.||++.|+.+..
T Consensus 610 ---------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 610 ---------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 111233345678999999999999999999999999998753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=334.60 Aligned_cols=256 Identities=21% Similarity=0.308 Sum_probs=200.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEE-cCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEe--CCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLE--TEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~--~~~~~lv~ 469 (721)
++|.+.+.||+|+||+||+|+. .+++.||||.++. ...+.+.+|+.++++++ ||||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 6799999999999999999986 4689999998764 33467899999999997 9999999999988 56779999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~~~ 548 (721)
||+++++|.+++. .+++..++.++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999885 3889999999999999999999999 99999999999999766 899999999987653
Q ss_pred CCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..+ ...........+.+.++.
T Consensus 184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~-~~l-~~~~~~~~~~~~~~~~~~ 259 (330)
T 3nsz_A 184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQL-VRIAKVLGTEDLYDYIDK 259 (330)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH-HHH-HHHHHHHCHHHHHHHHHH
T ss_pred CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchH-HHH-HHHHHhcCCchhhhHHHH
Confidence 322 233468999999999987 678999999999999999999999985433211 111 111111111111111110
Q ss_pred h-----------------------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 628 H-----------------------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 628 ~-----------------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. .........+.++.+|+.+||+.||++|||++|+++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 0001111134678999999999999999999999763
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-38 Score=338.16 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=206.5
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc--------hhhHHHHHHHHHHhhc-CCCceeeEE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE--------SKVDEFINEVAILSQI-NHRNVVKLL 456 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~il~~l-~h~niv~l~ 456 (721)
.......++|.+.+.||+|+||.||+|... +|+.||||.+..... ...+.+.+|+.+++++ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344566788999999999999999999986 699999998754321 1245788999999999 899999999
Q ss_pred EEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEE
Q 036483 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAK 536 (721)
Q Consensus 457 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~k 536 (721)
+++......++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ik 240 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEE
Confidence 99999999999999999999999997643 5999999999999999999999999 99999999999999999999
Q ss_pred EeeccCccccccCCceeeeeeecCCCCCCcccccc------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHH
Q 036483 537 VSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA 610 (721)
Q Consensus 537 l~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~ 610 (721)
|+|||++..+.... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||...... .
T Consensus 241 l~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------~ 312 (365)
T 2y7j_A 241 LSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------L 312 (365)
T ss_dssp ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------H
T ss_pred EEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------H
Confidence 99999998765332 2234569999999999864 35788999999999999999999998643211 1
Q ss_pred HHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 611 YFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 611 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+...... ...+. .. ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 313 -~~~~i~~~~~~-~~~~~-~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 313 -MLRMIMEGQYQ-FSSPE-WD----DRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp -HHHHHHHTCCC-CCHHH-HS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHHHHhCCCC-CCCcc-cc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111110 00000 01 123458999999999999999999999763
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=343.58 Aligned_cols=262 Identities=24% Similarity=0.273 Sum_probs=203.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC--------CCceeeEEEEEE---
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN--------HRNVVKLLGCCL--- 460 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--------h~niv~l~g~~~--- 460 (721)
.++|.+.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 478999999999999999999865 5889999988643 345678899999999985 788999999987
Q ss_pred -eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCC-----
Q 036483 461 -ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKY----- 533 (721)
Q Consensus 461 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~----- 533 (721)
+....++||||+ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+||||+.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 455789999999 6666666654332 3599999999999999999999998 8 99999999999999775
Q ss_pred --------------------------------------------cEEEeeccCccccccCCceeeeeeecCCCCCCcccc
Q 036483 534 --------------------------------------------RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569 (721)
Q Consensus 534 --------------------------------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~ 569 (721)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999876432 2334689999999999
Q ss_pred ccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHH---HHHHHHhhccchhhhhhhh------------------
Q 036483 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA---AYFLRAMKEDSLFEILDAH------------------ 628 (721)
Q Consensus 570 ~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~------------------ 628 (721)
.+..++.++||||||++||||++|+.||......+..... ..............+....
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 9999999999999999999999999999755433321111 1111111110000000000
Q ss_pred ----------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 ----------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ----------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.....+......+.+|+.+||+.||++|||+.|+++
T Consensus 346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 011245677788999999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=351.33 Aligned_cols=198 Identities=26% Similarity=0.383 Sum_probs=167.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Cc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET-----EV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-----~~ 464 (721)
.++|.+.+.||+|+||.||+|+.. +++.||||+++.. .....+.+.+|+.+|++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 478999999999999999999965 4889999988652 334567899999999999999999999999876 46
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+. ++|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 799999985 69999987543 5999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCc---------------------eeeeeeecCCCCCCcccc-ccCCCCccccchhHHHHHHHHHhCCccc
Q 036483 545 SMAIDQT---------------------HMTTQVQGTFGYLDPEYF-RSSRFTEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 545 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~SlGvll~elltG~~p~ 597 (721)
....... ...+...||+.|+|||++ ....++.++||||||+++|||++|..|+
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 7643321 123456799999999986 5567999999999999999999865444
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=332.92 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=200.5
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
..++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 3478999999999999999999976 488999999877666677899999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL 171 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence 9999999999876432 5899999999999999999999999 9999999999999999999999999976432111
Q ss_pred ceeeeeeecCCCCCCcccc-----ccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 551 THMTTQVQGTFGYLDPEYF-----RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.......||+.|+|||.+ ....++.++||||||+++|||++|+.||...... ............ ..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~-~~- 242 (302)
T 2j7t_A 172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDPP-TL- 242 (302)
T ss_dssp -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCCC-CC-
T ss_pred -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCCc-cc-
Confidence 112334689999999998 4667899999999999999999999998643321 111111111110 00
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.+|++|||+.++++.
T Consensus 243 ------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 243 ------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp ------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred ------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0112233568999999999999999999998663
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=339.85 Aligned_cols=259 Identities=24% Similarity=0.361 Sum_probs=199.9
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe--
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLE-- 461 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~-- 461 (721)
..++....++|.+.+.||+|+||.||+|... +++.||||.+... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 94 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN 94 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence 3344556788999999999999999999975 6899999987653 33457899999999999 89999999999987
Q ss_pred ----CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 462 ----TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 462 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp --CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEE
T ss_pred CccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEE
Confidence 457799999999999999997643 236899999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCCceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHH
Q 036483 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 538 ~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~ 612 (721)
+|||++........ ......||+.|+|||++. +..++.++||||||+++|||++|+.||...... ...
T Consensus 171 ~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~ 243 (326)
T 2x7f_A 171 VDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM------RAL 243 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH------HHH
T ss_pred eeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHH
Confidence 99999976543211 223346899999999987 567899999999999999999999998543221 111
Q ss_pred HHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 613 LRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. .+....... ......+..+.+++.+||+.+|++|||+.++++.
T Consensus 244 ~-~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 F-LIPRNPAPR--------LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp H-HHHHSCCCC--------CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred H-HhhcCcccc--------CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1 111111100 0111223568999999999999999999999874
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=368.43 Aligned_cols=244 Identities=22% Similarity=0.308 Sum_probs=203.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcce
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~ 466 (721)
..++|++.++||+|+||.||+|+.. +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4578999999999999999999976 5889999987642 344567889999999988 7999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
|||||+++|+|.++++... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 419 lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 9999999999999998754 5999999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.... .......||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+...+ ...+
T Consensus 493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~-~~~~----- 559 (674)
T 3pfq_A 493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIM-EHNV----- 559 (674)
T ss_dssp CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-SSCC-----
T ss_pred ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHH-hCCC-----
Confidence 3322 2234567999999999999999999999999999999999999999653321 1122111 1111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 659 (721)
.++...+.++.+|+.+||+.||++||++
T Consensus 560 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 560 -----AYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp -----CCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred -----CCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 1223344568999999999999999998
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.48 Aligned_cols=252 Identities=22% Similarity=0.278 Sum_probs=198.8
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC----chhhHHHHHHHHHHhhcCCCceeeEEEEEE--eCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID----ESKVDEFINEVAILSQINHRNVVKLLGCCL--ETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~----~~~~~~~~~E~~il~~l~h~niv~l~g~~~--~~~~ 464 (721)
..++|.+.+.||+|+||.||++... +++.||+|.++... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 3578999999999999999999975 58899999876532 344678999999999999999999999984 4457
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||++++ |.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 79999999876 7677665432 36999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCC-ceeeeeeecCCCCCCccccccCC--CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 545 SMAIDQ-THMTTQVQGTFGYLDPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 545 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
...... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~-~~~~i~~~~~ 230 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------K-LFENIGKGSY 230 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHCCC
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------H-HHHHHhcCCC
Confidence 764322 22233456899999999998654 377999999999999999999998643211 1 1111111111
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.||++|||+.|+++.
T Consensus 231 ----------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 231 ----------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ----------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ----------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1122234568899999999999999999999875
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=353.54 Aligned_cols=252 Identities=26% Similarity=0.357 Sum_probs=203.4
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
..++|.+.++||+|+||+||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4577999999999999999999976 6899999987542 234567899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC---CCCcEEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD---GKYRAKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGls~~ 545 (721)
|||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999887654 5999999999999999999999999 99999999999995 456799999999986
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+.......
T Consensus 174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~-- 241 (486)
T 3mwu_A 174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD-------ILKRVETGKYAF-- 241 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCCS--
T ss_pred CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCCC--
Confidence 64332 2334569999999999876 58999999999999999999999996533211 111121111100
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ......+.++.+|+.+||+.+|++|||+.|+++.
T Consensus 242 ~~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 DL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp CS----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred CC----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 0011223468899999999999999999999886
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=341.98 Aligned_cols=263 Identities=22% Similarity=0.343 Sum_probs=202.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC-----c
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE-----V 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~-----~ 464 (721)
..++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++++++||||+++++++.... .
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999965 58899999886533 344578999999999999999999999997653 5
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+. ++|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 789999996 5899988754 4999999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCcee--eeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 545 SMAIDQTHM--TTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 545 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
......... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. .............
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ---LNHILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH---HHHHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH---HHHHHHHhCCCCH
Confidence 765332221 234569999999998765 4589999999999999999999999975543321 1111111111100
Q ss_pred hh---hhh---hhh------c-----ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 622 FE---ILD---AHV------L-----KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 622 ~~---~~~---~~~------~-----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. +.+ ... . .......+.++.+|+.+||+.||++|||+.|+++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 000 000 0 00011223568999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=331.93 Aligned_cols=252 Identities=23% Similarity=0.328 Sum_probs=186.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.++|++.+.||+|+||+||++... +++.||+|+++... ....+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 477999999999999999999974 68999999876532 223334555556688889999999999999999999999
Q ss_pred eeccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 470 EFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 470 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||++ ++|.+++... .....+++..++.++.|++.||+|||++ + |+||||||+|||++.++.+||+|||+++...
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5887777542 1223699999999999999999999998 8 9999999999999999999999999998664
Q ss_pred cCCceeeeeeecCCCCCCcccc----ccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYF----RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
... ......||+.|+|||.+ .+..++.++||||||+++|||++|+.||...... ............
T Consensus 162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~--- 231 (290)
T 3fme_A 162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-----FQQLKQVVEEPS--- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-----HHHHHHHHHSCC---
T ss_pred ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-----HHHHHHHhccCC---
Confidence 332 22334589999999996 5567899999999999999999999998642211 111111111111
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
........+.++.+++.+||+.+|++|||+.|+++
T Consensus 232 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 ------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111223456899999999999999999999977
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=332.49 Aligned_cols=254 Identities=25% Similarity=0.318 Sum_probs=197.1
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--------chhhHHHHHHHHHHhhcCCCceeeEEEEEEe
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--------ESKVDEFINEVAILSQINHRNVVKLLGCCLE 461 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~ 461 (721)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 34578999999999999999999975 47899999875421 2234568899999999999999999999876
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc---EEEe
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR---AKVS 538 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~ 538 (721)
.+ .++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~ 159 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 159 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEEC
T ss_pred Cc-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEc
Confidence 55 799999999999999887543 6899999999999999999999999 999999999999987654 9999
Q ss_pred eccCccccccCCceeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 539 DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 539 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
|||+++...... ......||+.|+|||++. ...++.++||||||+++|||++|+.||....... .+...
T Consensus 160 Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~---- 231 (322)
T 2ycf_A 160 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQ---- 231 (322)
T ss_dssp CCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHH----
T ss_pred cCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHH----
Confidence 999998764321 122345899999999974 5678899999999999999999999986543221 11111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+....... .+.... ..+..+.+++.+||+.||++|||+.|+++.
T Consensus 232 ~~~~~~~~--~~~~~~----~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 232 ITSGKYNF--IPEVWA----EVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHHTCCCC--CHHHHT----TSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhCcccc--Cchhhh----hcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 11111100 000111 123568999999999999999999999753
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=350.57 Aligned_cols=252 Identities=27% Similarity=0.363 Sum_probs=199.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
..++|.+.+.||+|+||+||+|+.. ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999976 5889999987653 234467899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC---CcEEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGls~~ 545 (721)
|||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.. +.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887653 5899999999999999999999999 9999999999999764 4599999999987
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+ ....+...... .
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~-~- 256 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------ILRKVEKGKYT-F- 256 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHTCCC-C-
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHHHhCCCC-C-
Confidence 65332 233456999999999986 568999999999999999999999996543211 11122111110 0
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... ...+..+.+|+.+||+.+|++|||+.|+++.
T Consensus 257 ~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 257 DSPEW----KNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CSGGG----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred Cchhc----ccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 00000 1223468899999999999999999999864
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-38 Score=355.20 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=205.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
..++|.+.++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 3567999999999999999999976 6899999987542 23456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---CCCCcEEEeeccCcc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL---DGKYRAKVSDFGASR 544 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll---~~~~~~kl~DFGls~ 544 (721)
||||+.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999887643 5999999999999999999999999 9999999999999 567899999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||......+ ....+.......
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~i~~~~~~~- 246 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------ILKKVEKGKYTF- 246 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCCCC-
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHcCCCCC-
Confidence 764332 2233459999999999876 68999999999999999999999996543211 111222211100
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. .......+.++.+|+.+||+.+|++|||+.|++++
T Consensus 247 -~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 -E----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp -C----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 00011233568999999999999999999999875
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=334.30 Aligned_cols=263 Identities=26% Similarity=0.370 Sum_probs=202.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEE--cCCcEEEEeeccccC--chhhHHHHHHHHHHhhc---CCCceeeEEEEEE----
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGML--ADGRIVAIKKSKVID--ESKVDEFINEVAILSQI---NHRNVVKLLGCCL---- 460 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l---~h~niv~l~g~~~---- 460 (721)
+.++|.+.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999997 358899999875432 22345677888888776 8999999999987
Q ss_pred -eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEee
Q 036483 461 -ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSD 539 (721)
Q Consensus 461 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 539 (721)
.....++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCT-TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4567789999997 699999876543 25899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 540 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ ............
T Consensus 164 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i~~~~~~~ 238 (326)
T 1blx_A 164 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---QLGKILDVIGLP 238 (326)
T ss_dssp CCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCCC
T ss_pred CcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHHHcCCC
Confidence 99998664322 2234568999999999999999999999999999999999999986543221 111111111100
Q ss_pred ---chhhhh----------hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 620 ---SLFEIL----------DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 620 ---~~~~~~----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.+.... ............+..+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000 000011112233456899999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=339.15 Aligned_cols=264 Identities=23% Similarity=0.388 Sum_probs=203.4
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
.+++...++|.+.+.||+|+||.||+|...+ .+|+|.++.. .....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3444456889999999999999999999754 4899987553 33445678899999999999999999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++ ++.+||+|||+++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp EEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred eEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 999999999999999997643 35899999999999999999999999 99999999999998 6799999999987
Q ss_pred ccccCC----ceeeeeeecCCCCCCcccccc---------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH
Q 036483 545 SMAIDQ----THMTTQVQGTFGYLDPEYFRS---------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 545 ~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~ 611 (721)
...... ........|++.|+|||.+.. ..++.++||||||+++|||++|+.||.......
T Consensus 178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------- 250 (319)
T 2y4i_B 178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------- 250 (319)
T ss_dssp ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-------
T ss_pred ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------
Confidence 653211 111223458999999999874 457889999999999999999999986433211
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
....+........ .....+.++.+++.+||+.+|++|||+.++++.|+.+....
T Consensus 251 ~~~~~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 251 IIWQMGTGMKPNL--------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp HHHHHHTTCCCCC--------CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred HHHHhccCCCCCC--------CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111111111000 01112345889999999999999999999999999987653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=344.48 Aligned_cols=259 Identities=24% Similarity=0.320 Sum_probs=184.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC------
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET------ 462 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------ 462 (721)
..++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 3478999999999999999999964 5889999987542 334567889999999999999999999999754
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
...++|+|++ +++|.+++... .+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 4568999999 78999988753 5999999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc-
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS- 620 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 620 (721)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......+ .............
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID---QLKLILRLVGTPGA 251 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHHCSCCH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCH
Confidence 9865322 334568999999999987 678999999999999999999999997544321 1111111111100
Q ss_pred ----------hhhhhhhhh-cccC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 ----------LFEILDAHV-LKEA-----SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ----------~~~~~~~~~-~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+.... .... .......+.+|+.+||+.||++|||+.|+++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000000000 0000 01123568999999999999999999999765
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.60 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=200.3
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
...++|.+.+.||+|+||.||+|... +|+.||+|.+... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999976 4899999988653 34578999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRN--KTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHT--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999987433 25899999999999999999999999 999999999999999999999999999776432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... .... .........
T Consensus 179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~-~~~~~~~~~----- 245 (314)
T 3com_A 179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFM-IPTNPPPTF----- 245 (314)
T ss_dssp BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH-HHHSCCCCC-----
T ss_pred cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHH-HhcCCCccc-----
Confidence 22 2233468999999999999999999999999999999999999986432211 1111 111110000
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+...+..+.+++.+||+.||++|||+.++++.
T Consensus 246 --~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 246 --RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp --SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred --CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0111223568999999999999999999999774
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=350.05 Aligned_cols=253 Identities=28% Similarity=0.378 Sum_probs=202.5
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-------------chhhHHHHHHHHHHhhcCCCceeeEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-------------ESKVDEFINEVAILSQINHRNVVKLL 456 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------------~~~~~~~~~E~~il~~l~h~niv~l~ 456 (721)
.+.++|.+.++||+|+||+||+|... +++.||||.+.... ....+.+.+|+.+|++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35688999999999999999999976 47899999875422 13356889999999999999999999
Q ss_pred EEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC---
Q 036483 457 GCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY--- 533 (721)
Q Consensus 457 g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~--- 533 (721)
+++.+....++||||+++|+|.+++.... .+++..++.++.||+.||+|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999987654 5999999999999999999999999 99999999999998775
Q ss_pred cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
.+||+|||+++...... ......||+.|+|||++. ..++.++||||||+++|+|++|+.||......+ ..
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------II 256 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HH
Confidence 69999999998765432 233456999999999987 468999999999999999999999996543221 11
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+....... ...... ..+.++.+|+.+||+.||++|||+.|+++.
T Consensus 257 ~~i~~~~~~~--~~~~~~----~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 257 KKVEKGKYYF--DFNDWK----NISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHHHHCCCCC--CHHHHT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHcCCCCC--CccccC----CCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 2222221100 000001 123468999999999999999999999875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-38 Score=328.34 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=194.6
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe---------
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE--------- 461 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--------- 461 (721)
..++|++.+.||+|+||.||+|+.. +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 4567999999999999999999965 6899999988542 3456789999999999999999999999865
Q ss_pred ----CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEE
Q 036483 462 ----TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537 (721)
Q Consensus 462 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl 537 (721)
.+..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 345689999999999999998643 35888999999999999999999999 999999999999999999999
Q ss_pred eeccCccccccCC-------------ceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCcc
Q 036483 538 SDFGASRSMAIDQ-------------THMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFE 603 (721)
Q Consensus 538 ~DFGls~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~ 603 (721)
+|||+++...... ........||+.|+|||.+.+. .++.++||||||+++|||++ |+...
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~--- 231 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG--- 231 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH---
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc---
Confidence 9999998654221 1122345689999999999865 78999999999999999998 33211
Q ss_pred ccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 604 EDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 604 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... ....+... ........+...+..+.+++.+||+.||++|||+.++++.
T Consensus 232 --~~~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 --MERVN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp --HHHHH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --hhHHH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01111 11111111 0111122333445568999999999999999999999763
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=338.54 Aligned_cols=259 Identities=23% Similarity=0.345 Sum_probs=204.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCch-----------------hhHHHHHHHHHHhhcCCCceeeE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDES-----------------KVDEFINEVAILSQINHRNVVKL 455 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~E~~il~~l~h~niv~l 455 (721)
.++|.+.+.||+|+||.||+|.. +++.||||.+...... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 47899999999999999999999 8999999987542211 11789999999999999999999
Q ss_pred EEEEEeCCcceEEEeeccCCCcchh------ccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEE
Q 036483 456 LGCCLETEVPLLVYEFIINGTLFQY------LHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNIL 528 (721)
Q Consensus 456 ~g~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIl 528 (721)
++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999999 54421 3479999999999999999999999 88 999999999999
Q ss_pred ECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccC-CCCc-cccchhHHHHHHHHHhCCcccccCCccccc
Q 036483 529 LDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTE-KSDVYSFGVVLAELLTGERAIRVTNFEEDK 606 (721)
Q Consensus 529 l~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~SlGvll~elltG~~p~~~~~~~~~~ 606 (721)
++.++.+||+|||++...... ......|+..|+|||.+.+. .++. ++||||||+++|||++|+.||......
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--- 258 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL--- 258 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS---
T ss_pred EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH---
Confidence 999999999999999876433 23345689999999999887 6666 999999999999999999998654321
Q ss_pred cHHHHHHHHhhccchhhhhh---------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 607 SLAAYFLRAMKEDSLFEILD---------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 607 ~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ....+.........+ ...........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 259 --~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 --VE-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp --HH-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred --HH-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11 111222211100000 000000012334578999999999999999999999763
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=336.81 Aligned_cols=257 Identities=23% Similarity=0.342 Sum_probs=193.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
.++|.+.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 468999999999999999999965 588999998764 23445678899999999999999999999998665
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+++ +|.+++.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCSE-EHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCCC-CHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 67999999964 67777752 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc-----
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE----- 618 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 618 (721)
+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+ .+...+..
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~~ 246 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID------QWNKVIEQLGTPC 246 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHC-CCCCC
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCCCC
Confidence 865422 22334568999999999999999999999999999999999999997543221 11111100
Q ss_pred -----------------cc------hhhhhhhhhc---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 619 -----------------DS------LFEILDAHVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 619 -----------------~~------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
.. +......... .+.......++.+|+.+||+.||++|||++|+++.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp 320 (371)
T 2xrw_A 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 320 (371)
T ss_dssp HHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred HHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence 00 0000000000 001123356799999999999999999999998753
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-38 Score=345.91 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=196.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc------ce
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV------PL 466 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~------~~ 466 (721)
..+|.+.++||+|+||+||+|+...+..+|+|++.... ....+|++++++++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 45799999999999999999998877779999875422 122479999999999999999999965443 67
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCCcEEEeeccCccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFGASRS 545 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGls~~ 545 (721)
+||||++++.+............+++..+..++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.
T Consensus 115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~ 191 (394)
T 4e7w_A 115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI 191 (394)
T ss_dssp EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence 99999987654444332222346999999999999999999999999 99999999999999 799999999999987
Q ss_pred cccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
...... .....+|+.|+|||++.+. .++.++||||||+++|||++|+.||......+ .+.. ............+
T Consensus 192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~-i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVE-IIKVLGTPSREQI 266 (394)
T ss_dssp CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCCCCHHHH
T ss_pred ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHHH
Confidence 643322 2345689999999999765 58999999999999999999999997544221 1111 1111111100000
Q ss_pred --hhhhh-------------cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 625 --LDAHV-------------LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 625 --~~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..+.. ........+.++.+|+.+||+.||++|||+.|++++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000 011122234579999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-38 Score=333.51 Aligned_cols=259 Identities=22% Similarity=0.344 Sum_probs=204.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEE-c-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc------eeeEEEEEEeCCc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGML-A-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN------VVKLLGCCLETEV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~g~~~~~~~ 464 (721)
.++|.+.+.||+|+||+||++.. . +++.||||.++.. ....+.+.+|+.+++.++|++ ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 46899999999999999999986 3 5889999988643 344578899999999987654 9999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-------------
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG------------- 531 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~------------- 531 (721)
.++||||+ +++|.+++..... .++++..++.++.|++.||+|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8999999976543 36899999999999999999999999 999999999999987
Q ss_pred ------CCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc
Q 036483 532 ------KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605 (721)
Q Consensus 532 ------~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~ 605 (721)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 668999999999765322 2234689999999999999999999999999999999999999975443221
Q ss_pred ccHHHHHHHHhhccchhhhhh------------------------------h-hhcccCCHHHHHHHHHHHHHhhccCCC
Q 036483 606 KSLAAYFLRAMKEDSLFEILD------------------------------A-HVLKEASQEDIVTVAKLTNRCLNLNGK 654 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~------------------------------~-~~~~~~~~~~~~~l~~li~~cl~~~p~ 654 (721)
............ ..+.. + ..........+.++.+|+.+||+.||+
T Consensus 243 ---~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 318 (339)
T 1z57_A 243 ---LAMMERILGPLP-KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPA 318 (339)
T ss_dssp ---HHHHHHHHCSCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred ---HHHHHHHhCCCC-HHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcc
Confidence 111111111000 00000 0 000112334567899999999999999
Q ss_pred CCCCHHHHHHH
Q 036483 655 KRPTMKEVAVV 665 (721)
Q Consensus 655 ~RPt~~ev~~~ 665 (721)
+|||+.|+++.
T Consensus 319 ~Rpt~~ell~h 329 (339)
T 1z57_A 319 KRITLREALKH 329 (339)
T ss_dssp TSCCHHHHTTS
T ss_pred cccCHHHHhcC
Confidence 99999999754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=347.32 Aligned_cols=200 Identities=25% Similarity=0.335 Sum_probs=173.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc------CCCceeeEEEEEEeCCc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI------NHRNVVKLLGCCLETEV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l------~h~niv~l~g~~~~~~~ 464 (721)
...+|.+.++||+|+||+||+|... +++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++...+.
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567999999999999999999866 4889999988643 33456788899888877 57799999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc--EEEeeccC
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR--AKVSDFGA 542 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~--~kl~DFGl 542 (721)
.++||||+. ++|.+++...... .+++..++.++.||+.||+|||+.+ |+||||||+||||+.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999995 6899988765432 5899999999999999999999999 999999999999999887 99999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCC
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~ 601 (721)
++..... .....||+.|+|||++.+..++.++||||||++||||++|+.||....
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 9764322 223468999999999999999999999999999999999999987544
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=332.84 Aligned_cols=254 Identities=24% Similarity=0.343 Sum_probs=199.0
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcC--CCceeeEEEEEEeCCcce
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQIN--HRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~--h~niv~l~g~~~~~~~~~ 466 (721)
...++|.+.+.||+|+||.||++...+++.||||.+... .....+.+.+|+.++.+++ |+||+++++++.+.+..+
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~ 104 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 104 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence 345779999999999999999999888999999987543 3445678999999999997 599999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||| +.+++|.+++.... .+++..++.++.|+++||.|||+.+ |+||||||+|||+++ +.+||+|||+++..
T Consensus 105 lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 105 MVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQM 176 (313)
T ss_dssp EEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC-
T ss_pred EEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccc
Confidence 9999 56889999998653 6899999999999999999999999 999999999999975 79999999999876
Q ss_pred ccCCce-eeeeeecCCCCCCcccccc-----------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH
Q 036483 547 AIDQTH-MTTQVQGTFGYLDPEYFRS-----------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 547 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 614 (721)
...... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...... ......
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~~ 251 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA 251 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHH
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH-----HHHHHH
Confidence 533222 1234468999999999876 46888999999999999999999998533211 111111
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
+++.......+...+.++.+++.+||+.+|++|||+.|+++.-
T Consensus 252 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~ 294 (313)
T 3cek_A 252 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 294 (313)
T ss_dssp ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred ---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence 1111111122222245689999999999999999999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-38 Score=327.90 Aligned_cols=253 Identities=26% Similarity=0.388 Sum_probs=203.5
Q ss_pred HHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---------chhhHHHHHHHHHHhhcC-CCceeeEEEEE
Q 036483 391 TATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---------ESKVDEFINEVAILSQIN-HRNVVKLLGCC 459 (721)
Q Consensus 391 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~E~~il~~l~-h~niv~l~g~~ 459 (721)
...++|.+.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44578999999999999999999976 58899999875432 123467889999999995 99999999999
Q ss_pred EeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEee
Q 036483 460 LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSD 539 (721)
Q Consensus 460 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~D 539 (721)
.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999997653 5899999999999999999999999 99999999999999999999999
Q ss_pred ccCccccccCCceeeeeeecCCCCCCccccc------cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 540 FGASRSMAIDQTHMTTQVQGTFGYLDPEYFR------SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 540 FGls~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
||++....... ......|++.|+|||++. ...++.++||||||++++||++|+.||....... ..
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~ 238 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------ML 238 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------HH
Confidence 99998764332 223346899999999985 4568899999999999999999999986432211 11
Q ss_pred HHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 614 RAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 614 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...... . ........+..+.+++.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~-~-----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQ-F-----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCC-C-----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcc-c-----CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111110 0 00001123456899999999999999999999865
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=336.57 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=195.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEE-----------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCL----------- 460 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~----------- 460 (721)
.++|.+.+.||+|+||.||+|.... ++.||+|++...+....+.+.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4679999999999999999999775 8999999987766677789999999999999999999999874
Q ss_pred ---eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCCcEE
Q 036483 461 ---ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAK 536 (721)
Q Consensus 461 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~k 536 (721)
+....++||||++ ++|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999997 6999988643 5899999999999999999999999 99999999999997 567999
Q ss_pred EeeccCccccccCCce--eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHH
Q 036483 537 VSDFGASRSMAIDQTH--MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFL 613 (721)
Q Consensus 537 l~DFGls~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~ 613 (721)
|+|||+++........ ......+|..|+|||.+.+ ..++.++||||||+++|||++|+.||......+ ......
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE---QMQLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence 9999999876432211 1223357899999998876 678999999999999999999999997543221 111111
Q ss_pred HHhhccc---hhh-------hhhhhhc------ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 614 RAMKEDS---LFE-------ILDAHVL------KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 614 ~~~~~~~---~~~-------~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....... ..+ .+..... .......+.++.+++.+||+.||++|||+.|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 1100000 000 0000000 00111234568999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-39 Score=346.98 Aligned_cols=254 Identities=13% Similarity=0.062 Sum_probs=182.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhc--CCCceeeEE-------EEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQI--NHRNVVKLL-------GCC 459 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l--~h~niv~l~-------g~~ 459 (721)
..+|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 455889999999999999999965 68999999887643 23456778886555554 699988755 444
Q ss_pred EeCC-----------------cceEEEeeccCCCcchhccccCCCCCccHHHH------HHHHHHHHHHHHHHHhcCCCC
Q 036483 460 LETE-----------------VPLLVYEFIINGTLFQYLHDQNEEFPITWEIR------LRIAIEVSDAVSYLHSAASIP 516 (721)
Q Consensus 460 ~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~qia~~L~yLH~~~~~~ 516 (721)
.... ..+|||||++ ++|.+++..... .+.+..+ +.++.||+.||+|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 4332 3699999998 899999986432 2455555 788899999999999999
Q ss_pred eeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCC
Q 036483 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGE 594 (721)
Q Consensus 517 ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~ 594 (721)
|+||||||+||||+.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++||||||++||||++|+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999865321 113457799999999987 67999999999999999999999
Q ss_pred cccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 595 RAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 595 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.||........... .....................+..+.+|+.+||+.||++|||+.|+++
T Consensus 291 ~Pf~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGSW--------KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTCC--------CBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccch--------hhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99975532211100 000000000001111111233456899999999999999999999965
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=340.09 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=193.0
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEV 464 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~ 464 (721)
..+.....++|.+.+.||+|+||+||+|+.. +++.||||++... ....+.+.+|++.++.++||||+++++++.....
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 4456677899999999999999999999975 5899999987543 3344567888999999999999999999976443
Q ss_pred -------ceEEEeeccCCCcchhccc-cCCCCCccHHHHHHHHHHHHHHHHHHH--hcCCCCeeeccCcCccEEECC-CC
Q 036483 465 -------PLLVYEFIINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLH--SAASIPIYHRDIKSTNILLDG-KY 533 (721)
Q Consensus 465 -------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH--~~~~~~ivHrDlk~~NIll~~-~~ 533 (721)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 6899999976 44444332 223346899999999999999999999 888 999999999999996 89
Q ss_pred cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHH
Q 036483 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~ 612 (721)
.+||+|||+++....... .....||+.|+|||++.+.. ++.++||||||+++|||++|+.||....... .....
T Consensus 170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG---QLHEI 244 (360)
T ss_dssp EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH---HHHHH
Confidence 999999999987653322 23345899999999987654 8999999999999999999999997543321 11111
Q ss_pred HHHhhccc--hhhhhh----------------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 613 LRAMKEDS--LFEILD----------------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 613 ~~~~~~~~--~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.+...... ....++ ...........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 11111000 000000 001111222245679999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=342.70 Aligned_cols=264 Identities=22% Similarity=0.296 Sum_probs=196.3
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE---- 463 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~---- 463 (721)
++...++|.+.+.||+|+||+||+|+.. +++.||||++.... ....+|+++|++++||||+++++++....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 3456788999999999999999999964 68999999875432 22347999999999999999999985432
Q ss_pred ----------------------------------cceEEEeeccCCCcchhcccc-CCCCCccHHHHHHHHHHHHHHHHH
Q 036483 464 ----------------------------------VPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIRLRIAIEVSDAVSY 508 (721)
Q Consensus 464 ----------------------------------~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~qia~~L~y 508 (721)
..++||||++ ++|.+.+... .....+++..+..++.||++||+|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3689999997 5777777641 122369999999999999999999
Q ss_pred HHhcCCCCeeeccCcCccEEEC-CCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHH
Q 036483 509 LHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVV 586 (721)
Q Consensus 509 LH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvl 586 (721)
||+.+ |+||||||+|||++ .++.+||+|||+++....... .....+|+.|+|||.+.+. .++.++||||||++
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999998 688999999999987643332 2344689999999998875 48999999999999
Q ss_pred HHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh---------------hhhhcccCCHHHHHHHHHHHHHhhcc
Q 036483 587 LAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL---------------DAHVLKEASQEDIVTVAKLTNRCLNL 651 (721)
Q Consensus 587 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~l~~li~~cl~~ 651 (721)
+|||++|+.||......+ ................+. ........+...+.++.+|+.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~---~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSID---QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHH---HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999997543221 111111111111110000 00011112223445689999999999
Q ss_pred CCCCCCCHHHHHHH
Q 036483 652 NGKKRPTMKEVAVV 665 (721)
Q Consensus 652 ~p~~RPt~~ev~~~ 665 (721)
||++|||+.|+++.
T Consensus 309 dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 309 EPDLRINPYEAMAH 322 (383)
T ss_dssp SGGGSCCHHHHHTS
T ss_pred ChhhCCCHHHHhcC
Confidence 99999999999764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=345.92 Aligned_cols=268 Identities=22% Similarity=0.319 Sum_probs=184.5
Q ss_pred hcCCCC-CceEeeeCcEEEEEEEEc---CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcce
Q 036483 393 TDHYNT-NRILGQGGQGTVYKGMLA---DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPL 466 (721)
Q Consensus 393 ~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~ 466 (721)
.+.|.+ .++||+|+||+||+|+.. +++.||||++... ...+.+.+|+.+|++++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344665 568999999999999966 4788999988643 233578899999999999999999999965 56789
Q ss_pred EEEeeccCCCcchhccccC------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE----CCCCcEE
Q 036483 467 LVYEFIINGTLFQYLHDQN------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL----DGKYRAK 536 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll----~~~~~~k 536 (721)
+||||+. ++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 57777775321 2235999999999999999999999999 9999999999999 7788999
Q ss_pred EeeccCccccccCCc--eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCcccc------cc
Q 036483 537 VSDFGASRSMAIDQT--HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEED------KS 607 (721)
Q Consensus 537 l~DFGls~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~------~~ 607 (721)
|+|||+++....... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||........ ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643221 223345689999999999874 589999999999999999999999965432110 01
Q ss_pred HHHHHHHHhhccc---hhhh------------hhhhhcc---------cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 036483 608 LAAYFLRAMKEDS---LFEI------------LDAHVLK---------EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVA 663 (721)
Q Consensus 608 ~~~~~~~~~~~~~---~~~~------------~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~ 663 (721)
....+...+.... +..+ +...... .........+.+|+.+||+.||++|||++|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 1111111111000 0000 0000000 00001134678999999999999999999998
Q ss_pred HHH
Q 036483 664 VVL 666 (721)
Q Consensus 664 ~~L 666 (721)
+.-
T Consensus 333 ~hp 335 (405)
T 3rgf_A 333 QDP 335 (405)
T ss_dssp TSG
T ss_pred cCh
Confidence 764
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=346.71 Aligned_cols=259 Identities=24% Similarity=0.338 Sum_probs=193.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------cce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE------VPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------~~~ 466 (721)
.+|...++||+|+||.||+|+.. +++.||||++.... ..+.+|+++|++++||||+++++++.... ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46889999999999999999976 58999999875422 23457999999999999999999986432 256
Q ss_pred EEEeeccCCCcchhccc-cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-CcEEEeeccCcc
Q 036483 467 LVYEFIINGTLFQYLHD-QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASR 544 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-~~~kl~DFGls~ 544 (721)
+||||+++ +|.+++.. ......+++..++.++.||++||+|||+++ |+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 89999975 56555543 122336999999999999999999999999 9999999999999955 678999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.+..... .....||+.|+|||++.+. .++.++||||||++||||++|+.||......+ .+.. ....+.......
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~-i~~~lg~p~~~~ 280 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTREQ 280 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-HHHHHCSCCHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-HHHHhCCCCHHH
Confidence 7643322 2345689999999999765 79999999999999999999999997543221 1111 111111110000
Q ss_pred h--hhhh-------------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 I--LDAH-------------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~--~~~~-------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+ +.+. +...+....+.++.+|+.+||+.||++|||+.|++++
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 0 0000 0000112234678999999999999999999999865
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-38 Score=338.11 Aligned_cols=263 Identities=22% Similarity=0.318 Sum_probs=200.3
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Cc
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLET-----EV 464 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-----~~ 464 (721)
+.++|.+.+.||+|+||.||+|... +|+.||||++.... ......+.+|+.++++++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999976 58899999886533 34456788999999999999999999998764 56
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+. ++|.+++... .+++..++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999996 6899888763 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCce---------eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH
Q 036483 545 SMAIDQTH---------MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 545 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~ 614 (721)
........ ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........ ......
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~ 237 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ---LLLIFG 237 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHH
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHH
Confidence 76432211 1123468999999998765 6789999999999999999999999975442211 111111
Q ss_pred Hhhccc------------hhhhhhhh------hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 615 AMKEDS------------LFEILDAH------VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 615 ~~~~~~------------~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...... ..+.+... .........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 111000 00000000 0000011234568899999999999999999999764
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=323.46 Aligned_cols=254 Identities=26% Similarity=0.357 Sum_probs=203.9
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
....++|.+.+.||+|+||.||++... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999976 6889999987543 2345678999999999999999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC---CcEEEeeccCc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK---YRAKVSDFGAS 543 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~---~~~kl~DFGls 543 (721)
+||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.+ +.+||+|||++
T Consensus 98 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~ 171 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (287)
T ss_dssp EEECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGG
T ss_pred EEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcc
Confidence 9999999999999887654 5899999999999999999999999 9999999999999754 47999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
........ .....+|+.|+|||.+.+ .++.++||||||+++|+|++|+.||...... . ....+.......
T Consensus 172 ~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~-~~~~~~~~~~~~ 241 (287)
T 2wei_A 172 TCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------D-ILKRVETGKYAF 241 (287)
T ss_dssp GTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------H-HHHHHHHCCCCC
T ss_pred eeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH------H-HHHHHHcCCCCC
Confidence 86643321 223358999999999876 4899999999999999999999998643321 1 111121111100
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+... ....+.++.+++.+||+.+|++|||+.|+++.
T Consensus 242 --~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 --DLPQ----WRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp --CSGG----GTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred --Cchh----hhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0000 01223468999999999999999999999873
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=336.93 Aligned_cols=258 Identities=23% Similarity=0.332 Sum_probs=196.9
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc---
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP--- 465 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~--- 465 (721)
..++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999965 5899999987653 334467889999999999999999999999877655
Q ss_pred ---eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 466 ---LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 466 ---~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
++||||+. ++|.+++.. .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 678777742 4899999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc-
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS- 620 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~- 620 (721)
++..... .....||+.|+|||++.+ ..++.++||||||++++||++|+.||......+. ............
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~ 263 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPGT 263 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCcH
Confidence 9765322 233468999999999987 6899999999999999999999999965432211 111111110000
Q ss_pred -hh---------hhhhh---hhc---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 -LF---------EILDA---HVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 -~~---------~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.. ..... ... .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 00 00000 000 00011234578999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=332.32 Aligned_cols=257 Identities=23% Similarity=0.326 Sum_probs=197.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-----
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV----- 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~----- 464 (721)
.++|...+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 467999999999999999999975 5899999987552 33446788999999999999999999999987654
Q ss_pred -ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 465 -PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 465 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
.++||||+. ++|.+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 389999996 688887743 4899999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc--
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS-- 620 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 620 (721)
+..... .....+|+.|+|||++.+ ..++.++||||||++++||++|+.||......+ .............
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---~~~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD---QLTQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH---HHHHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHhCCCCHH
Confidence 765322 233568999999999887 678999999999999999999999997544221 1111111110000
Q ss_pred h---------hhhhh---hh---hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 L---------FEILD---AH---VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~---------~~~~~---~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ...+. .. .........+..+.+|+.+||+.||++|||+.|+++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 00000 00 0011122345679999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=330.99 Aligned_cols=202 Identities=27% Similarity=0.372 Sum_probs=172.5
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CC-----ceeeEEEEEEeC
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HR-----NVVKLLGCCLET 462 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~-----niv~l~g~~~~~ 462 (721)
+...++|.+.++||+|+||+||+|... +++.||||+++.. ....+++.+|+.+++.++ |+ +|+++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 345688999999999999999999966 5889999988642 334567888999998884 55 499999999999
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh--cCCCCeeeccCcCccEEEC--CCCcEEEe
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS--AASIPIYHRDIKSTNILLD--GKYRAKVS 538 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~--~~~~~ivHrDlk~~NIll~--~~~~~kl~ 538 (721)
+..++||||++ ++|.+++..... ..+++..++.++.|++.||.|||+ .+ |+||||||+||||+ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTNF-RGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcCc-CCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 599999986542 258999999999999999999995 45 99999999999994 57889999
Q ss_pred eccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCC
Q 036483 539 DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN 601 (721)
Q Consensus 539 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~ 601 (721)
|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999876432 233568999999999999999999999999999999999999997544
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=332.61 Aligned_cols=261 Identities=20% Similarity=0.272 Sum_probs=201.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-----------CCceeeEEEEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-----------HRNVVKLLGCCL 460 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~g~~~ 460 (721)
.++|.+.+.||+|+||+||+|+.. +++.||||.+.. +....+.+.+|+.++++++ |+||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 367999999999999999999964 688999998864 2334567889999999886 899999999998
Q ss_pred eCC----cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEEC-----
Q 036483 461 ETE----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLD----- 530 (721)
Q Consensus 461 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~----- 530 (721)
..+ ..++|||++ +++|.+++..... ..+++..++.++.||+.||+|||++ + |+||||||+||||+
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 678999999 8999999976443 2599999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccccc--
Q 036483 531 -GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKS-- 607 (721)
Q Consensus 531 -~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~-- 607 (721)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||..........
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999866432 223468999999999999999999999999999999999999997544222111
Q ss_pred -HHHHHHHHhhccch------------------------------hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCC
Q 036483 608 -LAAYFLRAMKEDSL------------------------------FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKR 656 (721)
Q Consensus 608 -~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 656 (721)
.............. .+++. .....+...+.++.+|+.+||+.||++|
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCcccc
Confidence 11111111110000 00000 0123456778889999999999999999
Q ss_pred CCHHHHHHH
Q 036483 657 PTMKEVAVV 665 (721)
Q Consensus 657 Pt~~ev~~~ 665 (721)
||+.|+++.
T Consensus 326 pt~~ell~h 334 (373)
T 1q8y_A 326 ADAGGLVNH 334 (373)
T ss_dssp BCHHHHHTC
T ss_pred CCHHHHhhC
Confidence 999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=326.61 Aligned_cols=247 Identities=28% Similarity=0.400 Sum_probs=191.8
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc------hhhHHHHHHHHHHhhc----CCCceeeE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE------SKVDEFINEVAILSQI----NHRNVVKL 455 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l----~h~niv~l 455 (721)
++.+...++|.+.+.||+|+||.||+|+.. +++.||||.+..... .....+.+|+.++.++ +|+||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 345666789999999999999999999864 688999998765322 2334567899999998 89999999
Q ss_pred EEEEEeCCcceEEEee-ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCC
Q 036483 456 LGCCLETEVPLLVYEF-IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKY 533 (721)
Q Consensus 456 ~g~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~ 533 (721)
++++.+.+..++|||+ +.+++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||+++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 9999999999999999 78999999998654 5899999999999999999999999 99999999999999 889
Q ss_pred cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCC-ccccchhHHHHHHHHHhCCcccccCCccccccHHHHH
Q 036483 534 RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFT-EKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~ 612 (721)
.+||+|||+++...... .....|+..|+|||++.+..+. .++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 99999999998765332 2344589999999999877765 48999999999999999999985211
Q ss_pred HHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 613 LRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 613 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
... ... ...+...+..+.+++.+||+.+|++|||+.|+++.
T Consensus 244 -~~~-~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 244 -EIL-EAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp -HHH-HTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred -HHh-hhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 000 01122234568999999999999999999999764
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=327.29 Aligned_cols=256 Identities=23% Similarity=0.327 Sum_probs=179.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHH-HHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVA-ILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~-il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.++|...+.||+|+||.||+|... +++.||||+++... .....++..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 478999999999999999999975 68999999886532 334456666666 677789999999999999999999999
Q ss_pred eeccCCCcchhccc--cCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 470 EFIINGTLFQYLHD--QNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 470 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
||+++ +|.+++.. ......+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++..
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99975 77777753 11233689999999999999999999998 8 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecCCCCCCcccc----ccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYF----RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
.... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||....... .. +. .+.
T Consensus 177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~----~~--~~~ 243 (327)
T 3aln_A 177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF-----DQ----LT--QVV 243 (327)
T ss_dssp -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------C--CCC
T ss_pred cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH-----HH----HH--HHh
Confidence 4322 22234689999999998 45678999999999999999999999986432110 00 00 000
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
....+.+........+..+.+|+.+||+.||++|||+.+|++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0000011111112234568999999999999999999999774
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-37 Score=328.84 Aligned_cols=258 Identities=21% Similarity=0.294 Sum_probs=200.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CC-cEEEEeeccccCchhhHHHHHHHHHHhhcCCCc------eeeEEEEEEeCCc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DG-RIVAIKKSKVIDESKVDEFINEVAILSQINHRN------VVKLLGCCLETEV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~l~g~~~~~~~ 464 (721)
.++|.+.+.||+|+||+||++... ++ +.||+|.++.. ....+.+.+|+.++++++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 478999999999999999999965 34 68999988643 344577889999999997766 9999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE---------------
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL--------------- 529 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll--------------- 529 (721)
.++||||+ +++|.+++..... ..+++..++.++.||+.||+|||+++ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 6677777765432 26999999999999999999999998 9999999999999
Q ss_pred ----CCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCcccc
Q 036483 530 ----DGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605 (721)
Q Consensus 530 ----~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~ 605 (721)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~- 246 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE- 246 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence 56789999999999764322 233468999999999999999999999999999999999999997544321
Q ss_pred ccHHHHHHHHhhccchhhhh--------------------------hh-----hhcccCCHHHHHHHHHHHHHhhccCCC
Q 036483 606 KSLAAYFLRAMKEDSLFEIL--------------------------DA-----HVLKEASQEDIVTVAKLTNRCLNLNGK 654 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~--------------------------~~-----~~~~~~~~~~~~~l~~li~~cl~~~p~ 654 (721)
............. .... .. ............++.+|+.+||+.||+
T Consensus 247 --~~~~~~~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 247 --HLVMMEKILGPIP-SHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp --HHHHHHHHHCCCC-HHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred --HHHHHHHHcCCCc-HHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 1111111110000 0000 00 000011234456799999999999999
Q ss_pred CCCCHHHHHH
Q 036483 655 KRPTMKEVAV 664 (721)
Q Consensus 655 ~RPt~~ev~~ 664 (721)
+|||+.|+++
T Consensus 324 ~Rpt~~e~l~ 333 (355)
T 2eu9_A 324 QRITLAEALL 333 (355)
T ss_dssp TSCCHHHHTT
T ss_pred hCcCHHHHhc
Confidence 9999999864
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=327.37 Aligned_cols=255 Identities=20% Similarity=0.260 Sum_probs=174.1
Q ss_pred HhcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcc
Q 036483 392 ATDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVP 465 (721)
Q Consensus 392 ~~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~ 465 (721)
..++|.+. ++||+|+||+||+|... +++.||||++... . ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45788885 46999999999999976 5899999987542 1 122223334566799999999999876 3457
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeeccC
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFGA 542 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGl 542 (721)
++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 899999999999999986543 36999999999999999999999999 999999999999976 45599999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
++..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......+....
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~-- 249 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI---SPGMKRRIRLGQ-- 249 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh---hhhHHHhhhccc--
Confidence 9765422 22334689999999999988899999999999999999999999864332211 000000000000
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
...........+.++.+|+.+||+.||++|||+.|+++.-
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 250 ----YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred ----cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0000011122345689999999999999999999998853
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=330.71 Aligned_cols=252 Identities=27% Similarity=0.425 Sum_probs=200.2
Q ss_pred cccCHHHHHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc------hhhHHHHHHHHHHhhcC--CCce
Q 036483 382 KLFTSKELETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE------SKVDEFINEVAILSQIN--HRNV 452 (721)
Q Consensus 382 ~~~~~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~il~~l~--h~ni 452 (721)
.....++.+...++|.+.+.||+|+||.||+|... +++.||||.+..... ...+.+.+|+.++++++ |+||
T Consensus 31 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i 110 (320)
T 3a99_A 31 KLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110 (320)
T ss_dssp ---------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred ccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCc
Confidence 33445556667789999999999999999999864 688999998755322 13356788999999996 5999
Q ss_pred eeEEEEEEeCCcceEEEeeccC-CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-
Q 036483 453 VKLLGCCLETEVPLLVYEFIIN-GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD- 530 (721)
Q Consensus 453 v~l~g~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~- 530 (721)
+++++++.+.+..++|||++.+ ++|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++
T Consensus 111 ~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~ 184 (320)
T 3a99_A 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDL 184 (320)
T ss_dssp CCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEET
T ss_pred eEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeC
Confidence 9999999999999999999976 89999997653 5899999999999999999999999 99999999999999
Q ss_pred CCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHH
Q 036483 531 GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLA 609 (721)
Q Consensus 531 ~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~ 609 (721)
+++.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------- 253 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------- 253 (320)
T ss_dssp TTTEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------
T ss_pred CCCCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------
Confidence 78999999999998764322 233458999999999987766 678999999999999999999985311
Q ss_pred HHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 610 AYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 610 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... .. ......+.++.+|+.+||+.+|++|||+.||++.
T Consensus 254 ----~~~~~-~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 254 ----EIIRG-QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp ----HHHHC-CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----hhhcc-cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 00 0111233468999999999999999999999763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-37 Score=337.76 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=187.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.|...++||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445567899999999998777778999999987542 345678999999886 8999999999999999999999999
Q ss_pred cCCCcchhccccCCCC----CccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCC-------------CcE
Q 036483 473 INGTLFQYLHDQNEEF----PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGK-------------YRA 535 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~-------------~~~ 535 (721)
. |+|.+++....... ..++..++.++.||+.||+|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999997643211 1133456789999999999999999 9999999999999654 589
Q ss_pred EEeeccCccccccCCce---eeeeeecCCCCCCcccccc-------CCCCccccchhHHHHHHHHHh-CCcccccCCccc
Q 036483 536 KVSDFGASRSMAIDQTH---MTTQVQGTFGYLDPEYFRS-------SRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEE 604 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~ 604 (721)
||+|||+++........ ......||+.|+|||++.+ ..++.++||||||+++|||++ |+.||......+
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999877543322 1234569999999999976 678999999999999999999 899985332111
Q ss_pred cccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 605 DKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 605 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. ..+...... +..........+.++.+|+.+||+.||++|||+.||++
T Consensus 248 -----~---~i~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 -----S---NIIRGIFSL----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp -----H---HHHHTCCCC----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----H---HHhcCCCCc----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0 011100000 00011123456678999999999999999999999976
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=353.55 Aligned_cols=269 Identities=24% Similarity=0.343 Sum_probs=204.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe------CCc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLE------TEV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~------~~~ 464 (721)
.++|.+.+.||+|+||+||+|... +|+.||||+++.. .....+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 378999999999999999999964 5889999987653 44556789999999999999999999999765 667
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCc---EEEeecc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR---AKVSDFG 541 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~---~kl~DFG 541 (721)
.++||||+++++|.+++........+++..++.++.|++.||+|||+.+ |+||||||+|||++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 7999999999999999987655556999999999999999999999999 999999999999996654 9999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHH----Hhh
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLR----AMK 617 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~----~~~ 617 (721)
+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....... .+... ...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-----~~~~~i~~~~~~ 242 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-----QWHGKVREKSNE 242 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-----HSSTTCC-----
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-----hhhhhhhcccch
Confidence 998764332 2234569999999999999999999999999999999999999986432110 00000 000
Q ss_pred ccchhhhhhh--------hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHhhccc
Q 036483 618 EDSLFEILDA--------HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE-----VAVVLAGIKA 671 (721)
Q Consensus 618 ~~~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----v~~~L~~l~~ 671 (721)
.....+.... ..........+..+.+++.+||+.||++|||+.| +.+.++.+..
T Consensus 243 ~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~ 309 (676)
T 3qa8_A 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILS 309 (676)
T ss_dssp -CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHC
T ss_pred hhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHh
Confidence 0000000000 0011234456678999999999999999999987 4556665544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=317.79 Aligned_cols=252 Identities=21% Similarity=0.353 Sum_probs=180.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc-h-hhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE-S-KVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~-~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.++|.+.+.||+|+||.||+|... +++.||||.+..... . ..+.+.++..+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 467889999999999999999976 689999998765332 2 2334455556788889999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
||+ ++.+..++.... ..+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 555555554322 2589999999999999999999995 8 99999999999999999999999999976543
Q ss_pred CCceeeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
.. ......||+.|+|||++. ...++.++||||||+++|||++|+.||...... ...+......... .
T Consensus 178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~-~ 249 (318)
T 2dyl_A 178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD-----FEVLTKVLQEEPP-L 249 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHHSCCC-C
T ss_pred Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc-----HHHHHHHhccCCC-C
Confidence 22 223346899999999994 557889999999999999999999998642211 1111111111110 0
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......+.++.+++.+||+.||.+|||+.|+++.
T Consensus 250 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 250 -------LPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -------CCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 00011233468999999999999999999999774
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=335.54 Aligned_cols=249 Identities=24% Similarity=0.359 Sum_probs=187.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..+|...++||+|+||+||.....+++.||||++... ..+.+.+|+++|+++ +||||+++++++.+....+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPE---CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTT---TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 3568889999999999976655667999999987542 234567899999999 799999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-----CCCcEEEeeccCcccc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-----GKYRAKVSDFGASRSM 546 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-----~~~~~kl~DFGls~~~ 546 (721)
+. |+|.+++..... .+.+..++.++.||+.||+|||+++ |+||||||+||||+ ....+||+|||+++..
T Consensus 100 ~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 95 699999976543 3445566789999999999999999 99999999999994 3346889999999876
Q ss_pred ccCCc--eeeeeeecCCCCCCccccc---cCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccc
Q 036483 547 AIDQT--HMTTQVQGTFGYLDPEYFR---SSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 547 ~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
..... .......||+.|+|||++. ...++.++||||||+++|||++ |..||....... .........
T Consensus 174 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~~~~~ 246 (432)
T 3p23_A 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILLGACS 246 (432)
T ss_dssp ------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHTTCCC
T ss_pred cCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHhccCC
Confidence 53322 2234456999999999998 4567889999999999999999 888884322110 111111111
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. .. ..........+.+|+.+||+.||++|||+.||++
T Consensus 247 ~-~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 247 L-DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp C-TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred c-cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0 00 0112234456889999999999999999999984
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=348.11 Aligned_cols=239 Identities=23% Similarity=0.354 Sum_probs=193.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc--CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc-----
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA--DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV----- 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~----- 464 (721)
.++|.+.++||+|+||.||+|... +++.||||++... +....+.+.+|+.++++++||||+++++++.+.+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 368999999999999999999975 5899999987543 34456788999999999999999999999988765
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+|||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||+++
T Consensus 159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence 6999999999999987754 5999999999999999999999999 9999999999999986 99999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 624 (721)
..... ....||+.|+|||++.+.. +.++||||||++|+||++|..|+....... +.
T Consensus 230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~-- 285 (681)
T 2pzi_A 230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LP-- 285 (681)
T ss_dssp ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CC--
T ss_pred hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------cc--
Confidence 76432 3346999999999997764 889999999999999999988875321110 00
Q ss_pred hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHhhc
Q 036483 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-MKEVAVVLAGI 669 (721)
Q Consensus 625 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~ev~~~L~~l 669 (721)
. ..........+.+++.+||+.||++||+ ++++...|..+
T Consensus 286 -~----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 286 -E----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp -T----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred -c----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0001122356889999999999999995 66666666654
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-36 Score=310.58 Aligned_cols=233 Identities=13% Similarity=0.109 Sum_probs=185.2
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC-CcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
.++|.+.+.||+|+||.||+|.... ++.||||.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4679999999999999999999764 8999999886532 33457899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++... .....+.+++.|++.||+|||+++ |+||||||+|||++.++.+||++++
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999998542 345568899999999999999999 9999999999999999999998543
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
|++| ++.++||||||+++|||++|+.||........... ....+...
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~------------~~~~~~~~ 221 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP------------AERDTAGQ 221 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE------------CCBCTTSC
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH------------HHHHhccC
Confidence 3333 68899999999999999999999975443221000 00000000
Q ss_pred --hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccCC
Q 036483 629 --VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674 (721)
Q Consensus 629 --~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~~ 674 (721)
.........+.++.+++.+||+.||++| |+.|+++.|+.+.....
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~ 268 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD 268 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence 0001112234568999999999999999 99999999999876543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=314.59 Aligned_cols=242 Identities=16% Similarity=0.200 Sum_probs=184.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC--------chhhHHHHHHHHHHhhcC---------CCceeeE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID--------ESKVDEFINEVAILSQIN---------HRNVVKL 455 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~il~~l~---------h~niv~l 455 (721)
.++|.+.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46788999999999999999998 68999999876532 233478899999999885 8888887
Q ss_pred EEEEE------------------------------eCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHH
Q 036483 456 LGCCL------------------------------ETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505 (721)
Q Consensus 456 ~g~~~------------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~ 505 (721)
.+.+. +.+..+|||||+++|++.+.+.+ ..+++..++.++.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 77653 25778999999999987777644 258999999999999999
Q ss_pred HHHHH-hcCCCCeeeccCcCccEEECCCC--------------------cEEEeeccCccccccCCceeeeeeecCCCCC
Q 036483 506 VSYLH-SAASIPIYHRDIKSTNILLDGKY--------------------RAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564 (721)
Q Consensus 506 L~yLH-~~~~~~ivHrDlk~~NIll~~~~--------------------~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~ 564 (721)
|+||| +.+ |+||||||+||||+.++ .+||+|||+++..... ...||+.|+
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~ 244 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM 244 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence 99999 899 99999999999999887 8999999999866432 346999999
Q ss_pred CccccccCCCCccccchhHHHH-HHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHH
Q 036483 565 DPEYFRSSRFTEKSDVYSFGVV-LAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK 643 (721)
Q Consensus 565 aPE~~~~~~~t~ksDV~SlGvl-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 643 (721)
|||++.+.. +.++|||||+.+ .+++++|..||..... .......+..... .............+.++.+
T Consensus 245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~d 314 (336)
T 2vuw_A 245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW------LHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQE 314 (336)
T ss_dssp CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH------HHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHHH
T ss_pred ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh------hhHHHHhhhhhhc---cCcccchhhhhhcCHHHHH
Confidence 999998776 889999998777 7788889998742100 0001111100000 0000111123356778999
Q ss_pred HHHHhhccCCCCCCCHHHHH
Q 036483 644 LTNRCLNLNGKKRPTMKEVA 663 (721)
Q Consensus 644 li~~cl~~~p~~RPt~~ev~ 663 (721)
|+.+||+.+ |++|++
T Consensus 315 li~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 315 FHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHGGGSS-----SHHHHH
T ss_pred HHHHHhccC-----CHHHHH
Confidence 999999966 888887
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-35 Score=323.52 Aligned_cols=244 Identities=14% Similarity=0.162 Sum_probs=180.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCC-Cce---------ee---
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINH-RNV---------VK--- 454 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h-~ni---------v~--- 454 (721)
.+.+|...++||+|+||+||+|... +|+.||||+++... ....+.|.+|+.+++.++| +|. +.
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 3455778899999999999999954 68999999876432 2336789999999999987 221 11
Q ss_pred ---------EEEEEEe-----CCcceEEEeeccCCCcchhccc----cCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCC
Q 036483 455 ---------LLGCCLE-----TEVPLLVYEFIINGTLFQYLHD----QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIP 516 (721)
Q Consensus 455 ---------l~g~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ 516 (721)
++.+... ....+++|+++ +++|.+++.. ......+++..++.++.||++||+|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 11335666654 7899988852 122346889999999999999999999999
Q ss_pred eeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCcccc----------ccCCCCccccchhHHHH
Q 036483 517 IYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF----------RSSRFTEKSDVYSFGVV 586 (721)
Q Consensus 517 ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~SlGvl 586 (721)
|+||||||+||||+.++.+||+|||+++..... .....| +.|+|||++ .+..++.++||||||++
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998765322 334457 999999999 55568889999999999
Q ss_pred HHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 587 LAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 587 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
+|||++|+.||......+. ...++.. ... .+..+.+|+.+||+.+|++|||+.++++.
T Consensus 307 l~elltg~~Pf~~~~~~~~---------------~~~~~~~--~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGG---------------SEWIFRS--CKN----IPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSC---------------SGGGGSS--CCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHHHCCCCCCCcchhhh---------------HHHHHhh--ccc----CCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 9999999999864332211 1111110 012 23569999999999999999998887543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=299.50 Aligned_cols=229 Identities=23% Similarity=0.306 Sum_probs=179.4
Q ss_pred hcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHH-hhcCCCceeeEEEEEEe----CCcc
Q 036483 393 TDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAIL-SQINHRNVVKLLGCCLE----TEVP 465 (721)
Q Consensus 393 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il-~~l~h~niv~l~g~~~~----~~~~ 465 (721)
.++|.+. ++||+|+||.||++... +++.||+|.++. ...+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 78999999999999974 688999998753 34677899988 55699999999999987 6678
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeeccC
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFGA 542 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGl 542 (721)
++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999987543 36999999999999999999999999 999999999999998 78999999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
+.... +..++.++||||||+++|||++|+.||........ .. .+.
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~-~~~ 211 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SP-GMK 211 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------C-CSC
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hH-HHH
Confidence 86432 23467799999999999999999999854322110 00 000
Q ss_pred hhhhhhhcccCC----HHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 036483 623 EILDAHVLKEAS----QEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666 (721)
Q Consensus 623 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L 666 (721)
..+.... ...+ ...+.++.+++.+||+.||++|||+.|+++.-
T Consensus 212 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 212 TRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp CSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 0000000 0011 12345689999999999999999999998753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=8.4e-29 Score=281.53 Aligned_cols=185 Identities=18% Similarity=0.116 Sum_probs=130.0
Q ss_pred EeeeCcEEEEEEE-EcCCcEEEEeecccc----------CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEEE
Q 036483 402 LGQGGQGTVYKGM-LADGRIVAIKKSKVI----------DESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 402 lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv~ 469 (721)
.+.|+.|.+..++ .--|+.+|+|.+... .+...++|.+|+++|+++ +|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4455555555443 223778999976432 123456799999999999 7999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||++|++|.++|.+.. +++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+++....+
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999998654 46653 58899999999999999 999999999999999999999999999876543
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCccc
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~ 597 (721)
.. ......||+.|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus 393 ~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 393 CS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp -C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred Cc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 32 2344569999999999976 4677899999999999887765554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=255.80 Aligned_cols=184 Identities=15% Similarity=0.213 Sum_probs=144.5
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC--c------hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID--E------SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~------~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
...++||+|+||+||++.. .++.+++|+..... . ...+.+.+|++++++++||||+++..++...+..+||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999954 46778888643211 1 1245689999999999999999666666678888999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++++|.+++.. ++.++.|+++||+|||+++ |+||||||+|||++. ++||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 4589999999999999999 999999999999999 999999999988754
Q ss_pred CCcee------eeeeecCCCCCCcccccc--CCCCccccchhHHHHHHHHHhCCccc
Q 036483 549 DQTHM------TTQVQGTFGYLDPEYFRS--SRFTEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 549 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~SlGvll~elltG~~p~ 597 (721)
..... .....||+.|||||++.. ..|+.+.|+|+..+-.++-+.++.++
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 32211 234579999999999987 56888899999999988888776654
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.5e-23 Score=211.36 Aligned_cols=150 Identities=16% Similarity=0.128 Sum_probs=120.8
Q ss_pred HHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCc------------------hhhHHHHHHHHHHhhcCCCc
Q 036483 390 ETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDE------------------SKVDEFINEVAILSQINHRN 451 (721)
Q Consensus 390 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~il~~l~h~n 451 (721)
......|.+.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.+|++++ |
T Consensus 86 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~ 163 (282)
T 1zar_A 86 VRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G 163 (282)
T ss_dssp HHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T
T ss_pred HhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C
Confidence 334456667799999999999999997799999998754221 13467899999999999 4
Q ss_pred eeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC
Q 036483 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG 531 (721)
Q Consensus 452 iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~ 531 (721)
+++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++
T Consensus 164 -~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~- 227 (282)
T 1zar_A 164 -LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS- 227 (282)
T ss_dssp -SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-
T ss_pred -CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-
Confidence 56665443 356799999999999998 432 124469999999999999999 99999999999999
Q ss_pred CCcEEEeeccCccccccCCceeeeeeecCCCCCCcccccc
Q 036483 532 KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571 (721)
Q Consensus 532 ~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 571 (721)
++.+||+|||+++ .+..++|||++..
T Consensus 228 ~~~vkl~DFG~a~--------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 228 EEGIWIIDFPQSV--------------EVGEEGWREILER 253 (282)
T ss_dssp TTEEEECCCTTCE--------------ETTSTTHHHHHHH
T ss_pred CCcEEEEECCCCe--------------ECCCCCHHHHHHH
Confidence 9999999999986 3456789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.76 E-value=6.1e-19 Score=180.39 Aligned_cols=136 Identities=19% Similarity=0.186 Sum_probs=105.8
Q ss_pred CCCCceEeeeCcEEEEEEEE-cCCcE--EEEeeccccCch------------------------hhHHHHHHHHHHhhcC
Q 036483 396 YNTNRILGQGGQGTVYKGML-ADGRI--VAIKKSKVIDES------------------------KVDEFINEVAILSQIN 448 (721)
Q Consensus 396 ~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~il~~l~ 448 (721)
|.+.+.||+|+||.||+|.. .+|+. ||||..+..... ....+.+|+.+|.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999997 67888 999975432110 1136889999999998
Q ss_pred CCce--eeEEEEEEeCCcceEEEeeccC-C----CcchhccccCCCCCccHHHHHHHHHHHHHHHHHHH-hcCCCCeeec
Q 036483 449 HRNV--VKLLGCCLETEVPLLVYEFIIN-G----TLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH-SAASIPIYHR 520 (721)
Q Consensus 449 h~ni--v~l~g~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH-~~~~~~ivHr 520 (721)
|+++ +.+++. +..+|||||+.+ | +|.++... .++..+..++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8754 444443 367899999942 4 45444321 234567889999999999999 888 9999
Q ss_pred cCcCccEEECCCCcEEEeeccCcccc
Q 036483 521 DIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 521 Dlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
||||+|||++. .++|+|||++...
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999998 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.63 E-value=1.4e-16 Score=169.48 Aligned_cols=136 Identities=14% Similarity=0.165 Sum_probs=99.4
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC--------------chhhHHH--------HHHHHHHhhcCCCce
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID--------------ESKVDEF--------INEVAILSQINHRNV 452 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~--------~~E~~il~~l~h~ni 452 (721)
-|.+.+.||+|++|.||+|...+|+.||||..+... ......+ .+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999999899999999754310 0001112 345666666644433
Q ss_pred e--eEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC
Q 036483 453 V--KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD 530 (721)
Q Consensus 453 v--~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~ 530 (721)
. ..++. ...+|||||+++++|.++.... ....++.|++.+|.+||+.+ ||||||||.||||+
T Consensus 176 ~vp~p~~~----~~~~LVME~i~G~~L~~l~~~~---------~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~ 239 (397)
T 4gyi_A 176 PVPEPIAQ----SRHTIVMSLVDALPMRQVSSVP---------DPASLYADLIALILRLAKHG---LIHGDFNEFNILIR 239 (397)
T ss_dssp SCCCEEEE----ETTEEEEECCSCEEGGGCCCCS---------CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred CCCeeeec----cCceEEEEecCCccHhhhcccH---------HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEe
Confidence 2 22222 2347999999998887664321 23568899999999999999 99999999999998
Q ss_pred CCC----------cEEEeeccCcccc
Q 036483 531 GKY----------RAKVSDFGASRSM 546 (721)
Q Consensus 531 ~~~----------~~kl~DFGls~~~ 546 (721)
+++ .+.|+||+-+...
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCcccccccccceEEEEeCCcccC
Confidence 776 3899999977543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.26 E-value=1.2e-11 Score=126.26 Aligned_cols=147 Identities=15% Similarity=0.102 Sum_probs=115.4
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~l 467 (721)
+....+.|.....++.|+.+.||+.... ++.+++|............+.+|+.+++.+. |..+.+++++..+.+..++
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 3445567888888999999999999854 6789999876532233457899999999984 6788899999998889999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC----------------------------------
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA---------------------------------- 513 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~---------------------------------- 513 (721)
||||++|.+|.+.+.. ......++.+++++|+.||+..
T Consensus 88 v~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 88 LMSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999998776421 1123478899999999999811
Q ss_pred ----------------------CCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 514 ----------------------SIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 514 ----------------------~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+.++|+|++|.|||++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1338999999999999876666799999874
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=8.2e-11 Score=119.53 Aligned_cols=136 Identities=16% Similarity=0.165 Sum_probs=101.2
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc--eeeEEEEEEeCCcceEEEeec
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN--VVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~g~~~~~~~~~lv~e~~ 472 (721)
.+.+..+.+.|..+.||+....+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++....+..++||||+
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i 97 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV 97 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence 34443333455569999998777888999986543 3356889999999996544 566888888877889999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA--------------------------------------- 513 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------- 513 (721)
+|.+|. ... .. ...++.++++.|+.||+..
T Consensus 98 ~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 98 PGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp SSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred CCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 998884 221 11 2357788888888888743
Q ss_pred ----------------CCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 514 ----------------SIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 514 ----------------~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
...++|+|++|.|||++++..+.|+||+.+.
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.6e-09 Score=115.84 Aligned_cols=142 Identities=14% Similarity=0.198 Sum_probs=106.7
Q ss_pred CCceEeeeCcEEEEEEEEcCCcEEEEeecc--ccC-chhhHHHHHHHHHHhhcC--CCceeeEEEEEEeC---CcceEEE
Q 036483 398 TNRILGQGGQGTVYKGMLADGRIVAIKKSK--VID-ESKVDEFINEVAILSQIN--HRNVVKLLGCCLET---EVPLLVY 469 (721)
Q Consensus 398 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~il~~l~--h~niv~l~g~~~~~---~~~~lv~ 469 (721)
..+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 35678999999999988754 567888765 321 123457889999999996 45688899988776 3479999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA------------------------------------ 513 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~------------------------------------ 513 (721)
||++|..+.+... ..++...+..++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999988754221 13678888999999999999999831
Q ss_pred -------------------CCCeeeccCcCccEEECCCCc--EEEeeccCccc
Q 036483 514 -------------------SIPIYHRDIKSTNILLDGKYR--AKVSDFGASRS 545 (721)
Q Consensus 514 -------------------~~~ivHrDlk~~NIll~~~~~--~kl~DFGls~~ 545 (721)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999997653 68999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.92 E-value=9.8e-10 Score=114.64 Aligned_cols=183 Identities=21% Similarity=0.214 Sum_probs=123.5
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCc--eeeEEEEEEeCC---cceEEEeec
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRN--VVKLLGCCLETE---VPLLVYEFI 472 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~n--iv~l~g~~~~~~---~~~lv~e~~ 472 (721)
.+.++.|....||+.. +.+++|.... ......+.+|+.+|+.+ .+.. +.+++......+ ..++|||++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4579999999999853 4588887543 23456789999999888 3333 445555543333 458999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA--------------------------------------- 513 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~--------------------------------------- 513 (721)
+|.+|.+.... .++..++..++.++++.|+.||+..
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888754321 3677888889999999999999621
Q ss_pred ----------------CCCeeeccCcCccEEECC--CCcEEEeeccCccccccCCceeeeeeecCCCC---CCcccccc-
Q 036483 514 ----------------SIPIYHRDIKSTNILLDG--KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY---LDPEYFRS- 571 (721)
Q Consensus 514 ----------------~~~ivHrDlk~~NIll~~--~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y---~aPE~~~~- 571 (721)
.+.++|+|++|.||++++ ...+.|+||+.+....+.. . ......+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~-D----l~~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN-D----FISLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH-H----HHTTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH-H----HHHHHhhccccCHHHHHHH
Confidence 134799999999999998 5568899999886432110 0 0001111 23332111
Q ss_pred ----CCC---------CccccchhHHHHHHHHHhCCccc
Q 036483 572 ----SRF---------TEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 572 ----~~~---------t~ksDV~SlGvll~elltG~~p~ 597 (721)
... ....+.|+++.+++.+.+|..++
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 011 12358899999999999998775
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.36 E-value=3e-06 Score=88.19 Aligned_cols=136 Identities=15% Similarity=0.174 Sum_probs=97.1
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCC---ceeeEEEEEE-eCCcceEEEeeccC
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHR---NVVKLLGCCL-ETEVPLLVYEFIIN 474 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~---niv~l~g~~~-~~~~~~lv~e~~~~ 474 (721)
.+.++.|....||+. ++.+++|... .......+.+|+.+|+.+.+. .+.+.+.+.. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999987 4567888743 233456889999999999642 3667777764 44567899999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC-----------------------------------------
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA----------------------------------------- 513 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~----------------------------------------- 513 (721)
.+|.+.... .++...+..++.++++.|+.||+..
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888763211 2455566666666776666666532
Q ss_pred ----------------CCCeeeccCcCccEEECC---CCc-EEEeeccCccc
Q 036483 514 ----------------SIPIYHRDIKSTNILLDG---KYR-AKVSDFGASRS 545 (721)
Q Consensus 514 ----------------~~~ivHrDlk~~NIll~~---~~~-~kl~DFGls~~ 545 (721)
.+.++|+|+++.|||++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 223699999999999987 355 58999998753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.28 E-value=2.8e-06 Score=86.49 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=98.0
Q ss_pred eEeeeCcE-EEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 401 ILGQGGQG-TVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 401 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
.+..|..+ .||+.... ++..+++|+... .....+.+|..+|+.+. +--+.++++++.+.+..++|||++++.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45556555 68987754 466788887543 24557888999998884 44477899999999999999999999887
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA-------------------------------------------- 513 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-------------------------------------------- 513 (721)
.+..... ......+..++++.|+.||+..
T Consensus 108 ~~~~~~~-------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEY-------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHC-------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCC-------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 7654321 1223456667777777777421
Q ss_pred -----------CCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 514 -----------SIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 514 -----------~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 11279999999999999887777999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=3.2e-06 Score=89.92 Aligned_cols=80 Identities=4% Similarity=-0.027 Sum_probs=57.1
Q ss_pred ceE-eeeCcEEEEEEEEc-------CCcEEEEeeccccC---chhhHHHHHHHHHHhhcC-C--CceeeEEEEEEeC---
Q 036483 400 RIL-GQGGQGTVYKGMLA-------DGRIVAIKKSKVID---ESKVDEFINEVAILSQIN-H--RNVVKLLGCCLET--- 462 (721)
Q Consensus 400 ~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~-h--~niv~l~g~~~~~--- 462 (721)
+.| +.|....+|+.... +++.+++|...... ......+.+|+.+++.+. + -.+.+++.+..+.
T Consensus 26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~ 105 (357)
T 3ats_A 26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL 105 (357)
T ss_dssp EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence 567 78889999988764 26678888754322 111256788999998884 3 3577888887665
Q ss_pred CcceEEEeeccCCCcch
Q 036483 463 EVPLLVYEFIINGTLFQ 479 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~ 479 (721)
+..++|||+++|..|.+
T Consensus 106 g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 106 GTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp SSCEEEEECCCCBCCCB
T ss_pred CCceEEEEecCCCChhh
Confidence 35689999999887764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.90 E-value=4.3e-05 Score=82.38 Aligned_cols=75 Identities=19% Similarity=0.168 Sum_probs=50.6
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-------chhhHHHHHHHHHHhhcCC--C-ceeeEEEEEEeCCcceE
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-------ESKVDEFINEVAILSQINH--R-NVVKLLGCCLETEVPLL 467 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-------~~~~~~~~~E~~il~~l~h--~-niv~l~g~~~~~~~~~l 467 (721)
.+.||.|..+.||++... +++.++||...... ....+.+..|.++|+.+.. + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 457899999999999754 46789999753211 1234567889999988742 3 34456654 3556789
Q ss_pred EEeeccCC
Q 036483 468 VYEFIING 475 (721)
Q Consensus 468 v~e~~~~g 475 (721)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00016 Score=74.18 Aligned_cols=79 Identities=18% Similarity=0.118 Sum_probs=59.0
Q ss_pred CCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-C--CceeeEEEEEEeCCcceEEEee
Q 036483 395 HYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-H--RNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h--~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.....+.+|.|..+.||+..+.||+.+.+|+...........|..|+..|+.|. . --++++++. +..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEEe
Confidence 344567899999999999999999999999865544444457889999999884 2 234556654 245899999
Q ss_pred ccCCCc
Q 036483 472 IINGTL 477 (721)
Q Consensus 472 ~~~gsL 477 (721)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.79 E-value=7.6e-05 Score=78.41 Aligned_cols=140 Identities=16% Similarity=0.156 Sum_probs=79.5
Q ss_pred ceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCC--CceeeEEE------EEEeCCcceEEEee
Q 036483 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINH--RNVVKLLG------CCLETEVPLLVYEF 471 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h--~niv~l~g------~~~~~~~~~lv~e~ 471 (721)
+.|+.|..+.||+....+| .+++|+.... .+.+..|+.++..|.. -.+++++. +....+..+++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 3455567889999887655 4888877641 1334455666655531 12333332 12245667899999
Q ss_pred ccCCCcc--------------hhccccCCCC-----------CccHHHH-------------------------------
Q 036483 472 IINGTLF--------------QYLHDQNEEF-----------PITWEIR------------------------------- 495 (721)
Q Consensus 472 ~~~gsL~--------------~~l~~~~~~~-----------~l~~~~~------------------------------- 495 (721)
++|..+. ..+|...... .-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9987653 1122111000 1123211
Q ss_pred HHHHHHHHHHHHHHHh----------cCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 496 LRIAIEVSDAVSYLHS----------AASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 496 ~~i~~qia~~L~yLH~----------~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
..+..++..++.+|+. .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 0111224446667763 123459999999999999888899999999774
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00018 Score=74.63 Aligned_cols=138 Identities=17% Similarity=0.144 Sum_probs=92.4
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC---CCceeeEEEEEEeCCcceEEEeeccCC
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN---HRNVVKLLGCCLETEVPLLVYEFIING 475 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~---h~niv~l~g~~~~~~~~~lv~e~~~~g 475 (721)
.+.|+.|....+|+... +++.+++|..... ....+..|+..|+.|. ...+++++.+....+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4667888876532 3567889999998883 367888999888888899999999988
Q ss_pred Ccch-----------hccccCC--CC-----------------CccHHHHH---HHHH----------------HHHHHH
Q 036483 476 TLFQ-----------YLHDQNE--EF-----------------PITWEIRL---RIAI----------------EVSDAV 506 (721)
Q Consensus 476 sL~~-----------~l~~~~~--~~-----------------~l~~~~~~---~i~~----------------qia~~L 506 (721)
.+.. .||.... .+ .-+|.... ++.. .+.+.+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6532 2232211 10 12454321 1111 111111
Q ss_pred -HHHHh-cCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 507 -SYLHS-AASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 507 -~yLH~-~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
..|.. ...+.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 23322 2245699999999999999887 8899974
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00065 Score=73.70 Aligned_cols=79 Identities=9% Similarity=-0.014 Sum_probs=45.6
Q ss_pred CCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCC---CCccccchhHHHHHHHH
Q 036483 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR---FTEKSDVYSFGVVLAEL 590 (721)
Q Consensus 514 ~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~SlGvll~el 590 (721)
...++|+|+++.|||++.++ ++|+||+.+..-.+...-......-...|++|+...... -....++......+|+.
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL 309 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence 34499999999999999876 999999988653211000000000012355555543111 11234555777777777
Q ss_pred HhC
Q 036483 591 LTG 593 (721)
Q Consensus 591 ltG 593 (721)
+.+
T Consensus 310 y~~ 312 (420)
T 2pyw_A 310 FNK 312 (420)
T ss_dssp HHH
T ss_pred HHH
Confidence 665
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.001 Score=69.07 Aligned_cols=158 Identities=14% Similarity=0.187 Sum_probs=90.2
Q ss_pred cCHHHHHHHhcCCCCC-----ceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc--eeeEE
Q 036483 384 FTSKELETATDHYNTN-----RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN--VVKLL 456 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~-----~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~l~ 456 (721)
++.+++...-.+|... +.|+.|....+|+....++ .+++|..... ...+.+..|+.++..+.... +.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 4566777666667653 3456688899999987666 5778876542 12345667888877774222 33333
Q ss_pred EE------EEeCCcceEEEeeccCCCcchh--------------ccccCCCC---------CccHHHHHH----------
Q 036483 457 GC------CLETEVPLLVYEFIINGTLFQY--------------LHDQNEEF---------PITWEIRLR---------- 497 (721)
Q Consensus 457 g~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~~~~---------~l~~~~~~~---------- 497 (721)
.. ....+..+++|+|++|..+... +|...... ...|.....
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 1223556899999988665321 12111000 012332111
Q ss_pred --HHHHHHHHHHHHHhc----CCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 498 --IAIEVSDAVSYLHSA----ASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 498 --i~~qia~~L~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
+...+.+.+++|+.. ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244556666542 12348999999999999987666899998774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0016 Score=67.09 Aligned_cols=72 Identities=14% Similarity=0.083 Sum_probs=45.8
Q ss_pred CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEeec-cCCC
Q 036483 399 NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFI-INGT 476 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e~~-~~gs 476 (721)
.+.|+.|....+|+. +.+++|+...... ..-...+|+.+++.+....+ .++++. +.+..++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~-~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTE-EYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCcc-ceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 678999999999998 4578887654221 12233568888877742222 466654 344468999999 6655
Q ss_pred cc
Q 036483 477 LF 478 (721)
Q Consensus 477 L~ 478 (721)
|.
T Consensus 95 l~ 96 (301)
T 3dxq_A 95 MS 96 (301)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0025 Score=69.61 Aligned_cols=75 Identities=15% Similarity=0.026 Sum_probs=48.9
Q ss_pred CceEeeeCcEEEEEEEEcC-CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEeeccCCC
Q 036483 399 NRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYEFIINGT 476 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e~~~~gs 476 (721)
.+.|+.|-...+|+....+ ++.+++|+....... .-+-.+|..++..|...++ .++++.+. + .+||||+++.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 3578888899999998765 477888875432211 1122589999998864444 56777762 2 36999998765
Q ss_pred cc
Q 036483 477 LF 478 (721)
Q Consensus 477 L~ 478 (721)
|.
T Consensus 188 l~ 189 (458)
T 2qg7_A 188 LS 189 (458)
T ss_dssp CC
T ss_pred CC
Confidence 53
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0011 Score=72.17 Aligned_cols=74 Identities=16% Similarity=0.139 Sum_probs=50.8
Q ss_pred CceEeeeCcEEEEEEEEcC--------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCcceEEE
Q 036483 399 NRILGQGGQGTVYKGMLAD--------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRN-VVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~g~~~~~~~~~lv~ 469 (721)
.+.|+.|-...+|+....+ ++.+++|+.... ...+.+.+|+.+++.+...+ .+++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 3568888899999998753 478888876321 11256668999998884333 3667776532 3899
Q ss_pred eeccCCCcc
Q 036483 470 EFIINGTLF 478 (721)
Q Consensus 470 e~~~~gsL~ 478 (721)
||+++.+|.
T Consensus 152 e~l~G~~l~ 160 (429)
T 1nw1_A 152 EYIPSRPLS 160 (429)
T ss_dssp CCCCEEECC
T ss_pred EEeCCcccC
Confidence 999875553
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0012 Score=70.27 Aligned_cols=140 Identities=20% Similarity=0.219 Sum_probs=83.7
Q ss_pred ceEeeeCcEEEEEEEEc--------CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEe
Q 036483 400 RILGQGGQGTVYKGMLA--------DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e 470 (721)
+.|..|-...+|+.... +++.+++|+.... ........+|..+++.|. +.-..++++.+.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 56777888889998864 2478899975332 123456678999998884 3334667776643 39999
Q ss_pred eccCCCcchh-----------------ccccCC--CCCc--cHHHHHHHHHHHHH-------------------HHHHHH
Q 036483 471 FIINGTLFQY-----------------LHDQNE--EFPI--TWEIRLRIAIEVSD-------------------AVSYLH 510 (721)
Q Consensus 471 ~~~~gsL~~~-----------------l~~~~~--~~~l--~~~~~~~i~~qia~-------------------~L~yLH 510 (721)
|++|.+|..- ||.... .... -|.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998766421 111110 1111 24555555544322 233333
Q ss_pred ----hc-CCCCeeeccCcCccEEECCC----CcEEEeeccCcc
Q 036483 511 ----SA-ASIPIYHRDIKSTNILLDGK----YRAKVSDFGASR 544 (721)
Q Consensus 511 ----~~-~~~~ivHrDlk~~NIll~~~----~~~kl~DFGls~ 544 (721)
.. ....++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 22 22348999999999999876 789999999875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.01 E-value=0.004 Score=64.99 Aligned_cols=141 Identities=12% Similarity=0.059 Sum_probs=72.2
Q ss_pred ceEeeeCcEE-EEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-C-CceeeEEEEEEeCCcceEEEeeccCCC
Q 036483 400 RILGQGGQGT-VYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-H-RNVVKLLGCCLETEVPLLVYEFIINGT 476 (721)
Q Consensus 400 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h-~niv~l~g~~~~~~~~~lv~e~~~~gs 476 (721)
+.|+.|.... +|+....+++.+++|...... .+.+..|+.++..+. + -.+.+++.+.. +..+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcc
Confidence 3465555554 567665446677777543321 134456777777663 2 23556776633 33378999987666
Q ss_pred cchhcccc---------------------CC--CCCccHHHHH-------H-------------HHHHHHHHHHHHHh--
Q 036483 477 LFQYLHDQ---------------------NE--EFPITWEIRL-------R-------------IAIEVSDAVSYLHS-- 511 (721)
Q Consensus 477 L~~~l~~~---------------------~~--~~~l~~~~~~-------~-------------i~~qia~~L~yLH~-- 511 (721)
+.+.+... .. ...++..... . ....+...+..|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 54333211 00 0011111000 0 00112222233311
Q ss_pred -cCCCCeeeccCcCccEEECCC----CcEEEeeccCccc
Q 036483 512 -AASIPIYHRDIKSTNILLDGK----YRAKVSDFGASRS 545 (721)
Q Consensus 512 -~~~~~ivHrDlk~~NIll~~~----~~~kl~DFGls~~ 545 (721)
.....++|||+.+.|||++.+ ..+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123459999999999999874 6899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0033 Score=66.77 Aligned_cols=73 Identities=12% Similarity=0.116 Sum_probs=45.1
Q ss_pred ceEeeeCcEEEEEEEEcC---------CcEEEEeeccccCchhhHHHHHHHHHHhhcCCCc-eeeEEEEEEeCCcceEEE
Q 036483 400 RILGQGGQGTVYKGMLAD---------GRIVAIKKSKVIDESKVDEFINEVAILSQINHRN-VVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~l~g~~~~~~~~~lv~ 469 (721)
+.|+.|....+|+....+ ++.+++|...... ........|..+++.+...+ ..++++.. ..++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 467778888999988654 2678888764322 12223467888888884333 45676554 247899
Q ss_pred eeccCCCc
Q 036483 470 EFIINGTL 477 (721)
Q Consensus 470 e~~~~gsL 477 (721)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0083 Score=62.31 Aligned_cols=159 Identities=13% Similarity=0.099 Sum_probs=89.5
Q ss_pred ccCHHHHHHHhcCCCC-----CceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCC--ceeeE
Q 036483 383 LFTSKELETATDHYNT-----NRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHR--NVVKL 455 (721)
Q Consensus 383 ~~~~~el~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~--niv~l 455 (721)
..+.+++..+-..|.+ .+.|+ |....||+....+|+.+++|...... ...+.+..|..++..+... .++++
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecce
Confidence 3455556555454533 23566 88889999887777789999865321 1235667788888877422 23444
Q ss_pred EEE-----EEeCCcceEEEeeccCCCcch----h----------ccccC------CCCCccHHHH----HHH--------
Q 036483 456 LGC-----CLETEVPLLVYEFIINGTLFQ----Y----------LHDQN------EEFPITWEIR----LRI-------- 498 (721)
Q Consensus 456 ~g~-----~~~~~~~~lv~e~~~~gsL~~----~----------l~~~~------~~~~l~~~~~----~~i-------- 498 (721)
+.. ....+..+++||+++|..+.. . +|... ....+++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 443 122345578999998765431 0 11100 0111222211 001
Q ss_pred -------HHHHHHHHHHHHhc----CCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 499 -------AIEVSDAVSYLHSA----ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 499 -------~~qia~~L~yLH~~----~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
...+...++.+... ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333321 233479999999999999 4 899999987753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0031 Score=60.59 Aligned_cols=99 Identities=16% Similarity=0.109 Sum_probs=64.9
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCceee
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~~ 554 (721)
-+|.++|...+. +|++++++.++.|.+.+|.-+-....+ ..+=+.|..|+|..+|.+-+.+ ..+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc----------
Confidence 378888876553 799999999999999998776221111 1233457899999999988874 2111
Q ss_pred eeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh
Q 036483 555 TQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT 592 (721)
Q Consensus 555 ~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt 592 (721)
.....+.+||... ...+.+.-|||||+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1123456887763 345678899999999998875
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.31 E-value=0.009 Score=62.61 Aligned_cols=31 Identities=19% Similarity=0.322 Sum_probs=27.2
Q ss_pred CCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 515 IPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 515 ~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4589999999999999888899999987753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.78 E-value=0.021 Score=61.53 Aligned_cols=141 Identities=15% Similarity=0.136 Sum_probs=85.4
Q ss_pred CceEeeeCcEEEEEEEEcC--------CcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEE
Q 036483 399 NRILGQGGQGTVYKGMLAD--------GRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~ 469 (721)
.+.|..|-...+|+....+ ++.+++|+..... ...-+-.+|..+++.+. +.-..++++.+ ..++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF----PEGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc----CCCEEE
Confidence 3567778889999988753 5788888754432 22223467888888884 33345666543 247999
Q ss_pred eeccCCCcchh-c----------------cc--c-----C---CCCCccHHHHHHHHHHH-------------------H
Q 036483 470 EFIINGTLFQY-L----------------HD--Q-----N---EEFPITWEIRLRIAIEV-------------------S 503 (721)
Q Consensus 470 e~~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~qi-------------------a 503 (721)
||++|.+|..- + |. . . ...+.-|..+.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 99998765321 1 11 0 0 11122344444443322 2
Q ss_pred HHHHHHHh---------------------cCCCCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 504 DAVSYLHS---------------------AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 504 ~~L~yLH~---------------------~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
..+.+|.+ .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11234899999999999 7788999999998753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.51 E-value=0.25 Score=52.72 Aligned_cols=29 Identities=34% Similarity=0.425 Sum_probs=24.7
Q ss_pred eeeccCcCccEEE------CCCCcEEEeeccCccc
Q 036483 517 IYHRDIKSTNILL------DGKYRAKVSDFGASRS 545 (721)
Q Consensus 517 ivHrDlk~~NIll------~~~~~~kl~DFGls~~ 545 (721)
++|+|+.+.|||+ +++..++|+||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 4567899999998853
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=84.30 E-value=1.7 Score=41.56 Aligned_cols=115 Identities=5% Similarity=0.022 Sum_probs=75.6
Q ss_pred CCCceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccE
Q 036483 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNI 527 (721)
Q Consensus 448 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NI 527 (721)
.||+++.. .+-.+.+...+.|+.-+ +...+-.-. .++...+++++..|+....++++ -+|--|.|+||
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~ik----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL 110 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNIK----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL 110 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGGG----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHHH----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence 68888876 45555565555555433 222222211 47888999999999988866654 35788999999
Q ss_pred EECCCCcEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCccc
Q 036483 528 LLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597 (721)
Q Consensus 528 ll~~~~~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~ 597 (721)
+++.++.+++.-.|+-..+.+.. +.+| .=.-.+=+++..+++++..|
T Consensus 111 ~f~~~~~p~i~~RGik~~l~P~~-------------~~ee----------~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 111 FFTRDGLPIAKTRGLQNVVDPLP-------------VSEA----------EFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EECTTSCEEESCCEETTTBSCCC-------------CCHH----------HHHHHHHHHHHHHHCTTCCH
T ss_pred EEcCCCCEEEEEccCccCCCCCC-------------CCHH----------HHHHHHHHHHHHHHcCCCCH
Confidence 99999999999888754332210 0111 11224667888888888776
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.80 E-value=0.11 Score=35.93 Aligned_cols=19 Identities=11% Similarity=0.100 Sum_probs=8.4
Q ss_pred HHHHHHHHHHHHHHHHHHH
Q 036483 328 GGFGMLCLLTGAWWMYKFL 346 (721)
Q Consensus 328 ~~~~~~~l~~~~~~~~~~~ 346 (721)
+++++++++++++|++.++
T Consensus 19 gGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 19 GALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHhhh
Confidence 3344444444444554443
|
| >1gl4_A Nidogen-1, entactin; immunoglobulin-like domain, extracellular matrix; HET: EPE; 2.0A {Mus musculus} SCOP: d.22.1.2 g.3.11.5 PDB: 1h4u_A | Back alignment and structure |
|---|
Probab=83.12 E-value=0.15 Score=50.82 Aligned_cols=30 Identities=17% Similarity=0.402 Sum_probs=23.7
Q ss_pred cCCCCCccccCCCcccCCCCCCCCcCCCCC
Q 036483 268 RHCAGDLICSTTSGHNCSECPQGYYLSSYN 297 (721)
Q Consensus 268 ~~C~~~~~C~~~~g~~c~~C~~g~~gn~~~ 297 (721)
..|..+..|.|+.|.|+|.|+.||.||...
T Consensus 13 ~~C~~~a~C~Nt~Gsy~C~C~~Gy~GnG~~ 42 (285)
T 1gl4_A 13 HQCSVHAECRDYATGFCCRCVANYTGNGRQ 42 (285)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEECSSS
T ss_pred CCCCCCCEeEcCCCCeEEEcCCCCCCCCCc
Confidence 467777788888887766999999987753
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.79 E-value=0.11 Score=35.89 Aligned_cols=20 Identities=25% Similarity=0.363 Sum_probs=8.8
Q ss_pred HHHHHHHHHHHHHHHHHHHH
Q 036483 328 GGFGMLCLLTGAWWMYKFLK 347 (721)
Q Consensus 328 ~~~~~~~l~~~~~~~~~~~k 347 (721)
+++++++++++++|+++++|
T Consensus 18 gGv~~v~ii~~~~~~~~RRR 37 (44)
T 2l2t_A 18 GGLFILVIVGLTFAVYVRRK 37 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHhhhh
Confidence 43444444444555544433
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=82.70 E-value=3 Score=39.97 Aligned_cols=86 Identities=13% Similarity=0.057 Sum_probs=58.8
Q ss_pred CCCceeeEEEEEEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHH-HHHhcCCCCeeeccCcCcc
Q 036483 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS-YLHSAASIPIYHRDIKSTN 526 (721)
Q Consensus 448 ~h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~-yLH~~~~~~ivHrDlk~~N 526 (721)
.||++ -..+-.+.+...+.|+.-+++.=...++ .++...+++++..|+.... ++++ -+|--|.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 67887 3333355666566666543332222222 4788899999988887666 5544 4677899999
Q ss_pred EEECCCCcEEEeeccCcccc
Q 036483 527 ILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 527 Ill~~~~~~kl~DFGls~~~ 546 (721)
|++|.++.++|.-.|+-..+
T Consensus 115 L~f~~~~~p~i~hRGi~~~l 134 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKESL 134 (219)
T ss_dssp EEECTTCCEEESCCEETTTB
T ss_pred EEEeCCCcEEEEEcCCcccC
Confidence 99999999999988875433
|
| >2bou_A EGF-like module containing mucin-like hormone receptor-like 2 precursor; CD97, CD55, 7TM, calcium-binding, cell adhesion, EGF-LI domain; 1.90A {Homo sapiens} PDB: 2bo2_A 2box_A | Back alignment and structure |
|---|
Probab=81.51 E-value=0.88 Score=40.56 Aligned_cols=57 Identities=21% Similarity=0.454 Sum_probs=38.3
Q ss_pred ccCCCCceeeccCCCccccccccCC--------------cc---------CcCCCCCccccCCCcccCCCCCCCCcCCCC
Q 036483 240 MCNKDNHCLLQLGTGHFCLCDYTRS--------------VA---------SRHCAGDLICSTTSGHNCSECPQGYYLSSY 296 (721)
Q Consensus 240 ~C~s~s~C~~~~~~G~~c~~~~~~~--------------~~---------~~~C~~~~~C~~~~g~~c~~C~~g~~gn~~ 296 (721)
.|..+..|++..+ +|.|.|..+.. .+ ...|.....|.++.|.|-|.|+.||.+...
T Consensus 54 ~C~~~~~C~n~~g-~y~C~C~~Gy~g~~~~~~~~~~~~~~C~dideC~~~~~~C~~~~~C~n~~g~y~C~C~~Gy~g~~~ 132 (143)
T 2bou_A 54 SCGKFSDCWNTEG-SYDCVCSPGYEPVSGAKTFKNESENTCQDVDECSSGQHQCDSSTVCFNTVGSYSCRCRPGWKPRHG 132 (143)
T ss_dssp CCCTTEEEEECSS-CEEEEECTTEEETTCCSCBSSGGGCCEEECCHHHHTCCCCCTTSEEEECSSCEEEECCSSSCBCTT
T ss_pred CCCCCCEEEcCCC-CeEeECCCCcccCcCccccccCCCCCcCCccCccCcCCCCCCCCEEECCCCCEEeeCCCCcccCCC
Confidence 5765677877543 78888863211 11 145777789999888653399999998775
Q ss_pred C
Q 036483 297 N 297 (721)
Q Consensus 297 ~ 297 (721)
.
T Consensus 133 ~ 133 (143)
T 2bou_A 133 I 133 (143)
T ss_dssp C
T ss_pred C
Confidence 3
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 721 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 7e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-64 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-62 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-61 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-61 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-60 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-59 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-59 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-58 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-57 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-56 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-55 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-54 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-54 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-54 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-53 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 9e-46 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-44 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-43 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-37 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-36 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-35 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 5e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-20 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (574), Expect = 7e-69
Identities = 67/288 (23%), Positives = 121/288 (42%), Gaps = 21/288 (7%)
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQI 447
+ E + +G G GTVYKG V + ++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
H N++ +G ++ +V ++ +L+ +LH +F + IA + + +
Sbjct: 62 RHVNILLFMGYSTAPQL-AIVTQWCEGSSLYHHLHIIETKFE--MIKLIDIARQTAQGMD 118
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA-IDQTHMTTQVQGTFGYLDP 566
YLH+ I HRD+KS NI L K+ DFG + + +H Q+ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 567 EYFR---SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
E R + ++ +SDVY+FG+VL EL+TG+ + + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------SNINNRDQIIFMVGRGYLSP 229
Query: 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
L V + + +L CL +RP ++ + +
Sbjct: 230 DLSK-VRSNCPKA----MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 1e-68
Identities = 70/303 (23%), Positives = 126/303 (41%), Gaps = 37/303 (12%)
Query: 389 LETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQ 446
+E D + LG G G V+K G ++A K I + ++ I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
N +V G + E + G+L Q L I +I +++I V +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
+YL I HRD+K +NIL++ + K+ DFG S + M GT Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED--------------------- 605
E + + ++ +SD++S G+ L E+ G I + +E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 606 --KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK----LTNRCLNLNGKKRPTM 659
+ L++Y + + ++FE+LD V + + + N+CL N +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 660 KEV 662
K++
Sbjct: 293 KQL 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 1e-64
Identities = 60/273 (21%), Positives = 113/273 (41%), Gaps = 21/273 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
+ LG G G V+ G VA+K K D F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+L + + ++ E++ NG+L +L + +T L +A ++++ ++++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
HRD+++ NIL+ K++DFG +R + ++ + + PE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
FT KSDV+SFG++L E++T R M + + L+
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVR 231
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ +L C + RPT + VL
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 213 bits (542), Expect = 3e-64
Identities = 81/300 (27%), Positives = 130/300 (43%), Gaps = 30/300 (10%)
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQ 446
+ E LG G G VY+G+ VA+K K D +V+EF+ E A++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKE 69
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
I H N+V+LLG C ++ EF+ G L YL + N + ++ + L +A ++S A+
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAM 128
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
YL HRD+ + N L+ + KV+DFG SR M D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
E ++F+ KSDV++FGV+L E+ T + + ++E+L+
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQESVESD 686
E + V +L C N RP+ E+ + QES SD
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF---------ETMFQESSISD 281
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-64
Identities = 72/276 (26%), Positives = 119/276 (43%), Gaps = 21/276 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
+ +G G G V+ G + VAIK + ++FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+L G CLE LV+EF+ +G L YL Q E L + ++V + ++YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
+ HRD+ + N L+ KVSDFG +R + DQ +T + + PE F SR
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
++ KSDV+SFGV++ E+ + + + E +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGK---------------IPYENRSNSEVVEDISTGFRLYK 223
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+ V ++ N C + RP + LA I
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-63
Identities = 67/278 (24%), Positives = 125/278 (44%), Gaps = 27/278 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
+ +G+G G V G G VA+K K +++ F+ E ++++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 63
Query: 454 KLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
+LLG +E + L +V E++ G+L YL + + + L+ +++V +A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 513 ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSS 572
HRD+ + N+L+ AKVSDFG ++ + + + PE R
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREK 175
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632
+F+ KSDV+SFG++L E+ + R + + ++ +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGR---------------VPYPRIPLKDVVPRVEKGYKMD 220
Query: 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670
A V ++ C +L+ RP+ ++ L IK
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-62
Identities = 67/280 (23%), Positives = 118/280 (42%), Gaps = 25/280 (8%)
Query: 391 TATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK--KSKVIDESKVDEFINEVAILSQI 447
+ + Y +G G G K +DG+I+ K + E++ ++EV +L ++
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 448 NHRNVVKLLGCCLETE--VPLLVYEFIINGTLFQYLHDQNEEF-PITWEIRLRIAIEVSD 504
H N+V+ ++ +V E+ G L + +E + E LR+ +++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 505 AVSYLH--SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
A+ H S + HRD+K N+ LDGK K+ DFG +R + D + GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPY 179
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
Y+ PE + EKSD++S G +L EL + +E ++E F
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK-F 231
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ E ++ R LNL RP+++E+
Sbjct: 232 RRIPYRYSDEL--------NEIITRMLNLKDYHRPSVEEI 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 2e-62
Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 25/272 (9%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
Y +GQG GTVY M +A G+ VAI++ + + K + INE+ ++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+V L L + +V E++ G+L + + + + E A+ +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS 134
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
+ HRDIKS NILL K++DFG + +Q+ +T V GT ++ PE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 572 SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631
+ K D++S G++ E++ GE +L +L+ I +
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPLRALYLIATNGTPE 235
Query: 632 EASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ E + + + NRCL+++ +KR + KE+
Sbjct: 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-61
Identities = 62/273 (22%), Positives = 114/273 (41%), Gaps = 21/273 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
+ LGQG G V+ G VAIK K + F+ E ++ ++ H +V
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+L E + +V E++ G+L +L + ++ + +A +++ ++Y+
Sbjct: 76 QLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMAAQIASGMAYVERM- 132
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
HRD+++ NIL+ KV+DFG +R + ++ + + PE R
Sbjct: 133 --NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 190
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
FT KSDV+SFG++L EL T R M + + ++
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNREVLDQVERGYRMPC 235
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
E ++ L +C ++RPT + + L
Sbjct: 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-61
Identities = 66/269 (24%), Positives = 110/269 (40%), Gaps = 21/269 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV 453
+ LG G G V G VAIK K DEFI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+L G C + ++ E++ NG L YL + F + L + +V +A+ YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK- 119
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
HRD+ + N L++ + KVSDFG SR + D+ + + + PE S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 574 FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633
F+ KSD+++FGV++ E+ + + E + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGK---------------MPYERFTNSETAEHIAQGLRLYR 222
Query: 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
V + C + +RPT K +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKIL 251
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 6e-61
Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 30/273 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGML-ADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ + R LG+G G VY I+A+K K+++ + EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
N+++L G + L+ E+ GT+++ L + + E+++A+SY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS + HRDIK N+LL K++DFG S + + GT YL PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMI 176
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
EK D++S GV+ E L G+ FE + Y + E + + +
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPP-----FEANTYQETYKRISRVEFTFPDFVTEG- 230
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
L +R L N +RP ++EV
Sbjct: 231 -----------ARDLISRLLKHNPSQRPMLREV 252
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 7e-61
Identities = 62/272 (22%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 399 NRILGQGGQGTVYKGMLAD-GRIVAIKK--SKVIDESKVDEFINEVAILSQINHRNVVKL 455
+ +G+G TVYKG+ + VA + + + +S+ F E +L + H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 456 LGCCLET----EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
T + +LV E + +GTL YL + ++ ++ + +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130
Query: 512 AASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
+ PI HRD+K NI + G K+ D G + + + V GT ++ PE +
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
++ E DVY+FG+ + E+ T E + E ++ A + R + D +
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYP-----YSECQNAAQIY-RRVTSGVKPASFDKVAI 239
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E ++ C+ N +R ++K++
Sbjct: 240 PEV--------KEIIEGCIRQNKDERYSIKDL 263
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 3e-60
Identities = 61/298 (20%), Positives = 119/298 (39%), Gaps = 29/298 (9%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCC 459
+G+G G V++G G VA+K E + E+ + H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 460 LETE----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA-- 513
+ LV ++ +G+LF YL+ + +T E +++A+ + +++LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 514 ---SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM---TTQVQGTFGYLDPE 567
I HRD+KS NIL+ ++D G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 568 YFRSS------RFTEKSDVYSFGVVLAELLTGERAIRVTNFEE----DKSLAAYFLRAMK 617
S +++D+Y+ G+V E+ + + D + + M+
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 618 EDSLFEILDAHVL-KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDG 674
+ + L ++ + S E + +AK+ C NG R T + L+ + +G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-60
Identities = 62/276 (22%), Positives = 106/276 (38%), Gaps = 26/276 (9%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRN 451
D + LG G G VYK + A K E ++++++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+VKLL ++ EF G + + + P+T + + DA++YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD 128
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF-- 569
I HRD+K+ NIL K++DFG S + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 570 ---RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
+ + K+DV+S G+ L E+ E + + L+ K +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ +CL N R T ++
Sbjct: 239 SRWSSNF--------KDFLKKCLEKNVDARWTTSQL 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (515), Expect = 5e-60
Identities = 66/291 (22%), Positives = 111/291 (38%), Gaps = 36/291 (12%)
Query: 379 DKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKV 434
D ++LF + E ++ R +G G G VY + + +VAIK S K
Sbjct: 3 DVAELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 435 DEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEI 494
+ I EV L ++ H N ++ GC L LV E+ + + P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 495 RLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT 554
+ ++YLHS + HRD+K+ NILL K+ DFG++ M
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APA 168
Query: 555 TQVQGTFGYLDPEYFRSS---RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY 611
GT ++ PE + ++ K DV+S G+ EL + +++A
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP-----LFNMNAMSAL 223
Query: 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ A E + H + + CL + RPT + +
Sbjct: 224 YHIAQNESPALQ--SGHWSEYF--------RNFVDSCLQKIPQDRPTSEVL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 8e-60
Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 30/288 (10%)
Query: 387 KELETATDHYN-TNRILGQGGQGTVYKGMLA---DGRIVAIKK-SKVIDESKVDEFINEV 441
K+L D+ + LG G G+V +G+ VAIK + +++ +E + E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 442 AILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIE 501
I+ Q+++ +V+L+G C + E +LV E G L ++L + EE P + +
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQ 117
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT--TQVQG 559
VS + YL HRD+ + N+LL ++ AK+SDFG S+++ D ++ T + +
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKE 618
+ PE +F+ +SDV+S+GV + E L+ G++ + E + +++
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQ 227
Query: 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
E E E + L + C + RP V +
Sbjct: 228 GKRMECPP-----ECPPE----LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 1e-59
Identities = 71/275 (25%), Positives = 124/275 (45%), Gaps = 29/275 (10%)
Query: 399 NRILGQGGQGTVYKGMLAD---GRIVAIK--KSKVIDESKVDEFINEVAILSQINHRNVV 453
++ LG G GTV KG + VA+K K++ D + DE + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
+++G C E E +LV E G L +YL + + + + +VS + YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQ--VQGTFGYLDPEYFRS 571
HRD+ + N+LL ++ AK+SDFG S+++ D+ + Q + + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 572 SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631
+F+ KSDV+SFGV++ E + + R MK + +L+
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQ---------------KPYRGMKGSEVTAMLEKGERM 229
Query: 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ L N C + + RP V + L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (509), Expect = 2e-59
Identities = 64/312 (20%), Positives = 127/312 (40%), Gaps = 47/312 (15%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKK-SKVIDESKVDEFIN 439
LE ++ R +G+G G V++ +VA+K + +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 440 EVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF----------- 488
E A++++ ++ N+VKLLG C + L++E++ G L ++L +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 489 ----------PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS 538
P++ +L IA +V+ ++YL HRD+ + N L+ K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 539 DFGASRSMA-IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597
DFG SR++ D ++ PE +R+T +SDV+++GVVL E+ +
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-- 240
Query: 598 RVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657
+ E+ ++ + D ++L + + L C + RP
Sbjct: 241 ------------QPYYGMAHEEVIYYVRDGNILACPENCPL-ELYNLMRLCWSKLPADRP 287
Query: 658 TMKEVAVVLAGI 669
+ + +L +
Sbjct: 288 SFCSIHRILQRM 299
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 3e-59
Identities = 72/285 (25%), Positives = 132/285 (46%), Gaps = 29/285 (10%)
Query: 396 YNTNRILGQGGQGTVYKGMLAD----GRIVAIKK-SKVIDESKVDEFINEVAILSQINHR 450
+ N ++G+G G VY G L D A+K +++ D +V +F+ E I+ +H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 451 NVVKLLGCCLETE-VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
NV+ LLG CL +E PL+V ++ +G L ++ ++ + + ++V+ +
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD--LIGFGLQVAKG---M 143
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA---IDQTHMTTQVQGTFGYLDP 566
AS HRD+ + N +LD K+ KV+DFG +R M D H T + ++
Sbjct: 144 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
E ++ +FT KSDV+SFGV+L EL+T D + + ++ L
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRRLL--QP 256
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671
+ + ++ +C + + RP+ E+ ++ I +
Sbjct: 257 EYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 199 bits (506), Expect = 6e-59
Identities = 65/304 (21%), Positives = 119/304 (39%), Gaps = 38/304 (12%)
Query: 384 FTSKELETAT---------DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKK-SKVI 429
FT ++ A +++G G G V G L VAIK
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 430 DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFP 489
E + +F++E +I+ Q +H NV+ L G ++ +++ EF+ NG+L +L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 490 ITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549
T + + ++ + YL HRD+ + NIL++ KVSDFG SR + D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 550 QTHMTT----QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED 605
+ T + + PE + +FT SDV+S+G+V+ E+++
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---------- 231
Query: 606 KSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665
M + ++ + + +L C + RP ++
Sbjct: 232 -----RPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 666 LAGI 669
L +
Sbjct: 287 LDKM 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-59
Identities = 64/316 (20%), Positives = 129/316 (40%), Gaps = 41/316 (12%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKK-SKVID 430
ID ++L + E + + + LG G G V + VA+K
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 431 ESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHD------ 483
++ + ++E+ +LS + NH N+V LLG C L++ E+ G L +L
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 484 ---------QNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYR 534
+++E + E L + +V+ +++L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 535 AKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG 593
K+ DFG +R + D ++ + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 594 ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNG 653
+ + + ++++ + + + + C + +
Sbjct: 244 GS--------------SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 654 KKRPTMKEVAVVLAGI 669
KRPT K++ ++
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 64/335 (19%), Positives = 132/335 (39%), Gaps = 50/335 (14%)
Query: 366 LLQQELASTEGN----IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGML------ 415
L ++ + N +D + + E ++ ++LG G G V
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 416 ADGRIVAIKK-SKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFII 473
VA+K + D S+ + ++E+ +++Q+ +H N+V LLG C + L++E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 474 NGTLFQYLHDQNEEF--------------------PITWEIRLRIAIEVSDAVSYLHSAA 513
G L YL + E+F +T+E L A +V+ + +L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT-TQVQGTFGYLDPEYFRSS 572
HRD+ + N+L+ K+ DFG +R + D ++ + ++ PE
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 573 RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632
+T KSDV+S+G++L E+ + + + + ++++ +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGV----NPYPGIPV----------DANFYKLIQNGFKMD 287
Query: 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667
+ + C + +KRP+ + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 2e-58
Identities = 67/288 (23%), Positives = 125/288 (43%), Gaps = 28/288 (9%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGMLADG-----RIVAIKK-SKVIDESKVDEFINEVAI 443
E +++G G G VYKGML VAIK E + +F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 444 LSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVS 503
+ Q +H N+++L G + + +++ E++ NG L ++L +++ EF + + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120
Query: 504 DAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ--THMTTQVQGTF 561
+ YL + HRD+ + NIL++ KVSDFG SR + D T+ T+ +
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
+ PE +FT SDV+SFG+V+ E++T + +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+ ++ + + +L +C +RP ++ +L +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (500), Expect = 3e-58
Identities = 67/273 (24%), Positives = 106/273 (38%), Gaps = 24/273 (8%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQINHRN 451
+ ++ + LG+G G V + VA+K + E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
VVK G E + L E+ G LF + + R ++ V YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID-QTHMTTQVQGTFGYLDPEYFR 570
I HRDIK N+LLD + K+SDFG + + + + ++ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 571 SSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
F E DV+S G+VL +L GE + S + KE + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
L ++ L N R T+ ++
Sbjct: 233 DSAP--------LALLHKILVENPSARITIPDI 257
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 197 bits (502), Expect = 1e-57
Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 23/272 (8%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
DHY+ + LG G G V++ A G A K ES + E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
V L + +++YEF+ G LF+ + D++ ++ + + +V + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 513 ASIPIYHRDIKSTNILLDGKY--RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
H D+K NI+ K K+ DFG + + Q+ T GT + PE
Sbjct: 144 ---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAE 198
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
+D++S GV+ LL+G N +E LR +K +D
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE-------TLRNVKSCDW--NMDDSAF 249
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
S++ + L + R T+ +
Sbjct: 250 SGISED----GKDFIRKLLLADPNTRMTIHQA 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 2e-56
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 26/287 (9%)
Query: 388 ELETATDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKK-SKVIDESKVDEFINEVA 442
+ E + R +G+G G V++G+ VAIK +S ++F+ E
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 443 ILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
+ Q +H ++VKL+G E V ++ E G L +L + + + + A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
S A++YL S HRDI + N+L+ K+ DFG SR M + ++ +
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
++ PE RFT SDV+ FGV + E+L D + ++
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERL 228
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669
+ + L +C + +RP E+ L+ I
Sbjct: 229 PMPP-----NCPPT----LYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-56
Identities = 66/274 (24%), Positives = 112/274 (40%), Gaps = 28/274 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ + +ILG+G TV LA R AIK K +I E+KV E ++S+++H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
VKL + E + NG L +Y+ E+ A+ YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYL 124
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID-QTHMTTQVQGTFGYLDPEY 568
H I HRD+K NILL+ +++DFG ++ ++ + + GT Y+ PE
Sbjct: 125 HGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628
+ SD+++ G ++ +L+ G R + F + +K + F
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKLEYDF---PEK 232
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+A L + L L+ KR +E+
Sbjct: 233 FFPKARD--------LVEKLLVLDATKRLGCEEM 258
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-55
Identities = 65/282 (23%), Positives = 111/282 (39%), Gaps = 29/282 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGML----ADGRIVAIK---KSKVIDESKVDEFINEVAILSQ 446
LG G G V +G VA+K + +D+FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
++HRN+++L G L + +V E G+L L F R A++V++ +
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGM 124
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH--MTTQVQGTFGYL 564
YL S HRD+ + N+LL + K+ DFG R++ + H M + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE ++ F+ SD + FGV L E+ T + + + + KE
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPR 236
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
+ + Q+ + + +C + RPT + L
Sbjct: 237 PE-----DCPQD----IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (482), Expect = 3e-55
Identities = 64/328 (19%), Positives = 135/328 (41%), Gaps = 32/328 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD-----GRIVAIKK-SKVIDESKVDEFINEVAILSQI 447
+ ++LG G GTVYKG+ VAIK+ + E ++E +++ +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 448 NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
++ +V +LLG CL + V L+ + + G L Y+ + + + L ++++ ++
Sbjct: 69 DNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMN 125
Query: 508 YLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDP 566
YL + HRD+ + N+L+ K++DFG ++ + ++ + ++
Sbjct: 126 YLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 567 EYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626
E +T +SDV+S+GV + EL+T + + IL+
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGS---------------KPYDGIPASEISSILE 227
Query: 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGTSNIIQESVESD 686
+ V + +C ++ RP +E+ + + + +IQ
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
Query: 687 IAESYETGESFTESYTDSVTIP--VDAD 712
+ ++ +F + D + VDAD
Sbjct: 288 LPSPTDS--NFYRALMDEEDMDDVVDAD 313
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 189 bits (480), Expect = 2e-54
Identities = 55/272 (20%), Positives = 105/272 (38%), Gaps = 23/272 (8%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
D+Y+ LG G G V++ + A GR+ K NE++I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
+ L + +L+ EF+ G LF + ++ + ++ + + + + ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEH 146
Query: 513 ASIPIYHRDIKSTNILLDGKY--RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
I H DIK NI+ + K K+ DFG + ++ + T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLATK--LNPDEIVKVTTATAEFAAPEIVD 201
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVL 630
+D+++ GV+ LL+G F + L + E + V
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSP-----FAGEDDLETLQNVKRCDWEFDEDAFSSVS 256
Query: 631 KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
EA L +KR T+ +
Sbjct: 257 PEAKD--------FIKNLLQKEPRKRLTVHDA 280
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 187 bits (475), Expect = 2e-54
Identities = 64/278 (23%), Positives = 104/278 (37%), Gaps = 20/278 (7%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAIL 444
K+ E D Y+ +LG G V ++VAIK +K E K NE+A+L
Sbjct: 2 KQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL 61
Query: 445 SQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
+I H N+V L L+ + + G LF + ++ T R+ +V D
Sbjct: 62 HKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLD 118
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
AV YLH + + LD + +SDFG S+ D + + GT GY+
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYV 176
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE +++ D +S GV+ LL G F ++ + E
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPP-----FYDENDAKLFEQILKAEYEFDSP 231
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ A + + +KR T ++
Sbjct: 232 YWDDISDSA--------KDFIRHLMEKDPEKRFTCEQA 261
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-54
Identities = 69/320 (21%), Positives = 122/320 (38%), Gaps = 41/320 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADG---RIVAIKK-SKVIDESKVDEFINEVAILSQI-N 448
+ ++G+G G V K + AIK+ + + +F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-------------PITWEIR 495
H N++ LLG C L E+ +G L +L ++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
L A +V+ + YL HRD+ + NIL+ Y AK++DFG SR + T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQ--EVYVKKT 184
Query: 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615
+ ++ E S +T SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACDGT 675
M L+E L E V L +C +RP+ ++ V L + T
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 676 ---SNIIQESVESDIAESYE 692
+ + ++ + I S E
Sbjct: 290 YVNTTLYEKFTYAGIDCSAE 309
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 184 bits (469), Expect = 6e-54
Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 30/282 (10%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQIN 448
+D Y ILG GG V+ L R VA+K D S F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 449 HRNVVKLLGCCLETE----VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
H +V + +P +V E++ TL +H + P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM--TTQVQGTFG 562
A+++ H I HRD+K NI++ KV DFG +R++A + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 563 YLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
YL PE R +SDVYS G VL E+LTGE F D ++ + ++
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----FTGDSPVSVAYQHVREDPIPP 234
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-TMKEVA 663
+ + + + L N + R T E+
Sbjct: 235 SARHEGLSADL--------DAVVLKALAKNPENRYQTAAEMR 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 3e-53
Identities = 61/279 (21%), Positives = 107/279 (38%), Gaps = 27/279 (9%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILS 445
KEL + Y LG+G G V++ + + + K K + + E++IL+
Sbjct: 1 KEL---YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILN 56
Query: 446 QINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDA 505
HRN++ L E ++++EFI +F+ ++ F + + +V +A
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREIVSYVHQVCEA 114
Query: 506 VSYLHSAASIPIYHRDIKSTNILLD--GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
+ +LHS I H DI+ NI+ K+ +FG +R + Y
Sbjct: 115 LQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEY 169
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
PE + + +D++S G ++ LL+G ++ M + F
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPF------LAETNQQIIENIMNAEYTF- 222
Query: 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
D KE S E +R L K R T E
Sbjct: 223 --DEEAFKEISIE----AMDFVDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 1e-52
Identities = 78/309 (25%), Positives = 126/309 (40%), Gaps = 40/309 (12%)
Query: 384 FTSKELETATDHYNTNRILGQGGQGTVYKGM------LADGRIVAIKK-SKVIDESKVDE 436
+ + + E D + LG+G G V + A R VA+K + S+
Sbjct: 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA 62
Query: 437 FINEVAILSQINHR-NVVKLLGCCLETEVPL-LVYEFIINGTLFQYLHDQNEEF------ 488
++E+ IL I H NVV LLG C + PL ++ EF G L YL + EF
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 489 -------PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541
+T E + + +V+ + +L S HRD+ + NILL K K+ DFG
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 542 ASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVT 600
+R + D + + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA----- 234
Query: 601 NFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK 660
+ + F R +KE + D + E + C + +RPT
Sbjct: 235 SPYPGVKIDEEFCRRLKEGTRMRAPD-YTTPEM--------YQTMLDCWHGEPSQRPTFS 285
Query: 661 EVAVVLAGI 669
E+ L +
Sbjct: 286 ELVEHLGNL 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 1e-51
Identities = 76/308 (24%), Positives = 129/308 (41%), Gaps = 33/308 (10%)
Query: 378 IDKSKLFTSKELETATDHYNTNRILGQGGQGTVYKGML------ADGRIVAIKK-SKVID 430
+ ++ E E A + +R LGQG G VY+G+ VAIK ++
Sbjct: 4 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63
Query: 431 ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEF-- 488
+ EF+NE +++ + N +VV+LLG + + L++ E + G L YL
Sbjct: 64 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123
Query: 489 -----PITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543
P + +++A E++D ++YL++ HRD+ + N ++ + K+ DFG +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 544 RSM-AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602
R + D + ++ PE + FT SDV+SFGVVL E+ T
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 603 EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E LR + E L + D + +L C N K RP+ E+
Sbjct: 241 NEQ------VLRFVMEGGLLDKPD-----NCPDM----LFELMRMCWQYNPKMRPSFLEI 285
Query: 663 AVVLAGIK 670
+
Sbjct: 286 ISSIKEEM 293
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 176 bits (448), Expect = 5e-51
Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 38/286 (13%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK---------SKVIDESKVDEFINEVAI 443
++Y ILG+G V + + + A+K S + + + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 444 LSQIN-HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
L +++ H N+++L LV++ + G LF YL ++ ++ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFG 562
+ + LH I HRD+K NILLD K++DFG S +D +V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPS 174
Query: 563 YLDPEYFRSSR------FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAM 616
YL PE S + ++ D++S GV++ LL G F K + +
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-----FWHRKQMLMLRMIMS 229
Query: 617 KEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
L +R L + +KR T +E
Sbjct: 230 GNYQFGSPEWDDYSDTV--------KDLVSRFLVVQPQKRYTAEEA 267
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 2e-50
Identities = 67/309 (21%), Positives = 120/309 (38%), Gaps = 42/309 (13%)
Query: 387 KELETATDHYNTNRILGQGGQGTVYKGML--------ADGRIVAIKK-SKVIDESKVDEF 437
E D + LG+G G V VA+K E + +
Sbjct: 6 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 438 INEVAILSQI-NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ------------ 484
I+E+ ++ I H+N++ LLG C + ++ E+ G L +YL +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125
Query: 485 -NEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543
N E ++ + + A +V+ + YL S HRD+ + N+L+ K++DFG +
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 544 RSMAIDQTHMTTQVQ-GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNF 602
R + + T ++ PE +T +SDV+SFGV+L E+ T +
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------ 236
Query: 603 EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ + LF++L + + + C + +RPT K++
Sbjct: 237 ---------PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQL 287
Query: 663 AVVLAGIKA 671
L I A
Sbjct: 288 VEDLDRIVA 296
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 169 bits (428), Expect = 4e-48
Identities = 57/283 (20%), Positives = 113/283 (39%), Gaps = 20/283 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRN 451
+ Y+ +G+G G VYK G A+KK ++ DE I E++IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 452 VVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS 511
+VKL + +LV+E + + + +++ + ++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD 118
Query: 512 AASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRS 571
+ HRD+K N+L++ + K++DFG +R+ I T ++ + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 572 SRFTEKSDVYSFGVVLAELLTGE------------RAIRVTNFEEDKSLAAYFLRAMKED 619
+++ D++S G + AE++ G I + K D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
F + + + + + L ++ L L+ +R T K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-47
Identities = 63/273 (23%), Positives = 109/273 (39%), Gaps = 29/273 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILS-QIN 448
+ + +++LG+G G V+ + AIK K V+ + V+ + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 449 HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
H + + E V E++ G L ++ + A E+ + +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 509 LHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
LHS I +RD+K NILLD K++DFG + + T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 569 FRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628
++ D +SFGV+L E+L G+ + EE +++ D+ F
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNPF--YPRW 225
Query: 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
+ KEA L + +KR ++
Sbjct: 226 LEKEA--------KDLLVKLFVREPEKRLGVRG 250
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-47
Identities = 66/291 (22%), Positives = 109/291 (37%), Gaps = 25/291 (8%)
Query: 392 ATDHYNTNRILGQGGQGTVYKG--MLADGRIVAIK--KSKVIDESKVDEFINEVAILSQI 447
A Y +G+G G V+K + GR VA+K + + +E I EVA+L +
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 448 ---NHRNVVKLLGCCLETEVPLLVYEFIINGTLFQ---YLHDQNEEFPITWEIRLRIAIE 501
H NVV+L C + ++ + Q D+ E + E + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTF 561
+ + +LHS + HRD+K NIL+ + K++DFG +R + + V T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS--VVVTL 179
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED-----KSLAAYFLRAM 616
Y PE S + D++S G + AE+ + R ++ + +
Sbjct: 180 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 617 KEDSLFEILDAHVLKEASQEDIVT-----VAKLTNRCLNLNGKKRPTMKEV 662
D H E VT L +CL N KR +
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 58/293 (19%), Positives = 116/293 (39%), Gaps = 30/293 (10%)
Query: 393 TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK-SKVIDESKVDEFINEVAILSQINHR 450
Y +G+G G V + VAIKK S ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N++ + + + +++ + L+ + ++ + ++ + Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMT--TQVQGTFGYLDPEY 568
SA + HRD+K +N+LL+ K+ DFG +R D H T+ T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 569 F-RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD- 626
S +T+ D++S G +LAE+L+ ++ + + L + ++ L I++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 627 -----------------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ A + + L ++ L N KR +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKAL----DLLDKMLTFNPHKRIEVEQA 292
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 57/284 (20%), Positives = 108/284 (38%), Gaps = 20/284 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK--KSKVIDESKVDEFINEVAILSQINHR 450
+++ +G+G G VYK G +VA+K + E I E+++L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+VKLL LV+EF+ D + I + ++ +++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
S + HRD+K N+L++ + K++DFG +R+ + T +V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 571 SSRFTEKSDVYSFGVVLAELLTGE------------RAIRVTNFEEDKSLAAYFLRAMKE 618
++ D++S G + AE++T I T D+ +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
F + L ++ L+ + KR + K
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 5e-46
Identities = 68/285 (23%), Positives = 105/285 (36%), Gaps = 33/285 (11%)
Query: 400 RILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDE-----FINEVAILSQINHRNVV 453
LG+G TVYK +IVAIKK K+ S+ + + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 454 KLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA 513
LL LV++F+ + +T + + YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 514 SIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSR 573
I HRD+K N+LLD K++DFG ++S T QV T Y PE +R
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 574 -FTEKSDVYSFGVVLAELLTGE---------------RAIRVTNFEEDKSLAAYFLRAMK 617
+ D+++ G +LAELL T EE +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
S I H+ A + + L N R T +
Sbjct: 237 FKSFPGIPLHHIFSAAGDD----LLDLIQGLFLFNPCARITATQA 277
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-46
Identities = 61/278 (21%), Positives = 106/278 (38%), Gaps = 29/278 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRN 451
D+ T+++LG G G V + A+K + + EV + + +
Sbjct: 12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPH 66
Query: 452 VVKLLGCC----LETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVS 507
+V+++ + L+V E + G LF + D+ ++ T I + +A+
Sbjct: 67 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQ 125
Query: 508 YLHSAASIPIYHRDIKSTNILLD---GKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
YLHS I HRD+K N+L K++DFG ++ + T T Y+
Sbjct: 126 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYV 180
Query: 565 DPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEI 624
PE ++ + D++S GV++ LL G F + LA +
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYE 235
Query: 625 LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
E S+E V L L +R T+ E
Sbjct: 236 FPNPEWSEVSEE----VKMLIRNLLKTEPTQRMTITEF 269
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 9e-46
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 31/274 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLAD-GRIVAIK---KSKVIDESKVDEFINEV---AILSQ 446
+ ++ +RI+G+GG G VY AD G++ A+K K ++ + +NE +++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 447 INHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAV 506
+ +V + + + + + G L +L + A E+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120
Query: 507 SYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP 566
++H+ + +RD+K NILLD ++SD G + + + H + GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174
Query: 567 EYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625
E + + +D +S G +L +LL G F + K+ + + M E+
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHS-----PFRQHKTKDKHEIDRMTLTMAVELP 229
Query: 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659
D E L L + +R
Sbjct: 230 D-SFSPEL--------RSLLEGLLQRDVNRRLGC 254
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 3e-45
Identities = 70/284 (24%), Positives = 112/284 (39%), Gaps = 32/284 (11%)
Query: 390 ETATDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESK---VDEFINEVA 442
E D+Y+T LG G V K + G A K K + + ++ EV+
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 443 ILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
IL +I H NV+ L +L+ E + G LF +L ++ +T E ++
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQI 122
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLD----GKYRAKVSDFGASRSMAIDQTHMTTQVQ 558
+ V YLHS I H D+K NI+L K R K+ DFG + ID + +
Sbjct: 123 LNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK--IDFGNEFKNIF 177
Query: 559 GTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
GT ++ PE ++D++S GV+ LL+G F D +
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGAS-----PFLGDTKQETLANVSAVN 232
Query: 619 DSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+ ++ A R L + KKR T+++
Sbjct: 233 YEFEDEYFSNTSALA--------KDFIRRLLVKDPKKRMTIQDS 268
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 161 bits (407), Expect = 4e-45
Identities = 54/279 (19%), Positives = 94/279 (33%), Gaps = 26/279 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
+ Y R +G G G +Y G +A G VAIK V ++K + E I +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 64
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
+ + C ++ ++ +L + + +F + L +A ++ + Y+HS
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFS--LKTVLLLADQMISRIEYIHSK 122
Query: 513 ASIPIYHRDIKSTNIL---LDGKYRAKVSDFGASRSMAIDQTH------MTTQVQGTFGY 563
HRD+K N L + DFG ++ +TH + GT Y
Sbjct: 123 N---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 564 LDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623
+ + D+ S G VL G + + K + E
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-KKMSTPIE 238
Query: 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
+L E A N C +L +P +
Sbjct: 239 VLCKGYPSEF--------ATYLNFCRSLRFDDKPDYSYL 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 161 bits (408), Expect = 7e-45
Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 31/272 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ R LG G G V+ +GR A+K K V+ +V+ +E +LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
++++ G + + ++ ++I G LF L + A EV A+ YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS I +RD+K NILLD K++DFG ++ + +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVV 173
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
+ + + D +SFG+++ E+L G F + ++ Y E +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTP-----FYDSNTMKTYEKILNAELRFPPFFNED- 227
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
V L +R + + +R +
Sbjct: 228 -----------VKDLLSRLITRDLSQRLGNLQ 248
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-44
Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 46/282 (16%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVD---EFINEVAILSQ 446
Y +LG GG G+VY G+ ++D VAIK K ++ D ++ EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 447 IN--HRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
++ V++LL + +L+ E + + E+ +V +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLE 121
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFGASRSMAIDQTHMTTQVQGTFGY 563
AV + H+ + HRDIK NIL+D + K+ DFG+ + + + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA---LLKDTVYTDFDGTRVY 175
Query: 564 LDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
PE+ R R+ + V+S G++L +++ G+ FE D+
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP-----FEHDE---------------- 214
Query: 623 EILDAHVL--KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
EI+ V + S E L CL L RPT +E+
Sbjct: 215 EIIRGQVFFRQRVSSE----CQHLIRWCLALRPSDRPTFEEI 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 1e-43
Identities = 66/287 (22%), Positives = 116/287 (40%), Gaps = 28/287 (9%)
Query: 396 YNTNRILGQGGQGTVYKGMLAD-GRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
Y +++G G G VY+ L D G +VAIKK E+ I+ +++H N+V+
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77
Query: 455 LLGCCLETEVP------LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSY 508
L + LV +++ H + + ++ +++Y
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 509 LHSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPE 567
+HS I HRDIK N+LLD K+ DFG+++ + + +++ + +
Sbjct: 138 IHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAPEL 193
Query: 568 YFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEED-----KSLAAYFLRAMKE---- 618
F ++ +T DV+S G VLAELL G+ + + K L ++E
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253
Query: 619 --DSLFEILDAHVLKEASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ F + AH + + A L +R L R T E
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 1e-43
Identities = 55/285 (19%), Positives = 103/285 (36%), Gaps = 22/285 (7%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKV--IDESKVDEFINEVAILSQINHR 450
Y +G+G GTV+K IVA+K+ ++ DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N+V+L + LV+EF + + EI ++ + + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
S + HRD+K N+L++ K+++FG +R+ I + +V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 571 SSRFTEKSDVYSFGVVLAELLTGER-------------AIRVTNFEEDKSLAAYFLRAMK 617
+ ++ D++S G + AEL R I + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 618 EDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEV 662
L + T L L N +R + +E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 1e-42
Identities = 61/305 (20%), Positives = 111/305 (36%), Gaps = 36/305 (11%)
Query: 384 FTSKELETAT----DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK--KSKVIDESKVDE 436
F +E+ Y + +G G G V + G VAIK E
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 437 FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQ-NEEFPITWEIR 495
E+ +L + H NV+ LL E +F + + + + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 496 LRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
+ ++ + Y+H+A I HRD+K N+ ++ K+ DFG +R + MT
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG--------ERAIRVTNFEEDKS 607
V + R+T+ D++S G ++AE++TG + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 608 LAAYFLRAMKEDSLFEILD----------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657
A F++ ++ D + A +L AS + L + L L+ ++R
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAV----NLLEKMLVLDAEQRV 293
Query: 658 TMKEV 662
T E
Sbjct: 294 TAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 7e-42
Identities = 68/272 (25%), Positives = 105/272 (38%), Gaps = 28/272 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIK---KSKVIDESKVDEFINEVAILSQINH 449
+ ++ ++LG+G G V A GR A+K K +I + +V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
+ L + V E+ G LF +L E T E E+ A+ YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYF 569
HS + +RDIK N++LD K++DFG + D M T GT YL PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 570 RSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629
+ + D + GVV+ E++ G + E F + E+ F
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEIRFP------ 225
Query: 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661
+ S E L L + K+R
Sbjct: 226 -RTLSPE----AKSLLAGLLKKDPKQRLGGGP 252
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 149 bits (378), Expect = 4e-41
Identities = 46/285 (16%), Positives = 89/285 (31%), Gaps = 28/285 (9%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV 452
HY R +G+G G +++G L + + VAIK S + +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKLLAGCTG 62
Query: 453 VKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA 512
+ + + + ++ ++ +L L +F + A ++ V +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK 120
Query: 513 ASIPIYHRDIKSTNILLDGKYR-----AKVSDFGASR------SMAIDQTHMTTQVQGTF 561
+ +RDIK N L+ V DFG + + + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 562 GYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621
Y+ + + D+ + G V L G + + K+ +
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK-AATNKQKYERIGEKKQSTP 236
Query: 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVL 666
L A +E K + NL P + +
Sbjct: 237 LRELCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLF 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 150 bits (379), Expect = 1e-40
Identities = 68/300 (22%), Positives = 115/300 (38%), Gaps = 37/300 (12%)
Query: 368 QQELASTEGNIDKSKLFTSKELETAT------DHYNTNRILGQGGQGTVYKGM-LADGRI 420
E S + + K+K K+ ET + D ++ + LG G G V G
Sbjct: 9 GSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNH 68
Query: 421 VAIK---KSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTL 477
A+K K KV+ +++ +NE IL +N +VKL + +V E++ G +
Sbjct: 69 YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM 128
Query: 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKV 537
F +L + A ++ YLHS + +RD+K N+L+D + +V
Sbjct: 129 FSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182
Query: 538 SDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAI 597
+DFG A T + GT L PE S + + D ++ GV++ E+ G
Sbjct: 183 TDFG----FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP- 237
Query: 598 RVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657
F D+ + Y + H + L L ++ KR
Sbjct: 238 ----FFADQPIQIYEKIVSGKVRFPS----HFSSDLKD--------LLRNLLQVDLTKRF 281
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-40
Identities = 57/299 (19%), Positives = 111/299 (37%), Gaps = 36/299 (12%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK--SKVIDESKVDEFINEVAILSQINHR 450
Y +GQG G V+K G+ VA+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 451 NVVKLLGCCLETEVP--------LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEV 502
NVV L+ C P LV++F + + T R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 503 SDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT---HMTTQVQG 559
++ L+ I HRD+K+ N+L+ K++DFG +R+ ++ + + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 560 TFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618
T Y PE R + D++ G ++AE+ T ++ + +L + ++
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 619 DSLFEILDAHVLKEASQEDIVTVAK---------------LTNRCLNLNGKKRPTMKEV 662
+ + + + ++ L ++ L L+ +R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 70/277 (25%), Positives = 111/277 (40%), Gaps = 30/277 (10%)
Query: 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIK---KSKVIDESK-VDEFINEVAILS 445
+++ ++LG G G V+ G++ A+K K+ ++ ++K + E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 446 QINHR-NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSD 504
I +V L L+ ++I G LF +L + T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 505 AVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYL 564
A+ +LH I +RDIK NILLD ++DFG S+ D+T GT Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 565 DPEYFRSSR--FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622
P+ R + D +S GV++ ELLTG V E S A R +K + +
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG--EKNSQAEISRRILKSEPPY 255
Query: 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTM 659
+E S L R L + KKR
Sbjct: 256 P-------QEMSAL----AKDLIQRLLMKDPKKRLGC 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 139 bits (352), Expect = 3e-37
Identities = 53/298 (17%), Positives = 112/298 (37%), Gaps = 45/298 (15%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRN 451
D Y R LG+G V++ + + + V +K ++ K + E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVK---ILKPVKKKKIKREIKILENLRGGPN 91
Query: 452 VVKLLGCCLE--TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
++ L + + P LV+E + N Q +T E+ A+ Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 510 HSAASIPIYHRDIKSTNILLDGK-YRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEY 568
HS I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 569 FRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627
+ + D++S G +LA ++ + + D + + + L++ +D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDK 258
Query: 628 HVLK----------------------EASQEDIVTVAK-LTNRCLNLNGKKRPTMKEV 662
+ ++ +Q + A ++ L + + R T +E
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 6e-36
Identities = 60/297 (20%), Positives = 110/297 (37%), Gaps = 33/297 (11%)
Query: 394 DHYNTNRILGQGGQGTVYKGM-LADGRIVAIKK--SKVIDESKVDEFINEVAILSQINHR 450
Y + +G G QG V R VAIKK +++ E+ ++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 451 NVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLH 510
N++ LL + + + L Q + + E + ++ + +LH
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 511 SAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFR 570
S I HRD+K +NI++ K+ DFG +R+ + M T T Y PE
Sbjct: 137 ---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYRAPEVIL 191
Query: 571 SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEE--------------------DKSLAA 610
+ E D++S G ++ E++ + ++ + ++
Sbjct: 192 GMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 251
Query: 611 YFLRAMKEDSL-FEILDAHVLKEASQEDIVTVAK----LTNRCLNLNGKKRPTMKEV 662
Y K L F L L A E A L ++ L ++ KR ++ +
Sbjct: 252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 9e-35
Identities = 60/305 (19%), Positives = 107/305 (35%), Gaps = 36/305 (11%)
Query: 384 FTSKELETA----TDHYNTNRILGQGGQGTVYKGM-LADGRIVAIK--KSKVIDESKVDE 436
F +EL + Y +G G G+V G VA+K
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 437 FINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRL 496
E+ +L + H NV+ LL + + L + + + +
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 497 R-IAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTT 555
+ + ++ + Y+HSA I HRD+K +N+ ++ K+ DFG +R MT
Sbjct: 124 QFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTG 177
Query: 556 QVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTN--------FEEDKS 607
V + + + D++S G ++AELLTG T+ +
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237
Query: 608 LAAYFLRAMKEDSLFEILD----------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRP 657
A L+ + +S + A+V A+ + L + L L+ KR
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAV----DLLEKMLVLDSDKRI 293
Query: 658 TMKEV 662
T +
Sbjct: 294 TAAQA 298
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 119 bits (299), Expect = 5e-30
Identities = 55/314 (17%), Positives = 102/314 (32%), Gaps = 50/314 (15%)
Query: 396 YNTNRILGQGGQGTVYKGM-LADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVK 454
Y R LG G TV+ + + VA+K + D+ + +E+ +L ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVR-GDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 455 LLGCCLETEVPLLVY-------------EFIINGTLFQYLHDQNEEFPITWEIRLRIAIE 501
+ LL + F + G L + E I +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 502 VSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFG-ASRSMAIDQTHMTTQVQG 559
+ + Y+H I H DIK N+L++ + A A T
Sbjct: 134 LLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191
Query: 560 TFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTG-------------------------- 593
T Y PE + + +D++S ++ EL+TG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL 251
Query: 594 ----ERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAK-LTNRC 648
+R + + LR + + + + D K +D +
Sbjct: 252 GELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM 311
Query: 649 LNLNGKKRPTMKEV 662
L L+ +KR +
Sbjct: 312 LQLDPRKRADAGGL 325
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.4 bits (213), Expect = 4e-20
Identities = 29/199 (14%), Positives = 63/199 (31%), Gaps = 36/199 (18%)
Query: 400 RILGQGGQGTVYKGMLADGRIVAIK----------KSKVIDESKVDEFINEVAILSQINH 449
+++G+G + V+ +K K K + F ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 450 RNVVKLLGCCLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYL 509
R + KL G + Y + + L D E + + E + + + V+
Sbjct: 66 RALQKLQGLAVPKV-----YAW-EGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 510 HSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDP--- 566
+ I H D+ N+L+ + + DF +++ + L+
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFP----QSVEVGEEGWR-----EILERDVR 166
Query: 567 ---EYFRSSRFTEKSDVYS 582
YF + + D+ S
Sbjct: 167 NIITYFS-RTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 721 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.46 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.88 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.45 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.76 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.0 | |
| d1gl4a2 | 40 | EGF-like domain of nidogen-1 {Mouse (Mus musculus) | 93.59 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 87.37 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.51 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=421.91 Aligned_cols=257 Identities=28% Similarity=0.426 Sum_probs=202.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|++.+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++||||++++|++.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 568889999999999999999998999999998753 3345789999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|+|.+++..... .+++..+++++.|||.||+|||+++ |+||||||+||||++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999876543 5899999999999999999999999 9999999999999999999999999998776544444
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcccC
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEA 633 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 633 (721)
.....||+.|+|||++.+..++.++||||||+++|||+|+..|+.... .... +...+..+ .....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-----~~~~-~~~~i~~~---------~~~~~ 223 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-----SNSE-VVEDISTG---------FRLYK 223 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-----CHHH-HHHHHHHT---------CCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-----CHHH-HHHHHHhc---------CCCCC
Confidence 445679999999999999999999999999999999999654432211 1111 11111111 11122
Q ss_pred CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 634 SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 634 ~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+...+.++.+|+.+||+.||++||||+||++.|++++.
T Consensus 224 p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 23344678999999999999999999999999998854
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=421.26 Aligned_cols=257 Identities=23% Similarity=0.384 Sum_probs=211.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
..++|++.+.||+|+||+||+|.+++++.||||+++... ...+.|.+|+++|++++|||||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356788999999999999999999888999999986533 345789999999999999999999998754 567999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+++|+|.+++..... ..++|..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++.......
T Consensus 89 ~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~ 164 (272)
T d1qpca_ 89 MENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164 (272)
T ss_dssp CTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE
T ss_pred CCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcc
Confidence 999999998765432 25899999999999999999999998 99999999999999999999999999998765544
Q ss_pred eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 552 HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.......||+.|||||++.+..++.++||||||+++|||+||..|+..... ... ....+... ...
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-----~~~-~~~~i~~~---------~~~ 229 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-----NPE-VIQNLERG---------YRM 229 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-----HHH-HHHHHHTT---------CCC
T ss_pred ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-----HHH-HHHHHHhc---------CCC
Confidence 444556789999999999999999999999999999999997665432211 111 11111111 111
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
..+...+.++.+|+.+||+.||++||||.||++.|+.+
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhh
Confidence 22333455789999999999999999999999999865
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.5e-51 Score=424.15 Aligned_cols=263 Identities=29% Similarity=0.421 Sum_probs=219.1
Q ss_pred HHHHhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 389 LETATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 389 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++...++|++.+.||+|+||+||+|++. +++.||||+++.. ....++|.+|+++|++++|||||++++++.+.+..++
T Consensus 12 wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 90 (287)
T d1opja_ 12 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 90 (287)
T ss_dssp TBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEE
Confidence 3334567899999999999999999976 4889999998653 3456789999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++..... ..+++..+++|+.||++||+|||+++ |+||||||+||||++++.+||+|||+++...
T Consensus 91 v~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 91 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred EeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecC
Confidence 9999999999999976433 37999999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
.+.........|++.|+|||++.+..++.++||||||+++|||++|..|+..... ... ... .+..
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~-~~~---------~i~~ 231 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQ-VYE---------LLEK 231 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHH-HHH---------HHHT
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHH-HHH---------HHhc
Confidence 5555555556789999999999999999999999999999999997776532211 111 111 1222
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
....+.+...+.++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 232 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 22223334455679999999999999999999999999987743
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-50 Score=414.51 Aligned_cols=260 Identities=26% Similarity=0.420 Sum_probs=206.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||+||+|++++ .||||+++.. +....+.|.+|+.+|++++|||||++++++.+ +..+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4679999999999999999998653 5999987643 45567889999999999999999999998754 56799999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.++++..+. .+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999976543 5999999999999999999999998 9999999999999999999999999998765332
Q ss_pred c-eeeeeeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 551 T-HMTTQVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 551 ~-~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
. .......||+.|||||++.+ ..++.++|||||||+||||+||+.||....... .....+..+...
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~~~---- 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLS---- 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHHTSCC----
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhcCCCC----
Confidence 2 23345679999999999864 358999999999999999999999986433211 111111111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+ .....+...+.++.+|+.+||+.||++|||++||++.|+.+++
T Consensus 229 p-~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 229 P-DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp C-CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 0 0112233345679999999999999999999999999998865
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-50 Score=407.77 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=215.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeecc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFII 473 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 473 (721)
++|++.++||+|+||+||+|++++++.||||+++... ...++|.+|+.++++++||||++++|++.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 6799999999999999999999888899999987543 345789999999999999999999999999999999999999
Q ss_pred CCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee
Q 036483 474 NGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM 553 (721)
Q Consensus 474 ~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~ 553 (721)
+|+|.+++..... .+++..+++++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999776543 5899999999999999999999998 9999999999999999999999999998776554444
Q ss_pred eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 554 TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 554 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
.....||+.|+|||.+.+..++.++||||||+++|||+| |+.||......+ ....+..+ ....
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~i~~~---------~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEHIAQG---------LRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHHHHTT---------CCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHHHHhC---------CCCC
Confidence 445668999999999999999999999999999999998 788986443221 11222211 1122
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
.+...+.++.+|+.+||+.||++|||+.||++.|.+|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 2334456799999999999999999999999998654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6e-50 Score=417.26 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=201.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-C---cEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-G---RIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++|++.++||+|+||+||+|+++. + ..||||++.. ......++|.+|+++|++++|||||+++|++.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 456777899999999999999753 3 2689998755 3445567899999999999999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.+++..... .++|..+++++.|||+||+|||+++ |+||||||+||||+.++++||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence 999999999998876443 5999999999999999999999998 99999999999999999999999999987754
Q ss_pred CCcee----eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 549 DQTHM----TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 549 ~~~~~----~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
..... .....||+.|||||.+.+..++.++||||||++||||+| |+.||...... . ....+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~-~~~~i~~----- 248 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------D-VINAIEQ----- 248 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------H-HHHHHHT-----
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------H-HHHHHHc-----
Confidence 32221 223457899999999999999999999999999999998 89998643321 1 1111211
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
......+...+.++.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 249 ----~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 249 ----DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp ----TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 11122334455679999999999999999999999999988753
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-50 Score=409.55 Aligned_cols=252 Identities=25% Similarity=0.369 Sum_probs=203.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|++.+.||+|+||+||+|+.+ +|+.||||++.... ....+.+.+|+++|++++||||+++++++.+.+..+||||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 357999999999999999999975 58999999875532 3345679999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997543 6999999999999999999999999 9999999999999999999999999998775433
Q ss_pred c-eeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 551 T-HMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 551 ~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. .......||+.|||||++.+..+ +.++||||||++||||++|+.||........ . +.........
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~--~---~~~~~~~~~~------- 225 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ--E---YSDWKEKKTY------- 225 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH--H---HHHHHTTCTT-------
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH--H---HHHHhcCCCC-------
Confidence 2 22345679999999999998876 5789999999999999999999965432211 1 1111111110
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.......+.++.+|+.+||+.||++|||++|+++
T Consensus 226 --~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 226 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0011122346889999999999999999999854
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=409.72 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=204.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCC-----cEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADG-----RIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
+.|+..++||+|+||+||+|.+++. ..||||+++.. .....++|.+|+.+|++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4678889999999999999997642 37999987653 34455689999999999999999999999999999999
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+.+++|.+++..... .++|..+++++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999998876543 5999999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCc--eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQT--HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.... .......||+.|||||++.+..++.++||||||+++|||++|..|+...... .. .... +
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~-~~~~---------i 226 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HE-VMKA---------I 226 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH-HHHH---------H
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HH-HHHH---------H
Confidence 4322 2233456899999999999999999999999999999999976665432211 11 1111 2
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
........+...+.++.+|+.+||+.+|++||||.||++.|+.+..
T Consensus 227 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred hccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 2222233344455679999999999999999999999999988764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=408.62 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=208.9
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++||||+++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 47999999999999999999964 68999999987666666788999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|.+++... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++++||+|||+++.+.....
T Consensus 100 ~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence 999999988654 4999999999999999999999999 99999999999999999999999999987754332
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ . ..
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~~-~-------~~ 237 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGTP-E-------LQ 237 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCSC-C-------CS
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCCC-C-------CC
Confidence 234456999999999999999999999999999999999999999643321 111111111110 0 11
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 238 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 12223456899999999999999999999865
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-49 Score=402.55 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=206.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.+ +++.||+|++... +....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56899999999999999999976 5889999987542 2344577899999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998654 5999999999999999999999999 999999999999999999999999999866432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. .....||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+ ..+.....
T Consensus 160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~-~~i~~~~~-------- 221 (263)
T d2j4za1 160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETY-KRISRVEF-------- 221 (263)
T ss_dssp C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH-HHHHTTCC--------
T ss_pred c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHH-HHHHcCCC--------
Confidence 2 23456999999999999999999999999999999999999999643321 111 11111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...+.++.+|+.+||+.||++|||++|+++
T Consensus 222 --~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 --TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 122233456899999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=407.18 Aligned_cols=247 Identities=28% Similarity=0.418 Sum_probs=201.3
Q ss_pred ceEeeeCcEEEEEEEEcC---CcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeeccC
Q 036483 400 RILGQGGQGTVYKGMLAD---GRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFIIN 474 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~~~ 474 (721)
++||+|+||+||+|.+++ ++.||||+++. .+....++|.+|+++|++++|||||+++|++.. +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999998653 46899998754 334456789999999999999999999999854 567899999999
Q ss_pred CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCcee-
Q 036483 475 GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTHM- 553 (721)
Q Consensus 475 gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~~- 553 (721)
|+|.++++... .+++..+++++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998654 6999999999999999999999998 9999999999999999999999999998775443332
Q ss_pred -eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 554 -TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 554 -~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.....||+.|||||.+.+..++.++||||||+++|||++ |+.||......+ ....+..+ ...
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~-------~~~~i~~~---------~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKG---------ERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTT---------CCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH-------HHHHHHcC---------CCC
Confidence 234568999999999999999999999999999999998 899986433211 11222221 112
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
+.+...+.++.+|+.+||+.||++|||+.+|.+.|+..
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 23334456799999999999999999999999988764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=408.84 Aligned_cols=255 Identities=27% Similarity=0.414 Sum_probs=208.4
Q ss_pred cCCCCCce-EeeeCcEEEEEEEEc---CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRI-LGQGGQGTVYKGMLA---DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.++ ||+|+||+||+|.++ ++..||||.++.. +....++|.+|+++|++++|||||+++|++.. +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999864 3557999998653 34557889999999999999999999999864 567999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.+++...+. .+++..+++++.||++||+|||+++ |+||||||+||||+.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999865432 5999999999999999999999998 99999999999999999999999999988754
Q ss_pred CCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 549 DQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 549 ~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
..... .....||+.|+|||++.+..++.++||||||+++|||+| |+.||......+ +...+..+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~i~~~------ 228 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQG------ 228 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHHHHTT------
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcC------
Confidence 43322 223458899999999999999999999999999999998 899986433211 11222221
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
...+.+...+.++.+|+.+||+.+|++|||+.+|.+.|+.+.
T Consensus 229 ---~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 229 ---KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 112233445567999999999999999999999999998653
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=408.79 Aligned_cols=259 Identities=24% Similarity=0.375 Sum_probs=206.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++|++.+.||+|+||+||+|++++++.||||+++.. ....+.|.+|+.+|++++|||||+++|++.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 4679999999999999999999998889999998654 3345789999999999999999999999854 5679999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|..++...... .++|..+++++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++........
T Consensus 94 ~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~ 169 (285)
T d1fmka3 94 SKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169 (285)
T ss_dssp TTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred CCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence 999999998764322 5999999999999999999999999 999999999999999999999999999877544444
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhhccc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKE 632 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 632 (721)
......||+.|+|||++....++.++||||||+++|||++|..|+...... .. ....+... ...+
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-----~~-~~~~i~~~---------~~~~ 234 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-----RE-VLDQVERG---------YRMP 234 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HH-HHHHHHTT---------CCCC
T ss_pred eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-----HH-HHHHHHhc---------CCCC
Confidence 445567999999999999999999999999999999999977665432211 11 11111111 1122
Q ss_pred CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 633 ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 633 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.+...+.++.+|+.+||+.||++||||.+|++.|+.....
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence 3334456799999999999999999999999999876543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-49 Score=406.58 Aligned_cols=254 Identities=25% Similarity=0.407 Sum_probs=196.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe--CCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLE--TEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~--~~~~~lv 468 (721)
++|++.+.||+|+||+||+|+.. +|+.||||.+... ++...+.+.+|+++|++++|||||++++++.+ .+..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 67999999999999999999965 5899999987553 34456789999999999999999999999875 3457899
Q ss_pred EeeccCCCcchhccccC-CCCCccHHHHHHHHHHHHHHHHHHHhcCC--CCeeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 469 YEFIINGTLFQYLHDQN-EEFPITWEIRLRIAIEVSDAVSYLHSAAS--IPIYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~qia~~L~yLH~~~~--~~ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
|||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.+. .+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999986532 23369999999999999999999999752 3499999999999999999999999999987
Q ss_pred cccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 546 MAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 546 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
+..+.. ......||+.|||||++.+..++.++||||||+++|||++|+.||...... . ....+.....
T Consensus 164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~-~~~~i~~~~~---- 231 (269)
T d2java1 164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------E-LAGKIREGKF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------H-HHHHHHHTCC----
T ss_pred cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------H-HHHHHHcCCC----
Confidence 754322 234567999999999999999999999999999999999999999643321 1 1122222221
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 1122234456999999999999999999999865
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=414.09 Aligned_cols=258 Identities=24% Similarity=0.443 Sum_probs=209.2
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEcC-C-----cEEEEeeccc-cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCC
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLAD-G-----RIVAIKKSKV-IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETE 463 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~ 463 (721)
..++|++.++||+|+||+||+|++.. + ..||+|++.. .+....+.+.+|+.+|.++ +|||||++++++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 34689999999999999999998653 2 3699998754 3445567899999999998 8999999999999999
Q ss_pred cceEEEeeccCCCcchhccccCC--------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNE--------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIK 523 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk 523 (721)
..++||||+++|+|.++|+.... ...+++..++.++.||++||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence 99999999999999999976432 135899999999999999999999998 9999999
Q ss_pred CccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCC
Q 036483 524 STNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTN 601 (721)
Q Consensus 524 ~~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~ 601 (721)
|+|||++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||+||||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999876544332 2344668999999999999999999999999999999998 899986433
Q ss_pred ccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHh
Q 036483 602 FEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLA 667 (721)
Q Consensus 602 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~ 667 (721)
... . +...+.. ....+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus 272 ~~~--~----~~~~~~~---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDA--N----FYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSH--H----HHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHH--H----HHHHHhc---------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 221 1 1112211 1122233344567999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=405.12 Aligned_cols=251 Identities=25% Similarity=0.348 Sum_probs=207.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......+.+.+|+++|++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56889999999999999999975 58899999987767777889999999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|.+++.+... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++++||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999999875432 5999999999999999999999999 9999999999999999999999999997654221 1
Q ss_pred eeeeeecCCCCCCccccc-----cCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh
Q 036483 553 MTTQVQGTFGYLDPEYFR-----SSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA 627 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 627 (721)
......||+.|||||++. ...|+.++|||||||+||||++|+.||......+ . +........ ..
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~---~---~~~i~~~~~-~~---- 234 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR---V---LLKIAKSEP-PT---- 234 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG---H---HHHHHHSCC-CC----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH---H---HHHHHcCCC-CC----
Confidence 223456999999999984 4568899999999999999999999996543322 1 111111111 00
Q ss_pred hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...+...+.++.+|+.+||+.||++|||+.|+++
T Consensus 235 ---~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ---LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ---CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---CCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0112233456899999999999999999999865
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-48 Score=394.21 Aligned_cols=246 Identities=24% Similarity=0.386 Sum_probs=197.3
Q ss_pred CCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEe----CCcceEEE
Q 036483 397 NTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLE----TEVPLLVY 469 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~----~~~~~lv~ 469 (721)
++.++||+|+||+||+|+.. +++.||+|++... .....+.|.+|+++|++++|||||++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 56678999999999999976 5889999987543 34556789999999999999999999999875 34568999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC-CCCcEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD-GKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~-~~~~~kl~DFGls~~~~~ 548 (721)
||+++|+|.+++.+.. .+++..++.++.||++||+|||+++ ++|+||||||+||||+ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998654 6999999999999999999999986 3499999999999996 578999999999986433
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
. ......||+.|||||++.+ .++.++||||||+++|||++|+.||...... .. ..+.+..+....
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~-~~~~i~~~~~~~----- 232 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQ-IYRRVTSGVKPA----- 232 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HH-HHHHHTTTCCCG-----
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HH-HHHHHHcCCCCc-----
Confidence 2 2345679999999999875 5999999999999999999999998633211 11 112222211111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+...++++.+|+.+||+.||++|||+.|+++
T Consensus 233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 111122345889999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=409.60 Aligned_cols=264 Identities=26% Similarity=0.397 Sum_probs=206.7
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|++.++||+|+||+||+|+.. +|+.||+|+++.. +....+.+.+|+.+|++++|||||++++++.+.+..+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 578999999999999999999965 6899999987653 34446789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
|+++|+|.+++.+.. .+++..+..++.|++.||.|||++ + |+||||||+||||++++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 999999999998654 599999999999999999999974 7 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHH-HH---------------
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAY-FL--------------- 613 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~-~~--------------- 613 (721)
......||+.|||||++.+..|+.++|||||||++|||++|+.||......+....... ..
T Consensus 159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 22345799999999999999999999999999999999999999975443221100000 00
Q ss_pred -------HHhhccchhhhhhhhhcc---cC-CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 614 -------RAMKEDSLFEILDAHVLK---EA-SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 614 -------~~~~~~~~~~~~~~~~~~---~~-~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.........+..+..... .. ....+.++.+|+.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 000000001111100000 00 01123568899999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-48 Score=405.09 Aligned_cols=264 Identities=24% Similarity=0.390 Sum_probs=214.4
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCL 460 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~ 460 (721)
+++...++|++.+.||+|+||+||+|+++ +++.||||+++... ....++|.+|+++|++++||||+++++++.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999864 35789999986543 334678999999999999999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccCC---------------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeee
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQNE---------------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYH 519 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivH 519 (721)
+.+..++||||+++|+|.++++.... ...+++..++.|+.|++.||+|||+.+ |+|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 99999999999999999999964321 235899999999999999999999999 999
Q ss_pred ccCcCccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCC-ccc
Q 036483 520 RDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE-RAI 597 (721)
Q Consensus 520 rDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~-~p~ 597 (721)
|||||+|||||.++++||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 999999999999999999999999876443322 234456899999999999999999999999999999999986 556
Q ss_pred ccCCccccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 598 RVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 598 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
......+ ....+..+.. ...+...+.++.+|+.+||+.+|++||||.||+++|+++.
T Consensus 244 ~~~~~~e-------~~~~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEE-------VIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHH-------HHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHH-------HHHHHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 4332211 1122222221 2223344567999999999999999999999999999875
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-48 Score=401.88 Aligned_cols=249 Identities=24% Similarity=0.376 Sum_probs=205.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.. +++.||||++.. .+....+.+.+|+++|++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 56999999999999999999975 689999998754 23445678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+||||++++.+||+|||+++.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999987654 6999999999999999999999999 999999999999999999999999999877543
Q ss_pred Cc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 550 QT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 550 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. .......||+.|||||++.+..++.++|||||||+||||++|+.||...... ..+.... ....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~-~~~~------- 227 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKII-KLEY------- 227 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHH-TTCC-------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHH-cCCC-------
Confidence 32 2234467999999999999999999999999999999999999999643321 1111111 1111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.++...+.++.+|+.+||+.||++|||++|++..
T Consensus 228 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 ---DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp ---CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred ---CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 1222334568999999999999999999997553
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=397.03 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=199.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC----CcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD----GRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
.++|++.+.||+|+||+||+|++.. +..||||+++.. .....+.|.+|+.+|++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 4678999999999999999998653 346899987653 3445678999999999999999999999986 467899
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
||||+++|+|.+++..... .+++..++.++.||++||.|||+++ |+||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998875443 5899999999999999999999999 9999999999999999999999999998776
Q ss_pred cCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 548 IDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 548 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
...........||+.|+|||++.+..++.++||||||+++|||++ |..||......+ + ...+..+.
T Consensus 160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~----~~~i~~~~------ 226 (273)
T d1mp8a_ 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---V----IGRIENGE------ 226 (273)
T ss_dssp -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---H----HHHHHTTC------
T ss_pred CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---H----HHHHHcCC------
Confidence 544444555678999999999999999999999999999999998 888886543322 1 11111111
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
....+...+.++.+|+.+||+.||++|||+.||++.|+.+.
T Consensus 227 ---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~ 267 (273)
T d1mp8a_ 227 ---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 267 (273)
T ss_dssp ---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 11223344567999999999999999999999999998875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-48 Score=392.93 Aligned_cols=251 Identities=26% Similarity=0.462 Sum_probs=201.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-CcceEEEeec
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLET-EVPLLVYEFI 472 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-~~~~lv~e~~ 472 (721)
++|++.+.||+|+||.||+|+++ |+.||||+++. ....++|.+|++++++++||||++++|++.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCC--CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 56788899999999999999985 77899999864 34457899999999999999999999999764 5679999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|.+++..... ..++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 84 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp TTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred CCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC---
Confidence 99999999975422 25899999999999999999999998 999999999999999999999999999865422
Q ss_pred eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhhhhhhcc
Q 036483 553 MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHVLK 631 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 631 (721)
.....+|..|+|||++.+..++.++||||||+++|||+| |+.|+......+ +. ..+.. ....
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~----~~i~~---------~~~~ 219 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEK---------GYKM 219 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTT---------TCCC
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHHHc---------CCCC
Confidence 223457899999999999999999999999999999998 677765433221 11 11111 1222
Q ss_pred cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 632 EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 632 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+.+...+.++.+|+.+||+.||++|||+.||++.|+.++.
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 3344455679999999999999999999999999998864
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.1e-47 Score=403.70 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=209.8
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
-++|++.+.||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 368999999999999999999975 6899999998776666678899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC--CCCcEEEeeccCccccccC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD--GKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGls~~~~~~ 549 (721)
+++|+|.+++..... .+++..++.++.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999865432 5999999999999999999999999 99999999999996 4678999999999876543
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. ......||+.|||||++.+..++.++|||||||++|||++|+.||...... ..+......... ....
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~---~~~~- 247 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCDWN---MDDS- 247 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC---SCCG-
T ss_pred c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---CCcc-
Confidence 3 334567999999999999999999999999999999999999999643321 111111111100 0001
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.....+.++.+|+.+||+.||++|||++|++++
T Consensus 248 ---~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 ---AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111223468999999999999999999999875
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.7e-47 Score=399.84 Aligned_cols=246 Identities=25% Similarity=0.358 Sum_probs=201.5
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC---chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID---ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+.|+..+.||+|+||+||+|+.. +++.||||+++... ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 45889999999999999999965 68899999876532 334567999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|..++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC
Confidence 9999999977665443 6999999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeeeeecCCCCCCcccccc---CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRS---SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
....||+.|||||++.+ ..|+.++|||||||++|||++|+.||...... ..+........ .
T Consensus 169 -----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~-~---- 232 (309)
T d1u5ra_ 169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES-P---- 232 (309)
T ss_dssp -----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-C----
T ss_pred -----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-C----
Confidence 23469999999999864 46899999999999999999999998643221 11111111111 0
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...+...+.++.+|+.+||+.||++|||+.|++++
T Consensus 233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 01112234568999999999999999999999763
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-47 Score=399.99 Aligned_cols=255 Identities=22% Similarity=0.461 Sum_probs=204.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCc----EEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGR----IVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~l 467 (721)
++|++.++||+|+||+||+|.+. +|+ .||+|+++. .+....++|.+|+.+|++++|||||+++|++.+. ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999865 343 689998764 3445567899999999999999999999999865 5678
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMA 547 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~ 547 (721)
++|++.+++|.+++..... .+++..+++++.|||.||+|||+++ |+||||||+||||+.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998876543 6999999999999999999999998 9999999999999999999999999998875
Q ss_pred cCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 548 IDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 548 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
...... .....||+.|+|||++.+..++.++||||||++||||+| |+.||......+ +. ..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~----~~i--------- 226 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---IS----SIL--------- 226 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HH----HHH---------
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HH----HHH---------
Confidence 443332 334568999999999999999999999999999999998 788876443221 11 111
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
........+...+.++.+|+.+||+.||++|||+.||++.|..+.
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence 111122233344567999999999999999999999999998774
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-47 Score=397.78 Aligned_cols=253 Identities=26% Similarity=0.326 Sum_probs=192.1
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
+.+.|++.+.||+|+||+||+|+.. +++.||||.+.... ....+.+.+|+.+|++++||||+++++++.+.+..+|||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4577999999999999999999976 58999999875432 333467889999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC---CCCcEEEeeccCcccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD---GKYRAKVSDFGASRSM 546 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGls~~~ 546 (721)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997643 6999999999999999999999999 99999999999994 5789999999999866
Q ss_pred ccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILD 626 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 626 (721)
.... ......||+.|||||++.+..++.++|||||||+||||++|+.||...... ............
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~~----- 227 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEYE----- 227 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCCC-----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCCC-----
Confidence 4322 234456999999999999999999999999999999999999999643221 111111111110
Q ss_pred hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 627 AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 627 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.........++++.+|+.+||+.||++|||+.|+++.
T Consensus 228 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 --FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp --CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0011112334568999999999999999999999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-46 Score=400.38 Aligned_cols=253 Identities=19% Similarity=0.271 Sum_probs=210.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 467999999999999999999965 6999999998765555667889999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC--CCCcEEEeeccCccccccC
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD--GKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~--~~~~~kl~DFGls~~~~~~ 549 (721)
+++|+|.+++.... ..+++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+++.+..+
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998876543 25999999999999999999999999 99999999999998 6789999999999887543
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
. ......||+.|+|||++.+..++.++|||||||+||||++|+.||...... ..+..... ... ..
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~-~~~------~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKR-CDW------EF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHH-CCC------CC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-CCC------CC
Confidence 3 334566999999999999999999999999999999999999999643321 11111111 110 00
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
........+.++.+|+.+||+.||++|||+.|++++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122334568999999999999999999999774
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=391.89 Aligned_cols=255 Identities=26% Similarity=0.398 Sum_probs=198.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC--C--cEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD--G--RIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
++|++.+.||+|+||+||+|++.. + ..||||+++.. +.+..++|.+|+.+|++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568899999999999999998642 2 36899987542 34456789999999999999999999999965 4678
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++|+|.+++..... .+++..+++++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999998876432 5999999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCcee--eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 547 AIDQTHM--TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 547 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
....... .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...... .........+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~---- 231 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEG---- 231 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSC----
T ss_pred ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCC----
Confidence 5443322 234457889999999999999999999999999999998 89998643322 1112222221
Q ss_pred hhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhc
Q 036483 624 ILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGI 669 (721)
Q Consensus 624 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l 669 (721)
...+.+...+.++.+|+.+||+.||++|||+.||.+.|++.
T Consensus 232 -----~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 232 -----ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 11122233445799999999999999999999999999865
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=392.51 Aligned_cols=254 Identities=27% Similarity=0.438 Sum_probs=204.9
Q ss_pred CceEeeeCcEEEEEEEEcCC----cEEEEeeccc-cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-CcceEEEeec
Q 036483 399 NRILGQGGQGTVYKGMLADG----RIVAIKKSKV-IDESKVDEFINEVAILSQINHRNVVKLLGCCLET-EVPLLVYEFI 472 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-~~~~lv~e~~ 472 (721)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999997542 2689998864 4555678899999999999999999999998764 5789999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
++|+|.++++.... .+++..+++++.|+++||.|||+.+ |+||||||+||||++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999876543 5889999999999999999999999 999999999999999999999999999876543222
Q ss_pred ---eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 553 ---MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 553 ---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..... .+..+.
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~----~i~~g~--------- 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITV----YLLQGR--------- 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH----HHHTTC---------
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHH----HHHcCC---------
Confidence 223356899999999999999999999999999999999988887532211 11111 111111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
....+...+.++.+|+.+||+.||++||+|.||++.|+++...
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 1112223445689999999999999999999999999999754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-47 Score=395.82 Aligned_cols=266 Identities=28% Similarity=0.392 Sum_probs=204.5
Q ss_pred HHHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEE
Q 036483 387 KELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGC 458 (721)
Q Consensus 387 ~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~ 458 (721)
.+++...++|++.++||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence 344444578999999999999999999854 2468999998653 344567788899988887 68999999999
Q ss_pred EEeCC-cceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcC
Q 036483 459 CLETE-VPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524 (721)
Q Consensus 459 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~ 524 (721)
+.+.+ ..++||||+++|+|.++++.... ...+++..++.++.||++||+|||+++ |+||||||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred eccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCc
Confidence 87655 57899999999999999975321 235899999999999999999999999 99999999
Q ss_pred ccEEECCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCC-cccccCCc
Q 036483 525 TNILLDGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE-RAIRVTNF 602 (721)
Q Consensus 525 ~NIll~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~-~p~~~~~~ 602 (721)
+||||++++++||+|||+|+........ ......||+.|||||++.+..++.++||||||+++|||++|. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876543322 234467999999999999999999999999999999999975 56643322
Q ss_pred cccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 603 EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
.+ .+...+..+. ....+...++++.+|+.+||+.||++|||+.||+++|+++.
T Consensus 243 ~~------~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il 295 (299)
T d1ywna1 243 DE------EFCRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 295 (299)
T ss_dssp SH------HHHHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH------HHHHHHhcCC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 11 1222222221 12223334556899999999999999999999999999875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=391.75 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=205.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC------chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID------ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVP 465 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~ 465 (721)
.++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 478999999999999999999975 68999999875421 22357899999999999999999999999999999
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC----cEEEeecc
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY----RAKVSDFG 541 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~----~~kl~DFG 541 (721)
+|||||+++|+|.+++.... .+++..++.++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999997654 6999999999999999999999999 99999999999998776 59999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
+++...... ......||+.|+|||++.+..++.++||||||++||||++|+.||...... ..+.. +.....
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~-i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLAN-VSAVNY 233 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHTTCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHH-HHhcCC
Confidence 998764332 233456899999999999999999999999999999999999999643321 11111 111110
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
. ..... ....+..+.+|+.+||+.||++|||++|+++
T Consensus 234 ~--~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E--FEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C--CCHHH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--CCchh----cCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00000 1112346889999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-47 Score=395.73 Aligned_cols=258 Identities=25% Similarity=0.399 Sum_probs=206.4
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcC-Cc--EEEEeeccc-cCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLAD-GR--IVAIKKSKV-IDESKVDEFINEVAILSQI-NHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~~~~~lv 468 (721)
++|++.++||+|+||+||+|++++ +. .||||+++. ......++|.+|+++|+++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 678889999999999999999764 43 578888754 3445667899999999999 799999999999999999999
Q ss_pred EeeccCCCcchhccccC-------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcE
Q 036483 469 YEFIINGTLFQYLHDQN-------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRA 535 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~ 535 (721)
|||+++|+|.++|+... ....+++..+++++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997541 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCc-ccccCCccccccHHHHHHH
Q 036483 536 KVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGER-AIRVTNFEEDKSLAAYFLR 614 (721)
Q Consensus 536 kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~-p~~~~~~~~~~~~~~~~~~ 614 (721)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|.. ||..... .. +..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~-~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AE-LYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HH-HHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HH-HHH
Confidence 999999998654222 2233458999999999999999999999999999999999765 5543221 11 112
Q ss_pred HhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 615 AMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 615 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.+..+ ...+.+...+.++.+|+.+||+.||++||||+||++.|+++...
T Consensus 238 ~i~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhc---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 22211 12223334556799999999999999999999999999988643
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=394.57 Aligned_cols=265 Identities=24% Similarity=0.400 Sum_probs=214.4
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCC 459 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~ 459 (721)
+++...++|++.++||+|+||.||+|++. +++.||||+++.. .......|.+|+.+++++ +|||||++++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34444578999999999999999999853 3568999998653 344566899999999999 699999999999
Q ss_pred EeCCcceEEEeeccCCCcchhccccC---------------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcC
Q 036483 460 LETEVPLLVYEFIINGTLFQYLHDQN---------------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKS 524 (721)
Q Consensus 460 ~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~ 524 (721)
.+.+..++||||+++|+|.++++... ....+++..+++++.||++||+|||+++ |+||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 99999999999999999999997643 2236899999999999999999999999 99999999
Q ss_pred ccEEECCCCcEEEeeccCccccccCCc-eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCC-cccccCCc
Q 036483 525 TNILLDGKYRAKVSDFGASRSMAIDQT-HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE-RAIRVTNF 602 (721)
Q Consensus 525 ~NIll~~~~~~kl~DFGls~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~-~p~~~~~~ 602 (721)
+|||++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||+|+. +|+.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999987754433 3334567999999999999999999999999999999999954 44433221
Q ss_pred cccccHHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcc
Q 036483 603 EEDKSLAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIK 670 (721)
Q Consensus 603 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~ 670 (721)
.+ .+.. ++........+...+.++.+|+.+||+.||++|||+.||+++|+++.
T Consensus 254 ~~------~~~~---------~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 254 DS------KFYK---------MIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SH------HHHH---------HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HH------HHHH---------HHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhh
Confidence 11 1111 11222222223334567999999999999999999999999998754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.7e-46 Score=384.22 Aligned_cols=259 Identities=28% Similarity=0.378 Sum_probs=205.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCc----
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEV---- 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~---- 464 (721)
.++|++.+.||+|+||+||+|+.. +|+.||||.++.. +....+.|.+|+++|++++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 477999999999999999999964 6899999987542 33456689999999999999999999999986543
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+|||||+++++|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+||||+.++..+|+|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 689999999999999887654 6999999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCc--eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 545 SMAIDQT--HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 545 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..... ...+...+......
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~------~~~~~~~~~~~~~~ 233 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP------VSVAYQHVREDPIP 233 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHCCCCC
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH------HHHHHHHHhcCCCC
Confidence 6543222 233456799999999999999999999999999999999999999964322 22223333332211
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHhhcc
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRP-TMKEVAVVLAGIK 670 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~ev~~~L~~l~ 670 (721)
. .......+.++.+++.+||+.||++|| |++++++.|..++
T Consensus 234 ~-------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp G-------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C-------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 1 111122345689999999999999999 8999999988764
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-46 Score=391.93 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=208.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.+ +|+.||||+++.. .....+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999965 6899999987542 3445678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|.+++.... .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 9999999999998755 5899999999999999999999999 999999999999999999999999999876433
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.. ......||+.|+|||++.+..|+.++|||||||++|||++|+.||...... ..+ ..+....+
T Consensus 159 ~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~-~~i~~~~~-------- 222 (337)
T d1o6la_ 159 GA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLF-ELILMEEI-------- 222 (337)
T ss_dssp TC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH-HHHHHCCC--------
T ss_pred Cc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHH-HHHhcCCC--------
Confidence 22 334567999999999999999999999999999999999999999754321 111 12211111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
.++...+.++.+|+.+||+.||++||+ +.|++++
T Consensus 223 --~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 223 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 122234456899999999999999995 7777653
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-46 Score=392.05 Aligned_cols=265 Identities=27% Similarity=0.399 Sum_probs=214.6
Q ss_pred HHHHHhcCCCCCceEeeeCcEEEEEEEEc------CCcEEEEeecccc-CchhhHHHHHHHHHHhhcCCCceeeEEEEEE
Q 036483 388 ELETATDHYNTNRILGQGGQGTVYKGMLA------DGRIVAIKKSKVI-DESKVDEFINEVAILSQINHRNVVKLLGCCL 460 (721)
Q Consensus 388 el~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~il~~l~h~niv~l~g~~~ 460 (721)
+++...++|.+.+.||+|+||+||+|.++ +++.||||+++.. .......|.+|+.++++++||||+++++++.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence 34445678999999999999999999864 2578999998653 3445567999999999999999999999999
Q ss_pred eCCcceEEEeeccCCCcchhccccC-------CCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC
Q 036483 461 ETEVPLLVYEFIINGTLFQYLHDQN-------EEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY 533 (721)
Q Consensus 461 ~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~ 533 (721)
..+..++||||+++|+|.++++... ....+++..+++++.|+|+||.|||+++ |+||||||+||||++++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence 9999999999999999999987532 2235799999999999999999999998 99999999999999999
Q ss_pred cEEEeeccCccccccCCcee-eeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCC-cccccCCccccccHHHH
Q 036483 534 RAKVSDFGASRSMAIDQTHM-TTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGE-RAIRVTNFEEDKSLAAY 611 (721)
Q Consensus 534 ~~kl~DFGls~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~-~p~~~~~~~~~~~~~~~ 611 (721)
++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+||. .|+..... ...
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~ 244 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQV 244 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHH
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHH
Confidence 99999999998765433322 23346899999999999999999999999999999999985 55543221 111
Q ss_pred HHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 612 FLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 612 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+. .+..+. ..+.+...+..+.+|+.+||+.+|++||||.+|++.|++...
T Consensus 245 ~~-~i~~~~---------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 245 LR-FVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HH-HHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH-HHHhCC---------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 11 121211 122233345679999999999999999999999999987643
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-45 Score=386.91 Aligned_cols=245 Identities=26% Similarity=0.364 Sum_probs=205.7
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.+ +|+.||||+++. ......+.+.+|+.+|++++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 56899999999999999999975 589999998754 23345678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+++|+|..++.... .+++..+..++.||+.||+|||+++ |+||||||+||||+.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999887654 5889999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....||+.|||||++.+..++.++|||||||+||||++|+.||...... ......... ..
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~-~~-------- 218 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA-EL-------- 218 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC-CC--------
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHcC-CC--------
Confidence 23457999999999999999999999999999999999999999643321 111111111 11
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAVV 665 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~~ 665 (721)
..+...+.++.+++.+||+.||++|| |++|++++
T Consensus 219 --~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 219 --RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 11223345689999999999999996 88888764
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-46 Score=388.17 Aligned_cols=260 Identities=26% Similarity=0.397 Sum_probs=208.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEcC--------CcEEEEeecccc-CchhhHHHHHHHHHHhhc-CCCceeeEEEEEEeC
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLAD--------GRIVAIKKSKVI-DESKVDEFINEVAILSQI-NHRNVVKLLGCCLET 462 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~~ 462 (721)
.++|.+.+.||+|+||.||+|+... +..||||+++.. ......++.+|+..+.++ +|||||++++++.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 4678899999999999999998532 247999998653 344567899999999988 899999999999999
Q ss_pred CcceEEEeeccCCCcchhccccCC-------------CCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEE
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNE-------------EFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILL 529 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll 529 (721)
+..++||||+++|+|.+++..... ...+++..+++++.||+.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 999999999999999999975431 236899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeeccCccccccCCce-eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHh-CCcccccCCcccccc
Q 036483 530 DGKYRAKVSDFGASRSMAIDQTH-MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLT-GERAIRVTNFEEDKS 607 (721)
Q Consensus 530 ~~~~~~kl~DFGls~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ellt-G~~p~~~~~~~~~~~ 607 (721)
+.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---- 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---- 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH----
Confidence 99999999999999877543322 2334568999999999999999999999999999999998 67787543321
Q ss_pred HHHHHHHHhhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 608 LAAYFLRAMKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 608 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
. ....+..+ .....+...+.++.+|+.+||+.||++|||+.||++.|++|.+
T Consensus 245 --~-~~~~i~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 --E-LFKLLKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp --H-HHHHHHTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --H-HHHHHHcC---------CCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1 12222221 1122233344569999999999999999999999999998854
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=384.11 Aligned_cols=267 Identities=22% Similarity=0.315 Sum_probs=201.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHH--HHHHhhcCCCceeeEEEEEEeCC----cceE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINE--VAILSQINHRNVVKLLGCCLETE----VPLL 467 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E--~~il~~l~h~niv~l~g~~~~~~----~~~l 467 (721)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.. ..+++..| +..+.+++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577788999999999999997 5889999988643 23344444 44556789999999999998754 4689
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcC-----CCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAA-----SIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~-----~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
||||+++|+|.+++++. .++|..+++++.|+|.||+|||+.. ..+|+||||||+||||+.++++||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999864 4999999999999999999999741 22499999999999999999999999999
Q ss_pred ccccccCCcee---eeeeecCCCCCCccccccCC------CCccccchhHHHHHHHHHhCCcccccCCcccc--------
Q 036483 543 SRSMAIDQTHM---TTQVQGTFGYLDPEYFRSSR------FTEKSDVYSFGVVLAELLTGERAIRVTNFEED-------- 605 (721)
Q Consensus 543 s~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~------~t~ksDV~SlGvll~elltG~~p~~~~~~~~~-------- 605 (721)
++......... .....||+.|+|||++.+.. ++.++||||||++||||+||..|+........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 98775433222 23467999999999987653 56789999999999999999887754332210
Q ss_pred ccHHHHHHHHhhccchhhhhhhhhcc-cCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhcccc
Q 036483 606 KSLAAYFLRAMKEDSLFEILDAHVLK-EASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKAC 672 (721)
Q Consensus 606 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~ 672 (721)
.............+.+ ++.+.. ..+.+.+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 0111111112111111 111111 11234566799999999999999999999999999988654
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.6e-45 Score=376.26 Aligned_cols=251 Identities=26% Similarity=0.379 Sum_probs=204.1
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc---------hhhHHHHHHHHHHhhcC-CCceeeEEEEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE---------SKVDEFINEVAILSQIN-HRNVVKLLGCCLE 461 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~E~~il~~l~-h~niv~l~g~~~~ 461 (721)
.++|++.+.||+|+||+||+|+.. +++.||||+++.... ...+.+.+|+.+|++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 468999999999999999999964 689999998754321 12346889999999997 9999999999999
Q ss_pred CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeecc
Q 036483 462 TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFG 541 (721)
Q Consensus 462 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFG 541 (721)
.+..+|||||+++|+|.++++... .+++..++.++.||++||+|||+++ |+||||||+||||+.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999997654 6999999999999999999999999 9999999999999999999999999
Q ss_pred CccccccCCceeeeeeecCCCCCCcccccc------CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHH
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRS------SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRA 615 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~ 615 (721)
+++.+.... ......||+.|+|||.+.+ ..++.++||||+|++||||++|+.||......+ .....
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~------~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMI 227 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH------HHHHH
Confidence 998775432 2344679999999999863 346889999999999999999999997543211 11111
Q ss_pred hhccchhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 616 MKEDSLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 616 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
.. .... .........++++.+|+.+||+.+|++|||+.||++
T Consensus 228 ~~-~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 228 MS-GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HH-TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred Hh-CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11 1110 001111123456899999999999999999999865
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5e-45 Score=387.81 Aligned_cols=244 Identities=22% Similarity=0.294 Sum_probs=205.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc---cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV---IDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~ 469 (721)
++|++.+.||+|+||+||+|+.+ +|+.||||++.. .+....+.+.+|+++|++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 57999999999999999999975 699999998753 23345678999999999999999999999999999999999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccC
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAID 549 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~ 549 (721)
||+.+|+|..++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999997664 5999999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhhh
Q 036483 550 QTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAHV 629 (721)
Q Consensus 550 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 629 (721)
.....||+.|||||++.+..++.++|||||||+||||++|+.||..... ...+.... ....
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~------~~~~~~i~-~~~~-------- 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP------IQIYEKIV-SGKV-------- 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHH-HCCC--------
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH------HHHHHHHh-cCCC--------
Confidence 2345799999999999999999999999999999999999999964321 11111111 1111
Q ss_pred cccCCHHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 036483 630 LKEASQEDIVTVAKLTNRCLNLNGKKRP-----TMKEVAV 664 (721)
Q Consensus 630 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~ev~~ 664 (721)
..+...+.++.+|+.+||+.||++|+ |++|+++
T Consensus 256 --~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 --RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp --CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 11223345689999999999999994 8888875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-44 Score=378.74 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=206.7
Q ss_pred HhcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 392 ATDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 392 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
+.++|.+.+.||+|+||+||+|+.. +++.||||.++... .....+.+|+++|++++||||+++++++.+.+..+||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 3578999999999999999999976 58899999886543 334568899999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC--CCcEEEeeccCcccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG--KYRAKVSDFGASRSMAI 548 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~--~~~~kl~DFGls~~~~~ 548 (721)
|+++|+|.+++.... ..+++.+++.++.||+.||+|||+++ |+||||||+|||++. ...+||+|||+++....
T Consensus 82 ~~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhcccc
Confidence 999999999997643 25999999999999999999999999 999999999999984 45899999999987643
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
.. ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||...... ..+......... ....
T Consensus 157 ~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~~~~---~~~~ 225 (321)
T d1tkia_ 157 GD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEYT---FDEE 225 (321)
T ss_dssp TC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCCC---CCHH
T ss_pred CC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---CChh
Confidence 32 234456899999999999999999999999999999999999999653321 112222211110 0001
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... .+.++.+|+.+||..||++|||+.|++++
T Consensus 226 ~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 226 AFKE----ISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hccC----CCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111 23458899999999999999999999874
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-44 Score=387.12 Aligned_cols=249 Identities=21% Similarity=0.276 Sum_probs=199.3
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHH---HHHHHHHhhcCCCceeeEEEEEEeCCcce
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEF---INEVAILSQINHRNVVKLLGCCLETEVPL 466 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~---~~E~~il~~l~h~niv~l~g~~~~~~~~~ 466 (721)
++|++.++||+|+||.||+|+.. +|+.||||.+... .......+ .+|+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999976 5899999987431 11122233 34577777889999999999999999999
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 9999999999999998654 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhh
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEIL 625 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 625 (721)
.... .....||+.|+|||++.. ..++.++|||||||+||||++|+.||......+. .. .........
T Consensus 158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~-~~~~~~~~~----- 225 (364)
T d1omwa3 158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HE-IDRMTLTMA----- 225 (364)
T ss_dssp SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH---HH-HHHHSSSCC-----
T ss_pred CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH---HH-HHHhcccCC-----
Confidence 5432 234569999999999975 5689999999999999999999999975443221 11 111111110
Q ss_pred hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHHH
Q 036483 626 DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAVV 665 (721)
Q Consensus 626 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~~ 665 (721)
...+...+.++.+|+.+||+.||++||| ++|++++
T Consensus 226 -----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 226 -----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 1112233456899999999999999999 5777653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-45 Score=384.13 Aligned_cols=247 Identities=23% Similarity=0.347 Sum_probs=204.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc---CchhhHHHHHHHHHHh-hcCCCceeeEEEEEEeCCcceEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI---DESKVDEFINEVAILS-QINHRNVVKLLGCCLETEVPLLV 468 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~il~-~l~h~niv~l~g~~~~~~~~~lv 468 (721)
++|.+.+.||+|+||+||+|+.. +++.||||+++.. .....+.+..|+.++. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999976 5899999987542 2344567778887766 68999999999999999999999
Q ss_pred EeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccccc
Q 036483 469 YEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAI 548 (721)
Q Consensus 469 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~ 548 (721)
|||+++|+|.++++... .+++..++.++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998654 5899999999999999999999999 99999999999999999999999999986653
Q ss_pred CCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhhh
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDAH 628 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 628 (721)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+.....
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~~~------- 220 (320)
T d1xjda_ 156 GDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMDNP------- 220 (320)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHCCC-------
T ss_pred ccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcCCC-------
Confidence 332 2344579999999999999999999999999999999999999996543221 1111211111
Q ss_pred hcccCCHHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 036483 629 VLKEASQEDIVTVAKLTNRCLNLNGKKRPTMK-EVAV 664 (721)
Q Consensus 629 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-ev~~ 664 (721)
..+...+.++.+|+.+||+.||++|||+. |+++
T Consensus 221 ---~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ---FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11223345689999999999999999996 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=378.43 Aligned_cols=256 Identities=23% Similarity=0.248 Sum_probs=194.6
Q ss_pred CceEeeeCcEEEEEEEEc-CCcEEEEeeccccCc-----hhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEeec
Q 036483 399 NRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDE-----SKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEFI 472 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~~ 472 (721)
.++||+|+||+||+|+.. +|+.||||+++.... ...+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999965 589999998754322 22457899999999999999999999999999999999999
Q ss_pred cCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCce
Q 036483 473 INGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQTH 552 (721)
Q Consensus 473 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~~ 552 (721)
.++++..++... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~ 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCccc
Confidence 888777666433 26889999999999999999999999 999999999999999999999999999876543322
Q ss_pred eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhhhhhh----
Q 036483 553 MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFEILDA---- 627 (721)
Q Consensus 553 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 627 (721)
.....||+.|+|||++... .++.++|||||||++|||++|+.||......+ ......+...........+.
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~---~l~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD---QLTRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHHHHCCCCTTTSSSTTSST
T ss_pred -ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH---HHHHHHHhcCCCChhhccchhccc
Confidence 2335699999999998755 57999999999999999999999986543221 11111111111000000000
Q ss_pred -----hhcccC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 628 -----HVLKEA-----SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 628 -----~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
...... ......++.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 000000 1122356899999999999999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=380.86 Aligned_cols=253 Identities=22% Similarity=0.291 Sum_probs=198.7
Q ss_pred hcCCCCC-ceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhc-CCCceeeEEEEEEe----CCcc
Q 036483 393 TDHYNTN-RILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQI-NHRNVVKLLGCCLE----TEVP 465 (721)
Q Consensus 393 ~~~~~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l-~h~niv~l~g~~~~----~~~~ 465 (721)
.++|.+. ++||+|+||+||+|+.. +++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 3678876 46999999999999964 689999998753 35678899997665 89999999999875 3567
Q ss_pred eEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC---CCcEEEeeccC
Q 036483 466 LLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG---KYRAKVSDFGA 542 (721)
Q Consensus 466 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~---~~~~kl~DFGl 542 (721)
+|||||+++|+|.+++.+... ..+++..++.|+.||+.||+|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999976432 36999999999999999999999999 999999999999985 56799999999
Q ss_pred ccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 543 SRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 543 s~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
++....... .....||+.|||||++.+..|+.++|||||||+||||++|+.||........ .......+.....
T Consensus 161 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~---~~~~~~~i~~~~~- 234 (335)
T d2ozaa1 161 AKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQY- 234 (335)
T ss_dssp CEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSS-
T ss_pred eeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH---HHHHHHHHhcCCC-
Confidence 987654332 3345699999999999999999999999999999999999999975433221 0001111110000
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..........+.++.+|+.+||+.||++|||+.|+++.
T Consensus 235 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 235 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -----SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -----CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000112334568999999999999999999999884
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.9e-44 Score=371.68 Aligned_cols=261 Identities=22% Similarity=0.334 Sum_probs=201.2
Q ss_pred cCCCCCceEeeeCcEEEEEEEEcCCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEee
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYEF 471 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e~ 471 (721)
++|++.++||+|+||+||+|+.++|+.||||+++.. ++...+.+.+|+.+|++++||||+++++++.+.+..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 589999999999999999999999999999987553 333467899999999999999999999999999999999999
Q ss_pred ccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCCc
Q 036483 472 IINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQT 551 (721)
Q Consensus 472 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~~ 551 (721)
+.++.+..+..... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98877776665443 6999999999999999999999998 99999999999999999999999999987643322
Q ss_pred eeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh---hhhh-
Q 036483 552 HMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF---EILD- 626 (721)
Q Consensus 552 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~- 626 (721)
......+++.|+|||.+.+. .++.++||||||+++|||++|+.||......+ .+.. ........... ....
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~--~~~~-i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMR-IFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-HHHHHCCCCTTTSTTGGGS
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH--HHHH-HHHhhCCCChhhccchhhh
Confidence 23344589999999998765 56899999999999999999999996543211 1111 11111110000 0000
Q ss_pred -----------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 627 -----------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 627 -----------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..............+.+|+.+||+.||++|||++|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111223356889999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-44 Score=374.19 Aligned_cols=264 Identities=23% Similarity=0.350 Sum_probs=199.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC--chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID--ESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|++.+.||+|+||+||+|+.. +|+.||||+++... +...+.+.+|+++|++++|||||++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999964 68999999875532 3346789999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
|+.++ +.+++.... ...+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~-~~~~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQD-LKKFMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEE-HHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCCc-hhhhhhhhc-ccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 99655 444443322 236999999999999999999999999 9999999999999999999999999998765333
Q ss_pred ceeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc-chhhhhh--
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED-SLFEILD-- 626 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-- 626 (721)
. ......||+.|+|||.+.... ++.++||||||+++|||++|+.||......+ .+...+....... .......
T Consensus 157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhccccccc
Confidence 2 233456999999999987765 5789999999999999999999997543211 1111111110000 0000000
Q ss_pred hhhcc------c-----CCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 627 AHVLK------E-----ASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 627 ~~~~~------~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
..... . .......++.+|+.+||+.||++|||+.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 00000 0 011223568899999999999999999999774
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-44 Score=369.80 Aligned_cols=241 Identities=27% Similarity=0.426 Sum_probs=196.3
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC------chhhHHHHHHHHHHhhcC--CCceeeEEEEEEeCC
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID------ESKVDEFINEVAILSQIN--HRNVVKLLGCCLETE 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~E~~il~~l~--h~niv~l~g~~~~~~ 463 (721)
.++|++.++||+|+||+||+|+.. +|+.||||+++... .....++.+|+.+|++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999965 68999999875421 122345789999999996 899999999999999
Q ss_pred cceEEEeeccC-CCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-CCcEEEeecc
Q 036483 464 VPLLVYEFIIN-GTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-KYRAKVSDFG 541 (721)
Q Consensus 464 ~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-~~~~kl~DFG 541 (721)
..++||||+.+ +++.+++.... .+++..++.++.||++||+|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 57777776544 6999999999999999999999999 999999999999985 4799999999
Q ss_pred CccccccCCceeeeeeecCCCCCCccccccCCC-CccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 542 ASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRF-TEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 542 ls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
+++..... ..+...||+.|+|||++.+..+ +.++||||||+++|||++|+.||.... .... ..
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~-~~ 220 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR-GQ 220 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH-CC
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhh-cc
Confidence 99865432 2344679999999999988775 567899999999999999999985311 0011 11
Q ss_pred hhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. ..+...+.++.+|+.+||+.||++|||++|+++.
T Consensus 221 ~----------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 V----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c----------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 0 1111233568999999999999999999999763
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=371.66 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=198.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-C-CcEEEEeecccc--CchhhHHHHHHHHHHhhc---CCCceeeEEEEEEe----
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-D-GRIVAIKKSKVI--DESKVDEFINEVAILSQI---NHRNVVKLLGCCLE---- 461 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~E~~il~~l---~h~niv~l~g~~~~---- 461 (721)
.++|++.+.||+|+||+||+|+.. + ++.||||+++.. .......+.+|+.+|+.| +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 478999999999999999999964 3 678999987542 233345677888887766 79999999999863
Q ss_pred -CCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeec
Q 036483 462 -TEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDF 540 (721)
Q Consensus 462 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DF 540 (721)
....+++|||++++.+........ ..+++..++.++.|++.||+|||+++ |+||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 235689999998877655444332 35899999999999999999999999 999999999999999999999999
Q ss_pred cCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc
Q 036483 541 GASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS 620 (721)
Q Consensus 541 Gls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 620 (721)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+. ..........
T Consensus 161 g~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~-~i~~~~~~~~ 235 (305)
T d1blxa_ 161 GLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLG-KILDVIGLPG 235 (305)
T ss_dssp CSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH-HHHHHHCCCC
T ss_pred hhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHH-HHHHhhCCCc
Confidence 9998654322 2345679999999999999999999999999999999999999997543221 111 1111111100
Q ss_pred hhhh-------------hhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 621 LFEI-------------LDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 621 ~~~~-------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... ................+.+|+.+||+.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 00000111122234568899999999999999999999764
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.7e-42 Score=358.52 Aligned_cols=264 Identities=17% Similarity=0.174 Sum_probs=209.6
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCC-CceeeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINH-RNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h-~niv~l~g~~~~~~~~~lv~e 470 (721)
.++|.+.+.||+|+||+||+|+.. +|+.||||.+... ...+.+.+|+++++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccc--cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999965 5889999986543 234567889999999965 899999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECC-----CCcEEEeeccCccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDG-----KYRAKVSDFGASRS 545 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~-----~~~~kl~DFGls~~ 545 (721)
|+ +++|.+++..... .+++..+++++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 98 7899998876543 5899999999999999999999999 999999999999974 56899999999987
Q ss_pred cccCCc------eeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhcc
Q 036483 546 MAIDQT------HMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKED 619 (721)
Q Consensus 546 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 619 (721)
+..... .......||+.|||||++.+..++.++||||||+++|||++|+.||......................
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 653221 12234579999999999999999999999999999999999999997554433222111111111111
Q ss_pred chhhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccccC
Q 036483 620 SLFEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKACD 673 (721)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~~~ 673 (721)
... .+ ....++++.+++..|++.+|++||+++.+.+.|+++....
T Consensus 236 ~~~-----~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 236 PLR-----EL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp CHH-----HH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred ChH-----Hh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 111 11 1123356899999999999999999999999988775443
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-42 Score=360.53 Aligned_cols=262 Identities=19% Similarity=0.244 Sum_probs=199.9
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce-eeEEEEEEeCCcceEEEe
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV-VKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~l~g~~~~~~~~~lv~e 470 (721)
.++|++.+.||+|+||+||+|+.. +|+.||||.+... ...+++..|++++++++|+|+ +.+.++..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~--~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESC--TTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchh--ccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 367999999999999999999965 5889999986643 233568899999999987665 555566677788899999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEEC---CCCcEEEeeccCccccc
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLD---GKYRAKVSDFGASRSMA 547 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~---~~~~~kl~DFGls~~~~ 547 (721)
|+ +++|.+.+..... .+++..++.++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++.+.
T Consensus 84 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99 5666666654332 5999999999999999999999999 99999999999986 45579999999998775
Q ss_pred cCCce------eeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch
Q 036483 548 IDQTH------MTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL 621 (721)
Q Consensus 548 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 621 (721)
..... ......||+.|||||.+.+..++.++||||||+++|||++|+.||........................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence 43221 223457999999999999999999999999999999999999999765443322211111111000000
Q ss_pred hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHhhccc
Q 036483 622 FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVVLAGIKA 671 (721)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~L~~l~~ 671 (721)
+. .....+.++.+++.+||+.+|++||++.++.+.|+.+..
T Consensus 238 -----~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 238 -----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -----HH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -----hH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 01 111234568999999999999999999999999887643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-42 Score=369.43 Aligned_cols=264 Identities=24% Similarity=0.311 Sum_probs=196.1
Q ss_pred CCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------cceE
Q 036483 395 HYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVVKLLGCCLETE------VPLL 467 (721)
Q Consensus 395 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------~~~l 467 (721)
+|+..++||+|+||+||+|+.. +|+.||||+++.... .+.+|+++|++++||||+++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999976 589999998865322 3347999999999999999999986532 3589
Q ss_pred EEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCcccc
Q 036483 468 VYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSM 546 (721)
Q Consensus 468 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~ 546 (721)
||||++++.+..+.+.......+++..+..++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987655544443333347999999999999999999999999 99999999999999775 8999999999876
Q ss_pred ccCCceeeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch----
Q 036483 547 AIDQTHMTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL---- 621 (721)
Q Consensus 547 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~---- 621 (721)
..... .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+ .+.. ..+.......
T Consensus 174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~-i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE-IIKVLGTPTREQIR 248 (350)
T ss_dssp CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHH-HHHHHCCCCHHHHH
T ss_pred cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHH-HHHHhCCChHHhhh
Confidence 54332 233569999999998875 468999999999999999999999996544221 1111 1111100000
Q ss_pred -----------hhhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH--Hhhcc
Q 036483 622 -----------FEILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV--LAGIK 670 (721)
Q Consensus 622 -----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~--L~~l~ 670 (721)
................+.++.+|+.+||+.||++|||+.|++++ +++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00000000011112234568999999999999999999999864 45554
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-42 Score=363.74 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=195.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC--------
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET-------- 462 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-------- 462 (721)
++|++.+.||+|+||+||+|+.. +|+.||||++... .+...+++.+|+++|++++||||+++++.+...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 78999999999999999999975 6999999987543 344567899999999999999999999998653
Q ss_pred CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccC
Q 036483 463 EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGA 542 (721)
Q Consensus 463 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGl 542 (721)
...++||||+.++.+..+..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~~---~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhhccc---ccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 35689999998877665544332 5889999999999999999999999 99999999999999999999999999
Q ss_pred ccccccCCce---eeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc
Q 036483 543 SRSMAIDQTH---MTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE 618 (721)
Q Consensus 543 s~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 618 (721)
++.+...... ......||+.|+|||++.+. .++.++||||||+++|||++|+.||......+.. .........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~~~ 240 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLCGS 240 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhcCC
Confidence 9876533221 12334699999999998765 6899999999999999999999999654322211 111111110
Q ss_pred ---cchhhh--------hhhhhcccCCH-------HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 619 ---DSLFEI--------LDAHVLKEASQ-------EDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 619 ---~~~~~~--------~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
...... +.......... .....+.+|+.+||+.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 000000 00000000000 112456789999999999999999999764
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-42 Score=366.69 Aligned_cols=263 Identities=22% Similarity=0.339 Sum_probs=197.4
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccC-chhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC----cce
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVID-ESKVDEFINEVAILSQINHRNVVKLLGCCLETE----VPL 466 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~----~~~ 466 (721)
+++|++.++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 467999999999999999999864 69999999986533 445678999999999999999999999997654 235
Q ss_pred EEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcccc
Q 036483 467 LVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSM 546 (721)
Q Consensus 467 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~ 546 (721)
++++++.+|+|.+++... .+++..++.++.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666777799999999754 4999999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeeeeecCCCCCCcccccc-CCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 547 AIDQTH--MTTQVQGTFGYLDPEYFRS-SRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 547 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
...... ......||+.|+|||.+.. ..++.++||||+|++++||++|+.||......+.. ..............
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL---NHILGILGSPSQED 236 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHH
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH---HHHhhhccCCChhh
Confidence 433222 2344569999999999854 56788999999999999999999999654322111 11111110000000
Q ss_pred --------h---h-hhhhcccC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 --------I---L-DAHVLKEA-----SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 --------~---~-~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
. . ........ ......++.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0 00000000 11122468899999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-42 Score=364.35 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=194.0
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCC------
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLETE------ 463 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~------ 463 (721)
.++|++.+.||+|+||+||+|... +|+.||||+++. .+....+.+.+|+++|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 578999999999999999999965 599999999864 23445678999999999999999999999998765
Q ss_pred cceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCc
Q 036483 464 VPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGAS 543 (721)
Q Consensus 464 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls 543 (721)
..++||||+ +.+|..+++.. .+++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 458999999 66777766543 4999999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccch-
Q 036483 544 RSMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSL- 621 (721)
Q Consensus 544 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 621 (721)
+..... .+...||+.|+|||.+.+. .++.++|||||||++|||++|+.||........ +. ...........
T Consensus 169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~--~~-~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ--LK-EIMKVTGTPPAE 241 (346)
T ss_dssp EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH-HHHHHHCCCCHH
T ss_pred eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHH--HH-HHHhccCCCcHH
Confidence 876432 2345699999999998764 578999999999999999999999965432211 11 01110000000
Q ss_pred ----------hhhh------hhhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 622 ----------FEIL------DAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 622 ----------~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.... ...............+.+|+.+||..||++|||+.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000 0000011112233467899999999999999999999875
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-42 Score=360.57 Aligned_cols=252 Identities=27% Similarity=0.339 Sum_probs=203.6
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc----CCcEEEEeecccc----CchhhHHHHHHHHHHhhcCC-CceeeEEEEEEeCCc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA----DGRIVAIKKSKVI----DESKVDEFINEVAILSQINH-RNVVKLLGCCLETEV 464 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~E~~il~~l~h-~niv~l~g~~~~~~~ 464 (721)
++|++.+.||+|+||+||+|+.. +|+.||||.++.. +....+.+.+|+++|++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 4789999987542 23345778999999999976 899999999999999
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+++|||+.+|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999998765 4788899999999999999999999 9999999999999999999999999998
Q ss_pred ccccCCceeeeeeecCCCCCCccccccC--CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSS--RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLF 622 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 622 (721)
.+............|++.|++||.+.+. .++.++|||||||+||||++|+.||......+. ...........
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~~~~---- 251 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS---- 251 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHC----
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcccC----
Confidence 7754444444556799999999999765 467899999999999999999999976543321 11111111111
Q ss_pred hhhhhhhcccCCHHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 036483 623 EILDAHVLKEASQEDIVTVAKLTNRCLNLNGKKRPT-----MKEVAV 664 (721)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~ev~~ 664 (721)
....+...+.++.+|+.+||+.||++||| ++|+++
T Consensus 252 -------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 252 -------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp -------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred -------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 11122334567999999999999999995 677754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-41 Score=353.35 Aligned_cols=262 Identities=22% Similarity=0.322 Sum_probs=204.0
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeCCcceEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~~~~~lv~e 470 (721)
++|++.+.||+|+||+||+|+.. +++.||||+++.. .....+++.+|+.+|++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999965 6889999987543 34457889999999999999999999999999999999999
Q ss_pred eccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCccccccCC
Q 036483 471 FIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASRSMAIDQ 550 (721)
Q Consensus 471 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~~~~~~~ 550 (721)
++.+++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999888776543 6899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeeeeecCCCCCCccccccCC-CCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccc---h---hh
Q 036483 551 THMTTQVQGTFGYLDPEYFRSSR-FTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDS---L---FE 623 (721)
Q Consensus 551 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~---~---~~ 623 (721)
. ......+++.|+|||.+.... ++.++||||||+++|||++|+.||....... .....+........ . ..
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH--HHHHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH--HHHHHHHhhcCCCChhhhhhhhh
Confidence 2 223345788899999988765 6899999999999999999999975332211 11111111111100 0 00
Q ss_pred hhh---------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 624 ILD---------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 624 ~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
..+ ..............+.+|+.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00011122233456889999999999999999999865
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.4e-41 Score=354.39 Aligned_cols=255 Identities=21% Similarity=0.290 Sum_probs=196.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeC--CcceEEE
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLET--EVPLLVY 469 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~--~~~~lv~ 469 (721)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.+|++++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 67999999999999999999974 6899999987643 3567899999999995 99999999999754 4578999
Q ss_pred eeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCC-cEEEeeccCcccccc
Q 036483 470 EFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKY-RAKVSDFGASRSMAI 548 (721)
Q Consensus 470 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~-~~kl~DFGls~~~~~ 548 (721)
||+++++|..+.+ .+++..++.++.||+.||+|||+++ |+||||||+||||+.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999987643 4899999999999999999999999 99999999999998654 699999999987654
Q ss_pred CCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhc---------
Q 036483 549 DQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKE--------- 618 (721)
Q Consensus 549 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--------- 618 (721)
... .....+|+.|+|||.+.+. .++.++||||+|++++||++|+.||.......... .........
T Consensus 183 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~--~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL--VRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH--HHHHHHHCHHHHHHHHHH
T ss_pred CCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH--HHHHHHHCCchhhhhhhh
Confidence 322 3345689999999998775 47999999999999999999999986544322111 111111100
Q ss_pred ---cch---hhhhhh--------hhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 036483 619 ---DSL---FEILDA--------HVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAV 664 (721)
Q Consensus 619 ---~~~---~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~ 664 (721)
... ...... ............++.+|+.+||+.||++|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 000000 0000011123356889999999999999999999976
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-40 Score=354.32 Aligned_cols=261 Identities=21% Similarity=0.306 Sum_probs=190.1
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccc--cCchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC------Cc
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKV--IDESKVDEFINEVAILSQINHRNVVKLLGCCLET------EV 464 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~------~~ 464 (721)
++|++.++||+|+||+||+|+.. +|+.||||+++. .+....+++.+|+.+|++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 67999999999999999999976 599999999764 3344566899999999999999999999999643 56
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.++||||+.++.+. .+.. .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 79999999765544 4432 4899999999999999999999999 9999999999999999999999999987
Q ss_pred ccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHH--------------
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAA-------------- 610 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~-------------- 610 (721)
..... .......+|+.|+|||++.+..++.++||||+|++++||++|+.||.............
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 65432 23344568999999999999999999999999999999999999996543211100000
Q ss_pred --HHHHHhhccc------hhhhhhhhhc---ccCCHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 611 --YFLRAMKEDS------LFEILDAHVL---KEASQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 611 --~~~~~~~~~~------~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
.......... .......... ..........+.+|+.+||..||++|||++|++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0000000000 0000000000 01123345678999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-41 Score=356.11 Aligned_cols=258 Identities=23% Similarity=0.326 Sum_probs=195.5
Q ss_pred hcCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeecccc--CchhhHHHHHHHHHHhhcCCCceeeEEEEEEeC-----Cc
Q 036483 393 TDHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVI--DESKVDEFINEVAILSQINHRNVVKLLGCCLET-----EV 464 (721)
Q Consensus 393 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~il~~l~h~niv~l~g~~~~~-----~~ 464 (721)
.++|++.+.||+|+||+||+|+.. +|+.||||+++.. +....+.+.+|+++|++++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 578999999999999999999964 6999999998653 334556889999999999999999999998643 34
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.+++++++.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 47778888899999999653 4999999999999999999999999 9999999999999999999999999997
Q ss_pred ccccCCceeeeeeecCCCCCCccccccC-CCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHHHHHhhccchhh
Q 036483 545 SMAIDQTHMTTQVQGTFGYLDPEYFRSS-RFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYFLRAMKEDSLFE 623 (721)
Q Consensus 545 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 623 (721)
..... .....||+.|+|||.+.+. .++.++||||||+++|+|++|+.||........ ............ .+
T Consensus 170 ~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~---~~~i~~~~~~~~-~~ 241 (348)
T d2gfsa1 170 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPG-AE 241 (348)
T ss_dssp CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCC-HH
T ss_pred ccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHHhcCCCC-hH
Confidence 65322 2334689999999987765 468899999999999999999999975432211 111111110000 00
Q ss_pred hhh-----------hhh--cccC-----CHHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 036483 624 ILD-----------AHV--LKEA-----SQEDIVTVAKLTNRCLNLNGKKRPTMKEVAVV 665 (721)
Q Consensus 624 ~~~-----------~~~--~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~ev~~~ 665 (721)
... ... .... ......++.+|+.+||+.||++|||++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 000 000 0000 01123568899999999999999999999764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.1e-36 Score=319.97 Aligned_cols=263 Identities=20% Similarity=0.217 Sum_probs=191.8
Q ss_pred cCCCCCceEeeeCcEEEEEEEEc-CCcEEEEeeccccCchhhHHHHHHHHHHhhcC-----------CCceeeEEEEEEe
Q 036483 394 DHYNTNRILGQGGQGTVYKGMLA-DGRIVAIKKSKVIDESKVDEFINEVAILSQIN-----------HRNVVKLLGCCLE 461 (721)
Q Consensus 394 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~l~g~~~~ 461 (721)
++|.+.++||+|+||+||+|+.. +|+.||||+++.. ....+.+.+|++++++++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 35999999999999999999964 6999999998643 334567889999988875 5789999998865
Q ss_pred C--CcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHh-cCCCCeeeccCcCccEEECCCC-----
Q 036483 462 T--EVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS-AASIPIYHRDIKSTNILLDGKY----- 533 (721)
Q Consensus 462 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~-~~~~~ivHrDlk~~NIll~~~~----- 533 (721)
. ...+++|++...+..............+++..+..++.||+.||+|||+ .+ |+||||||+||||+.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 4 3456677776655544444444444578999999999999999999998 77 99999999999998654
Q ss_pred -cEEEeeccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHHHHHhCCcccccCCccccccHHHHH
Q 036483 534 -RAKVSDFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLAELLTGERAIRVTNFEEDKSLAAYF 612 (721)
Q Consensus 534 -~~kl~DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~elltG~~p~~~~~~~~~~~~~~~~ 612 (721)
.+|++|||.+...... .....||+.|+|||++....++.++||||+|++++||++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 4999999999765322 23356999999999999999999999999999999999999998654332211111111
Q ss_pred H---HHhhccch---------hhhhh-------------------hhhcccCCHHHHHHHHHHHHHhhccCCCCCCCHHH
Q 036483 613 L---RAMKEDSL---------FEILD-------------------AHVLKEASQEDIVTVAKLTNRCLNLNGKKRPTMKE 661 (721)
Q Consensus 613 ~---~~~~~~~~---------~~~~~-------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 661 (721)
. ..+..... ....+ .............++.+|+.+||..||++|||++|
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e 324 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 324 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHH
Confidence 1 11100000 00000 00012334667788999999999999999999999
Q ss_pred HHH
Q 036483 662 VAV 664 (721)
Q Consensus 662 v~~ 664 (721)
+++
T Consensus 325 ~L~ 327 (362)
T d1q8ya_ 325 LVN 327 (362)
T ss_dssp HHT
T ss_pred Hhc
Confidence 865
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=7.2e-23 Score=197.39 Aligned_cols=170 Identities=16% Similarity=0.153 Sum_probs=121.1
Q ss_pred CCCceEeeeCcEEEEEEEEcCCcEEEEeeccccC------------------chhhHHHHHHHHHHhhcCCCceeeEEEE
Q 036483 397 NTNRILGQGGQGTVYKGMLADGRIVAIKKSKVID------------------ESKVDEFINEVAILSQINHRNVVKLLGC 458 (721)
Q Consensus 397 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------------------~~~~~~~~~E~~il~~l~h~niv~l~g~ 458 (721)
.+.++||+|+||+||+|...+|+.||||..+... ......+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 4578999999999999999899999999754210 0112345678889999999999998866
Q ss_pred EEeCCcceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCCCCeeeccCcCccEEECCCCcEEEe
Q 036483 459 CLETEVPLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAASIPIYHRDIKSTNILLDGKYRAKVS 538 (721)
Q Consensus 459 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~~~ivHrDlk~~NIll~~~~~~kl~ 538 (721)
. ..+++|||+++..+.+ +++....+++.|++++|+|||+++ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 3 3479999998765543 333445679999999999999999 9999999999999965 58999
Q ss_pred eccCccccccCCceeeeeeecCCCCCCccccccCCCCccccchhHHHHHH
Q 036483 539 DFGASRSMAIDQTHMTTQVQGTFGYLDPEYFRSSRFTEKSDVYSFGVVLA 588 (721)
Q Consensus 539 DFGls~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~SlGvll~ 588 (721)
|||++............ ..+... -.|. -...|+.++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~~~l--~rd~~~-~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWREIL--ERDVRN-IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHHHHH--HHHHHH-HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred ECCCcccCCCCCcHHHH--HHHHHH-HHHH-HcCCCCCcccHHHHHHHHh
Confidence 99999765432211000 000000 0011 1356778999999865443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.46 E-value=3e-07 Score=90.78 Aligned_cols=150 Identities=16% Similarity=0.124 Sum_probs=105.6
Q ss_pred HHHHHHHhcCCCCCceEeeeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCc
Q 036483 386 SKELETATDHYNTNRILGQGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEV 464 (721)
Q Consensus 386 ~~el~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~ 464 (721)
..|+......|...+..+.+....||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+..+.+.
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred CHHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 356677777777666544455578998764 45567788776554445567788999888774 4446788888888888
Q ss_pred ceEEEeeccCCCcchhccccCCCCCccHHHHHHHHHHHHHHHHHHHhcCC------------------------------
Q 036483 465 PLLVYEFIINGTLFQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHSAAS------------------------------ 514 (721)
Q Consensus 465 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~~~~------------------------------ 514 (721)
.++||+++++.++.+...... ....++.++++.|+.||+...
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~~--------~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDEQ--------SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTCS--------CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred eEEEEEecccccccccccccc--------cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 999999999988765443211 123355666666777774321
Q ss_pred --------------------------CCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 515 --------------------------IPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 515 --------------------------~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
..++|+|+.|.|||++++...-|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 117899999999999987666799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.88 E-value=2.3e-05 Score=76.38 Aligned_cols=130 Identities=17% Similarity=0.149 Sum_probs=87.2
Q ss_pred eEeeeCc-EEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcC--CCceeeEEEEEEeCCcceEEEeeccCCCc
Q 036483 401 ILGQGGQ-GTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQIN--HRNVVKLLGCCLETEVPLLVYEFIINGTL 477 (721)
Q Consensus 401 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~gsL 477 (721)
.+..|.. ..||+....++..+.+|..... ....+..|+..++.+. .-.+.+++.+..+.+..++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3444543 6789998888888888975543 2345778888888774 33467788888888889999999988766
Q ss_pred chhccccCCCCCccHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 036483 478 FQYLHDQNEEFPITWEIRLRIAIEVSDAVSYLHS---------------------------------------------- 511 (721)
Q Consensus 478 ~~~l~~~~~~~~l~~~~~~~i~~qia~~L~yLH~---------------------------------------------- 511 (721)
.+... . ...++.++++.|+-||+
T Consensus 94 ~~~~~--------~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSHL--------A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSCC--------C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred ccccc--------c---HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 44211 1 01122333334444442
Q ss_pred -----cC----CCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 512 -----AA----SIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 512 -----~~----~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.. .+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 11 1127999999999999987667899999874
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.45 E-value=0.00022 Score=74.02 Aligned_cols=77 Identities=19% Similarity=0.235 Sum_probs=50.5
Q ss_pred CceEeeeCcEEEEEEEEcC-CcEEEEeeccc----cC---chhhHHHHHHHHHHhhcC-C--CceeeEEEEEEeCCcceE
Q 036483 399 NRILGQGGQGTVYKGMLAD-GRIVAIKKSKV----ID---ESKVDEFINEVAILSQIN-H--RNVVKLLGCCLETEVPLL 467 (721)
Q Consensus 399 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~----~~---~~~~~~~~~E~~il~~l~-h--~niv~l~g~~~~~~~~~l 467 (721)
.+.||.|....||+....+ ++.++||.... .. ....++...|.+.|..+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3468999999999998654 67899996322 11 123455667888887762 3 346666654 4566789
Q ss_pred EEeeccCCCc
Q 036483 468 VYEFIINGTL 477 (721)
Q Consensus 468 v~e~~~~gsL 477 (721)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999976543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.76 E-value=0.002 Score=66.62 Aligned_cols=73 Identities=16% Similarity=0.129 Sum_probs=50.1
Q ss_pred ceEeeeCcEEEEEEEEcCC--------cEEEEeeccccCchhhHHHHHHHHHHhhcC-CCceeeEEEEEEeCCcceEEEe
Q 036483 400 RILGQGGQGTVYKGMLADG--------RIVAIKKSKVIDESKVDEFINEVAILSQIN-HRNVVKLLGCCLETEVPLLVYE 470 (721)
Q Consensus 400 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~il~~l~-h~niv~l~g~~~~~~~~~lv~e 470 (721)
+.|+.|-.-.+|+....++ +.|.++.... .. ..-...+|..+++.+. +.-..++++++. -.+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS----GGRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET----TEEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC----CceEEE
Confidence 5788899999999986543 4566665442 22 2335568999998884 444457788774 268999
Q ss_pred eccCCCcc
Q 036483 471 FIINGTLF 478 (721)
Q Consensus 471 ~~~~gsL~ 478 (721)
|+++..|.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EeccccCC
Confidence 99876554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.07 E-value=0.0097 Score=59.40 Aligned_cols=136 Identities=15% Similarity=0.127 Sum_probs=77.1
Q ss_pred cEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCcee--eEE-----EEEEeCCcceEEEeeccCCCcch
Q 036483 407 QGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNVV--KLL-----GCCLETEVPLLVYEFIINGTLFQ 479 (721)
Q Consensus 407 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~niv--~l~-----g~~~~~~~~~lv~e~~~~gsL~~ 479 (721)
--.||+....+|+.+++|..... ....+++..|...+..|....+. ..+ ......+..+.++++++|..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 46899999999999999976543 22346677888888877432221 111 11234556688999987654421
Q ss_pred h----c----------cc----c--CCCCCccHHH-------------------HHHHHHHHHHHHHHHHhc----CCCC
Q 036483 480 Y----L----------HD----Q--NEEFPITWEI-------------------RLRIAIEVSDAVSYLHSA----ASIP 516 (721)
Q Consensus 480 ~----l----------~~----~--~~~~~l~~~~-------------------~~~i~~qia~~L~yLH~~----~~~~ 516 (721)
. + |. . ..+..+++.. +..+...+.+.++.+... .+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 1 0 00 0 0111222211 111222223333333322 2334
Q ss_pred eeeccCcCccEEECCCCcEEEeeccCccc
Q 036483 517 IYHRDIKSTNILLDGKYRAKVSDFGASRS 545 (721)
Q Consensus 517 ivHrDlk~~NIll~~~~~~kl~DFGls~~ 545 (721)
++|+|+.+.|||++++ ..++||+-+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999854 45899998753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.00 E-value=0.015 Score=57.44 Aligned_cols=158 Identities=11% Similarity=0.062 Sum_probs=83.8
Q ss_pred cCHHHHHHHhcCCCCCceEe-----eeCcEEEEEEEEcCCcEEEEeeccccCchhhHHHHHHHHHHhhcCCCce--eeEE
Q 036483 384 FTSKELETATDHYNTNRILG-----QGGQGTVYKGMLADGRIVAIKKSKVIDESKVDEFINEVAILSQINHRNV--VKLL 456 (721)
Q Consensus 384 ~~~~el~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~il~~l~h~ni--v~l~ 456 (721)
.+.+|++.+..+|.+.+... .|---+.|+....+|+ +++|+.... ...+++..|++++..|.+.++ ...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccc
Confidence 46788988889998865543 5556888999877665 788876432 123455566777777643222 1111
Q ss_pred E------EEEeCCcceEEEeeccCCCcchhccc--------------cCC--------CCCccHH---------------
Q 036483 457 G------CCLETEVPLLVYEFIINGTLFQYLHD--------------QNE--------EFPITWE--------------- 493 (721)
Q Consensus 457 g------~~~~~~~~~lv~e~~~~gsL~~~l~~--------------~~~--------~~~l~~~--------------- 493 (721)
. +.........++.+..+......... ... .....+.
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 0 11223445566666655433221110 000 0000000
Q ss_pred -HHHHHHHHHHHHHHHHHhc-CCCCeeeccCcCccEEECCCCcEEEeeccCcc
Q 036483 494 -IRLRIAIEVSDAVSYLHSA-ASIPIYHRDIKSTNILLDGKYRAKVSDFGASR 544 (721)
Q Consensus 494 -~~~~i~~qia~~L~yLH~~-~~~~ivHrDlk~~NIll~~~~~~kl~DFGls~ 544 (721)
.....+..+...+...+.. -+.++||+|+.+.||+++++...-|.||+.+.
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 0111222222222222221 12349999999999999988777899999874
|
| >d1gl4a2 g.3.11.5 (A:359-398) EGF-like domain of nidogen-1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-like domain of nidogen-1 domain: EGF-like domain of nidogen-1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=93.59 E-value=0.0045 Score=40.50 Aligned_cols=29 Identities=17% Similarity=0.408 Sum_probs=22.1
Q ss_pred cCCCCCccccCCCcccCCCCCCCCcCCCC
Q 036483 268 RHCAGDLICSTTSGHNCSECPQGYYLSSY 296 (721)
Q Consensus 268 ~~C~~~~~C~~~~g~~c~~C~~g~~gn~~ 296 (721)
..|..+..|.|++|.|.|.|+.||.|+..
T Consensus 7 ~~C~~~A~C~Nt~Gsy~C~C~~Gy~GdG~ 35 (40)
T d1gl4a2 7 HQCSVHAECRDYATGFCCRCVANYTGNGR 35 (40)
T ss_dssp GGSCTTEEEEECSSCEEEEECTTEEECSS
T ss_pred CCCCCCCEeecCCCCeEeECCCCCcCCCC
Confidence 45666777777777665599999998865
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.37 E-value=0.066 Score=35.23 Aligned_cols=28 Identities=29% Similarity=0.423 Sum_probs=21.4
Q ss_pred cCCCCCccccCCCcccCCCCCCCCcCCC
Q 036483 268 RHCAGDLICSTTSGHNCSECPQGYYLSS 295 (721)
Q Consensus 268 ~~C~~~~~C~~~~g~~c~~C~~g~~gn~ 295 (721)
.+|..+++|.++.|.|-|.|+.||.|..
T Consensus 11 ~pC~n~g~C~n~~g~y~C~C~~G~~G~~ 38 (42)
T d2vj3a1 11 NPCEHAGKCINTLGSFECQCLQGYTGPR 38 (42)
T ss_dssp CSSSTTCEEEECSSSEEEECCTTEESTT
T ss_pred CCCCCCcEeECCCCCEEeECCCCCcCCC
Confidence 5677778888887766339999998763
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.51 E-value=0.25 Score=31.64 Aligned_cols=28 Identities=18% Similarity=0.415 Sum_probs=20.4
Q ss_pred cCCCCCccccCCCcccCCCCCCCCcCCC
Q 036483 268 RHCAGDLICSTTSGHNCSECPQGYYLSS 295 (721)
Q Consensus 268 ~~C~~~~~C~~~~g~~c~~C~~g~~gn~ 295 (721)
.+|...++|....+.|-|.|+.||.|..
T Consensus 6 ~PC~ngg~C~~~~~~y~C~C~~G~~G~~ 33 (39)
T d1xkba1 6 SPCQNQGKCKDGLGEYTCTCLEGFEGKN 33 (39)
T ss_dssp CCCCSSCEECCCSSSCCEECCTTEETTT
T ss_pred CCCCCCcEEECCCCCEEEECCCCCCcCc
Confidence 5677778887766544339999998765
|